<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005">
<channel>
<title><![CDATA[Progress in Biochemistry and Biophysics -->Early Online Releases]]></title>
<item>
<title><![CDATA[Rapid Bedside Assessment of Community-acquired Pneumonia Severity With Three-dimensional Electrical Impedance Tomography]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202604210000002]]></link>
<description><![CDATA[Objective Community-acquired pneumonia (CAP) is a common infectious disease encountered in emergency departments, and timely severity stratification is essential for early risk identification and individualized treatment. Chest CT can accurately evaluate the extent of pulmonary involvement; however, its use for repeated bedside assessment is limited by radiation exposure, cost, limited portability, and the need for patient transport. In contrast, EIT is a radiation-free, noninvasive, and bedside functional imaging modality that can continuously monitor regional ventilation. Nevertheless, its relatively low spatial resolution limits its ability to directly characterize the anatomical extent of pulmonary lesions. Therefore, this study constructed a CT shape-prior-guided 3D CT-EIT composite image and explored its value for CAP severity assessment.Methods A total of 60 adult patients with CAP who were admitted to the Emergency Department of the Third Hospital of Hebei Medical University between October 2023 and October 2024 were retrospectively included. According to a five-lobe CT score ranging from 0 to 25, the patients were divided into a light pneumonia (LP) group and a moderate-to-severe pneumonia (MSP) group. Patients with CT scores of 0–8 were classified into the LP group (<i>n</i>=29), whereas those with CT scores of 9–25 were classified into the MSP group (<i>n</i>=31). Clinical indices, including oxygenation index (PaO<sub>2</sub>/FiO<sub>2</sub>), fibrinogen, and pneumonia severity index (PSI), were collected. The 3D EIT composite image based on the individual CT images of each patient was constructed, and the percentage of ventilation blocked regions (PVBR), ventilation distribution center error (VDCE), and global ventilation delay index (GVDI) were established. Receiver operating characteristic (ROC) curves were plotted to evaluate the discriminative performance, and Pearson correlation coefficient (<i>r</i>) was used to assess the correlation between 3D EIT ventilation indices and CT score.Results There were no statistically significant differences in baseline characteristics between the two groups (<i>P</i>>0.05). Compared with the LP group, the MSP group showed lower PaO<sub>2</sub>/FiO<sub>2</sub> (166 mmHg<i> vs</i>. 298 mmHg, <i>P</i><0.01), higher fibrinogen (4.59 g/L<i> vs</i>. 3.90 g/L, <i>P</i><0.01), higher PSI (114.23 <i>vs</i>. 94.52, <i>P</i><0.01), higher PVBR (39.33 <i>vs</i>. 26.33, <i>P</i><0.001), higher VDCE (42.21 <i>vs</i>. 35.33, <i>P</i><0.05), and higher GVDI (0.48 <i>vs</i>. 0.38, <i>P</i><0.001). Among the conventional clinical indices, PaO<sub>2</sub>/FiO<sub>2</sub> showed the highest area under the ROC curve (AUC=0.723). Among the 3D EIT ventilation indices, PVBR showed the best performance, with an AUC of 0.775 and a specificity of 96.6%. CT score was negatively correlated with PaO<sub>2</sub>/FiO<sub>2</sub>, but positively correlated with fibrinogen, PSI, and 3D EIT ventilation indices. Among these, CT score showed the strongest correlation with PVBR (<i>r</i>=0.696).<b>Conclusion</b> 3D CT-EIT composite imaging is feasible for rapid bedside functional assessment of CAP severity. PVBR, VDCE, and GVDI provide complementary information on the extent of ventilation blockage, the spatial redistribution of ventilation, and the temporal delay in ventilation, respectively. Among these indices, PVBR showed the best discriminatory performance and the strongest correlation with CT-defined lesion severity. Although 3D EIT cannot replace CT for structural diagnosis, it may serve as a practical radiation-free functional complement for bedside severity stratification, serial ventilation monitoring, and early clinical decision-making in patients with CAP.]]></description>
<pubDate>2026/8/7 4:31:51</pubDate>
<category><![CDATA[人工智能及多模态传感技术专题]]></category>
<author><![CDATA[CUI Xin-Yue,DANG Si-Wen,LI Zhi-Wei,LIANG Xiao,LIU Kai,MAO Yan-Fei,SONG Yu-Jia,ZHANG Ying-Qi]]></author>
</item>
<item>
<title><![CDATA[Kynurenine Pathway and Its Metabolites in Autism Spectrum Disorder: a Close Link]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202605150000002]]></link>
<description><![CDATA[Kynurenine pathway (KP) is a major catabolic route of tryptophan, generating a series of bioactive metabolites including kynurenine, kynurenic acid, quinolinic acid, and 3-hydroxykynurenine. Beyond its fundamental role in amino acid metabolism, KP exerts critical regulatory functions in neurodevelopment, synaptic plasticity, and immune modulation. Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition with onset in early childhood, characterized by persistent deficits in social communication and restricted, repetitive behaviors. Despite extensive research, the etiological mechanisms underlying ASD remain highly complex and incompletely understood, involving genetic, environmental, and immunological factors. Emerging clinical evidence has consistently revealed a significant imbalance in KP metabolites in individuals with ASD, often accompanied by altered ratios of neuroprotective versus neurotoxic byproducts. However, the primary drivers of this metabolic dysregulation and its causative contribution to ASD pathogenesis are not yet fully elucidated. In this review, we systematically examine the enzymatic steps of KP and the principal physiological functions of its major metabolites, with particular emphasis on their dual roles in neuroprotection and neurotoxicity. We then analyze the potential pathogenic mechanisms through which KP dysfunction may contribute to ASD, focusing on two interconnected etiological dimensions. First, KP imbalance can promote oxidative stress, which in turn triggers chronic inflammatory responses via microglial activation and release of pro-inflammatory cytokines, thereby disrupting neuronal homeostasis. Second, aberrant KP metabolism affects neurotransmitter systems, particularly glutamatergic and dopaminergic signaling, leading to impaired neural circuit development and synaptic pruning. By integrating current findings on the KP–ASD association, this review offers a comprehensive etiological framework and a clinically relevant paradigm. Furthermore, we highlight that specific KP metabolites, such as the kynurenic acid/quinolinic acid ratio, hold promise as peripheral biomarkers for early diagnosis and disease stratification. Finally, we discuss the therapeutic potential of targeting KP enzymes or receptors for personalized intervention strategies, while acknowledging the challenges in translating these findings into clinical practice.]]></description>
<pubDate>2026/8/6 18:31:51</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DUAN Yi-Fan,Hakan ürey,Hasan Bayram,LEI Yu-Chen,Ghiladi Reza A.,LI Meng-Jiao,QIAO Li-Chen,RONG De-Chang,WANG Jun,XIAO Ya-Qian,ZUO Lan-Lan]]></author>
</item>
<item>
<title><![CDATA[The Regulatory Mechanism of Ornithine Decarboxylase Antizyme 1 on Polyamine Transport and The Prospect of Tumor Treatment]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202604300000005]]></link>
<description><![CDATA[Polyamine homeostasis is tightly coupled to tumor-cell proliferation, metabolic reprogramming, stress adaptation, and immune escape. Ornithine decarboxylase antizyme 1 (OAZ1) is a central negative regulator of this network. When intracellular polyamine levels increase, the ribosome shifts one nucleotide downstream and switches to a new reading frame during translation of OAZ1 mRNA, thereby enabling the production of the full-length active OAZ1 protein. OAZ1 then restrains polyamine accumulation through two complementary mechanisms. It binds ornithine decarboxylase (ODC), inhibits enzyme activity, promotes dissociation of the active ODC homodimer, and facilitates ubiquitin-independent proteasomal degradation of ODC, thereby reducing endogenous putrescine synthesis. In parallel, OAZ1 suppresses the polyamine transport system (PTS), limiting the uptake of extracellular polyamines that may compensate for reduced biosynthesis. Recent studies have reshaped the concept of the mammalian PTS. Rather than a single plasma-membrane transporter, it is now viewed as a multicomponent and compartmentalized network involving cell-surface enrichment by heparan sulfate proteoglycans, caveolin-associated endocytosis in selected cellular contexts, endosomal or lysosomal escape mediated by P5B-type ATPases such as ATP13A3 and ATP13A2, vesicular storage mediated by SLC18B1, and acetylation-coupled export mediated by spermidine/spermine N1-acetyltransferase 1 (SAT1) and the SLC3A2-associated diamine exporter pathway. These findings provide a broader framework for understanding how tumor cells maintain high polyamine availability even when synthesis is pharmacologically inhibited. However, several fundamental questions remain unresolved. The direct PTS targets recognized by OAZ1 have not been identified, the structural basis by which polyamine-induced OAZ1 dimerization contributes to transport inhibition is still unclear, and the relationship between dysregulation of the OAZ1-PTS axis and therapeutic responses varies among tumor types. In this review, we summarize the molecular mechanisms of OAZ1 polyamine sensing, programmed frameshift translation, ODC inhibition and degradation, and feedback control of polyamine uptake. We also integrate recent advances on ATP13A2, ATP13A3, ATP13A4, SLC3A2, SLC18B1, SAT1, and related transport or export modules, and compare their alterations in neuroblastoma, lung cancer, prostate cancer, colorectal cancer, hepatocellular carcinoma, breast cancer, pancreatic cancer, leukemia, glioma, and oral squamous cell carcinoma. Particular attention is given to tumor-type specificity. MYCN-driven neuroblastoma appears to depend on both enhanced biosynthesis and compensatory uptake, lung and prostate cancer models provide functional evidence for OAZ1-dependent feedback repression of uptake, hepatocellular carcinoma highlights the immunological role of acetylated-polyamine efflux, and breast and pancreatic cancer studies suggest nonredundant contributions of ATP13 family members. Finally, we discuss translational strategies that aim to mimic or restore the dual negative-feedback function of OAZ1, including difluoromethylornithine (DFMO), AMXT1501-based polyamine blockade therapy, ATP13A3-directed intervention, targeting of AZIN1-OAZ1 antagonism, and modulation of SAT1-SLC3A2-associated acetylated-polyamine export. Future work should combine transport assays, interaction mapping, spatial omics, metabolomics, and immune profiling to define actionable biomarkers, such as OAZ1, AZIN1, ODC, ATP13A3, SLC3A2, SAT1, and tumor polyamine signatures. Such biomarkers will be important for selecting patients, monitoring target engagement, and designing combinations with chemotherapy, targeted therapy, or immune checkpoint blockade. A better understanding of the OAZ1-PTS axis may support biomarker-guided patient stratification and rational combination therapies targeting polyamine dependence and the immunometabolic tumor microenvironment.]]></description>
<pubDate>2026/8/6 16:05:10</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LIU Sen,MO Wei-Ming]]></author>
</item>
<item>
<title><![CDATA[Different Exercise Modalities for Type 2 Diabetes Mellitus Complicated With Metabolic-associated Fatty Liver Disease]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202604150000003]]></link>
<description><![CDATA[Both type 2 diabetes mellitus (T2DM) and metabolic associated fatty liver disease (MAFLD) fall within the spectrum of metabolic diseases, and they exhibit a bi-directional causal relationship and robust reciprocal association. Their shared pathological cornerstone is insulin resistance (IR), which involves the interplay of mitochondrial dysfunction and chronic inflammation, forming a cascading pathological process of "IR—mitochondrial dysfunction—inflammation." This largely explains the notable upward trend in T2DM–MAFLD co-occurrence observed over recent years. Exercise intervention, as a safe and effective non-pharmacological approach, can improve the pathological progression of these patients at multiple levels. Following the logical framework of "pathogenesis—efficacy comparison—molecular mechanisms—clinical translation", this article systematically compares the efficacy and molecular mechanisms of moderate-intensity continuous training (MICT), resistance exercise, high-intensity interval training (HIIT), and combined training. MICT reduces intrahepatic triglycerides by promoting lipolysis and improving cardiorespiratory fitness; resistance exercise increases muscle mass and basal metabolic rate, offering unique advantages in preserving muscle while reducing fat and improving insulin sensitivity; HIIT is a time-efficient exercise modality that enhances patients"" cardiorespiratory fitness and insulin sensitivity by alternating brief periods of vigorous exertion with recovery periods, with a prominent short-term triglyceride-lowering effect; combined training produces synergistic effects, comprehensively improving glucolipid metabolism and showing the best long-term adherence. Mechanistically, exercise exerts its beneficial effects through three common pathways: (1)AMPK-mediated lipid oxidation and mitochondrial biogenesis; (2)IRS/PI3K/Akt-mediated insulin signaling sensitization; and (3) Nrf2/ARE anti-oxidation and TGF-β/Smads anti-fibrosis regulation. Different exercise modalities activate these pathways with distinct emphases: MICT most directly and persistently activates the AMPK pathway; resistance exercise uniquely improves IRS/PI3K/Akt signaling through muscle mass gain; HIIT induces the highest AMPK activation intensity and triggers unique lactate-mediated signaling regulation; combined training integrates the above multiple mechanistic advantages. For clinical translation, multidisciplinary team collaboration is essential to ensure safety and adherence; individualized prescriptions should be formulated according to the FITT-VP principle and patient phenotypes—frequency of 3–5 sessions/week of aerobic exercise combined with 2–3 sessions/week of resistance exercise; intensity of moderate-intensity (40%–<60% heart rate reserve (HRR))aerobic exercise and 60%–80% of one-repetition maximum (1-RM) for resistance exercise; time of at least 150 min/week of moderate-intensity aerobic exercise, 30–60 min per session; type of combined training as the preferred modality; total volume of ≥500–1 000 MET-min/week; and progression adjusted every 4–6 weeks—with real-time adjustments supported by wearable devices, ultimately forming a closed-loop management system from initial assessment to long-term follow-up. Notably, current studies have limitations such as small sample sizes and short intervention periods. Future research should focus on long-term follow-up, multi-omics biomarkers, and combined exercise-drug strategies. In conclusion, the systematic integration of structured, individualized, and sustainable exercise interventions into the multidisciplinary management pathway for patients with T2DM complicated by MAFLD is an urgent need in current clinical practice.]]></description>
<pubDate>2026/8/4 16:40:04</pubDate>
<category><![CDATA[运动对糖尿病并发症的干预研究专题]]></category>
<author><![CDATA[CHEN Fei-Long,GUO Yu-Xiao,Lü Lei,QIE Bei-Bei,YI Bo-Zong]]></author>
</item>
<item>
<title><![CDATA[Study on Tumor Microenvironment With Pump-probe Photoacoustic Tomography Based on a Fast Acquisition Sequence]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202606040000001]]></link>
<description><![CDATA[<b>Objective</b> Oxygen partial pressure (pO?) is a critical indicator of the tumor microenvironment and plays an essential role in regulating tumor progression and therapeutic response, particularly for oxygen-dependent treatments such as photodynamic therapy (PDT). Although photoacoustic imaging (PAI) has shown great potential for functional and molecular imaging, conventional oxygenation imaging approaches based on hemoglobin absorption mainly provide relative oxygen saturation information and cannot directly quantify tissue oxygen partial pressure. Therefore, this study aimed to develop a fast laser sequence-based pump-probe photoacoustic tomography (PP-PAT) system for quantitative, non-invasive, and dynamic monitoring of oxygen partial pressure in tumor tissues.<b>Methods</b> The proposed PP-PAT system was developed based on the oxygen-sensitive triplet-state lifetime characteristics of methylene blue (MB). Upon optical excitation, MB molecules undergo transitions from the ground state to an excited state and subsequently form metastable triplet states through intersystem crossing. The lifetime of the triplet state is strongly affected by surrounding oxygen concentration due to dynamic oxygen quenching, providing a direct correlation between triplet-state kinetics and local oxygen partial pressure. A dual-wavelength pump-probe excitation scheme was implemented to selectively interrogate MB triplet-state dynamics. The pump pulse was used to initiate the triplet-state population, while the delayed probe pulse was applied to detect the transient triplet-state response. By optimizing the temporal interval between the pump and probe pulses, transient triplet-state differential (TTD) signals were extracted to enhance the specificity of oxygen-dependent molecular information and suppress background interference from conventional photoacoustic signals. The performance of the PP-PAT system was systematically evaluated through phantom and <i>in vivo</i> experiments. First, a single-tube phantom containing MB solution was used to investigate signal stability, reproducibility, and the influence of signal averaging on imaging quality. Subsequently, a dual-tube phantom model was established to simulate oxygen consumption during PDT, where one MB-containing tube was exposed to laser irradiation and the other served as a control. Finally, <i>in vivo</i> experiments were performed using a subcutaneous tumor model in nude mice. MB was locally injected into the tumor region before imaging to evaluate the feasibility of tumor oxygen partial pressure mapping using the proposed PP-PAT system.<b>Results</b> Phantom experiments demonstrated that the extracted TTD signals exhibited high stability and effectively reflected MB triplet-state dynamics while reducing non-specific background contributions. Signal averaging significantly improved the signal-to-noise ratio, and 50 repeated acquisitions provided an optimal compromise between image quality and acquisition efficiency. In the dual-tube phantom experiments, continuous PDT irradiation induced progressive oxygen depletion in the treated sample. The corresponding TTD decay rate gradually decreased, accompanied by an increase in the calculated triplet-state lifetime, indicating reduced oxygen quenching and decreased oxygen partial pressure. In contrast, the control sample showed relatively stable TTD kinetics and oxygenation levels during the same period. These results demonstrated that PP-PAT could quantitatively characterize oxygen consumption dynamics associated with photochemical reactions. <i>In vivo</i> experiments further demonstrated the capability of PP-PAT for spatially resolved oxygen partial pressure imaging in MB-injected tumor tissues. The reconstructed pO? maps revealed heterogeneous oxygen distributions within tumors, showing relatively hypoxic regions in the tumor core and higher oxygenation levels near the tumor boundary. This spatial oxygen distribution pattern was consistent with the typical physiological characteristics of solid tumors, where abnormal vascular structures and limited oxygen diffusion result in intratumoral oxygen gradients.<b>Conclusion</b> This study presents a fast laser sequence-based PP-PAT system capable of quantitative and non-invasive imaging of tissue oxygen partial pressure. By utilizing the oxygen-dependent triplet-state lifetime of MB and extracting TTD signals, the proposed method provides molecularly specific information related to oxygen dynamics beyond conventional photoacoustic oxygenation imaging. The system enables dynamic monitoring of oxygen consumption during PDT and reveals spatial oxygen heterogeneity within tumors. This technique provides a promising imaging approach for tumor hypoxia characterization, evaluation of oxygen-dependent therapeutic responses, and precision-guided cancer treatment.]]></description>
<pubDate>2026/8/1 16:04:41</pubDate>
<category><![CDATA[技术与方法]]></category>
<author><![CDATA[CUI Xing-Yu,GUO Jian-Feng,WANG Bo,ZHANG Zhan-Jun]]></author>
</item>
<item>
<title><![CDATA[From Blood-brain Barrier Penetration to Barrier Functional Remodeling: New Intervention Strategies <i>via</i> Nanodelivery Systems for Alzheimer’s Disease]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202602210000001]]></link>
<description><![CDATA[Alzheimer""s disease (AD) is pathologically characterized by cerebral amyloid β-protein (Aβ) aggregation, neurofibrillary tangles and progressive cognitive deterioration. There is an urgent clinical demand for targeted therapeutic agents against AD, whereas the blood-brain barrier (BBB) acts as a critical physical barrier that blocks over 98% small-molecule drugs and nearly all biomacromolecules from entering brain parenchyma. Nanomedicine-based drug delivery systems (NDDSs) with tunable physicochemical properties can cross the BBB <i>via </i>multiple transcytosis pathways including adsorptive-mediated, receptor-mediated and transporter-mediated routes, opening a promising avenue for targeted AD treatment. A core academic viewpoint proposed herein is that robust <i>in vitro</i> endothelial penetration of nanocarriers cannot guarantee effective accumulation in brain target cells. Comprehensive evaluation of BBB-crossing delivery efficiency should not merely rely on <i>in vitro</i> permeability tests, but cover the full multi-step transcytosis cascade, cellular tropism in brain tissues and<i> in vivo</i> therapeutic outcomes. This review systematically sorts out diverse nanoplatforms applicable to BBB penetration for AD intervention. Inorganic nanomaterials such as gold and ceria nanoparticles possess large specific surface areas and intrinsic antioxidant capacity, which eliminate reactive oxygen species and hinder Aβ fibrillization. Liposomal formulations and solid lipid nanoparticles exhibit superior biocompatibility with biomimetic phospholipid bilayer architectures, capable of co-loading hydrophilic nucleic acids for Tau regulation and lipophilic Aβ inhibitors; relying on receptor-mediated transcytosis, they achieve sustained drug retention in the brain. Polymeric nanocarriers including nanogels and polyamidoamine dendrimers enable multi-target combinatorial therapy, and can be engineered to release cargo in response to inflammatory microenvironments, thereby suppressing excessive microglial activation and protecting neuronal mitochondria. Beyond conventional nanocarriers, this work elaborates two cutting-edge BBB-crossing delivery platforms: biomimetic nanosystems and metal-organic frameworks (MOFs). Biomimetic nanoparticles camouflaged with erythrocyte, platelet or macrophage membranes, as well as natural exosomes, evade immune clearance, prolong systemic circulation and inherently home to inflammatory lesions. Serving as "nano-decoys", they neutralize Aβ neurotoxins and remodel cerebral inflammatory microenvironments simultaneously. MOFs feature high porosity and customizable pore channels for co-delivery of multiple therapeutics, and can be integrated with near-infrared photothermal and photooxidation modalities to facilitate focal brain lesion therapy. This review highlights a transformative paradigm shift in the field of BBB-targeted AD therapy: research focus has shifted from simply maximizing cerebral drug penetration toward active modulation and functional restoration of the BBB. Impaired BBB transporters intrinsically impede endogenous Aβ clearance. Accordingly, BBB-regulating nanocarriers are designed to remodel the low-density lipoprotein receptor-related protein 1 (LRP1) trafficking cascade, redirecting endocytic vesicles from lysosomal degradation to non-degradable transcytosis and restoring the intrinsic Aβ efflux capacity of the BBB. Distinct from conventional strategies that only exert local lesion inhibition, this systemic clearance strategy eliminates cerebral Aβ deposits by accelerating peripheral excretion.]]></description>
<pubDate>2026/7/24 8:03:17</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Huan,HOU Hong-Wei,WANG Xu-Ran,WANG Yi-Kun,YIN Chang-Feng]]></author>
</item>
<item>
<title><![CDATA[Effects and Regulation of Glycosylation Modifications on G Protein-coupled Receptor Function]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202603100000001]]></link>
<description><![CDATA[Glycosylation constitutes a critical, highly intricate, and diverse co- and post-translational modification characterized by the covalent attachment of sugar moieties to proteins, lipids, or small RNAs. Complex glycans are ubiquitously present across nearly all living organisms. Despite their prevalence, our comprehension of glycan diversity remains limited, likely due to the inherent challenges associated with elucidating their structural complexity. Among post-translational modifications, protein glycosylation is notably prevalent, involving the enzymatic transfer of oligosaccharides to specific amino acid residues by glycosyltransferases. This modification plays a pivotal role in modulating protein function, including participation in various biological and biochemical recognition processes. G protein-coupled receptors (GPCRs), encoded by approximately one thousand genes, share a conserved architecture comprising seven transmembrane helices interconnected by three intracellular and three extracellular loops. Representing the largest family of human membrane proteins, GPCRs regulate a vast array of physiological and pathological processes, thereby constituting the most extensive class of therapeutic targets. In mammalian systems, the majority of GPCRs undergo glycosylation predominantly at their extracellular N-terminus or extracellular loops, primarily through N-linked and O-linked glycosylation. These covalent carbohydrate modifications exert profound effects on multiple facets of GPCR biology, including endoplasmic reticulum folding and quality control, membrane trafficking and surface expression, receptor internalization and recycling or degradation, ligand binding and signal transduction, biased signaling, and receptor dimerization. Notably, glycosylation can exert both positive and negative regulatory influences on these processes. Dysregulation of GPCR glycosylation has been implicated in a range of pathological conditions, such as cancer, diabetes, and neurological disorders, underscoring its physiological and pathological significance. Aberrant glycosylation patterns may lead to dysfunctional receptor signaling, thereby contributing to disease progression. Consequently, elucidating the precise roles of glycosylation in GPCR function not only enhances fundamental understanding of receptor biology but also facilitates the development of novel therapeutic strategies targeting glycosylation pathways or specific GPCR glycoforms. Although the functional consequences of glycosylation have been investigated for several decades, delineating their exact structural underpinnings has remained challenging due to the intrinsic flexibility and heterogeneity of carbohydrate structures. Recent advances in structural biology, particularly single-particle cryo-electron microscopy (cryo-EM) and X-ray crystallography, have catalyzed a paradigm shift in our understanding of GPCR glycosylation. The integration of these sophisticated structural techniques with biochemical approaches has redefined glycosylation as a complex structural element integral to receptor function. These developments provide a molecular framework for comprehending how glycans influence receptor pharmacology and open new avenues for the rational design of glyco-engineered biologics and allosteric modulators targeting specific extracellular motifs. This mini-review concentrates on glycosylation within the GPCR superfamily, summarizing the impact of glycosylation modifications on receptor function and regulatory mechanisms, recent progress in the structural biology of GPCR glycosylation, and prospective directions for future research in this field.]]></description>
<pubDate>2026/7/23 10:43:48</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LING Sheng-Long,SHI Pan,SUN Yu,TIAN Chang-Lin,WU Fang-Ming]]></author>
</item>
<item>
<title><![CDATA[Microfluidic-based Pre-amplification-free CRISPR-Cas Biosensing for Rapid Detection: Technologies and Applications]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202604080000001]]></link>
<description><![CDATA[CRISPR-Cas-based biosensing systems have become important platforms for rapid nucleic acid detection because of their programmable sequence recognition and high specificity. In many diagnostic workflows, the CRISPR reaction is coupled with polymerase chain reaction or isothermal pre-amplification to enrich low-abundance targets before readout. This design improves sensitivity, but it also introduces additional primers and enzymes, requirements for temperature control and reaction compatibility, and a higher demand for contamination management. These factors make the whole assay less convenient for integrated and field-deployable point-of-care testing. Developing pre-amplification-free CRISPR assays is therefore not simply a pursuit of shorter protocols, but a way to simplify molecular diagnosis at the system level, especially in settings where rapid decisions, closed workflows, and minimal manual operation are required. Microfluidic devices provide an important engineering route for this purpose. Their small reaction volumes, precise fluid manipulation, high-throughput partitioning, and compatibility with portable readout make it possible to integrate target confinement, reaction control, signal acquisition, and quantitative analysis on a chip. Droplet microfluidics and microwell arrays can divide a sample into large numbers of independent microreactors, enabling digital counting of rare recognition events. Continuous-flow, centrifugal, and paper-based microfluidic formats further provide options for automated operation, low-cost fabrication, and on-site use. In this context, microfluidics is not only a signal-enhancement method, but also a platform that connects CRISPR molecular recognition with practical assay implementation. This review summarizes recent progress in microfluidic-based pre-amplification-free CRISPR-Cas biosensing for rapid detection. We focus on four related technical directions. crRNA engineering, including spacer-length tuning, multi-crRNA design, chemical modification, and allosteric regulation, can improve recognition kinetics, nuclease stability, and mismatch discrimination. Digital microfluidic detection based on droplets or microwell arrays converts single-molecule recognition events into countable positive partitions, thereby improving quantitative capability without target pre-amplification. Physical signal transduction interfaces couple CRISPR activity to electrochemical, electrochemiluminescent, fluorescent, or surface-enhanced Raman scattering readouts, making weak molecular signals easier to detect with portable instruments. On-chip cascade signal amplification strategies further enhance output intensity through enzymatic reactions, DNA circuits, nanomaterials, or cross-domain amplification modules while avoiding direct amplification of the target nucleic acid. Together, these strategies show that the performance of a pre-amplification-free assay depends not only on biochemical recognition, but also on how the reaction is confined, amplified, transduced, and operated. In addition to describing these mechanisms, this review compares different strategies in terms of sensitivity improvement, operational complexity, cost, and suitability for point-of-care testing. Representative applications in food authenticity identification and rapid pathogen screening are also discussed to illustrate how these platforms perform in practical scenarios. Finally, we analyze the remaining challenges, including the detection of low-abundance targets in complex matrices, on-chip sample preparation, device-to-device reproducibility, long-term reagent storage, and standardization. Future development will likely depend on tighter integration of sample processing, CRISPR reaction, signal readout, and data interpretation, ultimately moving pre-amplification-free CRISPR diagnostics toward automated and user-friendly sample-to-answer systems.]]></description>
<pubDate>2026/7/18 21:14:38</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[GUO Guang-Sheng,LU An-Yan,WANG Xia-Yan,ZHAO Liang]]></author>
</item>
<item>
<title><![CDATA[Brain-heart Axis in Neurodegenerative and Cardiovascular Comorbidity: Oxidative Stress, Inflammation, and Biomarkers]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202605150000001]]></link>
<description><![CDATA[Neurodegenerative diseases (NDs), particularly Alzheimer''''s disease (AD) and Parkinson''''s disease (PD), and cardiovascular diseases (CVDs), including heart failure (HF) and coronary artery disease (CAD), are major chronic disorders associated with population aging. Their frequent coexistence in clinical practice suggests that they may not progress independently, but may instead be linked through bidirectional pathological communication within the brain-heart axis. Epidemiological evidence underscores this clinical burden: systematic reviews and meta-analyses have reported pooled relative risks for dementia of approximately 1.27 among individuals with a history of CAD and 1.60 among those with HF, while the pooled prevalence of cognitive impairment and dementia in patients with HF has been estimated at approximately 41.42% and 19.79%, respectively. This review synthesizes current evidence on the mechanistic links, disease-state manifestations, biomarkers, and potential therapeutic strategies involved in the comorbidity between NDs and CVDs from the perspective of the brain-heart axis. The brain and heart communicate through autonomic, neuroendocrine, neuroimmune, vascular, and humoral pathways. Sympathetic activation, parasympathetic withdrawal, vagal dysfunction, cerebral hypoperfusion, endothelial injury, blood-brain barrier (BBB) alterations, peripheral immune activation, and circulating inflammatory mediators may jointly contribute to cross-organ pathological signaling. Oxidative stress and inflammatory response are not specific to the brain-heart axis; rather, they may act as candidate amplifying processes within this network. Mitochondrial dysfunction and NADPH oxidase activation can increase the generation of reactive oxygen species and reactive nitrogen species, which may activate nuclear factor-κB, the NLRP3 inflammasome, and mitogen-activated protein kinase/c-Jun N-terminal kinase signaling. These pathways can promote the release of interleukin-1β, interleukin-6, tumor necrosis factor-α, and other inflammatory mediators, which may in turn aggravate mitochondrial injury, endothelial dysfunction, immune cell activation, and further oxidant generation. Cytokines, chemokines, oxidized lipids, mitochondrial DNA, damage-associated molecular patterns, and extracellular vesicles may transmit these signals between the cardiovascular and central nervous systems, whereas autonomic reflexes provide an additional route for bidirectional amplification. Distinct disease states illustrate different manifestations of this network. The association between AD and CVDs may involve vascular risk factors, impaired amyloid-β clearance, abnormal cholesterol homeostasis, cerebral microvascular injury, neuroinflammation, and endothelial dysfunction. HF-related cognitive impairment may be linked to reduced cardiac output, recurrent cerebral hypoperfusion, hypoxia-related signaling, BBB dysfunction, circulating inflammation, and impaired autonomic feedback. In PD, cardiovascular autonomic dysfunction and abnormalities in heart rate and blood pressure regulation may interact with vascular injury, reduced cerebral perfusion, inflammation, and oxidative stress. However, the relationship between PD and CAD remains heterogeneous and may be modified by age, ethnicity, medication use, metabolic factors, and coexisting diseases. Biomarker evaluation should therefore move beyond isolated indicators. Traditional markers, including malondialdehyde, superoxide dismutase, glutathione, C-reactive protein, and interleukin-6, reflect systemic oxidative or inflammatory burden but lack sufficient specificity to distinguish primary neurodegeneration, cardiovascular injury, or a comorbid state involving both. Greater clinical value may be obtained from cross-system panels that combine oxidative stress and inflammatory markers with cardiac stress or injury biomarkers, such as N-terminal pro-B-type natriuretic peptide; glial or neuronal biomarkers, such as glial fibrillary acidic protein and neurofilament light chain; BBB- or endothelial injury-related biomarkers; and omics-derived candidates, including microRNAs, long non-coding RNAs, DNA methylation signatures, metabolites, and proteins. Multi-omics integration and artificial intelligence-assisted analysis may support risk stratification, disease monitoring, and prediction of treatment response. However, these approaches require standardized analytical platforms, validation in independent cohorts, and careful distinction between associative findings and causal mechanisms. Potential interventions include antioxidant, anti-inflammatory, mitochondria-targeted, and multi-target combination strategies, together with emerging approaches such as nanodelivery, CRISPR/Cas9- or CRISPR/dCas9-based regulation, mesenchymal stem cell-mediated mitochondrial transfer, and ergothioneine supplementation. Nevertheless, most available evidence is indirect, preclinical, or derived from other disease indications, and no single drug or technology can currently be regarded as specific to brain-heart axis comorbidity. The clinical relevance of these strategies will depend on whether they can be matched to dominant pathological phenotypes and improve both neurological and cardiovascular outcomes. Overall, comorbidity between NDs and CVDs is more appropriately understood as a heterogeneous cross-organ regulatory network than as a disorder driven by a single pathway. Future research should prioritize multicenter longitudinal cohorts, standardized clinical phenotyping, validation of cross-system biomarker panels, and mechanism-guided interventions in clearly defined patient subgroups, with integrated assessment of cognitive function, cardiovascular events, quality of life, long-term safety, and treatment response.]]></description>
<pubDate>2026/7/18 20:13:56</pubDate>
<category><![CDATA[病理状态下血管微环境的生化特征与精准治疗策略专题]]></category>
<author><![CDATA[CHENG Jing,XIE Ying-Ao,LI Qiao-Qiao,LIU Xu-Lin,WANG Yun-Fei]]></author>
</item>
<item>
<title><![CDATA[Structure and Function of The α9 Nicotinic Acetylcholine Receptor]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202605200000004]]></link>
<description><![CDATA[Nicotinic acetylcholine receptors (nAChRs) are pentameric ligand-gated ion channels (pLGICs) that mediate rapid cholinergic synaptic transmission throughout the central and peripheral nervous systems. These receptors are integral to neuromuscular junction signaling, autonomic regulation, cognitive learning, reward-related behavior, and neuroplasticity. The nAChR family exhibits remarkable functional diversity through combinatorial assembly of seventeen identified subunits (α1-α10, β1-β4, γ, δ, and ε). Among these, the α9 subunit occupies a distinctive phylogenetic position, exhibiting greater sequence divergence from other neuronal α subunits and possessing unique biochemical properties that distinguish it from all other family members. α9 can form homopentamers and also co-assemble with the α10 subunit to form functional heteropentamers, primarily in (α9)&lt;sub&gt;2&lt;/sub&gt;(α10)&lt;sub&gt;3&lt;/sub&gt; and (α9)&lt;sub&gt;3&lt;/sub&gt;(α10)&lt;sub&gt;2&lt;/sub&gt; stoichiometries. This dual assembly strategy generates functional heterogeneity, as distinct subunit compositions confer differential ion permeation, ligand sensitivity, and desensitization kinetics. The structural determinants governing this stoichiometric variability remain incompletely resolved, representing a critical gap in our mechanistic understanding. Unlike most other nAChR subtypes, traditional agonists of nAChRs (such as nicotine) elicit virtually no agonistic effect on α9* nAChRs (α9-containing receptors, including α9 homopentamers and α9α10 heteropentamers). This pharmacological divergence reflects structural differences within the orthosteric site, particularly in regions at complementary subunit interfaces. As cation-selective channels, α9* nAChRs exhibit high permeability to Ca&lt;sup&gt;2+&lt;/sup&gt;. In cochlear outer hair cells, α9α10 nAChRs mediate cholinergic efferent modulation by the medial olivocochlear (MOC) bundle. Acetylcholine-evoked Ca&lt;sup&gt;2+&lt;/sup&gt; influx activates functionally coupled SK2 potassium channels, generating net hyperpolarization that dampens electromechanical amplification through a tightly constrained signaling microdomain. This Ca&lt;sup&gt;2+&lt;/sup&gt;-dependent excitatory-to-inhibitory conversion exemplifies sophisticated sensory gain control, and its disruption contributes to noise-induced hearing loss, age-related hearing loss, and tinnitus. Beyond canonical ionotropic signaling, α9* nAChR engages metabotropic transduction pathways. In macrophages, receptor activation modulates cytokine production and inflammatory responses. In keratinocytes, it regulates wound healing by modulating cell migration and differentiation. In dorsal root ganglion sensory neurons, α9* signaling contributes to nociceptive processing and inflammatory hyperalgesia. This functional pleiotropy, spanning both ionotropic signaling and metabotropic transduction, positions α9* nAChR as an exemplary model for investigating signal polymorphism within the pLGIC superfamily. Pathophysiologically, α9* nAChR dysfunction is implicated across multiple organ systems. In the auditory system, disruption of α9α10 nAChR-mediated MOC efferent feedback impairs cochlear gain control, predisposing to noise-induced synaptopathy and age-related hearing loss. In immune cells, dysfunctional α9* nAChR signaling disrupts cholinergic anti-inflammatory pathway activity, exacerbating pro-inflammatory responses. In the peripheral sensory system, aberrant α9* nAChR signaling has been implicated in neuropathic and inflammatory pain states. In skin, impaired receptor function compromises keratinocyte migration and re-epithelialization through disrupted signaling pathways, leading to chronic wound healing defects and inflammation. These pathophysiological associations have catalyzed pharmacological interest, yielding promising chemical entities including α-conotoxins, small-molecule antagonists/agonists, and allosteric modulators. α-Conotoxin peptides, in particular, demonstrate remarkable subunit selectivity and potent antinociceptive effects in preclinical pain models. However, therapeutic translation faces substantial challenges: the broad tissue distribution of α9* nAChR risks on-target adverse effects in non-target organs; pronounced species differences between rodent and human receptors complicate preclinical validation; and the complexity of ionotropic-metabotropic signaling crosstalk demands pharmacological strategies that extend beyond conventional orthosteric agonism or antagonism. Looking forward, integrating cryo-electron microscopy of full-length receptors in distinct conformational states with single-channel electrophysiology and systems-level circuit analysis promises to illuminate the molecular mechanisms governing α9* nAChR function and regulation. The development of signal pathway-biased ligands and tissue-selective delivery strategies may ultimately harness the therapeutic potential of this receptor while mitigating safety liabilities. As a paradigm for understanding pLGIC signaling diversification, α9* nAChR research will continue to inform broader questions regarding ion channel evolution, allosteric regulation, and pathophysiological mechanisms of chronic pain and autoimmune inflammatory diseases.]]></description>
<pubDate>2026/7/17 8:04:08</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LIU San-Ling,WANG Xu-Dong,ZHENG Yi-Ning]]></author>
</item>
<item>
<title><![CDATA[Assessing The Contribution of Non-crossover (NCO) to Genetic Diversity From a Complete Recombination Map]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202606030000001]]></link>
<description><![CDATA[Meiotic recombination is a core molecular event that generates genetic diversity in sexually reproducing organisms, and is of great significance for both genome evolution and proper chromosome segregation. Meiotic recombination occurs in two forms: crossover (CO) and non-crossover (NCO). Although NCO events are far more abundant than CO events, they have been difficult to detect. Consequently, previous research has largely focused on CO, leaving the characteristics and functional roles of NCO poorly understood. A recent study published in <i>Nature</i> used large-scale family-based whole-genome sequencing data to construct a high-resolution recombination map. This map revealed the mutational features induced by NCO—the dominant form of recombination—along with their sex-specific differences, and quantified, for the first time, the contribution of NCOs to de novo mutations and age-related effects, representing an important milestone in the field of meiotic recombination. Specifically, compared with paternal NCOs, maternal NCOs are fewer in number but span longer regions; they accumulate continuously with increasing maternal age and occur largely outside programmed recombination hotspots. NCOs also represent a major source of de novo mutations, with approximately 11% of maternal de novo mutations being attributable to NCOs. This study not only provides a high-resolution map of human meiotic recombination as a resource for future research, but also offers, for the first time, a genome-wide perspective on the contribution of meiotic NCO recombination to genetic diversity.]]></description>
<pubDate>2026/7/17 8:01:32</pubDate>
<category><![CDATA[动态与评论]]></category>
<author><![CDATA[CANG Jing,DU Zhi-Hao,LIU Guo-Qing]]></author>
</item>
<item>
<title><![CDATA[Regulating Organoid Formation Through Mechanical Properties of Biomaterials: From Microenvironment Sensing to Physiological and Pathological Remodeling]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202604020000003]]></link>
<description><![CDATA[Organoid technology has become a highly promising <i>in vitro</i> model in biomedical research, but its traditional culture relies on animal-derived basement membrane matrices, which suffer from batch-to-batch variability, undefined biochemical composition, and poorly controllable mechanical properties. Recent studies have confirmed that matrix stiffness, viscoelasticity, topography, and temporal mechanical dynamics play regulatory roles equally as critical as biochemical signals in stem cell self-organization, lineage specification, and functional maturation of organoids. This review systematically summarizes the progress in understanding how extracellular matrix (ECM) mechanical properties regulate organoid formation. Focusing on the YAP/TAZ factors and the integrin receptors, which engage in crosstalk with biochemical signals to synergistically determine cell fate. We then elaborate how specific mechanical parameters, such as stiffness, viscoelasticity, and topography, influence each distinct stage of organoid development, from initial aggregation and compaction, through proliferative expansion, to lineage-committed differentiation and terminal functional maturation. Appropriate stiffness facilitates efficient aggregation and symmetry breaking, while excessive rigidity impairs proliferation and accelerates cellular senescence. In hepatic organoid expansion where only stiffness matching liver tissue (~6.2 kPa) supported robust growth. Viscoelastic stress relaxation promotes integrin clustering, enhances focal adhesion maturation, and stimulates endogenous ECM deposition, thereby supporting self-organized crypt-villus architecture and basement membrane assembly. Notably, dynamic softening of hydrogels enables optimal crypt budding, whereas rapid stress relaxation permits nephron segment coiling and drives vascular organoid maturation toward arteriole differentiation, highlighting stress relaxation as a key temporal parameter. Topographical cues provide contact guidance that directs polarized outgrowth, lumen formation, and neuronal orientation, all of which are essential for achieving organotypic architecture. The embedded 3D printing of complex neural networks enables precise control over branching geometries, facilitating studies of morphogenesis under spatial constraints. The engineered mechanical microenvironments have been successfully applied to recapitulate disease phenotypes: stiff matrices induce fibrosis and epithelial-mesenchymal transition in liver organoids, promote chemoresistance in cholangiocarcinoma. Furthermore, we summarize engineering strategies for both natural and synthetic hydrogels aimed at creating mechanically defined culture platforms. Natural biomaterial modifications achieve spatial separation of mechanical constraints from biochemical support, enabling self-limited compressive stimulation within a defined time window. Synthetic polymers allow independent tuning of stiffness, ligand density, and viscoelasticity through adjustable crosslinking and dynamic non-covalent interactions, thus providing orthogonal control over multiple mechanical parameters. Dynamic microenvironments that mimic progressive stiffening as observed in development, tumor evolution, or fibrosis can be constructed using composites that undergo spontaneous structural transitions. In the future, critical challenges include deciphering the synergistic rules governing mechanical-biochemical interplay, developing spatiotemporally programmable hydrogels that enable on-demand modulation of local mechanics, establishing comprehensive databases of tissue-specific mechanical parameter windows, and advancing standardized high-throughput screening platforms to accelerate preclinical validation and clinical translation. Moreover, integrating real-time mechanical sensors and non-invasive imaging techniques would allow dynamic monitoring of intracellular forces and tissue-level stress during culture. Ultimately, this review aims to provide a theoretical foundation for deepening our understanding of mechano-biological coupling mechanisms and for rationally designing high-fidelity, physiologically relevant organoid culture platforms that fully harness the regulatory power of mechanical cues.]]></description>
<pubDate>2026/7/15 15:44:59</pubDate>
<category><![CDATA[生物材料力学微环境的时空调控与组织功能再生专题]]></category>
<author><![CDATA[LIU Xi-Qiu,TANG Rui-Zhi]]></author>
</item>
<item>
<title><![CDATA[Dynamic Enhancer–promoter Communication Beyond Loop Extrusion]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202605140000003]]></link>
<description><![CDATA[Enhancer-promoter communication is fundamental to the spatial and temporal control of gene expression. Cohesin-mediated loop extrusion has long been considered a major structural mechanism that brings distal regulatory elements into proximity with their target promoters. Recent findings from Aboreden <i>et al</i>. refine this view by showing that depletion of Nipped-B-like protein (NIPBL), a key regulator of cohesin loading and loop extrusion, markedly disrupts architectural chromatin loops, whereas many cis-regulatory contacts and broad post-mitotic transcriptional reactivation are only modestly affected. These observations suggest that loop extrusion is important, but not sufficient, for explaining productive regulatory communication. In this Comment, we discuss how transcriptional condensate-like assemblies may provide an additional biochemical and kinetic layer that helps convert regulatory proximity into transcriptional output. By locally enriching transcription factors, coactivators, Mediator and RNA polymerase II (Pol II) around active loci, such regulatory hubs may stabilize productive enhancer–promoter encounters and modulate transcriptional activity. We further propose that transcriptional bursting provides a useful framework for understanding this conversion, because gene expression can be decomposed into burst frequency, burst duration and burst size. Integrating chromatin architecture, condensate organization and bursting dynamics may therefore provide a more complete view of how enhancer-promoter communication is re-established after mitosis and how regulatory proximity is converted into transcriptional output through mechanisms beyond loop extrusion.]]></description>
<pubDate>2026/7/15 15:32:52</pubDate>
<category><![CDATA[动态与评论]]></category>
<author><![CDATA[CHU Xia-Kun,TANG Dai-Yan]]></author>
</item>
<item>
<title><![CDATA[Targeting Excessively Accumulated Pathological Tau: PROTAC Molecular Design Strategies and Challenges]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202604210000001]]></link>
<description><![CDATA[The abnormal accumulation, structural change, and spread of tau protein in the brain are now considered important factors in the progression of Alzheimer’s disease (AD) and many other tau-related neurodegenerative diseases. Clinical and pathological studies have shown that the amount and distribution of abnormal tau protein are closely related to synaptic damage, neuronal loss, and cognitive decline. Therefore, tau protein has become an important target for disease-modifying therapy. However, tau is difficult to target because it has no fixed structure, lacks a clear active site, undergoes many post-translational modifications, and forms different abnormal structures in different diseases and disease stages. Therefore, the effective and selective removal of harmful tau species is both a major opportunity and a major challenge in drug discovery for neurodegenerative diseases. Proteolysis-targeting chimeras (PROTACs) offer a new strategy to deal with this problem. Unlike traditional inhibitors, PROTACs do not simply block protein function. Instead, they bring the target protein close to an E3 ubiquitin ligase, which leads to ubiquitination and degradation of the target protein by the proteasome. This event-driven mechanism may be especially useful for disease-related proteins such as tau, which are hard to inhibit with traditional small molecules. In recent years, tau protein-targeting PROTACs and related degradation strategies have shown promising effects in cell and animal models. These effects include reducing abnormal tau protein levels, lowering synaptic toxicity, regulating disease-related signaling pathways, and improving behavioral or cognitive outcomes. These studies support targeted tau protein degradation as a promising therapeutic approach, although many problems still need to be solved before clinical use. In this review, we summarize recent progress in the development of tau protein-targeting PROTACs and discuss the main factors that affect their design and activity. We focus on the choice of tau protein-binding ligands, their binding sites, and their ability to recognize abnormal tau protein rather than normal tau protein. We also discuss the selection of E3 ligase recruiters, linker length and structure, ternary complex formation, and structure-activity relationships that influence degradation potency and selectivity. In addition, we introduce new strategies beyond traditional proteasomal degradation, including the regulation of tau protein phosphorylation and autophagy-based clearance. These approaches may be more suitable for different tau species or different stages of disease. A major challenge for tau protein-targeting PROTACs is delivery to the central nervous system. Many PROTACs have high molecular weight, large polar surface area, flexible structures, and may be removed by efflux transporters. As a result, they often have poor ability to cross the blood-brain barrier and may not reach enough free drug levels in the brain. Therefore, the therapeutic potential of tau protein-targeting PROTACs depends not only on their ability to degrade tau protein &lt;i&gt;in vitro&lt;/i&gt;, but also on whether they can achieve long-lasting, selective, and safe target engagement in important brain regions after practical administration. Future studies should focus on improving selectivity for abnormal tau protein, understanding E3 ligase function in neural cells, designing brain-penetrant molecules, developing better delivery methods, and testing these drugs in models that better reflect human disease. Overall, tau protein-targeting PROTACs are a promising and fast-developing strategy for treating tau-related diseases. However, their successful clinical translation will require progress in chemical biology, medicinal chemistry, neuroscience, drug delivery, and translational medicine.]]></description>
<pubDate>2026/7/9 21:10:59</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DING Yi,FANG Tian,LEI Yi-Qiao,LI Han,WU Zhong-Hui,XU Jia]]></author>
</item>
<item>
<title><![CDATA[Exercise Intervention Alleviates Diabetic Sarcopenia by Regulating Lipid Metabolic Reprogramming: Mechanisms and Strategies]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202605130000005]]></link>
<description><![CDATA[Diabetic sarcopenia (DS) is a common but often ignored skeletal muscle complication in individuals with diabetes mellitus. It is characterized by progressive loss of skeletal muscle mass, reduced muscle strength, and impaired physical performance, which may further increase the risk of falls, disabilities, metabolic disorders, and adverse clinical outcomes. Traditionally, DS has been attributed mainly to hyperglycemia, insulin resistance, aging-related muscle decline, and chronic complications of diabetes. However, increasing evidence suggests that lipid metabolic disturbance and pathological lipid metabolic reprogramming are not merely secondary consequences of diabetes, but may actively participate in the initiation and progression of DS. Under diabetic conditions, impaired fatty acid uptake, transport, oxidation, and storage disrupt skeletal muscle metabolic homeostasis, leading to ectopic lipid deposition and accumulation of lipotoxic intermediates. These lipid-derived metabolites can aggravate insulin resistance, impair mitochondrial energy production, enhance oxidative stress, activate chronic low-grade inflammation, and disturb protein synthesis and degradation balance, thereby accelerating skeletal muscle atrophy and functional decline. Lipid metabolic dysregulation may also interact with multiple pathological processes involved in DS, including mitochondrial dysfunction, inflammatory signaling, oxidative damage, impaired autophagy, and gut microbiota imbalance. These mechanisms do not occur independently; instead, they form a complex bidirectional vicious cycle with diabetes-related metabolic disorders. Specifically, mitochondrial dysfunction reduces fatty acid oxidative capacity, which further promotes lipid accumulation and lipotoxicity. Inflammatory activation can impair insulin signaling and muscle protein metabolism, while lipid overload may in turn amplify inflammatory responses. Similarly, gut microbiota dysbiosis and altered microbial metabolites may influence systemic inflammation, lipid metabolism, and skeletal muscle homeostasis. Therefore, lipid metabolic reprogramming provides an important mechanistic perspective for understanding the progression of DS from metabolic disturbance to structural and functional muscle impairment. Exercise intervention is an effective and clinically feasible non-pharmacological strategy for the prevention and management of DS. Both aerobic exercise and resistance training have been shown to improve insulin sensitivity, enhance fatty acid oxidation, increase mitochondrial biogenesis, reduce ectopic lipid deposition, and attenuate lipotoxic metabolite accumulation. These adaptations not only improved glucose and lipid metabolism, but alsoincreased the preservation of muscle mass, muscle strength, and physical function. Moreover, combined exercise strategies may provide complementary benefits by integrating the metabolic advantages of aerobic exercise with the anabolic and functional effects of resistance training. Based on analyses of publicly available datasets and literature evidences, this review systematically summarizes the role of lipid metabolic disorders in the pathogenesis of DS, with particular attention to the molecular mechanisms linking lipid dysregulation to insulin resistance, chronic inflammation, oxidative stress, mitochondrial dysfunction, and gut microbiota disturbance. Furthermore, this review discusses the potential mechanisms by which exercise intervention improves DS through the regulation of lipid metabolic reprogramming, and outlines exercise prescription strategies in terms of modality, intensity, frequency, and duration. Understanding the interaction between lipid metabolism and skeletal muscle dysfunction may provide new theoretical evidence for early identification, mechanistic research, and precision exercise therapy in DS. Overall, targeting pathological lipid metabolic reprogramming through exercise intervention represents a promising and clinically actionable approach for improving muscle health and prognosis in individuals with DS.]]></description>
<pubDate>2026/7/9 14:52:54</pubDate>
<category><![CDATA[运动对糖尿病并发症的干预研究专题]]></category>
<author><![CDATA[KOU Xian-Juan,Lü Meng-Lin,REN Qian-Qian,ZHANG Bao-Wen]]></author>
</item>
<item>
<title><![CDATA[From Metabolic Reprogramming to Lactylation: Targeting Dilemmas and Breakthrough Directions in Colorectal Cancer]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202605040000001]]></link>
<description><![CDATA[Colorectal cancer (CRC) is characterized by persistently high incidence and mortality. Current therapies are limited by drug resistance and modest patient benefit, underscoring the urgent need for new perspectives rooted in tumor biology. The unique metabolic landscape of CRC makes it an ideal model in which to dissect the pathological roles of lactylation regulatory networks: microsatellite-stable (MSS) CRC, which accounts for approximately 85% of cases, concurrently upregulates glycolysis and oxidative phosphorylation, engaging in intense metabolic competition with immune cells; the intratumoral lactate pool exhibits a distinctive “dual-source supply” feature—in addition to tumor-intrinsic glycolysis, substantial exogenous lactate is provided by gut microbiota dysbiosis and by colonizing bacteria within liver metastases; high-frequency oncogenic mutations and lactylation modifications establish a feed-forward circuit of “oncogene-driven lactate accumulation-lactylation-facilitated tumor progression”. Moreover, MSS CRC displays near-complete unresponsiveness to immune checkpoint inhibitors, a phenomenon underpinned by multiple immune evasion mechanisms mediated by lactate and lactylation. Lactate metabolism is a hallmark of metabolic reprogramming in cancer. Lactate homeostasis provides tumor cells with metabolic substrates, modulates redox status, and regulates fatty acid metabolism to promote malignant progression. Notably, lactate can drive lactylation—an emerging post-translational modification (PTM) in which lactyl groups are attached to lysine residues, dynamically governing gene transcription and protein function and thereby establishing a bridge between metabolism and epigenetics. Lactate and lactylation form a multidimensional, coordinated network: lactylation of key metabolic enzymes such as LDHA reinforces a positive feedback loop that sustains lactate production; lactylation of upstream transcription factors such as HIF-1α drives metabolic reprogramming; furthermore, lactylation engages in crosstalk with m6A and m5C RNA modifications as well as with other PTMs such as acetylation, profoundly reshaping cellular behavior. In CRC, histone lactylation drives malignant phenotypes by activating immunosuppressive programs, inhibiting ferroptosis, and promoting invasion and migration; non-histone lactylation accelerates translation elongation, stabilizes β-catenin, maintains redox homeostasis, and prevents PD-L1 degradation, thereby facilitating tumor progression. Lactylation-related gene signatures have demonstrated potential for prognostic stratification. Therapeutic strategies targeting the lactylation network range from upstream metabolic intervention to modulation of the modifying enzymes and direct blockade of lactylation modifications, forming a hierarchical interventional framework. However, current evidence derives predominantly from cell lines and xenograft models, and a causal relationship between lactylation and malignant progression in CRC has yet to be rigorously established. Whether inhibition of lactylation can alter CRC phenotypes independently of metabolic alterations and acetylation fluctuations remains a central unanswered question in the field. This review systematically examines the research progress and translational challenges surrounding lactylation regulatory networks, aiming to provide a circumspect assessment to inform the development of novel therapeutic strategies for CRC.]]></description>
<pubDate>2026/7/7 15:13:30</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DU Jie,GAO Feng,LI Zhao-Huan,ZHANG Xin,ZHAO Jing-Wen]]></author>
</item>
<item>
<title><![CDATA[A Personalized Brain-computer Interface Paradigm and Decoding Method for The Objective Evaluation of Auditory Frequency Difference Limen<sup>△,</sup>]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202605100000001]]></link>
<description><![CDATA[<b>Objective</b> The frequency difference limen (FDL) serves as a fundamental metric utilized for effectively quantifying the precise perceptual capabilities of the central auditory system. However, traditional measurement methods rely heavily on the active behavioral responses of subjects and are consequently highly susceptible to the negative influence of confounding subjective factors. Furthermore, existing research paradigms frequently employ uniform stimulus configurations that overlook critical individual perceptual differences. Based on brain-computer interface (BCI) technology, this comprehensive study aims to establish an objective and quantitative evaluation method for auditory frequency discrimination by systematically analyzing and decoding the specific neural responses elicited at the exact threshold state.<b>Methods</b> We designed a personalized rapid serial auditory presentation (RSAP) paradigm customized based on each individual’s precise FDL. A cohort of eleven healthy participants was recruited to evaluate the paradigm using pure-tone sequences at a baseline frequency of 4 000 Hz. This experimental paradigm simulates a realistic auditory perception environment through the continuous presentation of acoustic stimuli, thereby allowing for an in-depth investigation into the specific neural representations evoked by weak frequency deviations at the threshold state. Given that auditory stimulus-evoked response features exhibit complex and differentiated spatiotemporal distribution patterns across multiple frequency domains, this study further deeply integrates the cross-scale feature interaction module with the dynamic spatiotemporal attention allocation strategy, innovatively proposing the Multi-Scale Spatial-Temporal Dual Attention Network (MS-STAMNet). Specifically, the network constructs parallel processing branches with multiple receptive fields and introduces a dynamic adaptive weighting strategy to precisely localize core neural activity signals, further deeply integrating multi-scale information through cross-branch feature information interaction to achieve robust single-trial decoding of weak auditory evoked responses.<b>Results</b> The comprehensive electrophysiological data analysis demonstrated that subtle auditory frequency deviation stimuli presented at the threshold level successfully elicited pronounced N2 and P3 event-related potential features, reflecting pre-attentive mismatch detection and subsequent cognitive evaluation, which were prominently distributed over the frontal, central, and temporal regions of the scalp. In the complex time-frequency domain, the extracted neural response characteristics exhibited distinct, statistically significant event-related synchronization within both the low-frequency δ and θ frequency bands, which was simultaneously accompanied by a widespread, prominent event-related desynchronization within the higher α band. A comparative analysis of model performance demonstrated that MS-STAMNet achieved an average unweighted average recall (<i>UAR</i>) of (69.67±6.12)% and area under the curve (<i>AUC</i>) of 0.761 8±0.07, significantly outperforming the established baseline models such as EEGNet and PLNet. Furthermore, a distinct dissociation phenomenon was verified between neural decoding and behavioral performance through regression analysis (<i>R</i><sup>2</sup>=0.016, <i>P</i>=0.709), indicating that this model can effectively capture the implicit features of subtle frequency deviations, even when they fail to trigger explicit conscious responses. Additionally, attention weight visualization analysis further reveals the highly accurate focus of the network on key features concentrated over the bilateral temporal and fronto-parietal regions.<b>Conclusion</b> This study systematically and comprehensively uncovers the multi-dimensional spatiotemporal evolutionary patterns of complex neural responses processing subtle acoustic variations under long-sequence threshold auditory stimulation. Concurrently, it verifies the efficacy and robustness of the proposed MS-STAMNet architecture in accurately deciphering weak, single-trial electroencephalogram signals amidst complex background noise. Ultimately, these neurophysiological and algorithmic findings lay a solid theoretical and methodological foundation for the objective and quantitative evaluation of individual auditory cognitive capabilities in clinical applications, transcending the fundamental limitations of traditional behavioral paradigms and providing robust technical support for future auditory research and related clinical assessments.]]></description>
<pubDate>2026/7/6 23:17:29</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[AN Xing-Wei,LI Sheng-Ye,MING Dong,XIAO Xiao-Lin,XU Min-Peng,YU Shi-Hang,ZHANG Bei-Bei]]></author>
</item>
<item>
<title><![CDATA[A Mechanistic Framework of Exercise-induced Amelioration of Autism Spectrum Disorder <i>via</i> miR-132, miR-34a, and miR-146a]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202605230000001]]></link>
<description><![CDATA[Autism spectrum disorder (ASD) is a neurodevelopmental condition with a steadily rising global prevalence, yet effective pharmacological interventions remain notably limited, highlighting an urgent need for safe, accessible, and mechanism-based therapeutic strategies. Physical exercise has emerged as a promising non-pharmacological intervention that ameliorates both core symptoms—social communication deficits and restricted repetitive behaviors—and associated features including cognitive dysfunction and motor impairments, in children and adolescents with ASD. However, the molecular mechanisms mediating these beneficial effects remain incompletely defined, impeding the development of evidence-based exercise prescriptions and biomarker-driven rehabilitation protocols. MicroRNAs (miRNAs) are evolutionarily conserved small non-coding RNAs that post-transcriptionally regulate approximately 60% of protein-coding genes. Within the central nervous system, miRNAs orchestrate diverse neurobiological processes including neural progenitor proliferation, neuronal differentiation, dendritic spine morphogenesis, synaptic plasticity, and neuroinflammatory homeostasis. Notably, miRNAs are remarkably stable in biological fluids and can be packaged into extracellular vesicles, rendering them attractive candidates as both mechanistic mediators and non-invasive peripheral biomarkers. Among the hundreds of miRNAs expressed in the brain, three—miR-132, miR-34a, and miR-146a—have emerged as particularly relevant to ASD pathophysiology. This review focuses on these three miRNAs for the following reasons: miR-132 is a master regulator of activity-dependent synaptic plasticity through its modulation of BDNF/MeCP2/PTEN signaling and has been consistently downregulated in ASD prefrontal cortex; miR-34a functions as a pro-apoptotic factor that suppresses Bcl-2-mediated neuronal survival pathways and is upregulated in ASD cerebellum; and miR-146a serves as a key brake on neuroinflammation &lt;i&gt;via&lt;/i&gt; TLR7/IRAK1 signaling and shows region-specific dysregulation in ASD temporal lobe. We first summarize evidence from human post-mortem brain tissues and ASD animal models demonstrating the consistent dysregulation of these three miRNAs. Notably, the pathological consequences of these miRNA alterations—impaired synaptic plasticity, excessive neuronal apoptosis, and sustained neuroinflammation—are interconnected and collectively contribute to the heterogeneous symptomatology of ASD. We then present a synthesis of emerging evidence demonstrating that various exercise modalities, including swimming, treadmill running, and voluntary wheel running, can concurrently reverse these ASD-like behavioral phenotypes and normalize the expression of the three key miRNAs. These data provide the first direct experimental evidence linking exercise-induced miRNA modulation to ASD symptom improvement. On the basis of these findings, we propose an integrative “exercise-miRNA-ASD” framework wherein exercise functions as a multi-targeted modulator—simultaneously enhancing synaptic plasticity, promoting neuronal survival, and attenuating neuroinflammation—through coordinated regulation of the three miRNAs. Importantly, this framework is not merely descriptive but offers testable predictions: exercise-induced miRNA changes should be dose-dependent, show temporal correlation with behavioral improvements, and be blunted by miRNA-specific antagonists or CRISPR/Cas9-mediated knockout. Beyond its specific application to ASD, this framework has broader implications. The miR-132/BDNF, miR-34a/Bcl-2, and miR-146a/TLR7 pathways are not ASD-specific but represent fundamental neural stress and repair mechanisms that are dysregulated across Alzheimer’s disease (AD), traumatic brain injury, Parkinson’s disease (PD), and major depressive disorder. Exercise has been shown to modulate these same miRNAs in several of these conditions, suggesting that the “exercise-miRNA-neural function” axis may represent a conserved neuroprotective mechanism that transcends diagnostic boundaries. Thus, we propose that ASD serves as an ideal model disease for elucidating this universal mechanism, with findings potentially generalizable to other neurological disorders. We also critically evaluate current translational barriers: the near-absence of human clinical trials with serial miRNA profiling; the undefined dose-response relationships between exercise parameters and miRNA expression; the unresolved causality issue (current evidence demonstrates association, not causation); and the uncertain correlation between peripheral exosomal miRNA levels and brain miRNA dynamics. We argue that future research must prioritize CRISPR/Cas9-based miRNA manipulation in animal models combined with longitudinal exercise interventions to establish causality, and that cross-disease validation studies are essential to determine whether exercise-induced miRNA changes represent a shared neuroprotective signature or disease-specific responses. Ultimately, we envision a paradigm where a simple blood test measuring exosomal miR-132, miR-34a, and miR-146a levels could guide personalized exercise prescriptions, enabling precision rehabilitation for individuals with ASD and potentially other neurological conditions.]]></description>
<pubDate>2026/7/6 17:41:51</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LIU Niu,SHU Xin-Jian,WANG Yan-Yan,XUE Ya-Qi,YANG Xiao]]></author>
</item>
<item>
<title><![CDATA[The Influence of BDNF on Cortical Remodeling After Peripheral Nerve Injury]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202603030000007]]></link>
<description><![CDATA[Peripheral nerve injury (PNI) severs peripheral connections and induces profound reorganization of primary somatosensory (S1) and motor (M1) cortical maps, a dynamic process that critically shapes the extent and quality of functional recovery. Brain-derived neurotrophic factor (BDNF) has emerged as a central molecular hub linking the initial peripheral insult to subsequent central plastic changes. This review systematically examines BDNF-mediated cortical remodeling following PNI, with a particular emphasis on its spatiotemporally specific regulatory mechanisms and the therapeutic opportunities they present. Immediately after PNI, deafferented cortical territories undergo rapid functional silencing and, over time, become progressively encroached upon by adjacent intact representations. This maladaptive reorganization—characterized by sensory map fusion and motor compensatory invasion—actively impedes successful reinnervation and optimal recovery. Such phenomena have been consistently documented in both non-human primate models and human fMRI studies, spanning sensory and motor modalities. Motor remapping is also prominently observed in facial nerve injury and chronic nerve compression models, underscoring the universality of these plastic changes. Notably, a range of interventions including regional local anesthesia, auditory-tactile substitution, and guided tactile imagery can effectively mitigate this aberrant remodeling, revealing promising avenues for the therapeutic modulation of cortical plasticity during critical post-injury windows. BDNF coordinates post-PNI cortical remodeling through three mechanistically interconnected pathways. First, BDNF drives dendritic and axonal growth &lt;i&gt;via &lt;/i&gt;TrkB receptor signaling: retrogradely transported axonal signaling endosomes integrate CREB-dependent transcriptional programs with mTOR-mediated local protein synthesis to bolster dendritic arborization and axonal elongation, while BDNF-induced Limk1 translation precisely fine-tunes actin cytoskeletal dynamics, thereby stabilizing dendritic spine morphology. Second, BDNF governs GABAergic interneuron maturation and perineuronal net formation through the JNK signaling cascade, thereby acting as a “plasticity brake” that preserves the delicate excitatory/inhibitory balance and constrains indiscriminate, maladaptive rewiring. Third, BDNF robustly potentiates NMDAR-dependent long-term potentiation (LTP) by elevating NMDA channel open probability and increasing synaptic receptor density, thus tightly coupling structural remodeling with functional synaptic strengthening. Concurrently, long-term depression pathways are subject to modulation, with NMDAR antagonism exerting time-dependent, bidirectional effects that vary with the post-injury phase. Superimposed on these mechanisms, the functionally antagonistic actions of proBDNF/p75NTR (favoring pruning and growth cone collapse) and mature BDNF/TrkB (promoting survival and stabilization) add further layers of regulatory complexity, highlighting the absolute necessity for precise spatiotemporal control in any therapeutic strategy. Extending our previous experimental findings, we introduce a “cortical reclamation threshold” model. In this framework, early upregulation of BDNF-TrkB signaling enhances inhibitory tone to restrict cortical encroachment by neighboring intact regions, whereas delayed but precisely timed BDNF delivery following surgical nerve repair actively facilitates the reclamation of the original, deafferented cortical maps by regenerating afferent fibers. Importantly, the common BDNF Val66Met polymorphism may significantly modulate individual thresholds, providing a biologically grounded rationale for patient stratification and personalized timing of intervention. Despite this mechanistic promise, clinical translation faces considerable hurdles. These include inherently poor pharmacokinetics of BDNF, severely limited penetration across the blood-brain barrier, dose-dependent neurotoxicity mediated through the p75NTR receptor, and the overarching dual-edged nature of BDNF signaling, which can simultaneously promote both adaptive and maladaptive plasticity. Emerging delivery platforms——including engineered exosomes, polymeric nanoparticles, cryogel microcarriers, and adeno-associated virus (AAV)-based gene therapy——offer potential solutions, but all require rigorous pharmacokinetic, toxicological, and functional validation. Future research priorities should encompass: (1) comprehensive single-cell and spatial transcriptomic mapping to resolve BDNF cellular sources and real-time signaling dynamics across distinct cortical layers and cell types; (2) genotype-stratified dose-response studies to establish safe, effective, and personalized delivery protocols; and (3) large-scale multicenter clinical trials that seamlessly integrate BDNF-targeted interventions with multimodal rehabilitation strategies, such as repetitive transcranial magnetic stimulation and mirror therapy, with longitudinal neuroimaging serving as a biomarker for cortical reclamation. By systematically addressing these priorities, we aim to transform BDNF from a critical endogenous regulator into a precisely controllable and titratable therapeutic target, ultimately enabling a paradigm shift from mere structural repair to true functional neural reconstruction following PNI.]]></description>
<pubDate>2026/7/3 20:52:10</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Bo-Yuan,CHEN Hao-Ran,ZHANG Jie,ZHANG Tao]]></author>
</item>
<item>
<title><![CDATA[Mechanisms of Exercise Intervention in Cancer Bone Metastasis]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202604280000001]]></link>
<description><![CDATA[Bone metastases are a common and serious complication of solid tumors such as breast cancer, prostate cancer, lung cancer, and kidney cancer, and occur at a high rate in patients with advanced cancer. This pathological process not only frequently leads to skeletal-related events such as severe bone pain, pathological fractures, spinal cord compression, and hypercalcemia—conditions that severely impact patients’ quality of life—but may also significantly increase the risk of death. Cancer bone metastasis is a complex, multistage cascade involving key steps such as the detachment of tumor cells from the primary tumor, their invasion and entry into the bloodstream, and their colonization, dormancy, and reactivation within the bone microenvironment. In recent years, exercise—as a safe and easily implementable non-pharmacological intervention—has demonstrated significant potential in inhibiting bone metastasis, improving the bone microenvironment, and alleviating related clinical symptoms. Its mechanisms of action may involve multiple levels. First, at the mechanical load level, mechanical signals generated by exercise can directly act on bone cells, inhibiting tumor cell infiltration and colonization by regulating endothelial cell permeability and osteoclast activity. Second, at the endocrine and paracrine levels, exercise can alter the expression profiles of microRNAs (such as <i>miR-486</i> and <i>miR-34b</i>) carried by extracellular vesicles and particles (EVPs) in the circulation, thereby inhibiting tumor cell proliferation and migration by targeting cell cycle-related genes. Furthermore, exercise can remodel the immune microenvironment, enhance the cytotoxic activity of antitumor immune cells, and improve oxygen supply to tumor tissues, thereby alleviating hypoxia-induced immunosuppression. Finally, at the metabolic intervention level, exercise can induce systemic metabolic reprogramming, increasing the nutritional demands of normal tissues, thereby competing with tumor cells for nutrients and forming a “metabolic barrier” in distal organs such as bones. This article reviews the pathogenesis and classification of bone metastases, including osteolytic, osteogenic, and mixed types, and elaborates in detail on the complex processes by which tumor cells undergo colonization, dormancy, and reactivation within the bone microenvironment. Furthermore, based on a comprehensive analysis of human and animal studies on exercise interventions for bone metastases, this paper highlights the mechanisms by which exercise inhibits tumor formation, growth, and spread through the regulation of mechanical loading, extracellular vesicles and granules, as well as <i>via</i> immune and metabolic pathways, thereby interfering with bone metastasis. However, the array of exercise modalities and intensities available for patients grappling with the challenges of cancer-related bone metastases remains markedly constrained, and the formulation of tailored exercise prescriptions continues to be devoid of robust, evidence-based medical backing. This review aims to explore the effects of exercise on bone health in patients with bone metastases, analyze the factors and considerations that should be taken into account in exercise prescriptions, and provide new theoretical support and insights for developing personalized exercise programs for these patients and further advancing relevant clinical research. Future research directions should include the development of evidence-based, personalized exercise prescriptions and further clarification of the safety boundaries and best practice standards for exercise interventions, thereby promoting the advancement of relevant clinical research and ultimately improving patients’ clinical outcomes and quality of life.]]></description>
<pubDate>2026/6/30 9:19:22</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HE Meng-Lu,JIA Dan-Dan,YAN Si-Tong,YU Feng-Zhi,ZONG Bo-Yi]]></author>
</item>
<item>
<title><![CDATA[Molecular Mechanisms of Intraflagellar Transport in Regulating ciliogenesis and Ciliopathies]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202605050000001]]></link>
<description><![CDATA[Intraflagellar transport (IFT) is a core mechanism for ciliary assembly, length maintenance, ciliary proteome homeostasis and signal transduction. Most proteins required for ciliary structure and function are synthesized in the cytoplasm. Because the ciliary compartment is separated from the cell body by the selective barrier of the transition zone, these proteins cannot freely equilibrate between the cytoplasm and the cilium. Consequently, axonemal components, membrane proteins and signaling molecules must be actively imported into cilia, retrieved from the ciliary compartment, and recycled or degraded through highly ordered transport and sorting pathways. The IFT system is mainly composed of the IFT-A complex, IFT-B complex, kinesin-2, dynein-2 and the Bardet-Biedl syndrome protein complex (BBSome). Through coordinated anterograde and retrograde transport, these modules mediate the dynamic trafficking of different classes of ciliary cargoes. Anterograde transport delivers structural and membrane-associated components from the ciliary base toward the ciliary tip, whereas retrograde transport retrieves IFT components and selected cargoes back toward the ciliary base and cytoplasm. In this way, IFT not only supports the construction of the axoneme but also contributes to the maintenance of ciliary composition and the regulation of ciliary signaling activity. In recent years, advances in cryo-electron microscopy, &lt;i&gt;in situ&lt;/i&gt; cryo-electron tomography and single-molecule imaging have greatly improved our understanding of the molecular mechanisms underlying IFT. These approaches have revealed how IFT trains are assembled at the ciliary base, how they move along axonemal microtubule tracks, how they undergo directional switching at the ciliary tip, and how cargoes are retrieved and recycled. Among the IFT modules, IFT-B acts as the major scaffold of IFT trains. It participates in cargo loading, motor coupling and initiation of anterograde transport. IFT-A is involved in retrograde transport, membrane protein adaptor function and train remodeling. The BBSome, through reversible association with the IFT system, regulates ciliary membrane protein sorting, signaling receptor clearance and renewal of the ciliary proteome. These functions indicate that the IFT machinery is not a simple linear transport pathway, but rather a dynamic and reconfigurable transport system. The conversion of transport direction is a key step in the IFT cycle. This process is closely associated with disassembly of anterograde trains, dissociation of kinesin-2, activation of dynein-2 at the ciliary tip and reassembly of retrograde trains. In terms of pathogenic mechanisms, IFT abnormalities may cause ciliopathies through four major pathways: defects in ciliary assembly and structure, abnormal localization of ciliary cargoes, dysregulation of signaling pathways, and impaired cargo unloading and retrieval. These defects can affect multiple organ systems, including the retina, kidney, skeleton, respiratory tract, reproductive system, and neuro-metabolic system. Current therapeutic strategies are still mainly based on symptomatic support and maintenance of organ function. Overall, IFT is a dynamic transport system jointly regulated by axonemal structure, motor activity, cargo selection and cellular signaling. It links ciliary architecture with protein turnover and signaling regulation, thereby playing a fundamental role in both ciliary homeostasis and ciliopathy pathogenesis. Further elucidation of IFT regulatory mechanisms and their relationships with disease phenotypes will help promote mechanism-based classification, genetic diagnosis and precision intervention for ciliopathies.]]></description>
<pubDate>2026/6/26 20:47:20</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[GE Ting-Ting,NIU Chang-Min,YANG Fan,ZHENG Ying]]></author>
</item>
<item>
<title><![CDATA[DeepFusion-CDR: Prediction of Anticancer Drug Response Using a Multimodal Fusion Deep Learning Network Integrating Targets and Multi-omics Data]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202604120000003]]></link>
<description><![CDATA[&lt;b&gt;Objective&lt;/b&gt; Accurate prediction of anticancer drug response plays an important role in precision medicine and drug discovery. However, existing computational approaches often suffer from insufficient integration of heterogeneous biological data and limited generalization to unseen drugs. To address these challenges, this study proposes DeepFusion-CDR, a multimodal deep learning framework that integrates drug-target interaction information with multi-omics characteristics of cancer cell lines to improve the accuracy and generalization of anticancer drug response prediction.&lt;b&gt;Methods&lt;/b&gt; A drug-target interaction (DTA) prediction model based on the Kolmogorov-Arnold Network (KAN) was first developed to capture complex nonlinear relationships between drugs and target proteins. The pretrained model was then used to generate drug target activity profiles, which provide biologically meaningful representations of drug mechanisms of action. On the drug side, molecular fingerprints, molecular graph structures, and drug target activity profiles were integrated as complementary multi-view features to comprehensively characterize the chemical and biological properties of drugs. On the cell-line side, multi-omics data, including genomic mutations, gene expression profiles, and DNA methylation information, were incorporated to describe the molecular heterogeneity of cancer cells. Subsequently, a multimodal deep fusion architecture was designed to jointly model the interactions between drug features and cell-line features, enabling accurate prediction of drug responses. The proposed framework was evaluated on the Genomics of Drug Sensitivity in Cancer (GDSC) dataset under different experimental settings, and its robustness and generalization capability were further assessed using the independent Cancer Therapeutics Response Portal version 2 (CTRPv2) dataset.&lt;b&gt;Results&lt;/b&gt; Experimental results on the GDSC dataset demonstrated that DeepFusion-CDR consistently outperformed several state-of-the-art baseline methods and achieved superior predictive performance across multiple evaluation scenarios. The model demonstrated strong generalization capability, particularly in challenging settings involving unseen drugs. Validation on the independent CTRPv2 dataset further confirmed the model’s ability to generalize across different datasets. In addition, ablation studies revealed that both drug target activity profiles and multi-omics features made significant contributions to prediction performance. Removing any major feature modality led to a measurable decrease in model accuracy, indicating that different data sources provide complementary information for drug response prediction. These findings highlight the importance of multimodal collaborative learning and demonstrate the effectiveness of incorporating drug-target interaction knowledge into predictive modeling.&lt;b&gt;Conclusion&lt;/b&gt; DeepFusion-CDR achieves accurate prediction of anticancer drug responses by integrating drug mechanism-related information with multi-omics characteristics of cancer cell lines. The incorporation of drug target activity profiles provides complementary biological information beyond traditional chemical structure descriptors and enhances the predictive capability of the model for unseen drugs. By combining drug-target interaction knowledge with heterogeneous biological data within a unified deep learning framework, DeepFusion-CDR offers a promising computational approach for precision medicine, drug repurposing, and anticancer drug discovery.]]></description>
<pubDate>2026/6/26 20:42:22</pubDate>
<category><![CDATA[分子生物学中的计算资源——方法、数据库与算法驱动的机制解析与功能发现专题]]></category>
<author><![CDATA[LIN Wei-Zhong,LIU Zi,QIU Wang-Ren,WU Huan,XIAO Xuan,YANG Shuang]]></author>
</item>
<item>
<title><![CDATA[MADS-Net: a Multi-scale Attention and Dynamic Sparse Mask Fusion Network for Electrical Impedance Tomography Image Reconstruction in Breast Screening]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202604150000002]]></link>
<description><![CDATA[<b>Objective</b> To address the key challenges in breast electrical impedance tomography (EIT) reconstruction including the severe ill-posedness of the inverse problem, limited measurement information from the electrodes, low contrast of small lesions, as well as the common drawbacks of traditional reconstruction methods such as boundary blurring, low spatial resolution, and weak small-target detection capability, and to overcome the limitations of existing deep learning approaches namely low training efficiency, insufficient physical consistency, and substantial information loss during the low-to-high dimensional mapping process, this study proposes a multi-scale attention and dynamic sparse mask fusion network (MADS-Net). The proposed method aims to enhance high-resolution reconstruction accuracy, small-lesion detectability, noise robustness, and computational efficiency in breast-screening-oriented EIT, thereby providing a feasible solution for the application of EIT in breast functional imaging.<b>Methods</b> The proposed network adopts a strategy of "locate first, reconstruct later". It realizes adaptive allocation of computational resources through a dynamic mask module, alleviates information loss in the low-to-high dimensional mapping process <i>via</i> a multi-scale attention mechanism, and embeds physical constraints to improve the physical rationality of reconstruction results. The performance of the proposed method was validated through systematic numerical simulations, agar phantom experiments, and porcine tissue experiments. Comparisons were made with mainstream methods including the Gauss-Newton algorithm, convolutional neural networks, U-Net, and Deep D-Bar. The image correlation coefficient (ICC), root mean square error (RMSE), and peak signal-to-noise ratio (PSNR) were adopted as quantitative evaluation metrics. Furthermore, lesion-level evaluation metrics were introduced to assess the capability of different methods in reconstructing abnormal target boundaries and small-sized target regions.<b>Results</b> Experimental results demonstrate that MADS-Net outperforms all comparison methods across all test scenarios. In numerical simulations, it achieves higher accuracy in target morphology and spatial location recovery as well as better background suppression. In agar phantom experiments, its detection and imaging reliability for small targets is significantly superior to the comparison methods. In porcine tissue experiments, the model maintains good generalization performance and can adapt to complex biological tissue imaging scenarios. Quantitative results show that MADS-Net achieves an average <i>ICC</i> of 0.917 6±0.048 8, an <i>RMSE</i> as low as 0.060 6±0.031 6, and a <i>PSNR</i> of 23.893 9±2.685 3 dB. It successfully detects tiny targets as small as 5 mm within a 100 mm diameter sensing field, reduces the total training duration by 23.5% compared with the baseline method, and maintains stable reconstruction performance even under strong noise interference.<b>Conclusion</b> The results demonstrate that MADS-Net achieves favorable EIT reconstruction performance in numerical simulations, agar phantom experiments, and porcine tissue experiments, even under common practical imaging challenges including low signal-to-noise ratio and blurred tissue boundaries. This study provides a methodological reference for further research on EIT in breast-screening-related scenarios and other medical functional imaging tasks, and also offers a low-cost, radiation-free alternative for breast lesion screening that aligns with the clinical demand for non-invasive diagnostic tools. It should be noted that real clinical breast data have not yet been used for validation in this study, and the clinical applicability of the proposed method requires further investigation. Future work will prioritize collecting multi-center real clinical breast datasets, and further optimize the model""s generalization ability to adapt to individual differences in breast tissue composition to promote its clinical application.]]></description>
<pubDate>2026/6/26 17:08:48</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CHEN Huai-Jin,DING Li,HU Song-Pei,WANG Jia-Hui,YAO Jia-Feng,YE Xia,YU Cheng-Tao]]></author>
</item>
<item>
<title><![CDATA[Lysosomal Homeostasis and Chemoresistance in Liver Cancer: Natural Product-based Combination Strategies Targeting Lysosomes]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202603120000001]]></link>
<description><![CDATA[Liver cancer is one of the world""s serious diseases today because of its high frequency and fatality rate, genetic differences, and limited effectiveness of late-stage therapy. Although chemotherapy, targeted therapy, immunotherapy, ablation and transarterial chemoembolisation (TACE) have improved the disease control of some patients, recurrence and acquired resistance are still common, especially for tumors that are hypoxic, nutrient-deprived, acidic-stressed, vascularly insufficient and exposed to repeated drug pressure. A bad environment will cause a change in the quality-control system and metabolism of cancer cells, and as a result, lysosomes have started to alter. In addition to the above catabolic functions of lysosomes, they also take part in autophagic flux, substrate recycling, iron and lipid metabolism, nutrient sensing, drug distribution, membrane repair and cell death signalling. Under the stress of therapy in liver cancer cells, increased lysosomal acidification and enhanced terminal degradation lead to prolonged autophagy; TFEB/TFE3 promotes the formation of new lysosomes and lysophagosomes to sequester weakly basic drugs, thereby reducing the concentration of active drugs and mitigating proteotoxicity and oxidative stress to promote cell survival. The above processes produce a lysosome-dependent resistant phenotype that is particularly relevant to sorafenib and doxorubicin and other drugs whose effectiveness can be reduced by protective autophagy or changes in intracellular location. Conversely, the same dependency on lysosomal homeostasis is also a vulnerability. Natural products and monomeric compounds derived from Chinese herbal medicines have various structures, multiple target regulation capabilities, and the potential to act on several lysosome-related nodes simultaneously. Based on the evidence in this review, it is believed that such compounds may sensitise liver cancer cells by inhibiting V-ATPase-mediated acid hydrolysis, obstructing late-stage autophagy-mediated degradation, disrupting lysosomal calcium or membrane homeostasis, causing lysosomal membrane permeabilisation, reducing compensatory lysosomal biogenesis, promoting ferritin degradation and ferroptosis, or enhancing acid-responsive intracellular delivery. Agents that impair lysosomal function and protective autophagy, compounds that convert enlarged or drug-sequestering lysosomes into lethal targets, and nanodelivery systems that exploit the acidic environment of endolysosomes to co-deliver natural products with chemotherapeutic drugs are examples. Lysosome-targeted intervention will have different effects under different circumstances; for example, inhibiting autophagy may result in an increase in cytotoxic stress in some areas, whereas overstimulation of autophagy or iron release from lysosomes may induce autophagic cell death or ferroptosis in other areas. Therefore, the design of therapy should take into account the status of the tumour microenvironment, autophagic flux, lysosomal pH, TFEB/TFE3 activity, drug sequestration capacity, ferroptosis sensitivity, dosing sequence and delivery route. This review systematically examines the lysosomal homeostasis in the microenvironment of liver cancer, the mechanisms through which lysosomal adaptation contributes to chemoresistance, and the rationale for combining natural products with standard agents such as sorafenib and doxorubicin. Based on basic lysosome biology, pharmacodynamic and delivery data have also been collected; as a result, some applications for future studies have been proposed, such as dynamic monitoring of autophagy flux, <i>in vivo</i> spatial measurements of lysosomal functions, rational optimisation of combination therapy timings, and safety assessments in immunocompetent liver cancer models prior to clinical translation. Translation difficulties are also evident, such as insufficient tumour selectivity, pharmacokinetic limitations, compensatory lysosomal regeneration, toxicity to normal liver and immune cells, and a lack of validated predictive biomarkers. A new way will be found to use biomarkers to divide the patient group, optimize nanoparticles for better delivery, design specific schedules for combined treatments based on the problem they cause within the cell, etc., thereby overcoming drug resistance and reducing the harm patients suffer from toxic treatments. This system can help select biomarkers and rational drug pairs for the next round of lysosome-centred precision trials.]]></description>
<pubDate>2026/6/25 6:31:31</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HUANG Chun-Ping,LI Yong-Zhuo,ZHOU Jing]]></author>
</item>
<item>
<title><![CDATA[A Dual Breakthrough in Regulated Cell Death: From Cytoskeletal Disintegration in Anucleate Erythrocytes to Metabolic-immune Synergistic Membrane Lysis]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202605120000002]]></link>
<description><![CDATA[Regulated cell death (RCD) has long been conceptualized as an elaborate program orchestrated by the nucleus and mitochondria in eukaryotic cells. However, this paradigm was fundamentally changed in 2025 by two independent studies published in&lt;i&gt; Cell&lt;/i&gt;. One revealed that mature, enucleated erythrocytes execute a cytoskeletal disintegration-driven lysis&lt;i&gt; via&lt;/i&gt; a miniNLRP3-ASC-caspase-8-β-spectrin axis, termed spectrin-dependent death (spectosis), wherein caspase-8 undergoes a functional switch from an initiator to an executioner, reflecting an evolutionary adaptation in protein economy. The other uncovered mitoxypterilysis, a modality in which metabolic distress and innate immune signals converge to trigger mTORC2-mediated aberrant mitochondrial-plasma membrane contacts, culminating in localized lipid peroxidation and membrane rupture. Mitoxypterilysis shows a logic defined by dual metabolic-immune regulation. This paper systematically dissects the molecular architectures of both modalities, and through comparative analysis, delineates their distinctions from classical RCD pathways as well as their divergent dependencies on organellar integrity, triggering contexts, and executional programs. In parallel, we integrate the recent discovery of reductive death, which underscores a central metabolic checkpoint to contextualize these findings within an emerging framework. Finally, we evaluate their therapeutic implications in hemolytic diseases, oncology, and inflammatory pathologies, while critically reflecting on current limitations and future directions, with the aim of providing a renewed conceptual foundation for targeted intervention strategies.]]></description>
<pubDate>2026/6/24 23:06:51</pubDate>
<category><![CDATA[动态与评论]]></category>
<author><![CDATA[CHEN De-Jian,CHEN Ling-Yan,DAI Rong-Fang,JIANG Yi]]></author>
</item>
<item>
<title><![CDATA[Reconstructing The Testicular Niche: Mechanisms and Translational Perspectives of Stem Cell-derived Testicular Organoids]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202605060000002]]></link>
<description><![CDATA[Mammalian male germline development depends on a specialized gonadal somatic microenvironment. However, its &lt;i&gt;in vitro&lt;/i&gt; reconstruction remains challenging. Major barriers include the generation of appropriate supporting-cell lineages, organized tissue architecture, and culture conditions that sustain germ-cell maturation. Yoshino &lt;i&gt;et al&lt;/i&gt;. established a mouse pluripotent stem cell-derived testicular organoid model. This model reconstitutes the sex-determining region Y (Sry)-SRY-box transcription factor 9 (Sox9)-mediated sex-determination program and generates testicular somatic cell-like cells (TesLCs). When assembled with primordial germ cell-like cells (PGCLCs), TesLCs formed seminiferous tubule-like structures and supported male germline progression toward prospermatogonia and germline stem cell-like cells (GSCLCs). After transplantation into infertile recipient testes, organoid-derived GSCLCs produced fertilization-competent sperm and generated fertile offspring. The major significance of this work extends beyond sperm production. It integrates sex determination, germ-cell fate transition, and testicular niche self-organization into an experimentally tractable organoid system. This commentary discusses the technical strategy, sex-determination mechanism, value of testicular niche reconstruction, and translational limitations of this study. It also highlights its implications for &lt;i&gt;in vitro&lt;/i&gt; gametogenesis, male infertility modeling, and reproductive medicine.]]></description>
<pubDate>2026/6/24 23:04:04</pubDate>
<category><![CDATA[动态与评论]]></category>
<author><![CDATA[DONG Xia,GAN Mai-Lin,SHEN Lin-Yuan,ZHOU Tai-Zeng,ZHU Li]]></author>
</item>
<item>
<title><![CDATA[Mechanisms of Diabetic Tendinopathy and Exercise Intervention]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202604150000001]]></link>
<description><![CDATA[Diabetic tendinopathy is a common and disabling musculoskeletal complication of diabetes, clinically characterized by tendon thickening, pain, impaired healing capacity and compromised biomechanical performance, collectively undermining joint function and quality of life. Its pathogenesis is multifactorial. On the one hand, chronic hyperglycaemia promotes the abnormal accumulation of advanced glycation end products (AGEs) within tendon collagen, leading to non-enzymatic crosslinking and engagement of the receptor for AGEs (RAGE), which in turn triggers inflammasome activation and sustains inflammatory responses. On the other hand, the diabetic milieu disrupts collagen metabolic homeostasis, impairs microvascular function and induces peripheral neuropathy; together, these alterations drive extracellular matrix degeneration and weaken the mechanical properties of tendon. Exercise, as a non-pharmacological intervention, can ameliorate these pathological changes through multiple integrated mechanisms. First, exercise attenuates tendon inflammation and restores microenvironmental homeostasis. Regular physical activity reduces AGE-RAGE signalling, thereby suppressing downstream expression of tumour necrosis factor (TNF) and interleukin-1β (IL-1β), while upregulating the anti-inflammatory cytokine interleukin-10 (IL-10). This shift from a pro-inflammatory to a pro-resolving milieu not only restrains chronic inflammation but may also limit excessive inflammasome activation in tenocytes and tissue-resident immune cells. Second, exercise enhances local expression of insulin-like growth factor 1 (IGF-1), thereby activating the phosphoinositide 3-kinase (PI3K)-protein kinase B (Akt) signalling pathway. This axis stimulates tenocyte proliferation, augments synthesis of type I collagen —— the principal load-bearing component of tendon —— and thereby promotes tissue repair, preserves tensile strength and supports matrix synthesis and structural integrity. In addition, exercise improves blood supply and nutrient delivery to tendon by increasing the expression of vascular endothelial growth factor (VEGF), connective tissue growth factor (CTGF) and the small leucine-rich proteoglycan decorin (DCN), thereby enhancing capillary growth, coordinating collagen fibrillogenesis and actively suppressing pathological vascular calcification. Exercise also increases the expression of angiopoietin-like 4 (ANGPTL4), fibroblast growth factor 2 (FGF-2) and CD34. Through the concerted actions of these factors, exercise promotes angiogenesis, restores the microvascular network and ensures adequate oxygen and nutrient supply to relatively ischaemic tendon tissue. Finally, exercise elevates levels of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), supporting neuronal survival, axonal growth and the function of sensory and sympathetic nerve endings within tendon, thereby exerting neurotrophic and neuromodulatory effects and improving tendon innervation and neuromuscular control. Moreover, exercise upregulates collapsin response mediator protein 2 (CRMP-2), a molecule involved in axonal guidance and regeneration, and moderately increases the activity of substance P (SP), thereby helping to regulate neurogenic inflammation, pain perception and trophic support for tenocytes. Drawing together current evidence, this review systematically summarizes the mechanisms underlying diabetic tendinopathy and examines the mechanistic basis of exercise intervention, with the aim of providing a theoretical framework for the development of precise exercise strategies for affected individuals. However, several key issues remain unresolved: the therapeutic efficacy and mechanistic specificity of different exercise modalities in diabetic tendinopathy have yet to be defined, and early diagnostic biomarkers remain insufficiently characterized. Future studies should apply multi-omics approaches to profile AGE subtypes, miRNA signatures and collagen metabolic products, and should also clarify the adverse effects and underlying mechanisms of excessive exercise or mechanical overloading in diabetic tendinopathy. Such efforts will further elucidate the therapeutic effects and mechanisms of exercise in diabetic tendinopathy and provide a stronger basis for precision exercise prescription and fitness guidance in patients with diabetes.]]></description>
<pubDate>2026/6/23 8:39:17</pubDate>
<category><![CDATA[运动对糖尿病并发症的干预研究专题]]></category>
<author><![CDATA[DENG Rui,QIAN Shuai-Wei,WU Ya-Ke,XIE Yu-Miao,ZOU Fang]]></author>
</item>
<item>
<title><![CDATA[Transcranial Focused Ultrasound Stimulation of the Primary Somatosensory Cortex Evokes Hand Tactile Perception: The Effect of Sonication Duration<sup>△,</sup>]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202511120000001]]></link>
<description><![CDATA[<b>Objective</b> Transcranial focused ultrasound (tFUS) has emerged as a promising noninvasive neuromodulation technique capable of modulating neural activity with high spatial specificity. However, whether tFUS stimulation of the primary somatosensory cortex (S1) can reliably evoke conscious tactile perception without external peripheral sensory input remains unclear. Therefore, this study examined the feasibility of inducing hand-related tactile perception through targeted S1 stimulation and further investigated how sonication duration (SD), a key temporal parameter, influences the consistency of this perceptual response. The findings may provide empirical evidence for optimizing tFUS parameters in human somatosensory modulation.<b>Methods</b> Forty-eight healthy adults participated in the study and were assigned to two experiments. Experiment <i>1</i> included 24 participants and was designed to preliminarily examine whether S1-targeted tFUS could evoke hand-related tactile sensations. This experiment comprised two sub-experiments, Experiment <i>1</i>a and Experiment <i>1</i>b, with 12 participants in each. Specifically, Experiment <i>1</i>a used a randomized active stimulation protocol targeting the bilateral S1 to assess the initial feasibility of inducing contralateral tactile perception, whereas Experiment <i>1</i>b employed an alternating hemispheric design incorporating both active and sham stimulation to verify the specificity of the tFUS-induced sensations. Experiment <i>2</i> enrolled another 24 participants and used a real-sham dual-probe design to control for spatial tactile cues that might arise from probe-scalp contact. Five SD levels, including 200, 400, 600, 800, and 1 000 ms, were systematically tested to evaluate how stimulation duration influenced the behavioral response. The primary behavioral outcome was the perceptual consistency rate, quantified according to the accuracy of contralateral tactile localization.<b>Results</b> In Experiment <i>1</i>, 91.7% of participants reported reliable hand-related tactile sensations during active tFUS stimulation, including numbness, tingling, or similar sensory experiences. Contralateral localization accuracy under active stimulation was significantly higher than the 0.50 chance level (<i>P</i><0.05). In contrast, localization performance under sham stimulation did not differ from chance, suggesting that the observed tactile responses were mainly induced by active S1-targeted tFUS stimulation rather than nonspecific stimulation cues. In Experiment <i>2</i>, perceptual consistency rates significantly exceeded the chance level under the 400 and 1 000 ms SD conditions (<i>P</i><0.05), whereas no significant effect was observed at 200, 600, or 800 ms. Pairwise comparisons further showed that the 400 and 1 000 ms conditions produced significantly higher perceptual consistency rates than the 200 ms condition (<i>P</i><0.05).<b>Conclusion</b> tFUS stimulation of S1 can elicit distinct hand-related tactile sensations without peripheral sensory input, demonstrating the feasibility of using targeted cortical ultrasound stimulation to induce conscious somatosensory perception. The reliability of this perceptual effect was modulated by sonication duration, indicating that temporal stimulation parameters play an important role in shaping both the occurrence and consistency of behavioral responses. Among the tested conditions, 400 ms appeared to provide a favorable temporal window for generating stable tactile perception, whereas excessively short stimulation may be insufficient to produce consistent responses. These findings highlight the sensitivity of somatosensory networks to ultrasonic modulation and provide useful parameter guidance for the application of tFUS in noninvasive sensory enhancement and cortical functional mapping.]]></description>
<pubDate>2026/6/19 20:25:37</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CHEN Xu-Xu,LIANG Zhen,WANG Bo,XI Huan-Jun,ZHAO Xu-Dong]]></author>
</item>
<item>
<title><![CDATA[AutoMATA: an AI-enhanced Bioinformatics Platform for Multi-omics Data Processing, Exploration and Modelling]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202605070000002]]></link>
<description><![CDATA[<b>Objective</b> Multi-omics integration and analysis remain a major challenge in biomedical research. These tasks often require extensive coding skills and specialised bioinformatics expertise, which many biological and medical researchers do not have. Deep learning has emerged as a powerful approach for predictive modelling and data-driven discovery. However, most existing platforms focus only on traditional statistical analysis or basic machine learning. They do not combine deep learning support with standard statistical workflows. Moreover, none of them provide intelligent assistance to help with parameter tuning, error diagnosis, or result interpretation. To address this gap, we introduce AutoMATA, a fully code-free platform that streamlines multi-omics analysis from expression data to predictive modelling. AutoMATA is designed to lower the technical barrier for experimental biologists and clinical researchers who want to use advanced deep learning methods but lack programming experience.<b>Methods</b> AutoMATA''''s architecture is built around three core modules. The data processing and normalisation module automates essential steps such as gene and protein ID conversion and data normalisation. This module also allows users to integrate multi-omics data. The statistical analysis and visualisation module offers important and commonly used functions including differential expression analysis, principal component analysis, correlation analysis, and pathway enrichment for both GO and KEGG. Users can adjust thresholds and choose output formats for publication. The deep learning module provides twelve neural network architectures covering supervised, unsupervised, and semi-supervised learning. These include Multilayer Perception (MLP), Convolutional Neural Network (CNN), Recurrent Neural Network (RNN), Long Short-Term Memory (LSTM), Transformer, Autoencoder, Variational Autoencoder (VAE), Radial Basis Function Neural Network (RBFNN), Self-Organising Map (SOM), DeepCluster, Pseudo-Labeling, and Ladder Network. Users can customise key settings including epoch, regularisation method, regularisation weight, dropout rate, and feature selection method. Two training strategies (train-validation-test split and stratified K-fold) are available. In addition, two Artificial Intelligence (AI) agents, DeepSeek and Qwen, are integrated into the platform. These agents answer user questions about parameter suggestion, task failure diagnosis, and result interpretations based on the actual task context and platform logic.<b>Results</b> We demonstrate AutoMATA in three case studies using public datasets. First, for colon adenocarcinoma data, AutoMATA reproduces gold-standard differential expression and clustering results. It correctly identifies known upregulated genes such as CXCL3 and CXCL8, and visualises enriched pathways. This confirms that AutoMATA''''s statistical module works as reliably as existing tools. Second, using multi-omics data for bladder, pancreatic, and stomach cancers, AutoMATA''''s deep learning module predicts cancer recurrence with good performance. Recurrent neural networks achieve the best results, with accuracy above 79% for stomach cancer. The platform also reproduces known biomarkers such as CDK6 in bladder cancer. Third, for breast cancer subtype classification, AutoMATA achieves 88.2% accuracy using a tuned RNN model. This performance is better than traditional machine learning methods like logistic regression and random forest. The AI agents provide on-demand assistance, helping users understand why certain models perform better, suggest parameter adjustments, and explain the biological meaning of the output. This makes the platform especially useful for non-experts.<b>Conclusion</b> By offering advanced multi-omics integration, comprehensive statistical analysis, flexible deep learning modelling options, and built-in AI agents, AutoMATA empowers researchers to extract meaningful biological insights and build robust predictive models without writing any code. The platform and source code are freely accessible at<ext-link ext-link-type="uri" xlink:href="https://github.com/ABILiLab/AutoMATA">https://github.com/ABILiLab/AutoMATA</ext-link>.]]></description>
<pubDate>2026/6/18 17:56:14</pubDate>
<category><![CDATA[分子生物学中的计算资源——方法、数据库与算法驱动的机制解析与功能发现专题]]></category>
<author><![CDATA[BI Yue,GUO Xu-Dong,HAO Yi,JIA Pan,LI Fu-Yi,LIU Ning,RAN Zi-Xu,WANG Cong]]></author>
</item>
<item>
<title><![CDATA[Study of Single-cell Adhesion Kinetics by Fluidic Force Microscopy]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202603300000001]]></link>
<description><![CDATA[<b>Objective</b> Cell adhesion is a critical process that regulates cellular physiological functions. Quantitative characterization of adhesion dynamics is essential for elucidating the intrinsic mechanical mechanisms underlying cellular activities. Although atomic force microscopy-based single-cell force spectroscopy is widely used for single-cell adhesion measurements, it requires complex chemical modifications for preparation of live-cell probes, leading to limitations such as cumbersome operation, low throughput, and potential impacts on cell viability. Fluidic force microscopy, which combines atomic force microscopy with microfluidic probes, is a technique allowing the operation of force-controlled nanopipettes in aqueous environments. By applying negative or positive pressure <i>via</i> a pressure controller, a single living cell can be captured onto or released from the cantilever under physiological conditions. This procedure offers a simple workflow and high assay throughput for single-cell adhesion measurements without the need for chemical functionalization. In this study, fluidic force microscopy-based single-cell force spectroscopy was adopted to achieve long-term quantitative characterization of single-cell adhesion dynamics in a simpler and more efficient manner, comparing the dynamic differences in adhesion establishment between two cell lines with different differentiation levels.<b>Methods</b> HEK 293T and hTERT RPE-1 cells were non-invasively captured on the cantilever of a fluidic force microscope <i>via</i> its integrated microfluidic system during 40 h of adhesion culture. Cell-substrate detachment assays were performed, and force-distance curves were recorded to extract key mechanical adhesion parameters, including adhesion force, adhesion energy, and maximum detachment distance. These measurements were combined with real-time monitoring of cell spreading area to systematically characterize the dynamic evolution of single-cell adhesion.<b>Results</b> hTERT RPE-1 cells rapidly entered a stable adhesion phase within 1 h after seeding, with both area-normalized adhesion force and area-normalized adhesion energy reaching peak values. In contrast, HEK 293T cells required 4 h to achieve stable adhesion. Subsequently, the adhesion force, adhesion energy and maximum detachment distance of hTERT RPE-1 and HEK 293T cells stabilized at approximately 240 nN <i>vs</i>. 30 nN, 2.2 pJ <i>vs</i>. 0.12 pJ and 6 μm <i>vs</i>. 4 μm, respectively. hTERT RPE-1 cells reached the peak of area-normalized adhesion parameters earlier than HEK 293T cells, with their peak area-normalized adhesion force<sub> </sub>and area-normalized adhesion energy being substantially elevated relative to HEK 293T cells. HEK 293T cells presented stronger linear correlations among adhesion energy, maximum detachment distance<sub> </sub>and adhesion force compared with hTERT RPE-1 cells. For both cell lines, cell spreading area exhibited a weak correlation with adhesion force. Whereas the area-normalized adhesion parameters of HEK 293T cells remained relatively constant throughout the adhesion process, hTERT RPE-1 cells exhibited elevated values in the early phase, followed by a gradual decline. These results indicated distinct dynamic adhesion patterns between the two cell types, with hTERT RPE-1 cells exhibiting stronger adhesion strength and higher adhesion efficiency.<b>Conclusion</b> In this study, fluidic force microscopy-based single-cell force spectroscopy was successfully applied to perform long-term <i>in situ</i> quantitative measurement of the adhesion dynamics in single adherent cells. The approach revealed divergent adhesion patterns between HEK 293T and hTERT RPE-1 cells, suggesting a close association between cell differentiation and adhesion behaviors. These findings provide quantitative mechanical evidence for further understanding the underlying mechanisms of cell adhesion.]]></description>
<pubDate>2026/6/18 16:24:36</pubDate>
<category><![CDATA[技术与方法]]></category>
<author><![CDATA[HU Xi,LUO Yan,QIN Si-Ying,XU Tao,YOU Tian-Qi]]></author>
</item>
<item>
<title><![CDATA[Dual Targeting of TBK1 and JAK-STAT1 Pathways by (-)-epigallocatechin-3-gallate Suppresses Type I Interferon-driven Inflammation]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202603030000008]]></link>
<description><![CDATA[<b>Objective</b> Type I interferon (IFN-I) signaling is essential for antiviral innate immunity, yet its sustained or excessive activation contributes to the pathogenesis of several autoimmune diseases and interferonopathies, such as systemic lupus erythematosus and Aicardi-Goutières syndrome. Current strategies targeting this pathway, exemplified by JAK inhibitors, act mainly on downstream signal transduction and provide limited direct control over upstream IFN-I production, while also carrying the risk of broad immunosuppression. <i>Phyllanthus emblica</i> L. has long been used in traditional medicine for inflammatory disorders, but the bioactive constituent responsible for its regulation of IFN-I signaling and the underlying molecular mechanism have not been clearly defined. This study aimed to identify the active anti-inflammatory component of <i>P. emblica</i> and to characterize its mechanism of action on the IFN-I pathway in macrophages.<b>Methods</b> Active components of <i>P. emblica</i> and their candidate targets were screened by network pharmacology using the TCMSP and DrugBank databases (oral bioavailability≥30%, drug-likeness≥0.18) and intersected with inflammation-related genes retrieved from public databases. The predicted interaction between EGCG and IFN-I pathway proteins (TBK1, IRF3, STAT1) was evaluated by molecular docking, with BX795 and GSK8612 used as reference TBK1 inhibitors. Mechanistic experiments were performed in THP-1-derived macrophages and primary bone marrow-derived macrophages (BMDM). Upstream signaling was activated by transfection of the nucleic acid analogs poly(I∶C) and poly(dA∶dT) or by lipopolysaccharide (LPS) stimulation, whereas downstream signaling was activated by exogenous IFN-β. An siRNA-mediated TREX1 knockdown model was used to mimic endogenous nucleic acid-driven interferonopathy. Expression of IFN-β1 and interferon-stimulated genes (ISGs) was measured by RT-qPCR, protein phosphorylation by Western blot, and IFN-β secretion by ELISA. Cellular thermal shift assay (CETSA) and drug affinity responsive target stability (DARTS) were used to probe the interaction between EGCG and IRF3.<b>Results</b> Network pharmacology identified (-)-epigallocatechin-3-gallate (EGCG) as a candidate IFN-I-suppressive constituent of <i>P. emblica</i>, with predicted binding to TBK1, IRF3, and STAT1. Molecular docking yielded binding energies of -9.2, -7.2, and -8.2 kcal/mol for TBK1, IRF3, and STAT1, respectively, indicating an affinity for TBK1 comparable to that of the reference inhibitors BX795 (-5.7 kcal/mol) and GSK8612 (-6.4 kcal/mol). EGCG suppressed IFN-β1 and ISG mRNA expression under poly (I∶C), poly (dA∶dT), and LPS stimulation in both THP-1 macrophages and BMDM. At the protein level, EGCG reduced the phosphorylation of TBK1 and IRF3 without affecting the levels of the upstream sensors cGAS and RIG-I, and lowered IFN-β secretion in a concentration-dependent manner. CETSA and DARTS showed that EGCG did not enhance the thermal stability or protease resistance of IRF3, indicating that its effect on IRF3 is indirect. Following IFN-β stimulation, prolonged EGCG treatment reduced STAT1 phosphorylation in a time-dependent manner without an apparent change in IRF9, and partially attenuated ISG transcription; this effect was not monotonicly concentration-dependent, and CXCL10 showed the most consistent suppression. In TREX1-knockdown cells, the elevated mRNA levels of <i>ISG15</i>, <i>ISG56</i>, and <i>CXCL10</i> were reduced by EGCG.<b>Conclusion</b> EGCG suppresses IFN-I responses by concurrently inhibiting TBK1-IRF3-dependent IFN-β production and JAK-STAT1-mediated downstream transcription. These<i> in vitro</i> findings provide a mechanistic basis for the anti-inflammatory use of <i>P. emblica</i> in traditional medicine and identify EGCG as a candidate for further evaluation in interferon-driven autoimmune disease models.]]></description>
<pubDate>2026/6/17 11:05:14</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[JING Rui,LI Liang,LI Zhi-Min,LIU Huan,MAI Wei-Hua,SHENG Qi-Huan,SHI Jia-Lin,SUN Ying-Jie,XIE Xiao-Li,YANG Wen-Hao]]></author>
</item>
<item>
<title><![CDATA[Precise Assessment of Endometrial Receptivity: Microengineered Endometrial Chip Model Combined With The Endometrial Receptivity Scoring System]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202604140000003]]></link>
<description><![CDATA[The establishment of endometrial receptivity is a critical prerequisite for successful embryo implantation and early pregnancy. However, current clinical methods for assessing receptivity are insufficiently validated, and their reliability is inadequate for guiding precision medicine. Although microfluidic organ-on-a-chip models have emerged as promising &lt;i&gt;in vitro&lt;/i&gt; platforms garnering significant academic interest, their practical clinical translation has been hindered by challenges in accurately replicating patient-specific microenvironments and the lack of standardized quantitative evaluation systems. Recently, Lee &lt;i&gt;et al&lt;/i&gt;. published a groundbreaking study in &lt;i&gt;Nature Communications&lt;/i&gt;, which effectively addresses these critical limitations by integrating a patient-derived vascularized endometrium-on-a-chip (EoC) with a newly developed endometrial receptivity scoring system (ERS&lt;sup&gt;2&lt;/sup&gt;). This commentary offers a comprehensive analysis of the key findings from this work, systematically examining the design, construction, dynamic simulation validation, and translational potential of the EoC-ERS&lt;sup&gt;2&lt;/sup&gt; platform. This innovative approach successfully transforms conventional subjective assessments of endometrial receptivity into a digitized, objective, and quantitative evaluation framework. As a result, it establishes a robust foundation for a paradigm shift toward personalized infertility management and precision medicine in reproductive health.]]></description>
<pubDate>2026/6/15 13:32:56</pubDate>
<category><![CDATA[动态与评论]]></category>
<author><![CDATA[LIANG Xiao-Min,YUE Hui-Feng]]></author>
</item>
<item>
<title><![CDATA[Aerobic Exercise and MOTS-c Ameliorate Hepatic Oxidative Stress and Metabolic Disorder in Type 2 Diabetes <i>via</i> The NRF2/PPARγ Axis]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202603230000001]]></link>
<description><![CDATA[&lt;b&gt;Objective&lt;/b&gt; Type 2 diabetes mellitus (T2DM) often causes severe hepatic metabolic complications, dominated by metabolic dysfunction-associated steatotic liver disease (MASLD). Persistent hepatic steatosis and oxidative stress further trigger steatohepatitis and progressive liver damage, increasing the mortality risk of diabetic patients. Aerobic exercise effectively improves hepatic lipid metabolism and antioxidant capacity, but poor patient adherence restricts its long-term clinical application. Mitochondrial-derived mitochondrial open reading frame of the 12S rRNA type-c (MOTS-c) is a key peptide regulating insulin sensitivity and hepatic redox homeostasis. This study aimed to explore the protective mechanism of MOTS-c against T2DM-related liver injury and its combined beneficial effect with aerobic exercise &lt;i&gt;via&lt;/i&gt; the NRF2/PPARγ signaling axis. This study aimed to investigate whether MOTS-c cooperates with aerobic exercise to alleviate T2DM-associated hepatic oxidative stress and metabolic dysfunction by activating the NRF2/PPARγ axis, and to clarify the molecular and transcriptomic characteristics of their combined intervention.&lt;b&gt;Methods&lt;/b&gt; Stable MOTS-c overexpression and knockdown HepG2 cell lines were constructed using lentiviral transfection. An oleic acid-induced cellular lipid accumulation model and Nrf2-knockout cell model were applied to verify the NRF2-dependent mechanism of MOTS-c. Intracellular lipid deposition, triglyceride levels, antioxidant enzyme activities, and the expression of NRF2/PPARγ pathway-related genes and proteins were detected. &lt;i&gt;In vivo,&lt;/i&gt; a T2DM rat model with obvious hepatic steatosis was established &lt;i&gt;via&lt;/i&gt; a high-fat and high-sucrose diet combined with streptozotocin injection. Model rats received aerobic exercise, MOTS-c intraperitoneal injection, or combined intervention. We detected systemic glycolipid metabolic indicators, hepatic histopathological changes, and the expression of core proteins in the hepatic NRF2/PPARγ axis. Hepatic transcriptomic sequencing was performed to screen differentially expressed genes (DEGs) and enrich key pathways co-regulated by MOTS-c and aerobic exercise.&lt;b&gt;Results&lt;/b&gt; Cellular results showed that MOTS-c overexpression significantly reduced oleic acid-induced lipid deposition, enhanced antioxidant enzyme activity, and upregulated NRF2 and PPARγ expression. Conversely, MOTS-c knockdown aggravated hepatic lipid accumulation and oxidative damage and inhibited NRF2/PPARγ pathway activation. Nrf2 knockout completely eliminated the protective effects of MOTS-c on lipid metabolism and redox balance, confirming its NRF2-dependent regulatory mechanism. In T2DM rats, both MOTS-c supplementation and aerobic exercise effectively improved insulin resistance, corrected glycolipid metabolic disorders, and alleviated hepatic steatosis, while consistently activating the hepatic NRF2/PPARγ axis. Compared with single intervention, the combined treatment showed a better improvement trend in hepatic metabolic and oxidative injury, without definitive synergistic effects. Transcriptomic analysis revealed that the co-regulated DEGs of MOTS-c and aerobic exercise were primarily enriched in lipid metabolism and PPAR signaling pathways, with multiple antioxidant and lipid-regulating genes significantly modulated by combined intervention.&lt;b&gt;Conclusion&lt;/b&gt; MOTS-c exhibits obvious exercise-mimetic hepatoprotective effects in T2DM. It activates the hepatic NRF2/PPARγ axis to strengthen antioxidant defense, stabilize lipid metabolism, and relieve T2DM-associated hepatic steatosis and oxidative damage. Furthermore, MOTS-c produces additive beneficial effects with aerobic exercise, showing a superior intervention trend on diabetic liver dysfunction. This study identifies the NRF2/PPARγ axis as the core mechanism of MOTS-c-regulated hepatic protection, elucidates the transcriptomic basis of combined intervention, and provides a reliable theoretical basis and potential therapeutic target for clinical intervention in T2DM-complicated MASLD.]]></description>
<pubDate>2026/6/15 13:25:09</pubDate>
<category><![CDATA[运动对糖尿病并发症的干预研究专题]]></category>
<author><![CDATA[CHEN Fei-Long,Fu Yu,LI Shun-Chang,LI Zhi-Yu,Lü LEI,WANG Tu-Tu,XING Cheng-Yuan]]></author>
</item>
<item>
<title><![CDATA[High-throughput Meets Visualization: a Microscopy-based CRISPR Screening Platform in Ciliary Biology]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202604270000001]]></link>
<description><![CDATA[While pooled CRISPR screens have revolutionized functional genomics by enabling genome-scale interrogation, they have long faced a fundamental compatibility challenge with high-resolution microscopy-based phenotypes. The core issue lies in the technical disconnect between pooled screening formats, where cells are typically analyzed in bulk populations, and microscopy approaches that require spatial resolution and single-cell visualization. This limitation has created a significant blind spot in functional genomics, preventing researchers from systematically linking genetic perturbations to detailed subcellular architectural changes. To bridge this critical technological gap, a recent landmark study published in &lt;i&gt;Developmental Cell&lt;/i&gt; has unveiled an integrated microscopy-based CRISPR screening platform that represents a paradigm shift in the field. The most innovative breakthrough of the platform involves extending photoactivation-based labeling techniques to fixed, immunostained cells, thereby overcoming a key limitation of prior approaches that were restricted exclusively to live-cell reporter systems. This methodological advancement allows researchers to capture transient cellular states and preserve delicate subcellular structures that would otherwise be lost in live-cell imaging scenarios. By seamlessly integrating this enhanced labeling approach with sophisticated automated imaging workflows and high-content analysis pipelines, the system enables unprecedented high-throughput, organelle-level phenotypic profiling at true single-cell resolution. The platform’s capabilities were demonstrated through its application to a comprehensive genome-wide screen for regulators of cilium assembly, a complex cellular process involving intricate cytoskeletal dynamics and membrane remodeling events. The screening results validated the platform’s robustness by successfully recapitulating known ciliary machinery components while simultaneously uncovering novel regulatory factors. Most notably, the study identified SMIM27/TZMP1, a conserved transition zone microprotein, as a previously unrecognized regulator of ciliary function. This discovery provides crucial insights into the molecular mechanisms governing ciliary transition zone barrier formation and selectivity. This accessible and versatile framework effectively overcomes longstanding bottlenecks in microscopy-based screening technologies, offering a generalizable strategy for dissecting organelle biology and cellular architecture at scale. The platform’s ability to combine genome-wide screening power with detailed morphological analysis opens new avenues for investigating cellular responses to genetic perturbations across diverse biological contexts.]]></description>
<pubDate>2026/6/13 8:47:28</pubDate>
<category><![CDATA[动态与评论]]></category>
<author><![CDATA[HE Ran,LI Jian-Chao,XU Xiao-Han]]></author>
</item>
<item>
<title><![CDATA[Platelet Lipid Metabolism — a Pathway Involved in Organ Function and Disease Development]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202604040000001]]></link>
<description><![CDATA[Platelets play a crucial role in hemostasis and thrombosis. They have a complex and active metabolic system, particularly regarding lipid metabolism. The active and intricate lipid metabolism within platelets plays a central role in platelet activation, signal transduction, and functional regulation, making it crucial for studying the pathophysiological mechanisms of diseases. The platelet membrane structure is highly complex and it contains various lipids, including phospholipids, sphingolipids, cholesteryl esters, and triglycerides, etc. Current research has elucidated multiple metabolic pathways in platelets, such as phospholipid and sphingolipid metabolism, which profoundly influence platelet aggregation, release, and inflammatory responses. Upon activation, platelets release various lipids that interact with inflammatory cells in a paracrine manner. This review systematically describes the key lipid metabolism and its dynamic functional regulation. Lipid metabolism regulates processes such as platelet production, aging, and activation. This review emphasizes the interaction between lipid droplets and mitochondria, which is closely related to platelet activation. For instance, platelet-derived extracellular vesicles can transfer dysfunctional mitochondria from platelets to hepatocytes, leading to the dysfunction of lipid droplet-bound mitochondria and abnormal lipid droplet metabolism, thereby affecting hepatic lipid metabolism. The review summarizes interactions between platelet lipid metabolism and other cells, including leukocytes, erythrocytes, and lymphocytes. However, there are few studies on the interactions between platelets and cells through lipid metabolism, and the direct evidence is scarce. Further research is recommended in the future. It further explores the relationships between platelet lipid metabolism and the reproductive system, musculoskeletal system, the central nervous system, and the gut microbiota. Additionally, it reviews the close associations between platelet lipid metabolism and diseases such as diabetes, metabolic dysfunction-associated steatotic liver disease, immune thrombocytopenia, metabolic syndrome, and thrombotic disorders (thromboembolic diseases). For example, antiphospholipid syndrome (APS), typically characterized by reproductive impairment, may be associated with enhanced platelet activation and elevated phospholipase A2 activity in patients with APS. Moreover, lipid metabolism in the bone marrow microenvironment can promote platelet production. Under cellular stress, platelets transfer mitochondria to macrophages; in the spinal cord injury model, this process can regulate energy and lipid metabolism, leading to nerve and myelin regeneration and ultimately promoting the recovery of motor function. These findings indicate that modulating energy and lipid metabolism can influence platelet function, suggesting that targeting platelet lipid metabolism may provide a direction for disease treatment. Furthermore, the review covers the research on platelet lipid metabolism and related drugs, including traditional Chinese medicines and natural products. As the first selective 12-lipoxygenase (12-LOX) inhibitor to enter clinical trials, ML355 will facilitate future research on the biology of 12-LOX and its effects on regulation of platelet activity, hemostasis, and thrombosis, and promote the discovery of structure-based drugs. However, research on platelets and lipid metabolism still faces numerous challenges. For example, lipid droplet-mitochondria interaction in the liver regulates lipid metabolism. Meanwhile, there is controversy over whether autophagy serves a protective function or promotes the occurrence of liver disease. It is speculated that the interaction between mitochondrial autophagy and lipid droplets may be a future research direction. The precise regulatory mechanism of lipid metabolism and how to develop novel antithrombotic and anti-inflammatory drugs with high specificity and low side effects by targeting lipid metabolism remain current challenges. In summary, this review provides a comprehensive overview of platelet lipid metabolism, its interactions with other cells, and its roles in organ function and diseases. This contributes to the discovery of new disease-specific lipid biomarkers and drug targets. Future research could focus on structural modifications of drugs targeting lipid metabolism to enhance selectivity, offering directions for improving safety and efficacy, and developing the most effective individualized treatment plans for patients.]]></description>
<pubDate>2026/6/13 8:45:12</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Lin-Xi,CHEN Zhe,SU Tao,YANG Li]]></author>
</item>
<item>
<title><![CDATA[Fluorescence Suppression Method of Raman Spectroscopy and Its Application in Skin and Cosmetics Analysis]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202604080000002]]></link>
<description><![CDATA[Owing to its inherent advantages—such as being non-destructive, rapid, highly molecule-specific, and minimally interfered with by moisture—Raman spectroscopy has been widely adopted in the fields of skin barrier function assessment, monitoring the transdermal penetration of active cosmetic ingredients, and the identification and quality control of cosmetic products. Despite these strengths, the practical application of this technique faces a significant bottleneck: the strong fluorescence background generated by endogenous skin components and exogenous cosmetic additives. Endogenous skin substances, such as structural proteins (<i>e.g</i>., collagen and elastin), metabolic coenzymes (<i>e.g</i>., nicotinamide adenine dinucleotide), and pigments (<i>e.g</i>., melanin), together with exogenous cosmetic constituents like organic colorants, chemical sunscreens, and fragrances, often possess strong absorption and emission characteristics. When excited by lasers, these components produce a fluorescence background that can be 10<sup>6</sup> to 10<sup>8</sup> times stronger than the Raman scattering signals, effectively masking the inherently weak vibrational fingerprint information. In recent years, driven by the rapid development of optoelectronic hardware and artificial intelligence algorithms, fluorescence suppression strategies have evolved from isolated, single-method approaches into comprehensive, multi-level synergistic systems. These systems are categorized into three distinct tiers: sample preparation, signal acquisition, and data processing. At the sample preparation level, techniques such as photobleaching and surface-enhanced Raman spectroscopy (SERS) are employed to eliminate or bypass the generation of fluorescence at the source. At the signal acquisition level, instrumental improvements—including the use of long-wavelength near-infrared excitation (typically 785 nm or 1 064 nm), confocal spatial filtering, and shifted excitation Raman difference spectroscopy (SERDS)— are utilized to physically isolate Raman signals from the fluorescence background. Furthermore, at the data processing level, numerical baseline correction methods such as polynomial fitting, penalized least squares (<i>e.g</i>., airPLS, arPLS), wavelet transform, and derivative algorithms are increasingly integrated into the analytical pipeline to extract Raman spectral features from mixed signals without increasing hardware costs or acquisition time. This review provides a systematic categorization and critical evaluation of these fluorescence suppression methods, detailing their underlying principles, technical advantages, and inherent limitations in diverse experimental setups. By focusing on critical application scenarios—including skin barrier assessment, percutaneous absorption monitoring, the routine quality control of cosmetics, and the emerging field of portable on-site detection—this paper explores the current state of technique selection and optimization. Finally, the article discusses future development trends, emphasizing the necessity of constructing adaptive, tiered suppression strategies, developing intelligent and automated data processing algorithms, and promoting the integration of portable, multi-modal diagnostic devices. The objective of this review is to provide a comprehensive technical reference to facilitate the transition of Raman spectroscopy from a specialized laboratory tool into a routine, robust analytical platform for advancements in skin science and cosmetic research.]]></description>
<pubDate>2026/6/11 16:58:50</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Yun-Xia,LIN Shi-Wen,LIU Juan,LIU Ya-Nan,MA Xiao-Yue,WANG Jia-Rong,XI Guang-Cheng,ZHU Jian-Yu]]></author>
</item>
<item>
<title><![CDATA[The Dual Role and Clinical Potential of Core Fucosylation in Liver Diseases]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202604120000004]]></link>
<description><![CDATA[Core fucosylation, catalyzed exclusively by α-1,6-fucosyltransferase 8 (FUT8), is an evolutionarily conserved post-translational modification that has emerged as a central regulatory hub linking liver homeostasis, chronic disease progression, and malignant transformation. Liver diseases, particularly hepatocellular carcinoma, remain a leading global health burden characterized by late diagnosis, limited therapeutic options, and poor overall survival. While aberrant glycosylation is now recognized as a hallmark of cancer and inflammatory disorders, existing research on FUT8-mediated core fucosylation in liver diseases remains fragmented: the dynamic functional switch of FUT8 from a homeostatic regulator to a pathological driver across the full disease continuum has not been systematically delineated, and the integrated mechanisms by which core fucosylation modulates oncogenic signaling, metabolic reprogramming, and immune evasion remain poorly understood. This review synthesizes recent advances to establish a unified framework for understanding the dual role of core fucosylation in liver physiology and pathology, and evaluates its translational potential for precision medicine. At the molecular level, FUT8&quot;&quot;s unique catalytic specificity makes core fucosylation an irreplaceable modification, as evidenced by the perinatal lethality and severe organ dysfunction in &lt;i&gt;Fut8&lt;/i&gt; knockout mice. In hepatocellular carcinoma, genomic amplification of guanosine 5&quot;&quot;-diphosphate-fucose biosynthetic enzymes provides metabolic support for aberrant core fucosylation. FUT8 expression is tightly regulated by a multi-layered network: transcriptional activation &lt;i&gt;via&lt;/i&gt; Wnt/β-catenin and wild-type p53, epigenetic upregulation by lncRNAs, post-transcriptional repression by miR-122-5p and miR-34a, and virus-specific induction by hepatitis B virus/hepatitis C virus. Physiologically, core fucosylation maintains liver homeostasis through four core mechanisms: it acts as a molecular switch for epidermal growth factor receptor/hepatocyte growth factor receptor signaling to enable liver regeneration; directs polarized secretion of hepatocyte-derived glycoproteins into bile ducts; modulates cholesterol metabolism &lt;i&gt;via&lt;/i&gt; the hepatocyte nuclear factor 1α-proprotein convertase subtilisin/kexin type 9-low density lipoprotein receptor axis; and regulates aging through Insulin-Like Growth Factor 1 Receptor signaling. Pathologically, core fucosylation exhibits context-dependent dual functions: in liver fibrosis, FUT8 upregulation in hepatic stellate cells forms a negative feedback loop that limits excessive fibrogenesis; in hepatocellular carcinoma, however, aberrant FUT8 overexpression drives cell-autonomous malignancy by constitutively activating epidermal growth factor/hepatocyte growth factor receptor, transforming growth factor-β/Smad, and Wnt/β-catenin pathways, while simultaneously establishing a multi-layered immune evasion network by stabilizing programmed cell death ligand 1 and cluster of differentiation 47, and impairing natural killer cell homeostasis &lt;i&gt;via &lt;/i&gt;interleukin-2 receptor β glycosylation. Clinically, stage-specific core fucosylation biomarkers enable non-invasive monitoring of liver disease progression: low molecular weight kringle-Fc fusion protein outperforms conventional markers for early fibrosis detection, while alpha-fetoprotein-L3 and novel glycopeptides (α-2-macroglobulin N-linked glycosylation site 1424, lumican core fucosylated peptide) significantly improve early hepatocellular carcinoma diagnosis, especially in alpha-fetoprotein-negative patients. Next-generation detection technologies (chemoenzymatic labeling, site-specific mass spectrometry) overcome the specificity limitations of traditional lectin assays. Therapeutically, four promising strategies are emerging: small-molecule FUT8 inhibitors, afucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity, Fuc-modified targeted drug delivery systems, and core fucose-specific lectins for NASH treatment. The core challenge for clinical translation lies in FUT8’s inherent “double-edged sword” effect, as systemic inhibition disrupts its essential physiological functions beyond pathological roles. Long-term systemic FUT8 blockade not only impairs post-injury liver regeneration by abrogating epidermal growth factor/hepatocyte growth factor receptor signaling but also disrupts cholesterol homeostasis &lt;i&gt;via&lt;/i&gt; the hepatocyte nuclear factor 1α-proprotein convertase subtilisin/kexin type 9-low density lipoprotein receptor axis, leading to dyslipidemia and altered bile secretion. Critically, it compromises immune surveillance by destabilizing interleukin-2 receptor β on natural killer cells, reducing their cytotoxic activity against malignant and virally infected cells, and impairs IgG Fc-mediated effector functions, increasing susceptibility to infections. This fundamental trade-off between therapeutic efficacy and systemic toxicity necessitates a paradigm shift from non-specific global inhibition to precision modulation of pathological core fucosylation. By addressing these critical challenges, FUT8-mediated core fucosylation has the potential to transform liver disease management from late-stage intervention to early detection and precision therapy, ultimately improving patient outcomes and reducing the global burden of liver diseases.]]></description>
<pubDate>2026/6/10 11:09:02</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DU Hao-Qi,GUO Yong-Hong,LEI Zi-Han,XU Hui-Min,ZHAO De-Zhi]]></author>
</item>
<item>
<title><![CDATA[Technique and Application of Deep Learning-based EEG Denoising]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202604290000003]]></link>
<description><![CDATA[Electroencephalography (EEG) is a non-invasive neurophysiological monitoring technique. It records the electrical activity of the cerebral cortex using electrodes placed on the scalp surface. Owing to its high safety, portability, and millisecond-level temporal resolution, EEG has been widely utilized in a variety of fields, including clinical diagnosis, brain-computer interfaces (BCIs), and cognitive neuroscience research. However, due to its microvolt-level amplitude, EEG is highly susceptible to various artifacts, including electrooculographic (EOG), electrocardiographic (ECG), electromyographic (EMG), and power line interference (PLI). These artifacts can obscure genuine neural activity and introduce spurious electrophysiological features. Consequently, they may compromise EEG signal quality, thereby reducing the reliability of downstream analyses. To address this issue, numerous EEG artifact removal methods have been developed, including both traditional denoising techniques and deep learning-based approaches. Traditional EEG denoising methods have long served as the primary solutions for artifact removal. Representative approaches include filtering, regression, and blind source separation. Although these methods have demonstrated effectiveness in specific scenarios, they suffer from several inherent limitations. Filtering assumes that artifacts and EEG signals can be separated in the frequency domain, but many artifacts, such as EOG and EMG, overlap with EEG spectra, which may lead to the loss of valuable neural information. Regression methods require high-quality artifact references to estimate and subtract contaminations, limiting their effectiveness in reference-free scenarios. Blind source separation can remove artifacts without external references, but it typically requires the number of EEG channels to exceed the number of sources, restricting its application in single- or low-channel EEG recordings. Deep learning-based EEG denoising methods address these limitations effectively. First, they learn the nonlinear mapping between contaminated and clean EEG directly from data in an end-to-end manner. This approach does not rely on assumptions about spectral separability, thereby preserving neural activity more completely. Second, the reference information is incorporated during the training phase, allowing the trained model to perform artifact removal independently without external references. Third, deep learning models can be flexibly designed to accommodate various recording setups, achieving robust denoising for both high-density and single-channel EEG. Collectively, these advantages enable deep learning-based methods to overcome the main challenges of traditional approaches, providing more accurate and reliable EEG signal recovery. The superior denoising performance of deep learning-based EEG denoising methods has attracted increasing attention in EEG artifact removal research. As a result, many deep learning-based denoising methods have been developed and successfully applied in neural engineering areas. However, a systematic review of the techniques and applications in this field is still lacking. To address this gap, this paper reviews recent advances in deep learning-based EEG denoising from four perspectives: technical principle, benchmark dataset, denoising model, and evaluation method. Representative applications in neural signal analysis and BCI decoding are also summarized. Furthermore, the advantage, existing challenge, and future research direction of deep learning-based EEG denoising are discussed. This review aims to provide valuable theoretical insights and technical guidance for researchers. It is also expected to promote further advances and broader applications of deep learning-based EEG denoising techniques.]]></description>
<pubDate>2026/6/10 10:19:53</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[SHAN Bao-Lian,HUANG Yong-Zhi,MENG Jia-Yuan,MING Dong,XU Min-Peng,YU Hai-Qing,JUNG Tzyy-Ping]]></author>
</item>
<item>
<title><![CDATA[Long-chain Fatty Acids in Atherosclerosis: Focus on Metabolites and Mechanisms]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202512050000001]]></link>
<description><![CDATA[Atherosclerosis (AS) remains the core pathological basis underlying the high incidence and high rates of mortality and disability associated with cardiovascular disease (CVD) worldwide. Its essence is not merely lipid deposition, but rather an immune-mediated disease of the vascular wall characterized by an interplay of lipid metabolism disorders and chronic inflammation, with damage to vascular endothelial cells serving as the initiating event. As the disease progresses, it involves complex synergistic interactions among various cellular components, including endothelial cells, macrophages, and inflammatory cells, ultimately leading to plaque formation, instability, and even fatal thrombotic events. In recent years, the central driving role of lipid metabolic reprogramming in the progression of AS has garnered increasing attention from the scientific community. Among the vast array of lipid molecules, long-chain fatty acids (LCFAs) have become a primary focus of research due to their exceptional physiological functions. Traditional views have primarily emphasized the basic physiological functions of LCFAs: serving as highly efficient energy substrates through mitochondrial β-oxidation and acting as key structural components of cellular phospholipid membranes. However, emerging evidence clearly indicates that the functions of LCFAs extend far beyond those of mere metabolic fuel. They also act as potent bioactive signaling molecules, playing an indispensable multidimensional role in the pathogenesis of AS. Equally noteworthy and representing a paradigm shift in cardiovascular research is the emerging theory of the “gut-heart axis”. This theoretical framework views the human gut microbiota—comprising trillions of microorganisms—as a critical and metabolically active “bioreactor”. A wealth of clinical and multi-cohort epidemiological studies have conclusively demonstrated that imbalances in the composition and function of the gut microbiota are highly correlated with the clinical risk and severity of AS. Within this axis, the gut microbiota serves as the primary processing hub for dietary lipids. It actively participates in the digestion and biochemical remodeling of LCFAs, thereby altering their saturation and chemical structure and generating a wide variety of gut microbial metabolites. The effects of these gut-derived lipid metabolites extend far beyond the local intestinal microenvironment. Upon entering the bloodstream, these circulating microbiota metabolites act as endocrine signals. Given the extreme complexity of the underlying mechanisms, a comprehensive elucidation of the synergistic and bidirectional interactions between LCFAs and the gut microbiota in vascular pathology is particularly urgent. Therefore, this article aims to provide a systematic review of the multidimensional regulatory mechanisms of LCFAs and their associated gut microbiota metabolites in the onset, progression, and clinical manifestations of AS. By thoroughly exploring the interaction patterns within the “LCFAs-gut microbiota-AS” triad, this review seeks to fundamentally expand our understanding of the pathogenesis of CVDs. More importantly, translating these mechanistic insights into clinical practice holds tremendous promise. We hope to provide a solid theoretical foundation for the future development of novel AS prevention and treatment strategies based on non-traditional approaches. These include precision nutritional interventions (<i>i.e.</i>, dietary lipid intake plans tailored to an individual’s unique microbiome profile) and targeted microbiome modulation therapies (such as next-generation probiotics, prebiotics, or specific metabolite supplements). Targeting the gut as a “reactor” to treat vascular wall lesions represents a promising direction for future cardiovascular medicine.]]></description>
<pubDate>2026/6/7 10:41:40</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LI Zhao-Bing,LIU Shi-Yang,LIU Wang,PAN Jin-Qian,ZHOU Qin-Yi]]></author>
</item>
<item>
<title><![CDATA[Design Strategies and Antitumor Applications of Zinc-based Nanomaterials for Achieving “Zinc Overload”]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202603070000002]]></link>
<description><![CDATA[“Zinc overload” has emerged as a promising strategy in tumor nanomedicine, wherein exogenous modulation of metal ion homeostasis selectively triggers cancer cell death. Among various bioactive ions, zinc (Zn<sup>2+</sup>) stands out due to its unique ability to simultaneously disrupt energy metabolism, damage mitochondria, degrade mutant p53, and activate antitumor immunity. Notably, tumor cells exhibit greater sensitivity to Zn<sup>2+</sup> overload while normal cells maintain higher tolerance. This review systematically summarizes design strategies for achieving “zinc overload” using biodegradable zinc-based nanomaterials, focusing on two fundamental questions: how to specifically deliver Zn<sup>2+</sup> to tumors (targeted delivery), and how to trigger controlled release at the tumor site (release strategies). Current challenges are critically analyzed and future perspectives are offered. For targeted delivery, the strategies are categorized into passive, active, and biomimetic approaches. Passive targeting relies on the enhanced permeability and retention (EPR) effect but suffers from poor enrichment efficiency and rapid clearance. Active targeting conjugates ligands (<i>e.g.</i>, folic acid, hyaluronic acid) to recognize overexpressed receptors, significantly enhancing cellular uptake. It is emphasized that hyaluronic acid-modified ZIF-8 can co-deliver siRNA for <i>GLUT1</i> silencing, achieving systematic energy exhaustion. Biomimetic delivery using cell membranes confers immune evasion, prolonged circulation, and homologous targeting, exhibiting the lowest off-target toxicity. This approach is considered to guide future nanocarrier design. For Zn<sup>2+</sup> release, 4 mechanisms are discussed. Endogenous environment-responsive release exploits acidic pH to degrade materials like ZIF-8 or ZnO, causing mitochondrial dysfunction, reactive oxygen species (ROS) burst, and autophagic blockade. Incorporation of other ions (Ca<sup>2+</sup>, Mn<sup>2+</sup>, Ni<sup>2+</sup>) enables synergistic metabolic interference and immune activation. Exogenous responsive release using near-infrared light offers spatiotemporally precise activation. For example, a nanorobot combining black phosphorus with ZIF-8 accelerates Zn<sup>2+</sup> release under dual acid and light stimuli. Ion exchange represents an elegant trigger: zinc complexes (<i>e.g.</i>, Zn-carnosine) have higher affinity for Cu<sup>2+</sup>; competitive coordination releases Zn<sup>2+</sup> while depleting Cu<sup>2+</sup>, dually inhibiting oxidative phosphorylation and glycolysis. This mechanism is proposed to hold promise for overcoming metabolic reprogramming. Finally, biological regulation—silencing the ZnT1 zinc transporter to block Zn<sup>2+</sup> efflux—represents a paradigm shift from passive delivery to active homeostatic disruption. This “block and attack” strategy may prevent acquired resistance. The therapeutic consequences of zinc overload are multifaceted. Zn<sup>2+</sup> causes lysosomal membrane permeabilization and impaired SNARE complex formation, blocking autophagic flux and inducing a distinct cell death termed “zincosis”. In mitochondria, Zn<sup>2+</sup> inhibits glutathione reductase, causing oxidative stress and electron transport chain blockade. Meanwhile, Zn<sup>2+</sup> suppresses glycolytic enzymes (GAPDH, LDHA), leading to ATP depletion and reversing drug resistance by downregulating P-glycoprotein. Moreover, zinc overload triggers immunogenic cell death, promoting dendritic cell maturation and CD8<sup>+</sup> T cell infiltration. Combined with cGAS-STING activation, this reshapes the immunosuppressive tumor microenvironment and inhibits distant metastasis. These interconnected mechanisms endow zinc overload with a unique advantage over single-modality treatments. Despite remarkable preclinical efficacy, challenges remain: systemic toxicity from off-target release, potential zinc tolerance <i>via</i> metallothionein upregulation, and insufficient pharmacokinetic data. Future directions should prioritize: (1) intelligent stimuli-responsive materials; (2) combination with immune checkpoint inhibitors; (3) theragnostic integration; (4) deeper mechanistic studies; and (5) artificial intelligence-assisted screening. Zinc overload therapy is expected to become an indispensable component of integrated tumor treatment.]]></description>
<pubDate>2026/6/4 9:50:18</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[BAI Yun-Feng,FENG Feng,WANG Rong,ZHAO Lu]]></author>
</item>
<item>
<title><![CDATA[SIZ1 and ESD4 Mediate The Reversible SUMOylation of SnRK2.6 Through Direct Physical Interaction]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601080000001]]></link>
<description><![CDATA[<b>Objective</b> To investigate the novel post-translational modifications (PTMs) of SnRK2.6, a central component in the abscisic acid (ABA) signaling pathway, such as SUMOylation, and to establish a foundation for revealing the physiological functions and molecular mechanisms of SnRK2.6 regulated by these new modifications.<b>Methods</b> The interaction between SnRK2.6 and the SUMO E3 ligase SIZ1, as well as members of the SUMO protease family, was examined using yeast two-hybrid and <i>in vitro</i> pull-down assays. An <i>in vitro </i>SUMOylation system in <i>Escherichia coli </i>was utilized to determine whether SnRK2.6 undergoes SUMOylation. Mass spectrometry, combined with site-directed mutagenesis of candidate lysine residues, was employed to identify potential SUMOylation sites on SnRK2.6. <i>In vitro</i> de-SUMOylation assays were performed to assess whether SUMO proteases interacting with SnRK2.6 could catalyze the removal of SUMO moieties from modified SnRK2.6. The protein stability of SnRK2.6 was assessed in a cell-free degradation assay using bacterial-purified SnRK2.6 incubated with total protein extracts from Col and <i>siz1</i> mutant seedlings. To dissect the genetic relationship between <i>SnRK2.6</i> and <i>SIZ1</i>, stomatal aperture assays were performed under ABA treatment using <i>snrk2.6</i>, <i>siz1</i>, and <i>snrk2.6 siz1</i> double mutant plants.<b>Results</b> SnRK2.6 physically interacts with SIZ1 and the SUMO protease ESD4, with the binding domains localized to the C-terminal region of SIZ1 and the N-terminal region of ESD4, respectively. SnRK2.6 was found to be SUMOylated, exhibiting two distinct high-molecular-mass bands ranging from 70 to 100 ku, indicative of modified forms. Bioinformatics analysis predicted four putative SUMOylation sites on lysine residues K57, K63, K142, and K190. Mass spectrometry identified three SUMOylation sites on K63, K142, and K174. However, individual or combinatorial point mutations on these sites had minimal impact on the pattern or intensity of SUMOylation signals, suggesting that these residues may not be responsible for the SUMOylation on SnRK2.6. Instead, such mutations only weaken the protein stability or accelerate the protein mobility of SnRK2.6. Therefore, the exact SUMOylation sites on SnRK2.6 remain unidentified. In de-SUMOylation experiments, incubation of GST-ESD4 with SUMOylated SnRK2.6 for 1-2 h led to the near-complete disappearance of both SUMOylated bands. In contrast, neither the GST control nor the catalytically inactive mutant GST-ESD4<sup>C448S</sup> exhibited any de-SUMOylation activity. In protein turnover experiments, SnRK2.6 exhibited markedly enhanced half-life in <i>siz1</i> compared with Col, indicating that SIZ1-dependent SUMOylation promotes SnRK2.6 turnover.<i> </i>Phenotypically, <i>snrk2.6</i> mutants were completely insensitive to ABA-induced stomatal closure; <i>siz1</i> mutants displayed pronounced hypersensitivity; and the <i>snrk2.6 siz1</i> double mutant phenocopied <i>snrk2.6</i>—showing no significant response to ABA beyond that of the <i>snrk2.6</i> mutant. These data indicate that<i> SIZ1</i> acts as a negative regulator of ABA-triggered stomatal closure and<i> SnRK2.6</i> functions as a positive regulator, and the inhibitory activity of <i>SIZ1 </i>is strictly dependent on <i>SnRK2.6</i>, placing <i>SnRK2.6</i> genetically upstream of <i>SIZ1</i> in the ABA signaling pathway.<b>Conclusion</b> SnRK2.6 undergoes SUMOylation, although the specific SUMOylation sites have not been defined. SnRK2.6 is dynamically regulated by reversible SUMOylation—catalyzed by SIZ1 and reversed by ESD4—which controls its protein stability. SUMOylation acts as a destabilizing signal for SnRK2.6, and SIZ1 exerts its negative effect on ABA-triggered stomatal closure probably through promoting SnRK2.6 degradation <i>via</i> SUMOylation. These findings uncover SUMOylation as a critical regulatory layer fine-tuning SnRK2.6 abundance in ABA signaling.]]></description>
<pubDate>2026/6/3 7:43:15</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[FU Huan-Huan,HAN Yong-Feng,LI Meng-Yao,WEI Jian]]></author>
</item>
<item>
<title><![CDATA[A Cross-modal Transformer for Pulmonary Disease Diagnosis by Fusing Respiratory Sounds and Electrical Impedance Tomography]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202604110000001]]></link>
<description><![CDATA[<b>Objective</b> In order to address the challenge of rapid diagnosis in pulmonary diseases, this paper proposes a cross-modal fusion method based on the Cross-modal Transformer (CMT) that integrates respiratory sounds (RS) and electrical impedance tomography (EIT), with the aim of improving the accuracy and robustness of multi-classification tasks. RS encodes the acoustic characteristics of the airways via the Meyrieh spectrogram, whilst EIT depicts regional lung ventilation distribution through spatio-temporal image sequences. The two modalities are naturally complementary in terms of functional and spatial information, providing a physiological basis for multimodal fusion diagnosis.<b>Methods</b> A dual-branch feature extraction framework was constructed, employing Convolutional Neural Networks (CNNs) to extract local features from RS time-frequency spectra and EIT ventilation images, whilst utilising Bidirectional Long Short-Term Memory Networks (BiLSTMs) to model the temporal dependencies across modalities. The development of a transformer-based cross-modal attention fusion module represents a significant advancement in the field. The module utilises a multi-head self-attention mechanism and gated convolutional units to achieve deep semantic alignment and complementary information fusion between RS acoustic features and EIT spatial ventilation features. The model employs an end-to-end joint optimisation strategy, with a cross-entropy loss function supervising the overall training process, and utilises a time-synchronisation mechanism to ensure strict alignment of the dual-modal inputs within the respiratory cycle. The proposed CMT method was subjected to systematic experimental validation on two datasets: The BRACETS dataset (three-class classification, 795 samples) and the CleftPalate dataset (two-class classification, 549 samples) are the focus of this study. Quantitative evaluation was performed using accuracy, balanced accuracy (BAcc) and macroF1 score.<b>Results</b> On the BRACETS dataset, the CMT method achieved an accuracy of 87.21%, a balanced accuracy (BAcc) of 88.24%, and a macroF1 score of 87.40%. In comparison to the optimal baseline method, DCNN, the macroF1 score exhibited an enhancement of 8.73 percentage points, thereby substantiating a substantial performance superiority. The findings of the ablation experiments suggest that the three core modules – CNN, BiLSTM and Transformer – all contribute to performance enhancements. Upon the removal of these modules, the MacroF1 score decreased by 1.84%, 1.13% and 2.20%, respectively. Among these, the Transformer cross-modal fusion module had the most significant impact, validating its crucial role in the interaction of heterogeneous modal information. Hyperparameter sensitivity analysis indicates that the optimal parameter configuration is a sequence length of T=128 and a feature dimension of d=128, achieving a good balance between classification performance and computational efficiency. Sequences that are insufficiently extensive or dimensions that are unduly limited impede the capacity to adequately represent temporal dynamics, whilst excessively protracted sequences may engender superfluous information. On the CleftPalate dataset, the CMT method achieved an accuracy of 96.58%, a BAcc of 96.60%, and a MacroF1 of 96.56%, representing a further improvement of 2.51 percentage points compared to the DCNN. This result validates the model""s generalisation capability across different data distributions and task scenarios. The fusion representation learned by CMT has been shown to exhibit tighter intra-class cohesion and clearer inter-class separation boundaries, as evidenced by feature visualisation and case studies (Smith et al., 2022). The system has the capacity to adaptively aggregate effective features when the reliability of multimodal information is uneven, and can maintain correct classification even when ambiguity exists in a single modality.<b>Conclusion</b> The proposed method effectively achieves deep fusion of heterogeneous modal information from RS and EIT, fully exploiting the physiological complementary relationship between respiratory airflow acoustic features and regional lung ventilation distribution. The model displays excellent classification performance and stability across various data distributions and task scenarios, thus providing a novel technical pathway for the non-invasive intelligent diagnosis of pulmonary diseases.]]></description>
<pubDate>2026/6/2 14:18:02</pubDate>
<category><![CDATA[人工智能及多模态传感技术专题]]></category>
<author><![CDATA[GU Yu-Ying,HU Liu-Bing,JIANG Cheng-Hui,SUN Bo,WU Yang,YAO Jia-Feng,ZHOU Hai-Yan]]></author>
</item>
<item>
<title><![CDATA[The Neural Circuit Characteristics of Repetitive Transcranial Magnetic Stimulation Over The Dorsolateral Prefrontal Cortex for The Treatment of Migraine]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601160000001]]></link>
<description><![CDATA[<b>Objective</b> Migraine is a leading neurological disorder and the fourth most common cause of years lived with disability worldwide, affecting nearly 116 million individuals. Although pharmacological treatments are available, their efficacy is often limited by side effects and variable response rates. Repetitive transcranial magnetic stimulation (rTMS) over the dorsolateral prefrontal cortex (DLPFC) offers a safe, non-invasive alternative for migraine management. However, the neurophysiological mechanisms, particularly how rTMS modulates local cortical excitability and distributed pain-related circuits, remain poorly understood. Elucidating these mechanisms is essential for optimizing treatment protocols and improving clinical outcomes.<b>Methods</b> This study employed concurrent transcranial magnetic stimulation and electroencephalography (TMS-EEG) to investigate neuroplastic and neurocircuitry mechanisms of DLPFC-rTMS in migraine. Study <i>1</i> compared 30 migraineurs and 28 healthy controls to identify abnormalities in TMS-evoked potentials (TEPs) and significant current density (SCD) within sensory-discriminative regions including the primary somatosensory cortex (S1) and posterior insula (pINS), cognitive-affective regions including the anterior insula (aINS) and midcingulate cortex (MCC), and a descending modulatory region, the periaqueductal gray (PAG). Study <i>2</i> used a single-blind, crossover, sham-controlled design in 34 healthy participants. Each participant received both active (10 Hz, 80% RMT, 1 500 pulses) and sham DLPFC-rTMS in counterbalanced order. TMS-EEG and cold pain tolerance were assessed before and after each session.<b>Results</b> In Study <i>1</i>, migraineurs showed a significantly less negative N120 amplitude compared to healthy controls (<i>P</i>=0.027, Cohen’s <i>d</i>=0.60), indicating local intracortical disinhibition. No group differences were observed for N40, P60, or P180 components. At the source level, migraineurs exhibited significantly higher SCD in the S1, pINS, aINS, and MCC (all <i>Q</i><0.05), but not in the ventroposterior thalamus (vpTHAL), mediodorsal thalamus (mdTHAL), or PAG. In Study <i>2</i>, active rTMS significantly reduced SCD from pre- to post-stimulation in the S1, aINS, and MCC (all <i>Q</i><0.05). Sham stimulation also reduced SCD in the S1 (<i>Q</i><0.05) but not in the aINS or MCC. Although no significant group-level analgesic effect was observed between active and sham conditions (<i>P</i>=0.107), correlation analyses revealed that greater SCD reductions in the S1 and MCC were significantly associated with higher post-rTMS pain tolerance (<i>R</i>=-0.487 and -0.495, both <i>Q</i><0.01) and larger improvements in pain tolerance (<i>R</i>=-0.487 and -0.451, both <i>Q</i><0.05). No such correlations were found following sham stimulation, suggesting that the behavioural relevance of neural changes is specific to active rTMS.<b>Conclusion</b> This study provides novel evidence that migraineurs exhibit both local neuroplastic abnormalities (reduced N120 amplitude) and hyperactivity in key pain-processing regions (S1, pINS, aINS, MCC). A single session of DLPFC-rTMS reduced hyperactivity in the aINS, MCC, and S1. Notably, greater reductions in the S1 and MCC were associated with improved pain tolerance. These findings identify distinct cortical circuitries, particularly within the cognitive-affective pain network, that may serve as potential biomarkers for optimizing rTMS treatment in migraine and other chronic pain conditions. Future studies should validate these results in patient populations experiencing spontaneous migraine attacks and explore multi-session or accelerated rTMS protocols.]]></description>
<pubDate>2026/6/2 12:10:02</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CHE Xian-Wei,GAO Zhong-Ming,HE Ji-Qing,JIN Chen-Xia,LIU Hui-Li,TAN Bo-Lin,WANG Ling-Yan,WANG Yu-Jun,YAN Yong-Xing,YE Yang]]></author>
</item>
<item>
<title><![CDATA[Necroptosis in Exercise-induced Skeletal Muscle Damage: Roles and Regulatory Mechanisms]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202602060000002]]></link>
<description><![CDATA[Exercise-induced muscle damage (EIMD) is a frequent form of skeletal muscle microdamage that occurs after high-intensity, prolonged, or unaccustomed exercise, especially exercise dominated by eccentric contractions. It is commonly characterized by delayed-onset muscle soreness, transient loss of muscle strength, local inflammation, structural disruption of myofibers, and delayed functional recovery. Although mild EIMD may serve as a stimulus for training adaptation, excessive or insufficiently recovered muscle damage can impair exercise performance, disturb training continuity, and reduce participation in physical activity. Therefore, clarifying the molecular mechanisms that underlie the initiation, amplification, and resolution of EIMD is important for optimizing athletic training, improving post-exercise recovery, and guiding evidence-based public fitness practice. Necroptosis is a regulated form of programmed cell death mediated primarily by the receptor-interacting protein kinase (RIPK) 1/RIPK3/mixed lineage kinase domain-like protein (MLKL) signaling axis. Recent studies have shown that necroptosis is closely involved in tissue injury, sterile inflammation, and repair remodeling. However, whether necroptosis acts as an initiating driver, a secondary damage amplifier, or an adaptive signal required for repair after EIMD remains unclear. This review aimed to summarize the potential role of necroptosis in EIMD and to establish a mechanistic framework linking regulated cell death, inflammatory amplification, immune regulation, and skeletal muscle repair. Relevant studies concerning EIMD, necroptosis, RIPK1/RIPK3/MLKL signaling, damage-associated molecular patterns (DAMPs), inflammatory responses, immune cell recruitment, extracellular matrix remodeling, and muscle regeneration were reviewed and integrated. On this basis, the possible temporal and functional involvement of necroptosis in different phases of EIMD was analyzed. The main evidence summarized in this review suggests that EIMD is not merely a consequence of primary mechanical disruption. Instead, it develops through a dynamic sequence that includes sarcolemmal instability, calcium overload, mitochondrial dysfunction, oxidative stress, inflammatory mediator production, immune cell infiltration, necrotic tissue clearance, and regeneration-associated remodeling. Necroptosis may participate in this process through at least two interconnected mechanisms. First, in the early or progressive phase of EIMD, activation of the RIPK1/RIPK3/MLKL signaling axis may promote MLKL phosphorylation and plasma membrane permeabilization, leading to the release of DAMPs such as high-mobility group box 1, ATP, mitochondrial DNA, and other intracellular components. These signals may activate innate immune pathways, amplify inflammatory cytokine production, and enhance the recruitment of neutrophils and macrophages, thereby aggravating secondary inflammation and extending muscle fiber injury. Second, during the resolution and repair phases, necroptosis-related signaling may also contribute indirectly to the formation of a regenerative microenvironment. By influencing the clearance of necrotic debris, the recruitment and phenotypic transition of immune cells, and the remodeling of extracellular matrix components, necroptosis may affect satellite cell activation, myogenic repair, and the eventual structural and functional recovery of injured skeletal muscle. Thus, the biological effect of necroptosis in EIMD may be context dependent rather than uniformly harmful. Its outcome may depend on exercise intensity, the extent of tissue damage, the timing of pathway activation, the involved cell types, inflammatory status, training background, age, and metabolic condition. In conclusion, necroptosis may represent an important molecular link between skeletal muscle injury, sterile inflammation, and tissue repair after damaging exercise. It may exert a dual role in EIMD by amplifying secondary damage while also contributing to repair coordination under appropriate temporal and microenvironmental conditions. Future studies should determine the activation pattern of RIPK1/RIPK3/MLKL signaling after different exercise protocols, identify the major cell populations undergoing necroptosis in injured skeletal muscle, and examine whether targeted modulation of necroptosis can reduce excessive inflammation without impairing necessary regenerative responses. This review provides a theoretical basis for understanding the pathogenesis of EIMD and for developing targeted strategies to improve skeletal muscle recovery after exercise-induced injury.]]></description>
<pubDate>2026/5/31 22:40:09</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DONG Yun-Feng,KE Zhi-Fei,SHANG Hua-Yu,SONG Wen-Jing]]></author>
</item>
<item>
<title><![CDATA[Mitochondrial Dysfunction and Diabetic Retinopathy: From Pathogenesis to Therapeutic Targets]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202512300000004]]></link>
<description><![CDATA[Diabetic retinopathy (DR) is one of the most prevalent and vision-threatening microvascular complications of diabetes mellitus, yet its pathogenesis extends far beyond vascular injury alone. As the retina is among the most energy-demanding tissues in the body, its neurons, glial cells, pigment epithelial cells, pericytes, and endothelial cells are highly dependent on mitochondrial oxidative phosphorylation to maintain visual signal transduction, ionic homeostasis, and neurovascular integrity. This review summarizes current evidence indicating that mitochondrial dysfunction is not merely a downstream consequence of chronic hyperglycemia, but a central pathogenic hub that initiates, amplifies, and perpetuates retinal neurovascular degeneration in DR. Persistent hyperglycemia activates multiple abnormal metabolic pathways, including the polyol pathway, hexosamine pathway, protein kinase C signaling, advanced glycation end-product formation, and angiotensin II-related responses. Although these pathways differ mechanistically, they converge on excessive reactive oxygen species (ROS) generation, antioxidant depletion, and mitochondrial injury. Under diabetic stress, electron transport chain overload promotes mitochondrial ROS leakage, damages mitochondrial DNA, disrupts membrane potential, and impairs the transcription of key respiratory chain components. In parallel, mitochondrial quality-control systems become progressively compromised. The balance between fusion and fission shifts toward pathological fragmentation through reduced MFN1/2 and OPA1 activity and enhanced DRP1-mediated fission. Mitochondrial biogenesis is suppressed through inhibition of the AMPK/SIRT1/PGC-1α/NRF1/TFAM axis, while mitophagy changes from an early compensatory response to a later state of autophagic flux blockade and accumulation of dysfunctional mitochondria. Importantly, damaged mitochondria serve as signal amplifiers linking metabolic stress to inflammation and programmed cell death. Mitochondrial ROS, oxidized mitochondrial DNA, calcium overload, cardiolipin exposure, and membrane permeabilization activate interrelated death pathways, including intrinsic apoptosis, ferroptosis, and pyroptosis. Cytochrome C and apoptosis-inducing factor promote caspase-dependent and caspase-independent apoptosis; iron dyshomeostasis, glutathione depletion, GPX4 dysfunction, and lipid peroxidation drive ferroptosis; and mitochondrial danger signals activate the NLRP3 inflammasome and gasdermin-dependent pyroptosis. These pathways jointly damage the retinal neurovascular unit and contribute to pericyte loss, endothelial barrier breakdown, Müller cell dysfunction, retinal ganglion cell apoptosis, retinal pigment epithelial injury, and photoreceptor degeneration. This review also emphasizes the role of epigenetic regulation in stabilizing mitochondrial pathology. DNA methylation, histone modifications, and non-coding RNAs interact to silence mitochondrial protective genes, alter antioxidant responses, and maintain the “metabolic memory” of DR even after glycemic normalization. Therefore, mitochondrial dysfunction should be understood as a dynamic, multidimensional network rather than a single pathological event. Current clinical approaches, such as laser photocoagulation, intravitreal anti-VEGF therapy, and vitrectomy, mainly target advanced vascular lesions and are limited by invasiveness, incomplete responsiveness, recurrence, and potential adverse effects. Therapeutically, strategies targeting mitochondrial ROS, restoring mitochondrial dynamics, enhancing biogenesis, regulating mitophagy, inhibiting inflammasome activation, correcting epigenetic abnormalities, and improving targeted delivery systems show promising potential. However, major translational barriers remain, including retinal cell heterogeneity, stage-specific mitochondrial responses, insufficient organelle-specific drug delivery, and long-term safety concerns. A deeper understanding of mitochondrial regulatory networks may support earlier, more precise, and multi-target interventions for preventing or slowing DR progression.]]></description>
<pubDate>2026/5/31 17:03:39</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DU Wan-Li,JIN Tao,LIAN Lu-Lu,ZHANG Yu,ZHU Xiao-Yan]]></author>
</item>
<item>
<title><![CDATA[Structural Basis of Microtubule-regulated “Sequestration and Release” of GEF-H1 in Signal Transduction]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202603310000003]]></link>
<description><![CDATA[Microtubules have long been regarded as structural scaffolds that maintain cell shape, mediate intracellular transport, and drive cell division. Over the past two decades, this view has shifted, with accumulating evidence demonstrating that microtubules are dynamic and active participants in cellular signaling networks, regulating key physiological processes such as cell survival and differentiation through multiple mechanisms. Recently, the team led by Michel O. Steinmetz reported in <i>Cell</i> the first structural elucidation of how microtubules regulate immune responses by “sequestering and releasing” the guanine nucleotide exchange factor GEF-H1 protein. This work addresses a central question in microtubule-mediated signal transduction, provides a conceptual and methodological framework for basic research, and offers new targets and strategies for cancer immunotherapy and targeted drug development.]]></description>
<pubDate>2026/5/30 21:52:46</pubDate>
<category><![CDATA[动态与评论]]></category>
<author><![CDATA[REN Jin-Qi]]></author>
</item>
<item>
<title><![CDATA[Targeting GYS1: From Metabolic Regulatory Mechanisms to Precision Therapeutic Strategies]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202604100000002]]></link>
<description><![CDATA[Glycogen synthase 1 (GYS1) is the rate-limiting enzyme responsible for glycogen synthesis in skeletal muscle, heart, brain, and other extrahepatic tissues, playing a central role in systemic energy homeostasis. The human <i>GYS1</i> gene maps to chromosome 19q13.33, comprises 16 exons, and encodes a 737-amino-acid polypeptide that is highly conserved across mammals. GYS1 activity is subject to multilayered and precisely coordinated regulation. At the transcriptional level, the <i>GYS1</i> promoter contains a hypoxia response element (HRE) that mediates HIF-1α-dependent induction under low-oxygen conditions, as well as a muscle-specific enhancer harboring MEF2 and MyoD binding sites that confers tissue-restricted expression. At the post-translational level, a hierarchical phosphorylation cascade serves as the primary activity switch: glycogen synthase kinase 3β (GSK3β) sequentially phosphorylates four C-terminal serine residues following casein kinase II priming, while protein kinase A (PKA) and AMP-activated protein kinase (AMPK) provide parallel inhibitory inputs at both N- and C-terminal sites. Dephosphorylation and reactivation are mediated by protein phosphatase 1 (PP1) through tissue-specific glycogen-targeting regulatory subunits such as PPP1R3A and PPP1R3B, which anchor PP1 to glycogen particles and direct its activity toward GYS1. The allosteric activator glucose-6-phosphate (G6P) binds at the dimer interface, simultaneously enhancing catalytic efficiency and promoting dephosphorylation susceptibility, thereby establishing a feed-forward activation loop that couples substrate availability to glycogen synthesis. Beyond phosphorylation, GYS1 is regulated by ubiquitination (mediated by the E3 ligase PJA1), acetylation, O-linked β-N-acetylglucosamine (O-GlcNAc) modification, and SUMOylation, which collectively modulate protein stability, subcellular localization, and protein-protein interactions. Epigenetic mechanisms, including CpG island methylation and histone acetylation dynamics, govern chromatin accessibility at the GYS1 locus, while muscle-specific microRNAs such as <i>miR</i>-<i>1</i> and <i>miR</i>-<i>206</i> fine-tune GYS1 expression at the post-transcriptional level. Dysregulation of GYS1 has been identified as a central pathogenic driver in a spectrum of human diseases. In inherited glycogen storage disorders—including Lafora disease, adult polyglucosan body disease (APBD), and Pompe disease—loss of upstream regulatory control leads to GYS1 hyperactivation and the accumulation of structurally abnormal or excessive glycogen, resulting in progressive neurodegeneration, myopathy, and multiorgan dysfunction. In type 2 diabetes mellitus (T2DM), impaired insulin signaling through the PI3K-AKT-GSK3β axis maintains GYS1 in a hyperphosphorylated inactive state in skeletal muscle, compromising postprandial glucose disposal and exacerbating hyperglycemia. In oncology, GYS1 exhibits context-dependent roles across multiple cancer types. In hepatocellular carcinoma, FMO2<sup>+</sup> cancer-associated fibroblasts stabilize GYS1 by competitively inhibiting PJA1-mediated ubiquitination, and stabilized GYS1 subsequently activates NF-κB/CCL19 signaling to promote tertiary lymphoid structure formation and enhance anti-PD-1 immunotherapy responsiveness. In clear cell renal cell carcinoma, GYS1 promotes tumor progression through non-canonical NF-κB pathway activation <i>via</i> the scaffold protein RPS27A. In triple-negative breast cancer, GYS1 has been identified as a trigger of disulfidptosis and an activator of NF-κB signaling through non-enzymatic facilitation of IκBα degradation. In colorectal cancer, mitochondrial fission deficiency drives AMPK-dependent GYS1 upregulation and glycogen accumulation as a compensatory survival mechanism, while in cervical cancer, GYS1-maintained glycogen reserves fuel the pentose phosphate pathway to generate NADPH for ROS clearance, thereby conferring cisplatin resistance in cancer stem cells. Therapeutic strategies targeting GYS1 have gained substantial momentum across these disease contexts. For glycogen storage disorders, antisense oligonucleotides, small interfering RNAs (<i>e.g</i>., ABX1100), and small-molecule inhibitors (<i>e.g</i>., MZ-101) have demonstrated preclinical and early clinical efficacy in reducing pathological glycogen accumulation. For T2DM, pharmacological activation of GYS1 through GSK3β inhibition or enhancement of PP1-mediated dephosphorylation is being explored to restore insulin-stimulated glycogen synthesis. In cancer, GYS1-directed interventions—including targeted silencing to sensitize tumors to chemotherapy and immune microenvironment modulation to enhance immunotherapy—represent emerging precision oncology approaches. This review provides a comprehensive and integrated account of <i>GYS1</i> gene structure, tissue-specific distribution, regulatory networks, and pathogenic roles in metabolic disorders and malignancies, with the aim of establishing a theoretical framework for the development of GYS1-targeted precision therapies.]]></description>
<pubDate>2026/5/28 21:39:35</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[JIN Xiao-Feng,LI Hong,LI Yu-Xuan,ZHAO Jia-Nan,ZHU Jie]]></author>
</item>
<item>
<title><![CDATA[Novel Subset-specific Functions of Dendritic Cells: From Spatiotemporal Regulation of Lymph Node Immunity to Precision Targeting StrategiesA Commentary on The Study by Huang & Gerner (Cell, 2026)]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202604070000001]]></link>
<description><![CDATA[Dendritic cells (DCs) serve as a crucial link between innate and adaptive immunity and represent key modulatory nodes in the initiation of adaptive immune responses. Although DC-targeted vaccines and therapeutic strategies show great promise, their development remains in the early stages due to a limited understanding of the regulatory mechanisms governing distinct DC subsets in response to various immunogens and types of immune responses. Recently, a study by Jessica Y. Huang and Michael Y. Gerner published in <i>Cell</i> has uncovered a novel functional dimension of DCs. Beyond their classical roles in antigen presentation and T cell priming, DCs dynamically regulate the spatiotemporal organization of innate and adaptive immune responses within lymph nodes. During early type I immune responses, tissue-resident DC2s recruit innate immune cells and promote their trafficking, effectively limiting pathogen spread; however, this comes at the cost of disrupting lymph node architecture and suppressing the initiation of adaptive immunity. Following effective pathogen restraint, DCs shift their role to mediate the removal of apoptotic neutrophils and facilitate the restoration of lymph node structure, thereby reinstating adaptive immunity. These findings suggest that a deeper understanding of subset-specific regulatory networks of DCs in various immune contexts may enhance the precision and efficacy of DC-targeted immunotherapies.]]></description>
<pubDate>2026/5/25 11:00:44</pubDate>
<category><![CDATA[动态与评论]]></category>
<author><![CDATA[YANG Shao-Jun,ZHANG Xu-Yuan]]></author>
</item>
<item>
<title><![CDATA[Guyanxiao Tincture Alleviates Frozen Shoulder <i>via</i> Suppressing ACTC1 Induced Fibrosis in Shoulder Capsule]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202604120000002]]></link>
<description><![CDATA[<b>Objective</b> Frozen shoulder (FS) is a debilitating musculoskeletal disorder characterized by persistent inflammation and progressive fibrosis of the glenohumeral joint capsule, leading to pain and severely restricted range of motion. Given the limited efficacy of current pharmacotherapies, there is an urgent need for novel anti-fibrotic agents. Guyanxiao Tincture (GYX), a traditional Chinese herbal formula, has shown clinical benefits in alleviating FS symptoms. However, its bioactive constituents and the molecular mechanisms underlying its therapeutic effects remain poorly defined. This study aimed to systematically evaluate the therapeutic efficacy of GYX against FS and to elucidate the mechanisms by which GYX attenuates capsular fibrosis.<b>Methods</b> A Sprague-Dawley (SD) rat model of FS was established by immobilizing the unilateral shoulder with a plaster cast for 21 d. Following model induction, animals were administered with GYX or its serum-identified bioactive component, icariside F2. The absorbed prototype compounds of GYX in FS rat serum were profiled using ultraperformance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS). Therapeutic effects were assessed by measuring shoulder range of motion (ROM), histopathological evaluation of the capsule <i>via</i> hematoxylin-eosin staining, and quantification of transforming growth factor-β1 content by ELISA. To explore the underlying mechanisms, transcriptomic profiling of the shoulder capsule was performed using RNA sequencing, and differentially expressed genes were validated by real-time quantitative PCR. Protein expression and localization were examined through immunohistochemistry, immunofluorescence, and Western blot. Protein-protein interaction networks were constructed to identify key regulatory hubs. <i>In vitro</i>, primary shoulder capsule fibroblasts were stimulated with TGF-β1 to induce a fibrotic phenotype and then treated with icariside F2. The expression of ACTC1, α-smooth muscle actin, and collagen I was subsequently measured.<b>Results</b> Serum pharmacochemistry analysis identified icariside F2 as the predominant circulating bioactive component of GYX in FS rats. Both GYX and icariside F2 treatment significantly improved the ROM and ameliorated histopathological lesions, including the attenuation of synovial hyperplasia, inflammatory infiltration, and excessive collagen deposition in the shoulder capsule. Consistently, elevated TGF-β1 levels in the model group were markedly reduced after the interventions. RNA sequencing revealed that actin alpha cardiac muscle 1 (ACTC1) was dramatically upregulated in the fibrotic capsule, accompanied by the enrichment of fibrosis-associated pathways such as TGF-β signaling, focal adhesion, and ECM-receptor interaction. Protein-protein interaction network analysis demonstrated that ACTC1 directly interacts with core fibrotic genes, including <i>Col1a1</i>, <i>Col1a2</i>, <i>Thbs2</i>, and <i>Fn1</i>. Critically, icariside F2 administration significantly reversed the aberrant overexpression of ACTC1 and suppressed the activation of the aforementioned fibrosis-related pathways <i>in vivo</i>. In TGF-β1-stimulated fibroblasts, icariside F2 dose-dependently downregulated ACTC1 at both the mRNA and protein levels and concurrently decreased the expression of the fibrotic markers α-smooth muscle actin and collagen I. Immunofluorescence and Western blot further confirmed that icariside F2 attenuated stress fiber formation and collagen production <i>in vitro</i>.<b>Conclusion</b> GYX and its bioactive component icariside F2 effectively alleviate the progression of frozen shoulder by inhibiting capsular fibrosis. Mechanistically, the therapeutic action is functionally linked to the suppression of ACTC1 and its downstream profibrotic signaling cascade, highlighting ACTC1 as a promising therapeutic target for the management of frozen shoulder.]]></description>
<pubDate>2026/5/24 10:19:29</pubDate>
<category><![CDATA[炎症性疾病靶标发现与药物干预专题]]></category>
<author><![CDATA[LIU Yang,SUN Quan,WANG Yan,ZHANG Kai-Wei,ZHENG Rui,ZHENG Shu-Guang]]></author>
</item>
<item>
<title><![CDATA[Construction of Silver Nanoparticle-based Artificial Hydrolases <i>via</i> Conformational Engineering and Study of Its Catalytic Mechanism]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202603250000001]]></link>
<description><![CDATA[<b>Objective</b> This study employs a special conformational engineering (CE) technology to construct an α-chymotrypsin-like active center, which includes a catalytic triad, an oxyanion hole, and a substrate-binding site, on silver nanoparticles (AgNPs), thereby creating an AgNP-based artificial hydrolase with high catalytic activity. This study provides a new approach for the design of highly efficient artificial enzymes and enzyme-mimicking.<b>Methods</b> AgNPs were chosen as the scaffold to build the an α-chymotrypsin-like active center. A special CE procedure enables the designed peptide, Triad5, to adopt an α-helical conformation on AgNPs, with the key catalytic residues located on one side of the α-helix forming a catalytic active center with a catalytic triad, an oxyanion hole, and a substrate-binding site. The CE procedure consists of three steps, including conformation induction <i>via</i> trifluoroethanol (TFE), conformation stabilization on AgNPs <i>via</i> Ag-S bonds, and TFE removal <i>via</i> lyophilization. Circular dichroism (CD) spectra were used to confirm the formation and stabilization of the α-helix conformation. Mutations of the key residues combined with stopped-flow kinetic experiments were used to demonstrate the indispensability of each key residue and the synergistic effects among the catalytic triad, the oxyanion hole, and the substrate-binding site.<b>Results</b> CD spectra show that the designed Triad5 alone is in random coil conformation; when conjugated on AgNPs, Triad5 still remains largely unstructured; but after the CE treatment, Triad5 adopts a typical α-helical conformation on AgNPs as designed, thus produces an AgNP-based artificial hydrolase, Silverzyme. Silverzyme exhibits extremely high hydrolytic activity towards p-nitrophenyl acetate (p-NPA), with an extremely high catalytic turnover number per active site of 3.5 s<sup>-1</sup>, which is even higher than that of α-chymotrypsin. As a comparison, the AgNP-Triad5 conjugate without CE treatment shows much lower catalytic activity than Silverzyme, highlighting the important role of the right conformation of the active center for the catalytic activity and the power of the CE treatment. When the key residues of the catalytic triad of Silverzyme were mutated to alanine, the overall catalytic efficiency of this mutant dropped by about 2 orders of magnitude, unambiguously demonstrating the key role of the designed catalytic triad. Similarly, when the residues for the oxyanion hole were deleted, the mutant with the intact catalytic triad also showed significantly decreased catalytic activity, highlighting the indispensable role of the oxyanion hole for the catalytic activity. Unexpectedly, when both the catalytic triad and the oxyanion hole were kept intact, a slight change of the binding site also resulted in significantly decreased catalytic activity, indicating that the designed binding site is at the right position to align the substrate in the right orientation in the active center for catalytic hydrolysis. These results confirm the synergy among the catalytic triad, the oxyanion hole, and the substrate-binding site, indicating successful mimicking of the active center of α-chymotrypsin. Moreover, Silverzyme shows better thermal stability than α-chymotrypsin, and can even hydrolyze the tough non-activated ester diethyl phthalate, a priority pollutant by the United States Environmental Protection Agency (USEPA).<b>Conclusion</b> This study successfully mimicked the complex catalytic active center of α-chymotrypsin using a conformational engineering strategy, and produced a highly active artificial hydrolase with a well-defined structure and catalytic mechanism. The findings highlight the significant potential of conformational engineering.]]></description>
<pubDate>2026/5/23 10:07:21</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CAO Ao-Neng,GUO Yuan,WANG Hai-Fang,WANG Yan,ZHOU Tong-Tong]]></author>
</item>
<item>
<title><![CDATA[Inverse Association Between Alcohol Consumption and Parkinson’s Disease Risk and Identification of <i>RIT2</i> as a Linked Biomarker]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202603160000001]]></link>
<description><![CDATA[<b>Objective</b> As a common lifestyle habit, alcohol consumption has a controversial association with the onset of Parkinson’s disease (PD). To demonstrate the correlation between alcohol consumption and PD and to identify associated genes, we integrated findings from clinical surveys, genomics, transcriptomics, and animal experiments.<b>Methods</b> We investigated the alcohol consumption rates (including both before and after disease onset) among 244 PD patients in China and 177 PD patients from the U.S. NHANES database. Mendelian randomization (MR) analysis was performed using genome-wide association study (GWAS) data for three alcohol-related traits and seven PD-related datasets from the MRC IEU OpenGWAS database. Transcriptomic data from the substantia nigra of PD patients were obtained from three GEO datasets (GSE7621, GSE20141, and GSE49036) to analyze <i>RIT2</i> gene transcription. Finally, three groups of animal experiments (water/20% ethanol/20% liquor, with 4 C57BL/6J mice per group) were conducted to examine changes in brain <i>RIT2</i> gene expression and transcriptomic profiles following alcohol consumption.<b>Results</b> The alcohol consumption rates among PD patients in China and the U.S. (9%-18.87%) were significantly lower than the general population rates of 15%-45% in their respective regions (<i>P</i><0.001), suggesting a possible negative association between alcohol consumption and PD. Subsequently, in 21 bidirectional MR analyses using 3 alcohol-related GWAS datasets and 7 PD-related GWAS datasets, the forward MR analyses (alcohol intake as exposure, PD as outcome) yielded 12 negative associations (<i>OR</i><sub>IVW</sub><1) and 9 positive associations (<i>OR</i><sub>IVW</sub>>1). Among these, only two negative associations reached statistical significance: alcohol intake frequency (<i>OR</i><sub>IVW</sub>=0.75, 95% <i>CI</i>: 0.60-0.93, <i>P</i>=0.010) and alcohol consumption (<i>OR</i><sub>IVW</sub>=0.20, 95% <i>CI</i>: 0.05-0.83, <i>P</i>=0.026). The forward MR analysis (alcohol intake→PD) identified 235 SNPs, annotated to 316 genes, while the reverse MR analyses (PD→alcohol intake) identified 37 SNPs, annotated to 53 genes. Notably, only the <i>RIT2</i> gene appeared in both the forward and reverse MR analyses (alcohol intake→PD: rs28597806, rs8083110; PD→alcohol intake: rs4588066). <i>RIT2</i> is selectively expressed in the human brain (<i>FPKM</i>: 5.259±2.103), with low or no expression in peripheral tissues (<i>FPKM</i>: <1). Analysis of three human substantia nigra transcriptomic datasets revealed a decreasing trend in <i>RIT2</i> gene expression in PD patients (GSE20141 array signal: 3.49±1.23 <i>vs</i>. 2.33±0.87, <i>P</i>=0.044). Animal experiments demonstrated that administration of 20% ethanol or 20% liquor (approximately 8% ethanol) stimulated a >2-fold upregulation of <i>RIT2</i> gene expression in the mouse brain. Furthermore, transcriptomic sequencing revealed that the two alcohol-treated groups exhibited 96 (20% ethanol <i>vs</i>. water control) and 4 (20% liquor <i>vs.</i> water control) differentially expressed genes, respectively, indicating that low-dose alcohol consumption can achieve <i>RIT2</i> upregulation while minimizing impact on other brain genes. In addition to its anti-infective effects, low-dose alcohol consumption primarily influences signaling pathways related to neurodegenerative diseases such as PD and Prion diseases.<b>Conclusion</b> Alcohol consumption is generally considered as a harmful lifestyle habit. However, some studies have also shown a lower risk of mortality among individuals who consume low doses of alcohol (100 g/week of ethanol) or drink occasionally. Currently, one of the research focuses on alcohol consumption is whether the human body can benefit from low-dose alcohol intake. This study provides new evidence supporting a negative association between alcohol consumption and PD, and for the first time, through MR analysis, identifies the <i>RIT2</i> gene as a potential mediator of the effect of alcohol consumption on PD. <i>RIT2</i> is selectively expressed in the human brain. Building upon existing evidence indicating downregulated <i>RIT2</i> gene expression in PD pathogenesis, our experiments confirm that low-dose alcohol consumption can upregulate <i>RIT2</i> expression in the brain. In brief, alcohol consumption may suppress the pathogenesis of PD by upregulating <i>RIT2</i> expression in the substantia nigra. China is facing a serious problem of population aging. This study offers important insights for long-term PD prevention and treatment strategies, with the aim of benefiting more potential PD patients through lifestyle modifications, thereby improving the quality of life of the aging population and reducing the economic burden on healthcare.]]></description>
<pubDate>2026/5/21 8:55:31</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CHENG Xiu-Li,CUI Gui-Yun,DONG Li-Guo,LU Wei,PAN Xiao-Yun,WEI Yi-Liang,YANG Dan-Dan,ZOU Hui-Ling]]></author>
</item>
<item>
<title><![CDATA[Kinsenoside-loaded Recombinant High-density Lipoprotein Enhances Beta-amyloid Phagocytosis Capacity and Reduces Inflammatory Levels of Microglia]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202602260000003]]></link>
<description><![CDATA[<b>Objective</b> This study aims to construct a reconstituted high-density lipoprotein (rHDL) delivery system loaded with kinsenoside (KD@rHDL), and to systematically evaluate its function in enhancing the phagocytosis of amyloid β-protein (Aβ) by microglia and improving the inflammatory state of microglia, as well as to preliminarily explore its potential application value in the treatment of Alzheimer’s disease (AD).<b>Methods</b> KD@rHDL was prepared by the film hydration method combined with probe sonication and co-incubation. Its morphology was observed by transmission electron microscopy, and the particle size and Zeta potential were measured by dynamic light scattering. The encapsulation efficiency and drug loading were determined by high-performance liquid chromatography. The affinity between KD@rHDL and Aβ was analyzed by surface plasmon resonance (SPR) to assess its feasibility as a medium for Aβ clearance. At the cellular level, after treating mouse microglial cells (BV-2 cells) with KD@rHDL and adding fluorescently labeled Aβ, the phagocytic efficiency of microglia for Aβ was detected by confocal microscopy. Meanwhile, the CCK-8 method was used to evaluate the effect of KD@rHDL on cell viability to determine its safety. The trans-barrier transport ability of KD@rHDL was detected by Transwell assay. The expression levels of NLRP3 inflammasome and downstream inflammatory factor IL-1β in LPS-induced microglia were detected by Western blot to evaluate the regulatory effect of KD@rHDL on the inflammatory state of cells.<b>Results</b> Characterization results showed that the successfully prepared KD@rHDL presented a typical discoid structure under transmission electron microscopy, with a uniform particle size distribution, an average particle size of approximately (14.4±0.24) nm, and a suitable negative Zeta potential, demonstrating good colloidal stability. The drug content determination results indicated that the encapsulation efficiency of KD@rHDL for kinsenoside was (42.24±1.30)%, and the drug loading was (6.03±0.19)%, indicating a good drug loading capacity. The CCK-8 assay results showed that in the set concentration range, the survival rates of BV2 and HT22 cells in the KD@rHDL treatment group were all above 90%, with no significant difference from the control group, indicating good cell safety of the formulation. The results of the Aβ phagocytosis experiment indicated that, compared with the Aβ oligomers (Aβo) group alone, the fluorescence signal intensity within microglia in the KD@rHDL treatment group was significantly enhanced, and a large amount of fluorescence-labeled Aβ was observed to accumulate intracellularly under a fluorescence microscope. The SPR assay results showed that rHDL had a strong affinity for Aβ, with an affinity constant reaching the nanomolar level. Transwell assay results indicated that KD@rHDL could effectively cross the bEnd.3 cell monolayer barrier and be taken up by BV2 and HT22 cells. Western blot assay results showed that high-dose KD@rHDL treatment could significantly reduce the expression level of NLRP3 protein in LPS-induced microglia and simultaneously down-regulate the maturation and secretion of IL-1β, indicating that KD@rHDL can effectively inhibit the activation of the NLRP3 inflammasome pathway and improve the neuroinflammatory state mediated by microglia.<b>Conclusion</b> This study successfully constructed a reconstituted high-density lipoprotein delivery system loaded with kinsenoside (KD@rHDL). This nano-delivery system not only significantly enhances the phagocytic clearance ability of microglia towards Aβ, but also effectively inhibits the NLRP3/IL-1β-mediated inflammatory pathway, improving the inflammatory state of microglia. The above results indicate that KD@rHDL has a synergistic effect in promoting Aβ clearance and alleviating neuroinflammation, demonstrating potential therapeutic value for AD and providing new ideas and experimental basis for the development of subsequent AD treatment strategies.]]></description>
<pubDate>2026/5/21 0:59:51</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CHEN Lu-Yao,HUA Qian,MU Yan]]></author>
</item>
<item>
<title><![CDATA[Reactive and Enzyme-activated Probe Strategies for Imaging Acute Kidney Injury]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601230000004]]></link>
<description><![CDATA[Acute kidney injury (AKI) is a prevalent and life-threatening clinical syndrome characterised by a rapid decline in renal function and diverse pathological etiologies. The condition has been demonstrated to be associated with elevated mortality rates and an increased risk of progression to chronic kidney disease. At present, clinicians depend heavily on conventional functional markers, such as serum creatinine and urine output, for the diagnosis and staging of the disease. It is evident that these conventional indicators characteristically manifest a considerable temporal delay and only undergo modification subsequent to considerable tissue damage. This severely restricts the timeframe for early detection and timely therapeutic intervention. Furthermore, standard markers fail to provide specific biological information regarding the underlying cellular injury mechanisms. The utilisation of advanced probe technologies in molecular imaging offers a robust alternative to overcome these inherent diagnostic limitations.This comprehensive review systematically evaluates recent progress in the design and application of two primary categories of molecular imaging tools for acute kidney disease, specifically reactive probes and enzyme-activated probes. Reactive probes are engineered to specifically interact with redox-active chemical species, including hydrogen peroxide, peroxynitrite, hypochlorous acid, and sulfur dioxide. Because oxidative stress constitutes a primary early event in acute renal tubular damage, these probes enable researchers and clinicians to visualize early cellular injury and radical accumulation well before global renal functional decline becomes evident. We discuss the application of these reactive probes across multiple imaging modalities including fluorescence imaging, magnetic resonance imaging (MRI), positron emission tomography (PET), and photoacoustic techniques. Photoacoustic imaging combines high spatial resolution with deep tissue penetration and has successfully demonstrated the ability to provide diagnostic alerts up to 12 h before any detectable rise in serum creatinine levels. Additionally, specific reactive probes have shown promising translational potential when tested by high-throughput screening in clinical human urine samples. Enzyme-activated probes target the specific catalytic activity of disease-relevant enzymes. These include well-documented renal tubular structural biomarkers such as NAG, GGT, and ALP, along with apoptosis-related caspases and specific nitroreductases. By responding only to enzymatic cleavage, these tools provide highly specific and pathology-directed imaging readouts. Recent structural design strategies in this field have advanced significantly beyond single-enzyme detection. Researchers are now focusing on sophisticated dual-target recognition to minimize background noise, multimodal integration to cross-validate imaging signals, and theranostic applications where probes simultaneously deliver diagnostic feedback and therapeutic agents to injured tissues. Nanotechnology serves as a fundamental enabler for realizing these advanced probe functions. By precisely optimizing nanoparticle parameters such as hydrodynamic size, surface charge, and targeting ligands, researchers can achieve amplified signal output, highly precise kidney delivery, and protection against premature degradation in the systemic circulation. For example, modifying surface charges can significantly enhance the active uptake of nanoprobes by damaged renal tubular epithelial cells.While preclinical probe development has progressed rapidly, moving these technologies into routine clinical practice remains a major challenge. We analyze the translational feasibility and current obstacles from biological, technological, and regulatory perspectives. Although biological targets such as KIM-1, FAP, and ALP have been validated in extensive patient cohorts, practical barriers severely limit their immediate clinical application. These obstacles involve complex changes in <i>in vivo</i> pharmacokinetics. During an acute injury episode, the extreme drop in the glomerular filtration rate alters probe clearance and can cause unwanted systemic accumulation or confusing background imaging signals. Other major hurdles include a lack of comprehensive long-term toxicity data and the absence of standardized manufacturing protocols to ensure batch-to-batch consistency. Future successful translation will require rigorous multi-center clinical studies to confirm the true diagnostic value of these probes over traditional markers. Researchers must also establish strict standardization of imaging procedures and comprehensive safety evaluations. Ultimately, this review provides a thorough reference framework for designing clinically translatable molecular probes and building a precision diagnostic imaging system for acute kidney injury.]]></description>
<pubDate>2026/5/15 14:41:56</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CAI Lin-Tao,CHEN Ji-Hong,CHEN Jia-Ting,CHEN Ru-Long,LI Jie,XIE Ting-Fei,ZHANG Jin-Xin,ZHANG Peng-Fei]]></author>
</item>
<item>
<title><![CDATA[<i>In Vitro</i> Study of ROS-responsive Hydrogel Loaded With Polydopamine Nanoparticles for Neuronal Protection by Regulating Inflammatory Microenvironment]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202602260000002]]></link>
<description><![CDATA[<b>Objective</b> Cerebral ischemic injury triggers a complex pathological cascade characterized by excessive reactive oxygen species (ROS) accumulation, persistent oxidative stress, and sustained neuroinflammation in the injured brain microenvironment. These events collectively drive mitochondrial dysfunction, microglial overactivation, pro-inflammatory cytokine release, and progressive neuronal apoptosis, ultimately leading to severe and irreversible neurological deficits. However, conventional therapeutic strategies face critical limitations, including poor blood-brain barrier penetration, insufficient local drug concentration, uncontrolled drug release, and off-target systemic side effects. To address this pathological process, we rationally designed and fabricated an injectable ROS-responsive hydrogel loaded with polydopamine nanoparticles (PDA NPs) for spatiotemporally controlled antioxidation, anti-inflammation, and neuroprotection in the ischemic injury microenvironment. The present study aimed to systematically characterize the physicochemical properties, ROS-responsive drug release behavior, biocompatibility, and neuroprotective efficacy of this composite hydrogel system <i>in vitro</i>.<b>Methods</b> PDA NPs were fabricated <i>via</i> oxidative self-polymerization. The ROS-responsive hydrogel was cross-linked using N1-(4-boronobenzyl)-N3-(4-boronophenyl)-N1,N1,N3,N3-tetramethylpropane-1, 3-diaminium (TSPBA) and polyvinyl alcohol (PVA). Morphology, particle size, Zeta potential, and structure of PDA NPs were characterized by dynamic light scattering (DLS), Zeta potential analysis, scanning electron microscopy (SEM), and transmission electron microscopy (TEM). Microstructure, rheological properties, shear-thinning behavior, and ROS-triggered release profiles of the hydrogel were examined by SEM and rheometry. Biocompatibility was evaluated using HT22 mouse hippocampal neurons with CCK-8 and live/dead staining. An oxygen-glucose deprivation/reoxygenation (OGD/R) model was established to simulate ischemic injury <i>in vitro</i>. ROS levels and neuronal apoptosis were detected by DHE staining and TUNEL assay. Microglial polarization and pro-inflammatory cytokine expression were analyzed using immunofluorescence and RT-qPCR in BV-2 microglia. Transwell co-culture was used to verify the indirect neuroprotection mediated by modulated microglia.<b>Results</b> Characterization results confirmed that the as-prepared PDA NPs were monodispersed spherical nanoparticles with uniform diameter and negative surface potential, demonstrating favorable dispersibility and robust ROS-scavenging activity. The TSPBA-PVA hydrogel exhibited a highly porous interconnected network, suitable mechanical strength, and obvious shear-thinning behavior, supporting its application as an injectable implant. More importantly, the hydrogel displayed typical ROS-responsive degradation and on-demand PDA NP release in a ROS-concentration-dependent manner. <i>In vitro</i> cellular experiments demonstrated that the PDA NP-loaded hydrogel possessed excellent biocompatibility with HT22 cells. In the OGD/R model, the hydrogel significantly reduced intracellular ROS accumulation and markedly suppressed neuronal apoptosis. Furthermore, the composite hydrogel effectively redirected BV-2 microglia from the pro-inflammatory M1 toward the anti-inflammatory M2 phenotypes, downregulated the expression of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6, and reduced inflammatory damage. Transwell co-culture assays further validated that M2-polarized microglia mediated by the hydrogel significantly enhanced the survival of OGD/R-injured HT22 neurons and attenuated apoptosis.<b>Conclusion</b> In this study, we successfully developed a novel injectable ROS-responsive hydrogel loaded with PDA NPs for synergistic antioxidative and anti-inflammatory neuroprotection. This intelligent hydrogel system enables ROS-triggered on-demand release of PDA NPs, efficiently scavenges excessive ROS, inhibits oxidative stress injury, modulates microglial polarization, and suppresses neuroinflammation, thereby exerting robust neuroprotective effects <i>in vitro</i>. This biomaterial platform provides a promising strategy for the targeted and controlled delivery of bioactive nanomaterials in the central nervous system diseases and establishes a solid experimental foundation for the development of <i>in situ</i> injectable therapies for ischemic brain injury.]]></description>
<pubDate>2026/5/14 19:41:23</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[LIU Wei,SHA Chuan-Lu,SUN Tian-Yi,WANG Chang-Yong,WANG Chun-Lan,XIAO Yang]]></author>
</item>
<item>
<title><![CDATA[Improvements and Recent Advances of Metadynamics Enhanced Sampling Method]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202603220000001]]></link>
<description><![CDATA[The functional realization of proteins and other biological macromolecules depends on conformational dynamics and allosteric regulation, and elucidating their molecular mechanisms is an important foundation for understanding life processes. Molecular dynamics simulations are a powerful tool for investigating conformational evolution at the atomic level. However, traditional methods are limited by simulation timescales and high free-energy barriers, making it difficult to effectively capture rare conformations and their transition pathways. As a result, the development of enhanced sampling techniques has become key to overcoming this bottleneck. As a classical enhanced sampling technique, metadynamics suffers from several shortcomings, including strong dependence on collective variables and significant errors caused by bias potential accumulation. This article reviews three major improvement strategies. The first combines stochastic resetting with metadynamics, using trajectory-resetting mechanisms to improve sampling efficiency while avoiding the difficulty of optimizing collective variables. The second, SinkMeta, employs a “sinking” bias effect to enable efficient exploration of specific regions and paths. The third, OPES-based hybrid methods, improve the stability of free-energy estimation by optimizing the target distribution or the way the bias is constructed. These methods provide new ideas for characterizing free-energy landscapes and studying conformational transitions in complex biological systems, while also promoting the continued development of enhanced sampling methodologies.]]></description>
<pubDate>2026/5/14 11:42:00</pubDate>
<category><![CDATA[动态与评论]]></category>
<author><![CDATA[CAO Zan-Xia,SHI Zhi-Hong,TONG Ming-Qiong,YIN Yue-Wen]]></author>
</item>
<item>
<title><![CDATA[Plant-derived Exosome-like Nanovesicles in Biomedical Applications]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202604170000001]]></link>
<description><![CDATA[Plant-derived exosome-like nanovesicles (PELNs), characterized by a natural lipid bilayer membrane, have rapidly emerged as a prominent research frontier in medicine owing to their unique biological properties and robust therapeutic potential. This review comprehensively examines the biological profiles, mechanistic functions, and recent engineering advancements of PELNs. In terms of composition, PELNs are uniquely enriched in plant-specific glycolipids, phosphatidylserine, secondary metabolites, and highly stable 2""-O-methylated miRNAs. This distinct molecular makeup endows them with exceptional biocompatibility, negligible immunogenicity, and the capacity for cross-species molecular communication. Mechanistically, PELNs demonstrate profound anti-inflammatory efficacy by suppressing the NF-κB and NLRP3 inflammasome pathways. They also serve as potent immune modulators, driving macrophage M1/M2 polarization and regulating T cell activity. Additionally, PELNs exhibit promising antitumor capabilities, targeting malignancies <i>via</i> reactive oxygen species (ROS) induction, TRAIL pathway activation, and tumor microenvironment remodeling. Crucially, the plant miRNAs encapsulated within PELNs remain highly stable in the gastrointestinal tract, allowing them to selectively alter gene expression in specific gut microbiota communities. This interaction deeply influences host immunity and metabolism, highlighting the vital role in cross-species regulation. Advancements in bioengineering have further expanded the clinical utility of PELNs. Targeted delivery efficiency can be significantly amplified <i>via</i> surface functionalization (<i>e.g</i>., folate and RGD sequences) and state-of-the-art drug loading technologies such as sonication and electroporation. Consequently, engineered PELNs surpass traditional synthetic nanocarriers in penetrating natural physiological barriers, particularly for oral and transdermal drug administration. Despite these advantages, clinical translation is currently hindered by the lack of standardized isolation protocols, challenges in scalable manufacturing, and the need for robust quality control frameworks. Looking forward, the integration of multi-omics approaches and AI-driven “molecular fingerprinting”—coupled with the design of synthetic biomimetic vesicles—will be instrumental in overcoming these bottlenecks, ultimately establishing PELNs as a next-generation platform for precision medicine and targeted nanotherapeutic delivery.]]></description>
<pubDate>2026/5/14 11:22:43</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HUANG Sheng,LIU Si-Rui,LIU Xu,MA Jia-Yu,MOU Yu-Ting,SHI Ting-Yu,SONG Tian-Li]]></author>
</item>
<item>
<title><![CDATA[<b>Research: </b>Noninvasive Screening for Chronic Atrophic Gastritis Using Photoplethysmography-derived Meridian-labelled Harmonic Parameters]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202602280000004]]></link>
<description><![CDATA[<b>Objective</b> Chronic atrophic gastritis (CAG) is usually diagnosed by gastroscopy and histopathological biopsy. These procedures remain the reference standard, but their invasive nature and resource requirements may limit their use in large-scale population screening and repeated follow-up. A convenient and reproducible method for noninvasive auxiliary screening may help identify individuals who require further endoscopic assessment. Fingertip photoplethysmography (PPG) provides a noninvasive recording of peripheral pulse waves and allows harmonic features to be extracted from the signal. In this study, the so-called meridian-related variables were defined as PPG-derived harmonic parameters labelled according to meridian nomenclature, rather than as direct measurements of meridian physiology. This study aimed to compare these harmonic parameters between patients with CAG and non-CAG controls, identify parameters that remained different after age adjustment, and develop a multivariable model for noninvasive auxiliary screening and pre-endoscopic risk stratification of CAG.<b>Methods</b> A total of 343 participants were included, comprising 171 patients with CAG and 172 non-CAG controls. CAG diagnosis was established using gastroscopy and histopathology as the reference standard. Fingertip PPG signals were collected using a PPG-based pulse acquisition device. Eight PPG-derived harmonic parameters labelled according to meridian nomenclature were extracted for analysis. Between-group differences were first assessed using nonparametric tests. Age-adjusted analyses were then performed to reduce potential confounding by age. The false discovery rate (FDR) method was applied for multiple-comparison correction. A multivariable logistic regression model integrating age and multiple harmonic parameters was constructed. Model performance was evaluated using receiver operating characteristic (ROC) analysis and the area under the curve (AUC). Internal validation performance was assessed using stratified five-fold cross-validation and bootstrap optimism correction. Threshold performance was examined using both a high-specificity strategy and a Youden index-based cutoff. Decision curve analysis was used to evaluate the model’s net clinical benefit across a range of threshold probabilities.<b>Results</b> All eight harmonic parameters were non-normally distributed. In the univariate analysis, the stomach-labelled harmonic parameter (ST), bladder-labelled harmonic parameter (BL), and liver-labelled harmonic parameter (LR) differed between the CAG and non-CAG groups. After age adjustment and FDR correction, only ST and BL remained statistically significant. Compared with non-CAG controls, patients with CAG showed higher ST values and lower BL values. This finding indicates an associated differential harmonic pattern that was not fully explained by age distribution. However, the discriminative ability of a single harmonic parameter was limited. The best-performing single indicator was ST, with an <i>AUC </i>of 0.652 (95% <i>CI</i>: 0.595-0.707). The multivariable model integrating age and multiple harmonic parameters achieved an <i>AUC</i> of 0.791 (95% <i>CI</i>: 0.743-0.835), representing an improvement of 0.139 over ST alone. In internal validation, stratified five-fold cross-validation yielded a mean <i>AUC</i> of 0.753 (95% <i>CI</i>: 0.715-0.781), and the bootstrap optimism-corrected <i>AUC</i> was 0.748. These results suggest that the model retained moderate discriminative performance after internal validation.At a specificity of at least 95%, the model achieved a sensitivity of only 40.4% (95% <i>CI</i>: 25.7%-49.7%). This high-specificity cutoff may be suboptimal as the preferred threshold for an initial screening setting because of the potential risk of missed CAG cases. The Youden index-based optimal cutoff was 0.419, corresponding to a sensitivity of 80.7% and a specificity of 62.8%. This threshold may better match the practical aim of noninvasive auxiliary screening, where sensitivity is usually prioritized to reduce missed cases. Decision curve analysis showed that, within a threshold probability range of 10%-55%, the model provided higher net clinical benefit than the reference strategies of recommending gastroscopy for all participants or for none.<b>Conclusion</b> Patients with CAG showed associated harmonic differences in fingertip PPG-derived features, mainly characterized by higher ST and lower BL values after age adjustment and FDR correction. Compared with a single harmonic parameter, the multivariable model showed better overall discrimination and retained moderate internal validation performance. These findings suggest that PPG-derived harmonic parameters labelled according to meridian nomenclature may provide auxiliary information for noninvasive auxiliary screening and front-line triage before gastroscopic confirmation in CAG. The present results support further validation rather than immediate clinical implementation. External validation in independent, multicenter, and preferably prospective screening cohorts is needed to assess the model’s generalizability, screening performance, and potential clinical utility.]]></description>
<pubDate>2026/5/12 8:57:51</pubDate>
<category><![CDATA[中医药医工结合专题]]></category>
<author><![CDATA[CHEN Ai-Ping,CHEN Jian-Xin,LE Yun-Qing,LI Zhi-Hong]]></author>
</item>
<item>
<title><![CDATA[Small Molecule Microarrays: Surface Chemistry, Screening Strategies, and Advances in Drug Discovery]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202602050000001]]></link>
<description><![CDATA[Small-molecule therapeutics and chemical probes remain indispensable in modern biomedical research and drug discovery. However, with the rapid expansion of chemical space and the increasing diversification of biological target classes, high-throughput and material-efficient screening technologies are facing growing demands. Small-molecule microarrays (SMMs) provide a miniaturized and spatially addressable platform in which thousands to tens of thousands of compounds are immobilized on a solid surface and screened in parallel against proteins, cell lysates, or nucleic acid structures. Since the last comprehensive review of this field in 2014, SMM technology has undergone substantial methodological and application-oriented development; however, these advances have often been reported in a fragmented manner and still require systematic integration. This review therefore clarifies the terminology and scope of SMM and systematically summarizes its recent advances, with particular attention paid to four interconnected dimensions: surface chemistry, interface microenvironment modulation, signal detection, and applications. Regarding surface chemistry, immobilization methods are organized into tag-based and broad-spectrum strategies. Tag-based strategies use reactive handles or affinity tags, such as covalent tags, biotin, or fluorous tags, to achieve defined attachment and controllable molecular display, but require prior modification and may mask key pharmacophores. Broad-spectrum strategies exploit intrinsic functional groups or physicochemical properties, including isocyanate coupling, ultraviolet-activated photo-capture, and polymer-based immobilization. They show broader compatibility with diverse libraries, natural products, and approved drugs, but may increase ligand heterogeneity and nonspecific background. This classification provides references for selecting suitable surface construction strategies in SMM studies. Interface microenvironment modulation is another factor affecting the SMM performance. Because immobilized small molecules are displayed on solid substrates, steric hindrance and restricted conformational freedom may reduce target accessibility. Flexible linkers, polyethylene glycol spacers, oligonucleotide tethers, and quasi-three-dimensional polymer layers have therefore been introduced to increase ligand-substrate distance, alleviate steric constraints, and preserve solution-like binding behavior. This review also summarizes signal detection strategies, including fluorescence-based labeling, HaloTag-assisted readouts, and label-free technologies such as oblique-incidence reflectivity difference and surface plasmon resonance imaging. In applications, SMM has expanded from purified protein screening to more diverse biological contexts. Cell lysate-based screening enables interrogation of unstable, difficult-to-purify, or context-dependent targets, whereas structure-oriented screening against RNA/DNA motifs has extended SMM into nucleic acid-targeted discovery. These advances allow SMM to address challenging target classes, including transcription factors, intrinsically disordered proteins, membrane-associated proteins, and protein-protein interactions, targeted protein degradation systems, and higher-order nucleic acid structures. Compared with activity-based high-throughput screening or DNA-encoded library selection, SMM provides a direct, amplification-free binding readout and can capture weak interactions, although rigorous validation remains essential. Finally, this review discusses SMM in fragment-based drug discovery (FBDD) and artificial intelligence-assisted drug design (AIDD). In FBDD, SMM offers a parallel, low-consumption format for detecting weak fragments–target interactions and identifying fragment hits for validation and optimization. In AIDD, SMM can generate binding fingerprints, including fluorescence intensities, signal-to-noise ratios, <i>Z</i>-scores, and apparent affinity parameters in concentration-gradient designs. These datasets may support virtual screening, hit prioritization, binding landscape construction, functional group clustering, and structure–activity relationship inference. Overall, SMM has evolved into a versatile screening and data-generation platform, providing a methodological engine for expanding the druggable target space and accelerating early-stage discovery of chemical probes and lead compounds.]]></description>
<pubDate>2026/5/9 9:20:25</pubDate>
<category><![CDATA[原位生物传感研究专刊]]></category>
<author><![CDATA[GUO Shu-Juan,TAO Sheng-Ce,WANG Yu-Chao,XIE Jia-Hao,ZHOU Kuan]]></author>
</item>
<item>
<title><![CDATA[SIRT5 Potentiates Hepatocarcinogenesis by Modulating Protein Acylation in Mice]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202602280000001]]></link>
<description><![CDATA[<b>Objective</b> Hepatocellular carcinoma (HCC) represents 90% of all primary liver cancers. The main risk factors associated with HCC include viral hepatitis (B and/or C), alcohol abuse, and metabolic dysfunction-associated steatotic liver disease (MASLD), which progressively advance to liver fibrosis, cirrhosis, and ultimately evolve into HCC. Surgical resection represents the most effective treatment for HCC, while recent advances in immunotherapy, including immune checkpoint inhibitors and adoptive cell therapies, have provided improved treatment prospects for patients with unresectable HCC. However, the complex metabolic heterogeneity of HCC limits the therapeutic efficacy. Metabolic intermediates acyl-CoA not only provide energy and substrates for numerous biochemical reactions but also serve as donors for protein lysine acylation, a major class of post-translational modification (PTM). Therefore, a deeper understanding of the molecular mechanisms underlying protein lysine acylation and hepatocarcinogenesis is urgently needed.<b>Methods</b> The levels of protein lysine acylation and silence information regulator 5 (SIRT5) expression levels in clinical HCC samples were analyzed by Western blot. Quantitative malonylome and succinylome of HCC samples were analyzed by antibody-based affinity enrichment coupled with tandem mass spectrometry. The proliferation of HCC cells was analyzed with Cell Counting Kit-8 (CCK-8) assays, the apoptosis was quantified by Annexin V-FITC/propidium iodide (PI) staining coupled with flow cytometry, and the ability of cells to migrate was assayed by Transwell assays. The enzymatic activity of glutathione S-transferase Mu 1 (GSTM1) was quantified. Transgenic mice with hepatic overexpression of SIRT5 were constructed using CRISPR-Cas9, and primary hepatocarcinogenesis was induced by administration of diethylnitrosamine.<b>Results</b> Western blot analysis indicated that the expression level of SIRT5 was elevated in clinical samples from HCC patients, and the levels of lysine malonylation, glutarylation, and succinylation were significantly reduced in HCC tissues. Knockout of SIRT5 in MHCC-97H and MHCC-97L hepatoma cells suppressed cell proliferation, and increased the percentage of apoptotic cells significantly. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses of the differentially malonylome and succinylome of HCC samples revealed significant enrichment in two major classes of biological processes: core energy metabolism (<i>e.g.</i>, glycolysis/gluconeogenesis, tricarboxylic acid metabolic process, fatty acid beta oxidation) and detoxification and oxidative stress response (<i>e.g</i>., response to toxic substance, chemical carcinogenesis, reactive oxygen species (ROS)). SIRT5 removes malonylation from lysine residues in GSTM1 and restores its detoxification activity, which is crucial for the survival of hepatocytes under stressed conditions. More importantly, <i>in vivo</i> experiment indicated that hepatic-specific overexpression of SIRT5 in mice accelerated diethylnitrosamine-induced liver fibrosis and hepatocarcinogenesis, indicating the critical role of SIRT5 in HCC progression.<b>Conclusion</b> This study highlights the previously unrecognized SIRT5-GSTM1 axis as a key regulator in hepatocarcinogenesis, and suggests a potential target for the treatment of patients with HCC.]]></description>
<pubDate>2026/5/9 9:17:09</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CHEN Xiang-Yu,HU Hao,HUANG Zhen,LI Jia-Yun,REN Feng-Rui,SUN Qi,WANG Zi-Yi,WEI Tao-Tao,XIAO Min,ZHANG Ye,ZHANG Yu,ZHAO Jun-Cheng]]></author>
</item>
<item>
<title><![CDATA[Role of Adipose Tissue Macrophages and Adipokine in The Pathogenesis of Obesity-related Immune Diseases]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202602120000002]]></link>
<description><![CDATA[Adipose tissue macrophages (ATMs) are crucial immunomodulatory factors in the adipose tissue (AT) microenvironment, playing an irreplaceable role in maintaining the balance of the local immune system and regulating metabolic homeostasis. Under obese conditions, the excessive accumulation of lipids leads to abnormal expansion of adipose tissue, which further disrupts the homeostasis of the local microenvironment, including the imbalance of inflammatory factors, the occurrence of oxidative stress, and the damage of microcirculation. As an essential immune cell population in adipose tissue, ATMs are deeply involved in the occurrence and progression of metabolic disorders and multiple obesity-related diseases, and their functional abnormalities are closely related to the initiation and development of adipose tissue inflammation and systemic metabolic disorders. The interaction between ATMs and adipokines, including adiponectin, leptin, resistin and retinol-binding protein 4 (RBP4), acts as the core immunological and molecular mechanism linking adipose tissue inflammation to continuous disease deterioration, and this interaction is also a key research focus in the field of obesity-related diseases in recent years. This review discusses in detail the facilitating effect of the AT inflammatory microenvironment on the differentiation of peripheral monocytes into ATMs, elaborating on the specific molecular mechanisms by which various inflammatory mediators and abnormal metabolic products in the inflammatory microenvironment induce the differentiation of peripheral monocytes into functional ATMs. It also focuses on the regulatory mechanisms of chemokine-mediated ATM polarization and recruitment, including the specific roles of key chemokines like MCP-1 and CXCL10 in mediating the recruitment of ATMs to adipose tissue, as well as the molecular pathways that regulate the switch between M1 pro-inflammatory phenotype and M2 anti-inflammatory phenotype of ATMs. In addition, this review explores the specific process by which ATMs trigger AT inflammation by secreting various pro-inflammatory factors such as tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β), which further amplify the local inflammatory response and disrupt the metabolic homeostasis of adipose tissue. Furthermore, it analyzes the specific binding patterns and molecular characteristics of adiponectin, leptin, resistin and RBP4 with ATM surface receptors, and clarifies how the activation of downstream immune signaling pathways, such as JAK-STAT, NF-κB, and PI3K-AKT, triggered by these binding processes, induces the occurrence and development of various obesity-related diseases, including insulin resistance, cancer, metabolic-associated steatohepatitis (MASH) and cardiovascular diseases. This paper highlights the unique and crucial role of the interaction between ATMs and adipokines in the occurrence and progression of obesity-related diseases, emphasizing that this interaction is a key link connecting local adipose tissue inflammation to systemic metabolic disorders. It further summarizes the potential therapeutic strategies targeting the ATM-adipokine axis, and comprehensively illustrates three major clinical application barriers, namely biological complexity, technical bottlenecks, and clinical translation obstacles, in the process of applying these therapeutic strategies. For each barrier, this review puts forward corresponding feasible solutions and clear research directions, which not only enrich the theoretical system of the ATM-adipokine axis in the field of obesity research, but also provide a solid theoretical basis and practical ideas for the clinical intervention, prevention and treatment of obesity and its related diseases.]]></description>
<pubDate>2026/5/9 9:13:04</pubDate>
<category><![CDATA[病理状态下血管微环境的生化特征与精准治疗策略专题]]></category>
<author><![CDATA[DONG Pan-Pan,JIA Zi-Xuan,WANG Qing-Lu,YUAN Xiao-Tong]]></author>
</item>
<item>
<title><![CDATA[<b>Research: </b>Pathogenesis Reasoning Chain-of-thought Supervision for Large Language Models: Syndrome Manifestation Recognition and Multidimensional Evaluation in Spleen-stomach Disorders]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202603200000003]]></link>
<description><![CDATA[<b>Objective</b> The essence of syndrome manifestation recognition in traditional Chinese medicine (TCM) is to infer the body’s latent pathogenesis state from clinical observational information, rather than to perform simple label matching. However, previous studies have largely modeled this task as syndrome pattern classification within a fixed label space, which does not adequately reflect the cognition process of TCM syndrome differentiation centered on pathogenesis reasoning, and is also insufficient to capture the openness, semantic variability, and cross-disease reusability of syndrome manifestation expression. This study aimed to investigate whether introducing pathogenesis reasoning chain-of-thought (PR-CoT) supervision into large language models (LLMs) could improve the quality and cognitive consistency of syndrome manifestation recognition and support cross-disease transfer.<b>Methods</b> Syndrome manifestation recognition was formulated as a conditional generation task under the framework of clinical observational information (<i>X</i>)→pathogenesis structure (<i>Z</i>)→syndrome pattern output (<i>Y</i>), where <i>Z</i> serves as an explicit intermediate structural variable linking the clinical evidence and syndrome judgment. Within this framework, a PR-CoT-supervised dataset for syndrome manifestation recognition was constructed based on medical case records of spleen-stomach disorders. After preprocessing, information extraction, manual proofreading, and data cleaning, the dataset comprised 4 800 training cases, 400 development cases, and 400 test cases. Each sample was annotated with a structured PR-CoT consisting of three progressive levels: clinical information summarization, comprehensive pathogenesis analysis, and syndrome pattern output. Supervised fine-tuning was conducted on open-source LLMs, with an end-to-end model serving as the baseline. Qwen3-32B was used as the primary experimental model, and Qwen3-14B as the scale comparison model. A progressive multidimensional evaluation framework was further established, comprising a structural parsing level, a semantic similarity level, and an expert blind review level. At the structural parsing level, syndrome pattern expressions were decomposed into structural elements and evaluated using Precision, Recall, F1 score, and Jaccard similarity. At the semantic similarity level, independent LLMs scored the theoretical proximity between predicted and reference syndrome patterns. At the expert blind review level, three TCM experts independently evaluated model outputs on two dimensions: syndrome differentiation consistency and terminology standardization of syndrome patterns. In addition, zero-shot cross-disease transfer evaluation was conducted on gynecological and heart-system disorder test sets.<b>Results</b> At the structural parsing level, PR-CoT supervision did not lead to a stable improvement in the element-wise overlap of syndrome pattern structural components. Compared with the corresponding baselines, neither Qwen3-32B nor Qwen3-14B showed consistent advantages in structural matching metrics after the introduction of PR-CoT supervision. In contrast, at the semantic similarity level, PR-CoT supervision produced stable positive gains across different model scales and evaluation systems. The average semantic score of Qwen3-32B increased from 6.425 8 in the baseline model to 6.585 0 after PR-CoT supervision, and that of Qwen3-14B increased from 5.870 0 to 5.964 2. At the expert blind review level, the overall score of Qwen3-32B (PR-CoT) was 7.026 0±0.107 7, higher than 6.416 3±0.288 9 for its baseline. In zero-shot cross-disease testing, the PR-CoT model still showed advantages in semantic evaluation and expert evaluation on both gynecological and heart-system disorder test sets, indicating a certain degree of transferability.<b>Conclusion</b> The benefits of PR-CoT supervision are mainly reflected in TCM semantic consistency and clinical plausibility, rather than in improved hard matching of structural elements. These findings support understanding syndrome manifestation recognition as a process of generating and expressing latent pathogenesis structures, rather than as a classification task within a traditional fixed label space. By introducing pathogenesis reasoning as an explicit intermediate structure into the modeling process and combining it with a progressive multidimensional evaluation framework, this study provides a methodological pathway for intelligent TCM syndrome differentiation that integrates theoretical alignment, interpretability, and multi-level evaluation.]]></description>
<pubDate>2026/5/5 10:18:04</pubDate>
<category><![CDATA[中医药医工结合专题]]></category>
<author><![CDATA[HU Yu-Xin,LI Pan-Fei,TU Yu-Ying,YANG Shu-Han,YU Xin-Yu,ZANG Yi-Chang]]></author>
</item>
<item>
<title><![CDATA[<b>Research: </b>Rectal Administration of Leek and Konjac-derived Extracellular Vesicles Alleviates High-fat Diet-induced Obesity in Mice <i>via</i> Gut Microbiota Modulation]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601250000001]]></link>
<description><![CDATA[<b>Objective</b> Obesity, a global chronic metabolic disease, is closely associated with disruptions in lipid metabolism and gut microbiota. Current intervention strategies still have limitations in terms of safety and microecological regulation, necessitating the exploration of novel natural regulatory approaches. Based on the early pathological characteristics of obesity, this study innovatively employs a rectal delivery method alongside a high-fat diet (HFD)-induced obesity model to systematically evaluate the inhibitory effects, safety, and gut microbiota regulation mechanisms of leek-derived and konjac-derived extracellular vesicles on obesity development. By simulating early clinical intervention scenarios, this study aims to explore the preventive potential of plant-derived extracellular vesicles during the initial stages of obesity onset.<b>Methods</b> Extracellular vesicles from leek and konjac were isolated using ultracentrifugation combined with density gradient centrifugation. Their nanoscale properties were characterized by dynamic light scattering (DLS), transmission electron microscopy (TEM), and nanoparticle tracking analysis (NTA). Male C57BL/6J mice were randomly divided into four groups: normal control (NC), high-fat diet (HFD), leek-derived extracellular vesicles (LEVs), and konjac-derived extracellular vesicles (KEVs). Beginning simultaneously with HFD feeding, mice in the intervention groups received 20 g/L vesicles rectally every 3 d for 4 weeks. Body mass and body composition were monitored throughout. At endpoint, mouse serum, adipose tissue, and colonic contents were collected. Serum biochemical indices (lipid profile, liver and kidney function, cardiac markers) were assessed to evaluate safety and metabolic efficacy, while 16S rRNA sequencing was employed to analyze gut microbial structure and diversity.<b>Results</b> DLS, NTA, and TEM confirmed that both LEVs and KEVs exhibited typical cup-shaped nanostructures with average particle sizes of approximately 284 nm and 223 nm, respectively. LEVs and KEVs treatment significantly suppressed HFD-induced weight gain and elevation of body-fat percentage (<i>P</i><0.05), and reduced accumulation of abdominal white and epididymal adipose tissue. Serological analyses showed that both vesicles lowered total cholesterol, triglycerides and LDL-cholesterol, and ameliorated liver enzyme profiles (ALT, AST), demonstrating lipid-metabolic regulation and hepatoprotective effects. No hepatic, renal or cardiac dysfunction was observed, indicating favorable safety. Gut microbiota analyses revealed that vesicle intervention partially restored HFD-depleted microbial diversity and reshaped community structure. Notably, LEVs markedly increased the relative abundance of the beneficial taxon Lachnospiraceae at the family level, which is known for producing short-chain fatty acids and enhancing intestinal barrier function. Furthermore, Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt) functional prediction suggested that LEVs and KEVs modulated gut microbial functions through distinct mechanisms: LEVs downregulated pathways related to ribosomes and DNA replication while enhancing xenobiotic degradation, whereas KEVs tended to upregulate energy metabolism and protein synthesis toward healthy levels.<b>Conclusion</b> Rectally administered LEVs and KEVs exhibit excellent safety and pronounced metabolic benefits during the early phase of obesity, suppressing weight gain, correcting lipid dysregulation, and exerting effects <i>via</i> modulation of gut microbial composition and function. This study provides systematic experimental evidence supporting plant-derived exosome-like vesicles as an early intervention strategy against obesity.]]></description>
<pubDate>2026/5/5 10:17:09</pubDate>
<category><![CDATA[中医药医工结合专题]]></category>
<author><![CDATA[LIANG Cheng-Bang,MU Yan,TAN Yan,WU Yu-Jia,YU Xin-He,ZHANG Ya-Ru]]></author>
</item>
<item>
<title><![CDATA[Efficient Loading and Targeted Delivery of Plant Exosomes]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601300000005]]></link>
<description><![CDATA[Plant-derived extracellular vesicles (PDEVs) are nanoscale extracellular vesicles secreted by plant cells, characterized by a lipid bilayer structure. These vesicles carry a variety of bioactive molecules, including proteins, nucleic acids, and lipids, and play essential roles in intercellular communication and physiological regulation in plants. Compared to animal-derived extracellular vesicles, PDEVs offer several advantages, such as a broad range of sources, high biocompatibility, low immunogenicity, and low production costs. Furthermore, PDEVs have demonstrated remarkable potential as natural nanocarriers for drug delivery, due to their ability to efficiently traverse biological barriers, such as the blood-brain barrier, making them promising candidates for drug delivery systems. This review systematically elaborates on the complex composition of PDEVs, which consists of lipids, proteins, and nucleic acids, the typical structural characteristics of their lipid bilayers ranging from 30 to 150 nm, and their versatile loading capabilities as drug carriers, efficiently encapsulating various types of therapeutic agents such as hydrophilic small molecules, hydrophobic drugs, nucleic acids, and proteins. We systematically summarize the recent advancements in strategies for enhancing the loading efficiency of PDEVs, which include methods such as co-incubation, ultrasound-assisted loading, electroporation, freeze-thaw cycles, and microfluidic technology. These techniques are evaluated based on their underlying principles, suitable drug types, and their respective advantages. In addition to loading strategies, we focus on the engineered approaches to achieve targeted delivery using PDEVs, such as genetic engineering modifications, chemical ligand conjugation, membrane fusion technology, and polyethylene glycol (PEG) modification. We discuss the mechanisms of these strategies in enhancing targeting efficiency, prolonging <i>in vivo</i> circulation time, and improving therapeutic efficacy. Further, this review highlights the application of PDEVs in various disease models, including tumor, skin inflammation, metabolic disorders, and neurodegenerative diseases, showcasing their therapeutic potential as multifunctional delivery platforms. The ability of PDEVs to encapsulate diverse therapeutic agents and target specific tissues or cells opens up new avenues for the treatment of complex diseases, offering advantages over conventional drug delivery systems. However, despite the promising applications of PDEVs, several challenges remain in their development and clinical translation. These challenges include variability in source materials, standardization of preparation processes, quality control, scalability of production, and the need for clinical validation. To overcome these obstacles, the integration of advanced technologies such as artificial intelligence-assisted design and multi-omics analysis is proposed as a way to facilitate the precise development of PDEVs. These emerging technologies hold the potential to further enhance the precision and effectiveness of plant-based drug delivery systems, ultimately advancing the field of precision medicine. In conclusion, the use of PDEVs as a platform for drug delivery represents a promising area of research with the potential to revolutionize therapeutic strategies. Their ability to encapsulate and deliver a wide variety of bioactive molecules, along with their inherent advantages in biocompatibility and versatility, makes them a valuable tool in the development of more efficient and targeted therapeutic interventions. Continued research and innovation in this field will pave the way for the clinical implementation of PDEVs in the treatment of various diseases, offering new hope for more effective and sustainable therapeutic options.]]></description>
<pubDate>2026/5/3 13:04:41</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LEI Chong-Bin,LI Jie,TIAN Hong-Tao,XU Meng,XU Wen-Tao,ZHANG Yang-Zi,ZHU Long-Jiao]]></author>
</item>
<item>
<title><![CDATA[<b>Research:</b> Electroacupuncture Ameliorates NLRP3-mediated Pyroptosis in Spinal Cord Injury Rats by Reshaping The Gut Microbiota]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601140000001]]></link>
<description><![CDATA[<b>Objective</b> Spinal cord injury (SCI) directly impairs the regulatory function of the autonomic nervous system, induces intestinal dysfunction, and significantly reduces patients’ quality of life. Preclinical studies have shown that electroacupuncture (EA) therapy can regulate the brain-gut axis and is used to treat central nervous system diseases such as major depressive disorder, Alzheimer’s disease and Parkinson’s disease. Recent research has established that fecal microbiota transplantation (FMT) from EA-treated SCI rats restored intestinal motility and colonic morphology. However, it remains unclear whether the regulation of gut microbiota by EA therapy directly contributes to neural repair after SCI. This study aims to explore whether gut microbiota mediates the neuroprotective effect of EA in the treatment of SCI and its possible mechanism.<b>Methods</b> The study employed RNA transcriptome analysis of spinal cord tissue to characterize gene expression profiles and to identify key signaling pathways following EA treatment for SCI. Hematoxylin-Eosin (HE) staining and Nissl staining were used to observe the morphological changes in spinal cord tissue. Western blot (WB) and enzyme-linked immunosorbent assay (ELISA) were applied to detect the effects of EA on the expression of proteins related to nucleotide-binding domain leucine-rich repeat and pyrin domain-containing receptor 3 (NLRP3) -dependent pyroptosis. Using 16S rDNA sequencing, the study observed alterations in gut microbiota diversity and community composition in SCI rats. Prior to establishing SCI models, rats were pretreated with an antibiotic cocktail to induce gut dysbiosis, and the effects on intestinal function and spinal cord neural repair were evaluated. FMT was performed to investigate the regulatory effects of post-EA FMT on motor function, general status, liver and spleen indices, and NLRP3-mediated pyroptosis in SCI rats.<b>Results</b> EA improved motor function and reduced regulated neuronal cell death in SCI rats. Transcriptomic analysis demonstrated the activation of immune- and inflammation-related pathways post-SCI, including NOD-like receptors, nuclear factor-kappa B (NF-κB), and Toll-like receptor (TLR) pathways. EA primarily influenced intestinal inflammation and autoimmune functions. 16S rDNA sequencing illustrated that EA did not alter the diversity of gut microbiota. However, EA altered the gut microbiota composition in SCI rats, increasing <i>Lactobacillus</i> and <i>Akkermansia</i> genera while rebalancing the Firmicutes/Bacteroidetes ratio. Furthermore, depletion of gut microbiota by antibiotics disrupted the intestinal barrier, reduced the expression of intestinal barrier proteins Zonula Occludens-1 (ZO-1) and Occludin, elevated serum lipopolysaccharide-binding protein (LBP) levels, exacerbated spinal cord tissue damage, and hindered motor function recovery in SCI rats. FMT from donors treated with EA reduced LBP levels in the intestine, blood, and spinal cord of rats, inhibited the TLR4 myeloid differentiation primary response protein 88 (MyD88)-NF-κB pathway and NLRP3-dependent pyroptosis, and improved motor function. On the other hand, FMT treatment resulted in decreased body weight and food intake, whereas FMT using EA-treated donors effectively alleviated these alterations.<b>Conclusion</b> EA effectively alleviated neuroinflammatory responses in rats with SCI, primarily through regulating the gut microbiota and suppressing the NLRP3-dependent pyroptosis signaling pathway.]]></description>
<pubDate>2026/5/3 10:44:29</pubDate>
<category><![CDATA[中医药医工结合专题]]></category>
<author><![CDATA[CUI Yin-Jie,DU Hai-Lin,LI Hong-Ru,LIU Jing-Yi,LIU Shu-Wen,SONG Xiao-Juan,XIANG Jian-Qin,YANG Yuan,ZHENG Chen-Guang]]></author>
</item>
<item>
<title><![CDATA[Neuroelectromagnetic Activities Across Temporal Scales]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202511040000002]]></link>
<description><![CDATA[Although global brain science research has progressed rapidly in recent decades, several fundamental questions in neuroscience remain unresolved. In particular, the physical mechanism underlying neural signal transmission remains controversial, and the carriers responsible for neural information storage and retrieval have not yet been fully clarified. These unresolved issues motivate us to re-examine the processes of neural information generation, transmission, integration, storage, and retrieval from multiple perspectives. A key observation is that neural electromagnetic activities are closely associated with time. Their duration, temporal structure, and dynamic evolution play crucial roles in neural information processing. In this work, we analyze neural electromagnetic activities from the perspective of temporal scales (referred to here as the “time course”). By reviewing and integrating findings from previous studies, we examine the characteristic time requirements and dynamic features of neural processes occurring at different stages of information processing. These stages include neural signal generation, signal transmission along axons, synaptic integration, synaptic plasticity, and memory formation and retrieval. Based on this temporal analysis, we outline a framework describing neural electromagnetic activities across a wide range of time scales, spanning from microseconds to minutes, hours, or even longer periods associated with long-term memory, which suggests that neural information processing involves multiple physical processes operating at different time levels. Rapid electromagnetic events may occur on microsecond scales, whereas electrophysiological phenomena such as action potentials typically last on the order of milliseconds. Longer time scales are associated with synaptic plasticity and memory-related processes. From this perspective, we propose that the physical carrier of neural information may be transient electromagnetic pulses with durations on the microsecond scale. In this framework, action potentials can be interpreted as the macroscopic electrophysiological manifestation of underlying electromagnetic processes triggered by ionic currents across neuronal membranes. Rather than being the fundamental neural signal itself, the action potential may represent a measurable membrane-level response associated with the successful activation of these electromagnetic events. Moreover, we discuss a possible mechanism for long-term memory storage. Considering the apparent temporal contradiction between the millisecond-scale excitation of neurons and the long-term persistence of memories, we believe that long-term memory information may be stored within neural network topologies formed by electrical synapse coupling. Such structures, referred to as electrically coupled memory networks (ECMNs), may enable neurons within the same network to respond rapidly and synchronously to stimuli, thereby facilitating efficient memory retrieval. Overall, this study emphasizes the importance of considering the temporal organization of neural electromagnetic activities when interpreting neural signaling mechanisms. It may provide new insights into the physical nature of neural information carriers and the mechanisms of memory storage and retrieval. Furthermore, highlighting the potential role of electromagnetic interactions in neural activity may contribute to the development of new theoretical frameworks and experimental approaches in neuroscience. Such perspectives may also offer valuable references for future research on neural coding, brain function mechanisms, and neuromodulation technologies.]]></description>
<pubDate>2026/4/30 9:44:28</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[GUO Wei,LI Jing-Xin,SHEN Zhuo-Qun,TIAN Lan,WANG Yan-Qing,XU Jing-Jing,XU Xiao-Fei]]></author>
</item>
<item>
<title><![CDATA[Applications of Optical Technology in Non-invasive Hemoglobin Detection]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202603110000001]]></link>
<description><![CDATA[Hemoglobin (Hb) concentration is a key clinical biomarker for diagnosing and managing anemia, ischemic stroke, perioperative blood loss, and chronic diseases such as renal failure. Traditional venous blood sampling remains the gold standard due to its high accuracy, but its invasive nature limits frequent testing, real time monitoring, and large scale screening. This has driven growing interest in non-invasive Hb detection technologies over the past decade. Among these, optical methods are the most promising because of their safety, potential for continuous monitoring, and compatibility with portable or wearable devices. This paper systematically reviews major advances in optical non invasive Hb detection from the last ten years. We focus on near-infrared spectroscopy branches—photoplethysmography (PPG) and dynamic spectrum (DS)—and also cover color analysis/RGB imaging, Raman spectroscopy, and photoacoustic spectroscopy. For each technology, we explain its detection principles, analyze advantages and limitations, and summarize optimization strategies reported in recent literature. PPG, based on pulsatile blood volume changes, underpins many commercial continuous monitors. However, its accuracy is constrained by motion artifacts, individual physiological variations (<i>e.g</i>., skin tone, tissue thickness), and low AC signal to noise ratio. In contrast, DS—an advanced derivative of PPG—uses a differential principle to extract absorbance changes between systolic and diastolic peaks. This theoretically eliminates interference from static tissues (skin, bone, venous blood) and common mode noise (<i>e.g</i>., ambient light), positioning DS as a more robust framework for high precision Hb quantification. Beyond spectral methods, color analysis/RGB imaging offers a hardware minimalist approach. By analyzing images of vascular rich, thin tissues (<i>e.g</i>., conjunctiva, nail beds, palms), it enables Hb estimation using smartphone cameras. Recent advances have shifted from manual RGB feature extraction to deep learning models and spectral super resolution that reconstruct hyperspectral data from RGB inputs, significantly improving screening accuracy. Our academic perspective emphasizes critical and integrative analysis. We highlight persistent challenges that hinder clinical translation: profound individual biological variability (skin optics, microvascular architecture), sensitivity to measurement conditions (pressure, ambient light), and a lack of standardized validation protocols and multi center trials. A central thesis is that no single optical method is universally superior; each involves trade offs between accuracy, complexity, cost, and practicality. Looking forward, we posit that the next performance leap will come from multimodal information fusion—combining PPG, electrocardiogram (ECG), bioimpedance, or different optical modalities to compensate for individual differences and environmental noise. AI and deep learning are essential not only for image analysis but also for automated, end to end feature extraction from complex waveforms like PPG sequences. Advancing hardware (tunable lasers, quantum dot LEDs, novel sensor designs) is crucial to improve signal fidelity and portability. Finally, we advocate for clinical scenario specific optimization and rigorous standardized evaluation frameworks to gain regulatory approval (<i>e.g</i>., FDA, NMPA) and achieve widespread clinical acceptance. In conclusion, this review synthesizes a decade of progress. Optical non-invasive Hb detection has evolved from proof of concept studies to emerging products and validated screening tools, but the journey toward reliable, clinic ready quantitative devices continues. The convergence of smarter algorithms, fused sensing modalities, and focused clinical validation offers the most promising path to transform this potential into routine medical practice, ultimately enabling personalized, continuous, and accessible hematological management.]]></description>
<pubDate>2026/4/29 23:02:30</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LAN Bi-Tie,PENG Yao,WANG Xian-Long,YU Jian-Hai]]></author>
</item>
<item>
<title><![CDATA[<b>Editorial: </b>The Integration of Traditional Chinese Medicine and Engineering： Technological Empowerment and Paradigm Innovation in The Modernization of Traditional Medicine]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202604230000001]]></link>
<description><![CDATA[The Integration of Traditional Chinese Medicine and Engineering： Technological Empowerment and Paradigm Innovation in The Modernization of Traditional Medicine]]></description>
<pubDate>2026/4/27 7:53:22</pubDate>
<category><![CDATA[中医药医工结合专题]]></category>
<author><![CDATA[CHEN Yu-Feng,hUA Qian]]></author>
</item>
<item>
<title><![CDATA[Research on Electrical Impedance and Microwave Dual-modality Tomography Algorithm Based on Conditional Diffusion Models]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601220000001]]></link>
<description><![CDATA[<b>Objective</b> Stroke poses a heavy burden due to its high mortality and morbidity rates. Accurate and real-time detection of lesions is pivotal for prompt clinical intervention and favorable prognosis. Electrical impedance tomography (EIT) and microwave tomography (MWT) have emerged as compelling alternatives for stroke screening, owing to their non-ionizing, non-invasive and portable nature. EIT provides information on tissue conductivity, and MWT offers high sensitivity to changes in dielectric properties. However, single-modality imaging is inherently limited, EIT suffers from low sensitivity to deep-seated tissues and severe ill-posedness of inverse problems, whereas MWT is challenged by strong nonlinearity in inverse scattering and susceptibility to modeling errors. Consequently, the clinical utility of standalone EIT or MWT for stroke diagnosis remains constrained by poor spatial resolution and imaging artifacts. To improve the accuracy and robustness of stroke imaging, a dual-modality fusion conditional denoising diffusion probabilistic model (DM-DDPM) was proposed for high-precision dual-modality image reconstruction.<b>Methods</b> A dual-encoder network with a symmetric architecture and independently trained parameters was constructed to extract heterogeneous features separately from EIT boundary voltage measurements and MWT scattered field signals. Attentional feature fusion (AFF) is employed to integrate complementary information from the two modalities adaptively, generating robust fused priors that suppress redundant noise while preserving key physical characteristics. Subsequently, the fused priors are embedded into a Transformer-based diffusion model <i>via</i> a cross attention mechanism to guide the reverse denoising process. This approach effectively reduces artifacts and enhances the stability of conductivity distribution reconstruction. Time step embedding is introduced to enable the network to perceive the diffusion stage and further improve the accuracy of noise prediction.<b>Results</b> Simulated experiments demonstrated that DM-DDPM significantly outperforms single-modality and multi-modality networks under various noise levels. A head model simulation dataset was constructed based on COMSOL Multiphysics, and tests were carried out under 50 dB, 40 dB and 30 dB signal-to-noise ratio levels. At 30 dB, the average relative error (<i>RE</i>) was below 0.20, while the structural similarity index measure (<i>SSIM</i>) and correlation coefficient (<i>CC</i>) remained above 0.90 and 0.89, respectively. Compared with single-modality and multi-modality networks, artifacts were significantly reduced, lesion edges were clearer, and localization was more accurate. The model maintains high reconstruction quality and strong robustness for single, double, and triple lesions simultaneously. Furthermore, physical experiments were conducted using a 16-electrode EIT system and a 16-antenna MWT system with asynchronous data acquisition. These experiments confirmed the feasibility of the method in real-world scenarios and demonstrated that it can robustly reconstruct simulated lesions despite environmental interference and measurement noise, validating its reliability for practical clinical applications.<b>Conclusion</b> The proposed method effectively combines complementary dual-modality information with a conditional diffusion model. Low accuracy and poor noise resistance in single-modality imaging were effectively addressed, while the noise amplification issue caused by direct multimodal data fusion was avoided. The proposed algorithm exhibits strong anti-noise interference ability and high imaging stability in both simulation and physical experiments. Precise localization of stroke lesions with different quantities was achieved, providing a high-precision, and practical technical support for clinical stroke detection.]]></description>
<pubDate>2026/4/24 19:36:50</pubDate>
<category><![CDATA[技术与方法]]></category>
<author><![CDATA[LI Chun-Chan,LIU Jin-Zhen,MENG Xiang-Qian,XIONG Hui,ZHOU Li-Min]]></author>
</item>
<item>
<title><![CDATA[Innovative Development and Cutting-edge Applications of Split Intein Technology]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601260000002]]></link>
<description><![CDATA[Inteins are unique protein insertion sequences capable of self-excision, enabling the covalent ligation of flanking extein peptides <i>via</i> amide bond formation. This process proceeds spontaneously without requiring external enzymes, cofactors, or chemical reagents, granting inteins exceptional biocompatibility and traceless performance in protein engineering applications. Split inteins represent a specialized and versatile subclass whose splicing domains are encoded by two separate gene fragments rather than a single continuous open reading frame. These fragments, known as the N-terminal (IntN) and C-terminal (IntC) split inteins, associate through non-covalent interactions including hydrophobic forces, hydrogen bonds, and van der Waals forces to assemble into an active three-dimensional structure, which then drives efficient extein ligation and enables protein trans-splicing. Protein trans-splicing mediated by split inteins has become a cornerstone for traceless protein ligation owing to its high specificity and irreversibility, fundamentally reshaping strategies for protein modification, assembly, and functional regulation. Compared with traditional chemical ligation methods, split intein systems require no complex chemical derivatization of peptide fragments and can operate efficiently at micromolar concentrations under physiological conditions, thus avoiding structural and functional damage caused by organic reagents. In contrast to enzymatic ligation tools such as sortase, split inteins eliminate the need for additional enzymes or cofactors, simplifying reaction systems, reducing costs, and minimizing non-specific side products. These distinctive advantages render split inteins highly promising for applications in chemical biology, synthetic biology, and biopharmaceutical development. In recent years, deepened mechanistic understanding has established structure-guided rational design as the primary approach to overcoming key limitations of split inteins, including intrinsic aggregation propensity, strict extein sequence dependence, and limited splicing efficiency. Bioinformatic tools have been used to identify aggregation-prone regions in the IntN fragment, and site-directed mutagenesis of hydrophobic residues, relocation of split sites, or removal of misfolding-prone sequences has substantially reduced <i>in vitro</i> aggregation and improved soluble expression and assembly activity. Rational engineering of catalytic residues and adjacent flexible loops has relaxed strict amino acid preferences at extein junctions, enhancing sequence tolerance and reducing the risk of functional impairment in target proteins. Consensus design based on multiple sequence alignments has yielded ultra-fast splicing variants such as Cfa DnaE and Cat-TerL, which exhibit significantly accelerated kinetics and improved tolerance to denaturing conditions. Meanwhile, advances in structural biology have further clarified the conformational dynamics and catalytic mechanisms of splicing, supporting the precise design of high-performance intein modules. On this basis, electrostatic interaction tuning and metagenomic screening have yielded multiple mutually orthogonal split intein pairs, enabling selective multi-fragment protein ligation and providing new routes for the efficient synthesis of large multi-domain functional proteins. With these engineered split inteins offering continuously improved performance and expanded applicability, protein trans-splicing has been widely applied in numerous cutting-edge areas of protein research and biomedicine. In gene delivery, split intein-based systems overcome the packaging limit of adeno-associated viral vectors, enabling the accurate reconstitution of large therapeutic proteins and base editors in target cells, thereby enhancing the efficacy and scope of gene therapy for genetic diseases. In internal protein sequence editing, split inteins mediate precise sequence replacement and modification in flexible regions or loops of target proteins, without the need for complex multi-step ligation and protein refolding involved in traditional protein semisynthesis. In protein-protein interaction studies, intein-mediated splicing covalently captures transient and weak intracellular complexes, enabling sensitive, high-throughput interaction detection and drug screening. In synthetic biology, conditionally controllable splicing systems support the construction of diverse intracellular and cell-surface biological logic gates for the precise regulation of cellular behavior. In mechanistic biochemical research, split inteins enable photocatalytic proximity labeling and site-specific tagging, allowing the preparation of homogeneous protein samples carrying precise post-translational modifications such as ubiquitination and polyglutamylation for chromatin interactome analysis and epigenetic studies. Moreover, covalent trapping strategies using split inteins stabilize transient enzymatic intermediates, providing unprecedented insights into molecular mechanisms such as nucleosome ubiquitination that are difficult to elucidate using conventional methods. This review systematically summarizes key technological advances in split inteins over the past decade, highlighting engineering strategies, mechanistic insights, and the development of orthogonal components. It comprehensively surveys emerging applications at the frontiers of protein research, analyzes current core challenges, and proposes future directions, particularly emphasizing artificial intelligence-driven <i>de novo</i> design and novel splicing pathways to break existing technical bottlenecks. By enabling traceless, efficient, and versatile protein manipulation, split inteins continue to serve as indispensable tools that drive innovation in protein engineering and fundamental life science research.]]></description>
<pubDate>2026/4/22 23:22:43</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DENG Xiang-Yu,GAN Jin-Qiu,LI Jia-Bin,WANG Xin-Yan]]></author>
</item>
<item>
<title><![CDATA[Engineered Bacteriophages for The Treatment of Multidrug-resistant Bacterial Infections]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202512180000002]]></link>
<description><![CDATA[Multidrug-resistant (MDR) bacterial infections have emerged as a serious challenge of global public health crisis. The overuse and misuse of conventional antibiotics have dramatically accelerated the emergence, evolution and worldwide spread of drug-resistant bacterial strains, necessitating urgent exploration of novel antibacterial strategies. Bacteriophages serve as natural bacterial predators offering distinct advantages including high host specificity, autonomous self-replication capabilities and cost-effective large-scale production. However, wild-type phages present significant clinical limitations due to their narrow host ranges, susceptibility to rapid immune clearance and poor penetration of bacterial biofilms, which severely restrict their therapeutic applications. The convergence of synthetic biology, nanotechnology and advanced gene editing technologies has accelerated the development of engineered bacteriophage platforms, providing programmable, scalable and clinically translatable pathways to overcome these inherent biological constraints. Here, we systematically delineate four fundamental strategies for engineered bacteriophage development. Chemical modification utilizes reactive functional groups such as amino, carboxyl and thiol moieties on capsid proteins through esterification, amidation or click chemistry reactions to achieve precise drug conjugation and surface functionalization. <i>In vivo</i> editing encompasses ultraviolet or chemical mutagenesis for random mutation induction, homologous recombination for targeted genetic alterations, recombineering methodologies including electroporation-mediated bacteriophage recombination engineering, and CRISPR-Cas systems for precise genome editing to enable exact genetic reconstruction and host range reprogramming. <i>In vitro</i> synthesis leverages genome engineering platforms where intact phage genomes are transferred into yeast or host bacteria to facilitate highly efficient homologous recombination, enabling large DNA fragment assembly and cross-gene host range expansion without bacterial toxicity constraints. Directed evolution combines artificial selection through mutation library screening with rational design approaches involving chimeric receptor binding protein construction or site-specific mutagenesis, effectively balancing the discovery of unknown adaptive pathways with targeted host specificity modification. Moreover, we comprehensively discuss therapeutic applications across diverse clinical scenarios. Engineered bacteriophage effectively disrupt bacterial biofilms through sophisticated functionalized delivery platforms including nanozyme-conjugated phages, phage-liposome nanoconjugates and bio-responsive hydrogels, demonstrating significantly enhanced bactericidal efficiency compared to unmodified free phages. These bioengineered vectors attenuate bacterial virulence and resensitize pathogens to antibiotics by delivering CRISPR-Cas systems or base editors to disrupt critical virulence factors such as pili, capsule synthesis machineries and quorum sensing systems, or by inactivating antibiotic resistance determinants including beta-lactamase genes. As intelligent nanomedicine delivery platform, engineered bacteriophage enable precise pathogen elimination an through photocatalytic reactive oxygen species generation, immunomodulatory interventions, or controlled release of antibacterial drugs. Furthermore, oral administration of engineered bacteriophage facilitates microbiota modulation, which selectively eliminate intestinal pathogens while preserve beneficial commensal microbiota, thereby restoring microbial community balance and preventing complications associated with dysbiosis. Finally, we critically analyze persistent challenges including host strain matching complexity, evolution of bacterial resistance mechanisms, pharmacokinetic optimization requirements, optimal administration route selection, large-scale production quality control standards and clinical dosing determination protocols. Through multidisciplinary integration of synthetic biology, infectious disease medicine and immunology, future translational medicine studies of bacteriophage should establish comprehensive technical platforms encompassing rapid phage screening, intelligent rational design, rigorous <i>in vivo</i> evaluation and standardized clinical validation processes, ultimately advancing engineered bacteriophage from laboratory innovations to clinically approved therapeutics for effectively combating MDR bacterial infections.]]></description>
<pubDate>2026/4/18 17:16:11</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Yu-Ying,DAI Gui-Qin,HUANG Chun-Mei,LIU De-Liang,LU Hong-Zhou,PAN Jin-Zhi,ZHAO Peng-Fei,ZHENG Ming-Bin,ZHOU Yang]]></author>
</item>
<item>
<title><![CDATA[Antibody-drug Conjugates Targeting RON and Their Anti-cancer Effects]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601300000006]]></link>
<description><![CDATA[Receptor tyrosine kinases (RTKs) are a class of transmembrane cell surface enzyme-linked receptors that play essential roles in various cellular life processes under normal physiological conditions. Dysregulation of RTKs and their signaling pathways is closely associated with multiple human diseases, including cancer. RON is a member of the RTK family. When RON is abnormally expressed, it can actively drive the proliferation, metastasis, and epithelial-mesenchymal transition of cancer cells through complex downstream signal transduction pathways, thereby contributing to the occurrence and subsequent development process of various types of cancers. Consequently, RON is regarded as a potent target for cancer targeted therapy. In recent years, as RTKs have gradually become popular candidate targets for antibody-drug conjugates (ADCs), a variety of ADCs targeting RON have been successfully developed and studied. To highlight the therapeutic potential of anti-RON ADCs in cancer treatment and to provide a foundation for further development and clinical research of them, this article summarized the selected components and construction strategies of existing anti-RON ADCs, and systematically reviewed their<i> in vitro</i> and <i>in vivo</i> anticancer efficacy, as well as their pharmacological and toxicological characteristics. Anti-RON ADCs demonstrated favorable stability both <i>in vitro</i> and <i>in vivo</i>. In cellular models, anti-RON ADCs carrying different payloads all exhibited potent cytotoxic effects. In animal models, anti-RON ADCs have convincingly demonstrated significant anti-cancer activity, with stable pharmacological properties and manageable toxicity at therapeutic doses. Anti-RON ADCs have a number of distinct therapeutic advantages. Compared with ADCs targeting other RTKs, anti-RON ADCs have unique effects in regulating the immune microenvironment and can potentially provide additional therapeutic options for overcoming drug resistance. Compared with RON antibodies and small molecule inhibitors, anti-RON ADCs do not rely on the RON signaling pathways, thereby significantly enhancing therapeutic efficacy. Moreover, anti-RON ADCs show therapeutic potential for targeting RON variants. In summary, the results of basic researches indicated that anti-RON ADCs have favorable anti-cancer effects and show promising clinical translation prospects. In addition, this article analyzed the current limitations of anti-RON ADCs and emphatically discussed their future development directions. The payloads of the existing anti-RON ADCs are relatively limited, and the drug-to-antibody ratio (DAR) of each ADC is not uniform. There also remains considerable room for improvement in terms of endocytosis efficiency and drug combination strategies. Therefore, the development of the next-generation anti-RON ADCs should focus on the diversification of the payloads, and explore new types of ADCs, dual-load ADCs, <i>etc</i>. Additionally, the structure of antibodies or ADCs could be optimized to enhance the endocytosis efficiency and progressively overcome current limitations. At present, anti-RON ADCs are limited to basic research, and the current research outcomes and observations indicated their potential for clinical application. Therefore, the clinical translation of anti-RON ADCs will be an important objective for future development. To this end, it is necessary to carefully devise a rational clinical translation pathway for anti-RON ADCs, and comprehensively evaluate the potential challenges that may arise during the implementation, so as to accelerate the initiation of clinical trials. Ultimately, clinical application of anti-RON ADCs will be realized, providing more treatment options for cancer patients.]]></description>
<pubDate>2026/4/16 15:15:07</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[SUN Ting,YAO Hang-Ping]]></author>
</item>
<item>
<title><![CDATA[An Attention-weighted Tri-modal Ultrasound Network (TUS-Net) for Screening of Atypical Hepatocellular Carcinoma From LR-M Liver Nodules]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601240000002]]></link>
<description><![CDATA[<b>Objective</b> Discriminating atypical hepatocellular carcinoma (HCC) from other malignancies in liver nodules classified as Liver Imaging Reporting and Data System category M (LR-M) remains a significant diagnostic challenge on conventional ultrasound examination. The LR-M category, originally intended to capture non-HCC malignancies, paradoxically contains up to 63% of atypical HCCs that deviate from classic enhancement patterns, leading to potential misdiagnosis and suboptimal treatment planning. While deep learning has shown promise in HCC diagnosis, most existing models rely exclusively on single-modality ultrasound, overlooking the diagnostic benefits of integrating complementary information from multiple imaging sources. To address this gap, we propose a novel attention-weighted tri-modal ultrasound network (TUS-Net) that integrates contrast-enhanced ultrasound (CEUS), B-mode ultrasound (BUS), and time-intensity curves (TICs) to improve diagnostic accuracy for these clinically challenging lesions.<b>Methods</b> Our framework incorporates a three-dimensional convolutional neural network (C3D) backbone to extract spatiotemporal features from CEUS videos, capturing dynamic vascular patterns critical for lesion characterization. To effectively fuse complementary modalities, we introduce a dual-channel feature fusion module (DCFFM) that adaptively combines features from CEUS and BUS through channel-wise attention mechanisms, allowing the model to dynamically weigh the contribution of each modality based on diagnostic relevance. Additionally, we propose a temporal intensity feature fusion module (TIFFM) that leverages quantitative hemodynamic information from TICs to guide the model’s attention toward diagnostically critical temporal phases, such as arterial wash-in and portal venous washout. The model is further enhanced by automated lesion localization using YOLOX and class activation mapping for interpretability, ensuring that predictions align with clinically meaningful imaging features.<b>Results</b> Evaluated on a tri-modal ultrasound dataset comprising 161 patients with pathologically confirmed LR-M nodules (131 atypical HCC and 30 non-HCC malignancies), our model achieved an accuracy of 86.83%, a sensitivity of 92.50%, a specificity of 75.50%, and an <i>AUC</i> of 89.32% in screening atypical HCC. Compared to single-modality baselines, TUS-Net demonstrated superior specificity, a clinically critical metric given the higher risk associated with misclassifying non-HCC malignancies. Ablation studies confirmed the contribution of each module, with the full model outperforming both standard C3D and 3D ResNet backbones integrated with attention mechanisms. A reader study involving junior and senior radiologists further validated the clinical utility of AI assistance, showing consistent improvements in specificity and inter-reader consistency, particularly for less experienced clinicians.<b>Conclusion</b> These results surpass existing benchmark models and demonstrate the potential of our approach to enhance diagnostic precision in clinically specific cases. By intelligently fusing multi-modal ultrasound data with attention-guided mechanisms, TUS-Net offers a reliable and interpretable tool that holds promise for improving the non-invasive diagnosis of atypical HCC in challenging LR-M liver nodules.]]></description>
<pubDate>2026/4/16 8:30:33</pubDate>
<category><![CDATA[技术与方法]]></category>
<author><![CDATA[CHEN Ying-Ying,HUANG Liang-Hui,JIANG Shang-Lin,WANG Xue-Hua,ZENG Ya-Guang,ZHANG He-Chong,ZHENG Wei]]></author>
</item>
<item>
<title><![CDATA[<b>Research: </b>Sclera Vessel Segmentation Based on Fusion Filtering and Reflection Suppression]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601310000005]]></link>
<description><![CDATA[<b>Objective</b> In traditional Chinese medicine (TCM), the foundational doctrine that the eyes reflect the essence of the internal viscera establishes ocular observation as a cornerstone of diagnostic practice. Specifically, the morphological characteristics and coloration variations of the scleral microvasculature serve as critical clinical indicators for assessing the dynamic balance of Qi and Blood, as well as the pathological status of internal organs. Historically, however, TCM eye diagnosis has relied predominantly on the subjective clinical experience and visual acuity of individual practitioners, leading to inherent challenges in standardization and reproducibility. While automated computer-aided diagnostic systems offer a promising solution, existing vessel segmentation algorithms encounter significant domain-specific bottlenecks when applied to scleral imagery. These challenges primarily stem from the highly reflective and moist nature of the ocular surface, which generates severe reflective interference. Furthermore, the inherent low contrast of fine capillary networks against complex background textures, compounded by non-uniform illumination, frequently results in high false-positive rates, misdetections, and severe vessel fragmentation. To address these critical limitations and advance the objective quantification of TCM diagnostics, this paper proposes a novel, highly robust sclera vessel segmentation framework that innovatively integrates Frangi-Sato dual-filter adaptive enhancement with pixel-level reflection detection.<b>Methods</b> The proposed methodology systematically addresses the segmentation pipeline through three synergistic stages. First, to overcome the structural limitations of single-filter approaches, a multi-scale weighted fusion strategy is meticulously designed to harness the complementary extraction capabilities of both Frangi and Sato filters. This adaptive enhancement optimally balances the preservation of main vessel trunk continuity with the heightened sensitivity required for delineating delicate, low-contrast peripheral capillaries. Second, to tackle the persistent issue of reflective highlights, a sophisticated multi-feature synergistic reflection detection module is introduced. By jointly analyzing local information entropy, gradient field variations, and intensity statistical distributions, this module achieves precise, pixel-level identification and elimination of reflective artifacts without compromising the underlying vascular structures. Finally, a dual-level adaptive thresholding strategy, featuring an innovative “core protection” mechanism, is implemented. This critical step effectively suppresses complex background noise while rigorously preserving the structural and topological integrity of the intricate vessel network, preventing the structural breaks often seen in conventional binarization methods.<b>Results</b> The efficacy of the proposed framework was rigorously evaluated using both self-constructed clinical datasets specifically acquired for TCM research and standardized public datasets. Extensive experimental results demonstrate that the proposed method consistently outperforms state-of-the-art traditional approaches and contemporary deep learning models. Specifically, the proposed method achieves a Dice similarity coefficient of approximately 0.71 on the private clinical dataset, and secures the best performance across the majority of quantitative metrics on both datasets. Notably, the framework exhibits exceptional robustness and generalization capabilities in highly challenging scenarios characterized by intense reflective interference, low signal-to-noise ratios, and cross-domain image variations.<b>Conclusion</b> This study successfully realizes the high-integrity, automated segmentation of scleral vessel networks under complex clinical imaging conditions. By overcoming the fundamental algorithmic challenges of reflection interference and micro-vessel loss, the proposed methodology provides potential support for the digitization, objective standardization, and intelligent advancement of modern TCM eye diagnosis systems.]]></description>
<pubDate>2026/4/16 8:27:45</pubDate>
<category><![CDATA[中医药医工结合专题]]></category>
<author><![CDATA[FAN Fan,FAN Ming-Xuan,GAO Chu-Xiang,HUANG Guo-Liang,JIA Zhe-Xuan,MA Zong-Qing,SHI Yi-Xuan,ZHANG Zi-Hang,ZHU Jiang]]></author>
</item>
<item>
<title><![CDATA[Functional Remodeling of The DgpB/C Enzyme Into an <i>O</i>-Glycosyltransferase <i>via</i> Phase Transition]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601300000001]]></link>
<description><![CDATA[<b>Objective</b> Flavonoids are clinically significant natural products, yet their oxygen-glycosylation in aqueous environments relies heavily on expensive nucleotide-activated sugar donors such as UDP-glucose. Liquid-liquid phase separation (LLPS) creates specialized, membraneless physicochemical microenvironments capable of modulating enzymatic functions and overcoming mass transfer limitations. This study aims to investigate whether the gut microbiota-derived DgpB/C complex—a multienzyme system traditionally recognized for cleaving stable <i>C</i>-glycosidic bonds and facilitating isomerization—can undergo functional remodeling within phase-separated condensates. Our core objective is to elucidate the role of phase separation in expanding enzymatic catalytic plasticity and to provide a non-canonical, highly cost-effective biocatalytic mechanism for the direct utilization of free sugars in the synthesis of <i>O</i>-glycosylated natural products.<b>Methods</b> An artificial phase-separation platform was constructed utilizing the multivalent arginine-glycine-glycine motif (RGG)-repeat domain derived from the <i>Caenorhabditis elegans</i> LAF-1 protein. To ensure precise spatial compartmentalization, the DgpB/C complex was specifically recruited into the RGG condensates <i>via</i> a high-affinity SZ1/SZ2 heterodimerization tag system. Condensate formation and substrate partitioning were visualized using light and confocal fluorescence microscopy. The chemical structures and regioselectivity of the reaction products were rigorously characterized using high-performance liquid chromatography (HPLC) and liquid chromatography-mass spectrometry (LC-MS)/MS systems. Furthermore, molecular docking and 20-ns molecular dynamics (MD) simulations were performed <i>via</i> the Hermite platform and Uni-GBSA pipeline to elucidate the structural and thermodynamic basis underlying the phase-transition-induced functional shift.<b>Results</b> We observed that the condensates formed by RGG proteins selectively recruited and significantly enriched hydrophobic flavonoid substrates. Strikingly, within the LLPS microenvironment, the DgpB/C complex—which typically exhibits only degradative or isomerase activities—underwent a profound functional remodeling, transforming into an efficient <i>O</i>-glycosyltransferase. Diverging from canonical pathways that require high-energy donors, the sequestered DgpB/C complex directly utilized unactivated free glucose to catalyze the formation of new <i>O</i>-glycosidic bonds. This remodeled activity was found to be evolutionarily conserved across DgpB/C homologs from diverse gut microbiota strains, such as P581a and<i> </i>W974-1. LC-MS/MS analysis further revealed that the phase-separated environment reduced the regioselectivity constraints of the enzyme, enabling catalytic action on multiple hydroxyl positions of the flavonoid scaffold. MD simulations further indicated that the low-water-activity microenvironment of the condensates reconfigured the conformational dynamics of the catalytic pocket, favoring a spatial orientation highly conducive to dehydration condensation.<b>Conclusion</b> This study demonstrates that LLPS drives the functional remodeling of the gut microbiota enzyme DgpB/C through the reconfiguration of the physicochemical microenvironment. These findings challenge traditional perceptions regarding the functional boundaries of metabolic enzymes and reveal a novel biocatalytic pathway that bypasses the requirement for nucleotide-activated sugars. Consequently, this provides a highly promising artificial compartmentalization strategy for the green manufacturing of complex, high-value-added natural products.]]></description>
<pubDate>2026/4/15 7:48:59</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[LI Ping,LI Tian-Yu,MA Wen-Fu]]></author>
</item>
<item>
<title><![CDATA[<b>Review: </b>Mechanisms of Intervertebral Disc Degeneration and Traditional Chinese Medicine Intervention Based on Inflammatory-related Signaling Pathways]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601200000002]]></link>
<description><![CDATA[Intervertebral disc degeneration (IVDD) is the predominant pathological contributor to chronic low back pain, a pervasive musculoskeletal condition affecting over 630 million people globally and imposing tremendous socioeconomic and public health burdens. The etiopathogenesis of IVDD is remarkably complex and multifactorial, involving intricate crosstalk among chronic inflammatory responses, extracellular matrix (ECM) catabolism, cellular senescence, aberrant programmed cell death (including apoptosis, pyroptosis, and ferroptosis), mitochondrial dysfunction, and oxidative damage. Compelling evidence indicates that the inflammatory microenvironment acts as a decisive driving force throughout the entire degenerative course of IVDD. Among the diverse inflammatory mediators, interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) serve as core pro-inflammatory cytokines that initiate and perpetuate the degenerative cascade. These two pivotal cytokines collectively activate an array of canonical intracellular signaling pathways, including nuclear factor-κB (NF-κB), mitogen-activated protein kinase (MAPK), nucleotide-binding domain leucine-rich repeat and pyrin domain-containing receptor 3 (NLRP3) inflammasome, and the phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) cascade. Such interconnected signaling networks trigger a self-reinforcing positive feedback loop, which exacerbates inflammatory reactions, disrupts the anabolic-catabolic homeostasis of the ECM, promotes oxidative stress and mitochondrial injury, induces multiple forms of disc cell death, and ultimately leads to progressive structural collapse and functional deterioration of the intervertebral disc. Conventional therapeutic strategies, dominated by nonsteroidal anti-inflammatory drugs and surgical interventions, are limited by systemic adverse reactions, suboptimal long-term efficacy, and the risk of adjacent segment degeneration. In contrast, traditional Chinese medicine (TCM) exhibits prominent advantages in the prevention and treatment of IVDD by virtue of its holistic regulation, syndrome differentiation, and multi-component, multi-target, multi-pathway pharmacological properties. This review systematically elucidates the molecular mechanisms by which inflammation-associated signaling pathways modulate disc cell fate and ECM metabolic homeostasis, and comprehensively summarizes the experimental progress over the past five years on TCM monomers and compound formulas for intervening in IVDD. Accumulating studies have confirmed that numerous natural active ingredients isolated from herbal medicines (ferulic acid, mangiferin, paeonol, astragaloside IV) and representative TCM compound prescriptions (Bushen Huoxue Formula, Shensuitongzhi Formula, Fuzi Decoction) exert synergistic protective effects by coordinately targeting core signaling hubs. These TCM agents demonstrate potent anti-inflammatory, antioxidant, anti-apoptotic, anti-pyroptotic, anti-ferroptotic, ECM-protective, and autophagy-regulating bioactivities, thereby effectively decelerating the pathological progression of IVDD. Despite remarkable progress, current investigations are still confronted by several critical limitations. Most studies are restricted to validating the regulatory effects of single TCM components on individual signaling pathways, leaving the systematic, dynamic, and synergistic mechanisms of TCM compound formulas within multi-pathway regulatory networks largely unexplored. Furthermore, clinical translation of TCM is severely hampered by the lack of efficient targeted drug delivery systems, unclear pharmacokinetic profiles, suboptimal local bioavailability, and incomplete long-term safety assessments. Therefore, future research should adopt an interdisciplinary paradigm integrating multi-omics technologies, artificial intelligence, organoid models, and organ-on-chip systems to systematically decipher the scientific basis of TCM against IVDD. Concurrently, the development of intelligent, site-specific delivery systems (hydrogels, nanoparticles, exosome-based carriers) is urgently needed to enhance the local accumulation and sustained release of TCM ingredients. By deepening mechanistic exploration and accelerating translational research, TCM is expected to evolve into safe, effective, and personalized precision therapeutic regimens for IVDD, offering novel and reliable solutions for the clinical management of chronic low back pain.]]></description>
<pubDate>2026/4/14 17:21:29</pubDate>
<category><![CDATA[中医药医工结合专题]]></category>
<author><![CDATA[HE Lin-Lin,HUANG Tao,LIU Xin-Feng,WANG Chen-Chen,YANG Long,ZHANG Tian-Long,ZHANG Yan-Jun]]></author>
</item>
<item>
<title><![CDATA[Psychological Stress-induced Immune Dysregulation: The Key Factor Undermining Aerobic Exercise’s Antagonism Against Tumor Progression]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601140000002]]></link>
<description><![CDATA[Cancer is one of the most lethal and burdensome diseases worldwide. Its progression not only causes irreversible damage to the body, but also imposes a substantial psychological burden on patients due to its complex prognosis. Immune imbalance, a hallmark of the tumor microenvironment (TME), accelerates tumor invasion and metastasis by impairing the function of effector immune cells, promoting the abnormal infiltration of immunosuppressive cells, and disrupting cytokine homeostasis, thereby constituting a major barrier to the efficacy of cancer immunotherapy. Compared with conventional chemotherapy and radiotherapy, aerobic exercise has shown considerable potential in antagonizing tumor progression through relatively mild but effective immunomodulatory mechanisms. On the one hand, regular aerobic exercise enhances the number and activity of key effector immune cells, such as CD8<sup>+</sup> T cells, thereby strengthening their ability to recognize and eliminate tumor cells and alleviate immune imbalance. On the other hand, aerobic exercise promotes tumor vascular normalization, improves vascular maturity, and stimulates the secretion of irisin and other anti-inflammatory myokines, thereby remodeling the TME and relieving its immunosuppressive state to delay tumor progression. However, psychological stress following a cancer diagnosis can not only act as an independent disruptive factor that exacerbates immune imbalance within the TME, but also amplify the effects of other detrimental factors, such as reduced treatment adherence, thereby further weakening the antagonistic effect of aerobic exercise on tumor growth. Psychological stress, as a chronic stressor, promotes the excessive secretion of emotion-related hormones, including glucocorticoids (GCs) and norepinephrine (NE), which further suppress the activation and effector functions of antitumor immune cells such as CD8<sup>+</sup> T cells and natural killer (NK) cells, while facilitating the recruitment of protumor immune cells such as regulatory T cells (Tregs). These changes ultimately disrupt immune homeostasis in the TME, promote tumor immune evasion, accelerate tumor invasion and metastasis, and offset the beneficial effects of aerobic exercise on tumor control. In addition, psychological stress induces hyperactivation of the hypothalamic-pituitary-adrenal (HPA) axis and abnormal excitation of the sympathetic nervous system (SNS), thereby maintaining elevated levels of GCs, NE, and related stress hormones, suppressing inflammatory chemokine expression and immune cell recruitment, and further disturbing immune homeostasis in the TME, which accelerates tumor progression. More importantly, prolonged psychological stress can also disrupt the homeostasis of central neurotransmitters, such as 5-hydroxytryptamine (5-HT) and glutamate (Glu). This not only directly inhibits the activation and effector functions of antitumor immune cells and promotes the establishment of an immunosuppressive microenvironment, but also impairs cellular energy metabolism and continuously provides energy for tumor cells through metabolic reprogramming, thereby sustaining rapid tumor growth and adaptation to a hostile TME. Ultimately, these alterations contribute to the dysregulation of “neuro-endocrine-immune” axis and weaken the protective effect of aerobic exercise against tumor progression. Therefore, this review focuses on the interaction between psychological stress and the “neuro-endocrine-immune” axis, with particular emphasis on the mechanisms by which psychological stress induces immune imbalance and weakens the antagonistic effect of aerobic exercise on tumor progression. We further highlight the important role of psychological stress in tumor progression and propose that combining psychotropic interventions, aerobic exercise, and clinical antitumor immunotherapy may help restore the tumor-killing capacity of the immune system. Such a multimodal strategy may exert synergistic effects at multiple levels, including psychological stress relief, neuroendocrine regulation, and reconstruction of immune homeostasis, thereby providing new perspectives for identifying therapeutic targets in solid tumors, enhancing the efficacy of cancer immunotherapy, and improving patient prognosis.]]></description>
<pubDate>2026/4/10 9:34:59</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LIU Jing-Jing,PAN Hui-Xin,WANG Qing-Lu,ZHANG Hua,ZHANG Jing,ZHOU Xin]]></author>
</item>
<item>
<title><![CDATA[Cryo-lift-out Technique for Cryo-electron Tomography of Tissue Samples]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202512220000004]]></link>
<description><![CDATA[Cryo-electron tomography (cryo-ET) enables the determination of high-resolution three-dimensional structures of macromolecular complexes within cells in a near-physiological state, providing crucial structural insights into fundamental life processes. Cryo-ET has achieved landmark successes in single-cell models. However, many critical biological processes do not occur in isolated cells but emerge from intercellular coordination within tissues. Furthermore, many research subjects, including neural tissues, tumor biopsies, plant tissues, and clinical pathological samples, cannot be obtained through single-cell culture and must be directly dissected from organisms or tissue blocks. Advancing cryo-ET from single-cell to tissue-level applications is therefore crucial for capturing the full complexity of biological activities in their native context. A major technical bottleneck for tissue cryo-ET lies in the preparation of sufficiently thin (<300 nm) lamellae from vitrified tissue specimens. Although high-pressure freezing can vitrify tissues up to 200 μm thick, these samples are far too thick for direct transmission electron microscopy imaging. Among the available thinning methods, cryo-focused ion beam (cryo-FIB) milling has emerged as the most promising approach, as it avoids the mechanical artifacts inherent to cryo-ultramicrotomy. However, conventional on-the-grid cryo-FIB milling is inefficient for thick tissues, requiring excessive milling time and discarding most of the sample. To overcome these limitations, cryo-lift-out has been developed—a technique in which a micromanipulator physically extracts a chunk of interest from deep within the tissue and transfers it to a dedicated grid for final thinning. This approach bypasses the thickness barrier and enables site-specific analysis of internal structures. This review systematically traces the evolution of cryo-lift-out from its origins in materials science to its adaptation for biological tissues. In room-temperature lift-out, reliable attachment is achieved by gas-injection system (GIS)-assisted metal deposition. Transferring this approach to cryogenic conditions proved challenging because precursor gases condense on all cold surfaces, leading to contamination and poor adhesion. The development of copper-assisted redeposition marked a critical turning point: instead of relying on gas deposition, this method uses ion-beam sputtering to deposit copper atoms at the needle-chunk interface, creating a strong, low-contamination bond. This innovation has enabled robust cryo-lift-out workflows and paved the way for serial lift-out, in which multiple consecutive lamellae are prepared from a single tissue chunk, substantially increasing throughput and enabling volumetric imaging. Despite these advances, several technical challenges remain. Curtaining effects caused by uneven chunk surfaces can introduce artifacts into tomograms, requiring careful optimization of milling parameters and protective coating. The cryo-adhesion step still demands precise control of beam angle, needle positioning, and milling depth, making the process highly operator-dependent. Additionally, the choice of grid geometry is critical. Custom-designed grids with double-sided attachment improves stability and offer better compatibility with cryo-ET tilt series. Automation, which has greatly improved room-temperature lift-out, has not yet been achieved for cryo-lift-out due to the complexity of handling heterogeneous biological tissues and the need for real-time adaptation. Future progress will likely focus on integrating cryo-lift-out with volume electron microscopy to correlate ultrastructure across scales, developing intelligent control systems to reduce user intervention, and extending the technology to challenging samples such as plant tissues and some material science samples for interface study. A systematic analysis of the cryo-lift-out technique clarifies the key limiting factors for its large-scale application and lays a foundation for methodological refinement and technological innovation. By consolidating recent advances and identifying remaining bottlenecks, this review aims to support the broader adoption of cryo-lift-out and accelerate the development of tissue-scale <i>in situ</i> structural biology.]]></description>
<pubDate>2026/4/9 22:42:21</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[GAO Ning,GUO Qiang,QIN Chang-Dong]]></author>
</item>
<item>
<title><![CDATA[Pseudolaric Acid B-linked Double-network Hydrogel Alleviates Pruritus by Inhibiting The Growth of <i>Staphylococcus aureus</i>]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601270000002]]></link>
<description><![CDATA[<b>Objective</b> This study aimed to elucidate the mechanistic role of <i>Staphylococcus aureus </i>in the pathogenesis of atopic dermatitis (AD), a chronic inflammatory skin disorder characterized by pruritus and barrier dysfunction. A key focus was screening traditional Chinese medicine (TCM) active components with dual antibacterial and antipruritic efficacy, followed by systematic evaluation of their <i>in vitro</i> antibacterial activity. Additionally, a novel drug delivery system was constructed to enable localized efficient drug delivery, inhibiting <i>S. aureus </i>proliferation and alleviating its induced pruritus, thereby providing new strategies for targeted AD therapy.<b>Methods</b> Male C57BL/6J mice aged 6-8 weeks (body weight 18-22 g) were used to establish an AD model <i>via</i> repeated oxazolone sensitization. On day 14, microbial samples were collected from the lesional area (1 cm2) using sterile cotton swabs, followed by vortex mixing, serial dilution, and plating on 5% sheep blood agar plates (incubated at 37°C for 24 h). Single colonies with complete transparent β-hemolytic zones were isolated and identified as vancomycin-intermediate <i>S. aureus </i>(VISA) <i>via</i> 16S rRNA sequencing. An <i>S. aureus </i>mono-infection animal model was then established by applying gauze saturated with bacterial suspension (McFarland turbidity 0.1) to the nape and back skin of mice. The pruritic phenotype and inflammatory cell infiltration induced by <i>S. aureus </i>were evaluated using comprehensive approaches including behavioral assays (<i>e.g</i>., scratching frequency recording), hematoxylin-eosin (HE) staining, and toluidine blue staining. The <i>in vitro</i> antibacterial efficacy of the TCM monomer pseudolaric acid B (PAB) and double network hydrogel (DN) was separately assessed by disk diffusion assay, while the minimum inhibitory concentration (MIC) of PAB was determined <i>via</i> broth dilution method. Further validation of the pharmacodynamic characteristics of the composite system (PAB@DN, composed of PAB and DN) was conducted through behavioral assays, HE staining, and dermatitis scoring, with its drug release profile evaluated by mass spectrometry analysis. Based on scratching behavioral analysis and dermatitis scoring, the optimal ratio and concentration of PAB@DN were optimized.<b>Results</b> The <i>S. aureus </i>load in AD lesional tissues was significantly higher than in normal skin ((5.3±0.33)×10? CFU <i>vs</i>. (3.6±0.26)×10? CFU, <i>P</i><0.001). In the <i>S. aureus </i>mono-infection group, mice exhibited a 6.7-fold increase in scratching frequency compared to the control group. HE staining revealed marked epidermal thickening ((10.4±2.39) μm <i>vs</i>. (85.6±1.95) μm, <i>P</i><0.000 1), and toluidine blue staining showed a 23-fold increase in mast cell degranulation. Pseudolaric acid B exhibited a significant concentration-dependent inhibitory effect on <i>S. aureus </i>growth, with its <i>in vitro</i> antibacterial effect being 57% that of the antibiotic cefepime (inhibition zone diameter: PAB (1.885±0.036) cm <i>vs.</i> cefepime (3.636±0.005) cm, <i>P</i><0.000 1) and a minimum inhibitory concentration (MIC) of 1 g/L. The carrier double network hydrogel (DN) itself lacked direct antibacterial activity (no significant difference in inhibition zone diameter compared to the control) but effectively ameliorated the dry symptoms of AD-like lesions. The PAB@DN composite system demonstrated a synergistic effect compared to individual components, resulting in a 50% reduction in scratching behavior, an 86% decrease in dermatitis score, and a 60% reduction in epidermal thickening. It also reduced the <i>S. aureus </i>load in mouse skin by approximately 34%, with the optimal effective formulation being PAB at 1 g/L loaded onto DN.<b>Conclusion</b> <i>S. aureus </i>colonization plays a critical driving role in the onset and progression of AD. Using an <i>S. aureus </i>infection model, this study confirmed that the pseudolaric acid B-hydrogel composite delivery system (PAB@DN) can effectively alleviate <i>S. aureus</i>-induced pruritus and skin damage, providing experimental evidence for microbiota-targeted therapy of AD.]]></description>
<pubDate>2026/4/9 11:05:19</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CAI Cheng-Long,LI Tong-Yu,TANG Zong-Xiang,WANG Ting,YANG Yan,YOU Ye,ZHU Chan]]></author>
</item>
<item>
<title><![CDATA[Structural and Functional Abnormalities of White-matter Tracts in Male College Smokers]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202512120000001]]></link>
<description><![CDATA[<b>Objective</b> The present study aimed to investigate alterations in white matter microstructure and spontaneous neural activity in male college smokers, and to further explore their associations with nicotine dependence. Given that adolescence and early adulthood represent critical periods for brain maturation, particularly for white matter development, understanding the neural correlates of smoking behavior during this stage is of substantial importance for both neuroscience and public health.<b>Methods</b> A total of 115 male undergraduate students were initially recruited for this study. After quality control and exclusion procedures, 52 male college smokers and 42 demographically matched healthy non-smokers were included in the final analysis. All participants underwent multimodal magnetic resonance imaging (MRI), including diffusion tensor imaging (DTI) and resting-state functional MRI (rs-fMRI). White matter fiber tracts were reconstructed using the automated fiber quantification (AFQ) method, which enables precise identification and quantification of major fiber bundles. Eighteen major white matter tracts were segmented for each participant. Along the core trajectory of each tract, 100 equidistant nodes were sampled. Fractional anisotropy (FA) was calculated at each node to assess white matter microstructural integrity, while amplitude of low-frequency fluctuation (ALFF) was computed to evaluate spontaneous neural activity within white matter tracts. Between-group differences in <i>FA</i> and <i>ALFF</i> were assessed using two-sample <i>t</i>-tests, with appropriate corrections applied for multiple comparisons. Furthermore, Pearson correlation analyses were conducted to examine the relationships between imaging-derived metrics (<i>FA</i> and <i>ALFF</i> values in regions showing significant group differences) and nicotine dependence severity, as measured by the Fagerstr?m test for nicotine dependence (FTND).<b>Results</b> Compared with healthy non-smokers, male college smokers exhibited significantly increased <i>FA</i> values in several white matter tracts, including the left thalamic radiation, right corticospinal tract, forceps major of the corpus callosum, left uncinate fasciculus, and right arcuate fasciculus. These findings suggest altered microstructural organization or increased directional coherence within these pathways. In addition, smokers demonstrated significantly elevated <i>ALFF</i> values in the forceps major, right uncinate fasciculus, and left arcuate fasciculus, indicating enhanced spontaneous neural activity in these white matter regions. Correlation analyses revealed that <i>FA</i> values in the left thalamic radiation and right corticospinal tract were negatively correlated with FTND scores, suggesting that higher levels of nicotine dependence were associated with reduced microstructural integrity or altered fiber organization in these regions. In contrast, <i>ALFF</i> values in the forceps major and right uncinate fasciculus were positively correlated with FTND scores, indicating that greater nicotine dependence was associated with increased spontaneous neural activity in specific white matter pathways.<b>Conclusion</b> The present study provides evidence that male college smokers exhibit distinct alterations in both white matter microstructure and functional activity. These abnormalities are not uniformly distributed but rather localized to specific fiber tracts implicated in sensorimotor processing, interhemispheric communication, and higher-order cognitive and emotional regulation. Importantly, the observed associations between imaging metrics and nicotine dependence severity suggest that these structural and functional alterations may reflect neurobiological mechanisms underlying addiction. The combination of AFQ-based tract profiling and multimodal MRI offers a sensitive approach for detecting subtle changes along white matter pathways, highlighting its potential utility in identifying neuroimaging biomarkers of nicotine dependence. Overall, these findings indicate that smoking during early adulthood may disrupt ongoing white matter maturation, potentially leading to long-term consequences for brain function. This study provides novel insights into the neural basis of nicotine dependence and underscores the importance of early intervention and prevention strategies targeting young smokers.]]></description>
<pubDate>2026/4/9 7:37:28</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[DONG Fang,LI Xiao-Jiao,MA Yu-Xin,MAI Zhen-Zhen,WANG Juan,WANG Xu-Wen,XUE Ting,YU Da-Hua,YUAN Kai]]></author>
</item>
<item>
<title><![CDATA[Mechanistic Insights into The Role of LEPROTs and COPI Retrograde Transport in Regulating Golgi Morphology]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202602090000001]]></link>
<description><![CDATA[<b>Objective</b> The Golgi apparatus serves as a central hub in the eukaryotic secretory pathway, responsible for the processing, sorting, and trafficking of proteins and lipids. In mammalian cells, the Golgi typically forms a perinuclear ribbon-like structure composed of laterally connected cisternae stacks.The maintenance of Golgi ribbon structure depends on the balance of membrane flux across multiple intracellular trafficking pathways, yet the specific contributions of distinct trafficking branches to Golgi macroscopic morphology remain elusive. In mammalian cells, the Golgi ribbon is typically organized as a perinuclear, laterally connected structure composed of stacked cisternae, and its integrity is highly dynamic and sensitive to perturbations in membrane trafficking. This study aims to elucidate the role of coat protein complex I (COPI)-mediated retrograde transport in maintaining the Golgi ribbon and to dissect the functional relationship between the transmembrane cargo receptors LEPROT/LEPROTL1 (LEPROTs) and the COPI adaptor GOLPH3.<b>Methods</b> Using siRNA interference and gene-deficient cell lines, we selectively perturbed COPI- or adaptor protein complex 1 (AP-1)-mediated trafficking pathways in HeLa cells. To quantitatively evaluate Golgi morphology, we employed a “Golgi Angle”-based measurement to assess its circumferential distribution around the nucleus. The spatial distribution of the Golgi ribbon was quantitatively analyzed using confocal microscopy, while Golgi ultrastructure and vesicle density were examined <i>via</i> transmission electron microscopy. Additionally, the subcellular distribution of COPI components was assessed by immunofluorescence co-localization.<b>Results</b> Selective inhibition of COPI retrograde transport significantly induced the circumferential extension of the Golgi ribbon around the nucleus, whereas blocking AP-1-mediated anterograde transport resulted in Golgi compaction, indicating opposing roles. These results suggest that different trafficking branches downstream of ARF1 exert distinct and even antagonistic effects on Golgi morphology. LEPROTs-deficient cells exhibited a Golgi extension phenotype highly consistent with COPI impairment. Furthermore, knockdown of GOLPH3 in a LEPROTs double-knockout background produced a significant additive effect on Golgi extension, suggesting that LEPROTs and GOLPH3 play non-redundant roles in regulating COPI-related trafficking processes. Mechanistically, loss of either LEPROTs or GOLPH3 led to the aberrant accumulation of COPI components at endoplasmic reticulum exit sites, accompanied by a reduction in COPI-like vesicles around the Golgi. This redistribution indicates a defect in COPI recycling between the ER-Golgi interface and the Golgi apparatus. Ultrastructural analysis revealed that Golgi cisternae in defective cells became shorter and thicker while maintaining a stable number of stacks. In parallel, the density of Golgi-associated vesicles was markedly decreased, further supporting an impairment in COPI vesicle formation or budding processes.<b>Conclusion</b> This study demonstrates that active COPI retrograde transport is a critical factor in restricting the over-connection of the Golgi ribbon and maintaining its compactness. Rather than causing fragmentation, partial disruption of COPI function leads to a distinct morphological outcome characterized by Golgi ribbon extension at the light microscopy level and cisternal remodeling at the ultrastructural level. LEPROTs and GOLPH3 cooperatively promote the recycling and vesiculation of COPI components, thereby imposing a structural constraint on the Golgi periphery. Our findings support a model in which multiple adaptor proteins act in parallel to sustain efficient COPI cycling, thereby maintaining Golgi structural homeostasis. These findings provide new cell biological evidence for the membrane trafficking basis of Golgi morphological homeostasis.]]></description>
<pubDate>2026/4/8 10:11:24</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[GAO Jing-Hu,WU Yan-Fang,YAN Bing,ZHANG Yu-Lu,ZHAO Lin-Yue]]></author>
</item>
<item>
<title><![CDATA[The Pathogenesis and Therapeutic Strategies of Nasal Inflammatory Diseases From The Perspective of Glycolytic Metabolic Reprogramming]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601200000003]]></link>
<description><![CDATA[Aberrant activation of glycolysis represents a key metabolic mechanism underlying the initiation and progression of nasal inflammation. Allergic rhinitis, chronic rhinosinusitis, and vasomotor rhinitis exhibit distinct etiologies, yet all are characterized by inflammatory responses, impaired epithelial barrier function, and neurovascular dysregulation, in which glycolytic metabolic reprogramming acts as a central hub connecting immunometabolism and inflammatory regulation.Recent evidence indicates that glycolysis-dependent activation of immune cells provides the essential energy basis for inflammatory onset. In dendritic cells, eosinophils, mast cells, and Th2 cells, the expression of key glycolytic enzymes including HK2, PKM2, and LDHA is upregulated, thereby promoting cellular activation and proinflammatory cytokine release <i>via</i> the mTOR-HIF-1α signaling axis. Notably, the metabolic reprogramming of eosinophils prolongs their survival and enhances the release of cytotoxic granules, while in mast cells, enhanced glycolysis facilitates IgE-mediated degranulation and histamine release. Furthermore, glycolysis also influences the Th17/Treg balance, with enhanced glycolytic flux promoting Th17 differentiation and contributing to the heterogeneous inflammatory profiles observed across different rhinitis subtypes.As a central metabolite, lactate contributes to the formation of a metabolism-inflammation vicious cycle through multiple mechanisms. Lactate acidifies the local microenvironment to activate TRPV1 channels and facilitate neuropeptide release, mediates immune cell chemotaxis through GPR81, and regulates gene expression <i>via</i> histone lactylation, thereby sustaining proinflammatory gene transcription. These lactate-mediated processes collectively amplify local inflammation and contribute to the persistence of nasal symptoms.Glycolytic reprogramming in epithelial cells is modulated by the EGF/EGFR pathway, and its dysregulation may result in disrupted tight junctions, abnormal goblet cell hyperplasia, and subsequent tissue remodeling. Substance P and calcitonin gene-related peptide released from sensory neurons, in conjunction with metabolic products, synergistically maintain persistent inflammatory stimulation by activating mast cells, forming a neuro-immune-metabolic regulatory network that drives disease chronicity.From a therapeutic perspective, glycolytic inhibitors such as 2-deoxyglucose, FX11, and 3-bromopyruvate exert anti-inflammatory effects by targeting key enzymes including HK2 and LDHA, each with distinct mechanisms: 2-DG competitively inhibits hexokinase, FX11 selectively targets LDHA to reduce lactate production, and 3-BrPA modulates multiple glycolytic enzymes. Moreover, traditional Chinese medicine formulas, monomeric active components, and small-molecule compounds have shown promising potential in alleviating nasal inflammation by regulating the mTOR-HIF-1α axis, exerting antioxidant effects, and modulating endoplasmic reticulum stress pathways. The multi-target characteristics of these natural products offer advantages in addressing the complex pathophysiology of nasal inflammatory diseases.Despite these advances, several challenges remain. The non-selective inhibition of glycolysis may interfere with epithelial repair and mucosal regeneration, leading to delayed wound healing. Technical limitations in dynamic metabolic monitoring and sampling precision hinder the accurate assessment of local nasal metabolism. Furthermore, current animal models, which predominantly rely on acute stimulation protocols, inadequately recapitulate the chronic tissue remodeling processes characteristic of human rhinitis.This review systematically summarizes glycolysis as a common metabolic node shared by different rhinitis subtypes, offering a novel theoretical basis for the development of precision therapeutic strategies targeting metabolic reprogramming.]]></description>
<pubDate>2026/4/7 10:42:19</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CAI Ji-Tang,CAI Yi-Bo,LI Meng-Wei,TAN Meng-Ting,WANG Jun-Jie]]></author>
</item>
<item>
<title><![CDATA[Strategies and Challenges of Hydrogen Production Catalyzed by Bioencapsulated Hydrogenase]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202512190000002]]></link>
<description><![CDATA[Hydrogenases, as a class of highly efficient and reversible biological catalysts, can catalyze the reduction of protons to molecular hydrogen, thus demonstrating great potential in a wide range of fields such as renewable energy production and green chemistry. Despite their significant potential, the large-scale industrial application of hydrogenases has long been constrained by several inherent limitations, including high sensitivity to molecular oxygen, the challenges in the <i>in vitro</i> reconstitution and maturation of their catalytic centers, and the inefficiency and instability of the natural electron transfer pathways. To overcome these limitations and enhance the catalytic performance of hydrogenases, researchers have developed various strategies, among which enzyme molecular engineering, photo-driven modification, and enzyme immobilization techniques are the most common exploration directions. Particularly, enzyme immobilization technology is widely used to improve the reusability of hydrogenases, but traditional immobilization methods often come with disadvantages in practical applications, such as complex multi-step procedures and insufficient biocompatibility of the immobilization materials. In recent years, bioencapsulation technology has emerged as a promising alternative strategy to enhance the catalytic performance of hydrogenases. This method utilizes biologically derived encapsulation materials to construct physically confined and precisely defined chemical microenvironments around the enzyme molecules, offering simpler self-assembly processes and superior biocompatibility. With these biomimetic constructs, bioencapsulation technology not only provides better oxygen tolerance but also helps to create a local microenvironment conducive to sustained catalytic function. This article systematically reviews the latest research progress of two main bioencapsulation strategies for hydrogenases: one is the encapsulation technology based on protein-based nanocages; the other is the engineering strategy for whole-cell hydrogenase expression. In the nanocage-based systems, this article focuses on the structural and functional characteristics of virus-like capsids and carboxysome protein shells, which serve as efficient enzyme encapsulation scaffolds, not only providing a stable physical barrier to prevent oxygen diffusion but also enabling high-density enzyme loading, thereby promoting substrate channeling effects and electron transfer kinetics. This article also discusses whole-cell encapsulation systems, which achieve hydrogenase compartmentalization within engineered cellular structures or by using external natural polysaccharide-based encapsulation matrices to wrap whole-cell catalysts. Bioencapsulation strategies can bring multiple synergistic benefits: they can effectively protect hydrogenases from oxygen-mediated inactivation, significantly delay the decline of catalytic activity over time, and enhance the hydrogen production rate by increasing the local concentration of active enzyme molecules and optimizing the electron transfer efficiency from redox partners to the catalytic center.Despite the significant progress made, several technical challenges remain to be addressed. The main obstacles include limited enzyme loading and encapsulation efficiency, insufficient long-term stability of encapsulation materials under operating conditions, and the need to improve the matching of the photo-biological interface in systems integrating light-harvesting components with enzymatic catalysis. Future efforts can focus on the integration of multiple technological approaches, such as using computer-aided protein design to optimize encapsulation structures, developing engineered electron transfer pathways to enhance catalytic conversion efficiency, and designing composite multifunctional materials with both structural stability and functional adaptability. These directions collectively aim to achieve efficient, stable, and scalable hydrogen production applications of bioencapsulated hydrogenase systems.]]></description>
<pubDate>2026/4/7 8:30:49</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CAO Chang-Qian,XU Xiang]]></author>
</item>
<item>
<title><![CDATA[Advancements in Gas-releasing Micro/Nanoplatforms for Overcoming MDR Bacterial Infections in Diabetic Wounds]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601310000002]]></link>
<description><![CDATA[Chronic diabetic wounds, severely complicated by multidrug-resistant (MDR) bacterial infections, represent a profound and escalating global health crisis. The intrinsically hostile microenvironment of diabetic wounds, characterized by localized hypoxia, persistent oxidative stress, and poor vascularization, creates an ideal niche for opportunistic pathogens such as <i>Staphylococcus aureus</i> and <i>Pseudomonas aeruginosa</i>. These bacteria readily construct dense extracellular polymeric substance (EPS) biofilms, which not only physically shield the microbes from host immune responses but also actively trap the wound in a state of chronic, unresolved inflammation. Consequently, conventional systemic and topical antibiotic therapies are becoming increasingly futile, as poor perfusion at the wound site restricts drug bioavailability, while the rapid genetic evolution of bacteria and the impenetrable nature of biofilms lead to catastrophic treatment failures, often culminating in severe tissue necrosis and lower-extremity amputations. To circumvent the limitations of traditional antimicrobials, therapeutic gas delivery has emerged as a highly promising, paradigm-shifting strategy. Gaseous signaling molecules, particularly nitric oxide (NO), carbon monoxide (CO), hydrogen sulfide (H<sub>2</sub>S), and hydrogen (H<sub>2</sub>), possess unique physicochemical properties that allow them to seamlessly penetrate dense biofilm matrices and cellular membranes. Once inside, these gases operate <i>via</i> multi-targeted mechanisms that are incredibly difficult for bacteria to develop resistance against; for instance, NO induces severe lipid peroxidation and DNA cleavage in bacteria, CO downregulates pro-inflammatory cytokines, H<sub>2</sub>S significantly accelerates endothelial cell migration for neovascularization, and H<sub>2</sub> acts as a powerful selective antioxidant to neutralize tissue-damaging reactive oxygen species (ROS). Together, these therapeutic gases not only exert broad-spectrum bactericidal effects but also actively reprogram the wound bed by promoting the critical M1-to-M2 macrophage polarization and stimulating angiogenesis. Despite their immense biological potential, the direct clinical translation of gas therapies is severely hindered by inherent physicochemical drawbacks, including extreme volatility, short physiological half-lives, poor aqueous solubility, and the high risk of off-target systemic toxicity, if applied indiscriminately. To conquer these immense pharmacokinetic barriers, cutting-edge advancements in materials science have driven the development of gas-releasing micro- and nanoplatforms. Utilizing sophisticated carriers such as metal-organic frameworks (MOFs), mesoporous silica, polymeric nanoparticles, liposomes, and injectable hydrogels, researchers can now encapsulate gas-donor molecules to achieve sustained, localized delivery. More importantly, these advanced nanoplatforms are ingeniously engineered to be stimuli-responsive. By exploiting the pathological hallmarks of the diabetic wound environment, such as elevated glucose concentrations, acidic pH, and overexpressed ROS, or by utilizing external triggers like near-infrared (NIR) light irradiation and ultrasound, these intelligent platforms ensure on-demand, precise spatio-temporal gas release. This often allows for powerful synergistic combinations, such as photothermal or photodynamic therapy coupled with gas release, thereby obliterating biofilms while sparing healthy tissue. While the therapeutic outcomes of these smart delivery systems in eradicating MDR infections and accelerating tissue repair are unprecedented, several critical challenges remain before widespread clinical adoption, as long-term biosafety profiles of the carrier nanomaterials, complexities in large-scale good manufacturing practice (GMP) production, and stringent regulatory hurdles must be rigorously addressed. Looking forward, the next frontier lies in the realm of precision medicine and theranostics, where future research must focus on the seamless integration of these gas-releasing platforms with flexible, wearable biosensors capable of continuously monitoring wound biomarkers (<i>e.g.</i>, pH, temperature, uric acid) in real-time. Coupled with artificial intelligence algorithms to govern automated, closed-loop adaptive dosing, these next-generation smart dressings hold the ultimate potential to comprehensively transform the clinical management of complex, infected diabetic wounds.]]></description>
<pubDate>2026/4/3 14:17:14</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LIU Ruo-Can,WANG Yu-Qian,WU Xi-Long,WU Yun-Di,ZHANG Shuai,ZUO Shao-Zhi]]></author>
</item>
<item>
<title><![CDATA[The Role of Long Non-coding RNAs in Regulating Adipogenesis and Metabolism]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202512080000002]]></link>
<description><![CDATA[Obesity represents a critical global health challenge characterized by a complex pathogenesis involving dysregulated adipogenesis and lipid metabolism. In recent years, long non-coding RNAs (lncRNAs) have been established as crucial regulators in the initiation and progression of obesity. These RNA molecules, typically exceeding 200 nucleotides in length, have emerged as key modulators of various biological processes through multiple molecular mechanisms. This review innovatively defines lncRNAs as “molecular switches” in energy metabolism—they regulate adipogenesis and lipid metabolism through key signaling pathways, and exert bidirectional control over obesity <i>via</i> ceRNA mechanisms or recruitment of chromatin-modifying complexes in tissues such as adipose and liver. Additionally, circulating lncRNAs, owing to their tissue specificity and stability, hold promise as non-invasive liquid biopsy biomarkers for obesity and related metabolic disorders. Furthermore, we systematically summarize lncRNA-based intervention strategies, including targeting pathogenic lncRNAs using antisense oligonucleotides (ASOs) or CRISPR/Cas gene editing systems, utilizing viral vectors (such as adeno-associated virus, AAV) to deliver or mimic beneficial lncRNAs in target tissues, and employing exercise as a non-pharmacological intervention that ameliorates obesity and its related complications at multiple levels, offering novel insights for personalized therapeutic approaches. We also critically assess the current challenges in clinical translation, particularly addressing issues related to delivery efficiency, target specificity, and long-term safety concerns. Future research should focus on the following directions: integrating multi-omics with functional screening to elucidate the regulatory networks of lncRNAs in obesity and its complications; leveraging artificial intelligence to construct predictive models of lncRNA-target gene interactions; developing efficient and safe <i>in vivo</i> delivery systems, and optimizing drug design to enhance specificity and safety; establishing highly sensitive detection methods and stable circulating lncRNA biomarkers to enable precise patient stratification and real-time monitoring of therapeutic responses; investigating the synergistic effects of lncRNAs with existing treatments (<i>e.g</i>., GLP-1 receptor agonists, lifestyle interventions) to develop combination therapies and establish a multidimensional, personalized precision medicine framework for obesity. This review aims to provide novel perspectives for understanding the molecular mechanisms underlying obesity and to establish a solid theoretical foundation for developing lncRNA-targeted precision medicine strategies against obesity and its associated metabolic complications.]]></description>
<pubDate>2026/4/3 11:08:51</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[JI Wei-Xiu,KU Bo-Wei-Cheng,ZHAO Yun-Gang]]></author>
</item>
<item>
<title><![CDATA[Application and Prospects of Simultaneous Multicomponent Extraction Technology in Biological Samples]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202510280000003]]></link>
<description><![CDATA[With the rapid development of the biopharmaceutical field, the efficient and simultaneous extraction of multiple biological components from biological samples has become a critical process for advancing scientific research. The ability to simultaneously extract various molecular components such as metabolites, DNA, RNA, and proteins is pivotal for multi-omics studies, which aim to comprehensively understand the molecular mechanisms of biological systems. Traditional methods often extract these components separately, leading to challenges such as sample loss, time consumption, contamination, and inconsistencies across different data types. In contrast, simultaneous extraction techniques address these issues by maintaining the consistency of each biological component’s physiological state, improving data reliability and facilitating integration across omic platforms. This review systematically summarizes recent advances in simultaneous extraction technologies, focusing on methods such as methanol/chloroform extraction, TRIzol reagent extraction, and modified Folch extraction, which have shown significant promise in improving the efficiency and integrity of biological sample preparation. These methods offer various advantages, such as reduced sample volume requirements, decreased contamination risk, and enhanced extraction consistency, which are crucial for studies involving small sample sizes or precious clinical specimens. Among these, methanol/chloroform extraction stands out for its simplicity, low cost, and ability to extract a wide range of biological molecules. However, it does face limitations, such as its inefficiency in extracting lipids and potential RNA contamination. On the other hand, the TRIzol reagent method has become a widely adopted technique due to its ability to simultaneously isolate RNA, proteins, and metabolites from the same sample. Despite its effectiveness, the TRIzol method has limitations in RNA quality, especially when handling complex samples or those with high protein content. Modified Folch extraction, which combines liquid-liquid extraction with commercial kits, offers a highly efficient way to extract polar metabolites, lipids, RNA, DNA, and proteins from small tissue samples. This method has proven advantageous in terms of extraction yield, especially for challenging or rare samples, although it requires precise handling to avoid cross-contamination between phases. The integration of automated platforms, microfluidics, and high-throughput systems is another exciting avenue for improving simultaneous extraction. Automation facilitates large-scale, reproducible sample processing with minimal human error, while microfluidics provides high precision in sample handling and enables real-time monitoring of extraction efficiency. These innovations not only enhance the speed and reproducibility of sample preparation but also open new possibilities for single-cell analysis, where sample volumes are often limited, and extraction efficiency is critical. In addition to the technical aspects, the review also highlights the importance of optimizing extraction protocols for specific sample types, such as clinical tissues, plants, and microorganisms. For example, the challenge of extracting multiple components from cancer tissues, where sample degradation and contamination risks are high, can be mitigated by carefully selecting extraction reagents and minimizing sample handling steps. Similarly, in plant studies, where metabolite diversity is vast, the simultaneous extraction methods must be optimized to account for the unique composition of plant tissues, which often include complex secondary metabolites and cell wall components. Looking forward, the development of more efficient and standardized simultaneous extraction methods will be crucial for advancing multi-omics research. There is a growing need for protocols that can be tailored to specific research needs, ensuring both reproducibility and flexibility in diverse applications. Additionally, combining these extraction methods with high-resolution analytical techniques such as mass spectrometry and next-generation sequencing will further enhance the potential of multi-omics studies to provide comprehensive insights into biological systems. As these technologies continue to evolve, their application in personalized medicine, environmental research, and agriculture holds great promise for addressing critical scientific challenges. In conclusion, while simultaneous extraction technologies have made significant strides, several challenges remain in optimizing extraction efficiency, ensuring reproducibility, and reducing costs. Future research should focus on refining extraction protocols, developing innovative extraction reagents, and expanding the scope of these methods to cater to a broader range of biological samples. Ultimately, the continued integration of these advanced techniques will revolutionize the way biological samples are prepared, analyzed, and understood in the context of multi-omics research.]]></description>
<pubDate>2026/4/2 21:01:48</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[XUE Zhi-Chao,YE Zi-Hong,ZHANG Kun-Peng]]></author>
</item>
<item>
<title><![CDATA[A Computational Perspective on Differences Between MHC-I and MHC-II in TCR-pMHC Structure Prediction Resources: Review and Benchmarking]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601090000002]]></link>
<description><![CDATA[The initiation of adaptive immune responses relies on the precise recognition and interpretation of antigenic information. In this process, the specific binding of T cell receptors (TCRs) to peptide-major histocompatibility complex (pMHC) molecules represents one of the key molecular events in the initiation of adaptive immune responses. Accordingly, the structural features of TCR-pMHC complexes provide a fundamental basis for dissecting antigen recognition mechanisms and support rational vaccine design, therapeutic target discovery in TCR-based immunotherapy, and TCR identification and optimization. However, experimental determination of TCR-pMHC structures remains costly, time-consuming, and limited in coverage, making computational approaches essential for rapidly obtaining reliable structural information. Computational methods for predicting the structures of TCR-pMHC complexes have advanced rapidly in recent years, driven by progress in deep learning-based modeling frameworks and the increasing availability of structural and sequence resources. Despite these developments, most existing tools do not adequately distinguish the key structural and biophysical differences between MHC class I (MHC-I) and MHC class II (MHC-II) complexes during model construction. As a consequence, their predictive performance differs substantially between class I and class II complexes. In general, structural predictions for class I complexes outperform those for class II complexes. This discrepancy may be related to several fundamental differences between the two systems, including the architecture of the peptide-binding groove, the distribution of peptide lengths, and the properties of peptide flanking residues (PFRs). Compared with MHC-I molecules, MHC-II molecules usually bind longer antigenic peptides, which typically range from 13 to 25 amino acids in length. PFRs at both termini of these peptides participate in regulating the overall conformation of TCR-pMHC class II complexes and exert a pronounced effect on the geometric and physicochemical characteristics of the TCR-pMHC binding interface. Furthermore, within the TCR recognition interface, the complementarity-determining regions (CDRs) consist of segments that differ markedly in conformational behavior. They commonly include regions that are relatively rigid and structurally stable, together with highly flexible segments exhibiting substantial conformational plasticity. These rigidity-flexibility features constitute an essential structural basis enabling TCRs to recognize diverse peptide-MHC ligands and to accommodate conformational heterogeneity at the interface. However, many current modeling tools, in an effort to enforce global conformational stability or reduce structural noise, tend to over-constrain intrinsically flexible regions. Such oversimplification may lead to inappropriate rigidification of flexible CDR loops, resulting in local structural distortions, compromised interface geometry, or even complete modeling failure for specific complexes. Against this background, the review approaches the field from the perspective of computational differences between MHC-I and MHC-II complexes. We first systematically organize and summarize available resources related to TCRs and pMHCs, including structural datasets, sequence databases, prediction tools, and benchmarking studies. We then focus on five representative tools capable of predicting both class I and class II complexes—AlphaFold2, AlphaFold3, TCRmodel2, tFold-TCR, and TCR-pHLA_ModellerS. After excluding structures present in the training sets of these tools, we constructed a benchmark dataset comprising 25 class I and 10 class II TCR-pMHC complexes in the bound state and conducted a systematic evaluation using this dataset. We first employ widely used general evaluation metrics, including All-Atom Root Mean Square Deviation (All-Atom RMSD), Backbone RMSD, Template Modeling score (TM-score), and DockQ, to assess the global conformational accuracy and interface modeling quality of class I and class II complexes. For class II complexes, we propose for the first time a peptide flanking residue deviation index, including the PFRs-Deviation Index (PFRs-DI), N-PFR-Deviation Index (N-PFR-DI), and C-PFR-Deviation Index (C-PFR-DI), to quantitatively characterize conformational deviations in PFRs. In addition, we propose the CDR conformational consistency index (CCC) designed to qualitatively evaluate the ability of prediction tools to capture TCR CDR conformational flexibility. These metrics collectively assess a tool’s ability to model both overall conformation and critical functional regions, thereby addressing the limitations of existing evaluation criteria that overemphasize global structure while inadequately capturing modeling quality in key functional areas. This establishes a unified analytical framework for MHC-I and MHC-II complexes to guide data resource selection, modeling strategy formulation, and evaluation system development. The framework further advances computational modeling and provides crucial support for multi-scale analysis of TCR-pMHC recognition mechanisms and their biological functions.]]></description>
<pubDate>2026/4/2 21:01:09</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CAO Yang,DAI Wen-Tao,LI Bin-Yu,LIU Da-Wei,LIU Yang,WU Xiao-Qin]]></author>
</item>
<item>
<title><![CDATA[Neuroprotective Effects of Transcranial Magneto-acoustic Stimulation on Parkinson’s Disease Model Mice by Regulating Mitophagy and Mitochondrial Homeostasis]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601050000002]]></link>
<description><![CDATA[<b>Objective</b> Transcranial magneto-acoustic stimulation (TMAS) is an emerging non-invasive neuromodulation technique that may provide a novel non-pharmacological intervention strategy for Parkinson""s disease (PD). PD is characterized by the progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNc), leading to motor impairments such as bradykinesia, tremor, and rigidity. Increasing evidence indicates that mitochondrial dysfunction and impaired mitochondrial quality control are central mechanisms underlying dopaminergic neuronal loss. In particular, abnormalities in mitophagy and mitochondrial fission-fusion balance contribute substantially to oxidative stress, energy metabolic failure, and neuronal injury. At present, most clinical treatments for PD mainly alleviate symptoms but do not effectively halt disease progression. Therefore, exploring new interventions targeting the core pathological mechanisms is of considerable significance. This study aims to investigate whether TMAS can improve neural damage and motor dysfunction in PD mice by regulating mitophagy and the fission/fusion dynamic balance, thereby providing theoretical and experimental support for its application in PD treatment.<b>Methods</b> Male C57BL/6 mice were used in this study. A PD model was established by intraperitoneal injection of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) for 7 consecutive days. After model induction, mice in the intervention group received TMAS once daily for 14 consecutive days, whereas the corresponding control group received sham stimulation. The stimulation target was positioned over the primary motor cortex (M1). Motor performance was evaluated using the pole test and the open-field test. To verify the activation effect of TMAS on the target cortical region, c-Fos immunohistochemistry was performed in the M1. To assess nigral dopaminergic neuronal injury, tyrosine hydroxylase (TH) immunohistochemistry was used to quantify TH-positive neurons in the SNc. Mitochondrial function was evaluated by measuring reactive oxygen species (ROS) levels and adenosine triphosphate (ATP) content in the SNc. Western blot was further performed to determine the expression of mitophagy-related proteins, including PINK1, Parkin, LC3-II, and p62, as well as mitochondrial dynamics-related proteins, including Drp1 and Opa1.<b>Results</b> TMAS significantly increased the number of c-Fos-positive cells in M1 (<i>P</i><0.000 1), indicating effective activation of neurons in the targeted cortical region. Compared with the control group, MPTP-treated mice exhibited marked motor dysfunction, including a significant reduction in total distance traveled in the open-field test (<i>P</i><0.000 1) and mean speed (<i>P</i>=0.000 1), as well as significant prolongation of turn time and total climbing time in the pole test (<i>P</i><0.000 1). These behavioral impairments were accompanied by a substantial loss of TH-positive dopaminergic neurons in the SNc, whereas TMAS significantly increased TH-positive neuron survival (<i>P</i><0.000 1). In parallel, MPTP induced a pronounced increase in ROS levels and a significant reduction in ATP content, indicating severe mitochondrial dysfunction and energy metabolism impairment (<i>P</i><0.01). TMAS treatment significantly improved motor performance, as reflected by the reversal of MPTP-induced impairment in the open-field and pole tests, and significantly reduced ROS accumulation (<i>P</i><0.01) while restoring ATP production (<i>P</i><0.001). At the molecular level, MPTP markedly downregulated PINK1 and Parkin, decreased p62 expression, increased LC3-II accumulation, elevated Drp1 expression, and reduced Opa1 expression, whereas TMAS significantly reversed these abnormalities, suggesting restoration of mitophagy-related mitochondrial quality control and re-establishment of mitochondrial fission-fusion balance. Collectively, these findings indicate that TMAS ameliorates MPTP-induced neurotoxicity and restores mitochondrial homeostasis and energy metabolism.<b>Conclusion</b> TMAS effectively attenuates neural damage and improves motor dysfunction in MPTP-induced PD mice. Its neuroprotective effects are closely associated with multidimensional regulation of the mitochondrial quality control system, including restoration of PINK1/Parkin-mediated mitophagy and rebalancing of Drp1/Opa1-related mitochondrial dynamics. Rather than acting only as a symptomatic neuromodulatory intervention, TMAS may influence a key pathological axis of PD by improving mitochondrial homeostasis in SNc and protecting nigral dopaminergic neurons. These findings provide experimental evidence supporting TMAS as a promising non-invasive physical intervention for PD.]]></description>
<pubDate>2026/4/2 21:00:02</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[AN Yu-Chen,LIU Ji-Zhou,LU Xiao-Chao,MI Jin-Rui,SUN Jia-Qi,WANG Yan-Bin,XU Yi-Hao,ZHANG Shuai]]></author>
</item>
<item>
<title><![CDATA[The Diversity of Filamentous Morphologies and Magnetic Sensitivity Modulated by Diverse MagR Expression in Bacteria]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601200000001]]></link>
<description><![CDATA[Objective Magnetoreception, the remarkable ability of diverse animals to sense and utilize the geomagnetic field for orientation and navigation, remains a molecularly unresolved mystery in sensory biology. The putative magnetoreceptor (MagR, previously known as IscA1) is a highly conserved iron-sulfur protein implicated in both magnetoreception and iron metabolism; however, the functional diversity among its cross-species homologs remains poorly understood. Cellular morphology is a key genetically determined trait that can be altered through genetic or environmental modifications—a process known as cell morphology engineering. Constructing engineered cells with specific morphological features and magnetic sensitivity to achieve remote, non-invasive magnetic modulation represents a crucial goal in this field with significant application potential. Therefore, this study aims to systematically investigate the effects of MagR heterologous expression on bacterial morphology and magnetic sensing capabilities, screen for MagR-based magnetically sensitive morphology engineering pathways, and reveal the underlying molecular mechanisms. Methods We systematically screened 28 MagR homologous genes from diverse prokaryotic and animal taxa to evaluate their expression and corresponding phenotypic effects in Escherichia coli (<i>E. coli</i>). To compare the differential magnetic responses among bacteria expressing various recombinant MagR proteins, we utilized high-throughput automated bright-field microscopic imaging and scanning electron microscopy (SEM). Furthermore, comprehensive biochemical and biophysical characterizations of iron and iron-sulfur cluster binding were performed using Ferrozine colorimetric assays, electron paramagnetic resonance (EPR) spectroscopy, ultraviolet-visible (UV-Vis) absorption, and circular dichroism (CD) spectroscopy. Additionally, 100 mT static magnetic field (SMF) exposure experiments were conducted to assess magnetically tunable phenotypes, while the intrinsic magnetic properties of purified MagR proteins were directly measured using a superconducting quantum interference device (SQUID) magnetometer. Results Our results demonstrated that the heterologous expression of MagR homologs induced varying degrees of bacterial filamentation. From this comprehensive screen, two distinct morphological patterns were identified: hydra (<i>Hydra vulgaris</i>) MagR (hyMagR) promoted uniform cell elongation and filamentation, exhibiting robust magnetic sensitivity manifested as significantly enhanced filamentation under the 100 mT SMF. In contrast, pigeon (<i>Columba livia</i>) MagR (clMagR) induced only low-frequency, extreme filamentation (sporadically exceeding 80 μm) with a relatively weaker magnetic morphological response. Mechanistically, our data unambiguously proved that these phenotypic differences are primarily driven by distinct iron redox preferences rather than total cellular iron accumulation. Specifically, hyMagR preferentially binds ferrous iron (Fe<sup>2+</sup>), whereas clMagR favors ferric iron (Fe<sup>3+</sup>) and forms more stable iron-sulfur clusters. Intriguingly, although SQUID magnetometry showed that purified clMagR exhibited approximately five-fold higher mass magnetic susceptibility than hyMagR, its cellular magnetic response was weaker. We hypothesize that the Fe<sup>2+</sup>-preferred intracellular environment associated with hyMagR overexpression primes the cell for enhanced generation of reactive oxygen species (ROS) <i>via</i> the Fenton reaction. Exposure to an SMF synergizes with this primed redox state, triggering the bacterial SOS response and upregulating cell division inhibitors to efficiently induce uniform filamentation. Conclusion Our findings identify the Fe<sup>2+</sup>/Fe<sup>3+</sup> redox state as a critical determinant of MagR-mediated morphological remodeling and magnetic responsiveness. This discovery suggests a potential strategy for engineering magnetically responsive cellular systems for synthetic biology applications, and provides a plausible framework, which potentially combines intrinsic protein magnetism with redox-state modulation, for further investigating the evolutionary mechanisms of MagR-mediated magnetoreception.]]></description>
<pubDate>2026/3/26 14:29:21</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CAI Tian-Tian,CHANG Ya-Fei,HE Pei-Qi,WANG Jun-Feng,WEI Meng-Ke,XIE Can,ZHANG Jing,ZHANG Peng,ZHOU Xiu-Juan]]></author>
</item>
<item>
<title><![CDATA[cGAS: Its Canonical and Non-canonical Functions]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202512250000003]]></link>
<description><![CDATA[Cyclic GMP-AMP synthase (cGAS), a pivotal molecule in innate immunity, has emerged as a keypoint in interdisciplinary research at the intersection of basic immunology and tumor biology. As a cytosolic nucleic acid sensor, cGAS is primarily characterized by its capacity to recognize double-stranded DNA (dsDNA) in the cytosol. Upon binding to dsDNA, cGAS undergoes a conformational change that promotes its dimerization and subsequent enzymatic activation. Once activated, it catalyzes the synthesis of the second messenger 2"",3""-cGAMP from ATP and GTP. cGAMP then binds to the adaptor protein STING, which resides on the endoplasmic reticulum (ER) membrane. The binding process triggers STING to traffic from the ER to the Golgi apparatus, where it is phosphorylated by the kinase TBK1. Phosphorylated STING serves as a docking site for the transcription factor IRF3, facilitating its phosphorylation by TBK1. Once phosphorylated, IRF3 forms dimers and translocates to the nucleus, where it drives the expression of type I interferons and pro-inflammatory cytokines, initiating a potent antimicrobial state. The DNA-sensing mechanism of cGAS is inherently non-selective regarding the origin of its ligand. It readily detects exogenous DNA from invading pathogens, thereby playing an indispensable role in host defense against microbial infections. However, this same mechanism also enables cGAS to recognize self-DNA that leaks from the nucleus or mitochondria into the cytosol under various cellular stress conditions. While critical for immunity, the recognition of self-dsDNA by cGAS can disrupt cellular homeostasis and trigger aberrant inflammatory responses. The loss of self-tolerance can precipitate or exacerbate the pathogenesis of autoimmune disorders such as systemic lupus erythematosus (SLE) and Aicardi-Goutières syndrome (AGS), highlighting the dual role of cGAS as both a sentinel for infection and a potential driver of autoimmune pathology. Notably, the subcellular localization of cGAS is not still. Increasing recent researches have revealed that cGAS is also abundant within the nucleus, challenging the traditional view of it solely as a cytosolic nucleic acid sensor. Within the nucleus, cGAS exhibits non-canonical functions that are distinct from its canonical immunological role. First, cGAS exists in a state of stringent immunological silence in the nucleus, with mechanisms involving its competitive binding to histones and its post-translational modifications which block the activation of cGAS enzymatic activity, thus, effectively preventing it from mounting an autoimmune attack on genomic DNA. Second, cGAS plays a critical role in maintaining genomic stability. Upon DNA damage, cGAS is rapidly recruited to the lesion site and participates in the DNA damage repair process. Moreover, under conditions of DNA replication stress, cGAS contributes to the stabilization of replication forks, preventing the cell from entering a state of uncontrolled hyper-replication. Consequently, in light of the dual role of cGAS in both immune regulation and tumor development, the development of small-molecule drugs targeting cGAS holds significant therapeutic promise. This review summarizes the structural characteristics of cGAS and its canonical function as a pattern recognition receptor in the cytosol, including the types of pathogens it recognizes and the autoimmune responses resulting from erroneous recognition of self-DNA. It then focuses on its emerging non-canonical functions within the nucleus, detailing its nucleocytoplasmic shuttling, the mechanisms underlying its nuclear immune quiescence, and its role in mediating DNA damage repair and replication fork stabilization. Finally, the review discusses the progress and application prospects of small-molecule drugs targeting cGAS for the treatment of autoimmune diseases and cancer.]]></description>
<pubDate>2026/3/23 11:24:24</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[JIA Shu-Ting,XIONG Meng-Jie,ZHENG Wen-Xian,ZHOU Ruo-Yu]]></author>
</item>
<item>
<title><![CDATA[Effects of <i>SPBC1604.04</i> Gene Deletion on Mitotic Cell Dynamics in <i>Schizosaccharomyces pombe</i>]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202510210000002]]></link>
<description><![CDATA[<b>Objective</b> Mitochondria are not only the central organelles responsible for cellular energy metabolism but also play essential roles in regulating cell cycle progression and cytoskeletal dynamics. In recent years, accumulating evidence has demonstrated that mitochondrial homeostasis is closely associated with mitotic progression and cytokinesis. <i>Schizosaccharomyces pombe</i> serves as a classical and well-established model organism. Because its cell cycle regulatory mechanisms are highly conserved throughout evolution, its genetic background is clearly defined, and experimental manipulation is efficient and convenient, it has been extensively applied in studies of cell growth, division, and reproductive mechanisms. The <i>SPBC1604.04 </i>gene<i> </i>encodes a previously uncharacterized mitochondrial carrier protein in <i>Schizosaccharomyces pombe</i>. This gene is located on chromosome II and spans 1 018 base pairs in length. It encodes a protein consisting of 238 amino acids with a predicted molecular mass of approximately 31.03 ku. Bioinformatic analysis predicts that this protein is responsible for the transport of thiamine pyrophosphate (TPP) into mitochondria. However, the effects of <i>SPBC1604.04</i> gene deletion on mitotic cell dynamics under different temperature conditions have not been fully elucidated.<b>Methods</b> The<i> SPBC1604.04</i> deletion strain of <i>Schizosaccharomyces pombe</i> was used as the experimental model. Fluorescent protein markers were constructed in the deletion background to label mitochondria, microtubules, actin, myosin, the nuclear envelope, and chromosomes. Live-cell imaging was performed using a TCS-SP8 laser scanning confocal microscope under normal temperature conditions (25℃) and heat stress conditions (37℃). Time-lapse microscopy was applied to dynamically monitor mitochondrial morphology and distribution, spindle assembly and elongation, chromosome segregation, as well as the formation and constriction of the actomyosin ring during cytokinesis. ImageJ software was used for quantitative measurements, including microtubule length during mitosis, spindle length at different mitotic stages, mitochondrial fluorescence intensity as an indicator of mitochondrial content, actomyosin ring length, nuclear envelope area, and chromosome segregation timing. Statistical analyses were conducted to compare phenotypic differences between the wild-type and <i>SPBC1604.04</i> deletion strains at both temperature conditions. Through these analyses, we systematically investigated the impact of <i>SPBC1604.04</i> deletion on mitotic cell dynamics in fission yeast under both normal physiological conditions and temperature stress.<b>Results</b> At 25℃, compared with wild-type cells, the <i>SPBC1604.04</i>Δ strain exhibited a pronounced tendency toward mitochondrial fragmentation, accompanied by abnormal mitochondrial content and a significant reduction in mitochondrial fluorescence intensity. These observations suggest impaired mitochondrial homeostasis under normal growth conditions. In addition, the constriction time of actomyosin ring during cytokinesis was markedly prolonged, indicating that deletion of <i>SPBC1604.04</i> affects the dynamics of the contractile machinery. However, no obvious defects were observed in spindle assembly, spindle elongation, or chromosome segregation. Under heat stress at 37℃, mitochondrial morphology in the <i>SPBC1604.04</i>Δ strain showed a tendency to recover toward a continuous tubular network structure. Mitochondrial content was restored, fluorescence intensity increased, and the constriction time of the actomyosin ring returned to levels comparable to those of wild-type cells. These results indicate that the mitotic defects observed at normal temperature are partially or fully alleviated under heat stress conditions.<b>Conclusion</b> This study demonstrates that deletion of the <i>SPBC1604.04</i> gene leads to abnormal mitochondrial content in <i>Schizosaccharomyces pombe</i>. The mitochondrial carrier protein SPBC1604.04 participates in regulating actomyosin ring constriction during mitosis but does not appear to be directly involved in the regulation of spindle dynamics or chromosome segregation. Our findings provide key experimental evidence for understanding the functional link between the <i>SPBC1604.04</i> gene, mitochondrial homeostasis, and mitotic regulation.]]></description>
<pubDate>2026/3/23 11:21:59</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[DING Xiang,HE Jia-Yi,HE Shu-Rong,HOU Yi-Ling,MA Shuai,XU Jia-Ni,ZHENG Lang-Lin]]></author>
</item>
<item>
<title><![CDATA[The Role and Molecular Mechanism of N⁶-methyladenosine Modification in Spermatogenesis]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202512040000001]]></link>
<description><![CDATA[Spermatogenesis is a highly ordered and spatiotemporally regulated developmental process in the male reproductive system, during which spermatogonial stem cells (SSCs), supported by the seminiferous tubule microenvironment, sequentially undergo mitosis, meiosis, and spermiogenesis to ultimately generate structurally intact spermatozoa. This complex process is accompanied by extensive transcriptional reprogramming, chromatin remodeling, and finely tuned post-transcriptional regulation. Precise control of RNA fate is therefore essential for maintaining the continuity and fidelity of spermatogenesis, and its disruption represents a major molecular basis of male infertility. N<sup>6</sup>-methyladenosine (m<sup>6</sup>A), the most abundant internal RNA modification in eukaryotes, has emerged as a critical regulator of post-transcriptional gene expression. m<sup>6</sup>A methyltransferases (“writers”) catalyze the addition of a methyl group to the N<sup>6</sup> position of adenosine, m<sup>6</sup>A demethylases (“erasers”) remove the modification, and m<sup>6</sup>A-binding proteins (“readers”) recognize m<sup>6</sup>A-modified transcripts. Through the coordinated actions of these factors, m<sup>6</sup>A regulates transcript fate at multiple levels, including RNA splicing, nuclear export, stability, translation, and decay. Emerging evidence indicates that m<sup>6</sup>A-mediated regulation is essential across multiple stages of spermatogenesis, including SSC self-renewal and differentiation, meiotic progression, maintenance of chromosomal stability, and sperm morphogenesis. Beyond its intrinsic functions in germ cells, m<sup>6</sup>A also contributes to the regulation of the testicular microenvironment. In sertoli cells, m<sup>6</sup>A is involved in maintaining blood-testis barrier integrity, RNA processing, and paracrine signaling, thereby providing structural and metabolic support for germ cell development. In Leydig cells, m<sup>6</sup>A regulates steroidogenesis, particularly testosterone synthesis, and participates in cellular stress responses and metabolic homeostasis. Through these mechanisms, m<sup>6</sup>A indirectly influences spermatogenesis by modulating the functional state of testicular somatic cells, highlighting an integrated regulatory mode that combines cell-intrinsic and microenvironment-mediated effects. Notably, distinct classes of m<sup>6</sup>A regulators exhibit pronounced stage-specific functions and coordinated division of labor, collectively forming a multilayered and dynamic regulatory network. Writers often display dosage- and temporal window-dependent effects; erasers contribute to stage-specific demethylation and functional compensation; while readers function through a “switch-buffer” dual-layer architecture, and RNA-binding proteins (RBPs) participate in substrate selection and post-transcriptional regulation. Importantly, emerging evidence suggests that some m<sup>6</sup>A-related proteins can function through noncanonical mechanisms independent of m<sup>6</sup>A recognition, such as intrinsic RNA-binding activity, helicase function, or ribonucleoprotein complex assembly, thereby expanding the functional landscape of the m<sup>6</sup>A regulatory system. Dysregulation of m<sup>6</sup>A machinery can lead to multiple spermatogenic defects, including impaired SSC self-renewal, meiotic arrest, abnormal chromatin remodeling, and defective sperm formation, ultimately resulting in male infertility. Despite substantial advances, several critical questions remain unresolved, including the distinction between m<sup>6</sup>A-dependent and -independent mechanisms, the spatiotemporal dynamics of m<sup>6</sup>A modifications at single-cell resolution, and the coordination and antagonism among different regulatory factors. In this review, we systematically summarize the dual regulation of spermatogenesis by germ cell-intrinsic mechanisms and the testicular microenvironment, and delineate the molecular mechanisms and stage-specific functions of the dynamic m<sup>6</sup>A regulatory network. We further discuss the current limitations in the field and propose feasible experimental strategies for future investigation. Collectively, this work aims to provide a comprehensive framework for understanding the epitranscriptomic regulation of spermatogenesis and to offer theoretical insights into the pathogenesis and clinical management of male infertility.]]></description>
<pubDate>2026/3/21 21:51:39</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHENG Xu,LU Wen-Ting,MENG Shi-Qi,NIU Chang-Min,YANG Fan,ZHEGN Ying]]></author>
</item>
<item>
<title><![CDATA[HER2 in Metastatic Colorectal Cancer: Diagnostic and Therapeutic Opportunities and Challenges]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202511020000001]]></link>
<description><![CDATA[Colorectal cancer (CRC) is the third most commonly diagnosed malignancy and the second leading cause of cancer-related mortality worldwide. Despite therapeutic advancements over recent decades, the prognosis for patients with metastatic CRC (mCRC) remains poor. Approximately 2%-4% of mCRC cases exhibit human epidermal growth factor receptor 2 (HER2) amplification or overexpression, defining a distinct molecular subtype. This HER2-positive status is strongly associated with primary resistance to anti-epidermal growth factor receptor (EGFR) therapies, which are the standard of care for patients with RAS wild-type tumors. Beyond its well-established role in breast and gastric cancers, HER2 has emerged as a pivotal biomarker and actionable therapeutic target in mCRC. However, selecting appropriate treatment strategies remains challenging due to patient heterogeneity and diverse molecular subtypes. This review systematically summarizes the molecular biology, diagnostic strategies, and advances in targeted therapies for HER2-positive mCRC. On the diagnostic front, we discuss the applications of immunohistochemistry (IHC), fluorescence <i>in situ</i> hybridization (FISH), next-generation sequencing (NGS), and circulating tumor DNA (ctDNA) detection technologies. We highlight discrepancies in diagnostic criteria across key clinical trials—such as HERACLES, DESTINY, and MOUNTAINEER—underscoring the urgent need for standardized, CRC-specific definitions to ensure consistent patient selection and comparability of efficacy data across studies. Although NGS enables comprehensive genomic profiling, its cost-effectiveness relative to traditional methods must be carefully considered. Therapeutically, we summarize clinical trial data for HER2-directed agents, including tyrosine kinase inhibitors (TKIs) such as tucatinib and lapatinib, monoclonal antibodies like trastuzumab, bispecific antibodies, and antibody-drug conjugates (ADCs) such as trastuzumab deruxtecan. We review dual-targeting strategies and note recent FDA approvals that represent significant milestones in second-line treatment. Additionally, we explore the potential of combining immune checkpoint inhibitors with HER2-targeted therapies to enhance antitumor immunity through mechanisms including antibody-dependent cellular cytotoxicity (ADCC) and modulation of the tumor microenvironment. ADCs enable precise delivery of cytotoxic payloads, reducing off-target toxicity while effectively inhibiting oncogenic pathways. A substantial portion of this review is dedicated to dissecting the molecular mechanisms underlying primary and acquired resistance to HER2-targeted therapies—persistent challenges that limit clinical benefit. These mechanisms include reactivation of downstream signaling pathways such as PI3K/AKT/mTOR and MAPK, concurrent mutations in genes like KRAS or BRAF, and alterations in HER2 expression that compromise treatment efficacy. For instance, specific HER2 mutations (<i>e.g.</i>, L755S) can reduce drug binding affinity, while ctDNA monitoring facilitates early detection of emerging resistance clones during disease progression, thereby enabling timely therapeutic adjustments. Tumor heterogeneity and dynamic interactions with the microenvironment further complicate resistance patterns observed in clinical practice. HER2-targeted therapy represents a new frontier in precision oncology for mCRC, offering renewed hope for improving patient outcomes. Realizing this potential will require continued optimization of diagnostic algorithms and treatment workflows. Future efforts must focus on overcoming resistance, validating liquid biopsy approaches for dynamic monitoring, and establishing unified clinical guidelines. HER2 has become an essential biomarker for stratifying mCRC patients beyond traditional RAS and BRAF status, underscoring the shift from empiric treatment to biomarker-driven precision medicine. International, multidisciplinary collaboration will be critical to validate emerging biomarkers and refine treatment algorithms globally.]]></description>
<pubDate>2026/3/18 14:54:44</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Chen,GAI Feng-Yu,LI Tong,PAN Zhao-Tao,QING Yan-Ping]]></author>
</item>
<item>
<title><![CDATA[The Role of FASN in Tumors and Its Targeted Therapy]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202512170000001]]></link>
<description><![CDATA[Malignant tumors represent a major threat to global health. Conventional anti-tumor pharmacotherapy often encounters challenges such as drug resistance, highlighting an urgent need for the development of novel therapeutic strategies. Fatty acid synthase (FASN), the key enzyme catalyzing <i>de novo</i> fatty acid synthesis, is subject to precise regulation at multiple levels, including transcriptional control, various post-translational modifications such as ubiquitination and phosphorylation, as well as modulation by diverse signaling pathways. Recent studies have revealed that FASN is aberrantly overexpressed in various malignant tumors and is closely associated with tumor progression and poor patient prognosis. FASN is a homodimer composed of seven functional domains that catalyzes the NADPH-dependent condensation of acetyl-CoA and malonyl-CoA to generate saturated fatty acids, primarily palmitic acid. Its stability is regulated by multiple ubiquitin ligases and deubiquitinating enzymes. Additionally, FASN is subject to upstream regulation <i>via</i> neural precursor cell-expressed developmentally downregulated 8 (Nedd8) modification and the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway, thereby establishing a metabolic-signaling positive feedback loop. As a core executor of metabolic reprogramming, FASN promotes tumorigenesis through dual mechanisms. First, its fatty acid synthesis product, palmitate, participates in membrane phospholipid synthesis, lipid raft formation, and protein palmitoylation, thereby activating several key oncogenic signaling pathways, including PI3K/AKT/mTOR, wingless-type MMTV integration site family member (Wnt)/β-catenin, and signal transducer and activator of transcription 3 (STAT3)/matrix metalloproteinase (MMP), leading to tumor development and progression. Second, FASN plays a pivotal role in modulating the anti-tumor functions of immune cells and remodeling the tumor immune microenvironment. Specifically, FASN enhances immune checkpoint inhibition by inducing programmed death-ligand 1 (PD-L1) palmitoylation, suppresses the activation of cytotoxic T lymphocytes and natural killer cells, and promotes the polarization of M2-type macrophages, consequently facilitating tumor immune evasion and malignant progression. Precisely due to its significant overexpression in tumor cells, its critical functional role, and its differential expression compared to normal cells, FASN has emerged as a highly promising target for anti-tumor drug development. Highly selective small-molecule inhibitors, notably represented by TVB-2640, have advanced to clinical trial stages and demonstrated favorable anti-tumor activity. Furthermore, the combination of FASN inhibitors with other chemotherapeutic agents or targeted drugs can overcome the limitations of monotherapy through synergistic effects or by resensitizing tumor cells to conventional drugs, achieving a “1+1>2” therapeutic outcome. With the advancement of modern traditional Chinese medicine (TCM), numerous active ingredients derived from TCM have been confirmed to exert anti-tumor effects by modulating FASN-related pathways. This integrated approach leverages the precision of Western medicine while simultaneously harnessing the holistic regulatory benefits of TCM to alleviate the side effects of radiotherapy and chemotherapy. Despite the promising prospects of FASN-targeted therapies, challenges remain, including tumor cell metabolic plasticity, tumor context-dependent responses, and heterogeneity. This review systematically summarizes the molecular structure, physiological functions, and mechanisms of FASN in tumorigenesis, as well as recent advances in targeted therapies. Future directions—including the precise identification of responsive patient populations using spatial transcriptomics, the development of novel combination regimens, and the active exploration of integrative strategies combining traditional Chinese and Western medicine—will facilitate the clinical translation of FASN-targeted therapies and open new avenues for improving the quality of life and prognosis of cancer patients.]]></description>
<pubDate>2026/3/18 14:48:35</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[JIANG Wen-Jing,LI Xiao,SUN Ya-Wen,TAI Yu-Qing,ZHANG Ruo-Xi,ZHANG Xi-Yu]]></author>
</item>
<item>
<title><![CDATA[Low-input Proteomics Reshapes Our Understanding of Regulatory Mechanisms in Early Embryonic Development]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202602050000002]]></link>
<description><![CDATA[Early mammalian embryogenesis represents a central question in life sciences, yet its molecular regulation has long been inferred primarily from transcriptomic and translatomic analyses. Recently, a study by Zhu <i>et al.</i> (2025) based on low-input proteomic approaches systematically charted protein dynamics from oocytes to blastocysts in both mice and humans, further interrogating molecular signatures of developmentally compromised human embryos at the single-embryo level. This work not only substantially expands proteome coverage during early development, but also reveals a pervasive uncoupling between transcriptional activation, translational initiation, and protein accumulation. These findings provide new perspectives on the relationship between zygotic genome activation (ZGA) and lineage specification. This paper discussed the central role of low-input proteomics in this study, highlighted its implications for reshaping current paradigms of early embryonic development, and considered its potential applications across broader areas of biomedical research.]]></description>
<pubDate>2026/3/17 15:02:15</pubDate>
<category><![CDATA[动态与评论]]></category>
<author><![CDATA[CHEN Hong-Yu]]></author>
</item>
<item>
<title><![CDATA[Study on The Anti-aging Effects of Longevity-enriched Metabolite Dimethylglycine]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202512300000003]]></link>
<description><![CDATA[<b>Objective</b> The exacerbating trend of global population aging poses profound socioeconomic and public health challenges, making the comprehensive elucidation of biological aging mechanisms and the discovery of effective anti-aging interventions an urgent priority in the life sciences. Based on our previous serum metabolomics findings that dimethylglycine, an intermediate metabolite of amino acid metabolism naturally present in the human body, was significantly enriched in the serum of longevity families, this study aimed to systematically investigate the anti-aging effects of dimethylglycine both in living organisms and in controlled laboratory environments, and to preliminarily elucidate its underlying molecular mechanisms. While existing literature indicates that dimethylglycine possesses antioxidant and immunomodulatory properties, its direct anti-aging efficacy and the specific molecular pathways through which it operates remain largely unexplored.<b>Methods</b> To comprehensively evaluate the anti-aging properties of dimethylglycine, we utilized replicative senescent human embryonic lung fibroblasts, specifically the WI-38 cell line, as an experimental model in a controlled laboratory environment. Cell viability and safety were thoroughly assessed using Cell Counting Kit-8 and lactate dehydrogenase release assays across various concentrations of dimethylglycine. The impact of dimethylglycine on cellular senescence phenotypes, oxidative stress, and proliferative capacity was evaluated <i>via</i> senescence-associated beta-galactosidase staining, reactive oxygen species fluorescence detection, and 5-ethynyl-2"-deoxyuridine incorporation assays. Furthermore, the molecular alterations of senescence-associated secretory phenotype factors and core senescence signaling pathways were quantified using quantitative reverse transcription polymerase chain reaction for the messenger RNA levels of interleukin-6, interleukin-8, p21, and matrix metalloproteinase-1, and enzyme-linked immunosorbent assay for the measurement of p16 and p21 protein expression levels. For the living organism model, the wild-type nematode <i>Caenorhabditis elegans </i>was used to evaluate systemic physiological effects. We conducted a comprehensive lifespan analysis at 20°C, heat stress resistance survival assays at 35℃, senescence-associated beta-galactosidase staining, lipofuscin accumulation tracking, intracellular reactive oxygen species measurement, and Oil Red O staining to ascertain systemic lipid accumulation. Additionally, network pharmacology bioinformatics tools, including PharmMapper and STRING databases, and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis were utilized to predict target pathways, alongside highly detailed molecular docking simulations utilizing SwissDock and Protein-Ligand Interaction Profiler to examine interactions with the cytochrome P450 family 2 subfamily C member 9 protein.<b>Results</b> The experimental outcomes robustly demonstrate the potent anti-aging capabilities of dimethylglycine. At the cellular level, toxicity analyses firmly confirmed that dimethylglycine is highly safe; continuous treatment with 50 mol/L and 70 mol/L of dimethylglycine for 5 d did not induce any cellular membrane damage or cytotoxicity, but rather actively promoted cellular proliferation. Utilizing the optimal standardized concentration of 50 mol/L, dimethylglycine treatment significantly ameliorated senescent phenotypic markers in human embryonic lung fibroblasts, which was evidenced by a drastic and highly significant reduction in the senescence-associated beta-galactosidase positive cell percentage (<i>P</i><0.000 1) and intracellular reactive oxygen species levels (<i>P</i><0.000 1), alongside a marked increase in the 5-ethynyl-2"-deoxyuridine-positive proliferation rate (<i>P</i>=0.003 5). On a molecular expression scale, dimethylglycine significantly downregulated the messenger RNA expression of multiple core senescence-associated secretory phenotype inflammatory factors, including interleukin-6, interleukin-8, p21, and matrix metalloproteinase-1. Concurrently, it effectively suppressed the protein expression of critical cell cycle arrest markers, diminishing p16 protein levels by 57.3% (<i>P</i>=0.000 4) and p21 protein levels by 27.2% (<i>P</i>=0.000 7). In the nematode <i>Caenorhabditis elegans</i> animal model, dimethylglycine significantly extended the mean lifespan from 20.402 d to an impressive 23.066 d (<i>P</i><0.000 1) and notably enhanced overall survival rates under severe heat stress environmental conditions (<i>P</i>=0.017). Furthermore, systemic dimethylglycine intervention significantly mitigated age-related physiological decline by decreasing bodily lipofuscin accumulation (<i>P</i><0.000 1), significantly reducing senescence-associated beta-galactosidase activity, lowering systemic reactive oxygen species fluorescence (<i>P</i>=0.008), and effectively alleviating overall fat accumulation (<i>P</i><0.000 1). Mechanistically, extensive network pharmacology and Kyoto Encyclopedia of Genes and Genomes analyses strongly revealed that the potential targets of dimethylglycine are significantly enriched in fundamental drug metabolism and oxidative stress response pathways. Precision molecular docking simulations conclusively demonstrated that dimethylglycine forms highly stable structural interactions with the cytochrome P450 family 2 subfamily C member 9 protein, specifically highlighting the definitive formation of 5 stable hydrogen bonds involving serine 365, leucine 366, and serine 429 residues, as well as two critical salt bridge formations with arginine 97 and histidine 368 residues. It is additionally predicted to interact favorably with glutathione S-transferase family proteins.<b>Conclusion</b> Dimethylglycine exhibits a profoundly significant and multifaceted anti-aging activity at both the cellular and entire living animal levels. By powerfully alleviating oxidative stress, heavily suppressing the core p16 and p21-dependent cellular senescence signaling pathways, and substantially mitigating the detrimental senescence-associated secretory phenotype, dimethylglycine effectively delays fundamental cellular senescence processes and drastically extends whole-organism lifespan. The biological mechanisms driving these robust protective effects are highly likely closely associated with its direct stable interactions with crucial metabolic and detoxifying enzyme systems, such as cytochrome P450 family 2 subfamily C member 9 and glutathione S-transferase family proteins, thereby systemically improving metabolic dysregulation and restoring critical redox homeostasis. This comprehensive study provides highly solid experimental evidence supporting dimethylglycine as a highly potent and safe potential anti-aging intervention agent, while simultaneously offering a clear molecular mechanistic explanation for the previously documented high abundance of dimethylglycine observed within exceptionally long-lived human populations.]]></description>
<pubDate>2026/3/17 14:24:44</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[AN Jing,AN Wei-Wei,CAO Ju,HU Jie,LI Jun-Lin,LI Xue-Meng,LIN Zhi-Xin,PU Gong-Yu]]></author>
</item>
<item>
<title><![CDATA[m<sup>6</sup>ATEpre: Predicting YTHDF1-mediated mRNA Translation Efficiency Regulated by m<sup>6</sup>A Sites <i>via</i> Multi-omics Data Integration]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601040000002]]></link>
<description><![CDATA[<b>Objective</b> The most prevalent mRNA modification, N6-methyladenosine (m<sup>6</sup>A) plays an important role in various RNA metabolism, including gene expression and translation. By recruiting different “reader” proteins and their cofactors, m<sup>6</sup>A modification can affect messenger RNA (mRNA) degradation, splicing, nuclear export and translation. However, the selective mechanism by which m<sup>6</sup>A sites regulate mRNA translation through m<sup>6</sup>A reader YTHDF1 binding remains poorly understood, due to a lack of computational methods for identifying context-specific m<sup>6</sup>A sites that regulate translation. To address this, we developed a novel computational framework named m<sup>6</sup>ATEpre, the first tool designed to predict cell-specific m<sup>6</sup>A sites that regulate translation efficiency.<b>Methods</b> m<sup>6</sup>ATEpre integrates multi-omics data, introduces a novel feature representation strategy for m<sup>6</sup>A site sequences, and employs an autoencoder to effectively capture embedded feature representations. Specifically, m<sup>6</sup>ATEpre first integrated MeRIP-seq data and PAR-CLIP data through overlapping m<sup>6</sup>A sites with YTHDF1 binding sites and identified YTHDF1-mediated m<sup>6</sup>A sites. Then, m<sup>6</sup>ATEpre detected the translation gene by analyzing the Ribo-seq data under YTHDF1 knockdown <i>vs</i> control condition. Genes whose translation is mediated by YTHDF1 in an m<sup>6</sup>A-dependent manner were identified by a significant decrease in translation efficiency upon YTHDF1 knockdown. Next, we proposed a binary vector indicating the presence or absence of YTHDF1 binding motifs to characterize each m<sup>6</sup>A site sequence. This represents a novel feature representation strategy for m<sup>6</sup>A sites. m<sup>6</sup>ATEpre utilized the autoencoder to extract the potentially important feature representations and constructed a multilayer perceptron neural networks model to predict potential m<sup>6</sup>A sites that regulating translation efficiency.<b>Results</b> A comprehensive evaluation of m<sup>6</sup>ATEpre was conducted through a series of experiments. We compared its performance against that of a similar prediction task model, as well as other classifiers. The results indicate that m<sup>6</sup>ATEpre achieved the best prediction performance. In addition, we analyzed different feature representation strategies and performed ablation experiments to validate the rationality of the model design. The results demonstrate that our proposed feature representation strategy has a greater advantage in improving prediction performance. In the HeLa cell line, bioinformatic analysis of the metagene distribution and sequence minimum free energy of m<sup>6</sup>A sites regulating translation efficiency (m<sup>6</sup>A-reg-TE sites) revealed their specific properties in translation regulation. Functional enrichment analysis indicated that m<sup>6</sup>A-reg-TE genes are associated with specific biological processes and KEGG pathways. By integrating the binding sites of YTHDF1 co-factors with m<sup>6</sup>A-reg-TE sites, we revealed that YTHDF1-mediated and m<sup>6</sup>A-dependent translation efficiency regulation requires the cooperation of multiple translation-regulatory RNA-binding proteins among its co-factors in the HeLa cell line. Furthermore, we extended our predictions to the dataset of the HEK293T cell line. Similarly, bioinformatic analysis of the metagene distribution and functional enrichment revealed the cell-specific characteristic of these predicted m<sup>6</sup>A-reg-TE sites in HEK293T cells. Likewise, integrated analysis of multiple YTHDF1 co-factors and m<sup>6</sup>A-reg-TE sites predicted in the HEK293T cell line reveals their m<sup>6</sup>A-dependent cooperation in regulating translation efficiency.<b>Conclusion</b> m<sup>6</sup>ATEpre is a timely tool that will advance our understanding of the mechanisms of m<sup>6</sup>A regulation in translation efficiency. The source code and datasets used in this work can be downloaded from <ext-link ext-link-type="uri" xlink:href="https://www.scidb.cn/s/bAZZFr">https://www.scidb.cn/s/bAZZFr</ext-link>.]]></description>
<pubDate>2026/3/17 11:29:07</pubDate>
<category><![CDATA[技术与方法]]></category>
<author><![CDATA[LIU Lian,ZHANG Ming,ZHANG Shao-Wu,ZHANG Teng]]></author>
</item>
<item>
<title><![CDATA[The Role of Histone Lactylation in Diseases and Intervention by Traditional Chinese Medicine]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601140000003]]></link>
<description><![CDATA[Histone lactylation is a recently identified post-translational modification, wherein lactate mediates the enzymatic addition of lactyl groups to lysine residues on histones. Since its discovery, extensive research has demonstrated that histone lactylation is widely present in human tissues and plays a pivotal role in regulating the transcription of specific genes. Subsequent studies have further established this modification as a widespread epigenetic mark with significant physiological implications. With advancing research, accumulating evidence confirms that lactylation at distinct histone sites elicits diverse biological effects—such as promoting cell proliferation, driving inflammatory responses, and enhancing fibrosis—all of which profoundly influence disease progression and serve as key drivers of disease onset and development. Conversely, inhibiting histone lactylation can alter disease outcomes, positioning histone lactylation as a promising therapeutic target. Moreover, studies have revealed crosstalk between histone lactylation and other post-translational modifications, such as acetylation and methylation, which collectively regulate disease progression. Notably, lactylation occurs not only on histones but also on non-histone proteins. Histone lactylation activates specific gene transcription and reshapes metabolic epigenetics, while non-histone lactylation directly modulates enzyme activity, signal transduction, and protein stability. These two facets form a synergistic network through shared lactate pools, common modifying enzyme systems, and pathway crosstalk, thereby constructing a multi-dimensional regulatory framework—namely, the “histone lactylation-metabolism hub-non-histone lactylation” axis. This architecture bridges metabolism and epigenetics, and deciphering its topological structure may provide novel targets for precise intervention in diseases driven by lactate-mediated signaling hijacking. Traditional Chinese medicine (TCM), grounded in clinical practice, has been shown to regulate histone lactylation by modulating lactate metabolism and lactylation-related enzymes, thereby influencing disease progression. Moreover, certain TCM formulations exhibit potential as alternative therapies for drug-resistant diseases, underscoring the significance of further exploring TCM-mediated regulation of histone lactylation in future therapeutic strategies. This review aims to elucidate the mechanisms underlying histone lactylation, systematically delineate the associations between site-specific histone lactylation and various diseases, present a comprehensive landscape of the “lactate-histone lactylation and functional protein lactylation” axis, and summarize the mechanistic basis and research advances in TCM-mediated regulation of histone lactylation for disease treatment. Additionally, we discuss current challenges in histone lactylation research and propose future directions, ultimately aiming to deepen understanding and broaden perspectives on the roles and therapeutic potential of histone lactylation in disease.]]></description>
<pubDate>2026/3/16 11:18:30</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DU Jie,GAO Feng,LI Zhao-Huan,ZHANG Xin]]></author>
</item>
<item>
<title><![CDATA[<b>Research: </b>Study on The Effect and Mechanism of Luteolin Against <i>Mycoplasma pneumoniae</i>]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202512010000002]]></link>
<description><![CDATA[<b>Objective</b> This study aimed to investigate the anti-<i>Mycoplasma pneumoniae</i> (MP) activity of luteolin and elucidate its underlying mechanisms.<b>Methods</b> Luteolin was identified as the primary active compound from the polyphenol extract of <i>F. diotrys</i> using network pharmacology. Its efficacy was evaluated against two MP strains: the standard strain M129 and the multidrug-resistant strain M19. A modified culture medium with visual characteristics was employed to determine the minimum inhibitory concentration (<i>MIC</i>) of luteolin. The expression of key proteins involved in MP growth and pathogenicity was assessed by qRT-PCR following luteolin treatment. Additionally, the viability of A549 cells infected with MP was compared between luteolin-treated and untreated groups. <i>In vivo</i> anti-MP activity was evaluated using a mouse model, and the expression of inflammatory cytokines in lung tissues was analyzed.<b>Results</b> Luteolin effectively inhibited both MP strains, with <i>MIC</i><sub>90</sub> values of 100 mg/L for M19 and M129. Treatment with luteolin significantly downregulated the expression of adhesion proteins P1 and P30 in both strains. However, the expression of P65, HMW3, TrmB, and CARDS TX was reduced only in the M19 strain following luteolin intervention. Luteolin also enhanced the growth and viability of A549 cells infected with MP. In the mouse model, luteolin treatment resulted in steady weight gain and was well tolerated. The bacteriostatic rate of luteolin in lung tissues was 50.7%, significantly higher than the 25.2% observed in the roxithromycin group. Furthermore, luteolin reduced the expression of inflammatory factors, including IL-6, TNF-α, and HMGB1, in MP-infected mice.<b>Conclusion</b> Luteolin effectively and safely inhibits the proliferation and pathogenicity of MP, particularly the drug-resistant M19 strain, by downregulating the expression of toxicity-associated proteins (P1, P30, P65, HMW3, TrmB, CARDS TX) and modulating host inflammatory responses. These findings suggest that luteolin may offer a novel therapeutic strategy for treating MP infections, especially those caused by drug-resistant strains.]]></description>
<pubDate>2026/3/15 9:25:39</pubDate>
<category><![CDATA[中医药医工结合专题]]></category>
<author><![CDATA[DING Kai-Yi,LIAO Guo-Yang,LIU Ze,LIU Zhao-Hong,OU Xia,TANG Lei,XIA Jian-Ming,YANG Kai,ZHANG Ji-Hong]]></author>
</item>
<item>
<title><![CDATA[<b>Research: </b>The Specificity of Electroacupuncture at Different Acupoints in Promoting Cerebrospinal Fluid Flow in Mice]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601270000005]]></link>
<description><![CDATA[<b>Objective</b> Cerebrospinal fluid (CSF) plays a crucial role in maintaining the homeostasis of the central nervous system (CNS). CSF rapidly exchanges with interstitial fluid (ISF) <i>via</i> the glymphatic system within the brain parenchyma. CSF-ISF circulation and its associated mechanisms are often referred to as the brain lymphatic system. This system is connected directly to meningeal lymphatic vessels (mLVs), jointly performing the function of clearing metabolic waste from the CNS. Emerging evidence indicates that this system is closely associated with the onset and progression of neurodegenerative diseases (NDs) such as Alzheimer’s disease (AD). Importantly, abnormal CSF circulation is not only a downstream consequence of AD pathology, but also a risk factor. In AD, the dynamics of CSF flow within the CNS are diminished, immune dysregulation occurs, and this may increase the risk of AD by exacerbating the burden of amyloid β-protein (Aβ). In the mouse model of AD, impaired CSF flow compromises this clearance function, leading to cognitive deficits. Clinically, acupuncture at cognition-related acupoints is commonly used for the prevention and treatment of AD. However, whether its therapeutic effects are mediated through the modulation of CSF dynamics remains unclear. This study aimed to evaluate the impact of acupuncture on CSF flow and investigate its acupoint specificity.<b>Methods</b> Mice were randomly assigned to experimental groups for the different electroacupuncture groups with the following acupoints: Baihui point (GV 20), Ear point, Neiguan point (PC 6), and Tianshu point (ST 25). Wild-type mice on a C57BL/6J background were used as controls. Fluorescent tracer was injected into the cisterna magna to label CSF flow. Fluorescence imaging was employed to assess the distribution of CSF within the brain before and after acupuncture stimulation.<b>Results</b> Following tracer injection into the cisterna magna, fluorescence signals rapidly reached the cerebellum and medulla—the regions closest to the injection site. Fluorescence intensity was higher in ventral brain regions compared to dorsal regions, likely due to greater vascular density in ventral areas facilitating CSF-ISF exchange. Electroacupuncture at the GV 20 produced the most pronounced enhancement of CSF across the whole brain, while stimulation at the ST 25 primarily augmented flow within subcortical regions. In contrast, electroacupuncture at the Ear point or the PC 6 had no observable effect on CSF in mice.<b>Conclusion</b> Electroacupuncture promotes CSF flow into the brain parenchyma in an acupoint-specific manner, with GV 20 exhibiting the most pronounced enhancement of CSF dynamics. These findings suggest that acupuncture-mediated facilitation of CSF flow may represent a potential therapeutic strategy for preventing or delaying age-related cognitive decline.]]></description>
<pubDate>2026/3/12 23:03:55</pubDate>
<category><![CDATA[中医药医工结合专题]]></category>
<author><![CDATA[DENG Chen-Geng,HUA Qian,LIU Zhao-Heng,NIE Yu-Xin,PENG Tian-Tian,SHI Yu,WANG Xu]]></author>
</item>
<item>
<title><![CDATA[The Role and Regulatory Mechanisms of FOXO1 in Hepatic Lipid Deposition]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202511230000001]]></link>
<description><![CDATA[Metabolic associated fatty liver disease (MAFLD) is fundamentally driven by an imbalance in hepatic fatty-acid flux: the influx of fatty acids exceeds the liver’s capacity for disposal, resulting in excessive hepatic lipid accumulation, predominantly in the form of triglycerides (TGs). The occurrence and progression of MAFLD depend on disordered regulation across multiple metabolic steps, including fatty-acid uptake, <i>de novo</i> lipogenesis (DNL), fatty-acid oxidation (FAO), and very low-density lipoprotein (VLDL) export. Forkhead box protein O1 (FOXO1) is a key transcriptional regulator within the hepatic network coordinating glucose and lipid metabolism. Under metabolic stress and insulin resistance (IR), FOXO1 expression is frequently increased, whereas its inhibitory phosphorylation is reduced. These changes enhance FOXO1 nuclear localization and transcriptional activity, thereby reprogramming the expression of genes related to metabolism in the liver. Because hepatic lipid deposition is the central pathological feature of MAFLD, the functional status of FOXO1 directly influences hepatic lipid homeostasis. Growing evidence suggests that FOXO1 can exert bidirectional, environment-dependent effects on hepatic lipid accumulation; however, the molecular basis for this functional switch remains incompletely understood. This review systematically summarizes the biological functions and regulatory mechanisms of FOXO1 and its roles in hepatic lipid metabolism, with a particular focus on its crosstalk with insulin signaling. FOXO1 expression is shaped by RNA modifications and epigenetic regulation mediated by non-coding RNAs. Its transcriptional output is precisely governed by post-translational modifications—such as phosphorylation and acetylation—as well as by coordinated nucleocytoplasmic shuttling. Notably, these regulatory patterns vary markedly across nutritional states, degrees of insulin resistance, and stages of disease. In the fed state, insulin/IGF-1 signaling activates the PI3K-AKT pathway, promoting the inhibitory phosphorylation of FOXO1 and facilitating additional modifications, including acetylation, methylation, and ubiquitination. Together, these events drive FOXO1 export from the nucleus and dampen its transcriptional activity, suppressing gluconeogenesis and constraining lipogenic programs. Conversely, during fasting or when insulin signaling is weakened, FOXO1 inhibition is relieved. FOXO1 accumulates in the nucleus, binds to DNA, and regulates the transcription of downstream target genes. Mechanistically, FOXO1 can aggravate hepatic lipid accumulation by activating genes involved in TG synthesis while repressing FAO-related pathways, thereby favoring storage over oxidation. However, under specific conditions, FOXO1 may also alleviate the hepatic lipid burden by promoting TG hydrolysis and enhancing VLDL secretion, thereby reducing the net hepatic lipid load. In addition, lipotoxic signals mediated by ceramides and diacylglycerols (Cer/DAG) activate atypical protein kinase C (aPKC), further exacerbating the disruption of the AKT-FOXO1 axis. This vicious cycle ultimately produces a metabolic paradox in which increased hepatic glucose output coexists with persistent, insulin-independent lipogenesis, accelerating MAFLD progression. Importantly, FOXO1 regulation is not uniform: during early metabolic overload, insulin-mediated suppression may remain effective, whereas in advanced insulin resistance, the loss of AKT control permits sustained FOXO1 activity. Such stage-dependent dynamics may help explain why FOXO1 can either promote steatosis or, in certain contexts, support programs that facilitate lipid turnover. Accordingly, interventions should be liver-specific and tuned to the disease stage, aiming to curb maladaptive FOXO1 signaling while preserving its capacity to promote triglyceride hydrolysis and VLDL secretion when advantageous. Overall, this review offers an important perspective on MAFLD pathogenesis, emphasizing FOXO1 as a potential therapeutic target and providing a theoretical basis for developing liver-specific, disease-course-dependent precision interventions.]]></description>
<pubDate>2026/3/10 22:07:40</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HE Jia-Han,JIA Meng,LI Ai-Ju,LI Fang-Hui,LI Yin-Lu,NI Pin-Shi,WANG Yi-Le,YAN Shi-Zhan]]></author>
</item>
<item>
<title><![CDATA[Lysosomes as Regulators of Cancer Stemness and Drug Resistance]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202512180000003]]></link>
<description><![CDATA[Cancer stem cells (CSCs) represent a distinct subpopulation of cells characterized by self-renewal capacity, differentiation potential, and critical roles in driving tumor progression, therapeutic resistance, recurrence, and maintenance of the tumor microenvironment. Targeting CSCs has emerged as a pivotal direction in cancer research, offering novel strategies to overcome drug resistance and prevent metastasis and relapse. Lysosomes, traditionally recognized as central organelles for intracellular degradation and recycling, are indispensable for cellular homeostasis. Dysregulation of lysosomal function is intimately linked to various diseases, including cancer. In tumors, aberrant lysosomal activity can promote malignant progression through mechanisms such as altering metabolic pathways, enhancing lysosomal exocytosis, modulating drug resistance, and interfering with autophagy-lysosomal pathways. Recent studies have underscored the involvement of lysosomes in regulating CSC properties. This review synthesizes findings on lysosomal regulation of CSCs through the following aspects. (1) Lysosomes exert complex and critical bidirectional control over CSC stemness maintenance through three degradation pathways that are dependent on their degradative function. (i) The lysophagy pathway. This pathway exhibits dual roles. Activation can sustain CSC functions; for instance, in glioblastoma, hypoxia upregulates Gal-8 <i>via</i> the STAT3/HIF1α signaling axis to induce autophagy, supporting stem cell survival. In head and neck squamous cell carcinoma, degradation of GSK3β activates the Wnt pathway, enhancing stemness. Conversely, this pathway can suppress stemness by degrading stemness-related proteins such as BMI-1 and OCT4A, thereby impairing CSC self-renewal capacity. (ii) Mitophagy pathway. In non-small cell lung cancer stem cells, mitophagy-related mechanisms, such as the accumulation of mitochondrial DNA (mtDNA) activating the TLR9-Notch1-AMPK signaling axis, have been shown to promote CSC proliferation. (iii) Autophagosome-dependent lysosomal degradation pathway. This pathway directly regulates stemness-related proteins in a bidirectional manner. Enhanced degradative function can promote CSC properties, exemplified by the degradation of NUMB to activate Notch signaling. Conversely, attenuated degradative function can also enhance stemness by stabilizing oncoproteins (<i>e.g</i>., protecting Frizzled-1 from degradation to sustain Wnt signaling) or preventing the degradation of tumor suppressors (<i>e.g</i>., inhibiting Notch degradation). (2) Constituent proteins of lysosomes, including membrane proteins and luminal acid hydrolases, participate in regulating CSC stemness. Regarding membrane proteins, LAMP2A facilitates chaperone-mediated autophagy to maintain stemness in glioblastoma and ovarian cancer. V-ATPase, by maintaining an acidic luminal environment, promotes proliferation and drug resistance in glioma stem cells. Among hydrolases, cathepsins B and L are highly expressed in pancreatic and ovarian cancers and correlate with poor prognosis. Furthermore, targeting lysosomes to induce lysosomal membrane permeabilization (LMP) triggers lysosome-mediated cell death, presenting a potential therapeutic strategy for eradicating CSCs. (3) The acidic luminal environment, single-membrane structure, and the presence of transmembrane transporters (<i>e.g</i>., ABCA3) enable lysosomes to passively trap or actively uptake and sequester chemotherapeutic drugs. Subsequent drug extrusion <i>via</i> exocytosis confers drug resistance. In CSCs, this lysosome-mediated drug sequestration, often cooperating with autophagy, establishes multimodal drug resistance. Therefore, targeting lysosomal function represents a potential strategy to overcome therapy resistance. The central role of lysosomes in regulating CSC stemness and resistance positions them as highly promising therapeutic targets. Strategies aimed at disrupting lysosomal function to selectively eliminate CSCs include: inhibiting the lysosome-autophagy system using agents like IITZ or lovastatin; inducing lysosomal membrane permeabilization (LMP) with compounds such as hexamethylene amiloride to compromise membrane stability; and disrupting the acidic luminal environment using drugs like siramesine or the K/H transport compound 2. In conclusion, lysosomes critically regulate CSC stemness maintenance and drug resistance through degradative pathways, membrane protein functions, luminal hydrolase activities, and drug sequestration mechanisms. This redefines the lysosome from a traditional “waste disposal unit” to a “signal integration center” in CSCs. The duality and context-dependency of lysosomal function in CSCs offer novel insights into the heterogeneity observed across different tumors. Targeting lysosomal vulnerabilities—such as inducing LMP, disrupting acidity, or blocking autophagic flux—provides a strategy to bypass canonical CSC resistance mechanisms and directly trigger cell death. This establishes the lysosome as a key target to overcome CSC-mediated therapy resistance, paving the way for developing diverse candidate drugs and innovative combination therapies in oncology.]]></description>
<pubDate>2026/3/10 20:39:42</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DUAN Hong-Yu,TAN Si-Qi,WU Xiao-Ming,YU Di-Ping,ZHOU Fa-Xiao]]></author>
</item>
<item>
<title><![CDATA[Mass Spectrometry-based Antibody Sequencing Technologies]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202510120000002]]></link>
<description><![CDATA[Antibodies play a critical role in adaptive immune responses and serve as key components in disease diagnosis and treatment. These molecules exhibit dynamic post-translational modifications (PTMs), such as glycosylation and phosphorylation, which regulate their effector functions. To date, nearly all of our knowledge about antibody repertoires has come from B cell receptor (BCR) sequencing (BCR-seq), which facilitates the profiling of clonal composition and the tracing of maturation trajectories within B-cell repertoires. However, circulating antibodies found in bodily fluids—such as serum, saliva, milk, mucosal secretions, and cerebrospinal fluid—exhibit diversities and specificities beyond what BCR-seq alone can predict. Therefore, identifying and quantifying antibody clonotypes at the protein level could enhance diagnosis, prognosis, and treatment strategies in personalized medicine. The critical gap between genotype and phenotype necessitates complementary methodologies that enable the direct characterization of antibody proteins in their native functional states. Mass spectrometry (MS)-based antibody repertoire sequencing (Ab-seq) is currently the only feasible approach for this task and primarily includes database-dependent methods—such as bottom-up, middle-down, and top-down approaches—as well as database-independent <i>de novo</i> sequencing technology. These strategies enable multi-level, high-precision characterization ranging from peptides and domains to intact antibody molecules. Unlike the shotgun strategy commonly used in routine proteomics, obtaining full sequences of all antibodies presents unique challenges. It requires specialized methodological adaptations to address issues related to dynamic range, sequence variation, and sample complexity. This review introduces the technical principles, methodological workflows, and recent applications of various mass spectrometry-based antibody repertoire sequencing (Ab-seq) strategies, with a focus on approaches designed to improve sequence coverage and identification accuracy. These include multi-enzyme digestion, hybrid fragmentation methods, and artificial intelligence-assisted <i>de novo</i> sequencing. By systematically comparing database-dependent techniques—such as bottom-up, middle-down, and top-down approaches—with database-independent <i>de novo</i> sequencing, this review outlines their respective advantages and limitations in terms of sample throughput, sequence coverage, post-translational modification characterization, and data analysis complexity. In addition, this review discusses emerging technological trends, including the integration of ion mobility separation, native mass spectrometry, and artificial intelligence-driven data interpretation, which are expected to enhance the depth and accuracy of antibody characterization. Although current methods continue to face challenges related to sample complexity, dynamic range, and unambiguous sequence variant assignment, we emphasize the importance of integrating BCR-seq and Ab-seq data to construct gene-protein association maps. These maps help validate sequence accuracy and facilitate epitope discovery. This dual-platform strategy helps bridge the gap between genotype and phenotype, thereby enhancing both the resolution and scope of antibody repertoire studies. Such an integrative approach also offers a valuable tool for therapeutic antibody development, structure-function analysis, and precise evaluation of vaccine efficacy.]]></description>
<pubDate>2026/3/6 22:33:44</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LIU Sheng-Mei,WANG Xiao-Jian,XUE Peng]]></author>
</item>
<item>
<title><![CDATA[Exploring CRISPR/Cas9 Technology for The Modernization of Traditional Chinese Medicine]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202511130000002]]></link>
<description><![CDATA[The clustered regularly interspaced short palindromic repeats (CRISPR)/associated protein 9 (CRISPR /Cas9) immune system is an adaptive immune system widely distributed in bacteria and archaea. It precisely defends against invasion by exogenous phages, viruses, and plasmids through sequence-specific endogenous immune response mechanisms. As the most prominent member of this family, the CRISPR/Cas9 system has evolved into the most widely applied, flexible, and efficient technical platform in the field of genome engineering due to its exceptional genome modification capabilities. Within the CRISPR/Cas9 system, the Cas9 protein, precisely guided by a single-stranded guide RNA (gRNA), can specifically recognize target DNA sequences and induce double-strand breaks. This activates the cell’s DNA repair mechanisms, enabling gene knockout, knock-in, or modification. Demonstrating significant advantages in specificity, flexibility, and operability, CRISPR/Cas9 technology has shown immense potential in the medical field, opening new avenues for modernizing traditional Chinese medicine (TCM) research. On one hand, this technology can be used to construct precise disease models and tailor personalized treatment plans. It enables in-depth elucidation of the molecular mechanisms underlying the action targets and signaling pathways of TCM formulas and active components, thereby unraveling the scientific secrets of their complex mechanisms of action. On the other hand, it demonstrates powerful tool value in improving TCM germplasm resources, identifying and screening superior varieties, evaluating the controllability of TCM quality, and producing innovative drugs, providing technical support for the standardization and precision of TCM. Simultaneously, the high-throughput omics data generated by CRISPR technology is driving artificial intelligence (AI) to construct virtual disease models and drug prediction systems. This empowers the intelligent screening of effective TCM components, the precise prediction of potential targets, and the exploration of “reducing toxicity while enhancing efficacy” through formula combinations. This synergistic innovation between CRISPR and AI aligns perfectly with precision medicine’s urgent demand for personalized, efficient drug development, injecting new momentum into the modernization and transformation of TCM. This paper first systematically reviews and explains the developmental trajectory, structural basis, and action mechanisms of the CRISPR/Cas9 system, tracing its scientific evolution from a bacterial immune system to a gene-editing tool. It then comprehensively outlines the current state of convergence between precision medicine concepts and modernization research in TCM, analyzing the synergistic points and potential spaces for their integration. Against the backdrop of rapid precision medicine advancement, this paper emphasizes how CRISPR/Cas9 gene editing technology empowers in-depth analysis of TCM mechanisms—including specific applications in disease model construction, therapeutic target validation, and multi-target network regulation studies. It further elaborates on its multidimensional practical contributions to modernizing TCM, spanning key domains such as germplasm resource innovation, bioactive compound biosynthesis, quality standardization control, and novel TCM drug development. Finally, this paper envisions the future landscape of deep integration between CRISPR technology and AI: from data-driven intelligent drug screening to high-throughput precision discovery of effective TCM components, and further to intelligent model construction based on “reducing toxicity while enhancing efficacy” mechanisms. The synergistic convergence of these multidimensional technologies will pioneer new scientific paradigms and translational pathways for TCM modernization, propelling TCM toward leapfrogging development in the era of precision medicine.]]></description>
<pubDate>2026/3/6 19:02:39</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[Guo Fei-Fei,MA Guang-Qiang,WANG Shu-Xian]]></author>
</item>
<item>
<title><![CDATA[Resolution Assessment in Super-resolution Optical Microscopy: Adaptive Methods and Recent Advances]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202512090000001]]></link>
<description><![CDATA[Optical microscopy is essential for exploring biological and material structures, with resolution determining the level of observable detail. The advent of super-resolution fluorescence microscopy has broken the diffraction limit, achieving nanoscale resolution. However, traditional assessment methods, such as the Rayleigh criterion and point spread function (PSF) width measurement, rely on empirical judgments and diffraction-limited models, rendering them inadequate for modern super-resolution imaging. This review systematically traces the evolution of resolution assessment methodologies, from classical criteria to advanced strategies tailored for various super-resolution modalities. We first discuss Fourier-based quantitative methods. Fourier ring correlation (FRC) and its 3D counterpart, Fourier shell correlation (FSC), objectively determine resolution by evaluating the statistical correlation of two independent image reconstructions in frequency space. These methods offer robustness against noise and provide a global resolution metric, but they require data independence and are computationally intensive. They have become the prevailing standards in electron and super-resolution microscopy. Subsequently, we examine adaptations for specific super-resolution techniques. For single-molecule localization microscopy (SMLM) techniques such as PALM and STORM, the Fourier image resolution (FIRE) method extends FRC by incorporating a physical model that accounts for localization precision and labeling density. For stimulated emission depletion (STED) microscopy and other nonlinear techniques, assessment strategies differ. While PSF shrinkage measurements using fluorescent beads are useful for system calibration, evaluating the effective resolution directly on biological samples is more practical. This is typically performed <i>via</i> linewidth analysis of known structures (<i>e.g</i>., microtubules) or edge-spread function measurements, capturing the effects of photobleaching and sample-induced aberrations. A major paradigm shift is parameter-free resolution estimation based on decorrelation analysis. This method analyzes the autocorrelation decay of a single image’s Fourier spectrum to identify the cutoff spatial frequency without requiring dual datasets or user-defined thresholds. Its high efficiency and broad applicability have been validated across widefield, confocal, STED, SIM, and SMLM modalities. Optimized rendering strategies for SMLM data further enhance its accuracy, and it is emerging as a tool for real-time optimization of experimental parameters. The review also addresses the “gold standard” of resolution validation using well-defined nanostructures, such as DNA origami and nuclear pore complexes, which provide ground truth for verifying resolution claims and detecting artifacts. In the era of artificial intelligence, deep learning plays a dual role: it powerfully enhances image resolution but also introduces challenges, as models may generate “hallucinations” or false details. This underscores the need for new validation metrics to verify the physical fidelity of AI-generated content. Finally, we outline future directions: developing unified cross-modality standards, enabling real-time dynamic resolution monitoring for live-cell imaging, creating techniques for generating local resolution maps to capture sample heterogeneity, and integrating intelligent error correction to ensure data veracity. By providing a comprehensive overview of resolution assessment progress and challenges, this review aims to equip researchers with the knowledge to select appropriate tools, thereby fostering rigorous quantitative imaging in the life and material sciences.]]></description>
<pubDate>2026/3/6 8:29:29</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Jing-Yao,FANG San-Hua,LIU Li,YANG Dan]]></author>
</item>
<item>
<title><![CDATA[Mitoxyperilysis——a Novel Pathway of Cell Death Connecting Dietary Interventions and Innate Immune Activation]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202602070000003]]></link>
<description><![CDATA[Dietary interventions such as fasting are gaining increasing attention for their synergistic effects in anti-tumor therapy, yet the precise underlying mechanisms remain incompletely understood. Recent research has unveiled a novel mode of cell death named “mitoxyperilysis”, providing a fresh perspective on the molecular mechanisms by which fasting may interfere with tumor treatment. This form of death is primarily triggered by the synergy between metabolic dysfunction and innate immune activation. Its mechanism involves the mTORC2 signaling pathway mediating prolonged abnormal contact between damaged mitochondria and the plasma membrane. This leads to massive local release of reactive oxygen species (ROS), which further induces lipid peroxidation of the plasma membrane, ultimately resulting in the physical rupture and death of the cell. The most significant distinction between mitoxyperilysis and classical cell death pathways lies in its independence from caspases and GSDMD. This comment aims to systematically elucidate the process, molecular mechanisms, and differences from other classical cell death pathways of mitoxyperilysis, while also exploring its potential for clinical translation in oncological diseases. Targeting induction of mitoxyperilysis may enhance the efficacy of existing anti-tumor drugs and overcome chemotherapy resistance. However, intervention protocols require further optimization to achieve an optimal balance between safety and therapeutic effectiveness in clinical application.]]></description>
<pubDate>2026/3/4 14:24:32</pubDate>
<category><![CDATA[动态与评论]]></category>
<author><![CDATA[CHEN Lin-Xi,CHEN Zhe,LI Xin,WANG Yi]]></author>
</item>
<item>
<title><![CDATA[Strategies of HIV-1 Vaccines Based on mRNA Platforms]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202511170000002]]></link>
<description><![CDATA[Since its emergence in the 1980s, the human immunodeficiency virus (HIV) has caused a global pandemic, posing a severe threat to human life and health as well as social development. Although pre-exposure prophylaxis (PrEP) effectively curbs HIV transmission and antiretroviral therapy (ART) significantly extends the lifespan of patients, vaccines remain a pivotal tool for blocking transmission and ending the pandemic. The high genetic variability of HIV-1, the glycan shield of its envelope glycoproteins, and the long-term persistence of latent reservoirs have repeatedly led to bottlenecks in traditional vaccine strategies. In recent years, mRNA technology has offered a novel approach to addressing these challenges, leveraging advantages such as sequence programmability, short production cycles, native conformational expression of antigens, and self-adjuvant effects. In recent years, mRNA vaccine technology has emerged as a transformative solution to longstanding vaccinology challenges, characterized by its sequence programmability, rapid production cycles, native conformational antigen expression, and intrinsic self-adjuvanting properties. Unlike traditional platforms reliant on pathogen culture or recombinant proteins, mRNA vaccines can be expeditiously designed and updated based solely on viral genomic sequences. Lipid nanoparticle (LNP)-encapsulated mRNA facilitates endogenous antigen expression and presentation, simultaneously eliciting potent humoral and cellular immune responses. Within this landscape, self-amplifying mRNA (saRNA) further extends <i>in vivo</i> antigen expression to enhance the persistence of immune responses. Moreover, the LNP delivery system not only protects mRNA from degradation and mediates endosomal escape but also synergizes with mRNA to optimize immune activation <i>via</i> self-adjuvant effects. Importantly, mRNA platforms circumvent the pre-existing immunity associated with viral vectors and the genomic integration risks of DNA vaccines, positioning them as a cornerstone for global pandemic preparedness. This review systematically delineates recent advances in mRNA technology for HIV-1 vaccine development, focusing on four pivotal research frontiers. First, mRNA innovations building upon the RV144 trial optimize antigens through codon modification and multivalent designs to induce more durable and broad-spectrum immunity. Second, particulate mRNA vaccine strategies, utilizing virus-like particles (VLPs) and ferritin nanoparticles, achieve <i>in situ</i> antigen self-assembly, significantly enhancing B cell activation and reducing infection risks in non-human primate models. Third, germline-targeting mRNA vaccines address the low-affinity barrier of broadly neutralizing antibody (bNAp) precursors, efficiently activating rare precursor B cells and promoting affinity maturation. Fourth, therapeutic mRNA vaccines offer unique advantages for an HIV functional cure; combining immunogens with mRNA-encoded adjuvants potentiates cellular immunity, while LNP-mediated “shock-and-kill” strategies specifically activate latent reservoirs to guide immune clearance. Comparative analyses with traditional platforms reveal that mRNA technology redefines antigen production and presentation, simulating chronic infection through sustained expression and enabling dual-pathway presentation <i>via</i> endogenous synthesis. Furthermore, we explore the mechanistic innovations of mRNA vaccines in inducing bNAps: sustained <i>in vivo</i> production prolongs the activation window for precursor B cells and maintains germinal center (GC) reactions; endogenously expressed antigens adopt native conformations to expose conserved epitopes; and self-adjuvanting effects modulate the functions of antigen-presenting cells (APCs) and follicular helper T cells (Tfh), driving somatic hypermutation and affinity maturation. We also address critical clinical translation challenges, including immune durability, adaptability to special populations, and large-scale LNP manufacturing, while proposing targeted optimization strategies. In conclusion, this review establishes a theoretical framework for utilizing mRNA technology to overcome HIV-1 immune escape, transitioning from a descriptive paradigm to a problem-solving-based synthesis of evidence. By integrating preclinical and early clinical data, we bridge the gap between basic design and translational verification. mRNA technology is poised to become a central pillar in HIV-1 prevention and therapy, providing a robust toolset to achieve the global goal of ending the AIDS pandemic and offering a blueprint for vaccine development against other recalcitrant infectious diseases.]]></description>
<pubDate>2026/3/4 10:16:09</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Xin-Xin,FANG Zhong-Yue,GU Ying,LI Shao-Wei,LIU Pei]]></author>
</item>
<item>
<title><![CDATA[Skeleton Binding Protein 1 of <i>Plasmodium berghei </i>Influences Deformability and Cytoskeletal Ultrastructure of Infected Erythrocyte]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601060000003]]></link>
<description><![CDATA[<b>Objective</b> The malaria parasites remodel the host erythrocyte structure by exporting parasite proteins that interact with the membrane skeleton proteins of red blood cells (RBCs), facilitating their intracellular survival and pathogenicity. Skeleton-binding protein 1 (SBP1) is a conserved exported protein across <i>Plasmodium</i> species. In <i>Plasmodium falciparum</i>, SBP1 has been reported to interact with erythrocyte membrane skeleton proteins 4.1R and spectrin, while its contribution to erythrocyte remodeling and parasite virulence in <i>Plasmodium berghei </i>(<i>Pb</i>) remains unclear. This study aims to determine whether <i>Pb</i>SBP1 associates with the host cytoskeletal protein 4.1R and to investigate its role in the remodeling of host RBCs and the pathogenicity of<i> Plasmodium berghei</i>.<b>Methods</b> In <i>Plasmodium berghei</i>, the relationship between <i>Pb</i>SBP1 and the erythrocyte cytoskeletal protein 4.1R was examined using co-immunoprecipitation. A <i>Pbsbp1</i> gene knockout mutant of <i>Plasmodium berghei</i> (<i>Pbsbp1</i>?) was generated based on the principle of double crossover homologous recombination. The deformability of erythrocytes infected with <i>Pbsbp1</i>? parasites was assessed using microfluidic methods. Microchannels with an array of cylindrical pillars were used to detect modifications in infected RBC deformability. The infected RBCs were squashed between the rows and recovered between the columns and the transit velocity (μm/s) of infected RBCs travelling through the microchannel was recorded. The component of the erythrocyte membrane skeleton junctional complex, tropomodulin (TMOD), was fluorescently labeled, and the cytoskeletal network of infected erythrocytes was imaged using super-resolution stochastic optical reconstruction microscopy (STORM) to analyze ultrastructural changes in the cytoskeleton of wild-type (WT) and <i>Pbsbp1</i>?-infected erythrocytes. Actin-based junctional complexes were displayed as individual clusters by the labeled TMOD in the STORM images, and the cluster densities and distances between adjacent clusters of infected RBCs were calculated. Additionally, rodent malaria models (BALB/c mice) and experimental cerebral malaria models (C57BL/6 mice) were employed to monitor the growth of <i>Pbsbp1</i>? and WT parasites during the intraerythrocytic stage and their capacity to induce cerebral malaria in mice.<b>Results</b> <i>Pb</i>SBP1 may participate in the remodeling of infected erythrocytes through direct or indirect interaction with the erythrocyte cytoskeletal protein 4.1R. Microfluidic assays revealed that the deformability of erythrocytes infected with <i>Pbsbp1</i>? parasites was significantly enhanced compared to those infected with WT parasites. STORM imaging further demonstrated that the ultrastructure of the erythrocyte cytoskeleton in <i>Pbsbp1</i>?-infected cells was altered relative to that in WT-infected erythrocytes. The distances between nearest neighbors of clusters had a tendency to increase while the cluster densities were decreased in <i>Pbsbp1</i>?-infected RBCs compared to WT-infected RBCs. Subsequent phenotypic analysis indicated that the growth rate of <i>Pbsbp1</i>? parasites during the intraerythrocytic stage was significantly slower than that of WT parasites, and their ability to induce cerebral malaria in mice was also attenuated. These findings suggest that <i>Pb</i>SBP1 is involved in the remodeling of the erythrocyte membrane skeleton, likely through its direct or indirect interaction with protein 4.1R, thereby regulating the deformability of infected erythrocytes and influencing the pathogenicity of the blood-stage parasites.<b>Conclusion</b> This study establishes a role for <i>Pb</i>SBP1 in host erythrocyte remodeling and parasite virulence, providing new research strategies for the prevention and treatment of malaria.]]></description>
<pubDate>2026/3/1 21:36:43</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[GUO Xin-Yue,JIANG Ru-Meng,LI Yao-Xian,PAN Lei-Ting,SHI Xiao-Yu,WANG Qian,ZHAO Huan-Qi,ZHONG Yan-Xuan]]></author>
</item>
<item>
<title><![CDATA[The Role of Mitochondrial Unfolded Protein Response in Neurodegenerative Diseases]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202509110000001]]></link>
<description><![CDATA[As the core hub of energy metabolism in eukaryotes, mitochondria participate in a variety of cellular activities, including metabolic regulation of the cell matrix, apoptosis, and the activation of signal transduction pathways. Their functional status is closely linked to the initiation and progression of various diseases. Neurodegenerative diseases are primarily characterized by the progressive loss and dysfunction of neurons, and mitochondrial dysfunction is considered one of the key triggers in this process. The specific mechanisms by which mitochondrial dysfunction contributes to neurodegenerative diseases have attracted widespread attention. When misfolded or unfolded proteins are detected, a process known as the mitochondrial unfolded protein response (mtUPR) is activated to promote proper protein folding or degradation, thereby restoring mitochondrial function. As a mitochondrial stress defense mechanism, mtUPR primarily regulates the expression of nuclear-encoded genes, such as chaperones and proteases, to alleviate mitochondrial stress. Studies have shown that, in addition to misfolded and unfolded proteins, other mitochondrial stresses—such as mitochondrial DNA abnormalities and reactive oxygen species (ROS)—can also induce mtUPR. The biological functions of mtUPR extend beyond mitochondria and are crucial for the health of the entire cell and even the whole organism. The mtUPR process involves communication between mitochondria and the nucleus, a phenomenon that is highly conserved and has been observed across different species. Abnormal activation or inhibition of mtUPR is closely associated with the development of various neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease. An in-depth exploration of the dynamic regulatory role and molecular mechanisms of mtUPR is therefore of great significance for understanding the pathogenesis of these disorders. In addition to neuron loss, neurodegenerative diseases are characterized by the accumulation of misfolded proteins in the brain, including insoluble fibrils of amyloid beta, phosphorylated tau, or α-synuclein. While the molecular pathways of mtUPR are largely conserved across different diseases, the possibility of differential regulatory factors cannot be excluded. Although mtUPR activation is predominantly recognized for its cytoprotective role, it may exert deleterious effects when overstimulated or sustained. Chronic mtUPR activity has been linked to mitochondrial dysfunction and increased neuronal vulnerability, contributing to the pathogenesis of various neurodegenerative diseases. This review summarizes the fundamental concepts, major inducers, and signaling pathways of the mtUPR. We focus on the intrinsic relationship and regulatory patterns between mtUPR and neurodegenerative diseases, providing insights that may aid the development of targeted therapies. Finally, we discuss the challenges and future directions of mtUPR research in this field, aiming to pave the way for new therapeutic breakthroughs. A major limitation arises from the experimental models currently used; most findings rely on model organisms or cultured cells, which cannot fully replicate the complexity of human neurons. Future research should therefore focus on three main directions: (1) defining the molecular switches that determine whether mtUPR acts in a protective or detrimental manner; (2) elucidating differences in mtUPR molecular pathways across various models of neurodegenerative diseases; and (3) establishing robust biomarkers for mtUPR activity.]]></description>
<pubDate>2026/3/1 21:28:47</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LI Yang,WANG Ke,ZHAO Di]]></author>
</item>
<item>
<title><![CDATA[Regulatory Mechanism of Extracellular Vesicles in The Tumor Immune Microenvironment and Its Application in Diagnosis and Treatment]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202511130000001]]></link>
<description><![CDATA[Extracellular vesicles (EVs) are pivotal mediators of intercellular communication within the tumor immune microenvironment (TME). They are broadly categorized into exosomes, microvesicles, and apoptotic bodies based on their distinct biogenesis pathways. Exosomes originate from the endosomal system <i>via</i> multivesicular body fusion, microvesicles bud directly from the plasma membrane, and apoptotic bodies are released during programmed cell death. By shuttling diverse bioactive cargoes—including proteins, lipids, and nucleic acids such as mRNA, miRNA, and DNA—EVs exert dual modulatory effects on tumor initiation, progression, and immune evasion. Importantly, EVs exhibit remarkable compositional heterogeneity that is intrinsically linked to their cellular origin. Tumor-derived EVs (TDEVs) are typically enriched with immunosuppressive molecules like PD-L1, TGF-β, and miR-21, which promote tumor immune escape and metastasis. In contrast, EVs derived from immune cells, such as dendritic cells or cytotoxic T lymphocytes, often carry immunostimulatory components including antigens, co-stimulatory molecules, and granzymes, thereby potentiating anti-tumor immunity. This review systematically delineates the biogenesis and molecular composition of EVs, with a particular emphasis on their dynamic regulatory functions within the TME. Specifically, we discuss how EVs mediate intricate crosstalk between immune and tumor cells, facilitating signal transfer that reshapes immune surveillance. For instance, TDEVs can induce macrophage polarization toward an M2-like pro-tumor phenotype, while also suppressing natural killer cell cytotoxicity and dendritic cell maturation. The clinical utility of EV-associated biomarkers in liquid biopsy is increasingly recognized. Circulating EVs carry tumor-specific molecular signatures that mirror the genetic and proteomic alterations of primary tumors, enabling non-invasive early diagnosis, molecular subtyping, and real-time monitoring of therapeutic responses. Their natural biocompatibility, low immunogenicity, and intrinsic ability to traverse biological barriers make them ideal candidates for drug delivery systems. This review explores cutting-edge applications, including the use of EVs in immune checkpoint blockade therapy—for instance, engineered EVs displaying anti-PD-1 antibodies or carrying siRNA to silence immunosuppressive genes. Moreover, EV-based tumor vaccines are being developed, leveraging dendritic cell-derived EVs loaded with tumor antigens to elicit potent T cell responses. The feasibility of loading EVs with therapeutic molecules such as chemotherapeutic agents, oncolytic viruses, or CRISPR-Cas9 components is also under active investigation. The advent of engineered EVs has further expanded their therapeutic potential. Through surface modification or cargo encapsulation, EVs can be tailored for targeted delivery and controlled release, enhancing precision immunotherapy. However, several hurdles impede clinical translation. Current isolation and purification methods, such as ultracentrifugation and size-exclusion chromatography, suffer from low yield and purity. Distinguishing EV subpopulations remains technically challenging due to overlapping size and marker expression. Moreover, the lack of standardized protocols for EV production, characterization, and quality control poses significant barriers to regulatory approval and clinical adoption. Looking forward, the convergence of multi-omics technologies with artificial intelligence offers a powerful approach to decipher EV heterogeneity and identify robust diagnostic signatures. Machine learning algorithms can integrate proteomic, transcriptomic, and lipidomic data from large patient cohorts to construct predictive models for cancer diagnosis and prognosis. Concurrently, advances in bioengineering are enabling the design of next-generation EVs with enhanced targeting specificity, on-demand drug release, and reduced off-target effects. Future efforts should also focus on establishing good manufacturing practice (GMP)-compliant production processes and conducting rigorous preclinical and clinical evaluations. In summary, this review provides a comprehensive overview of EV biology, their multifaceted roles in the TME, and their transformative potential in cancer diagnostics and therapeutics. By addressing current challenges and leveraging emerging technologies, EV-based strategies are poised to revolutionize precision oncology.]]></description>
<pubDate>2026/2/28 22:22:53</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HUANG Yuan-Yu,LU Mei,WANG Jing,WANG Zi-Qi]]></author>
</item>
<item>
<title><![CDATA[Three-dimensional Electrical Impedance Tomography for Monitoring Gastric Hemorrhage]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202511240000002]]></link>
<description><![CDATA[<b>Objective</b> Gastric hemorrhage is one of the most common and life-threatening emergencies of the upper digestive tract. Early identification and continuous monitoring are essential for reducing rebleeding rates and mortality, particularly within the critical early hours after onset. Although endoscopy and radiological imaging can accurately localize bleeding sites, these approaches are invasive, resource-intensive, and unsuitable for continuous bedside monitoring. Electrical impedance tomography (EIT), as a noninvasive and radiation-free functional imaging technique, offers real-time visualization of conductivity distribution and has the potential for detecting intragastric bleeding based on the electrical contrast between blood and surrounding gastric tissues. In this study, a three-dimensional gastric EIT (3D-gEIT) framework is proposed to achieve noninvasive, real-time, and dynamic monitoring of gastric hemorrhage, with emphasis on spatial localization and quantitative volume assessment.<b>Methods</b> A three-dimensional upper-abdominal simulation model incorporating the stomach, gastric wall, gastric contents, and surrounding tissues was established. Three electrode configurations, namely the dual layer ring, the four layer staggered ring, and the opposed dual plane array, were designed and systematically compared to evaluate their influence on depth sensitivity and spatial resolution. Based on the Tikhonov-Noser hybrid regularization scheme, a region-clustering constraint was introduced to develop the TK-Noser-RCC algorithm. This approach aggregates spatially adjacent elements with similar conductivity variations, thereby enhancing structural continuity and suppressing isolated noise artifacts. To validate the proposed framework, an upper-abdominal physical phantom was constructed using agar to simulate background tissue conductivity. Hemispherical high-conductivity inclusions with volumes ranging from 10 ml to 50 ml were attached to the inner gastric wall to mimic localized bleeding under different gastric filling states. Boundary voltages were acquired under a 120 kHz excitation current and reconstructed using the TK-Noser-RCC algorithm. Furthermore, an<i> in vivo </i>animal experiment was performed using a porcine model with adult-scale abdominal dimensions. A total of 100 ml of autologous blood was injected incrementally into the stomach to simulate progressive gastric hemorrhage, and time-difference EIT reconstruction was conducted at each injection stage to assess the dynamic system response under physiological conditions.<b>Results</b> Simulation results demonstrated that the opposed dual-plane electrode array achieved superior depth sensitivity distribution and spatial resolution. For a 40 ml hemorrhage model, the average <i>ICC</i> and <i>SSIM</i> improved by 55.9% and 38.8% compared with the dual-layer ring configuration, and by 64.0% and 39.5% compared with the four-layer staggered configuration. The proposed region-clustering constraint significantly enhanced reconstruction stability. Under added Gaussian noise of 40 dB and 30 dB, <i>ICC </i>values remained approximately 0.85, indicating effective artifact suppression and preservation of boundary integrity. In physical phantom experiments, reconstructed hemorrhage volumes increased approximately linearly with the preset hemispherical volumes, and the reconstructed high-conductivity regions closely matched the actual bleeding locations. Both empty-stomach and full-stomach conditions were evaluated, demonstrating that the opposed dual-plane configuration maintained stable imaging performance across varying gastric contents. In the animal experiment, reconstructed low-impedance regions expanded progressively with increasing injected blood volume. The spatial localization of the hemorrhage remained stable throughout the procedure, and no significant artifacts were observed. Quantitative analysis showed that reconstructed volume and average conductivity variation exhibited an approximately linear growth trend with injected blood volume, confirming the sensitivity of the system to dynamic intragastric conductivity changes.<b>Conclusion</b> The proposed 3D-gEIT framework enables quantitative reconstruction of gastric hemorrhage volume and spatial distribution with improved depth sensitivity, structural continuity, and noise robustness compared with conventional EIT approaches. By integrating optimized electrode configuration and a region-clustering-constrained reconstruction algorithm, the system provides stable dynamic monitoring under both controlled phantom conditions and <i>in vivo</i> physiological environments. This method offers a noninvasive, real-time, and low-cost imaging strategy for early diagnosis, postoperative monitoring, and bedside surveillance of gastric bleeding.]]></description>
<pubDate>2026/2/26 8:24:40</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[HUANG Jing-Shi,LI Nan,LI Zhi-Wei,SUN Bo,WU Yang,YAO Jia-Feng,ZHAO Tong,ZHAO Zi-Han]]></author>
</item>
<item>
<title><![CDATA[Compact Fundus Imaging System Using Shack-Hartmann Wavefront Sensing for High-speed Auto-focus]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202511050000003]]></link>
<description><![CDATA[<b>Objective</b> The widespread adoption of portable fundus cameras for primary care and community screening is hindered by limitations in current autofocus(AF) technologies. Image-based methods relying on sharpness evaluation require iterative searches, resulting in slow convergence, while projection-based techniques are susceptible to optical artifacts and calibration errors. To address these challenges, this study introduces a novel AF system based on direct wavefront sensing, designed to deliver simultaneous high speed, high precision, and operational robustness within the compact form factor essential for portable ophthalmic devices.<b>Methods</b> Our approach fundamentally reimagines the AF process by directly measuring the ocular wavefront aberration. We developed a custom portable fundus camera integrating a miniaturized Shack-Hartmann wavefront sensor (SHWS) into the optical path. An 850 nm laser diode projects a point source onto the retina <i>via</i> oblique illumination to minimize corneal reflections. Light scattered from this spot carries the eye’s refractive error through the imaging optics and is directed to the SHWS, positioned at a plane optically conjugate to the primary color CMOS imaging sensor. A microlens array within the SHWS samples the incident wavefront, generating a pattern of focal spots on a CCD. Real-time centroid analysis of these spots provides a map of local wavefront slopes. These measurements are processed through a singular value decomposition (SVD) algorithm to fit a Zernike polynomial basis set, enabling real-time reconstruction of the wavefront phase. The defocus component (<i>S</i>) is extracted from the second-order Zernike coefficients, providing a direct, quantitative measure of the refractive error in diopters. This value serves as a precise error signal in a closed-loop control system, which commands a voice-coil actuated focusing lens to its null position in a single, deterministic step, eliminating the need for iterative search algorithms.<b>Results</b> Comprehensive evaluation demonstrated the system’s high performance. Testing on a calibrated model eye (OEMI-7) established a highly linear relationship between the computed defocus <i>S</i> and the focusing lens position across a ±20 Diopter (D) compensation range, achievable within a 5 mm mechanical travel. The system achieved a focusing precision of 0.08 D, corresponding to an 18-fold improvement over a conventional projection spot-size method tested under identical conditions. The total focus acquisition time, encompassing wavefront measurement, computation, and lens actuation, averaged under 0.5 s. Clinical validation with 25 human volunteers (50 eyes, refractive range -15 D to +10 D) confirmed practical efficacy. The wavefront-sensing AF succeeded in 92% of attempts with a mean time of 0.5 s, substantially outperforming a projection-based benchmark which achieved only a 32% success rate with an average time of 4.25 s. The system provided instantaneous directional guidance and maintained stability during minor ocular movements. Objective assessment of image quality, <i>via</i> amplitude contrast of retinal vasculature, showed consistent and significant enhancement following AF correction across the entire tested diopter range.<b>Conclusion</b> This work successfully implements and validates a direct wavefront-sensing autofocus paradigm for portable fundus cameras. By directly quantifying and compensating for the optical defocus aberration, this method bypasses the fundamental limitations of image-processing and projection-based techniques, enabling rapid, precise, and deterministic diopter compensation. The developed system delivers an exceptional combination of a wide operational range (±20 D), high accuracy (0.08 D), fast convergence (0.5 s), and a compact physical footprint. This technology provides a practical and high-performance focusing solution capable of enhancing the reliability, throughput, and diagnostic utility of portable retinal imaging in large-scale screening applications. Future efforts will be directed towards system cost optimization and performance adaptation for diverse ocular conditions.]]></description>
<pubDate>2026/2/11 8:55:38</pubDate>
<category><![CDATA[技术与方法]]></category>
<author><![CDATA[CHEN Long,DING Wen-Zheng,DONG Jia-Xin,HAN Ding-An,HUANG Jin-Tian,LIN Zhe-Kai,WANG Xue-Hua,YANG Shang-Pan,ZENG Ya-Guang,ZHENG Geng-Yong]]></author>
</item>
<item>
<title><![CDATA[Fibroblast Growth Factors in Parkinson’s Disease: Multi-target Neuroprotective Mechanisms Involving Neuroinflammation, Cellular Stress, and Ferroptosis]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202512280000002]]></link>
<description><![CDATA[Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the selective loss of dopaminergic neurons in the substantia nigra pars compacta and the pathological accumulation of α-synuclein. Although extensive progress has been made in elucidating its pathogenesis, current therapeutic approaches remain largely symptomatic, and effective disease-modifying treatments are still unavailable. Increasing evidence indicates that PD is driven by the interaction of multiple pathological processes, including neuroinflammation, iron homeostasis dysregulation and ferroptosis, endoplasmic reticulum (ER) stress, mitochondrial dysfunction, oxidative stress, and impaired protein homeostasis, which together contribute to neuronal vulnerability and degeneration. Fibroblast growth factors (FGFs) comprise a family of 22 ligands that play important roles in neural development, stress responses, metabolic regulation, and the maintenance of nervous system homeostasis. Recent studies have shown that several FGF family members, such as FGF1, FGF2, FGF9, and FGF21, exert neuroprotective effects in cellular and animal models of PD. These effects include the regulation of inflammatory responses, oxidative stress, iron homeostasis, cellular stress adaptation, and neuronal survival. Compared with therapeutic strategies targeting a single pathogenic pathway, FGFs appear to influence multiple disease-related processes, suggesting their potential relevance to the complex pathophysiology of PD. Experimental evidence indicates that altered FGF signaling may contribute to dopaminergic neuron dysfunction through the coordinated regulation of several interconnected mechanisms. FGFs have been reported to modulate neuroinflammation by affecting the activation of microglia and astrocytes, thereby influencing the inflammatory environment in the central nervous system. In addition, FGFs are involved in the regulation of iron homeostasis and ferroptosis, partly through antioxidant signaling pathways associated with NRF2, SLC7A11, and GPX4. Moreover, FGFs can alleviate ER stress and mitochondrial dysfunction by activating intracellular signaling pathways such as PI3K/AKT, AMPK-PGC-1α, as well as SIRT1-dependent programs, which support cellular energy metabolism and redox balance. Recent advances in single-cell and spatial transcriptomic studies further suggest that FGF signaling is not limited to neuron-intrinsic mechanisms but also involves interactions among different glial cell types. Altered FGF ligand-receptor communication between astrocytes and oligodendrocytes has been observed in PD models and is associated with increased susceptibility of dopaminergic neurons to oxidative stress and ferroptosis. These findings indicate that the biological effects of FGFs are influenced by cell type and disease stage and may vary under different pathological conditions. In this review, we summarize recent progress in understanding the roles of FGF family members in PD, with a focus on their involvement in iron homeostasis dysregulation and ferroptosis, neuroinflammation, cellular stress responses, and neuronal protection and regeneration. By integrating current evidence, this review aims to provide a clearer understanding of how FGFs participate in PD pathogenesis and to offer a theoretical basis for future studies exploring their potential value in disease-modifying therapeutic strategies.]]></description>
<pubDate>2026/2/11 8:54:31</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HAN Teng-Teng,TIAN Xue-Wen,WANG Hui,YANG Chang-Zhi,ZHOU Zi-Gui]]></author>
</item>
<item>
<title><![CDATA[His-ADPR: Revealing The Chemical Milestones of Immune Signal Evolution]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601020000001]]></link>
<description><![CDATA[The evolutionary arms race between life and pathogens drives diversification in immune system signaling mechanisms. Recent research has found that the TIR protein of the bacterial type II Thoeris defense system can produce a novel “hybrid” immune signaling molecule—histidine-ADP-ribose (His-ADPR). This molecule, formed by the direct linkage of an amino acid and a nucleotide, challenges the traditional view that TIR enzymes generate only pure nucleotide derivatives. This signal is specifically recognized by the Macro domain of an effector protein, triggering the transmembrane domain to disrupt the membrane for defense. The study further reveals that phages can evade immunity by expressing “signal sponge” proteins that bind and sequester His-ADPR. This offensive-defensive pressure drives TIR enzymes to continuously expand their “chemical arsenal” of signaling molecules. The discovery not only confirms the shared biochemical core of bacterial TIR signaling molecules (based on NAD<sup>+</sup> modification), but also highlights their remarkable chemical plasticity and evolutionary innovative capacity. It provides a new perspective for understanding the origin and diversity of immune signaling.]]></description>
<pubDate>2026/2/10 17:19:05</pubDate>
<category><![CDATA[动态与评论]]></category>
<author><![CDATA[CHENG Rui,LU Qiang]]></author>
</item>
<item>
<title><![CDATA[A Method for Position Correction of Ultrasonic Arrays Used in High-resolution Photoacoustic Tomography]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202512020000002]]></link>
<description><![CDATA[<b>Objective</b> Photoacoustic tomography (PAT) holds significant potential for high-resolution deep-tissue imaging. In preclinical research, custom-designed concave arc-shaped ultrasound transducer arrays are often used to maximize the detection aperture. However, manufacturing limitations and assembly tolerances frequently cause the actual physical positions of array elements to deviate from their theoretical design. Additionally, concave arrays are typically covered with an acoustic lens, which introduces a mismatch in the speed of sound between the coupling medium and the lens material. The combination of these geometric and acoustic-phase errors leads to severe image artifacts, reduced contrast, and degraded resolution. This study proposes a systematic two-step calibration strategy to address these issues and substantially improve image quality.<b>Methods</b> First, a high-intensity isotropic photoacoustic point source was constructed using a multi-mode optical fiber coated with carbon nanotubes (CNTs) to acquire high signal-to-noise ratio calibration data. The Akaike information criterion (AIC) was employed to accurately determine the time of arrival (ToA) of photoacoustic signals. Subsequently, a geometric calibration algorithm based on nonlinear least-squares (NLS) estimation was developed. This algorithm iteratively solves for the true spatial coordinates of each array element by minimizing the residual between theoretical and measured acoustic path lengths. To further address sound-speed inhomogeneity caused by the acoustic lens, a phase compensation algorithm based on bilinear interpolation was proposed. This algorithm computes a pixel-specific phase delay map across the imaging region and performs point-by-point signal correction during delay-and-sum (DAS) reconstruction. The proposed methods were validated using a custom 96-channel concave arc-shaped array (center frequency: 12 MHz) through both phantom imaging and <i>in vivo</i> mouse tumor models.<b>Results</b> Phantom experiments showed that at an imaging depth of 14 mm, the reconstruction position deviation of the point source in the uncalibrated system reached up to 1 mm. After applying the combined calibration, the lateral resolution (full width at half maximum, <i>FWHM</i>) at the focal point of the arc array reached 95 μm—representing a 85% reduction compared to the uncalibrated state and a 79% reduction compared to geometric calibration alone without phase compensation. <i>In vivo</i> experiments demonstrated that the calibrated system clearly resolved the microvascular network of subcutaneous tumors in mice. Photoacoustic signals were strictly confined within tumor boundaries delineated by ultrasound imaging (USI), eliminating the vascular spillover artifacts commonly observed in uncalibrated images. Furthermore, after intravenous injection of indocyanine green (ICG), the system successfully detected weak photoacoustic signals at a depth of 5 mm, performing significantly better than the uncalibrated system.<b>Conclusion</b> The proposed calibration method, which integrates nonlinear least-squares estimation with phase compensation, significantly improves image fidelity and spatial resolution consistency across a wide field of view by correcting systemic geometric errors and acoustic phase aberrations. This approach demonstrates high robustness and provides a reliable technical foundation for the clinical translation of photoacoustic probes with non-standard geometries.]]></description>
<pubDate>2026/2/10 11:03:13</pubDate>
<category><![CDATA[技术与方法]]></category>
<author><![CDATA[HUANG Xing,PENG Kuan,TANG Yang,ZHANG Zhan-Jun]]></author>
</item>
<item>
<title><![CDATA[Research and Outlook on The Application of Radar-based Non-contact Health Monitoring Technology]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202509110000002]]></link>
<description><![CDATA[Radar-based non-contact health monitoring technology (RBNHMT) has emerged as a transformative paradigm in continuous health sensing, enabling non-invasive and continuous monitoring of physiological parameters and behavioral patterns by transmitting electromagnetic waves, analyzing the reflected signals, and detecting subtle bodily movements—ranging from millimeter-scale chest wall displacements due to respiration to micro-scale vibrations associated with cardiac activity—ultimately transforming them into quantifiable health data. Distinguished by its non-contact operation, inherent privacy preservation, and adaptability to diverse scenarios, RBNHMT exhibits stronger resistance to environmental interference than conventional contact-based monitoring, and has solidified its position as a prominent and dynamic research focus in the field of non-contact health monitoring. Currently, significant and multifaceted progress has been made across several key areas. In human activity recognition (HAR), systems leveraging micro-Doppler signatures or point cloud sequences achieve high-precision detection of gait, gestures, and fall events, with state-of-the-art deep learning-based models achieving accuracy rates exceeding 99% in controlled experimental settings. For vital sign and sleep monitoring, it not only tracks respiratory and heart rates continuously but also extracts clinically relevant metrics such as heart rate variability (HRV) for autonomic nervous system assessment and estimates blood pressure through indirect methods like pulse transit time analysis, while maintaining robustness in dynamic settings through advanced motion compensation algorithms. In sleep monitoring, it further enables sleep posture classification and apnea event detection. In emotion and stress recognition, it provides a non-intrusive approach for psychological assessment by analyzing autonomic-response physiological signal patterns or behavioral features. Furthermore, its applications in auxiliary medical diagnosis have expanded to promising interdisciplinary areas such as non-contact heart sound auscultation, radar-based screening for obstructive sleep apnea (OSA), and emerging research into breast cancer detection using microwave and millimeter-wave imaging techniques. However, several challenges impede its practical deployment. Signal quality is significantly compromised by multipath interference in complex indoor environments and clutter from static objects, and by motion artifacts in dynamic scenarios where gross body movements obscure the subtle physiological signals. Algorithmically, separating signals from multiple targets in close proximity and calibrating for substantial individual physiological differences, such as body habitus, baseline vital signs, remain difficult and limit generalizability. Hardware design also faces the challenge of balancing power consumption, cost, integration, and performance, often requiring trade-offs that constrain miniaturization, battery life, or measurement sensitivity. Future advancement, therefore, requires collaborative and targeted innovation across multiple dimensions. Algorithmically, developing adaptive signal processing models based on emerging paradigms such as few-shot learning (for user-specific calibration with minimal data) and reinforcement learning (for dynamic noise suppression) is essential. At the hardware level, highly integrated radar SoCs with embedded processing capabilities and advanced packaging technologies are crucial for achieving the dual goals of device miniaturization and cost reduction without sacrificing performance. At the system level, fusing radar data with complementary modalities such as infrared and acoustic sensing can create a synergistic, multi-modal framework that significantly enhances perceptual robustness and reliability in complex, real-world environments. This review provides a comprehensive synthesis that systematically summarizes the relevant theoretical foundations and application progress, and offers an in-depth analysis of the current technical bottlenecks. It aims to provide a clear development path and a foundational academic reference for the in-depth integration and practical application of RBNHMT in critical scenarios including rehabilitation engineering, smart elderly care, in-vehicle health monitoring, and beyond, thereby offering innovative technical support for the vision of universal, proactive, and personalized health management.]]></description>
<pubDate>2026/2/9 14:36:43</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[QIAN Shuai-Wei,ZHANG Qing,ZHONG Jia-Bin]]></author>
</item>
<item>
<title><![CDATA[Biomimetic Nanotechnology Integrating TargetedDelivery and Immune Regulation in Stroke Therapy]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202602060000001]]></link>
<description><![CDATA[Biomimetic Nanotechnology Integrating TargetedDelivery and Immune Regulation in Stroke Therapy]]></description>
<pubDate>2026/2/9 10:56:37</pubDate>
<category><![CDATA[Highlights]]></category>
<author><![CDATA[LIU Yang]]></author>
</item>
<item>
<title><![CDATA[​ Exploration and Practice of a Generative AI-assisted Four-dimensional Integration Platform of “Teaching, Learning, Evaluation, and Research” for The Biochemistry and Molecular Biology Courses]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202511030000002]]></link>
<description><![CDATA[<b>Objective</b> Biochemistry and Molecular Biology, a discipline that elucidates life phenomena at the molecular level, serves as a core foundational course in medical education. It provides the theoretical basis for studying other basic and clinical medical subjects, as well as for understanding pathogenesis, disease diagnosis, and treatment. However, its complex content and highly abstract concepts have posed a dual challenge to traditional teaching models: “inefficient instruction” and “inadequate learning outcomes”. Within limited classroom hours, how to engage students and stimulate their intrinsic motivation, and how to help them recognize, understand, and develop a passion for biochemistry from the perspective of the discipline’s essence, have long been key focuses of curriculum research.<b>Methods</b> Using the lipid metabolism chapter as an example, this study employs “Rain Classroom”, a generative artificial intelligence (AI)-assisted platform, to support education in four dimensions: teaching, learning, evaluation, and research. In teaching, it assists instructors through virtual experiments, lesson preparation support, knowledge mapping, and assignment design. For learning, it serves as an intelligent study assistant for students, providing automated assignment review, enabling educational resource sharing, and facilitating personalized learning pathways. In evaluation, the platform automates assignment grading, analyzes student performance data, and offers diagnostic feedback and teaching recommendations. In research, it aids educators in collecting and analyzing teaching data, as well as searching for and summarizing relevant literature.<b>Results</b> The results indicate that an educational model integrating teacher-led instruction, student-centered learning, and generative AI assistance significantly enhances teaching quality, students’ self-directed learning abilities, and knowledge mastery. Furthermore, with the support of generative AI, curriculum-based ideological education—focusing on cutting-edge disciplinary advances and topical medical issues—helps cultivate students’ medical spirit of “honoring life and healing the wounded”, thereby fostering the establishment of appropriate professional values. Finally, while generative AI presents both opportunities and challenges for higher education, this study also analyzes potential risks in its teaching applications, emphasizing the need for both instructors and students to avoid over-reliance and to ensure that technological tools consistently serve the fundamental goals of education.<b>Conclusion</b> This study demonstrates that integrating generative AI, specifically <i>via</i> the “Rain Classroom” platform, can effectively enhance biochemistry education. By supporting teaching, learning, evaluation, and research, this approach improves both educational effectiveness and student outcomes. It also facilitates the incorporation of cutting-edge knowledge and professional ethics, nurturing a patient-centered mindset. Additionally, the study addresses potential implementation risks to ensure that such technological tools remain aligned with the core purpose of education.]]></description>
<pubDate>2026/2/9 7:23:36</pubDate>
<category><![CDATA[科教融合]]></category>
<author><![CDATA[CHEN Pan,CHEN Qiang,GUO Jun-Ming,JIN Xiao-Feng,SUN De-Sen,XI Yang]]></author>
</item>
<item>
<title><![CDATA[TGF-β1-engineered Biomimetic Platelet Nanoparticles for Targeted Therapy of Ischemic Stroke]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202512090000002]]></link>
<description><![CDATA[<b>Objective</b> Post-ischemic acute inflammation and the subsequent persistent dysregulation of the immune microenvironment represent major pathological drivers that aggravate neuronal injury and severely restrict functional recovery following ischemic stroke. Although current reperfusion therapies partially restore blood flow, they fail to effectively modulate the secondary inflammatory cascade and oxidative stress, which remain critical barriers to neurological restoration. To address this challenge, this study aimed to engineer and systematically evaluate a biomimetic nanosystem composed of transforming growth factor-β1 (TGF-β1)-loaded platelet membrane-camouflaged lipid nanoparticles (PLP). This nanosystem was designed to achieve dual lesion-targeted delivery and immune microenvironment remodeling. By verifying its spatiotemporal accumulation, anti-inflammatory activity, and neuroprotective efficacy, we sought to establish an integrated therapeutic strategy that simultaneously enables lesion targeting, immune regulation, and functional recovery after ischemic injury.<b>Methods</b> The physicochemical properties of PLP, including hydrodynamic particle size, zeta potential, structural stability, and morphology, were characterized using dynamic light scattering, zeta potential analysis, and transmission electron microscopy. The preservation of platelet membrane-derived adhesion and immunoregulatory proteins was confirmed by SDS-PAGE through comparative analysis of protein band profiles between PLP and native platelet membranes. The <i>in vitro</i> biological activities of PLP were evaluated using two complementary cellular models. LPS-induced M1-polarized RAW264.7 macrophages were employed to assess inflammatory modulation, while oxygen glucose deprivation/reperfusion (OGD/R)-induced BV2 microglial cells and SH-SY5Y neuronal cells were utilized to investigate neuroinflammatory regulation and neuronal protection. For<i> in vivo </i>validation, a transient middle cerebral artery occlusion (tMCAO) mouse model was established to mimic ischemia-reperfusion injury. The spatiotemporal biodistribution and lesion-targeting capability of the PLP were monitored through live fluorescence imaging. Therapeutic efficacy was comprehensively evaluated by triphenyltetrazolium chloride (TTC) staining, glial fibrillary acidic protein (GFAP) immunofluorescence analysis, body weight monitoring, and neurological severity score (NSS) assessment.<b>Results</b> PLP nanoparticles displayed a uniform spherical morphology, nanoscale particle size distribution, and stable negative surface charge, indicating favorable colloidal stability and circulation potential. SDS-PAGE results confirmed the effective retention of key platelet membrane proteins associated with endothelial adhesion, immune evasion, and inflammatory regulation, demonstrating the successful biomimetic construction. Optimal therapeutic concentrations were determined in OGD/R-induced BV2 cells, where PLP exhibited excellent cytocompatibility and anti-inflammatory activity. <i>In vitro</i> experiments demonstrated that PLP significantly inhibited the polarization of RAW264.7 macrophages toward the pro-inflammatory M1 phenotype and markedly reduced neuronal apoptosis under ischemia-reperfusion conditions. <i>In vivo</i> fluorescence imaging revealed that PLP rapidly accumulated in the ischemic brain hemisphere and maintained prolonged retention for up to 7 d, suggesting enhanced lesion-specific targeting and sustained drug release. Compared with control group, PLP treatment significantly reduced cerebral infarct volume, attenuated reactive astrogliosis, improved weight recovery, and accelerated neurological functional restoration, as reflected by significantly improved NSS scores.<b>Conclusion</b> This study establishes a multifunctional biomimetic nanoplatform that integrates platelet membrane-mediated active targeting with the anti-inflammatory, antioxidative, and neuroprotective properties of TGF-β1. The PLP system enables rapid lesion homing and long-term retention while synergistically regulating the post-stroke inflammatory microenvironment by suppressing pro-inflammatory immune activation, reducing neuronal apoptosis, and limiting excessive astrocyte reactivity. Importantly, this study proposes a conceptually therapeutic paradigm that combines targeted delivery with immune microenvironment remodeling to achieve comprehensive neurovascular protection. These findings provide strong experimental evidence supporting the translational potential of biomimetic nanotherapeutics as next-generation precision interventions for ischemic stroke.]]></description>
<pubDate>2026/2/6 20:23:34</pubDate>
<category><![CDATA[研究快报]]></category>
<author><![CDATA[CAI Lin-Tao,CHEN Li-Qi,HUANG Guo-Jun,KANG Tian-Fang,MA Ai-Qing,PAN Hong,YIN Ting]]></author>
</item>
<item>
<title><![CDATA[Ionizing Radiation-induced Lens Injury: Epidemiology, Dose-effect Relationship, and Molecular Mechanisms]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202510090000001]]></link>
<description><![CDATA[The crystalline lens of the eye is recognized as one of the most radiosensitive tissues in the human body. While the International Commission on Radiological Protection (ICRP) has classified ionizing radiation (IR)-induced cataracts as a tissue reaction (deterministic effect) and subsequently reduced the occupational equivalent dose limit for the lens, significant uncertainties remain regarding the precise dose threshold and the complex biological pathways driving lens opacification. This review provides a comprehensive synthesis of current knowledge concerning radiation-induced lens damage, integrating epidemiological exposure characteristics with dose-response modeling and mechanistic molecular insights. First, we analyze exposure characteristics through four epidemiological dimensions: dose, time, space, and population. Clinical evidence suggests that radiation cataracts—particularly posterior subcapsular opacities—exhibit a distinct latency period that is inversely correlated with dose. We highlight that risk is not confined to acute high-dose scenarios (such as in atomic bomb survivors) but is increasingly relevant in chronic low-dose occupational settings (<i>e.g</i>., interventional radiology) and medical diagnostics (<i>e.g</i>., CT scans). Crucially, individual susceptibility is modified by genetic background, age, and environmental co-factors, complicating risk assessment. Second, we critically examine the dose-effect relationship. Although the ICRP suggests a threshold of 0.5 Gy, emerging data challenge the traditional threshold model, with some studies advocating for a linear non-threshold (LNT) relationship. We further discuss the critical roles of radiation quality and dose rate. High linear energy transfer (LET) radiation demonstrates a significantly higher relative biological effectiveness (RBE) for cataractogenesis compared to low-LET radiation. Paradoxically, and unlike many other tissues, the lens may exhibit an “inverse dose-rate effect,” where fractionated or protracted exposures potentially enhance biological damage—a finding that challenges classical radiobiological paradigms. Third, drawing upon the “cataractogenic load” hypothesis and the unique physiological constraints of the lens, this review elucidates the multidimensional molecular mechanisms driving radiation-induced opacification. Key mechanisms include four aspects. (1) DNA damage and repair: IR induces DNA double-strand breaks (DSBs) that, due to the lens’ limited repair capacity (modulated by genes such as ATM, Ptch1, and Ercc2), lead to the accumulation of damage. (2) Antioxidant defense system: dysfunction of the Nrf2/HO-1 antioxidant axis results in redox imbalances, triggering NF-κB-mediated inflammation and protein aggregation. (3) Cell proliferation and senescence: IR disrupts cell cycle regulation, causing a dichotomy of effects—driving premature senescence in some cell populations (evidenced by ATM nuclear foci) while inducing aberrant proliferation <i>via</i> growth factor upregulation (FGF2, TGFβ) in others. (4) Cell migration and adhesion: activation of the Wnt/β-catenin pathway and alterations in the E-cadherin complex promote the abnormal migration of epithelial cells to the posterior capsule, a hallmark of radiation-induced cataracts. In conclusion, radiation-induced cataractogenesis is a multifactorial process in which genetic susceptibility and environmental stressors converge to overwhelm the lens’ homeostatic thresholds. Future research must prioritize longitudinal cohort studies to refine dose thresholds and employ multi-omics approaches to map the crosstalk between DNA damage responses and matrix remodeling. Establishing a robust mechanistic model is essential for developing targeted radioprotective strategies and optimizing radiation protection standards for occupational and medical safety.]]></description>
<pubDate>2026/2/5 20:29:51</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HU Cheng-Hao,REN Shao-Han,ZHAN Jing-Ming,ZHANG Hai-Tao]]></author>
</item>
<item>
<title><![CDATA[The Structure and Function of The YopJ Family Effectors in The Bacterial Type III Secretion System]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202509030000003]]></link>
<description><![CDATA[The Type III Secretion System (T3SS) serves as a pivotal virulence apparatus for numerous Gram-negative bacterial pathogens, enabling them to infect both animal and plant hosts. Functioning as a molecular syringe, the T3SS directly translocates bacterial effector proteins from the bacterial cytoplasm into the interior of eukaryotic host cells. These effectors are central weapons that precisely manipulate a wide spectrum of host cellular physiological processes, ranging from cytoskeletal dynamics to immune signaling, to establish a favorable niche for bacterial survival and proliferation. Among the diverse arsenal of T3SS effectors, the YopJ family constitutes a critical group of virulence factors. Members of this family are characterized by a conserved catalytic triad structure—a hallmark of the CE clan of cysteine proteases that has been evolutionarily repurposed to confer acetyltransferase activity. A defining and intriguing feature of these enzymes is their stringent dependence on a host-derived eukaryotic cofactor, inositol hexakisphosphate (IP<sub>6</sub>), for allosteric activation. This requirement acts as a sophisticated molecular safeguard, ensuring enzymatic activity only within the appropriate host environment, thereby preventing detrimental effects on the bacterium itself. While seminal studies on individual members such as <i>Yersinia</i>’s YopJ and <i>Salmonella</i>’s AvrA have provided deep mechanistic insights, a systematic and integrative understanding of the structure-function relationships across the entire family remains fragmented. Key questions persist regarding how a conserved catalytic core has diverged to recognize distinct host substrates in different kingdoms of life. To address this gap, this article provides a systematic review of the YopJ family, focusing on three interconnected aspects: their structural features, their catalytic mechanism, and their divergent immunosuppressive strategies in animal versus plant hosts. By conducting a comparative analysis of the sequences and resolved three-dimensional structures of three representative members (<i>e.g</i>., HopZ1a, PopP2, AvrA), we elucidate regions of significant variation embedded within the conserved core catalytic architecture. These variable regions, often involving surface loops and substrate-binding interfaces, are crucial determinants of target specificity and functional specialization. The functional divergence of this effector family is most apparent when comparing their modes of action in different hosts. In animal hosts, YopJ-family effectors primarily sabotage innate immune signaling pathways. They achieve this by acetylating key serine and threonine residues within the activation loops of critical kinases in the MAPK and NF-κB pathways. This post-translational modification blocks the phosphorylation and subsequent activation of these kinases, leading to potent suppression of inflammatory cytokine production. Conversely, in plant hosts, the strategy broadens to dismantle the two-tiered plant immune system. YopJ homologs target a more diverse set of substrates, including immune-associated receptor-like cytoplasmic kinases (RLCKs), microtubule networks <i>via</i> tubulin acetylation (which disrupts cellular trafficking and signaling), and transcription factors central to defense gene regulation. This multi-target approach effectively suppresses both Pattern-Triggered Immunity (PTI) and Effector-Triggered Immunity (ETI). In conclusion, this synthesis aims to deepen the mechanistic understanding of YopJ family-mediated pathogenesis by integrating structural biology with cellular function across host kingdoms. Elucidating the precise molecular basis for substrate selection—how conserved platforms achieve target diversity—is a major frontier. Furthermore, this knowledge provides a vital theoretical foundation for developing novel anti-virulence strategies. Targeting the conserved IP<sub>6</sub>-binding pocket or the catalytic acetyltransferase activity itself represents a promising avenue for designing broad-spectrum inhibitors that could disarm this critical family of bacterial effectors, potentially offering new therapeutic approaches against a range of pathogenic bacteria.]]></description>
<pubDate>2026/2/4 21:05:53</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LI Ao-Ning,LI Wen-Bo,LU Yu-Ying,QIN Yu-Long,ZHANG Zhao-Huan,ZHAO Yong,ZHU Min-Hui]]></author>
</item>
<item>
<title><![CDATA[Establishment and Preliminary Analysis of GP73 Interactome Using Proximity-dependent Labeling Technology]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202509290000002]]></link>
<description><![CDATA[<b>Objective</b> Protein-protein interactions (PPIs) are fundamental to the execution of biological functions within living cells. However, traditional biochemical methods, such as co-immunoprecipitation (Co-IP), often fail to capture transient, weak, or membrane-associated interactions due to the stringent detergent requirements for cell lysis. Proximity labeling (PL) has emerged in recent years as a transformative technology for mapping the proteomes of specific subcellular compartments and identifying dynamic interactomes <i>in situ</i>. Golgi protein 73 (GP73, also known as GOLPH2), a resident type II Golgi transmembrane protein, is a well-recognized clinical biomarker for liver diseases, including hepatocellular carcinoma (HCC). Despite its clinical significance, the comprehensive physiological and pathological functions of GP73 remain partially understood. This study aims to establish an APEX2-mediated proximity labeling system specifically targeting GP73 to map its interactome in a living cellular environment, thereby providing new insights into its molecular roles and regulatory mechanisms.<b>Methods</b> To achieve spatial specificity, we first constructed a stable cell line expressing a fusion protein consisting of GP73 and the engineered soybean peroxidase APEX2. The localization of the GP73-APEX2 fusion protein was validated to ensure it correctly targeted the Golgi apparatus. The proximity labeling reaction was initiated by incubating the cells with biotin-phenol (BP) for 30 min, followed by a brief (1 min) treatment with 1 mmol/L hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>). This catalytic reaction converts BP into highly reactive, short-lived biotin-phenoxyl radicals that covalently attach to endogenous proteins within a small labeling radius of the GP73-APEX2 enzyme. Subsequently, the cells were quenched, and biotinylated proteins were enriched using high-affinity streptavidin-coated magnetic beads. The captured “neighbor” proteins were subjected to on-bead digestion and analyzed <i>via</i> liquid chromatography-tandem mass spectrometry (LC-MS/MS) for high-throughput identification. Rigorous bioinformatics analysis, including Gene Ontology (GO) enrichment, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and protein-protein interaction network mapping, was performed to interpret the biological significance of the identified candidates.<b>Results</b> Our results demonstrate the successful establishment of a robust and sensitive APEX2-based proximity labeling system for GP73. We identified a total of 95 high-confidence interacting proteins that were significantly enriched in the GP73 proximity proteome compared to control groups. Bioinformatics analysis revealed that these interactors were predominantly associated with biological processes such as vesicular transport, protein localization, and, most notably, molecular functions related to “ribosome binding” and “translation regulation”. This suggested an unexpected role for the Golgi-resident GP73 in the cellular translation machinery. To validate these findings, we performed targeted biochemical assays which confirmed a direct interaction between GP73 and the subunits of the eukaryotic translation initiation factor 3 (eIF3) complex, specifically EIF3G and EIF3I. Furthermore, functional validation using the surface sensing of translation (SUnSET) assay—a non-radioactive method to monitor protein synthesis—revealed that the overexpression of GP73 significantly promoted global protein translation levels in the cell, whereas its depletion or inhibition resulted in reduced translation efficiency.<b>Conclusion</b> This study successfully utilized APEX2-mediated proximity labeling to provide the first systematic map of GP73 interactome in living cells. Our findings uncover a novel, unconventional function of GP73 as a regulator of cellular protein translation, likely mediated through its interaction with the eIF3 complex. This discovery significantly broadens our understanding of the biological roles of GP73 beyond its traditional function in the Golgi apparatus and suggests that it may act as a bridge between Golgi-related trafficking and the protein synthesis machinery. Furthermore, the technical framework established in this study provides a valuable template for investigating other complex organelle-associated protein networks and resolving transient macromolecular interactions in various physiological and pathological contexts.]]></description>
<pubDate>2026/2/4 8:41:42</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[LIU Mu-Yi,WAN Lu-Ming,WEI Cong-Wen,YAN Xin-Long,YANG Meng-Xin,ZHANG Chang]]></author>
</item>
<item>
<title><![CDATA[The Dual Role of p21 in Hormone-related Cancers and Its Therapeutic Implications]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202512010000005]]></link>
<description><![CDATA[p21 (encoded by the <i>CDKN1A</i> gene) is a critical cell cycle regulatory protein endowed with versatile biological functions. In various sex hormone-related cancers, p21 exhibits a paradoxical dual role, capable of both inhibiting tumorigenesis and promoting cancer progression, exerting dual, often opposing, effects on cellular fate that are dictated by the specific context. The clinical targeting of p21 remains elusive, largely due to its functionally pleiotropic and context-dependent nature within intricate regulatory networks. During the initial, hormone-dependent phase of cancers like breast and prostate cancer, p21 expression and activity are largely governed by the transcriptional programs of estrogen or androgen receptor signaling. This hormonal regulation contributes to the control of tumor cell proliferation and underpins the initial efficacy of endocrine therapies. In contrast, as these diseases advance to late stages or evolve into non-hormone-dependent subtypes—exemplified by castration-resistant prostate cancer (CRPC) and specific forms of triple-negative breast cancer (TNBC)—these conventional hormonal control mechanisms often become dysfunctional or are entirely bypassed. This fundamental transition creates a critical therapeutic void, highlighting the urgent need to identify and exploit alternative molecular pathways to effectively target p21’s function. Promising strategies may include the precise modulation of its upstream transcriptional regulators, downstream effector proteins, or the intersecting parallel signaling networks that critically influence its activity. This review provides a systematic synthesis of the intricate and interconnected mechanisms that underpin the dual effects of p21 in sex hormone-related tumors. These mechanisms are categorized into three core, interrelated functional domains. (1) cell cycle regulation: p21 executes its canonical tumor-suppressive role by binding to and inhibiting cyclin-dependent kinases (CDKs) and by directly interacting with proliferating cell nuclear antigen (PCNA), thereby inducing cell cycle arrest, predominantly at the G1/S checkpoint; (2) apoptosis modulation: p21 exerts a highly context-dependent influence on programmed cell death, functioning either as a pro-apoptotic agent under severe genotoxic stress or as a pro-survival factor by inhibiting apoptosis through interactions with proteins like Bcl-2; (3) hormonal and signaling crosstalk: p21 is an integral node within broader cellular networks, engaging in direct physical interactions with hormone receptors (<i>e.g</i>., AR, ER) and participating in complex feedback loops with key oncogenic pathways, including PI3K/AKT, MAPK/ERK, and p53. Critically, the role of p21 is not static but highly dynamic. It can undergo a functional switch from tumor-suppressive to tumor-promoting in response to therapeutic pressures, metabolic alterations, or evolving tumor microenvironment cues. These adaptive shifts are frequently implicated in the development of therapy resistance and disease recurrence, particularly in advanced, hormone-resistant cancers. By synthesizing these insights, this review aims to establish a coherent theoretical framework to guide the future development of novel therapeutic strategies that target the p21 pathway. It underscores the necessity of moving beyond a simplistic, binary view of p21 and emphasizes the forthcoming challenges, such as the discovery of reliable biomarkers to predict its functional state and the rational design of context-specific pharmacological modulators to selectively harness its therapeutic potential.]]></description>
<pubDate>2026/2/3 10:00:41</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Yang,GUO Zhi-Yi,LI Jia-Wen,MA Yu-Kai,WANG Jia-Qi]]></author>
</item>
<item>
<title><![CDATA[Primary Cilium-mediated Mechano-metabolic Coupling: Cross-system Homeostatic Regulation of The Nervous, Bone, Vascular, and Renal Systems]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202512300000002]]></link>
<description><![CDATA[Primary cilia—those solitary, microtubule-based projections extending from the surface of most eukaryotic cells—are increasingly recognized not merely as cellular appendages, but as sophisticated signaling hubs. By compartmentalizing specific receptors (<i>e.g</i>., GPCRs) and effectors within a microdomain guarded by the transition zone, these organelles function effectively as high-gain sensors capable of integrating mechanical stimuli with metabolic cues. In this review, we examine the pivotal role of primary cilia across the nervous, bone-vascular, and renal landscapes, arguing for a unified “mechano-metabolic coupling” framework. Here, conserved ciliary modules are not static; rather, they are differentially deployed to uphold systemic homeostasis. Within the central nervous system, we position primary cilia as upstream integrators. We highlight how hypothalamic neuronal cilia concentrate metabolic receptors, such as the melanocortin 4 receptor (MC4R), to interpret energy status. Moreover, the recent identification of serotonergic “axon-cilium synapses” points to a direct mode of neurotransmission, wherein 5-HT6 receptors drive nuclear signaling and chromatin accessibility to rapidly modulate gene expression. Through these mechanisms, central cilia modulate sympathetic tone and neuroendocrine output, effectively establishing the mechanical and metabolic “boundary conditions” under which peripheral organs operate. Dysfunction in these central hubs is linked to obesity and neurodevelopmental disorders, including Bardet-Biedl syndrome. In peripheral tissues, cilia serve as versatile mechanotransducers that convert physical forces into biochemical responses. Regarding the bone-vascular system, we discuss the translation of mechanical loads and fluid shear stress into structural remodeling. In osteoblasts, specifically, ciliary integrity is intrinsically linked to cholesterol and glucose metabolism, fine-tuning the balance between Hedgehog and Wnt/β-catenin signaling to govern osteogenesis and bone repair. A similar dynamic exists in the vasculature, where endothelial cilia sense shear stress to modulate KLF4 expression and endothelial-to-mesenchymal transition—processes critical for valvulogenesis and vascular remodeling. Meanwhile, in the kidney, tubular cilia act as terminal effectors within a “shear-cilia-metabolism” axis. Here, fluid shear stress engages ciliary signaling to trigger AMPK-mediated lipophagy and mitochondrial biogenesis, thereby securing the ATP supply required for solute transport. Notably, dysregulation of this axis leads to metabolic reprogramming and aberrant proliferation, acting as a hallmark driver of cystogenesis in polycystic kidney disease (PKD). Crucially, this review attempts to dissect the often-conflated logic of cross-system integration by distinguishing 3 non-equivalent pathways: direct communication <i>via</i> ciliary extracellular vesicles, though this remains largely hypothetical in long-range signaling; “physiology-mediated cascades”, where ciliary dysfunction in a single organ—such as the kidney—precipitates systemic pathology through hemodynamic and metabolic shifts (<i>e.g</i>., altered blood pressure, fluid volume, or uremic toxins); and “parallel molecular defects”, where shared genetic mutations in ubiquitous components like the IFT machinery cause simultaneous, independent failures across multiple organ systems. Building on these distinctions, we propose a nested-loop model that links central set-points with peripheral feedback <i>via</i> physiological variables. Furthermore, we construct a “causality-to-translation” roadmap that pinpoints structural repair (<i>e.g</i>., targeting IFT assembly) and metabolic rescue (<i>e.g</i>., AMPK activation or autophagy induction) as promising therapeutic avenues. Ultimately, this framework provides a theoretical basis for deciphering the shared pathological mechanisms of multisystem ciliopathies, offering a strategic guide for the development of targeted interventions that go beyond symptomatic treatment.]]></description>
<pubDate>2026/2/3 9:44:04</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Lin-Xi,DUAN Liang-Chen,HU Hao-Liang,WANG Shu-Zhi,YAN Jia-Long]]></author>
</item>
<item>
<title><![CDATA[RAD6A-RAD18 Ubiquitination Complex-mediated Nuclear-cytoplasmic Trafficking and Viral Budding of Henipavirus M Protein]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601190000002]]></link>
<description><![CDATA[The ubiquitination modification of henipavirus (HNV) M protein is essential for its nuclear-cytoplasmic trafficking and viral budding, but the precise regulatory mechanism has remained unclear. A recent study published in <i>Emerging Microbes & Infections</i> demonstrated that the RAD6A-RAD18 ubiquitination complex plays a unique and pivotal role in the nuclear-cytoplasmic trafficking of the HNV M protein and the process of viral budding. Furthermore, this study revealed that treating cells with TZ9 (a RAD6 inhibitor) or RAD18 RING domain-binding peptides markedly impaired the ubiquitination level of HNV M protein, resulting in its nuclear retention and subsequent impairment of viral budding and replication. These findings lay a theoretical foundation for the development of novel antiviral drugs and specific antiviral therapies targeting HNV infections, and provide valuable references for investigating the biological functions of M protein’s ubiquitination as well as the replication and pathogenic mechanisms of other paramyxoviruses.]]></description>
<pubDate>2026/2/2 11:45:41</pubDate>
<category><![CDATA[动态与评论]]></category>
<author><![CDATA[DUAN Zhi-Qiang]]></author>
</item>
<item>
<title><![CDATA[Effect of Oral Sodium Butyrate on Skeletal Muscle Atrophy <i>via</i> The Gut-muscle Axis in Antibiotic-pretreated CT26 Tumor-bearing Mice and Its Mechanism]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202510290000001]]></link>
<description><![CDATA[<b>Objective</b> To explore the effect of oral sodium butyrate on skeletal muscle atrophy in CT26 tumor mice through the gut microbiota-skeletal muscle axis and its potential mechanism.<b>Methods</b> Sixty SPF BALB/c male mice aged 8 weeks were randomly divided into a normal control group (NC, <i>n</i>=18) and a ABX-depleted group (ABX, <i>n</i>=42). The ABX mice were pretreated with a quadruple antibiotic cocktail <i>via</i> oral gavage (0.2 ml per administration, once daily, 6 d per week, for 2 weeks), whereas NC received an equal volume of sterile water. The quadruple antibiotic cocktail consisted of metronidazole (1 g/L), vancomycin (0.5 g/L), ampicillin (1 g/L), and gentamicin (1 g/L). Following successful pretreatment, six mice from each group were randomly selected for gut microbiota sequencing analysis and designated as the Abx group and the NC0 group, respectively. Theremaining mice in ABX were subcutaneously inoculated in the dorsum with 0.2 ml of CT26 cell suspension (at a cell density of 1×10<sup>7</sup>/ml). Then these mice were randomly allocated into three subgroups: a control tumor bearing model group (0_NaB, <i>n</i>=12), a tumor-bearing model group receiving low-dose oral sodium butyrate (L_NaB, <i>n</i>=12), a tumor-bearing model group receiving high-dose oral sodium butyrate (H_NaB, <i>n</i>=12). And mice in NC were inoculated at the same site with 0.2 ml of normal saline. The administration dose for L_NaB was Remaining 0.3 g/(kg·d), that for H_NaB was 0.5 g/(kg·d), while NC and 0_NaB were given the same volume of normal saline (0.2ml per time, once daily, 6 d per week, for 4 weeks). The general condition of mice was monitored, and forelimb grip strength gastrocnemius muscle mass and its muscle fiber cross-sectional area were measured for each group. The structural changes in gut microbiota were assessed by 16S rRNA sequencing of cecal contents. Pathological alterations in the intestinal wall were examined <i>via</i> HE staining. Serum and gastrocnemius muscle levels of TNF-α, IL-6, IL-1β, and LPS were quantified using ELISA. The protein expression of ZO-1 and occludin in the small intestine, as well as proteins associated with the TLR4/MyD88/NF-κB signaling pathway in the gastrocnemius muscle, were detected by Western blot analysis.<b>Results</b> (1) The alpha-diversity in Abx was significantly lower than that in NC0 (<i>P</i><0.01), a significant decrease of the mass and muscle fiber cross-sectional area of the gastrocnemius (<i>P<</i>0.01), with the majority of gut microbiota being effectively depleted. (2) Compared with NC, the subcutaneous tumors of mice in 0_NaB were prominent, a significant increase of the mass and muscle fiber cross-sectional area of the gastrocnemius, accompanied by a significant decrease in body weight at the end of the 3th and 4th week (<i>P<</i>0.05), and a significant weakening of the forelimb grasping strength at the 5th and 6th week (<i>P<</i>0.01). Compared with 0_NaB, the tumor mass of mice in L_NaB and H_NaB showed a significant decreasing trend, and the grip strength of the forelimbs significantly increased at the 5th and 6th week (<i>P</i><0.05, <i>P</i><0.01). (3) Compared with 0_NaB, the Shannon and Observed species indices in α diversity of L_NaB and H_NaB were significantly increased (<i>P</i><0.05). At the genus level, compared with 0_NaB, L_NaB exhibited a significant decrease in the relative abundance of <i>Parasutterella</i> (<i>P</i>< 0.01), while H_NaB showed significant reductions in the relative abundances of both<i> Escherichia-Shigella</i> and <i>Parasutterella</i> (<i>P</i> < 0.01). (4) Compared with 0_NaB, the small intestinal tissue structure in L_NaB and H_NaB was more intact, the infiltration of inflammatory cells was significantly reduced, and the capillaries were slightly dilated. The expression levels of ZO-1 and occludin proteins in L_NaB were significantly increased (<i>P</i><0.01). (5) The LPS concentration in the gastrocnemius muscle and the protein expression levels of TLR4, MyD88, p-IκBα, and p-NF-κB p65 in L_NaB and H_NaB were significantly lower than those in 0_NaB (<i>P</i><0.05). The serum TNF-α concentration in H_NaB and TNF-α concentration in the gastrocnemius muscle of the L_NaB and H_NaB were significantly lower than those in 0_NaB (<i>P<</i>0.05, <i>P<</i>0.01, <i>P<</i>0.01).<b>Conclusion</b> Oral administration of NaB can improve gut microbiota α diversity, adjusting its composition, improving intestinal mucosal barrier function, reducing the LPS-induced pro-inflammatory response, and delaying skeletal muscle atrophy. The underlying mechanism may involve down regulation of TLR4/MyD88/NF-κB signaling in skeletal muscle.]]></description>
<pubDate>2026/2/2 10:54:00</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[FAN Jia,HU Shi-Liang,LI Shun-Chang,SUN Jun-Zhi,WANG Jun-Wei,WANG Tu-Tu,ZHANG Shu-Ling]]></author>
</item>
<item>
<title><![CDATA[Reshaping “Cerebellar Inhibition”: Mechanistic Insights and Precision Medicine Perspectives for rTMS in Machado-Joseph Disease]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601050000001]]></link>
<description><![CDATA[Machado-Joseph disease, or spinocerebellar ataxia type 3 (SCA3), represents the most common autosomal dominant cerebellar ataxia worldwide. Despite its progressive and debilitating nature, disease-modifying therapies remain elusive. Repetitive transcranial magnetic stimulation (rTMS) has emerged as a promising non-invasive intervention; however, its clinical application has been hindered by inconsistent protocols and a lack of mechanistic understanding. A recent landmark study published in <i>Brain Stimulation</i> by Chen<i> et al.</i> addressed these challenges by combining a high-dose intermittent theta-burst stimulation (iTBS) protocol with concurrent transcranial magnetic stimulation-electroencephalography (TMS-EEG). This commentary provides an in-depth analysis of their findings, highlighting the restoration of cerebello-cortical inhibition (CBI) as a key therapeutic mechanism. Furthermore, we discuss the broader implications of this work, proposing that future translational research should integrate accelerated iTBS (aiTBS) paradigms, cortical response measurements (CRM), and individualized neuro-navigation to establish a new era of precision neuromodulation for ataxia.]]></description>
<pubDate>2026/2/2 8:46:54</pubDate>
<category><![CDATA[动态与评论]]></category>
<author><![CDATA[CHE Xian-Wei,CHEN Yu-Chao,GAO Zhong-Ming,HAN Ya-Zhen,ZHOU Jie]]></author>
</item>
<item>
<title><![CDATA[Thyroid Hormone Network Regulation in MASLD: Mechanisms and Targeted Therapies]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202510280000004]]></link>
<description><![CDATA[Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the most prevalent chronic liver disease worldwide, affecting approximately 32%-38% of the adult population and posing a growing public health burden. MASLD represents a continuous disease spectrum ranging from simple steatosis to metabolic dysfunction-associated steatohepatitis (MASH), progressive hepatic fibrosis, cirrhosis, and ultimately hepatocellular carcinoma (HCC). The pathological core of MASLD lies in disruption of hepatic lipid metabolic homeostasis, characterized by an imbalance among <i>de novo</i> lipogenesis, fatty acid β-oxidation, and very-low-density lipoprotein (VLDL)-mediated lipid export. This metabolic disequilibrium subsequently drives inflammatory injury and fibrotic progression. Among the multiple regulatory pathways involved, thyroid hormone (TH) signaling has emerged as a central regulator of hepatic metabolic homeostasis. The liver is a major peripheral target organ of TH action, where TH predominantly exerts its metabolic effects through thyroid hormone receptor β (TRβ). Large-scale epidemiological studies and meta-analyses have demonstrated that hypothyroidism is significantly associated with increased MASLD prevalence, more severe histological injury, and advanced hepatic fibrosis, suggesting that dysregulation of TH signaling may participate throughout the entire MASLD disease spectrum. At the molecular level, TH regulates hepatic lipid metabolism by coordinating suppression of lipogenesis, enhancement of mitochondrial fatty acid oxidation, and promotion of VLDL assembly and secretion through integrated genomic actions of the T3-TRβ axis and non-genomic signaling pathways. Across different stages of MASLD, TH signaling exerts stage-dependent protective effects. In the steatosis stage, TH improves metabolic flexibility by modulating insulin sensitivity, glucose metabolism, and lipid droplet clearance, thereby alleviating early lipotoxic stress. During progression to MASH, TH attenuates inflammatory amplification by improving mitochondrial homeostasis, suppressing activation of the NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome, and modulating the gut-liver axis microenvironment. In advanced stages, TH signaling influences hepatic stellate cell activation and extracellular matrix deposition, partly through interaction with the transforming growth factor-β (TGF-β)/SMAD pathway, while alterations in intrahepatic TH availability, mediated by dynamic changes in iodothyronine deiodinase 1 (DIO1), contribute to fibrosis progression and hepatocellular dedifferentiation. In hepatocellular carcinoma, coordinated downregulation of TRβ and DIO1 establishes a tumor-associated hypothyroid state that promotes metabolic reprogramming and tumor progression. The clinical relevance of TH signaling in MASLD has been underscored by the recent approval of Resmetirom, a liver-targeted TRβ-selective agonist, for the treatment of non-cirrhotic MASH with moderate-to-severe fibrosis (F2-F3). This approval represents a landmark transition from mechanistic understanding to metabolism-centered precision therapy in MASLD. Clinical trials have demonstrated that Resmetirom not only improves key histological endpoints, including MASH resolution and fibrosis regression, but also favorably modulates atherogenic lipid profiles, highlighting the therapeutic potential of selectively targeting hepatic TH pathways. This review systematically summarizes the multidimensional regulatory roles of TH across the MASLD disease spectrum and discusses emerging diagnostic and therapeutic implications of TH-based interventions, aiming to inform future mechanistic research and optimize clinical management strategies.]]></description>
<pubDate>2026/1/29 15:43:38</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[GUAN Heng,HAN Wen,LIU Fang,LUO Bing-Bing,MA Yang,WAN Sha,WANG Wu-Feng,XIAO Wen-Ping]]></author>
</item>
<item>
<title><![CDATA[Pleiotrophin (PTN): Multifunctional Regulation and Therapeutic Potential in The Nervous System]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202509300000003]]></link>
<description><![CDATA[Neurological disorders, including Alzheimer’s disease (AD), Parkinson’s disease (PD), cerebral ischemia, and multiple sclerosis (MS), impose an escalating global health burden and remain largely incurable. These disorders arise from multifactorial and interconnected pathological processes, such as chronic neuroinflammation, oxidative stress, protein misfolding and aggregation, demyelination, and neurovascular dysfunction. Despite substantial advances in elucidating disease-associated molecular mechanisms, current therapeutic strategies are predominantly symptomatic and fail to effectively halt or reverse disease progression. This limitation highlights the urgent need to identify endogenous regulatory molecules capable of coordinating neuronal survival, synaptic maintenance, inflammatory control, and tissue repair within the central nervous system (CNS). Pleiotrophin (PTN) is a heparin-binding, growth-associated cytokine that has emerged as a key regulator of neural development, plasticity, and regeneration. Structurally, PTN contains multiple high-affinity heparin-binding domains that facilitate interactions with extracellular matrix components and cell surface proteoglycans, enabling spatially restricted and context-dependent signaling. Through these molecular properties, PTN functions as a multifunctional organizer of neural growth, plasticity, and tissue remodeling across developmental and adult stages. Its diverse biological effects are executed through a multi-receptor signaling system that integrates extracellular cues with intracellular programs governing cellular survival, migration, and differentiation. Notably, PTN displays a highly dynamic and cell type-specific expression pattern in the central nervous system, being enriched in neural progenitor cells during development and later restricted to discrete neuronal populations, neural stem cells, and non-neuronal niche cells—including astrocytes, pericytes, and vascular endothelial cells—which serve as critical sources of PTN under physiological and pathological conditions. PTN expression is tightly regulated during development and exhibits pronounced plasticity in response to pathological stimuli. Under physiological conditions, PTN is transiently expressed during critical windows of neural growth and synaptogenesis, supporting neuron-glia interactions and myelin formation. In contrast, in pathological contexts such as amyloid-β protein (Aβ) accumulation in AD, dopaminergic neuron degeneration in PD, demyelination in MS, and ischemic brain injury, PTN expression is frequently dysregulated, suggesting an active role in disease-associated remodeling rather than a passive bystander effect. Importantly, accumulating evidence indicates that PTN exerts a dual and context-dependent influence on neurological disorders. On the one hand, aberrant PTN signaling may contribute to maladaptive responses, including sustained glial activation, dysregulated neuroinflammation, extracellular matrix remodeling, and enhanced Aβ deposition. On the other hand, PTN displays robust neuroprotective and reparative functions by promoting neuronal survival, enhancing oligodendrocyte maturation and remyelination, and stimulating post-injury angiogenesis, thereby facilitating tissue repair and functional recovery. At the mechanistic level, PTN signaling is characterized by extensive cross-talk among receptor-dependent pathways. Activation of anaplastic lymphoma kinase (ALK) triggers canonical PI3K-AKT-mTOR and MAPK cascades that support neuronal survival and axonal integrity. PTN binding to protein tyrosine phosphatase receptor type Z1 (PTPRZ1) induces conformational inhibition of its phosphatase activity, resulting in increased phosphorylation of downstream effectors such as β-catenin, Fyn, and Src, which regulate neuronal migration and synaptic stabilization. Syndecan-3 (SDC3) functions as both a co-receptor and an independent signaling mediator by capturing extracellular PTN, amplifying ALK- and PTPRZ1-dependent signaling, and directly modulating cytoskeletal dynamics through PKC and ERK pathways. In parallel, PTN interaction with αVβ3 integrin contributes to remodeling of the neurovascular niche, linking angiogenesis with neurogenesis and neural repair. From a translational perspective, therapeutic strategies targeting PTN can be broadly classified into 3 categories: direct enhancement of PTN signaling through exogenous protein supplementation or gene therapy-mediated upregulation, pharmacological modulation of PTN-associated receptor pathways and downstream signaling nodes, and exploitation of PTN as a dynamic biomarker to inform disease stratification and therapeutic responsiveness. These complementary approaches underscore the growing interest in PTN-centered interventions across a spectrum of neurological disorders. In summary, PTN functions not merely as a classical trophic factor but as a central signaling hub integrating inflammatory regulation, neural regeneration, and vascular remodeling within the CNS. This review aims to synthesize current insights into PTN’s molecular architecture, multi-receptor signaling mechanisms, and disease-specific functions, and to highlight emerging therapeutic strategies targeting PTN. By conceptualizing PTN as a dynamic modulator of neuronal resilience rather than a static biomarker, we propose that precise modulation of PTN signaling may offer promising avenues for therapeutic development in neurodegenerative and neuroinflammatory diseases.]]></description>
<pubDate>2026/1/27 18:39:30</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[Lü Tao,LUO Fu-Cheng,TIAN Xin,ZHANG Zhen]]></author>
</item>
<item>
<title><![CDATA[<b>Science and Education: </b>Construction and Practice Evaluation of an Integrated Traditional Chinese and Western Medicine Postoperative Rehabilitation Teaching Model Supported by MedOncoGPT]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202512150000001]]></link>
<description><![CDATA[<b>Objective</b> To enhance teaching in postoperative cancer rehabilitation, this study developed an integrative Chinese-Western medicine postoperative oncology rehabilitation system, termed the medical oncology generative pre-trained transformer (MedOncoGPT). By introducing MedOncoGPT as an intelligent assistant, an integrated teaching model combining Chinese and Western medicine was established. The study evaluated its impact on students’ integrative clinical reasoning and practical abilities, providing support for instructional reform in related courses.<b>Methods</b> Using teaching resources as the knowledge base, MedOncoGPT was built upon the open-source ChatGLM model and incorporated Low-Rank Adaptation (LoRA) fine-tuning and retrieval-augmented generation (RAG) techniques to address postoperative integrative oncology scenarios. The system was applied in courses and clinical clerkships related to integrative oncology. In alignment with course objectives, a five-stage instructional process—pre-class preparation, in-class inquiry, simulated multidisciplinary consultation, clinical reinforcement, and teaching reflection—was designed to guide students in completing syndrome differentiation, comprehensive assessment, and follow-up planning within real or simulated case contexts. Comparative analyses of student engagement, syndrome differentiation thinking, evidence-based awareness, and interdisciplinary integration skills before and after the teaching reform were conducted using questionnaires, course assessments, classroom observations, and semi-structured interviews.<b>Results</b> Following the implementation of MedOncoGPT, students demonstrated improved performance in case analysis, prescription formulation, and integrative Chinese-Western medical evaluation compared with those receiving traditional instruction. Classroom participation and the relevance of student inquiries also increased. Self-assessment results indicated high levels of satisfaction with respect to clarity of integrative clinical reasoning, ability to retrieve and apply guideline-based evidence, and awareness of appropriate use of intelligent tools in clinical decision-making. More than 92% of students reported that the system facilitated understanding of abstract theoretical concepts presented in textbooks. Instructors noted that the system helped reduce lesson preparation time, enriched typical case materials and discussion scenarios, and promoted the translation of research findings into classroom teaching. Pilot data showed that, with MedOncoGPT assistance, the mean time for initial syndrome differentiation decreased from 18.4 min to 12.1 min, and the agreement rate increased from 68.3% to 82.5%. In the teaching pilot, the experimental group achieved a higher mean score on the final case analysis assessment than the control group (82.6 <i>vs</i>. 74.3).<b>Conclusion</b> The integration of MedOncoGPT into teaching on postoperative integrative cancer rehabilitation enabled the establishment of a stable instructional process within existing curricula and enhanced students’ integrative clinical reasoning and evidence-based practice capabilities. The approach demonstrates positive potential for advancing the integration of research, clinical practice, and education and represents a valuable exploratory strategy for instructional reform in courses on integrative Chinese-Western medicine.]]></description>
<pubDate>2026/1/26 16:06:35</pubDate>
<category><![CDATA[中医药医工结合专题]]></category>
<author><![CDATA[BAI Can,GAO Yuan,HAN Xian-Jun,TANG Yong,WU Zi-Jian]]></author>
</item>
<item>
<title><![CDATA[Gold Nanoclusters-based Anticancer Therapeutic Agents：Current Applications and Future Challenges]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202509250000003]]></link>
<description><![CDATA[Malignant tumors remain one of the most critical global public threats to human health. The early diagnosis and precise therapeutic interventions are pivotal for improving patient survival rates and prognosis. Gold nanoclusters (Au NCs), distinguished by their ultra-small size (3 nm), tunable optical properties, and exceptional biocompatibility, have emerged as transformative agents in precision oncology. This comprehensive review systematically summarizes the multifaceted applications of Au NCs in malignant tumor treatment. We discuss their roles as follows. (1) Intelligent delivery vehicles for targeted chemotherapy and controlled release through surface functionalization. (2) Therapeutic agents for chemodynamic therapy (CDT). This capability stems from their intrinsic enzyme-like catalytic activity or potent thioredoxin reductase (TrxR) inhibitory function, which disrupts the intracellular redox homeostasis and effectively activates downstream apoptotic pathways. (3) Direct therapeutic agents are characterized by their energy conversion capabilities: they can either convert absorbed light into heat to directly kill cancer cells, or transfer that photon energy to surrounding oxygen molecules to generate cytotoxic reactive oxygen species (ROS), leading to cell apoptosis or necrosis. (4) Potent radiosensitizers that enhance radiotherapy efficacy by enhancing localized radiation dose and promoting ROS generation. This review systematically summarizes the recent advances in Au NCs as intelligent delivery systems, direct chemotherapeutic agents, phototherapeutic agents, and efficient radiosensitizers in tumor treatment, elucidating how Au NCs overcome traditional therapeutic limitations through synergistic strategy. It establishes a robust theoretical foundation for next-generation nanotheranostic platforms. However, the translation of laboratory findings into functional clinical technologies confronts three significant challenges. First, although researchers can synthesize atomically precise Au NCs, achieving large-scale production of batches with completely consistent structure, size, and surface chemistry remains extremely challenging. To effectively control the final synthetic product, a deep understanding of the characteristics and formation mechanisms of Au NCs is essential. The traditional “trial-and-error” experimental approach faces inherent limitations when dealing with vast combinations of variables, which is time-consuming, labor-intensive, and struggles with systematic exploration and reproducibility. Machine learning has emerged as a powerful tool to bridge fundamental research and clinical application, which can guide experiments in reverse by predicting synthesis success through data mining and multi-variable analysis. In the future, we anticipate to achieve precise prediction and on-demand design of Au NCs’ structure and properties. Secondly, a systematic framework for evaluating the <i>in vivo</i> pharmacokinetics and long-term toxicity of Au NCs is absent. To address this gap, it is crucial to develop advanced imaging methodologies and integrated theranostic platforms. Au NCs, serving as both a therapeutic core and a highly promising photoluminescent material, are key to constructing such platforms through integration with other agents. These multifunctional systems are designed to achieve optimal synergistic therapy by combining multiple treatment modalities. Finally, the investigation of Au NCs is still largely confined to preclinical cellular and animal studies. Progress necessitates comprehensive clinical research to rigorously assess their safety and efficacy across a range of human cancer models, thereby ensuring broad clinical applicability. In summary, Au NCs-based platforms hold immense promise for translation into clinical anticancer therapy.]]></description>
<pubDate>2026/1/26 10:30:09</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[GAO Liang,Lü Jia,WANG Ruo-Ping,ZHU Lin-Lin]]></author>
</item>
<item>
<title><![CDATA[The Role of Lysosomal Dysfunction in Hepatocellular Carcinoma: From Pathogenesis to Targeted Therapies]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202510120000001]]></link>
<description><![CDATA[Hepatocellular carcinoma (HCC) is a lethal cancer with high morbidity rates worldwide. It is a major threat to public health in China, due to the combination of known and new risk factors, such as endemic hepatitis B virus (HBV), dietary aflatoxin exposure, and the occurrence of metabolic dysfunction-associated steatotic liver disease (MASLD). Although many methods for surveillance and multimodal therapies, such as surgery, local ablation, transarterial therapy, and new systemic agents, have been available, the survival rates of HCC remains poor. They have very limited durable responses, long post-treatment recurrence rates, and high resistance to treatment. This reflects an imperfect picture of the biological cause of the disease and a need for new mechanistic or targeted techniques. A significant characteristic of HCC, in common with other aggressive cancers, is the presence of reprogrammed, hyperactive cell metabolism. Tumor cells hijack metabolic pathways to promote their uncontrolled growth, stress survival, invasion and metastasis. While classical mechanisms such as the Warburg effect, lipid metabolism and glutamine utilization have been understood, the lysosome, which was once viewed as a static “waste disposal unit” to remove old organelles and proteins, is instead a dynamic signaling and metabolic core. The lysosomes incorporate nutrients, energy and stress signals by master regulators such as mTORC1 (activated on its surface) that balance anabolic growth and catabolic recycling to the cellular demands. In HCC, lysosomes are not passive, but are highly active and dysregulated. HCC cells upregulate lysosomes, which scavenge intracellular components <i>via</i> enhanced autophagy and engulf extracellular proteins <i>via</i> macropinocytosis, crucial for survival in the nutrient-poor, hypoxic tumor microenvironment. In addition to metabolism, lysosomes exhibit pro-invasive functions by secreting hydrolases to remodel the extracellular matrix, promote angiogenesis, and suppress stromal immune cells to foster a pro-tumor microenvironment. In a clinical context, lysosomes play an important role in therapeutic resistance: they sequester and inactivate chemotherapeutics <i>via</i> lysosomal sequestration, and enhanced autophagic flux protects the cell from therapy-induced damage, contributing to relapse, as lysosomal dysfunction is a key cause of treatment failure. This makes lysosomes promising yet challenging therapeutic targets in HCC. Recent preclinical and early clinical studies investigate multiple strategies to exploit the susceptibility of lysosomes: lysosome-specific agents, alkalinizing the lysosome lumen or inducing membrane permeabilization and lysosome-dependent cell death; pharmacological inhibition of key lysosomal enzymes or autophagy to impair nutrient recycling and stress adaptation; smart nanotherapeutic agents or antibody-drug conjugates, specifically activated in the acidic lysosomal environment or utilizing lysosomal pathways for efficient intracellular drug release; and combination strategies of lysosome-targeting agents with tyrosine kinase inhibitors or immunotherapy to overcome resistance and achieve synergistic antitumor effects. In summary, our review systematically presents the role of lysosomes in HCC, from metabolic reprogramming and microenvironmental adaptation to therapeutic resistance. By synthesizing the latest mechanistic insights and preclinical advances, this review highlights the indispensable role of lysosomes in the complex HCC biological network, emphasizing that an in-depth understanding of this dynamic organelle holds great promise for developing innovative, targeted therapies, offering new hope for improving the poor prognosis of global HCC patients.]]></description>
<pubDate>2026/1/26 10:29:29</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Xin,TANG Jing-Feng,WU Yue-Yan,ZHANG Rui,ZHOU Ce-Fan]]></author>
</item>
<item>
<title><![CDATA[Mechano-immune Crosstalk in Osteoarthritis and Rheumatoid Arthritis: Cytoskeletal and Mechanotransductive Biomarkers and Translational Therapeutic Targets in Postmenopausal Disease]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202510300000003]]></link>
<description><![CDATA[Osteoarthritis (OA) and rheumatoid arthritis (RA) have long been framed as degenerative and autoimmune entities, respectively; mounting evidence instead supports a unified mechano-immune paradigm in which joint loading and inflammatory signaling are reciprocally reinforcing. In this review, we synthesize advances across mechanotransduction (Piezo1; YAP/TAZ), focal-adhesion/cytoskeletal regulation (vinculin, filamin-A; upstream talin-1/Kindlin-2/paxillin), and niche inflammatory mediators (HE4, IL-36/IL-38) to explain how mechanical stress and cytokines co-produce persistent catabolism, synovial invasion, and fibrotic remodeling. We articulate a dual-hit model in which OA is predominantly mechanical-overload-driven, with secondary inflammation, whereas RA is immune-driven but imposes abnormal mechanical stress that further distorts joint biomechanics; both converge on canonical hubs (NF-κB/MAPK/JAK-STAT) to accelerate matrix degradation and apoptosis. Building on this framework, we propose integrated multi-marker panels that combine mechanosensors and adhesion proteins with conventional assays (CRP, ESR, anti-CCP) to enhance differential diagnosis and prognostication, particularly in postmenopausal women, where estrogen decline heightens mechano-immune susceptibility, thereby offering a means to quantify the impact of mechano-immune dysregulation. Integrating mechanotransductive and cytoskeletal biomarkers with conventional serological indices has been reported to improve differential diagnosis between osteoarthritis and rheumatoid arthritis in exploratory studies. While the magnitude of diagnostic gain varies across cohorts, combined biomarker strategies generally show enhanced discriminatory performance compared with single-marker approaches. These findings highlight translational potential but require validation in large, standardized clinical populations before routine implementation. Finally, we map translational opportunities spanning Piezo1 inhibition (GsMTx4), YAP/TAZ blockade (verteporfin), IL-36 axis antagonism (IL-36Ra, IL-38), anti-HE4 strategies for RA-ILD, and adhesion-stabilizing approaches, alongside mechanoresponsive biomaterials for regenerative applications and precision medicine guided by biomarker profiles. Collectively, this review reframes OA and RA as mechano-immune syndromes and delineates a clinically actionable roadmap from biophysics to bedside.]]></description>
<pubDate>2026/1/23 11:44:47</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[ABBAS Salma Abdulredha,ABOD Kareem Salim]]></author>
</item>
<item>
<title><![CDATA[Mechanistic Interpretation of Zheng’s San Qi San Powder in Treating Skeletal Muscle Injury <i>via </i>Bioinformatics Prediction, Chemical Analysis and Experimental Verification]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202509250000001]]></link>
<description><![CDATA[<b>Objective</b> Zheng’s San Qi San (ZSQS) power, a classic traditional Chinese medicine (TCM) formula, is used for treating soft tissue injuries involving muscles, tendons, and ligaments. However, its underlying therapeutic mechanisms remain unclear. This study aimed to screen and identify pharmaceutically active ingredients and their candidate biomolecule targets, and further elucidate the molecular mechanism of ZSQS in the treatment of skeletal muscle injury.<b>Methods</b> Network pharmacology was employed to construct “ZSQS-component-target”, “protein-protein interaction (PPI)” and “active ingredient-core protein-pathway” networks to predict the key active ingredients and potential core targets of ZSQS for skeletal muscle injury. The predicted results were then validated <i>via</i> microarray data from the GEO database. Molecular docking was then performed to assess the binding ability between the screened active ingredients of ZSQS and the candidate core targets. Moreover, liquid chromatography-mass spectrometry (LC-MS) was used for qualitative and quantitative analysis to verify the active components of the drug and ZSQS serum. Finally, an animal model of eccentric exercise-induced skeletal muscle injury and a myotube cell model of oxidative stress-induced injury were established to validate the effects of ZSQS and its interventional effects on the biological functions of critical targets, thereby demonstrating the potential therapeutic mechanism of ZSQS.<b>Results</b> Among the 111 active components identified in ZSQS and their corresponding 204 targets related to the skeletal muscle injury repair process, 14 core targets (including AKT1) and 4 core active components (quercetin, luteolin, kaempferol, and β-sitosterol) were screened out, while the corresponding metabolites of quercetin, luteolin and kaempferol were detected in the ZSQS serum. Among these targets, 5 candidate genes (<i>IL-6</i>, <i>CASP3</i>, <i>HIF1A</i>, <i>STAT3</i>, and <i>JUN</i>) overlapped with the differential expression screening results with GEO data, and IL-6 was confirmed to be enriched in the PI3K/AKT pathway. Combined with the prediction results of the AKT expression levels, these findings suggest that the phosphorylation level of AKT1 plays a core role in the therapeutic mechanism of ZSQS. Molecular docking analysis further revealed that the PH domain of AKT1 had high binding energy with all 4 core active components, as verified by LC-MS. Finally, animal model studies have shown the promoting effect of ZSQS administration on skeletal muscle injury repair and its possible antioxidant damage mechanism. Cell model studies further demonstrated that ZSQS-containing serum, core active ingredient combination therapy, and quercetin monomer could increase the phosphorylation level of AKT, promote the nuclear translocation of Nrf2, upregulate the expression of downstream antioxidant enzymes (SOD, GPx, and GR), and inhibit the expression of inflammatory factors (IL-6 and TNF-α), thereby alleviating oxidative stress and the inflammatory response.<b>Conclusion</b> ZSQS alleviates skeletal muscle injury mainly by activating the AKT/Nrf2 signaling pathway, enhancing cellular antioxidant and anti-inflammatory capabilities. The results of this study provide a scientific basis for the clinical application and modernized development of ZSQS.]]></description>
<pubDate>2026/1/22 14:46:15</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[LIU Yun-Xin,Lü Lei,Lü Jia-Hao,WANG Ding-Rui,QIE Bei-Bei,XING Cheng-Yuan,XU Jun-Jie,YANG Liu]]></author>
</item>
<item>
<title><![CDATA[Breaking Through Oral Gene Delivery Barriers： Peptide Nanocarriers Delivering CAR Genes for Targeted Pancreatic Cancer Therapy]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202601120000001]]></link>
<description><![CDATA[]]></description>
<pubDate>2026/1/20 21:34:15</pubDate>
<category><![CDATA[Highlights]]></category>
<author><![CDATA[YIN Ting]]></author>
</item>
<item>
<title><![CDATA[Olfactory Receptors Expressed in The Intestine and Their Functions]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202507090000002]]></link>
<description><![CDATA[Olfactory receptors (ORs) form the largest superfamily of G protein-coupled receptors (GPCRs). Traditionally recognized for their role in the nasal olfactory epithelium, where they mediate the sense of smell, accumulating evidence has firmly established their ectopic expression in non-olfactory tissues, including the intestine, lungs, and kidneys. The intestine, as the primary site for nutrient digestion and absorption, harbors a highly complex chemical environment. To adapt to this environment, the gut employs a sophisticated network of “chemosensors” to monitor luminal contents and maintain homeostasis. Among these sensors, intestinal ORs have emerged as crucial functional components, serving as a molecular bridge that connects environmental chemical signals—such as food-derived odorants—to specific physiological responses. This discovery has significantly deepened our understanding of how dietary flavors and compounds influence intestinal physiology at the molecular level. This review systematically summarizes the expression profiles, ligand classification, and biological functions of ORs within the gastrointestinal tract. Studies indicate that intestinal ORs exhibit distinct spatial distribution patterns across different gut segments and display cell-type specificity, particularly within enterocytes and enteroendocrine cells. These receptors function as versatile sensors capable of recognizing a wide variety of ligands, including exogenous dietary components, gut microbiota metabolites such as short-chain fatty acids, and endogenous small molecules like azelaic acid. Upon activation by specific ligands, intestinal ORs trigger intracellular signaling cascades, primarily involving the AC-cAMP-PKA pathway or calcium influx channels. A major focus of this review is to elucidate the molecular mechanisms by which these receptors regulate the secretion of gut hormones. Activation of specific ORs in enteroendocrine cells has been shown to stimulate the release of hormones such as glucagon-like peptide-1 (GLP-1), peptide YY (PYY), and serotonin (5-HT), thereby modulating systemic energy metabolism, glucose homeostasis, and gastrointestinal motility. Furthermore, the review addresses the critical roles of ORs in immune regulation and pathology. Evidence suggests that specific ORs contribute to the maintenance of intestinal immune homeostasis and may offer protection against inflammation. Beyond their involvement in inflammatory responses, ORs such as Olfr78 have been shown to regulate the differentiation and function of intestinal endocrine cells. Similarly, Olfr544 has been demonstrated to alleviate intestinal inflammation by remodeling the gut microbiome and metabolome. These findings collectively suggest that specific ORs hold promise as therapeutic targets for mitigating intestinal inflammation and maintaining gut homeostasis. Additionally, the review explores the emerging role of ORs in cancer. Although OR expression is often downregulated in tumor tissues compared to normal mucosa, activation of specific ORs by certain ligands can inhibit tumor cell proliferation and migration and induce apoptosis <i>via</i> pathways such as MEK/ERK and p38 MAPK. Conversely, other receptors, such as OR7C1, may serve as biomarkers for cancer-initiating cells. In conclusion, intestinal ORs represent a vital component of the gut’s sensory network. The review also discusses the translational potential of these findings. By elucidating the precise pairing relationships between dietary components and specific ORs, novel therapeutic strategies could be developed. Intestinal ORs may thus emerge as promising targets for nutritional and pharmacological interventions in metabolic diseases, inflammatory bowel diseases, and malignancies.]]></description>
<pubDate>2026/1/17 20:34:39</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LI Peng,MAO Xiao-Shuang,MAO Zhong-Yi,QI Gui-Hong,SUN Shi-Hao,XIE Jian-Ping,YANG Pei-Wen,YANG Yi-Nan,YANG Ying,YUAN Meng-Meng,ZHOU Meng-Sha,ZHOU Ying]]></author>
</item>
<item>
<title><![CDATA[Polypeptide-based Nanocarriers for Oral Targeted Delivery of CAR Genes to Pancreatic Cancer]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202511140000002]]></link>
<description><![CDATA[<b>Objective</b> Pancreatic ductal adenocarcinoma (PDAC) exhibits a limited response to current treatments due to its dense fibrotic stroma and highly immunosuppressive tumor microenvironment. In recent years, advancements in cellular immunotherapy, particularly chimeric antigen receptor macrophage (CAR-M) therapy, have offered new hope for pancreatic cancer treatment. Although CAR-M therapy demonstrates dual potential in directly killing tumor cells and remodeling the immune microenvironment, it still faces challenges such as complex <i>in vitro</i> preparation processes and low <i>in vivo</i> targeting and delivery efficiency. Therefore, developing strategies for efficient and targeted <i>in vivo</i> delivery of CAR genes has become crucial for overcoming current therapeutic limitations. This study aims to develop an orally administrable nano-gene delivery system for the targeted delivery of CAR genes to pancreatic tumor sites.<b>Methods</b> Core nano-gene particles (PNP/pCAR) were constructed by loading plasmid DNA encoding CAR (pCAR) with cationic polypeptides (PNP). Subsequently, PNP/pCAR was surface-modified with β-glucan to prepare the targeted nanoparticles (βGlus-PNP/pCAR). The loading efficiency of PNP for pCAR was quantitatively assessed by gel retardation assay. The particle size, Zeta potential, morphology, and storage stability of PNP/pCAR were characterized using a Malvern particle size analyzer and transmission electron microscopy. At the cellular level, RAW 264.7 macrophages were selected. The cytotoxicity of PNP/pCAR was evaluated using the CCK-8 assay. The cellular uptake efficiency and lysosomal escape ability of the nanoparticles were assessed <i>via</i> flow cytometry and confocal microscopy. Transfection efficiency was quantitatively evaluated by detecting the expression of the reporter gene GFP using flow cytometry. At the <i>in vivo</i> level, an orthotopic pancreatic cancer mouse model was established. Cy7-labeled βGlus-PNP/pCAR nanoparticles were administered orally, and the fluorescence distribution in mice was dynamically monitored at 1, 2, 4, 8, and 16 h post-administration using a small animal <i>in vivo</i> imaging system. Forty-eight hours after oral gavage, the mice were euthanized, and pancreatic tumor tissues were collected for further analysis of intratumoral fluorescence signals using the imaging system. Additionally, βGlus-PNP/pCAR-GFP nanoparticles loaded with the reporter gene (GFP) were administered orally. Forty-eight hours post-administration, pancreatic tumor tissues were harvested to prepare frozen sections, and GFP expression was observed and analyzed under a fluorescence microscope.<b>Results</b> The PNP carrier exhibited a high loading capacity for pCAR. The successfully prepared PNP/pCAR nanoparticles were regular spheres with a hydrodynamic diameter of approximately (120±10) nm and a Zeta potential of about +(6±1) mV. They maintained good structural stability after incubation in PBS buffer for 7 d. Cell experiments demonstrated that PNP/pCAR exhibited no significant cytotoxicity in RAW 264.7 cells while being efficiently internalized and effectively escaping lysosomal degradation. The transfection positive rate of PNP/pCAR-GFP in RAW 264.7 cells reached (25±3)%, surpassing that of Lipofectamine 2000-loaded pCAR-GFP (Lipo/pCAR-GFP), which was (20±1)%. <i>In vivo</i> experiments revealed that, compared to unmodified PNP/pCAR, βGlus-PNP/pCAR exhibited stronger <i>in situ</i> pancreatic tumor targeting ability after oral administration. Furthermore, oral administration of βGlus-PNP/pCAR-GFP resulted in significant GFP protein expression detectable within pancreatic tumor tissues.<b>Conclusion</b> This study successfully constructed and validated an orally administrable, pancreatic cancer-targeting polypeptide-based nano-gene delivery system. It provides an important technological foundation in delivery systems and experimental basis for the subsequent development of <i>in situ</i> CAR-M-based therapeutic strategies for pancreatic cancer.]]></description>
<pubDate>2026/1/14 10:00:02</pubDate>
<category><![CDATA[研究快报]]></category>
<author><![CDATA[CAI Lin-Tao,FANG Quan,LI Zhao-Zhen,LIANG Rui-Jing,LIU Lan-Lan,REN Jian,XIN Feng]]></author>
</item>
<item>
<title><![CDATA[Spatiotemporal Electrical Impedance Tomography for Speech Respiratory Assessment in Cleft Palate: an Interpretable Machine Learning Study]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202510270000002]]></link>
<description><![CDATA[<b>Objective</b> Cleft palate (CP) is a common congenital deformity often associated with velopharyngeal insufficiency (VPI), which disrupts the physiological coupling between respiration and speech. Conventional clinical assessments, such as nasometry and spirometry, provide limited static data and fail to visualize the dynamic spatiotemporal distribution of lung ventilation during phonation. This study introduces spatiotemporal electrical impedance tomography (ST-EIT) to evaluate speech-respiratory functional features in CP patients compared to normal controls (NC). The aim is to characterize multi-domain respiratory patterns and to validate an interpretable machine learning framework for providing objective, quantitative evidence for clinical assessment.<b>Methods</b> Seventy-five participants were enrolled in this study, comprising 37 patients with surgically repaired CP and 38 healthy volunteers matched for age, gender, and body mass index (BMI). All subjects performed standardized sustained phonation tasks while undergoing synchronous monitoring with a 16-electrode EIT system and a pneumotachograph. A comprehensive feature engineering pipeline was developed to extract physiological parameters across 3 complementary domains. (1) Temporal domain: including inspiratory/expiratory phase duration (tPhase), time constants (Tau), and inspiratory-to-expiratory time ratios (TI/TE); (2) airflow domain: comprising mean flow, peak flow, and instantaneous flow at 25%, 50%, and 75% of tidal volume; and (3) spatial domain: quantifying global and regional tidal impedance variation (TIV), global inhomogeneity (GI), and center of ventilation (CoV). Extreme Gradient Boosting (XGBoost) classifiers were trained using 5 distinct data sources (Spirometry, Nasometry, Inspiratory-EIT, Expiratory-EIT, and fused ST-EIT). Model performance was rigorously evaluated <i>via</i> stratified 5-fold cross-validation, and Shapley additive explanations (SHAP) were employed to quantify global and local feature contributions.<b>Results</b> The CP group exhibited a distinct respiratory phenotype compared to controls. In the temporal domain, CP patients showed significantly shorter inspiratory (1.60 s <i>vs</i>. 1.85 s, <i>P</i><0.001) and expiratory phase durations (2.45 s <i>vs</i>. 3.95 s, <i>P</i><0.001), indicating a rapid, shallow breathing rhythm. In the airflow domain, while inspiratory flows were comparable, the CP group demonstrated significantly elevated mean and peak flows during the expiratory phase (<i>P</i><0.001), reflecting compensatory respiratory effort. Spatially, CP patients presented significant ventilation redistribution, characterized by higher regional TIV in the right-anterior (ROI1) and left-posterior (ROI4) quadrants, but lower TIV in the left-anterior (ROI2) quadrant. In terms of diagnostic accuracy, the multi-modal ST-EIT model achieved the highest performance (<i>AUC</i>: 0.915±0.012, <i>Accuracy</i>: 0.843±0.019, <i>F1</i>-score: 0.872±0.017), substantially outperforming models based on spirometry (<i>AUC</i>: 0.721) or nasometry (<i>AUC</i>: 0.625) alone. Interpretability analysis revealed that spatial domain features were the most critical, contributing 53.4% to the model’s decision-making, followed by temporal (25.0%) and airflow (21.6%) features.<b>Conclusion</b> ST-EIT successfully captures the temporal, airflow, and spatial deviations in CP speech respiration that are undetectable by conventional methods—specifically, rapid phase transitions, hyperdynamic expiratory airflow, and regional ventilation heterogeneity. This study validates ST-EIT as a robust, non-invasive, and radiation-free tool for characterizing speech-respiratory dysfunction, offering high clinical value for bedside screening, rehabilitation planning, and longitudinal monitoring of patients with cleft palate.]]></description>
<pubDate>2026/1/12 16:53:26</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[JIANG Cheng-Hui,SUN Bo,WU Yang,YAO Jia-Feng,YU Hao,ZHANG Xiao-Jing]]></author>
</item>
<item>
<title><![CDATA[Construction of Organoid-on-a-chip and Its Applications in Biomedical Fields]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202507220000003]]></link>
<description><![CDATA[Organoid-on-a-chip technology represents a promising interdisciplinary advancement that merges two cutting-edge biomedical platforms: stem cell-derived organoids and microfluidics-based organ-on-a-chip systems. Organoids are self-organizing three-dimensional (3D) cell cultures that mimic the key structural and functional features of <i>in vivo</i> organs. However, traditional organoid culture systems are often static, lacking dynamic environmental cues and suffering from limitations such as batch-to-batch variability, low stability, and low throughput. Organ-on-a-chip platforms, by contrast, utilize microfluidic technologies to simulate the dynamic physiological microenvironment of human tissues and organs, enabling more controlled cell growth and differentiation. By integrating the advantages of organoids and organ-on-a-chip technologies, organoid-on-a-chip systems transcend the limitations of conventional 3D culture models, offering a more physiologically relevant and controllable <i>in vitro</i> platform. In organoid-on-a-chip systems, stem cells or pre-formed organoids are cultured in micro-engineered environments that mimic <i>in vivo</i> conditions, enabling precise control over fluid flow, mechanical forces, and biochemical cues. Specifically, these platforms employ advanced strategies including bio-inspired 3D scaffolds for structural support, precise spatial cell patterning <i>via</i> 3D bioprinting, and integrated biosensors for real-time monitoring of metabolic activities. These synergistic elements recreate complex extracellular matrix signals and ensure high structural fidelity. Based on structural complexity, organoid-on-a-chip systems are classified into single-organoid and multi-organoid types, forming a trajectory from unit biomimicry to systemic simulation. Single-organoid chips focus on highly biomimetic units by integrating vascular, immune, or neural functions. Multi-organoid chips simulate inter-organ crosstalk and systemic homeostasis, advancing complex disease modeling and PK/PD evaluation. This emerging technology has demonstrated broad application potential in multiple fields of biomedicine. Organoid-on-a-chip systems can recapitulate organ development <i>in vitro</i>, facilitating research in developmental biology. They mimic organ-specific physiological activities and mechanisms, showing promising applications in regenerative medicine for tissue repair or replacement. In disease modeling, they support the reconstruction of models for neurodegenerative, inflammatory, infectious, metabolic diseases, and cancers. These platforms also enable <i>in vitro</i> drug testing and pharmacokinetic studies (ADME). Patient-derived chips preserve genetic and pathological features, offering potential for precision medicine. Additionally, they reduce species differences in toxicology, providing human-relevant data for environmental, food, cosmetic, and drug safety assessments. Despite progress, organoid-on-a-chip systems face challenges in dynamic simulation, extracellular matrix (ECM) variability, and limited real-time 3D imaging, requiring improved materials and the integration of developmental signals. Current bottlenecks also include the high technical threshold for automation and the lack of standardized validation frameworks for regulatory adoption. Meanwhile, the concept of a “human-on-a-chip” has been proposed to mimic whole-body physiology by integrating multiple organoid modules. This approach enables systemic modeling of drug responses and toxicity, with the potential to reduce animal testing and revolutionize drug development. Future advancements in bio-responsive hydrogels and flexible biosensors will further empower these platforms to bridge the gap between bench-side research and personalized clinical interventions. In conclusion, organoid-on-a-chip technology offers a transformative <i>in vitro</i> model that closely recapitulates the complexity of human tissues and organ systems. It provides an unprecedented platform for advancing biomedical research, clinical translation, and pharmaceutical innovation. Continued development in biomaterials, microengineering, and analytical technologies will be essential to unlocking the full potential of this powerful tool.]]></description>
<pubDate>2026/1/11 11:26:47</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HOU Hong-Wei,HUANG Long,LI Xiao,LIU Rui-Xia,LIU Yi,ZHANG Jing]]></author>
</item>
<item>
<title><![CDATA[Advances in RNA Synthetic Biology: Gene Circuit Design and Application in Precision Medicine]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202509030000002]]></link>
<description><![CDATA[RNA synthetic biology, as a frontier interdisciplinary field, is driving the leap from fundamental research to precision medicine in life sciences through the engineered design of RNA components and the construction of genetic circuits. This paper aims to systematically outline the design principles, key technological breakthroughs, and biomedical applications of synthetic RNA genetic circuits. Building upon this foundation, it provides an in-depth analysis of current research bottlenecks and proposes future development directions. Commencing with a foundational role in the central dogma of RNA, this paper establishes a systematic classification framework for synthetic biology RNA components. At the <i>cis</i>-acting element level, it elaborates on how components such as riboswitches, RNA thermometers, and Toehold switches achieve precise gene expression regulation by responding to specific ligands, temperatures, or trigger RNAs through conformational changes. Concerning trans-acting elements, it delves into the molecular mechanisms of miRNA-mediated gene silencing, the high stability and “sponge-like adsorption” function conferred by the closed-loop structure of circRNA, the targeting role of siRNA within the RNAi pathway, and the targeting specificity of sgRNA within the CRISPR system. The paper emphasizes that rational design, sequence optimization, and chemical modifications can significantly enhance the performance and orthogonality of these natural elements. Secondly, the paper focuses on the design and optimization strategies for synthetic RNA regulatory modules. Taking miRNA-responsive circRNA switches as an example, it elucidates the principles of customized miRNA responsiveness. The engineering applications of circRNA are explored, introducing strategies for constructing functional RNA nanostructures <i>via</i> siRNA self-assembly. Building upon this, the paper emphasizes synthetic genetic circuits: from logical operations to resource allocation, enabling advanced cellular logic and functional regulation. For instance, by combining transcriptional cascade switches or utilizing the CRISPR-Cas13a system, an AND logic gate responsive to multiple miRNAs (such as miRNA-155 and miRNA-21) was constructed, significantly enhancing the specificity of disease diagnosis. Addressing the challenges of resource competition and expression noise faced by synthetic circuits within cells, this paper introduces computational models such as MIRELLA, with particular emphasis on the design of endogenous miRNA-based iFFLs. These advanced circuits, illustrated in this paper, have been successfully applied to real-time monitoring of cellular differentiation states and regulation of stem cell-directed differentiation. For cellular state detection and dynamic regulation, miRNA switches can be integrated with fluorescent systems to track differentiation statuses in real time <i>via</i> fluorescent signal changes. Synthetic genetic circuits, meanwhile, utilize endogenous miRNA logic integration alongside miSFITs technology to achieve state-specific protein regulation in human pluripotent stem cells, laying the groundwork for customized cellular control. This approach ingeniously harnesses intrinsic cellular regulatory mechanisms to buffer gene expression burdens, thereby enhancing circuit robustness. These advanced circuits, illustrated schematically herein, have been successfully applied to real-time monitoring of cellular differentiation states and regulation of stem cell-directed differentiation. At the therapeutic translation level, the paper systematically reviews application strategies for RNA technologies across multiple fields, including cancer, metabolic diseases, neurodegenerative diseases, cardiovascular diseases, regenerative medicine engineering, immunotherapy, and vaccine applications. For instance, in cancer treatment, specific killing of tumor cells is achieved by embedding targets for miRNAs specific to healthy cells within the genomes of oncolytic viruses (such as Zika virus). Within metabolic and degenerative diseases, LNP-delivered mRNA therapeutics and antisense oligonucleotide (ASO) technologies have demonstrated significant clinical progress. Finally, this paper highlights ongoing challenges in the field, including limited programmability of RNA elements, low <i>in vivo</i> delivery efficiency, and inadequate off-target risk assessment systems. It advocates for future integration of epigenomics and computational modelling to optimize element functionality, establishing an integrated “element-circuit-delivery” platform. Furthermore, leveraging single-cell sequencing and organoid technologies to develop a multidimensional safety assessment system is proposed to advance the deep integration and translation of RNA synthetic biology in personalized medicine. Consequently, RNA engineering has transcended single-dimensional regulation, evolving towards multi-layered, dynamic, and intelligent synthetic biological systems. Its deep integration with clinical needs will reshape disease diagnosis and treatment paradigms.]]></description>
<pubDate>2026/1/8 9:36:44</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DAI Yi-Han]]></author>
</item>
<item>
<title><![CDATA[<b>Research: </b>Effect of Acupuncture at Neiguan (PC6) on Improving Autism by Promoting Myelination Through The METTL14/m⁶A/PTEN Axis Based on “Xuanfu-Suiqiao” Theory]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202511240000001]]></link>
<description><![CDATA[<b>Objective</b> To clarify whether METTL14 mediates the core role of acupuncture at Neiguan (PC6) in promoting myelination and improving behavior in young autistic rats through gene intervention technology.<b>Methods</b> The ASD model was established by intraperitoneal injection of valproic acid (VPA) in pregnant rats. Male offspring were intracerebroventricularly injected with adenovirus-packaged METTL14 shRNA (sh-METTL14) or its control (sh-NC) on postnatal day 1, with a model group set as well. Subsequently, the juvenile rats were divided into model group, acupuncture group, acupuncture+sh-NC group, and acupuncture+sh-METTL14 group. The acupuncture group received acupuncture at Neiguan (PC6) from postnatal day 7, once daily for 21 consecutive days. Neurobehavioral changes were evaluated by behavioral tests; METTL14 knockdown efficiency and the expression of METTL14, METTL3, and PTEN were detected by quantitative real-time PCR (qRT-PCR) and Western blot (WB); PTEN m<sup>6</sup>A levels were measured by RNA immunoprecipitation-qPCR (RIP-qPCR); myelin ultrastructure, expression of myelin basic protein (MBP) and neurofascin 155 (NF155), and dendritic spine density were observed using transmission electron microscopy (TEM), enzyme-linked immunosorbent assay (ELISA), immunofluorescence, qRT-PCR, and primary neuron culture.<b>Results</b> Behaviorally, knockdown of METTL14 significantly counteracted the beneficial effects of acupuncture in improving self-grooming, open field exploration, three-chamber social interaction, and Morris water maze learning and memory (<i>P</i><0.05, <i>P</i><0.01). Compared with the acupuncture+sh-NC group, the acupuncture+sh-METTL14 group showed significantly decreased mRNA and protein expression of hippocampal METTL14 (<i>P</i><0.01), and the upregulating effects of acupuncture on METTL3 and PTEN expression were reversed (<i>P</i><0.01). Meanwhile, knockdown of METTL14 significantly inhibited the acupuncture-induced increase in PTEN m<sup>6</sup>A levels (<i>P</i><0.01). Morphologically, knockdown of METTL14 attenuated the improvement of myelin structure by acupuncture, reversed the downregulation of MBP and upregulation of NF155 induced by acupuncture, and blocked the increase in dendritic spine density (<i>P</i><0.05, <i>P</i><0.01).<b>Conclusion</b> METTL14 is a key molecule mediating the therapeutic effect of acupuncture at Neiguan. Acupuncture at Neiguan upregulates METTL14, thereby enhancing m<sup>6</sup>A methylation modification of <i>PTEN</i> mRNA to stabilize its expression, ultimately promoting myelin development and improving behavioral symptoms in ASD juvenile rats. This preliminarily reveals the modern biological connotation of “opening Xuanfu and dredging myelin”.]]></description>
<pubDate>2026/1/8 9:34:43</pubDate>
<category><![CDATA[中医药医工结合专题]]></category>
<author><![CDATA[CAO Jia-Lei,DANG Wei-Li,LI Yu-Xin,LI Zhi-Yao,LIANG Lü-Yuan,LIU Sai-Dan,MA Bing-Xiang,MA Rong-Ze,WANG Yun-Kai,WEI Bing-Qi,YANG Xiao-Qing]]></author>
</item>
<item>
<title><![CDATA[The Role of MAPK in Depressive Disorder and Research on Related Drugs]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202509090000002]]></link>
<description><![CDATA[Depressive disorder is a prevalent mental illness characterized by pronounced and enduring symptoms of depression and cognitive impairment. The escalating pressures of modern society have led to a corresponding rise in the number of depressive disorder patients, particularly those exposed to adverse social, economic, political, and environmental factors which exacerbate the risk of this disorder. The pathogenesis of depressive disorder is multifaceted, encompassing oxidative stress, neuroplasticity alterations, neuroinflammation, neurotransmitter system imbalances, and intestinal microecological disruptions, among others. Clinically, conventional antidepressants are primarily predicated on the monoamine neurotransmitter hypothesis. This theory posits that depressive disorder can be ameliorated by regulating the levels of neurotransmitters within the body through a singular mechanism. However, the complex and multifaceted pathogenesis of depressive disorder results in limited selectivity for these drugs. Mitogen-activated protein kinase (MAPK) is a conserved serine/threonine kinase that plays a crucial role in various cellular physiological and pathological processes, including cell growth, differentiation, stress adaptation, and inflammatory response. It is instrumental in maintaining cellular homeostasis and regulating cellular responses. Numerous studies indicate that MAPK is involved in the pathogenesis and progression of depressive disorder through various pathogenesis. However, what deserves attention is that the interaction between the pathogenesis and dynamics of regulatory process remains unclear. Modulating MAPK has been shown to influence the onset and progression of depressive disorder, though the precise mechanism remains elusive. Within the MAPK family, aberrant activity of extracellular signal-regulated kinase (ERK) can damage hippocampal neurons and overactivate microglia, precipitating depressive disorder. Excessive activation of c-Jun N-terminal kinase (JNK) results in heightened neuronal apoptosis in the hippocampus and prefrontal cortex, and suppresses the expression of neurotrophic factors. p38, a key regulator in inflammatory reactions, can induce neuroinflammation when overactive, leading to depressive disorder. ERK, JNK, and p38 sub-pathways do not function in isolation but rather interact synergistically and/or antagonistically through shared activators and common target molecules. Consequently, these sub-pathways form a complementary and coordinated regulatory network. In addition, MAPK family members can jointly influence the process of depressive disorder by sharing upstream factors and regulating common downstream targets, and there is a lack of identification of their markers and screening for subgroups. The collective abnormal activities of these MAPK family members illuminate the underlying mechanisms of depressive disorder, suggesting that MAPK could serve as a potential therapeutic target for this disorder. As for the study of ERK, different models of depressive disorder have contradictory effects on its activity. The primary cause of these differences can be attributed to the distinct pathological environments utilized in the creation of depressive disorder models. In the future, it is suggested that we use the inducement of depressive disorder as a modeling standard to accurately simulate the onset of depressive disorder to carry out accurate treatment according to the causes of depressive disorder. Research shows that classic clinical drugs, novel MAPK inhibitors and certain traditional Chinese medicines can prevent and treat depressive disorder by regulating the MAPK signaling pathway. Research on MAPK remains limited, particularly concerning the permeability and cellular specificity across the blood-brain barrier and the identification of objective predictive markers. Although inhibitors face challenges, they also possess significant advantages and developmental potential. This paper systematically summarizes the current status of MAPK in the treatment of depressive disorder, in order to provide insights for researching the pathogenesis of depressive disorder and developing new antidepressant drugs.]]></description>
<pubDate>2026/1/5 14:04:22</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LIU Yan-Xia,WANG Chun-Yu]]></author>
</item>
<item>
<title><![CDATA[Research on The Genealogical Inference Efficiency of High-density SNPs]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202507180000001]]></link>
<description><![CDATA[<b>Objective</b> This study aims to explore the potential of different orders of magnitude single-nucleotide polymorphism (SNP) locus combinations for predicting distant kinship relationships. A high-density SNP locus set was constructed, and a comprehensive assessment of its inference capability was conducted.<b>Methods</b> Firstly, we selected three commercial chip panels, CGA (Chinese genotyping array, Illumina), GSA (Global screening array, Illumina), Affy (23MF_V2 high-density SNP array, Affymetrix) and merged them after quality control, forming a high-density SNP locus panel(1 180 k). Secondly, we selected 161 samples and collected their peripheral blood samples by using whole-genome sequencing technology. Within this sample population, the levels of kinship relationships fully covered the range from level 1 to level 9, and the number of kinship pairs at each level was consistently maintained at over 50 pairs. From 161 samples data of whole-genome sequencing, the 1 180 k locus set was extracted, which is referred to as the high-density SNP locus set in the following text. The kinship inference was conducted using the identity-by-descent (IBD) algorithm with the selected optimal parameters. To comprehensively evaluate the performance of the high-density SNP locus set in kinship inference, we compared it with the three commercial chip panels, the intersection of these three chip loci, and the control sets constructed by randomly reducing the number of the high-density SNP locus set. Based on the changes in the IBD lengths, as well as the dynamic trends in prediction accuracy, we conducted a scientific assessment of the kinship inference capability of the high-density SNP locus set.<b>Results</b> After screening, a set of 1 184 334 autosomal SNPs was obtained. During the process of screening the optimal IBD length threshold, the result revealed that 0 cM, 1 cM, and 2 cM all demonstrated good applicability. However, to avoid the issue of a large amount of redundant information caused by setting a too low IBD length threshold, this study ultimately selected 2 cM as the optimal threshold. Compared with the average results of three chip panels, the high-density SNP locus set increased the total IBD length and the average IBD length across levels 1-9; the accuracy of the confidence interval for level 8 was 70.97%, which represented a 3.50% improvement; the average confidence interval accuracy for levels 1-8 was 91.39%, representing a 1.00% increase; and the false negative rates at levels 8 and 9 were reduced by 2.42% and 6.76%, respectively. The system efficacy of the high-density SNP locus set for kinship inference of first to eighth degree relationships reached 98.91%. Through random reduction of the high-density SNP locus set results, it is found that increasing the number of SNPs with the panel, the detection efficiency of IBD length showed a significant upward trend. At the same time, the overall trend in the accuracy of kinship relationship prediction as well as the confidence interval accuracy also indicated that both metrics steadily increased with the addition of more loci.<b>Conclusion</b> The results show that the high-density SNPs panel significantly enhances the efficacy of distant kinship inference, accurately covering kinship degrees, with the average confidence interval accuracy for first to eighth degree relationships stably above 90%. The study finds that increasing the number of SNPs panel can improve the ability to predict distant kinship.]]></description>
<pubDate>2026/1/4 22:38:33</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[LI Cai-Xia,LI Jing,LIU Jing,SUN Yi-Jie,TANG Zi-Chen,ZHAO Wen-Ting]]></author>
</item>
<item>
<title><![CDATA[The Regulatory Effects and Mechanisms of Piezo1 Channel on Chondrocytes and Bone Metabolic Dysregulation in Osteoarthritis]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202507260000001]]></link>
<description><![CDATA[Osteoarthritis (OA), a highly prevalent degenerative joint disease worldwide, is defined by articular cartilage degradation, abnormal bone remodeling, and persistent chronic inflammation. It severely compromises patients’ quality of life, and currently, there is no radical cure. Abnormal mechanical stress is widely regarded as a core driver of OA pathogenesis, and the exploration of mechanical signal perception and transduction mechanisms has become crucial for deciphering OA’s pathophysiological processes. Piezo1, a key mechanosensitive cation channel belonging to the Piezo protein family, has recently gained significant attention due to its pivotal role in mediating cellular responses to mechanical stimuli in joint tissues. This review systematically examines Piezo1’s expression patterns, regulatory mechanisms, and pathological functions in OA, with a particular focus on its dual roles in modulating chondrocyte homeostasis and bone metabolism disorders, while also delving into the underlying molecular signaling pathways and potential therapeutic implications. Piezo1, consisting of approximately 2 500 amino acids and forming a unique trimeric propeller-like structure, is widely expressed in chondrocytes, osteocytes, mesenchymal stem cells, and synovial cells. It exhibits permeability to cations such as Ca<sup>2+</sup>, K<sup>+</sup>, and Na<sup>+</sup>, and directly responds to membrane tension changes induced by mechanical stimuli like fluid shear stress and mechanical overload. In OA patients and animal models, Piezo1 expression is significantly upregulated, especially in cartilage regions subjected to abnormal mechanical stress (<i>e.g</i>., human temporomandibular joint cartilage). This overexpression is closely associated with aggravated cartilage degeneration, increased chondrocyte apoptosis, accelerated cellular senescence, and intensified inflammatory responses. Mechanical overload and pro-inflammatory cytokines (<i>e.g</i>., IL-1β) are key inducers of Piezo1 upregulation: IL-1β activates the PI3K/AKT/mTOR signaling pathway to enhance Piezo1 expression, forming a pathogenic positive feedback loop that inhibits chondrocyte autophagy, promotes apoptosis, and further accelerates joint degeneration. Mechanistically, Piezo1 mediates OA progression through multiple interconnected pathways. When activated by mechanical stress, Piezo1 triggers excessive Ca<sup>2+</sup> influx, leading to endoplasmic reticulum stress (ERS) and mitochondrial dysfunction, which directly induce chondrocyte apoptosis. This process involves the activation of downstream signaling cascades such as cGAS-STING and YAP-MMP13/ADAMTS5. YAP, a transcriptional regulator, upregulates the expression of matrix metalloproteinase 13 (MMP13) and aggrecanase (ADAMTS5), thereby accelerating cartilage matrix degradation. Additionally, Piezo1-driven Ca<sup>2+</sup> overload promotes the accumulation of reactive oxygen species (ROS) and upregulates senescence markers (p16 and p21), accelerating chondrocyte senescence <i>via</i> the p38MAPK and NF-κB pathways. Senescent chondrocytes secrete senescence-associated secretory phenotype (SASP) factors (<i>e.g</i>., IL-6, IL-1β), further amplifying joint inflammation. In terms of bone metabolism, Piezo1 maintains joint homeostasis by promoting the differentiation of fibrocartilage stem cells into chondrocytes and balancing bone formation and resorption through regulating the FoxC1/YAP axis and RANKL/OPG ratio. Therapeutically, targeting Piezo1 shows promising potential. Preclinical studies have demonstrated that Piezo1 inhibitors (<i>e.g</i>., GsMTx4) can reduce joint damage and alleviate pain in OA mice. Simultaneously, siRNA-mediated co-silencing of Piezo1 and TRPV4 (another mechanosensitive channel) decreases intracellular Ca<sup>2+</sup> concentration, inhibits chondrocyte apoptosis, and promotes cartilage repair. Conditional knockout of Piezo1 using Gdf5-Cre transgenic mice alleviates cartilage degeneration in post-traumatic OA models by downregulating MMP13 and ADAMTS5 expression. Despite existing challenges, such as off-target effects of inhibitors, inefficient local drug delivery, and interindividual genetic variability, strategies like developing selective Piezo1 antagonists, optimizing targeted nanocarriers, and combining Piezo1-targeted therapy with physical therapy provide viable avenues for clinical translation. The authors propose that Piezo1 serves as a critical therapeutic target for OA, and future research should focus on deciphering its context-dependent regulatory networks, developing tissue-specific intervention strategies, and validating their efficacy and safety in clinical trials to address the unmet medical needs of OA patients.]]></description>
<pubDate>2026/1/1 22:29:42</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[BAI Bi-Hui,CHEN Wen,GU Yu-Biao,HE Zhi-Jun,LI Fei,LI Jin-Peng,LI Yan,LIU Tao,TIAN Hui-Qing,ZHANG Lei]]></author>
</item>
<item>
<title><![CDATA[The Neural Oscillatory Mechanisms of Emotion Affecting Working Memory: a Dual-path Model Based on Competition and Interference]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202507220000002]]></link>
<description><![CDATA[Working memory (WM) serves as the core of advanced cognitive functions, enabling the temporary storage and manipulation of information, which is crucial for reasoning, comprehension, and decision-making. However, its performance is influenced by emotional states; for instance, stress or anxiety may impair accurate recall or prioritize the processing of threatening stimuli. This review integrates research on the neural oscillatory mechanisms by which emotions affect WM, emphasizing shared patterns in the θ, α, β, and γ frequency bands. Emotions activate distinct neural circuits and alter oscillatory characteristics through arousal and valence, overlapping with the neural activities required for WM processes. This article aims to elucidate these mechanisms and propose a dual-pathway theoretical framework for emotional influences on WM. The cognitive efficiency hypothesis posits that emotions and WM compete for shared oscillatory resources. Both emotional processing and high WM load enhance cortical excitability by reducing α power to optimize attention allocation. Negative emotions, under sufficient presentation time, prioritize resource allocation to improve WM precision through enhanced sustained α suppression, albeit at the cost of reducing the number of remembered items. The patterns of θ power increases induced by emotions and task load overlap, potentially leading to θ/β saturation under high load, which limits cognitive regulation, while under low load, they synergistically support information maintenance. Emotional states and the β oscillations relied upon for WM maintenance converge in frequency, prone to synergy or competition. High arousal induced by emotions, as well as anxiety alleviation through music, can reduce prefrontal β oscillation power, bringing the brain closer to the low-β state required for WM maintenance, thereby enhancing memory performance and neural efficiency. Similar γ oscillations and α-γ coupling patterns induced by emotions and WM compete for neural resources, interfering with inter-brain region information integration and weakening the regulation of γ amplitude by α rhythms, thus impairing information exchange efficiency and processing stability. The interference hypothesis suggests that emotions directly disrupt the rhythms required for WM. Negative emotions typically reduce the power and synchrony of α oscillations, a change opposite to the α enhancement mode needed during the WM maintenance phase, thereby weakening interference shielding capabilities. The decrease in θ oscillation power induced by negative emotions contrasts with the θ enhancement required for WM tasks, thereby interfering with information maintenance, manipulation, and multi-item integration, leading to declines in memory capacity and precision. Negative or high-arousal emotions significantly disrupt β oscillation power and synchrony in WM tasks, resulting in impaired inter-brain coordination, reduced information stability, and consequently weakened task performance. Emotions directly alter γ oscillation power and θ-γ coupling patterns, with these changes opposing the enhancement direction required for WM tasks, thereby causing neural activity imbalances and information integration obstacles. The cognitive efficiency hypothesis and the interference hypothesis, as a dual-pathway model for emotional influences on WM, are not opposing explanatory frameworks but rather reflect a dynamic and complementary regulatory mechanism in emotion-cognition interactions. The brain flexibly selects interference or efficiency pathways based on current task load, emotional intensity, and individual states to maintain overall functional stability, with its core mechanism lying in the limited and adaptive allocation of brain neural oscillatory resources.Future research should delve into the impacts of emotional states, cognitive load, emotional arousal, and regulatory strategies on WM and its neural modulatory effects, to optimize personalized cognitive intervention strategies.]]></description>
<pubDate>2025/12/31 10:44:26</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DONG Xin-Wen,LI Yong-Hui,SHEN Xun-Bing,TANG Yu-Ting]]></author>
</item>
<item>
<title><![CDATA[Interaction Mechnisms Between Gut Microbiota and Ischemic Stroke<sup>* </sup><bold>——</bold>A Study Based on the “Microbiota-Gut-Brain Axis” Integrating 16S rRNA Sequencing with Fecal Microbiota Transplantation]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202505160000001]]></link>
<description><![CDATA[<b>Objective</b> This Study was conducted to investigate the interaction mechemisms between gut microbiota dysregulation and ischemic stroke by establishing a rat model of ischemic stroke and employing fecal microbiota transplantation (FMT).<b>Methods</b> A preliminary experiment was conducted to establish an antibiotic-induced pseudo-sterile (ABX) rat model through antibiotic treatment, and a cerebral ischemia model was prepared using the middle cerebral artery occlusion (MCAO) method. Fecal microbiota from stroke patients and healthy individuals were transplanted <i>via</i> FMT, followed by behavioral testing. 16S rRNA sequencing was used to analyze the microbial community, hematoxylin and eosin (HE) staining to observe histopathological status, transmission electron microscopy (TEM) to examine the tight junction structure of the small intestine, and enzyme-linked immunosorbent assay (ELISA) to detect levels of inflammatory factors and intestinal barrier-related markers.<b>Results</b> 16S rRNA sequencing of fecal samples showed that compared with the normal control group and the metronidazole group, the abundance and diversity of fecal microorganisms in the quadruple antibiotic group were significantly reduced, indicating successful establishment of the ABX model. After transplanting fecal microbiota from stroke patients into ABX rats, significant changes in gut microbiota composition were observed. Behavioral tests revealed that the MCAO model group showed significant decreases in both horizontal movement and vertical exploration abilities. ELISA results indicated that IL-17 concentration in the ABX+mFMT (antibiotic-treated+control fecal microbiota transplantation) group was lower than in the ABX+cFMT (antibiotic-treated+model fecal microbiota transplantation) group, suggesting that IL-17 may serve as a key inflammatory indicator for evaluating the impact of stroke intervention on gut microbiota. Triphenyltetrazolium chloricle staining (TTC) staining suggested that gut microbiota intervention may increase the risk of stroke. HE staining showed that, except for the control group, all groups exhibited ischemic changes and inflammatory infiltration in brain tissues. TEM revealed that microvilli of small intestinal epithelial cells in the ABX+mFMT group were sparser than those in the ABX+cFMT group, indicating that microbial intervention affects intestinal barrier function.<b>Conclusion</b> The ABX model established using broad-spectrum antibiotics showed no significant differences in physiological characteristics compared to normal rats, and the findings were consistent with those from germ-free rat models. Stroke prognosis appears to be influenced by intestinal dysbiosis, accompanied by significantly elevated levels of the pro-inflammatory cytokine IL-17, which may exacerbate neural injury <i>via</i> the gut-brain axis. Behavioral experiments indicated that transplantation of gut microbiota from stroke rats impaired cognitive function. Furthermore, IL-17 demonstrated sensitivity to alterations in the gut microbiota, suggesting its potential as a key therapeutic target for stroke intervention.]]></description>
<pubDate>2025/12/30 14:23:35</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[JIANG Chao,WANG Ting,ZHANG Jing-Hao]]></author>
</item>
<item>
<title><![CDATA[Nanopackaged Astaxanthin Improves Demyelination in Multiple Sclerosis Model Mice by Scavenging Excessive Endogenous Formaldehyde]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202507220000005]]></link>
<description><![CDATA[<b>Objective</b> Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS); however, its underlying neurological pathogenic mechanisms remain incompletely understood. Endogenous formaldehyde (FA), a metabolic byproduct of methylation-demethylation cycles, has recently been implicated in neurotoxicity, oxidative damage, and cognitive impairment. This study aimed to investigate whether excessive FA contributes to myelin sheath demyelination in mice and to evaluate the protective effects and mechanisms of two FA-elimination strategies: sodium bisulfite (NaHSO<sub>3</sub>), a classical FA scavenger, and polyethylene glycol-modified astaxanthin nanoparticles (PEG-ATX@NPs), a brain-targeted nano-antioxidant formulation.<b>Methods</b> A chronic demyelination model was established by feeding female C57BL/6J mice a diet containing 0.2% cuprizone (CPZ) for four weeks, followed by a two-week intervention period. Eighty mice were randomly assigned to four groups: NS (normal saline), CPZ+NS, CPZ+NaHSO<sub>3</sub>, and CPZ+PEG-ATX@NPs. Behavioral tests, including open-field, Y-maze, and pole-climbing assays, were conducted to assess locomotor activity, motor coordination, and working memory. FA levels in serum, corpus callosum, and spinal cord were measured using an Na-FA fluorescent probe and quantified <i>via in vivo</i> and <i>ex vivo </i>fluorescence imaging. Neuroinflammatory responses were evaluated by measuring TNF-α, IL-1β, and IL-6 levels using ELISA, while oxidative stress was assessed by reactive oxygen species (ROS) fluorescence intensity. Demyelination was examined <i>via </i>Luxol fast blue staining, and microglial activation was analyzed by Iba1 immunofluorescence. Correlation analyses were performed to explore relationships among FA levels, inflammatory cytokines, ROS intensity, and behavioral parameters.<b>Results</b> Compared with the NS group, mice in the CPZ+NS group exhibited significant weight loss, impaired motor coordination and memory, and markedly reduced myelin regeneration (<i>P</i><0.05). FA levels and pro-inflammatory cytokines were significantly elevated in serum, corpus callosum, and spinal cord (<i>P</i><0.05). FA-associated fluorescence in brain and spinal tissues, as well as ROS intensity across all tissues examined, also increased substantially (<i>P</i><0.05). CPZ treatment induced pronounced microglial activation and severe demyelination in the corpus callosum (<i>P</i><0.01). Both NaHSO<sub>3</sub> and PEG-ATX@NPs effectively reduced FA accumulation in the brain and spinal cord, attenuated demyelination, suppressed microglial activation, decreased inflammatory cytokine levels, and improved motor and cognitive performance. These results confirm that CPZ induced severe demyelination accompanied by oxidative stress, neuroinflammation, and abnormal FA accumulation. Following intervention with either NaHSO<sub>3</sub> or PEG-ATX@NPs, endogenous FA levels in the CNS were substantially reduced. Both treatments alleviated demyelination and significantly decreased the number of activated microglia. Levels of TNF-α, IL-1β, and IL-6 in serum, corpus callosum, and spinal cord were downregulated. Behavioral performance improved significantly, as evidenced by enhanced locomotor activity, better coordination, and improved memory function. These findings indicate that both FA-scavenging agents mitigate CPZ-induced biochemical and behavioral abnormalities.<b>Conclusion</b> This study demonstrates that excessive endogenous FA is closely associated with cognitive impairment, inflammatory dysregulation, and demyelination in a CPZ-induced chronic demyelination mouse model. Clearing abnormally elevated FA effectively reduces neuroinflammation, suppresses microglial overactivation, decreases oxidative stress, and alleviates demyelination, ultimately improving motor and cognitive outcomes in mice. These results suggest that targeting endogenous FA represents a promising therapeutic strategy for MS and other demyelinating disorders. Further investigations are warranted to explore the long-term safety, dosage optimization, and molecular pathways involved in FA-mediated neurotoxicity.]]></description>
<pubDate>2025/12/29 15:08:27</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[Lü Wan-Jia,MA Ping,TONG Zhi-Qian,WU Mei-Na,XING Yang,YANG Xu,ZENG Xin]]></author>
</item>
<item>
<title><![CDATA[The Potential and Challenges of Temporal Interference Stimulation in Chronic Pain Management]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202509100000002]]></link>
<description><![CDATA[Chronic pain is a complex condition shaped by long-standing alterations in both physiological and psychological processes. Rather than representing a simple continuation of acute nociceptive signaling, chronic pain is increasingly understood as the outcome of progressive dysregulation within distributed neural systems that govern sensation, affect, motivation, and cognitive control. Neuroimaging and electrophysiological studies indicate that this state is accompanied by extensive plastic changes in deep brain structures and large-scale networks. Beyond well-described central sensitization processes, chronic pain is characterized by disrupted oscillatory rhythms and altered connectivity within large-scale brain networks, including thalamo-cortical circuits and prefrontal-limbic-reward networks. These findings support a conceptual shift from viewing chronic pain as a focal, lesion-driven phenomenon toward recognizing it as a disorder of distributed network pathology. Pharmacological treatments remain central to clinical practice, yet their long-term efficacy is often limited and frequently accompanied by substantial side effects. The ongoing concerns about opioid-related risks and the inadequate therapeutic response in a subset of patients highlight the need for safe, non-pharmacological approaches that can address not only pain but also comorbid disturbances in mood, sleep, and social functioning. Neuromodulation provides a promising path toward mechanism-based and non-pharmacological management of chronic pain by employing physical or chemical stimulation to alter the excitability and synchrony of specific neural populations within central, peripheral, and autonomic systems. While invasive deep brain stimulation demonstrates that targeting deep brain structures can be effective, its clinical application is restricted by surgical risks and cost, highlighting the importance of non-invasive techniques capable of reaching deep targets. Current non-invasive approaches, such as transcranial electric stimulation, are constrained by limited penetration depth and insufficient spatial precision. These limitations hinder reliable engagement of deep regions implicated in pain, including the thalamus and nucleus accumbens, and tend to produce broad, non-specific modulation of cross-network oscillatory activity. Temporal interference (TI) stimulation has emerged as a means of overcoming these obstacles. By delivering interacting high-frequency currents that generate a low-frequency envelope within the head, TI enables focal stimulation of deep targets while minimizing superficial current delivery. Recent multiscale modeling and animal studies indicate that TI exploits the nonlinear rectification properties of neuronal membranes in response to high-frequency carriers, as well as their phase-locked responses to low-frequency envelopes, to generate “peak-focused” electric fields in deep regions under relatively low superficial current loads. Moreover, TI appears to exhibit potential advantages in terms of cell-type selectivity and rhythm-specific engagement, including differential responses across neuronal subtypes and distinct coupling to θ-, β-, and γ-band oscillations. These features suggest a promising avenue for correcting abnormal rhythms and network dynamics that contribute to chronic pain. This review summarizes current knowledge of the neural mechanisms underlying chronic pain and recent advances in TI research. It examines functional disturbances across key pain-related regions and networks, outlines the principles and technical characteristics of TI, and discusses potential deep-brain targets and stimulation strategies relevant to chronic pain. Evidence to date indicates that TI, with its non-invasiveness, tolerability, and capacity for precise deep brain modulation, holds great promise for the management of treatment-resistant chronic pain and may evolve into a new generation of precise and efficient non-pharmacological analgesic strategies.]]></description>
<pubDate>2025/12/29 13:43:00</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DUAN Hao-Qing,GOU Yu-Qi,HU Li,LI Ya-Wen,Lü Xue-Jing]]></author>
</item>
<item>
<title><![CDATA[From Golgi Stress to Golgiphagy—a New Regulatory Model Involved in Glucose and Lipid Metabolism]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202510110000003]]></link>
<description><![CDATA[The Golgi body, a core organelle in eukaryotic cells, plays a critical role in protein modification, sorting, vesicular transport, and serves as a key site for lipid synthesis and glycosylation. Glucose and lipid metabolism are central processes for cellular energy maintenance and biosynthesis, and are closely linked to Golgi function. Recent studies have revealed the extensive involvement of the Golgi body in regulating glucose and lipid metabolism, where maintaining its structural and functional homeostasis is crucial for normal physiological activity. Under various stress conditions such as acidosis, hypoxia, and nutrient deficiency, the Golgi body undergoes structural and functional disruption, leading to Golgi stress. This in turn activates specific signaling pathways, such as those mediated by the cAMP-responsive element binding protein 3 (CREB3) and proteoglycans, to alleviate Golgi stress and enhance Golgi function. Golgi stress contributes to glucose and lipid metabolic disorders by affecting the activity of insulin receptors, glucose transporters, and lipid metabolism-related enzymes. For example, Golgi stress triggers the cleavage and release of the active fragment of CREB3, which enters the nucleus and upregulates the transcription of ADP-ribosylation factor 4 (ARF4) and key gluconeogenic enzymes, including phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase). ARF4 promotes vesicle retrograde transport between the Golgi and endoplasmic reticulum, maintains secretory capacity, and enhances hepatic glucose output. This pathway is particularly active under high-fat or lipotoxic stress, leading to fasting hyperglycemia. When damaged Golgi components accumulate beyond a tolerable threshold, the cell initiates an autophagic response, selectively encapsulating the damaged Golgi into autophagosomes, which then fuse with lysosomes to form autolysosomes, leading to Golgiphagy. This process results in the degradation and clearance of damaged Golgi, thereby regulating Golgi quantity, quality, and function. Golgiphagy also plays a significant role in regulating glucose and lipid metabolism. For instance, under high-glucose conditions, autophagic flux may be suppressed, impairing the timely clearance and renewal of damaged Golgi, compromising its normal function, and further exacerbating glucose metabolism disorders. Additionally, Golgiphagy may participate in lipid degradation and influence lipid synthesis and transport. Research indicates that Golgi stress and Golgiphagy play important roles in glucose and lipid metabolism-related diseases. For example, the leucine zipper protein (LZIP) under Golgi stress conditions can promote hepatic steatosis. In mouse primary cells and human tissues, LZIP induces the expression of apolipoprotein A-IV (APOA4), which increases peripheral free fatty acid uptake, resulting in lipid accumulation in the liver and contributing to the development of fatty liver disease. This review systematically outlines the structure and function of the Golgi apparatus, the molecular regulatory mechanisms of Golgi stress and Golgiphagy, and their synergistic roles. It further elaborates on how Golgi stress and Golgiphagy participate in the regulation of glucose and lipid metabolism, discusses their clinical significance in related diseases such as diabetes, fatty liver disease, and obesity, and highlights potential novel therapeutic strategies from the perspective of Golgi-targeted medicine<bold>.</bold> Finally, this article addresses the challenges and future directions in Golgi-targeted interventions, aiming to advance the clinical translation of such strategies and foster breakthroughs in the treatment of glucose and lipid metabolism-related disorders.]]></description>
<pubDate>2025/12/26 21:25:35</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Lin-Xi,CHEN Shu-Jing,WANG He-Ming,WANG Shu-Zhi,WEI Hai-Jun]]></author>
</item>
<item>
<title><![CDATA[Assessing High-density Y-SNP Panels for Paternal Haplogroup Assignment in Forensic Practice]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202511030000001]]></link>
<description><![CDATA[<b>Objective</b> The accuracy of Y-chromosome haplogroup assignment is crucial for tracing paternal lineage in male samples. With the advancement of high-throughput sequencing technologies, high-density Y-SNP genotyping from whole-genome or array-based data has become a standard method for determining Y-chromosome haplogroups. This study systematically evaluated the performance of 4 commonly used high-density SNP genotyping systems—namely, the Global Screening Array (GSA), Chinese Genotyping Array (CGA), Affymetrix array, and the 1240K capture panel—for haplogroup assignment. This work provides a reference for data comparison across different systems.<b>Methods</b> We extracted genotype data for the 4 Y-SNP panels from 30× whole-genome sequencing (WGS) data of 1 590 male samples from the 1000 Genomes Project. Additionally, GSA array genotype data from 384 relative pairs (spanning 1st- to 12th-degree relationships) from 109 Chinese Han families were collected. Haplogroup assignment was performed using Y-LineageTracker v1.3.0 software. We assessed the concordance and resolution of haplogroup assignments between the four Y-SNP panels and the WGS data. The consistency and resolution of haplogroup assignments were also evaluated for both the 1000 Genomes Project samples and the 109 family samples collected in this study. Furthermore, the impact of varying numbers of Y-SNPs on haplogroup assignment was examined.<b>Results</b> The GSA and CGA panels demonstrated superior resolution and discrimination of haplogroup subclades compared with the other two panels. The haplogroup assignments from the GSA, CGA, and 1240K panels showed high concordance with WGS data, with consistency rates exceeding 88.70%, whereas the Affymetrix platform exhibited a significantly lower consistency rate of 61.89%. Specifically, the GSA and CGA panels consistently demonstrated superior performance compared with the other two panels in the assignment of haplogroups O-M175 and H-L901, achieving complete concordance (100%) for both haplogroups. In contrast, the Affymetrix panel erroneously assigned all individuals belonging to haplogroup O-M175 to haplogroup K2-M526. Furthermore, its accuracy for haplogroup H-L901 was exceedingly low, at merely 1.41%. This poor performance was characterized by the misassignment of 98.59% of H-L901 samples—specifically, 1.41% to J-M304 and a predominant 97.18% to F-M89. For haplogroup R-M207, all four panels exhibited uniformly high levels of consistency, with concordance values exceeding 94.00%. Notably, for haplogroup E-M96, the 1240K and Affymetrix panels outperformed the GSA and CGA panels in terms of concordance, representing the first instance in which these two panels surpassed the latter. Conversely, for haplogroups J-M304, Q-M242, and I-M170, all 4 panels showed relatively elevated misclassification rates, with the Affymetrix array demonstrating the poorest overall performance. None of the four panels showed any discordant haplogroup assignments among the familial relative pairs analyzed. A positive correlation was observed between the number of Y-SNPs (ranging from 1 000 to 10 000) and classification consistency; however, classification consistency plateaued when the number of Y-SNPs exceeded 10 000. Furthermore, a random sampling analysis conducted on the GSA and CGA panels demonstrated that the haplogroup misclassification rate exhibited negligible fluctuation across the Y-SNP range of 500 to 1 000. Conversely, a marked enhancement in classification consistency was observed as the number of markers increased from 1 000 to 5 000, ultimately reaching a plateau within the interval of 5 000 to 8 000 markers.<b>Conclusion</b> These findings indicate that the GSA and CGA panels provide high resolution and concordance, delivering reliable Y-haplogroup assignment for forensic investigations.]]></description>
<pubDate>2025/12/26 10:19:04</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[GAO Jing,HUANG Jiang,JIANG Li,LOU Lin-Lin,NI Meng,WANG Chun-Nian,ZHANG De-Qin]]></author>
</item>
<item>
<title><![CDATA[Effect of Microorganisms on The Spoilage of Donkey Hides From Different Regions]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202511090000001]]></link>
<description><![CDATA[<b>Objective</b> Donkey hide is the sole legally designated raw material for the preparation of the traditional Chinese medicine Ejiao. The quality stability of donkey hide during preservation directly determines the efficacy and safety of Ejiao. This study focuses on the dynamic succession of microbial communities during the preservation of donkey hides from different origins, aiming to clarify the correlation between microbial biodiversity difference and the degradation profiles of hide collagen and critical biochemical components, thereby providing a theoretical foundation for developing targeted preservation strategies based on microbial regulation.<b>Methods</b> Donkey hides originating from four different regions were subjected to an accelerated microbial aging assay to simulate the spoilage process. The microbial community succession was analyzed using high-throughput sequencing. Microstructure changes and pore structure characteristics were assessed by scanning electron microscopy and mercury intrusion porosimetry, respectively. Additionally, the content of major components, including lipids, proteins, and sugars were determined by biochemical methods.<b>Results</b> After 96 h of aging, the collagen fiber structure in Africa donkey hides (ADH) exhibited significant degradation and collapse, followed by Xinjiang donkey hides (XDH). Instead, the microstructure of Dong’e black donkey hides (DDH) and Peru donkey hides (PDH) remained relatively intact. The porosities of DDH, XDH, PDH, and ADH increased from 27.9%, 15.7%, 30.3%, and 46.2% to 36.5%, 52.6%, 42.8%, and 57.7%, respectively, during the aging process, which suggested that the originally compact fiber structure was disrupted by microbial aging. Fourier transform infrared spectrometer analysis revealed the amide bands in XDH exhibited relatively weak intensity, and no collagen amide I band was observed in ADH. Meanwhile, the lipid and protein contents decreased in all four types of donkey hides, indicating that these components served as the primary nutrient sources for the growth of microorganism. Notably, the most severe collagen degradation was observed in XDH and ADH. A substantial increase was detected in the total soluble sugar in PDH aging solution and hydroxyproline in the ADH aging solution, respectively. These results indicated that donkey hides exhibit distinct patterns of structural degradation and nutrient utilization. Furthermore, the viable cells number of donkey hides increased sharply after 48 h of aging. Metagenomic analysis revealed that the relative abundance of Euryarchaeota in ADH, PDH and XDH declining from initial 93.19%, 97.73% and 30.08% to 0.79%, 1.43% and 0.02% after 96 h, respectively. Conversely, a significantly increase was observed in the abundance of Bacillota, with a marked increase in ADH, peaking at 92.75%. Additionally, the abundance of Pseudomonadota in PDH increased from 0.10% to 87.84%, suggesting that Bacillota and Pseudomonadota may be key factors exacerbating donkey hide spoilage. Unlike the other three types of donkey hides, the dominant bacterial phylum in DDH shifted from Pseudomonadota to Bacteroidota, characterized by a substantial abundance increase of Bacteroidota from 0.13% to 44.22%.<b>Conclusion</b> Regional variation in origin significantly influence the microbial aging of donkey hides, leading to distinct patterns of structural deterioration and differential nutrient utilization. Therefore, implementing origin-specific preservation strategies, through the precisely controlling environmental factors to suppress harmful phyla such as Bacillota and Pseudomonadota, is crucial for enhancing the storage quality of donkey hides.]]></description>
<pubDate>2025/12/22 11:08:50</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[KANG Jia-Wei,LI Qiu-Mei,LI Xia,YU Jie,YU Yue,ZHANG Meng]]></author>
</item>
<item>
<title><![CDATA[Discovery of Regulatory T Cells and Their Prospective Therapeutic Applications]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202511140000001]]></link>
<description><![CDATA[Regulatory T cells (Treg cells) are a specialized subset of CD4<sup>+</sup> T cells defined by expression of the lineage-specifying transcription factor FOXP3 and a potent capacity to maintain peripheral immune tolerance. The modern concept of Tregs was catalyzed by Shimon Sakaguchi’s identification of CD4<sup>+</sup>CD25<sup>+</sup> suppressive T cells and subsequent work establishing FOXP3 as a central determinant of Treg cell development and function; together with landmark FOXP3 genetic discoveries by Mary E. Brunkow and Fred Ramsdell, these advances transformed understanding of immune homeostasis and were recognized by the 2025 Nobel Prize in Physiology or Medicine. Under normal physiological conditions, FOXP3<sup>+</sup> Treg cells restrain autoreactive lymphocytes, prevent excessive inflammation, and shape antigen-presenting cell activity through contact-dependent pathways and suppressive cytokines, thereby protecting tissues from immune-mediated damage. Disruption of Treg abundance, stability, or suppressive capacity can therefore lead to immune dysregulation and disease. Over the past two decades, Treg cells have become a major focus of immunology because their roles are highly context-dependent. In autoimmune and chronic inflammatory diseases, impaired Treg cell function or insufficient Treg activity contributes to loss of tolerance and persistent tissue injury, supporting therapeutic approaches designed to enhance Treg cell number, stability, and suppressive potency. In contrast, many cancers exploit Treg cells by promoting their expansion, activation, and recruitment into the tumor microenvironment (TME), where they blunt antitumor immunity by suppressing cytotoxic T-cell priming and effector function, limiting dendritic cell activation, and fostering immune escape. In both settings, immune checkpoint pathways critically influence Treg cell biology. Beyond PD-1/PD-L1 and CTLA-4, emerging checkpoints and costimulatory receptors, including TIGIT, TIM-3, LAG-3, and OX40, modulate Treg cell generation, stability, and suppressive functions, thereby shaping the balance between tolerance and immunity. Meanwhile, immunometabolic adaptations further tune Treg cell fitness and function in inflamed tissues and tumors; lipid utilization and mitochondrial programs, among other metabolic axes, enable Treg cells to persist in nutrient- and oxygen-restricted microenvironments, while microenvironmental stress can drive functional remodeling or fragility in a subset-dependent manner. In this review, we summarize the discovery and defining biological features of Treg cells, highlight core suppressive mechanisms and regulatory circuits, and synthesize evidence for the dual roles of Treg cells in preventing autoimmunity yet enabling tumor immune evasion. We further outline current and emerging therapeutic strategies aimed at augmenting Treg cell activity to restore tolerance in autoimmune disease, or selectively depleting, functionally inhibiting, and reprogramming tumor-resident Treg cells to enhance cancer immunotherapy. Overall we discuss how deeper insight into Treg heterogeneity, checkpoint control, and immunometabolic regulation may enable more precise Treg cell-directed interventions and inform next-generation immunotherapeutic combinations across immune-mediated and malignant diseases.]]></description>
<pubDate>2025/12/18 16:11:21</pubDate>
<category><![CDATA[2025年诺贝尔奖解读]]></category>
<author><![CDATA[RIAZ Farooq,FAN Zu-Sen,JIANG An-Mei,LI Yi-Kui,LIANG Ming-Wei,PAN Fan,ZHANG Zhen-Zhen,ZHOU Zhi-Yi]]></author>
</item>
<item>
<title><![CDATA[Translational Mechanisms of Circular RNAs and The Roles of Their Encoded Peptides in Tumor Initiation and Regulation]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202510280000001]]></link>
<description><![CDATA[Circular RNAs (circRNAs) represent a distinct group of RNA molecules produced through back-splicing of precursor mRNAs. Their covalently closed structure, which lacks both a 5′ cap and a poly(A) tail, renders them highly resistant to exonucleolytic degradation and contributes to their remarkable intracellular stability. Although circRNAs were historically viewed as noncoding transcripts, accumulating evidence indicates that certain circRNAs can undergo translation under appropriate molecular contexts. Two major modes of noncanonical translation have been described so far: initiation mediated by internal ribosome entry sites (IRESs) and translation triggered by N6-methyladenosine (m6A) modification. Recent studies have revealed that, beyond their canonical classification as non-coding RNAs, circRNAs can give rise to functional peptides through cap-independent translational mechanisms. Accumulating evidence indicates that circRNA-encoded peptides participate in key biological processes during tumor initiation and progression by modulating tumor-associated signaling pathways and protein-protein interaction networks. Functionally, these peptides may promote tumor cell proliferation, migration, invasion, and epithelial-mesenchymal transition, while others exert tumor-suppressive effects by inhibiting oncogenic signaling pathways or interfering with critical protein interactions. Their dual and context-dependent functions highlight the complexity of circRNA-mediated regulation and suggest that these translation products participate in multiple layers of tumor initiation and progression. In this review, we synthesize current knowledge regarding the molecular mechanisms that enable circRNAs to be translated, with particular attention to IRES-driven initiation, m6A-dependent regulation, ribosome accessibility, and the structural determinants required for translation competence. We further summarize well-characterized circRNA-encoded peptides and discuss how they influence tumor-associated signaling networks. In addition, we examine the potential translational applications of these peptides, including their value as diagnostic indicators, prognostic markers, or therapeutic entry points. Their inherent sequence stability, relative expression specificity, and detectability in clinical specimens make circRNA-derived peptides promising candidates for future biomarker and therapeutic development. Overall, circRNA translation research is reshaping our understanding of RNA function and offers new perspectives for studying tumor biology. We propose that expanding investigations into circRNA-encoded peptides will not only improve the mechanistic resolution of cancer research but may also pave the way for innovative strategies in precision oncology, including RNA-based therapeutics and peptide-targeting interventions.]]></description>
<pubDate>2025/12/15 11:10:59</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LI Zan,LING Yun,XIANG Qiong,YANG Li-Chang]]></author>
</item>
<item>
<title><![CDATA[Establishment of a Multicellular Co-culture System Based on Droplet Microfluidic Chip for Analysis of Antitumor Drug Sensitivity]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202510100000003]]></link>
<description><![CDATA[<b>Objective</b> This study aimed to construct a cell co-culture microfluidic chip based on droplet microfluidic to investigate the influence of multicellular interactions in complex microenvironments on the sensitivity of anti-tumor drugs.<b>Methods</b> We constructed a droplet microfluidic chip consisting of 12 co-culture units, with each unit containing 4 microwells for holding cell droplets, enabling the co-culture of 4 types of cells. To evaluate whether the co-culture of multiple cell types can be achieved in the droplet microfluidic chip, as well as to observe and analyze the interactions between different cell types, we investigated the interaction between microenvironmental cells and tumor cells through cell co-culture experiments. To construct a stable co-culture system capable of evaluating drug sensitivity, we conducted diffusion experiments with blue ink and model drugs to investigate the ability of drugs to diffuse in the chip and be taken up by cells. To investigate the effect of the complex microenvironment on cellular drug sensitivity, we carried out cell co-culture experiments combined with drug treatment to explore the changes in the drug sensitivity of tumor cells in the presence of microenvironmental cells. To explore the reasons for drug resistance in tumor cells under co-culture conditions, we detected DNA double-strand break marker using immunofluorescence.<b>Results</b> Experiments on cell culture within droplets showed that cells in each droplet exhibited good proliferation ability and consistent cell status, laying a foundation for the co-culture of multiple kind of cells. Cell co-culture experiments showed that compared with the mono-culture group, the numbers of LoVo cells, HUVECs, and macrophages in the co-culture group increased significantly. This confirms that there are obvious interactions between cancer-associated fibroblasts (CAFs), endothelial cells (HUVECs), macrophages, and tumor cells in the microenvironment, which promotes cell proliferation in the co-culture chip. Experiments on blue ink diffusion showed that drugs could diffuse uniformly and effectively into wells in different directions within the chip. Experiments on the diffusion of doxorubicin (a model drug) demonstrated that identical cells in different wells exhibited consistent drug uptake capacity. Additionally, cell co-culture experiments combined with oxiliplatin treatment revealed that with the concentration of 80 μmol/L, the survival rate of LoVo cells cultured alone was only 25%, whereas it reached 96% under co-culture conditions; With the concentration of 160 μmol/L, the survival rate of LoVo cells cultured alone was merely 2%, while that under co-culture conditions was 50%. These results indicate that the complex microenvironment composed of CAFs, HUVECs, and macrophages significantly reduces the drug sensitivity of LoVo cells to oxaliplatin through intercellular interactions. The immunofluorescence results showed that the expression level of γH2AX in LoVo cells decreased under co-culture conditions.<b>Conclusion</b> Our study achieved co-culture of the main constituent cells of the tumor microenvironment and analysis of their drug sensitivity in a droplet microfluidic chip for the first time. The research found that crosstalk between different microenvironmental cells strongly affects the drug sensitivity of tumor cells to oxaliplatin, suggesting that targeting the interactions between tumor microenvironmental cells is an effective strategy to improve the efficacy of tumor therapy. Our study provides new methods and approaches for the efficacy evaluation of anti-tumor drugs and the screening of new drugs. In addition, the open structural design of the co-culture chip can be combined with various omics technologies to analyze the molecular characteristics of cells under co-culture and drug treatment conditions. This is expected to provide new methods and experimental evidence for elucidating the mechanisms of drug action and identifying novel drug targets in the context of the microenvironment.]]></description>
<pubDate>2025/12/15 11:09:11</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CHEN Shuo,FANG Jin,ZHANG Xue-Tong]]></author>
</item>
<item>
<title><![CDATA[Applications of Metal-organic Frameworks in The Field of Biomedicine]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202511200000002]]></link>
<description><![CDATA[Metal-organic frameworks (MOFs), a class of porous crystalline materials formed by the self-assembly of metal ions/clusters and organic ligands, have shown broad application potential in the biomedical field due to their high specific surface area, precisely tunable pore structure, designable framework composition, and good biocompatibility. This paper traces the origin and development of MOFs, summarizes the contributions of the main promoters, and then systematically reviews the conventional synthesis and characterization methods of MOFs. Subsequently, it conducts an in-depth discussion around three application directions in the biomedical field: first, in the integration of cancer diagnosis and treatment, MOF-based treatment systems can integrate multiple modes such as chemotherapy, radiotherapy, photodynamic therapy, photothermal therapy, chemodynamic therapy, starvation therapy, and immunotherapy through single or combined strategies to exert a synergistic anti- tumor therapeutic effect; second, by constructing MOF-based carriers, including pH-responsive, GSH-responsive, and photo-responsive carriers, effective loading and precise delivery of drug molecules, including biological macromolecules, can be achieved; third, in the field of <i>in vitro</i> diagnosis, various MOF-based biomarker detection methods have been developed, providing technical means for the precise early diagnosis of diseases. Meanwhile, this paper deeply analyzes the key challenges that MOFs still face in clinical translation, including large-scale preparation, long-term stability, and biological safety assessment, and prospects the future development directions and application prospects.]]></description>
<pubDate>2025/12/15 11:06:33</pubDate>
<category><![CDATA[2025年诺贝尔奖解读]]></category>
<author><![CDATA[FANG Xiao-Cui,GENG Fu-Kang,LEI Sheng-Bin,WANG Chen]]></author>
</item>
<item>
<title><![CDATA[MCC950 Targeted Inhibition of TXNIP-NLRP3 Axis-mediated Podocyte Pyroptosis in Diabetic Nephropathy]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202508220000003]]></link>
<description><![CDATA[Diabetic Nephropathy (DN) is the leading cause of end-stage renal disease (ESRD) globally, representing a major global health burden with limited disease-modifying therapies. Podocyte injury serves as the core pathological hallmark of DN, and conventional treatments targeting metabolic disorders or hemodynamic abnormalities fail to reverse the progressive decline of renal function. Accumulating evidence over the past decade has established that high glucose-induced podocyte pyroptosis—a pro-inflammatory form of programmed cell death—is a key driving force in DN progression. Its core molecular mechanism hinges on the activation of the TXNIP-NLRP3 inflammasome axis. Under sustained hyperglycemic conditions, excessive reactive oxygen species (ROS) are generated <i>via</i> pathways including the polyol pathway, advanced glycation end products (AGEs) accumulation, and mitochondrial dysfunction. Concurrently, methylglyoxal (a glucose metabolite) mediates post-translational modification of thioredoxin-interacting protein (TXNIP). These events collectively trigger the dissociation of TXNIP from thioredoxin (TRX), a redox-regulating protein. The free TXNIP then translocates to the mitochondria, where it binds to The NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) and promotes inflammasome assembly. This assembly activates cysteine-aspartic acid protease 1 (caspase-1), which cleaves Gasdermin D (GSDMD) to generate its N-terminal fragment (GSDMD-NT). GSDMD-NT oligomerizes to form membrane pores, leading to podocyte swelling, rupture, and the release of pro-inflammatory cytokines interleukin-1β (IL-1β) and interleukin-18 (IL-18). These cytokines amplify local inflammatory responses, induce mesangial cell proliferation, and accelerate extracellular matrix deposition, ultimately exacerbating glomerulosclerosis. MCC950, a highly selective NLRP3 inhibitor, exerts its therapeutic effects through a multi-layered mechanism: it binds to the NACHT domain (NAIP, CIITA, HET-E and TP1 domain) of NLRP3 with nanomolar affinity, forming hydrogen bonds with key residues (Lys-42 and Asp-166) within the ATP-hydrolysis pocket to block ATP hydrolysis, thereby locking NLRP3 in an inactive conformational state. Additionally, MCC950 interferes with the protein-protein interaction between TXNIP and NLRP3 and regulates mitochondrial homeostasis to reduce ROS production. Preclinical studies have demonstrated that MCC950 dose-dependently reduces proteinuria, restores the expression of podocyte-specific markers (nephrin and Wilms tumor 1 protein, WT1), and alleviates podocyte foot process fusion and glomerulosclerosis in both streptozotocin (STZ)-induced type 1 diabetic models (characterized by absolute insulin deficiency) and db/db type 2 diabetic models (driven by insulin resistance). However, discrepancies in therapeutic outcomes exist across different models—some studies report exacerbated renal inflammation and fibrosis in STZ-induced models—which may stem from differences in disease pathogenesis, intervention timing (early <i>vs.</i> mid-stage disease), and dosing duration. Despite its promising preclinical efficacy, MCC950 faces significant translational challenges, including low oral bioavailability, insufficient podocyte targeting, potential hepatotoxicity, and drug-drug interactions with statins (commonly prescribed to diabetic patients for cardiovascular risk management). Furthermore, off-target effects such as the inhibition of carbonic anhydrase 2 have been identified, raising concerns about its safety profile. Nevertheless, its unique mechanism of action—directly blocking podocyte pyroptosis by targeting the TXNIP-NLRP3 axis—endows it with substantial translational value. In the future, strategies to overcome these barriers are expected to advance its clinical application: targeted delivery via nanocarriers (<i>e.g</i>., PLGA-PEG nanoparticles or nephrin antibody-conjugated systems) to enhance renal accumulation and podocyte specificity; precise patient stratification based on biomarkers such as serum IL-18 and renal TXNIP/NLRP3 expression to identify “inflammatory-phenotype” DN patients most likely to benefit; and combination therapy with sodium-glucose cotransporter 2 (SGLT2) inhibitors—whose metabolic benefits synergize with MCC950’s anti-inflammatory effects. These approaches hold great potential to break through clinical translation bottlenecks, offering a novel, precise anti-inflammatory treatment option for DN and addressing an unmet clinical need for therapies targeting the inflammatory underpinnings of the disease.]]></description>
<pubDate>2025/12/13 14:04:01</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LIU Hang,MO Zhong-Cheng,PAN Xi-Zhang,WEI Bing,ZHENG Hong]]></author>
</item>
<item>
<title><![CDATA[Applications of Lactoferrin and Its Nanoparticles in Cancer Therapy]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202506240000002]]></link>
<description><![CDATA[Cancer remains a leading cause of global mortality, necessitating the development of advanced therapeutic strategies with enhanced efficacy and reduced systemic toxicity. Among promising bioactive agents, lactoferrin (LF)—a multifunctional iron-binding glycoprotein abundantly found in mammalian milk and exocrine secretions—has garnered significant interest for its potent and multifaceted anti-cancer properties. This review provides a comprehensive analysis of the current understanding of LF’s role in oncology, encompassing its structural biology, diverse mechanisms of action, and groundbreaking advancements in its application through nano-engineering. LF exerts anti-tumor effects through multiple pathways, including extracellular action, intracellular action, and immune regulation. It demonstrates a remarkable affinity for cancer cell membranes, binding to overexpressed anionic components such as glycosaminoglycans and sialic acids, as well as to specific receptors including the low-density lipoprotein receptor-related protein-1 (LRP-1). This selective binding facilitates targeted uptake. Upon internalization, LF orchestrates a direct assault by inducing cell-cycle arrest in phases such as G0/G1 or S phase through the modulation of key regulators including cyclins, CDKs, and p53. Furthermore, it promotes programmed cell death via apoptotic pathways, involving caspase activation and downregulation of anti-apoptotic proteins such as survivin. A more recently elucidated mechanism is the induction of ferroptosis, an iron-dependent form of cell death characterized by overwhelming lipid peroxidation. Beyond direct cytotoxicity, LF acts as a potent immunomodulator. It enhances natural killer (NK) cell activity, modulates T-lymphocyte populations, and crucially reprograms tumor-associated macrophages (TAMs) from a pro-tumor M2 state to an anti-tumor M1 state, thereby reversing the immunosuppressive tumor microenvironment (TME). The translation of LF’s potential has been significantly accelerated by nanotechnology. The inherent biocompatibility and natural tumor-targeting capabilities of LF make it an ideal platform for sophisticated drug-delivery systems. This review details various fabrication strategies for LF-based nanoparticles (NPs), including self-assembly, sol-in-oil emulsion, and electrostatic nanocomplexes, among others. Research demonstrates that nano-formulations not only protect LF from degradation but also enhance its bioactivity and anti-cancer potency. More importantly, LF NPs serve as versatile carriers for a wide array of therapeutic agents, including conventional chemotherapeutics, natural compounds, and imaging agents. These engineered systems enable synergistic therapy and facilitate site-specific delivery. Notably, the ability of LF to bind to receptors on the blood-brain barrier (BBB) has been leveraged to develop nano-systems for glioblastoma treatment. Other innovative designs utilize LF to modulate the TME—for instance, by alleviating tumor hypoxia to sensitize cells to radiotherapy and chemotherapy. Despite compelling pre-clinical evidence, the clinical translation of LF and its nano-formulations remains nascent. While early-phase trials have established a favorable safety profile for recombinant human LF, larger Phase III studies have yielded mixed results, underscoring the complexity of its action in humans. Key challenges include enhancing drug targeting, optimizing loading efficiency, ensuring batch-to-batch reproducibility, and achieving deep tumor penetration. Future research must focus on the rational design of next-generation LF-NPs. This entails developing standardized manufacturing protocols, engineering “smart” stimuli-responsive systems for targeted drug release in the TME, and constructing multi-targeting platforms. A concerted interdisciplinary effort is paramount to bridge the gap between bench and bedside. In conclusion, LF, particularly in its nano-engineered forms, represents a highly promising and versatile agent in the oncological arsenal, holding immense potential for precise and effective cancer therapy.]]></description>
<pubDate>2025/12/13 13:51:47</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[AN Qin,DONG Wen-Wen,HE Shu-Rong,MENG Qing-Yong,YUE Wen-Tian,ZHANG Ya-Li,ZOU Yun-Xia]]></author>
</item>
<item>
<title><![CDATA[Regulation of Social Interaction through Transcranial Electrical Stimulation-based Multibrain Stimulation]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202509090000003]]></link>
<description><![CDATA[Deciphering how the brain enables humans to interact, coordinate, and learn from one another remains one of the most compelling challenges in contemporary cognitive neuroscience. Social interaction is a dynamic, reciprocal process. Over the past decade, hyperscanning research has consistently identified inter-brain synchronization (IBS) as a neural signature accompanying successful cooperation, communication, joint attention, and social learning. However, the correlational nature of these findings leaves a critical question unresolved: does IBS cause better social interaction, or does it merely reflect it? While traditional hyperscanning paradigms are powerful in revealing inter-brain neural dynamics “in the wild”, they cannot on their own determine the direction of causality. This gap has motivated the emergence of multibrain stimulation (MBS)—a new generation of causal inference tools designed to actively manipulate neural coupling across individuals. MBS leverages non-invasive transcranial electrical stimulation (tES) to modulate neural activity simultaneously in two or more interacting brains. Unlike conventional tES applied to a single individual, MBS employs coordinated stimulation parameters, such as synchronized waveforms or matched frequencies, to directly perturb the neural mechanisms underlying social interaction. By providing an exogenous, precisely controlled intervention on IBS, MBS satisfies interventionist criteria for establishing causal relationships: researchers can test whether modifying inter-brain synchrony leads to predictable changes in behavior, communication, or shared understanding. This capability represents a fundamental methodological shift, transforming interpersonal neuroscience from a largely descriptive discipline into one capable of mechanistic inquiry. The biophysical underpinnings of MBS vary depending on the specific modality used. Transcranial alternating current stimulation (tACS) functions through cross-brain entrainment: when two individuals receive oscillatory currents matched in frequency and phase (<i>e.g.</i>, theta-, beta-, or gamma-band stimulation), their endogenous neural rhythms tend to align with the exogenous signal and, consequently, with each other. This alignment effectively instantiates principles of the communication through coherence (CTC) framework, which posits that coherent oscillations optimize information exchange by synchronizing periods of excitability across neural populations. Meanwhile, transcranial direct current stimulation (tDCS) exerts its influence by altering the excitability of targeted cortical regions in a polarity-dependent manner, thereby tuning the computational readiness of social-cognitive hubs such as the temporoparietal junction, superior temporal cortex, or inferior frontal gyrus. A growing body of empirical evidence demonstrates that such manipulations yield robust behavioral effects. In joint motor tasks, in-phase tACS enhances interpersonal coordination by aligning motor preparation dynamics, reducing temporal variability, and enabling individuals to anticipate each other’s actions more effectively. In communication and social learning contexts, MBS targeting high-order integrative regions promotes conceptual alignment, accelerates knowledge transfer, and supports more efficient encoding of shared representations. Notably, the effects of MBS often persist beyond the stimulation period, suggesting short-term plasticity in cross-brain networks. Post-stimulation improvements in synchronization and coordination indicate that MBS may temporarily recalibrate the neural architecture underlying social interaction. However, these benefits exhibit strong parameter specificity—precise phase relationships (<i>e.g.</i>, 0° in-phase versus 180° anti-phase) and frequency matching are essential for generating reliable behavioral outcomes. Taken together, MBS represents a transformative step toward establishing the causal principles of human sociality and offers a new avenue for probing how multiple brains become functionally aligned during interaction.]]></description>
<pubDate>2025/12/10 9:19:59</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Han-Lin,LI Qi,LI Yuan-Yuan,PAN Ya-Feng]]></author>
</item>
<item>
<title><![CDATA[The Prospect of Trimethylamine N-oxide Combined With Short-chain Fatty Acids in Atherosclerosis Risk Prediction]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202509080000001]]></link>
<description><![CDATA[Atherosclerosis (AS), the primary pathological contributor to cardiovascular diseases (CVDs), has increasingly affected younger populations due to modern dietary habits and sedentary lifestyles. Current diagnostic modalities, including ultrasound, MRI, and CT, primarily identify advanced lesions and inadequately evaluate plaque vulnerability, thereby hindering early detection. Conventional treatments, which involve long-term medications associated with side effects such as hepatic injury and surgical interventions that carry risks of restenosis and hemorrhage, underscore the urgent need for non-invasive, cost-effective early diagnostic methods and targeted therapies. Gut microbiota metabolites are pivotal in AS pathogenesis, with trimethylamine N-oxide (TMAO) and short-chain fatty acids (SCFAs) serving as functionally opposing biomarkers. TMAO is produced when gut bacteria, specifically Firmicutes and Proteobacteria, metabolize dietary choline and carnitine into trimethylamine (TMA), which the liver subsequently converts to TMAO<i> via</i> flavin-containing monooxygenase 3 (FMO3); TMAO is then excreted in urine. Variability in TMAO levels is influenced by marine food consumption and FMO3 modulation, which can be affected by genetics, age, and diet. Mechanistically, TMAO exacerbates AS by disrupting cholesterol metabolism, inducing endothelial dysfunction through the elevation of reactive oxygen species (ROS) and pro-inflammatory cytokines such as IL-6, and reducing nitric oxide levels. Additionally, TMAO activates NF-κB and NLRP3 pathways while enhancing platelet reactivity. Clinically, elevated TMAO levels correlate with early AS and serve as predictors of mortality in patients with stable coronary artery disease (CAD) and acute coronary syndrome (ACS), as well as major adverse cardiovascular events (MACE) in stroke patients. Conversely, SCFAs—namely acetate, propionate, and butyrate—are produced by gut bacteria such as <i>Akkermansia muciniphila</i> and <i>Faecalibacterium prausnitzii</i> through the fermentation of dietary fiber. These metabolites exert anti-AS effects: acetate aids in maintaining metabolic homeostasis; propionate protects endothelial function and reduces plaque area; and butyrate fortifies intestinal barriers while suppressing inflammation. Furthermore, SCFAs cross-regulate bile acid metabolism, thereby influencing TMAO levels, and antagonize the pro-inflammatory and lipid-disrupting effects of TMAO. The use of TMAO and SCFAs as standalone biomarkers is constrained by limitations. TMAO lacks specificity, while SCFA levels fluctuate based on gut microbiota and dietary intake. Traditional AS risk assessment tools, which include clinical indicators, imaging techniques, and single biomarkers such as CRP, LDL-C, and ASCVD scores, overlook gut metabolism and demonstrate inadequate performance in younger populations. This review advocates for an “antagonistic-complementary” combined strategy: utilizing acetate and TMAO for early AS, propionate and TMAO for progressive AS, and butyrate and TMAO for advanced AS, addressing endothelial dysfunction, lipid deposition, and plaque stability/thrombosis risk, respectively. For clinical application, standardization of detection methods is crucial; liquid chromatography-mass spectrometry (LC-MS) is the gold standard, necessitating a unified sample pretreatment protocol, such as extraction with 1% formic acid in methanol. Additionally, dried blood spots (DBS) facilitate non-invasive testing, provided that dietary controls are implemented prior to detection, including a 12-hour fast and avoidance of high-choline and high-fiber foods. Existing challenges encompass the absence of standardized systems, limited large-scale validation, and ambiguous interactions with conditions such as hypertension. The authors’ team has previously established connections between gut metabolites and AS, including the reduction of TMAO as a preventive measure for AS, thereby reinforcing this proposed strategy. Future research should prioritize standardization, the development of machine learning-optimized models, validation of interventions, and the exploration of multi-omics-based “gut microbiota-metabolite-vascular” networks. In conclusion, the combined detection of TMAO and SCFAs offers a novel framework for AS risk assessment, facilitating early diagnosis and targeted interventions while enhancing the integration of gut metabolism into cardiovascular disease management.]]></description>
<pubDate>2025/12/10 8:45:33</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Si-Yi,LIU Shi-Guo,SHI Zhi-Chao,TIAN Xu-Ping]]></author>
</item>
<item>
<title><![CDATA[Regulatory T cells and FOXP3: Milestones and Cutting-edge Breakthroughs in Peripheral Immune Tolerance]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202511110000002]]></link>
<description><![CDATA[The 2025 Nobel Prize in Physiology or Medicine was awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi in recognition of their groundbreaking contributions to unraveling the mechanisms of peripheral immune tolerance. Regulatory T cells (Treg cells), as the core components maintaining peripheral immune tolerance, exhibit high plasticity and heterogeneity. Dysregulation of Treg function is closely associated with autoimmune diseases, tumor progression, and transplant rejection. Forkhead box protein P3 (FOXP3) is a key transcription factor that controls the development and function of Tregs. This review discusses the classification of Tregs into thymic-derived Tregs (tTregs), peripherally induced Tregs (pTregs), and <i>in vitro</i>-induced Tregs (iTregs). It also elaborates on how Treg cells exert their inhibitory functions through multiple pathways, including the secretion of inhibitory factors, metabolic interference <i>via</i> competitive uptake of IL-2, and direct cell-cell contact. In recent years, significant advances have been made in Treg and FOXP3 research, progressively deepening our understanding of Treg plasticity. Investigations have revealed their capacity to adapt and acquire features of effector T helper cell subsets—such as Th1, Th2, and Th17—under specific microenvironmental cues. This plasticity also poses challenges for therapeutic interventions, as Tregs can potentially lose their suppressive function and acquire pro-inflammatory properties, thereby exacerbating disease pathology. Furthermore, the concept of tissue-specific Treg specialization has emerged, highlighting distinct functional subsets resident in organs such as the gut, adipose tissue, and tumors. For instance, gut-resident Tregs maintain tolerance to commensal bacteria and dietary antigens, while tumor-infiltrating Tregs promote immune evasion by suppressing anti-tumor immunity. Concurrently, studies on the metabolic and epigenetic regulation of Tregs, including post-translational modifications of FOXP3 such as acetylation and ubiquitination, have uncovered intricate layers of control over their stability and function. Building upon these fundamental insights, this review synthesizes FOXP3-targeted therapeutic strategies. These encompass approaches to enhance Treg function in autoimmune diseases and transplantation, including adoptive cell therapies and pharmacological interventions. Conversely, strategies to antagonize Treg-mediated immunosuppression in oncology, such as immune checkpoint blockade, are discussed. Notably, the development of programmable engineered Tregs represents a particularly promising frontier for achieving antigen-specific immune modulation with enhanced precision and efficacy. However, the field of Treg research continues to grapple with several complex challenges. The deeper, underlying regulatory networks governing Treg biology remain incompletely understood. A comprehensive resolution of Treg heterogeneity is still lacking, and significant hurdles exist in maintaining the stability and function of Tregs during <i>in vitro</i> expansion and culture. Furthermore, the precision and efficacy of translating these findings into clinical applications require substantial improvement. Consequently, both the development of Treg-targeting pharmacological agents and the refinement of Treg-based cellular therapies demand more profound exploration. The ultimate goal is to overcome these obstacles and achieve transformative, breakthrough clinical outcomes in the foreseeable future.]]></description>
<pubDate>2025/12/7 10:07:30</pubDate>
<category><![CDATA[2025年诺贝尔奖解读]]></category>
<author><![CDATA[FAN Jing-Yuan,JIANG Huang-Hao,LI Bin,PENG Cheng]]></author>
</item>
<item>
<title><![CDATA[Implementing The IPDPS Teaching Concept in “Biology in Daily Life” General Education Course for Cultivating Elite Innovators at Universities]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202510010000002]]></link>
<description><![CDATA[This paper presents a comprehensive exploration of the IPDPS teaching concept—a framework built upon the 5 core principles of interdisciplinarity, practicality, diversity, process-oriented, and soul-forging—and its systematic implementation in the general education course “Biology in Daily Life” at Sun Yat-sen University. Developed over 8 years of iterative practice, this educational model is designed to address critical challenges in cultivating top innovative talents within higher education. It specifically targets the overcoming of disciplinary barriers, the disconnection between academia and industry, the limitations of one-way knowledge transmission, the rigidity of traditional evaluation systems, and the lack of value guidance. The curriculum is innovatively structured around four life-centric modules—birth, aging, illness, and food—which seamlessly integrate cutting-edge advancements in life sciences with interdisciplinary knowledge, making complex biological concepts accessible and relevant to students from diverse academic backgrounds. Pedagogically, the course employs a rich array of teaching methods to activate student engagement and foster higher-order thinking skills. These include case-based learning? driven by real-world problems, multi-sensory interactive experiences?, storytelling? to illustrate scientific discovery processes, and contrastive analysis? of ethical dilemmas in science. A cornerstone of the implementation is a multi-tiered practical teaching system, encompassing mandatory in-class experiments, optional social investigations, corporate visits, and face-to-face sessions with industry leaders. This structure ensures learning extends from the classroom to real-world societal and industrial contexts. A significant reform is the shift from a summative to a process-oriented evaluation system. This system diversifies assessment methods and incorporates multiple evaluators, including teacher assessment, self-assessment, and structured peer review using detailed rubrics. This approach aims to stimulate intrinsic motivation, foster a growth mindset, and provide a more holistic measurement of student development. Fundamentally, the course deeply integrates value-shaping elements? into its fabric. By incorporating themes of national identity, scientific spirit, bioethics, and cultural confidence through specific cases, the course forges students’ sense of social responsibility and ethical reasoning, ensuring their innovative capacities are guided by a strong moral compass. Assessment data from 2017 to 2024 demonstrates significant positive outcomes. Course satisfaction ratings have shown a remarkable increase, rising from 80.5% to 96.8%. Survey data from 245 students (2021-2024) indicates that the course effectively broadens interdisciplinary horizons, enhances independent thinking and problem-solving abilities, and successfully integrates knowledge acquisition with capacity building and value orientation. The course has successfully functioned as an “initial incubator and screening mechanism”?for identifying and nurturing talented individuals, with some students even shifting their academic focus to biology as a result. In conclusion, the “Biology in Daily Life” course, underpinned by the IPDPS framework, provides a replicable and scalable paradigm for educational innovation in cultivating elite innovators. It represents a successful model for achieving the organic unity of knowledge impartation, ability cultivation, and value shaping in higher education. Future work will focus on optimizing differentiated content design for diverse student backgrounds, deepening practical teaching experiences, and establishing long-term tracking mechanisms for learning outcomes.]]></description>
<pubDate>2025/12/6 10:10:59</pubDate>
<category><![CDATA[科教融合]]></category>
<author><![CDATA[LI Lian,YANG Jin-E,ZHU Ying]]></author>
</item>
<item>
<title><![CDATA[Treg Cells and Peripheral Immune Tolerance: From Discovery to Precise Immune Regulation]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202510260000001]]></link>
<description><![CDATA[Regulatory T cells (Treg cells) have reshaped modern immunology by establishing the conceptual and mechanistic foundation of peripheral immune tolerance. Since the pioneering identification of CD4<sup>+</sup>CD25<sup>+</sup> suppressive T cells by Shimon Sakaguchi and the subsequent discovery of the lineage-defining transcription factor forkhead box P3 (Foxp3) by Mary E. Brunkow and Fred Ramsdell, Treg cells have been recognized as indispensable guardians of immune homeostasis. These advances collectively clarified that central tolerance alone is insufficient to eliminate all self-reactive lymphocytes, and peripheral tolerance—critically mediated by Treg cells—serves as a second barrier preventing pathological autoimmunity. Contemporary research has therefore expanded the functional and therapeutic significance of Treg cells across the fields of autoimmunity, cancer, transplantation, and tissue repair. Treg cells originate from two major developmental pathways: thymus-derived Treg (tTreg) cells, which arise from high-affinity self-reactive TCR interactions in the thymus, and peripheral Treg (pTreg) cells, which are induced in mucosal and other peripheral tissues via antigen stimulation under tolerogenic cytokine cues such as IL-2 and TGF-β. Their differentiation is orchestrated by a multilayered transcriptional and epigenetic network within the Foxp3 locus, including CNS0-CNS3 elements that integrate TCR, cytokine and environmental signals to support lineage stability. Treg cells are identified by a combination of surface and intracellular markers——CD25, CD127<sup>low/-</sup>, CTLA-4, GITR, TNFR2, CD39/CD73, and Foxp3——although marker specificity varies with context, activation state, and species. Their notable heterogeneity enables Treg cells to adopt Th1-, Th2-, Th17- or Tfh-like programs through transcription factors such as T-bet, GATA3, RORγt and Bcl6, thereby permitting precise suppression of corresponding effector responses. Tissue-resident Treg subsets in adipose tissue, skin, skeletal muscle and the CNS have emerged as highly specialized regulators that integrate local metabolic and stromal signals, contributing not only to immunosuppression but also to tissue regeneration. Mechanistically, Treg cells maintain tolerance through three synergistic strategies: (1) secretion of suppressive cytokines (IL-10, TGF-β, IL-35) and cytotoxic mediators (granzyme B, perforin); (2) cell-contact-dependent interactions <i>via</i> CTLA-4, PD-1/PD-L1, and LAG-3 to limit dendritic cell maturation and T-cell activation; and (3) metabolic regulation including IL-2 consumption, adenosine production <i>via</i> CD39/CD73, cAMP transfer through gap junctions, and adaptation to hypoxic or nutrient-restricted microenvironments. Dysregulation of Treg cell quantity or function contributes directly to pathogenesis across a spectrum of diseases. In autoimmune diseases such as type 1 diabetes, systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis, impaired Foxp3 stability, epigenetic abnormalities, defective IL-2 signaling or inflammatory cytokine exposure undermine Treg suppressive capacity, facilitating excessive autoreactive T- and B-cell activation. In contrast, within the tumor microenvironment, Treg cells are often enriched through chemokine axes such as CCL22-CCR4 and reinforced by interaction with myeloid-derived suppressor cells and tumor-associated macrophages. Their enhanced metabolic fitness and suppressive phenotype enable tumors to evade immune destruction. In transplantation, Treg cells are essential for promoting graft tolerance, restraining effector T-cell activation, and facilitating tissue repair after injury. Rapid therapeutic progress has been driven by Treg-based immunomodulation. Polyclonal Treg adoptive transfer has demonstrated safety and preliminary efficacy in type 1 diabetes, autoimmune disorders, solid-organ transplantation, and graft-versus-host disease. Gene-engineered Treg therapies, including antigen-specific CAR-Treg and TCR-Treg platforms, offer superior precision and stability, enabling targeted suppression at disease sites. Additional strategies——including low-dose IL-2 therapy, small-molecule modulation, and selective depletion of intratumoral Treg using antibodies against CCR4, CCR8, CTLA-4 or CD25×TIGIT bispecifics——further expand the translational landscape. Collectively, advances in Treg biology——from lineage ontogeny and molecular regulation to specialized functions and therapeutic engineering——highlight Treg cells as central orchestrators of immune equilibrium. Continued integration of single-cell multi-omics, systems immunology and gene-editing technologies is expected to accelerate the development of highly specific, durable and safe Treg-centered therapies, ultimately enabling precision control of immune tolerance in autoimmunity, transplantation and cancer.]]></description>
<pubDate>2025/12/5 10:24:29</pubDate>
<category><![CDATA[2025年诺贝尔奖解读]]></category>
<author><![CDATA[CHEN Meng-Yu,WANG Fu-Yan,XIAO Teng,XIONG Wei,YI Lei]]></author>
</item>
<item>
<title><![CDATA[Differential Role of Rotational Positioning in Pioneer Transcription Factor Binding to Nucleosomes <i>In vivo</i> <i>vs.</i> <i>In vitro</i>]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202510020000001]]></link>
<description><![CDATA[<b>Objective</b> Pioneer transcription factors (PTFs) possess the unique ability to recognize and bind their target DNA sequences within compacted nucleosomal DNA, thereby initiating chromatin opening and gene expression. They play pivotal roles in fundamental biological processes such as embryonic development, cellular reprogramming, and tumorigenesis. The specific regulatory mechanism by which nucleosomal rotational positioning governs PTF-nucleosome interactions remains inadequately elucidated. This study aims to systematically investigate the role of the rotational orientation of motifs in PTF-nucleosome binding.<b>Methods</b> We employed a DNA deformation energy model to predict the rotational positioning of DNA on nucleosomes. We analyzed high-throughput <i>in vitro</i> data from the NCAP-SELEX assay, which profiles the binding landscapes of numerous transcription factors to nucleosomal DNA. For <i>in vivo</i> analysis, we integrated genome-wide binding data (ChIP-seq) and nucleosome positioning data (MNase-seq) for eight well-characterized pioneer factors (OCT4, SOX2, KLF4, GATA4, MYOD1, FOXA1, CEBPA, and ASCL1) in human cells. Binding motifs were classified as “TF-bound” if they overlapped with ChIP-seq peaks and “TF-unbound” otherwise. DNA bendability profiles and fast Fourier transform (FFT) analysis were used to assess rotational positioning patterns around these motif sites. This analytical framework was further applied to specific biological contexts, including cellular reprogramming from IMR90 fibroblasts to induced pluripotent stem cells (iPSCs) and the differentiation of human embryonic stem cells (hESCs) to human neuroectodermal cells (hNECs).<b>Results</b> Our <i>in vitro</i> analysis revealed a strong dependence of transcription factor binding on the rotational orientation of TF-binding motifs. For SOX7, the unbound motifs at specific enrichment peaks exhibited a rotational phase clearly opposite to that of the SOX7-bound motifs. Similarly, analysis of P53 binding sequences confirmed that successful binding <i>in vitro</i> correlated with model-predicted exposure of the DNA minor groove at the motif center, consistent with P53’s binding mode. Genome-wide <i>in vivo</i> analysis of the eight PTFs showed that their DNA binding motifs were generally associated with DNA sequences exhibiting significant 10-bp periodicity in bendability, suggesting an inherent potential for nucleosome association. Crucially, for most factors (except ASCL1), the average rotational positioning preferences were remarkably similar between TF-bound and TF-unbound motifs. This indicates that, at a global genomic level, rotational positioning is not the primary determinant dictating whether a nucleosomal motif is bound by its cognate PTF <i>in vivo</i>. This phenomenon persisted during cellular reprogramming (IMR90 to iPSC), where the rotational positioning of OSKM factor motifs bound versus unbound in nucleosomal regions showed no significant overall difference. Interestingly, during hESC differentiation to hNECs, SOX2 binding sites underwent comprehensive reprogramming. In hNECs, the rotational positioning of nucleosomal SOX2-bound motifs was significantly different and, unexpectedly, opposite to the general preference observed in hESCs and for unbound motifs in hNECs, suggesting a cell context-dependent rewiring of binding mechanisms.<b>Conclusion</b> This study suggests a distinction in the role of DNA rotational positioning in TF-nucleosome binding between <i>in vitro </i>and <i>in vivo</i> environments. While rotational positioning critically governs the binding efficiency of factors like SOX7 and P53 in simplified in vitro systems, PTFs <i>in vivo </i>appear to overcome this steric hindrance at the binding interface. The ability of PTFs to bind nucleosomal motifs, even when key interaction surfaces are partially buried, might stem from their unique structural properties (<i>e.g.</i>, intrinsically disordered regions, DNA distortion/binding domains), nucleosome breathing which transiently exposes DNA, and potential cooperativity with other factors. Our results highlight the unique capacity of pioneer factors to drive chromatin openness through mechanisms beyond rotational positioning.]]></description>
<pubDate>2025/12/4 14:50:58</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CANG Jing,GUO Xing-Yue,LIU Guo-Jun,LIU Guo-Qing,ZHANG Zhi]]></author>
</item>
<item>
<title><![CDATA[Exercise-induced Biomarkers in Methamphetamine Addiction: Molecular Mechanisms and Clinical Implications]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202509200000002]]></link>
<description><![CDATA[Methamphetamine (METH) addiction is a severe and increasingly prevalent neuropsychiatric disorder for which current diagnostic and therapeutic approaches remain limited and predominantly symptom-oriented. Exercise, as a safe, accessible and cost-effective non-pharmacological intervention, has emerged as a promising strategy to ameliorate METH-induced neurotoxicity and addiction-related behaviors. Growing evidence indicates that these benefits are closely linked to the regulation of exercise-induced biomarkers, defined as molecular indicators whose expression or activity is dynamically altered during or after physical activity. This review focuses on the core regulatory role of exercise-induced biomarkers in METH addiction and systematically summarizes their involvement in key neurobiological pathways, outlining molecular pathological mechanisms such as dysregulation of dopamine, glutamate and GABA neurotransmitter systems, neuroinflammation and oxidative stress, and epigenetic remodeling, and emphasizing how these processes converge on changes in candidate biomarkers in the brain and periphery. On this basis, the review describes how exercise modulates neural plasticity, neurotransmitter systems, inflammation and oxidative stress through biomarkers such as brain-derived neurotrophic factor (BDNF), exerkines, inflammatory cytokines, metabolites and non-coding RNAs, with particular attention to neurotrophic and immune-related markers, microRNAs and other epigenetic regulators that can reverse METH-induced synaptic and structural abnormalities and promote recovery of cognitive and emotional functions. Advances in high-throughput omics technologies, including transcriptomics, metabolomics and multi-omics integration, are summarized to illustrate the screening and identification of key exercise-responsive biomarkers. Studies in METH-addicted animal models have revealed differentially expressed genes, signaling pathways (<i>e.g</i>., PI3K-Akt, mTOR, Wnt) and core nodes such as NFKBIA and CXCL12 that may mediate the protective effects of exercise. The review further discusses the potential of exercise-mediated biomarkers as objective indicators for diagnosis, dynamic monitoring of therapeutic efficacy and patient stratification. Multi-gene diagnostic models based on peripheral samples (<i>e.g.</i>, hair follicles, blood) demonstrate how biomarker panels can distinguish non-recovered, almost-recovered and healthy individuals, providing a molecular basis for staging METH use disorder and evaluating the impact of exercise interventions. The temporal dynamics of biomarker changes before and after exercise are highlighted, underscoring the value of longitudinal monitoring of factors such as BDNF, immune-related genes and circulating microRNAs to capture treatment-relevant windows of plasticity. In addition, the underlying molecular basis of exercise as an adjunct therapy and gene-targeted exercise strategies that leverage individual biomarker and gene expression profiles to optimize exercise prescriptions are summarized. Current conceptual and technical challenges are outlined, including heterogeneity of biomarker responses, individual variability, assay sensitivity and specificity, and gaps between preclinical findings and clinical application, together with future directions for integrating exercise with multi-omics, artificial intelligence-assisted biomarker discovery and, prospectively, gene-editing-based interventions. Particular emphasis is placed on the need to standardize exercise protocols, incorporate stage-specific and sex-sensitive designs, and combine exercise with pharmacotherapy and psychosocial rehabilitation in real-world clinical settings across diverse healthcare systems. Overall, this review aims to provide a comprehensive and integrated mechanistic framework and updated theoretical support for the application of exercise-mediated biomarkers in the diagnosis, therapeutic effect monitoring and personalized intervention of METH addiction, and to offer new and clinically relevant insights into the development of precision medicine strategies for substance use disorders.]]></description>
<pubDate>2025/12/4 10:39:31</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HE Jin-Ke,LI Xue,XU Ji-Sheng,ZHANG Xue-Jie]]></author>
</item>
<item>
<title><![CDATA[Research on Multi-dimensional Feature Fusion Model for Osteoporosis Risk Assessment Based on Deep Learning]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202508090000001]]></link>
<description><![CDATA[<b>Objective</b> Osteoporosis is a progressive metabolic bone disorder characterized by reduced bone mass and microarchitectural deterioration, leading to increased skeletal fragility and susceptibility to fracture. Conventional diagnostic and risk-assessment approaches, such as dual-energy X-ray absorptiometry (DXA) and the FRAX? algorithm, remain limited because they rely primarily on bone mineral density (BMD) and a restricted set of clinical factors, failing to capture the multidimensional determinants of bone strength. This study aimed to develop and validate a deep learning-based multi-dimensional feature fusion model that integrates heterogeneous biological, structural, functional, and genetic information to improve the early identification of osteoporosis and enhance fracture risk prediction.<b>Methods</b> A total of 12 856 participants were aggregated from three major data repositories: the International Osteoporosis Foundation database, a clinical research database on osteoporosis, and a large-scale medical informatics dataset. A unified data-extraction protocol was applied to ensure cross-database harmonization, followed by quality control, variable standardization, and missing-data handling using multiple imputation by chained equations (MICE). A multimodal deep learning framework was constructed to integrate six categories of features: BMD measurements, quantitative bone microarchitecture parameters, bone turnover biomarkers, established clinical risk factors, osteoporosis-related genetic polymorphisms, and sensor-derived balance and gait metrics. A multi-task learning strategy was adopted to simultaneously predict osteoporosis status and 10-year fracture probability. Model training used five-fold cross-validation, and external validation was conducted in an independent clinical cohort. Model performance was benchmarked against DXA alone and the FRAX tool.<b>Results</b> In the internal test cohort, the proposed model achieved an <i>AUC</i> of 0.936 (95% <i>CI</i>: 0.927-0.945), with a sensitivity of 87.5% and a specificity of 91.2%, significantly outperforming DXA alone (<i>AUC</i>=0.889) and FRAX (<i>AUC</i>=0.842) (both <i>P</i><0.05). External validation yielded an <i>AUC</i> of 0.918 (95% <i>CI</i>: 0.905-0.931) and demonstrated strong calibration (Brier score=0.087). SHAP analyses revealed that, beyond BMD, key predictors included trabecular separation, serum C-terminal telopeptide of type I collagen, balance-related metrics, gait speed, and specific SNPs within the <i>RANKL</i> and <i>VDR</i> loci. A simplified model incorporating only BMD, clinical features, and bone turnover markers preserved high accuracy (<i>AUC</i>=0.917), underscoring its feasibility for resource-limited clinical environments.<b>Conclusion</b> The deep learning-based multi-dimensional feature fusion model markedly enhances the precision and individualization of osteoporosis assessment compared with traditional tools. By integrating biological, structural, metabolic, genetic, and functional dimensions of bone health, the model provides a comprehensive representation of skeletal integrity and robustly improves both diagnostic accuracy and fracture risk prediction. Its strong generalizability across demographic subgroups highlights its clinical applicability. This work offers a promising direction for developing next-generation intelligent decision-support systems that may meaningfully improve osteoporosis screening, risk stratification, and preventive care.]]></description>
<pubDate>2025/12/2 16:19:41</pubDate>
<category><![CDATA[技术与方法]]></category>
<author><![CDATA[MENG Chao,WANG Chao-Ya]]></author>
</item>
<item>
<title><![CDATA[The Molecular Mechanisms of HDACi in Regulating Ischemic Stroke]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202509090000004]]></link>
<description><![CDATA[Ischemic stroke (IS) accounts for approximately 80% of all stroke cases and is a leading cause of death and long-term disability worldwide. Its core pathological mechanism involves the interruption of cerebral blood flow, leading to neuronal cell death and ischemic tissue necrosis in the brain, which is associated with multiple molecular processes including apoptosis, inflammation, and oxidative stress. This review systematically discusses the classification of HDACs, the mechanisms of action of HDAC inhibitors, and their multiple effects in inhibiting cell apoptosis, regulating neuroinflammation, repairing the blood-brain barrier, and improving cognitive function following IS. HDACs function by removing acetyl groups from histone lysine residues, leading to chromatin condensation and gene silencing. The HDAC family is classified into four classes: class I (HDAC1, 2, 3, 8), class IIa (HDAC4, 5, 7, 9), class IIb (HDAC6, 10), and class IV (HDAC11), with class III being the NAD<sup>+</sup>-dependent sirtuins. Histone deacetylase inhibitors (HDACi) exert significant neuroprotective effects following ischemic stroke through a multi-target, multi-pathway synergistic mechanism. The core mechanisms include inhibition of neuronal apoptosis, regulation of neuroinflammation, protection of the blood-brain barrier (BBB), and improvement of cognitive impairments (PSCI). HDACi regulate gene expression epigenetically by upregulating genes such as <i>p21</i>/<i>CIP1</i>, leading to cell cycle arrest, while also modulating apoptosis-related proteins by inhibiting pro-apoptotic signaling pathways, thereby reducing neuronal cell death. In terms of neuroinflammation, HDACi suppress NF-κB and activate Nrf2 pathways, decreasing the release of pro-inflammatory cytokines and preventing the pro-inflammatory polarization of microglia and macrophages, thus modulating the inflammatory response. Regarding BBB protection, HDACi regulate the expression and restoration of tight junction proteins such as occludin and claudin-5, while inhibiting the release of destructive factors like MMP-9, alleviating vasogenic edema, and maintaining BBB integrity. Furthermore, HDACi promote the transcription of neurotrophic factors and synaptic-associated genes, enhancing neuroplasticity and repairing neuronal networks, ultimately improving cognitive functions. Therefore, HDACi demonstrate great potential as a multifaceted therapeutic strategy for ischemic stroke. HDACis represent a powerful multi-target therapeutic approach that transcends the limitations of traditional thrombolytic therapies. HDACis represent a powerful multi-target therapeutic approach that transcends the limitations of traditional thrombolytic therapies, which are hampered by a narrow time window and risks of reperfusion injury. Histone acetylation is increased by HDACis, which relaxes chromatin and reactivates protective gene transcription. Their selectivity and chemical structure are used to classify them. Trichostatin A (TSA) and sodium butyrate (SB), a short-chain fatty acid, are examples of broad-spectrum inhibitors that are effective in lowering infarct volume and reducing neuroinflammation. More selective inhibitors, including Tubastatin A (HDAC6-selective) and Entinostat (class I-selective), may have fewer adverse effects while increasing efficacy. By suppressing apoptosis by modifying the p53, Bcl-2, and JNK pathways, reducing neuroinflammation by blocking NF-κB and NLRP3 activation, preserving the integrity of the blood-brain barrier by strengthening tight junction proteins, and promoting synaptic plasticity, neurogenesis, and the expression of neurotrophic factors like BDNF, these inhibitors provide neuroprotection through a variety of interrelated mechanisms.Despite their great potential, HDACis’ clinical translation is fraught with difficulties, mostly because of non-selective inhibition-related adverse effects such as hepatotoxicity and gastrointestinal problems with valproic acid (VPA). In order to accomplish targeted delivery to the brain, future research is consequently shifting toward the development of highly selective inhibitors, refining dosing regimes, and utilizing cutting-edge drug delivery technologies like nanoparticles. In summary, the development of effective neuroprotective and neurorestorative treatments for IS may be greatly aided by a nuanced, spatiotemporally accurate understanding of HDAC activities and the judicious use of subtype-selective HDACis.]]></description>
<pubDate>2025/11/27 8:50:26</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Jing,PAN Feng-Yuan,XU Yi-Wei,ZOU Xin-Yu]]></author>
</item>
<item>
<title><![CDATA[The Mechanism of Lipid Metabolic Reprogramming in Cognitive and Emotional Impairments of Parkinson’s Disease]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202510200000002]]></link>
<description><![CDATA[Parkinson’s disease (PD), the second most prevalent neurodegenerative disorder worldwide after Alzheimer’s disease, is pathologically characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta and the abnormal intracellular aggregation of α-synuclein into Lewy bodies. Traditionally, the clinical symptoms of PD have focused on motor dysfunction, which includes characteristic signs such as resting tremor, rigidity, bradykinesia, and postural instability. However, increasing evidence from both clinical and basic research suggests that the clinical presentation of PD is highly diverse, with neuropsychiatric complications representing a significant and unavoidable aspect of the disease’s overall burden. From the perspective of clinical phenotypes, the range of neuropsychiatric symptoms associated with PD is extensive, primarily including depressive disorders, generalized anxiety, apathy, impulse control disorders, and cognitive impairments related to executive function and memory. Notably, emotional and cognitive dysfunctions often manifest years prior to the onset of motor symptoms. This clinical observation indicates that the pathological processes of PD may originate within the non-motor circuits of the central nervous system (CNS), particularly in neural networks closely linked to emotional regulation and cognitive function. As one of the human body’s most lipid-rich organs, the CNS comprises lipids that account for approximately 50%-60% of the dry weight of brain tissue. These lipid molecules serve not only as structural components but also actively participate in the formation of cell membrane phospholipid bilayers, myelin sheath insulation layers, and various signal transduction complexes. From a functional perspective, lipids not only provide the structural foundation necessary for maintaining neuronal membrane fluidity, synaptic plasticity, and ion channel activity, but also act as essential molecules in energy metabolism, signal transduction, and epigenetic regulation. Notably, the frontal cortex—particularly its evolutionarily specialized prefrontal cortex (PFC)—functions as the brain’s “executive center for cognition and emotion”. This region is pivotal for higher cognitive functions, including working memory, decision-making, and behavioral inhibition, as well as for the complex regulation of emotions, such as reward and risk assessment. This region displays an exceptionally high synaptic density and is abundant in structural lipids, including unsaturated fatty acids and cholesterol, which makes it particularly vulnerable to disturbances in lipid metabolism. In PD research, lipid imbalance has become a central focus. As investigations progress, the importance of lipid metabolic pathways becomes increasingly apparent. Simultaneously, pharmacological therapies aimed at lipid regulation show considerable efficacy in addressing cognitive and emotional deficits associated with PD. In light of this, the present study utilizes bioinformatics analysis to identify differentially expressed genes in the peripheral blood of PD patients, demonstrating significant enrichment in processes such as chronic depression, cholesterol metabolism, fatty acid metabolism, AMPK signaling pathways, and insulin resistance. Expanding on this groundwork, the present review systematically explores the connections between dysregulated lipid metabolism and metabolic reprogramming in cognitive and emotional impairments associated with PD. Through the analysis findings, intervention approaches focusing on various fundamental pathological pathways such as neuroinflammation, mitochondrial dysfunction, imbalance in lactate homeostasis, and disrupted protein homeostasis are suggested. These proposals provide innovative perspectives for advancing mechanistic investigations and therapeutic advancements targeting cognitive and emotional disorders in PD.]]></description>
<pubDate>2025/11/21 10:55:31</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[KOU Xian-Juan,LIU Xiao-Qian,Lü Meng-Lin]]></author>
</item>
<item>
<title><![CDATA[Does Doxorubicin Cause Heart Damage by Interfering With Heart Energy Metabolism?]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202508070000003]]></link>
<description><![CDATA[As oncologic therapies continue to advance, the overall survival of cancer patients has markedly increased. Nevertheless, virtually every anticancer treatment modality is accompanied by some degree of cardiotoxicity. Epidemiological data indicate that approximately 30 % of cancer survivors ultimately die from cardiovascular disease. Among the cardiotoxic agents, the anthracycline doxorubicin (DOX) is the most widely used. It effectively suppresses a variety of malignant tumors——including breast cancer, lymphoma, and acute leukemia——but its cardiac toxicity limits further escalation of clinical dosing. Literature reports identify a cumulative dose of ≥250 mg/m2 as the threshold of high risk, with roughly 25 % of patients receiving DOX developing varying degrees of myocardial injury; severe cases progress to heart failure. Even at cumulative doses below the traditional safety limit, some patients exhibit cardiac dysfunction after the first administration, suggesting that cardiotoxicity is not solely a linear function of dose. DOX related cardiotoxicity can be classified as acute (hours to days after administration), sub acute (weeks to months), and chronic/late onset (years later). Most patients initially exhibit only mild reductions in left ventricular ejection fraction (LVEF) or subtle abnormalities in global longitudinal strain (GLS), often without symptoms. Recently, cardiac biomarkers (cTn, NT proBNP) combined with high sensitivity echocardiography (speckle tracking) have been recommended for monitoring high risk individuals, enabling detection of subclinical injury before overt LVEF decline. Currently, several preventive and therapeutic approaches are used in clinical practice, which can be summarized into the following four points. (1) Dose limitation and administration strategies: fractionated low dose regimens, liposomal encapsulation, or continuous infusion lower peak plasma concentrations, thereby reducing cardiac exposure. (2) Pharmacologic prophylaxis: β blockers (<i>e.g</i>., carvedilol) and ACE inhibitors/ARBs have shown protective effects on LVEF in some randomized trials, though results remain inconsistent and require larger confirmatory studies. (3) Metabolic targeted interventions: animal experiments indicate that activation of PPARα or supplementation with L carnitine restores fatty acid oxidation and improves ATP generation, suggesting metabolic modulators as promising cardioprotective candidates. (4) Lifestyle modifications: regular aerobic exercise up regulates mitochondrial biogenesis genes (PGC-1α) and reduces reactive oxygen species (ROS) production; small clinical studies have demonstrated a potential benefit in attenuating cTnT elevation. However, DOX-induced cardiotoxicity has not been effectively controlled, indicating that the core mechanism underlying DOX-related cardiac toxicity remains unidentified. Cardiomyocytes are high energy demand cells, and metabolic dysregulation is considered a central component of DOX induced cardiotoxicity. DOX disrupts myocardial metabolic balance through several interrelated pathways. (1) Oxidative stress and mitochondrial damage: DOX generates abundant ROS within cells, leading to mitochondrial membrane potential loss, lipid peroxidation, and iron accumulation, which suppress electron transport chain activity and markedly reduce ATP synthesis efficiency. (2) Autophagy dysregulation: DOX interferes with autophagic flux, preventing the clearance of damaged mitochondria and further aggravating apoptosis and inflammatory responses. (3) Inflammation and cytokine release: oxidative stress activates NF-κB, up-regulating pro inflammatory cytokines such as TNF-α and IL-6, creating a chronic inflammatory microenvironment that weakens myocardial contractility. (4) Epigenetic modifications: studies have shown that DOX alters DNA methylation and histone acetylation patterns in cardiomyocytes, affecting the expression of key metabolic genes (<i>e.g</i>., PGC-1α, CPT-1) and further inhibiting fatty acid β oxidation. These mechanisms collectively lead to suppressed fatty acid oxidation and compensatory up regulation of glycolysis, manifested by an elevated lactate/pyruvate ratio, accumulation of medium chain acyl carnitines, and a pronounced decline in ATP production. The resulting energy deficit precipitates left ventricular contractile dysfunction and, ultimately, heart failure. Despite extensive basic and clinical research on DOX cardiotoxicity, a unified risk assessment model and precise interventions targeting metabolic disturbances remain lacking. This review systematically summarizes recent progress on DOX induced cardiotoxicity and highlights that impairment of myocardial energy metabolism is a central mechanism of injury, thereby deepened our understanding of how impaired myocardial energy metabolism drives DOX induced injury, we can move toward safer chemotherapy protocols that achieve “cure cancer without harming the heart”.]]></description>
<pubDate>2025/11/21 8:04:12</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DAN Ju-Hua,GU Dan,JIA Tong-Xin,LIU Jia-Wei,SU Wen-Hua,WU Jia-Zhen]]></author>
</item>
<item>
<title><![CDATA[Mechanisms and Therapeutic Prospects of The Sirtuins Family in Spinal Cord Injury]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202508120000002]]></link>
<description><![CDATA[Spinal cord injury (SCI) is a highly disabling trauma of the central nervous system, characterized by a complex pathological process involving intertwined multiple mechanisms. Key pathological events include excessive activation of neuroinflammation, oxidative stress injury, neuronal apoptosis, autophagic dysfunction, and energy metabolism imbalance, which severely disrupt the integrity of spinal cord neural function and significantly reduce patients’ quality of life. Currently, clinical neurorepair strategies for SCI have limited efficacy and are difficult to achieve synergistic intervention targeting multiple pathological links. Therefore, exploring novel core therapeutic targets and precise intervention regimens has become an urgent need in this field. The Sirtuins family (SIRT1-SIRT7), as NAD<sup>+</sup>-dependent deacetylases, play a central role in critical biological processes such as cellular metabolism regulation, immune homeostasis maintenance, and stress injury repair, and have been identified as potential intervention targets for neurological diseases. This review systematically summarizes the cellular localization and core biological functions of each member of the Sirtuins family, with a focus on their regulatory roles and molecular mechanisms in the pathological process of SCI: SIRT1, 3, 5, and 6 inhibit the excessive activation of the NF-κB pathway and block NLRP3 inflammasome assembly through deacetylation modification, thereby participating in the regulation of neuroinflammation after SCI; meanwhile, they alleviate oxidative stress injury in spinal cord tissues by activating the Nrf2 antioxidant pathway and enhancing the activity of antioxidant enzymes such as SOD and NADPH, forming a “anti-inflammatory-antioxidant” synergistic protective effect. SIRT7 delays neuronal apoptosis by promoting DNA damage repair and inhibiting apoptotic signaling pathways. SIRT3 and SIRT5 target mitochondrial function, improve mitochondrial energy metabolism by regulating the modification status of enzymes involved in the tricarboxylic acid cycle and oxidative phosphorylation, and restore autophagic homeostasis by modulating the acetylation levels of FOXO3a and AMPK, providing metabolic support for neural repair. We summarize that a variety of natural Chinese herbal components (<i>e.g</i>., resveratrol, matrine) and synthetic compounds (<i>e.g</i>., SRT1720, AGK2) can influence the pathological progression of SCI by targeting and regulating members of the Sirtuins family. We propose that Sirtuins-targeted combined therapeutic strategies (<i>e.g</i>., combined with stem cell transplantation, neurotrophic factor supplementation, or antioxidant intervention) are expected to break through the limitations of single therapies and enhance the repair effect of SCI through multi-mechanism synergistic actions. In conclusion, the Sirtuins family exhibits critical mechanisms of action and potential intervention value in the pathophysiological process of SCI. This review summarizes and prospects novel Sirtuins-targeted therapeutic strategies, aiming to provide new insights for basic research and clinical translation in this field.]]></description>
<pubDate>2025/11/20 10:44:23</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CUI Yin-Jie,DU Hai-Lin,LI Hong-Ru,ZHANG Jian,ZHENG Chen-Guang]]></author>
</item>
<item>
<title><![CDATA[The Crosstalk Between Viral Infection and The NLRP3 Inflammasome]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202505190000003]]></link>
<description><![CDATA[The inflammatory response is the foundation and a critical component of innate immunity. It serves as a vital defense mechanism, enabling the body to rapidly recognize and resist the invasion of foreign pathogenic microorganisms through a spontaneous immune reaction. Through pattern recognition receptors (PRRs), the host can effectively identify pathogen-associated molecular patterns (PAMPs) from microbes like bacteria and viruses, as well as damage-associated molecular patterns (DAMPs) released by injured cells. This allows for swift identification and resistance against pathogenic invasions, fulfilling a cellular surveillance function. As one of the most important protein complexes in innate immunity, the NLRP3 inflammasome—a large multi-protein complex—is among the most extensively studied inflammasomes. It assembles in response to pathogenic invasion or other danger signals and is crucial for the processing and release of pro-inflammatory mediators. This process helps the body distinguish between “self” and “non-self” and plays a significant role in both inflammatory and antiviral responses, thereby maintaining the host’s internal homeostasis. However, under certain conditions, immune regulation can become dysregulated, leading to an inflammatory response that is either too weak or too strong. This imbalance between pro-inflammatory and anti-inflammatory states can ultimately result in disease and tissue damage. Notably, not all viral infections activate the inflammasome. The activation mechanism of the NLRP3 inflammasome remains unclear and is even a subject of debate. On one hand, viruses are recognized by the host’s innate immune system, which can activate the NLRP3 inflammasome to mobilize immune and inflammatory responses for antiviral defense. Upon viral infection, the host receptor protein NLRP3 recognizes inflammatory signals, recruits the adapter protein ASC, and forms an inflammasome complex with pro-caspase-1. This triggers a cascade of activation events that initiate the innate immune response. Strategies involved in this process include altering intracellular and extracellular ion concentrations, affecting host cell energy metabolism, and directly interacting with components of the NLRP3 inflammasome to regulate its activation. On the other hand, viruses have evolved multiple strategies to inhibit NLRP3 inflammasome activation and evade immune responses. These include regulating NLRP3 ubiquitination and degradation, inhibiting the assembly and activation of the NLRP3 inflammasome, and modulating its effector functions. Furthermore, while NLRP3 inflammasome activation upon viral infection helps clear the virus and is crucial for antiviral defense, viruses can also evade this immune mechanism to facilitate their own replication and proliferation. A deeper understanding of the interplay between inflammasome activation and viral replication will contribute to the precise and effective prevention and treatment of currently incurable viral diseases. Therefore, this article will focus on the complex interactions between viral infection and the NLRP3 inflammasome. It will review recent advances in understanding virus-induced NLRP3 inflammasome activation and the immune evasion strategies viruses employ by modulating NLRP3 inflammasome activity, with the ultimate goal of fundamentally controlling viral replication in the host. In-depth research in this area will not only enhance our understanding of viral pathogenesis but also provide new strategies for clinical antiviral therapy and drug development.]]></description>
<pubDate>2025/11/17 16:06:04</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[BAI Guang-Ye,CHEN Deng-Jin,CHEN Shan,HAO Hai-Yu,HAO Xiao-Jing,LI Jing-Lin,LI Peng,LIU Kai-Dong,YI Fu-De,ZHANG Lei,ZHANG Qian]]></author>
</item>
<item>
<title><![CDATA[The Role and Mechanism of Alternative Lengthening of Telomeres in Telomerase-negative Tumors and Senescent Cells]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202506300000003]]></link>
<description><![CDATA[The alternative lengthening of telomeres (ALT) is a homology-directed repair (HDR)-based mechanism that maintains telomere length independently of telomerase by hijacking the canonical double-strand break (DSB) repair machinery. In ALT-positive cells, a RAD51-, MUS81-, and BLM-dependent recombination cascade copies telomeric tracts from sister chromatids, extrachromosomal telomeric circles (t-circles), or inter-chromosomal templates, thereby restoring a functional TTAGGG repeat array. This process is characterized by a distinct molecular signature:(1) chronic replication stress, manifested by elevated ATR-CHK1 signaling, R-loop accumulation, and fragile telomere phenotypes;(2) clustering of telomeric chromatin into ALT-associated PML bodies (APBs), which serve as SUMO-dependent recombination hubs enriched for SLX4-SLX1, MRE11-RAD50-NBS1, and FANCD2 complexes; and (3) global chromatin remodeling, marked by the eviction of histone H3.3 and its chaperones ATRX/DAXX, derepression of the long non-coding RNA TERRA, and acquisition of constitutive heterochromatin marks (H3K9me3/H4K20me3) along with the facultative heterochromatin mark H3K27me3. Together, these changes establish a chromatin environment permissive for homologous recombination. Importantly, these alterations are not merely passive by-products but are functionally required for homology search, strand invasion, and resolution of recombination intermediates. This is supported by CRISPR screens identifying ATRX, DAXX, and the SUMO E2 enzyme UBC9 as essential ALT fitness genes. While 85%-90% of human cancers re-express telomerase reverse transcriptase (TERT), the remaining 10%-15% are telomerase-null and rely exclusively on ALT for immortality. ALT tumors are enriched in osteosarcomas, glioblastomas, pancreatic neuroendocrine tumors, and aggressive soft-tissue sarcomas. In telomerase-negative somatic cells, progressive telomere shortening during each S phase eventually reaches a critical length, triggering a persistent DNA damage response (DDR) at chromosome ends. This activates the p53-p21 and p16INK4A-Rb tumor suppressor pathways, driving cells into stable replicative senescence. Although this telomere-length-dependent senescence acts as a potent barrier to malignant progression, recent single-cell analyses reveal that senescent fibroblasts and epithelial cells transiently display ALT-like features—such as accumulation of telomeric γH2AX/53BP1 foci, formation of APB-like PML condensates containing SUMOylated TRF1 and TRF2, and intermittent TERRA upregulation. These observations suggest that telomerase-negative tumors and senescent cells share a recombination-permissive chromatin state. Although senescent cells do not achieve net telomere elongation—likely due to intact p53/p16 checkpoints restraining unscheduled HDR—transient ALT activation may enable rare clonal escape. This further implies that ALT operates not only as a tumor-cell survival pathway but also as a protective mechanism against environmental stress. Indeed, spontaneous immortalization of TERT<sup>-/-</sup> fibroblasts <i>in vitro</i> is preceded by stochastic ALT induction, indicating that stochastic recombination at dysfunctional telomeres can overcome senescence barriers and initiate malignant transformation. Consistent with this model, whole-genome sequencing of ALT-positive tumors frequently identifies early driver mutations in TP53, ATRX, and DAXX, which disable replicative-senescence checkpoints while simultaneously enhancing telomeric HDR. Here, we synthesize the convergent molecular features of ALT tumors and senescent cells, highlighting:(1) replication stress as a common initiating cue, (2) SUMO-dependent phase separation as a platform for telomere-templated recombination, and (3) epigenetic erosion of ATRX/DAXX-mediated heterochromatin as a rate-limiting step. Finally, we discuss therapeutic implications: (1) pharmacological inhibition of SUMO E1/E2 enzymes to prevent APB scaffold nucleation, (2) synthetic-lethal exploitation of replication stress via ATR/CHK1 inhibitors, and (3) immune-microenvironment-targeting strategies that remodel the senescence-associated secretory phenotype (SASP). Collectively, this review elucidates the mechanisms by which ALT regulates cellular senescence and tumorigenesis, offering druggable vulnerabilities and translational strategies for the clinical management of telomerase-negative tumors.]]></description>
<pubDate>2025/11/17 15:52:58</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HOU Kai-Long,JIA Shu-Ting,JIA Tong-Xin,LIU Jia-Hua,LIU Jing,XIONG Meng-Jie,ZHANG Hao-Nan]]></author>
</item>
<item>
<title><![CDATA[Catalpol Promotes Differentiation of Neural Stem Cells into Oligodendrocyte <i>via</i> Caveolin-1-dependent Pathway in The 3D Microfluidic Chip]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202507170000001]]></link>
<description><![CDATA[<b>Objective</b> Cerebral palsy (CP) is a prevalent neurodevelopmental disorder acquired during the perinatal period, with periventricular white matter injury (PWMI) serving as its primary pathological hallmark. PWMI is characterized by the loss of oligodendrocytes (OLs) and the disintegration of myelin sheaths, leading to impaired neural connectivity and motor dysfunction. Neural stem cells (NSCs) represent a promising regenerative source for replenishing lost OLs; however, conventional two-dimensional (2D) <i>in vitro</i> culture systems lack the three-dimensional (3D) physiological microenvironment. Microfluidic chip technology has emerged as a powerful tool to overcome this limitation by enabling precise spatial and temporal control over 3D microenvironmental conditions, including the establishment of stable concentration gradients of bioactive molecules. Catalpol, an iridoid glycoside derived from traditional medicinal plants, exhibits dual antioxidant and anti-apoptotic properties. Despite its therapeutic potential, the capacity of catalpol to drive NSC differentiation toward OLs under biomimetic 3D conditions, as well as the underlying molecular mechanisms, remains poorly understood. This study aims to develop a microfluidic-based 3D biomimetic platform to systematically investigate the concentration-dependent effects of catalpol on promoting NSCs-to-OLs differentiation and to elucidate the role of the caveolin-1 (Cav-1) signaling pathway in this process.<b>Methods</b> We developed a novel multiplexed microfluidic device featuring parallel microchannels with integrated gradient generators capable of establishing and maintaining precise linear concentration gradients (0-3 g/L catalpol) across 3D NSCs cultures. This platform facilitated the continuous perfusion culture of NSC-derived 3D spheroids, mimicking the dynamic <i>in vivo</i> microenvironment. Real-time cell viability was assessed using Calcein-AM/propidium iodide (PI) dual staining, with fluorescence imaging quantifying live/dead cell ratios. Oligodendrocyte differentiation was evaluated through quantitative reverse transcription polymerase chain reaction (qRT-PCR) for <i>MBP</i> and <i>SOX10</i> gene expression, complemented by immunofluorescence staining to visualize corresponding protein changes. To dissect the molecular mechanism, the Cav-1-specific pharmacological inhibitor methyl-β-cyclodextrin (MCD) was employed to perturb the pathway, and its effects on differentiation markers were analyzed.<b>Results</b> Catalpol demonstrated excellent biocompatibility, with cell viability exceeding 96% across the entire tested concentration range (0-3 g/L), confirming its non-cytotoxic nature. At the optimal concentration of 0-3 g/L, catalpol significantly upregulated both MBP and SOX10 expression (<i>P</i><0.05, <i>P</i><0.01), indicating robust promotion of oligodendroglial differentiation. Intriguingly,<i> Cav-1</i> mRNA expression was progressively downregulated during NSC differentiation into OLs. Further inhibition of Cav-1 with MCD further enhanced this effect, leading to a statistically significant increase in OL-specific gene expression (<i>P</i><0.05, <i>P</i><0.01), suggesting Cav-1 acts as a negative regulator of OLs differentiation.<b>Conclusion</b> This study established an integrated microfluidic gradient chip-3D NSC spheroid culture system, which combines the advantages of precise chemical gradient control with physiologically relevant 3D cell culture. The findings demonstrate that 3 g/L catalpol effectively suppresses Cav-1 signaling to drive NSC differentiation into functional OLs. This work not only provides novel insights into the Cav-1-dependent mechanisms of myelination but also delivers a scalable technological platform for future research on remyelination therapies, with potential applications in cerebral palsy and other white matter disorders. The platform’s modular design permits adaptation for screening other neurogenic compounds or investigating additional signaling pathways involved in OLs maturation.]]></description>
<pubDate>2025/11/3 15:09:16</pubDate>
<category><![CDATA[研究快报]]></category>
<author><![CDATA[LIU Jing,SHEN Li-Ming,WANG Liang,WANG Ya-Chen]]></author>
</item>
<item>
<title><![CDATA[Structural Design and Application of Bispecific Antibodies]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202507190000001]]></link>
<description><![CDATA[Bispecific antibodies, engineered to simultaneously bind two distinct antigens or two epitopes on the same antigen, are now widely utilized in tumor therapy and various other fields. Depending on their mechanisms of action, bispecific antibodies can be designed into diverse structural formats, including IgG-like bispecific antibodies containing an Fc region. The Fc region mediates immune effector functions by interacting with receptors on immune cells or soluble immune components. However, antibodies containing an Fc region have a relatively high molecular mass, which limits their tissue penetration. They also exhibit slow systemic clearance <i>in vivo</i> and possess pharmacokinetic characteristics marked by a long terminal elimination half-life. Symmetric IgG-like bispecific antibodies feature a symmetric structure and are bivalent for each target antigen. During production, since the two heavy chains carrying the Fc region are identical, issues related to chain mispairing do not arise, thereby simplifying the manufacturing and purification processes. Moreover, the pairing of two identical natural Fc chains allows for correct disulfide bond formation, resulting in a more stable structure. Glycosylation of the Fc region remains in its natural state, preserving Fc-mediated functions. However, as the variable regions of the two antigen-binding sites are linked to the same heavy chain, the design must account for potential steric hindrance when the antibody binds both antigens simultaneously. In contrast, asymmetric IgG-like bispecific antibodies consist of two different heavy chains, each carrying antigen-binding domains that recognize distinct antigens or epitopes, offering greater structural design flexibility. Their development, however, requires addressing challenges related to heavy chain and light chain pairing. Strategies to prevent heavy chain mispairing include engineering the spatial configuration of the Fc region, facilitating Fab arm exchange, applying IgG-IgA chain exchange techniques, and introducing charge modifications in the Fc domain. To ensure correct light chain-heavy chain pairing, approaches such as introducing electrostatic interactions or novel disulfide bonds between the chains, swapping the CH1 and CL domains, or replacing the CH1-CL module with a T-cell receptor-derived structure have been employed. Non-IgG-like bispecific antibodies lack an Fc region. They are characterized by their small size and low molecular mass, which confer enhanced tissue penetration, rapid systemic clearance, and high structural versatility. Unlike IgG-based formats, they do not bind Fc receptors or activate the complement system directly. Different bispecific antibodies exert therapeutic effects through distinct mechanisms, which are largely determined by their structural design and target specificity. Currently recognized mechanisms of action include T cell redirection, dual signaling pathway blockade, immune checkpoint inhibition, formation of ternary complexes by binding two molecules, neutralization of soluble ligands, and acting as cofactors to mimic or enhance biological processes. Bispecific antibodies are extensively applied in cancer therapy. Beyond oncology, they are also being developed for the treatment of autoimmune diseases, infectious diseases, hematological disorders, and other conditions. Different structural designs offer unique advantages across therapeutic areas. This article elaborates on the structural designs of various types of bispecific antibodies and reviews their mechanisms of action and applications in therapeutics.]]></description>
<pubDate>2025/10/31 15:52:08</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[ZHANG Ding,ZHANG Wei,ZHENG Yue-Ting]]></author>
</item>
<item>
<title><![CDATA[The Mechanism of Conformational Transition and Stabilisation Strategies of Viral Membrane Fusion Proteins]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202506110000001]]></link>
<description><![CDATA[Viral membrane fusion proteins facilitate the fusion of viral and host cell membranes by undergoing a transition from a prefusion conformation to a post-fusion conformation, thereby enabling the transfer of viral nucleic acids into the cell interior. This transition process is characterized by peptide exposure, membrane insertion, and structural refolding. The prefusion configuration represents an optimal target for vaccine formulation and antiviral pharmacotherapy. However, the metastable nature of the prefusion conformation makes it prone to spontaneous conversion into the stable post-fusion conformation, thereby complicating structural analysis and vaccine design. Investigating the mechanisms of conformational change in these proteins and developing methods to stabilize their prefusion state remain challenging research topics. This review summarizes the structural and functional differences among three classes of membrane fusion proteins: class I proteins, which are predominantly composed of α-helices, form trimers, and rely on receptor binding or low pH to trigger fusion peptide release; class II proteins, which are mainly β-sheet-rich, rearrange from dimers to trimers and activate fusion loops <i>via</i> low pH; and class III proteins, which combine α-helices and β-structures, with mechanisms involving internal fusion loop insertion and membrane remodeling. It is evident that a comprehensive understanding of the mechanisms underlying viral membrane fusion is crucial for developing effective stabilization strategies for the prefusion conformation of these proteins. This paper presents several such methods that have been successfully employed in this endeavor, including: disulfide bond formation to stabilize domain-domain interactions; hydrophobic cavity filling to enhance core stability; proline substitution to restrict structural transitions in hinge regions; and multimer domains stabilizing the trimeric conformation. The stabilization strategies summarized and discussed herein have been validated in studies of multiple viral membrane fusion proteins and further applied in the design of vaccine antigens. Moreover, this paper highlights the potential applications of novel techniques, such as time-resolved cryo-EM, in capturing conformational intermediates and resolving dynamic transition processes. Such stabilization efforts, informed by structural insights, have yielded promising outcomes—for instance, prefusion-stabilized RSV F antigens that elicit potent neutralizing antibodies in clinical trials. Looking ahead, integrating computational modeling, such as AlphaFold predictions, with experimental data will further refine these approaches. Ultimately, these innovations promise to enable structure-guided therapeutics to combat emerging viral threats. This review provides a theoretical foundation for developing stable viral membrane fusion proteins, offering crucial insights for understanding viral membrane fusion mechanisms and advancing next-generation vaccines and antiviral drugs.]]></description>
<pubDate>2025/10/31 11:58:04</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DONG Xiang-Ge,XIE Chen-Yi,LIU Yang,YU Jia-Yu,YU Xin,ZHAN Jiu-Yu,ZHANG Xing-Xiao,ZHU Hong-Wei]]></author>
</item>
<item>
<title><![CDATA[RMDfold: an End-to-end RNA Secondary Structure Prediction Method Based on Residual Mamba and Dense Connections]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202508260000001]]></link>
<description><![CDATA[<b>Objective</b> Non-coding RNA (ncRNA) plays a crucial regulatory role in various biological processes. Numerous studies have shown that the functions of ncRNAs depend not only on their nucleotide sequences but also closely on their spatial conformations, particularly their secondary structures. Traditional methods for predicting RNA secondary structures often have low accuracy, usually around 50 to 70 percent, and their performance further declines when dealing with complex structures or long sequences. Although deep learning methods have improved prediction performance to some extent, they still face challenges such as high model complexity, difficulty in capturing long-range dependencies, and poor generalization in predicting complex structures. Therefore, it is necessary for RNA secondary structure prediction to develop new methods.<b>Methods</b> This study proposed an end-to-end prediction model RMDfold, which employed a feature extraction strategy combining residual Mamba (resMamba) and dense connections (Dense). The model framework consisted of three modules: one-dimensional (1D) modeling, feature mapping, and two-dimensional (2D) modeling. For the 1D modeling module, the model learned contextual dependencies among nucleotides from RNA sequences, providing the foundation for possible base-pairing; for the feature mapping module, the 1D features were projected into a 2D space to form a constraint matrix that represented potential base-pairing relationships; for the 2D modeling module, the model further learned the pairing patterns between nucleotides, and determined the unique pairing of each nucleotide through pairing constraints, to obtain the final secondary structure. For both 1D and 2D modeling modules, a four-layer Dense block composed of batch normalization, ReLU activation, and convolution was used to extract short-range features; and a dual-branch residual structure resMamba based on a state-space model was used to model long-range dependencies, thereby achieving effective integration of short- and long-range features. To validate the effectiveness of the proposed method, it was compared with Ufold, REDfold, TransUfold, and sincfold on the three public datasets RNAStralign, ArchiveII, and bpRNA-new.<b>Results</b> The proposed RMDfold method demonstrates superior performance compared with existing algorithms in structure prediction, pseudoknot prediction, sequence prediction across varying lengths, and model complexity analysis, while requiring fewer parameters and achieving faster inference. For the structure prediction, the method achieved <i>F1</i>, Matthews correlation coefficient (<i>MCC</i>), <i>precision</i> and <i>recall</i> of 0.973 5, 0.973 1, 0.975 6 and 0.972 3 on RNAStralign, 0.854 3, 0.855 6, 0.874 7 and 0.876 2 on ArchiveII, and 0.382 8, 0.401 5, 0.536 5 and 0.318 7 on bpRNA-new, respectively. For the pseudoknot prediction based on ArchiveII, the model achieved <i>F1</i>, <i>MCC</i>, <i>precision</i> and <i>recall </i>of 0.741 4, 0.743 3, 0.752 5 and 0.739 6. For the sequence prediction across different lengths, RMDfold maintained an accuracy of 0.70 for sequences ranging from 200 to 500 nt. In terms of model complexity, RMDfold required 2.886 7 M parameters and achieves an inference speed of 0.026 0 s.<b>Conclusion</b> RMDfold enables highly accurate prediction of RNA secondary structures. It helps to deeply and comprehensively reveal the central roles of RNA molecules in gene expression regulation, molecular recognition, and catalysis. and also provides important structure support for elucidating disease-related variant mechanisms, designing RNA-targeted drugs, and advancing research in evolution and comparative genomics.]]></description>
<pubDate>2025/10/31 10:54:01</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[HAO Ze-Zhou,YANG Yan-Ling,YAO Xu-Feng,ZHOU Liang]]></author>
</item>
<item>
<title><![CDATA[Development and Application of Proximal Biotin Labeling Techniques]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202507270000001]]></link>
<description><![CDATA[The formation of protein-protein interaction (PPI) networks is a central event in biochemical reactions within organisms. These interactions not only regulate normal physiological functions but are also closely associated with the onset and progression of diseases. PPIs are intricately regulated by proteins, nucleic acids, and their interactions. The complex molecular networks formed between these molecules serve as the foundation for most biochemical reaction events. Moreover, biological information is transmitted through countless molecular interactions within the cellular environment. A wide range of technologies has been developed to study PPIs, among which proximity-dependent biotinylation is a novel technique for labeling proteomes in living cells. This method utilizes engineered biotin ligases to specifically label nearby proteins or RNA molecules, enabling the capture of transient, weak, or stable interactions and facilitating the systematic construction of molecular interaction maps. Through continuous enzyme optimization and refinement, proximity-dependent biotinylation techniques have evolved into diverse systems with improved operational convenience and labeling efficiency. Each proximity-dependent biotinylation technique offers unique advantages: BioID is non-toxic to cells but suffers from low labeling efficiency, requires 18-24 h for labeling, and yields limited biotinylated products. TurboID achieves efficient labeling within 10 min, but its high activity and strong biotin affinity may lead to cytotoxicity. AirID enables low-toxicity labeling under low biotin concentrations but requires several hours to complete. UltraID offers the highest labeling activity with the smallest molecular mass but is prone to over-labeling. APEX provides convenient operation and can resolve protein topology, yet it has concentration-dependent limitations—forming dimers at high concentrations and lacking sensitivity at low concentrations. RNA-BioID is tailored for studying RNA-protein interactions but is limited by non-specific binding. TransitID can capture dynamic protein translocation at the subcellular level, though its temporal resolution still requires improvement. This review systematically summarizes the development, mechanisms, advantages, and disadvantages of proximity-dependent biotinylation techniques such as BioID, TurboID, AirID, UltraID, RNA-BioID, APEX, and TransitID. It also explores their cutting-edge applications in functional regulation and disease research. Proximity-dependent biotinylation techniques are widely used in disease-related studies. In tumor research, they are primarily applied to investigate the transcriptional regulation and chromosomal structural changes of proto-oncogenes and tumor suppressor genes. In the field of neuroscience, they are used to study mechanisms underlying nervous system function and neurological diseases. In viral infection mechanisms, they help elucidate virus-host interaction networks. In immune regulation, they contribute to the study of immune signaling pathways. In stem cell research, they aid in understanding cell differentiation processes. Furthermore, proximity-dependent biotinylation techniques hold promise for integration with spatial biology technologies, enabling more comprehensive and detailed protein studies. These techniques are expected to provide more accurate and efficient tools for life science research and to advance the medical and health fields to a higher level. By comprehensively analyzing the strengths, limitations, and innovative potential of each method, this review also highlights their advantageous applications in molecular interaction studies, aiming to provide methodological guidance and theoretical support for molecular mechanism research in the life sciences.]]></description>
<pubDate>2025/10/29 14:57:25</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Hui,CHEN Lu-Yi,CHEN Shi-Yu,FANG Tian-Yuan,HUANG Yu-Han,JIANG Yi,LEI Bin,LI Li-Ping,LIN Zhi-Cheng,YE Zhi-Tao,YING Jia-Qin,ZHANG Chu-Xia,ZHOU Chen-Xuan,ZHOU Yu-Yu]]></author>
</item>
<item>
<title><![CDATA[Strategic Optimization of CHO Cell Expression Platforms for Biopharmaceutical Manufacturing]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202508030000005]]></link>
<description><![CDATA[Chinese hamster ovary (CHO) cells are the most established and versatile mammalian expression system for the large-scale production of recombinant therapeutic proteins, owing to their genetic stability, adaptability to serum-free suspension culture, and ability to perform human-like post-translational modifications. More than 70% of biologics approved by the U.S. Food and Drug Administration rely on CHO-based production platforms, underscoring their central role in modern biopharmaceutical manufacturing. Despite these advantages, CHO systems continue to face three persistent bottlenecks that limit their potential for high-yield, reproducible, and cost-efficient production: excessive metabolic burden during high-density culture, heterogeneity of glycosylation patterns, and progressive loss of long-term expression stability. This review provides an integrated analysis of recent advances addressing these challenges and proposes a forward-looking framework for constructing intelligent and sustainable CHO cell factories. In terms of metabolic regulation, excessive lactate and ammonia accumulation disrupts energy balance and reduces recombinant protein synthesis efficiency. Optimization of culture parameters such as temperature, pH, dissolved oxygen, osmolarity, and glucose feeding can effectively alleviate metabolic stress, while supplementation with modulators including sodium butyrate, baicalein, and S-adenosylmethionine promotes specific productivity (qP) by modulating apoptosis and chromatin structure. Furthermore, genetic engineering strategies—such as overexpression of <i>MPC1</i>/<i>2</i>, <i>HSP27</i>, and<i> SIRT6</i> or knockout of <i>Bax</i>, <i>Apaf1</i>, and <i>IGF-1R</i>—have demonstrated significant improvements in cell viability and product yield. The combination of multi-omics metabolic modeling with artificial intelligence (AI)-based prediction offers new opportunities for building self-regulating CHO systems capable of dynamic adaptation to environmental stress. Regarding glycosylation uniformity, which determines therapeutic efficacy and immunogenicity, gene editing-based glycoengineering (<i>e.g.</i>, <i>FUT8</i> knockdown or <i>ST6Gal1</i> overexpression) has enabled the humanization of CHO glycan profiles, minimizing non-human sugar residues and enhancing drug stability. Process-level strategies such as galactose or manganese co-feeding and fine control of temperature or osmolarity further allow rational regulation of glycosyltransferase activity. Additionally, <i>in</i> <i>vitro</i> chemoenzymatic remodeling provides a complementary route to construct human-type glycans with defined structures, though industrial applications remain constrained by cost and scalability. The integration of model-driven process design and AI feedback control is expected to enable real-time prediction and correction of glycosylation deviations, ensuring batch-to-batch consistency in continuous biomanufacturing. Long-term expression stability, another critical challenge, is often impaired by promoter silencing, chromatin condensation, and random genomic integration. Molecular optimization—such as the use of improved promoters (CMV, EF-1α, or CHO endogenous promoters), Kozak and signal peptide refinement, and incorporation of chromatin-opening elements (UCOE, MAR, STAR)—helps maintain durable transcriptional activity, while site-specific integration systems including Cre/loxP, Flp/FRT, φC31, and CRISPR/Cas9 can enable single-copy, position-independent gene insertion at genomic safe-harbor loci, ensuring stable, predictable expression. Collectively, this review highlights a paradigm shift in CHO system optimization driven by the convergence of genome editing, synthetic biology, and artificial intelligence. The transition from empirical optimization to rational, data-driven design will facilitate the development of programmable CHO platforms capable of autonomous regulation of metabolic flux, glycosylation fidelity, and transcriptional activity. Such intelligent cell factories are expected to accelerate the transformation from laboratory-scale research to industrial-scale, high-consistency, and economically sustainable biopharmaceutical manufacturing, thereby supporting the next generation of efficient and customizable biologics manufacturing.]]></description>
<pubDate>2025/10/21 21:55:50</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LI Meng-Lin,ZHANG Rui-Ming,ZHANG Xing-Xiao,ZHU Hong-Wei]]></author>
</item>
<item>
<title><![CDATA[The Effects and Mechanisms of Exercise on The Crosstalk Among Post-translational Modifications of Proteins]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202506300000001]]></link>
<description><![CDATA[Post-translational modification (PTM) of proteins refers to the covalent addition of functional groups to amino acid residues or structural alterations in proteins during or after translation, primarily mediated by enzymatic reactions and secondarily by non-enzymatic chemical processes. PTM crosstalk denotes interactions between distinct modification sites or different types of modifications on a single protein, which regulate protein functions through synergistic, antagonistic, or cascading mechanisms. Lactylation, phosphorylation, and acetylation are three pivotal types of protein PTMs, involving the covalent attachment of lactic acid, phosphate, and acetyl groups to specific amino acid residues, respectively. These reversible modifications are dynamically regulated by cellular metabolic status and signaling pathways. Phosphorylation primarily facilitates rapid signal transduction; acetylation broadly regulates metabolism and gene expression; and lactylation is closely associated with high-lactate microenvironments and metabolic stress. Through competitive binding at identical or adjacent sites, reciprocal modulation of metabolite levels, and cross-regulation of signaling pathways, these three modifications form an intricate crosstalk network that coordinately regulates cellular adaptive responses to internal and external environmental changes. As a physiological stimulus with broad effects on bodily functions, exercise induces a series of changes in intracellular metabolism and signal transduction, thereby influencing PTMs and their crosstalk. On one hand, exercise activates multiple interconnected cellular systems, including energy metabolism, signal transduction, and molecular interaction networks. Within the energy metabolism system, exercise alters the pattern of cellular ATP production and utilizes metabolic intermediates as signaling molecules to directly or indirectly modulate the activity of enzymes involved in these three modifications. In the signal transduction system, exercise activates pathways such as AMP-activated protein kinase (AMPK) and mitogen-activated protein kinase (MAPK), which precisely regulate the activity and subcellular localization of modification-related enzymes via phosphorylation cascades. In the molecular interaction system, exercise promotes protein-protein and protein-metabolite interactions, thereby remodeling the regulatory network of PTMs. On the other hand, exercise facilitates crosstalk among lactylation, phosphorylation, and acetylation through a multi-level progressive regulatory model: “metabolic initiation → signal transduction → molecular interaction”. At the metabolic level, alterations in metabolites provide the initial driving force for crosstalk; signaling pathways amplify these signals and precisely modulate the direction of crosstalk through cascade reactions; and molecular interactions further integrate signals to establish a refined regulatory network. Ultimately, this multi-system and multi-level crosstalk enables precise regulation of cell proliferation, differentiation, and apoptosis, thereby mediating cellular adaptation to exercise and playing a central role in enhancing exercise capacity and improving metabolic health. This article systematically examines how exercise influences crosstalk among these three key PTMs—lactylation, phosphorylation, and acetylation—and the underlying mechanisms, including the regulation of metabolite levels, modification-related enzyme activity, cellular signaling pathways, metabolic homeostasis, and gene expression. This work provides a novel perspective for gaining deeper insights into how exercise regulates physiological functions.]]></description>
<pubDate>2025/10/20 11:23:43</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LI Hong,LI Ting-Ting,LIU Yu,WANG Shi-Da,ZHANG Hai-Feng]]></author>
</item>
<item>
<title><![CDATA[From Self-assembly to Smart Delivery: Construction Strategies and Frontier Applications of Prolamin-based Multicomponent Complex Nanocarriers]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202509020000001]]></link>
<description><![CDATA[This review synthesizes recent advances in prolamin-based multicomponent nanocarriers, with a focus on their physicochemical properties, modification strategies, and potential applications in functional foods, biomedicine, and sustainable agriculture. The abundance of hydrophobic amino acid residues in prolamins facilitates spontaneous self-assembly into nanoparticles, making them promising carriers for poorly water-soluble bioactive compounds such as curcumin and resveratrol. However, native prolamin nanoparticles suffer from limitations including poor colloidal stability, tendency to aggregate under processing or physiological conditions (<i>e.g.</i>, pH, ionic strength, enzymatic degradation), and limited functional diversity. To address these drawbacks, extensive research has been devoted to modification strategies aimed at enhancing stability, structural integrity, and cargo protection. Polysaccharide modification enables the formation of stable core-shell structures through electrostatic interactions, hydrogen bonding, and steric hindrance. Coatings with pectin, chitosan, or alginate improve stability across a broad range of pH values and ionic strengths, enhance resistance to gastric digestion, and enable sustained release in the intestine, thereby improving bioavailability. Polyphenol modification introduces hydrogen bonding, hydrophobic interactions, and occasionally covalent cross-linking, which modify nanoparticle structure and surface properties. These composites exhibit improved hydrophilicity, colloidal stability, and resistance to oxidative or UV-induced degradation, along with intrinsic antioxidant activity. Lipid modification leverages hydrophobic interactions with oils or fatty acids to form composite nanoparticles or Pickering emulsions. This approach increases the loading capacity for hydrophobic compounds, creates a protective barrier, and enhances oral bioavailability by promoting emulsification and intestinal absorption. Additional strategies include the incorporation of auxiliary proteins (<i>e.g</i>., casein, whey protein) to improve stability and emulsifying capacity, as well as the use of inorganic nanomaterials (<i>e.g.</i>, SiO<sub>2</sub>, AuNPs) to impart mechanical reinforcement, antibacterial properties, and stimuli-responsive functions. Genetic engineering further allows molecular-level tailoring of amino acid sequences to fine-tune hydrophobicity, amphiphilicity, and self-assembly behavior. These engineered nanocarriers exhibit advanced functionalities. They enable sustained and stimuli-responsive release triggered by pH, redox potential, enzymes, temperature, or light, facilitating on-demand delivery that maximizes efficacy while minimizing off-target effects. Targeting can be achieved passively through the enhanced permeability and retention (EPR) effect, or actively <i>via</i> conjugation with ligands, antibodies, or peptides that recognize specific receptors. The applications of these systems are broad. In functional foods and nutraceuticals, prolamin-based carriers improve the stability, bioavailability, and controlled release of sensitive bioactive ingredients, supporting personalized nutrition. In biomedicine, they enhance oral drug delivery, enable targeted cancer therapy with reduced systemic toxicity, and serve as scaffolds for tissue engineering. In agriculture, they facilitate the controlled release of pesticides, fertilizers, and growth regulators, helping to reduce environmental contamination and promote sustainable practices; they are also being explored for smart food packaging applications. Despite significant progress, challenges remain in clinical and industrial translation. There is an urgent need for standardized characterization methods, comprehensive <i>in vivo</i> safety and efficacy evaluations, and scalable, regulation-compliant manufacturing processes. Future research should adopt rational design principles to develop multi-stimuli-responsive and sustainable systems. The integration of artificial intelligence and data-driven approaches may further accelerate the development of personalized theranostic platforms and co-delivery systems. Continued innovation is expected to solidify the role of prolamin-based nanocarriers in advancing global health and sustainable development.]]></description>
<pubDate>2025/10/16 16:35:31</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HUANG Yun-Jie,MEI Han-Fang,Qi Li-Li,WANG Jin-Bo,WANG Meng-Ting,YU Yong]]></author>
</item>
<item>
<title><![CDATA[Ferroptosis in Alzheimer’s Disease: Potential Mechanisms and Intervention Strategies]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202508110000001]]></link>
<description><![CDATA[Alzheimer’s disease (AD) is a common chronic neurodegenerative disorder of the central nervous system characterized by progressive impairments in memory, cognition, and behavior, eventually leading to severe dementia and loss of self-care ability. Despite decades of investigation, the precise molecular mechanisms underlying AD remain incompletely understood, and effective disease-modifying treatments are still lacking. The traditional pathological hallmarks of AD including amyloid β-protein (Aβ) plaques and neurofibrillary tangles (NFTs) composed of hyperphosphorylated Tau fail to account for the complex biochemical and cellular alterations observed in AD brains. Ferroptosis, a distinct iron-dependent form of non-apoptotic programmed cell death, is increasingly recognized as a contributor to AD pathogenesis. Ferroptosis is driven by excessive accumulation of lipid peroxides and reactive oxygen species (ROS), leading to oxidative destruction of cellular membranes. Unlike apoptosis or necrosis, ferroptosis is morphologically characterized by shrunken mitochondria with condensed membrane densities and biochemically defined by the loss of glutathione peroxidase 4 (GPX4) activity. Disruption of iron homeostasis, a central hallmark of ferroptosis, triggers a cascade that inhibits the cystine/glutamate antiporter (System Xc<sup>-</sup>), suppresses glutathione (GSH) synthesis, and impairs GPX4-mediated detoxification of lipid peroxides, leading to uncontrolled lipid peroxidation and oxidative stress that ultimately trigger ferroptotic cell death. This iron-driven cell death exhibits distinct morphological and biochemical characteristics compared with other forms of cell death. Ferroptosis contributes to AD pathogenesis through multiple mechanisms and is closely associated with disease onset and progression. Iron overload can affect early amyloid precursor protein processing, accelerate Aβ production and plaque deposition, reduce Tau protein solubility, and promote Tau hyperphosphorylation and aggregation into NFTs. Therapeutic strategies targeting ferroptosis—such as iron chelation with deferoxamine to reduce labile iron levels and inhibit Fenton reaction-driven oxidative damage, supplementation with antioxidants such as α-tocopherol or α-lipoic acid to neutralize ROS and scavenge lipid radicals, and administration of selenium or activators of the Nrf2-SLC7A11-GPX4 axis and the SIRT1/Nrf2 signaling pathway to restore glutathione-GPX4 function—can effectively block lipid peroxidation and suppress iron-dependent cell death. By modulating iron metabolism, enhancing antioxidant defenses, and inhibiting lipid peroxidation, these approaches hold promise for mitigating ferroptosis-related neuronal injury. These interventions collectively aim to modulate iron metabolism, strengthen antioxidant defenses, and suppress lipid peroxidation, thereby mitigating neuronal injury and delaying cognitive deterioration. Ferroptosis represents a pivotal intersection of iron metabolism, oxidative stress, and neurodegeneration in AD. Exploring ferroptotic mechanisms not only deepens our understanding of AD pathophysiology but also opens new avenues for therapeutic intervention. This review aims to comprehensively summarize the molecular basis of ferroptosis, elucidate its pathological roles in AD, and propose ferroptosis-centered therapeutic strategies, thereby providing a theoretical framework for future research and drug development in AD.]]></description>
<pubDate>2025/10/16 11:20:57</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Hui,CHEN Lu-Yi,CHEN Shi-Yu,HUANG Yu-Han,JIANG Yi,LEI Bin,LI Li-Ping,LI Wan-Yi,LIN Zhi-Cheng,LIU Zhi-Tao,YANG ZI-YU,YE Zhi-Tao,YING Jia-Qin,ZHOU Chen-Xuan]]></author>
</item>
<item>
<title><![CDATA[Impact of Dietary Pattern Interventions on Gut Microbiota in Obesity: a Systematic Review and Meta-analysis]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202507110000003]]></link>
<description><![CDATA[Obesity has become a major global public health concern, affecting more than one billion individuals worldwide. As a low-grade chronic inflammatory condition, obesity is closely associated with cardiometabolic disorders and gut microbial dysbiosis. Diet-based interventions are recognized as one of the safest and most effective strategies for long-term weight management. Increasing evidence indicates that specific dietary patterns can modulate gut microbiota (GM) composition and metabolic function. However, comparative evidence regarding the effects of different dietary strategies remains limited and inconsistent. This systematic review and meta-analysis comprehensively evaluated the effects of the very-low-calorie ketogenic diet (VLCKD), Mediterranean diet (MD), and intermittent fasting (IF) on gut microbiota in obese populations. Systematic searches of PubMed, EBSCOhost, Cochrane, and Web of Science were conducted up to September 2025. Meta-analyses using R software assessed changes in microbial diversity and characteristic taxa abundance, with subgroup analyses by body mass index (BMI), age, and intervention duration. A total of 42 studies were included. Random-effects meta-analysis revealed that VLCKD significantly increased the Shannon index, observed OTUs, and Faith’s phylogenetic diversity (PD), promoted <i>Akkermansia </i>abundance and the Firmicutes/Bacteroidetes (F/B) ratio, but reduced <i>Bifidobacterium </i>abundance, indicating a bidirectional regulatory effect on gut microbial structure. MD significantly increased the Shannon index as well as the abundance of <i>Akkermansia</i>, <i>Bifidobacterium</i>, and Bacteroidetes, while decreasing Firmicutes abundance and the F/B ratio, suggesting a balanced and sustained improvement in gut microbial composition. In contrast, IF significantly decreased the PD index while increasing <i>Akkermansia</i> and reducing Firmicutes, reflecting partial structural optimization but limited enhancement of phylogenetic diversity; long-term interventions were associated with a decline in Shannon diversity, indicating limited stability. Subgroup analyses revealed distinct moderator effects. Under VLCKD, improvements in microbial diversity were more pronounced among individuals with <i>BMI</i>≤30 kg/m<sup>2</sup> and those aged >30 years, and meta-regression confirmed that the magnitude of diversity gains increased with age. Regarding BMI, increases in <i>Akkermansia</i> abundance were most evident in individuals with <i>BMI</i> 30-35 kg/m<sup>2</sup>, whereas <i>Bifidobacterium</i> abundance significantly decreased in the same range, suggesting a threshold-dependent microbial response to adiposity. With respect to age, both <i>Akkermansia</i> (increase) and <i>Bifidobacterium</i> (decrease) exhibited significant changes in individuals aged >40 years. In terms of intervention duration, <i>Akkermansia</i> increased significantly within 6 weeks, while <i>Bifidobacterium </i>decreased within 12 weeks. For MD, increases in Shannon diversity were consistently observed across all BMI, age, and duration subgroups; notably, <i>Akkermansia </i>abundance increased significantly among participants with <i>BMI</i>>30 kg/m<sup>2</sup>, aged 30-50 years, and during interventions ≤6 months, while <i>Bifidobacterium</i> abundance rose markedly in participants with <i>BMI</i>≤30 kg/m<sup>2</sup>, aged 40-50 years, and during interventions of 6-12 months. Under IF, Shannon diversity increased significantly in individuals with <i>BMI</i>≤30 kg/m<sup>2</sup> and aged >40 years but declined when the intervention exceeded 4 weeks, suggesting reduced long-term stability. In conclusion, VLCKD, MD, and IF all modulate gut microbiota in obesity but differ in magnitude, direction, and durability. VLCKD exerts strong yet dual effects—enhancing diversity while reducing beneficial taxa; MD shows stable, sustained modulation; whereas IF offers selective improvements but lowers phylogenetic diversity with limited persistence. Future studies should conduct large, multicenter randomized controlled trials to determine optimal intervention duration, confirm the moderating roles of age and BMI, and develop personalized microbiota-based dietary strategies for obesity management and gut health improvement.]]></description>
<pubDate>2025/10/14 9:30:39</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[BAO Zi-Han,LI Zi-Yang,LIU Feng-Hu,WANG Shun,WANG Xun-Ling,ZHAO Meng-Qi]]></author>
</item>
<item>
<title><![CDATA[The Mechanism of Exerkines on The Comorbidity of Sarcopenia and Cognitive Impairment]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202506150000002]]></link>
<description><![CDATA[The comorbidity of sarcopenia and cognitive impairment constitutes a degenerative syndrome that progresses significantly with age. It has emerged as a critical global health challenge, contributing to functional disability, reduced quality of life, and increased pressure on public healthcare systems. This comorbidity is characterized by a synergistic decline in both physical and cognitive capabilities, manifesting as reduced skeletal muscle mass, diminished muscle strength, impaired physical function, and progressive deterioration in cognitive domains such as memory, executive function, and information processing speed. This dual degeneration not only creates a vicious cycle where each condition exacerbates the other but also substantially increases the risk of falls, fractures, hospitalization, and mortality among older adults. Against the backdrop of rapid global population aging, the prevalence of this comorbidity is anticipated to rise further without effective interventions. Consequently, investigating its underlying mechanisms and developing preventive and therapeutic strategies hold substantial clinical and public health significance. Current evidence indicates that the pathogenesis involves multi-system and multi-level pathophysiological processes, with chronic inflammation, mitochondrial dysfunction, and gut microbiota dysbiosis, identified as three core interacting mechanisms. Age-related chronic low-grade inflammation, termed inflammaging, arises from the senescence-associated secretory phenotype (SASP) and persistent immune cell activation. This inflammatory state inhibits the intramuscular IGF-1/Akt/mTOR anabolic pathway through proinflammatory cytokines (<i>e.g</i>., IL-6, TNF-α), while simultaneously activating protein degradation systems including the ubiquitin-proteasome system (UPS) and autophagy-lysosomal pathway (ALP), ultimately leading to accelerated protein breakdown and muscle atrophy. These circulating inflammatory factors can also compromise blood-brain barrier integrity, activate microglia, trigger neuroinflammation, and consequently damage synaptic structures and neuronal function, thereby accelerating cognitive decline in this comorbidity. Mitochondrial dysfunction presents as impaired oxidative phosphorylation efficiency, excessive reactive oxygen species (ROS) production, and dysregulated mitochondrial quality control. This not only results in inadequate cellular energy supply but also enables mitochondrial-derived factors (<i>e.g</i>., extracellular mtDNA) to activate innate immune pathways such as cGAS-STING, propagating stress signals and amplifying tissue damage in both muscle and brain. Additionally, gut microbiota dysbiosis impairs intestinal barrier function, increases lipopolysaccharide (LPS) translocation into circulation, and reduces short-chain fatty acid (SCFA) production. These changes induce systemic inflammation and metabolic disturbances that further impact muscle metabolism and promote pathological protein accumulation in the brain, thereby establishing a gut-brain-muscle axis that exacerbates the progression of this comorbidity. Exerkines represent a class of biologically active signaling molecules—including cytokines, peptides, metabolites, and exosomes—secreted by various tissues in response to exercise. These exerkines mediate systemic adaptations and protective effects through endocrine and paracrine actions on target organs. Key exerkines such as IL-6, irisin, brain-derived neurotrophic factor (BDNF), insulin-like growth factor-1 (IGF-1), fibroblast growth factor-21 (FGF-21), lactate, and cathepsin B (CTSB) play central roles in coordinately ameliorating the comorbidity of sarcopenia and cognitive impairment. The beneficial effects of these exerkines are mediated through multiple mechanisms including inflammation modulation, energy metabolism remodeling, neuroprotection, and enhanced neuroplasticity. As a non-pharmacological intervention, exercise effectively stimulates the production and release of exerkines, thereby targeting the comorbidity through multiple pathways. Aerobic exercise elevates lactate levels and activates the Sirt1/PGC-1α pathway, improving cerebral metabolism and cognitive function. Resistance training significantly upregulates IGF-1, irisin, and CTSB expression, enhancing muscle anabolism and hippocampal function. Other modalities like high-intensity interval training (HIIT) and traditional practices also help modulate inflammatory status and optimize the neurotrophic environment through the action of various exerkines. Different exercise types work synergistically by engaging distinct signaling pathways and exerkine combinations, collectively alleviating chronic inflammation, correcting mitochondrial dysfunction, and optimizing gut microecology to achieve concurrent musculoskeletal and cognitive protection against this comorbidity. Synthesizing current evidence, this review emphasizes the necessity of transcending a single-organ perspective by recognizing muscle and brain as an integrated functional unit, with exerkines playing a pivotal role in the muscle-brain axis. The field nevertheless faces several challenges: the secretion dynamics of exerkines during aging remain unclear, mechanisms underlying individual differences in exercise response require elucidation, and the compensatory and imbalance characteristics of exercise-induced exerkine networks across disease stages need further characterization. Future research should employ large-sample cohorts and randomized controlled trials integrated with multi-omics technologies to establish personalized exercise interventions based on exerkine profiling for managing this comorbidity. Parallel efforts should focus on developing quantifiable efficacy assessment systems to provide robust theoretical foundation and practical guidance for precise management of the comorbidity of sarcopenia and cognitive impairment and the promotion of healthy aging.]]></description>
<pubDate>2025/10/13 15:58:06</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DENG Qi,HAO Hong-Tao,LIANG Ji-Ling,XIA Jun-Mei]]></author>
</item>
<item>
<title><![CDATA[Development and Validation of a Multiplex PCR-capillary Electrophoresis System for Identification of Frequently Encountered Species]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202506250000003]]></link>
<description><![CDATA[<b>Objective</b> To address the challenge of identifying unknown animal-derived components in the fields of forensic evidence and food safety, we developed and validated a sensitive and efficient multiplex polymerase chain reaction-capillary electrophoresis (PCR-CE) detection system capable of simultaneously identifying DNA from 13 species—cattle (<i>Bos taurus</i>), mouse (<i>Mus musculus</i>), dog (<i>Canis lupus familiaris</i>), rat (<i>Rattus norvegicus</i>), pig (<i>Sus scrofa</i>), Chinese hamster (<i>Cricetulus griseus</i>), cat (<i>Felis catus</i>), horse (<i>Equus caballus</i>), human (<i>Homo sapiens</i>), chicken (<i>Gallus gallus</i>), duck (<i>Anas platyrhynchos</i>), donkey (<i>Equus asinus</i>), and sheep (<i>Ovis aries</i>)—within a single-tube reaction.<b>Methods</b> Species-specific primers were meticulously designed targeting hypervariable regions of the mitochondrial DNA (including <i>Cytb</i>,<i> COI</i>, <i>16S rRNA</i>, and <i>ND2</i> genes), with primer specificity rigorously verified in silico using BLAST analysis against non-target species. A multiplex PCR system was constructed, and critical reaction parameters, including primer concentrations and annealing temperature, were systematically optimized through gradient experiments to ensure balanced amplification of all 13 targets without non-specific products or primer-dimer formation. Amplification products were subsequently separated and detected based on their characteristic fragment lengths and distinct fluorescent labels (6-FAM, HEX) using a capillary electrophoresis platform. The established multiplex PCR-CE system was comprehensively evaluated across several parameters: specificity was tested against 17 species (13 target species and 4 non-target species); sensitivity was determined using serial dilutions of mixed DNA templates; the ability to detect adulteration was assessed using simulated mixed meat samples with known adulteration percentages (10% to 0.1%); and practical applicability was investigated by analyzing 27 commercially available meat products and authentic casework samples from a fatal dog attack incident.<b>Results</b> The optimized multiplex PCR-CE system successfully demonstrated specific and simultaneous amplification for all 13 target species, with zero cross-reactivity observed with 4 non-target species. The system exhibited high sensitivity, with detection limits ranging from 0.05 ng to 0.001 ng of DNA template depending on the species; ten species were detectable at the 0.001 ng level. In simulated adulteration studies, the system reliably detected duck DNA in sheep meat at 0.5%, pork in beef at 0.5%, and horse meat in donkey meat at a remarkably low level of 0.1%. Analysis of commercial meat products revealed an 18.52% (5/27) mislabeling rate. These findings were consistent with validation tests using national and industry standard methods. Furthermore, the system effectively identified human and dog DNA from real forensic case evidence (clothing fragments from bite marks), and even detected trace pig DNA, suggesting the dog’s prior pork consumption.<b>Conclusion</b> This study successfully established a highly specific, sensitive, and practical multiplex PCR-CE system for the simultaneous identification of 13 species. By combining the power of multiplex PCR with capillary electrophoresis, our approach delivers a significant advantage in terms of throughput, resolution, and automation over traditional gel-based methods. The system’s proven effectiveness in detecting low-level adulteration in complex mixtures and processed food products, along with its successful application to genuine forensic specimens, underscores its substantial value and broad potential for routine use in forensic laboratories for evidence analysis and in regulatory settings for ensuring food authenticity and safety monitoring.]]></description>
<pubDate>2025/10/9 14:54:49</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CHEN Li-Ping,GUO Run-Ze,HE Yong-Feng,HU Sheng,SONG Zhen,SUN Qi-Fan,YANG Rui-Qin,ZHANG Ying]]></author>
</item>
<item>
<title><![CDATA[Multi-contextual Driving Mechanisms of Brain-to-brain Coupling in Social Interaction]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202505260000002]]></link>
<description><![CDATA[Social interaction is central to the development of human cognition and behavior. Studying the neural mechanisms of social interaction helps reveal the neurobiological basis of social functions, such as group cooperation and knowledge transfer. In recent years, social neuroscience research has adopted hyperscanning technology and brain-to-brain coupling (BBC) measurements to reveal the group neural dynamics mechanisms under social interactions. Existing studies have primarily focused on three social contexts highly relevant to social interaction, namely interpersonal communication, task collaboration, and teacher-student instruction. However, the driving factors of BBC across these contexts and their interaction patterns under naturalistic paradigms have not yet been systematically analyzed within a unified framework, and the underlying driving mechanisms remain unclear. To address this limitation, the present review focused on three social contexts with increasing ecological validity in social interaction. It systematically examines the exogenous and endogenous drivers of BBC across these contexts and reveals commonalities and differences across contexts. Exogenous factors provide external conditions and spatiotemporal framework for interaction through sensory input and behavioral patterns. These external conditions induce BBC by guiding individuals to focus on the same target within the same time window, thereby invoking shared attention. However, exogenous drivers can only ensure surface alignment of interactions. Without the support of endogenous drivers, brain-brain coupling is difficult to maintain or deepen. Endogenous factors determine the depth and continuity of interactions through high-level social cognitive processing. Specifically, social closeness enhances trust and empathy between interacting partners, promoting interpersonal multimodal information integration and emotional empathy. Shared attention is the key link for individuals to move from behavioral alignment to initial coupling at the neural level. Shared intentionality led individuals to converge on goals and strategies, forming cognitive predictions during the cooperation process. Shared understanding ensures that individuals can perform high-level cognitive processing based on a common knowledge framework. The above-mentioned endogenous driving factors enhance BBC by engaging higher-order cognitive regions such as the prefrontal cortex, temporoparietal junction, and default mode network. This engagement enables the interaction to shift from transient attention coupling to stable intention alignment and cognitive sharing. Therefore, the formation of BBC can be viewed as a process that evolves “from external to internal, from weak to strong”. Exogenous driving factors initiate neural alignment through shared attention. Endogenous driving factors then strengthen BBC <i>via</i> shared understanding and shared intentionality. Together, these processes support the construction of group-level shared cognition. Finally, this article summarized the current challenges in research on the driving mechanisms of BBC and provided an outlook for future development. First, it is necessary to theoretically establish a hierarchical model of brain-brain coupling based on a hierarchy of cognitive complexity, systematically distinguishing between the characteristics of BBC driven by low-level processes and higher-level interpersonal shared cognitive mechanisms. Second, at the methodological and technical level, future development of multimodal hyperscanning systems such as EEG-fNIRS and closed-loop hyper-transcranial alternating current stimulation could comprehensively analyze the dynamic evolution of BBC related to shared cognition in the temporal, spatial, and frequency domains. In summary, this article constructed a theoretical framework for the driving mechanisms of BBC across social contexts, hoping to provide a methodological basis for controlling the driving factors of naturalistic paradigms in social neuroscience research.]]></description>
<pubDate>2025/9/29 15:57:39</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Yuan-Fang,MING Dong,SHU Lei-Jin,WANG Zheng-Yi,XU Min-Peng,YU Hai-Qing,JUNG Tzyy-Ping]]></author>
</item>
<item>
<title><![CDATA[Multidimensional System of Precision Exercise Interventions for Parkinson’s Disease: Dynamic Regulation Based on Genetic Typing, Motor Subtypes, Clinical Staging, and Wearable Digital Biomarkers]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202506030000002]]></link>
<description><![CDATA[Parkinson’s disease (PD), the second most common neurodegenerative disorder worldwide, presents significant heterogeneity in clinical manifestations, genetic background, and response to interventions. While conventional exercise therapies demonstrate benefits in alleviating motor and non-motor symptoms through mechanisms such as modulating α-synuclein aggregation, enhancing mitophagy, and reducing neuroinflammation, their efficacy varies considerably among individuals. This variability may stem from endogenous factors such as genetic background, clinical phenotypes, stages of pathological progression, as well as exogenous factors like the type, intensity, and frequency of movement. Thus, this review first discusses the necessity of precise exercise interventions for PD patients, focusing on the epidemiological burden, heterogeneity in disease mechanisms, and differences in intervention response (Why). Next, we systematically explain how to develop precise exercise intervention strategies by stratifying interventions based on genetic background, clinical phenotype, and disease stage, combined with technological aids (How). Genetically, mutations in genes such as <i>GBA1</i>, <i>PRKN</i>, <i>PINK1</i>, and <i>SNCA</i> dictate distinct molecular pathologies—including lysosomal dysfunction, impaired mitophagy, and α-synuclein aggregation—which necessitate tailored exercise regimens. For instance, patients with <i>PRKN</i>/<i>PINK1</i> mutations may benefit from moderate-intensity endurance training to support mitochondrial biogenesis without exacerbating oxidative stress, whereas carriers of <i>GBA1</i> mutations might require exercises focusing on enhancing lysosomal function and managing oxidative damage. Clinically, patients are stratified into tremor-dominant (TD) and postural instability/gait difficulty (PIGD) subtypes, which demand divergent exercise priorities: coordinative, rhythm-based activities like dance or Tai Chi for TD-PD to engage cerebellar circuits, versus targeted balance and strength training, potentially aided by virtual reality, for PIGD-PD to mitigate axial symptoms and fall risk. Furthermore, intervention strategies must evolve with disease progression: high-intensity exercise is prioritized in early stages to leverage neuroplasticity and potential disease modification, while mid- and late-stage management focuses on functional maintenance, fall prevention, and compensatory strategies, respectively. Critical to implementing this framework is the adoption of digital biomarkers <i>via</i> wearable technology (<i>e.g</i>., inertial sensors, smartwatches), which enables continuous, objective monitoring of gait, tremor, and physiological responses. This facilitates a closed-loop feedback system, allowing for the remote adjustment of exercise parameters (intensity, frequency, duration) in real-time, thus optimizing efficacy and ensuring safety. Finally, we detail how to configure exercise parameters through personalized adaptation (What), including exercise type, intensity, frequency and dose. Higher volumes of physical activity are associated with reduced PD risk and slower progression, though optimal thresholds remain incompletely defined. Aerobic exercise improves cardiovascular fitness and may aid clearance of pathogenic proteins; resistance training counters sarcopenia and bradykinesia; balance training reduces falls; and mind-body exercises (<i>e.g</i>., Tai Chi) integrate motor and cognitive components. Multimodal regimens are often most beneficial. High-intensity aerobic exercise appears particularly effective in early PD, enhancing neural connectivity and mitigating disease progression in randomized trials. Most evidence supports supervised sessions occurring 3-5 times per week, lasting 30-60 min, adapted to individual tolerance and disease stage. In conclusion, this narrative review outlines a comprehensive precision medicine framework for exercise intervention in PD, moving beyond symptomatic management towards targeting underlying pathophysiology. By stratifying patients based on genetic, phenotypic, and staging characteristics, and by leveraging digital technology for dynamic personalization, exercise therapy can be transformed into a more potent, individualized, and disease-modifying strategy. Future research must validate these biomarker-driven approaches in large-scale trials and establish definitive guidelines for translating precision exercise into clinical practice.]]></description>
<pubDate>2025/9/26 10:42:35</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LIU Guo-Qiang,TIAN Xue-Wen,WANG Hui,WEN Xiao,YAN Min,ZHOU Zi-Gui]]></author>
</item>
<item>
<title><![CDATA[Microbial-nanomaterial Hybrid Systems]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202504260000001]]></link>
<description><![CDATA[Microorganisms, as one of the Earth’s most abundant genetic resources, demonstrate tremendous application potential in fields such as medicine, energy, and environmental protection. However, natural microorganisms often suffer from poor stability and low catalytic efficiency. The emergence of microorganism-nanomaterial hybrid systems offers novel strategies to overcome these limitations. These systems integrate nanomaterials with microorganisms or their components (<i>e.g.</i>, cell membranes, metabolites, or biomacromolecules) through methods such as biomineralization, electrostatic assembly, surface modification, and genetic engineering. This enables programmable design from the nanoscale to the macroscale, demonstrating broad application prospects and attracting extensive research interest. First, microbial-nanomaterial hybrid systems are classified based on the types of nanomaterials (organic, inorganic, organic-inorganic) and microorganisms (bacteria, fungi, viruses, algae, probiotics). Both types of systems leverage the unique catalytic selectivity of microorganisms and the diverse physicochemical properties of nanomaterials to achieve multidimensional synergy. Their synergistic mechanisms involve both the biochemical processes of microorganisms and the surface/interface reactions of nanomaterials, representing a multidisciplinary achievement spanning microbial interface engineering, biomimetic catalysis, controllable nanomaterial fabrication, and interfacial transport and reaction processes. Next, the application progress in biomedical fields (such as anti-infection, intestinal diseases, and cancer therapy) and energy conversion (<i>e.g.</i>, light-driven hybrid systems for proton reduction to hydrogen, CO<sub>2</sub> reduction and conversion, and nitrogen fixation) is elaborated in detail, highlighting their significant advantages in functional integration and synergistic performance. Microorganism-nanomaterial hybrid systems combine the specific recognition and precise metabolic capabilities of microorganisms with the catalytic, drug-delivery, and optoelectronic functions of nanomaterials, enabling the construction of various multifunctional synergistic platforms for catalysis, diagnosis, and therapy. These advances have greatly promoted development in nanomedicine, energy, and environmental applications. In medical contexts, such systems utilize the natural chemotaxis of microorganisms for precise targeting, achieve controlled drug release through environmentally responsive delivery and metabolic regulation, and enhance therapeutic efficacy <i>via</i> combined chemical-biological treatments and immune modulation. Improved biosafety can be achieved through attenuated microbial designs and nanomaterial coatings, offering diverse strategies for the precise treatment of various diseases. In the energy sector, the excellent light-harvesting properties of semiconductor materials and the precise catalytic capabilities of biological systems have been integrated to successfully construct light-driven biocatalytic systems, significantly improving light utilization efficiency. Finally, this review discusses the key challenges facing the practical application of these systems. Nanomaterials may exert toxic effects on microorganisms, impairing their activity and raising environmental safety concerns. The potential release of engineered nanomaterials into ecosystems necessitates careful risk assessment and long-term monitoring. In real-world environments, microbial functions are easily compromised, nanostructures are prone to damage, and reactive oxygen species (ROS) tend to accumulate, resulting in insufficient system stability. Stringent culture conditions, costly raw materials, and significant batch-to-batch variability hinder large-scale production and commercialization. The synergistic mechanisms between microorganisms and nanomaterials are not yet fully understood, particularly regarding molecular-level interactions and long-term compatibility. In medical applications, off-target risks persist due to unpredictable microbial colonization and immune responses, while environmental applications lack sufficient selective recognition capabilities, indicating a need for improved targeting and specificity. Furthermore, interdisciplinary barriers between biology, materials science, and engineering complicate collaborative innovation, and the absence of well-established standards for evaluation, regulation, and scalability also constrains further development. Future efforts should focus on enhancing biocompatibility, optimizing fabrication processes, and establishing comprehensive safety and performance standards to accelerate the transition of these promising systems from laboratory research to real-world applications.]]></description>
<pubDate>2025/9/25 16:28:20</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Ren-Ju,LI Chun-Bin,LIN Feng,LUO Bang-Lan,QUAN Chun-Shan,ZHANG Yan-Mei]]></author>
</item>
<item>
<title><![CDATA[Artificial Intelligence for Nucleic Acid Aptamers: Methods and Applications]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202507290000001]]></link>
<description><![CDATA[Nucleic acid aptamers represent a class of single-stranded oligonucleotides capable of high-affinity and specific binding to diverse targets, including proteins, small molecules, cells, and metal ions. Their advantages over antibodies—such as simpler synthesis, lower immunogenicity, superior stability, and easier modification—have positioned them as powerful tools in therapeutics, diagnostics, and biosensing. This review systematically surveys the integral role of bioinformatics and artificial intelligence (AI) in modern aptamer development, spanning from in silico selection and structural prediction to the generative design of novel aptamer sequences. The application of high-throughput SELEX (HT-SELEX) has greatly accelerated the discovery of aptamers, but also introduced computational challenges in processing large-scale sequencing data. Bioinformatics pipelines now routinely include tools like AptaPLEX and AptaSuite for preprocessing raw reads, including demultiplexing, adapter trimming, and quality filtering. Subsequent analytical steps involve clustering-based tools (<i>e.g</i>., FASTAptamer, AptaCLUSTER) to identify enriched sequences, and motif discovery algorithms (such as AptaTRACE and MPBind) that uncover conserved sequence-structure patterns associated with binding functionality. These approaches allow researchers to move beyond manual curation and extract meaningful candidates from complex selection rounds. Accurate prediction of secondary and tertiary structures is essential for understanding aptamer function and interaction mechanisms. Conventional tools, including RNAfold and Mfold, employ thermodynamics-based models to predict RNA folding, yet often struggle with pseudoknots and non-canonical pairs. Recent advances in deep learning—exemplified by SPOT-RNA, E2Efold, and UFold—have significantly improved prediction accuracy by leveraging neural networks trained on large structural datasets. For tertiary structure, methods range from fragment assembly (Rosetta FARFAR2) and homology modeling (RNAComposer) to deep learning-aided approaches such as AlphaFold-RNA and RoseTTAFoldNA. While these tools offer new insights, predicting structures for short, flexible aptamers remains non-trivial. Predicting aptamer-target interactions draws on both physics-based and data-driven approaches. Molecular docking programs—AutoDock Vina, ZDOCK, and MDockPP—provide initial binding poses, which can be refined using molecular dynamics simulations (with GROMACS, AMBER, or NAMD) and free energy perturbation techniques to estimate binding affinity. Complementarily, machine learning models are increasingly employed to predict interactions from sequence and structural features. Early efforts used hand-engineered features with classifiers like SVM and random forest, while contemporary deep learning models (AptaNet, AptaBERT, PAIR) utilize pre-trained language models to capture intricate sequence-binding relationships with superior generalization. Perhaps the most transformative development is the use of generative AI for <i>de novo</i> aptamer design. Conditional variational autoencoders (<i>e.g</i>., RaptGen), generative adversarial networks (<i>e.g.</i>, AptaDesigner), and diffusion models (<i>e.g</i>., AptaDiff) can generate novel aptamer sequences conditioned on target properties or desired binding affinities. Reinforcement learning and evolutionary algorithms, including Monte Carlo tree search (Apta-MCTS) and NSGA-II, support multi-objective optimization toward high specificity, stability, and low immunogenicity. These approaches mark a paradigm shift from selective discovery to intentional design, greatly expanding the functional sequence space. Aptamers designed using<i> </i>these computational strategies are increasingly used across biomedical and environmental applications, including targeted therapeutics, diagnostic biosensors, and food-safety monitoring. Nonetheless, key challenges persist: data scarcity and heterogeneity, model interpretability, and experimental validation bottlenecks. Future progress will depend on standardized data sharing, improved explainable AI, and the integration of computational design with high-throughput experimental screening—ultimately enabling robust, clinically viable aptamer technologies.]]></description>
<pubDate>2025/9/25 16:23:48</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DENG Ke-Jun,LIN Hao,LIU Ru-Ming,LIU Shang-Hua,TANG Li-Xia,YAN Dan,ZENG Hong-Juan,ZHANG Hong-Qi]]></author>
</item>
<item>
<title><![CDATA[The Cellular Mechanism of Irisin in improving Diabetic Cardiomyopathy]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202505170000001]]></link>
<description><![CDATA[Irisin, a myokine discovered in recent years, has been widely confirmed to exert cardioprotective effects. This review comprehensively elaborates on the molecular mechanisms of irisin in diabetic cardiomyocytes and its close associations with pathophysiological processes such as disordered glycolipid metabolism, oxidative stress, and autophagy. In terms of regulating glycolipid metabolism, irisin significantly improves energy metabolism in cardiomyocytes by activating the AMPK signaling pathway, thereby reversing diabetes-induced metabolic abnormalities. It promotes the browning of white adipose tissue (WAT), a process in which subcutaneous fat demonstrates a greater propensity to brown compared to visceral fat, thereby enhancing energy expenditure and exerting anti-inflammatory effects. These browned adipocytes secrete bioactive substances such as FGF and adiponectin, which further contribute to metabolic balance. Meanwhile, irisin reduces the glucolipotoxic burden on pancreatic β-cells: by modulating signaling pathways including PI3K/AKT and AMPK, it not only inhibits β-cell apoptosis but also improves their function and morphology. It enhances insulin secretion by regulating key proteins including Glut2, Glk, and Pdx1 through the AMPK pathway. Additionally, irisin accelerates the oxidation of free fatty acids (FFA) <i>via</i> activation of pathways such as PPARα, ameliorates insulin resistance, and thus optimizes the metabolic environment of cardiomyocytes. In the context of cellular stress regulation, irisin exhibits potent antioxidant properties. It not only directly counteracts the accumulation of reactive oxygen species (ROS) to alleviate oxidative damage but also inhibits ferroptosis by upregulating the MITOL/MARCH5 signaling axis, thereby helping to maintain mitochondrial homeostasis. Regarding endoplasmic reticulum stress (ERS), irisin downregulates key proteins including GRP78 and PERK, thus mitigating ERS-induced cardiomyocyte apoptosis and fibrosis—a protective mechanism that has also been validated in other diseases such as pancreatitis and osteoporosis. In maintaining the balance between autophagy and cell death, irisin sustains cellular homeostasis by coordinating both mitochondrial-targeted autophagy and non-selective autophagy. It promotes FUNDC1-mediated mitophagy to support mitochondrial turnover and ensure proper organelle function. At the same time, it suppresses excessive autophagy-induced cell damage through pathways such as PI3K/AKT/mTOR. In terms of apoptosis regulation, irisin downregulates pro-inflammatory factors (<i>e.g</i>., TNF-α, IL-6) and apoptosis-related proteins such as Caspase-3, while upregulating the anti-apoptotic protein Bcl-2. It inhibits cardiomyocyte apoptosis through multiple signaling pathways, including AMPK/mTOR and miR-19b/PTEN. In summary, irisin plays a crucial protective role in improving metabolic disorders, reducing cellular stress damage, and regulating cell death in diabetic cardiomyopathy (DCM) through multi-target and multi-pathway synergistic mechanisms. Its diverse actions provide an important theoretical basis and potential therapeutic targets for the clinical prevention and treatment of DCM. However, further research is needed to clarify its systemic effects, the safety of clinical interventions, and optimal treatment strategies to fully realize its therapeutic potential.]]></description>
<pubDate>2025/9/23 11:17:28</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HE En-Peng,LI Jia-Yue,YAN Xue-Ru,ZHANG Hao-Da,ZHANG Yue-Jun]]></author>
</item>
<item>
<title><![CDATA[Educational Practice of Undergraduate Course Cell Biology at The University of Chinese Academy of Sciences]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202505060000003]]></link>
<description><![CDATA[Cell Biology is one of the most rapidly developing branches of modern life sciences, characterized by distinct interdisciplinary integration. It provides theoretical foundations, experimental skills, and cutting-edge perspectives for undergraduate and graduate students in bioscience and related majors. Against the backdrop of higher education reform in the new era, the Cell Biology teaching team at the University of Chinese Academy of Sciences (UCAS) has restructured the curriculum. The course focuses on the fundamental structures and life processes of cells while incorporating ideological and political elements to foster students’ scientific mindset, patriotic sentiment, and social responsibility. By optimizing teaching design, enhancing practical components, and innovating assessment methods, the course integrates knowledge transfer, skill development, and value education. This paper summarizes preliminary experiences from the teaching development and educational practice of the undergraduate Cell Biology course at UCAS, serving as a reference for collaborative research- and teaching-oriented courses in science and engineering.]]></description>
<pubDate>2025/9/22 18:01:33</pubDate>
<category><![CDATA[科教融合]]></category>
<author><![CDATA[WEI Tao-Tao,ZHANG Lei,ZHANG Ying,ZHAO Jun-Cheng]]></author>
</item>
<item>
<title><![CDATA[Research on Microwave Induced Thermoacoustic and Ultrasound Dual-modality Microscopy]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202504300000003]]></link>
<description><![CDATA[<b>Objective</b> This study aims to develop a microwave-induced thermoacoustic and ultrasound dual-modality microscopy system that integrates the advantages of both imaging techniques to investigate the dielectric properties of biological tissues at a microscopic level.<b>Methods</b> This paper first discusses a method to enhance system resolution by combining short-pulse microwave excitation with high-frequency point-focused ultrasonic transducer detection. A three-dimensional microwave-induced thermoacoustic microscopic imaging system was constructed based on this approach and further developed into a dual-modality system capable of both thermoacoustic and ultrasonic imaging. The image reconstruction and dual-modality image fusion strategies are also described. Subsequently, experiments were conducted in the following sequence: imaging of copper wires to evaluate the system’s spatial resolution along the <i>X</i>/<i>Y</i>/<i>Z</i> axes; imaging of tubes containing 3% and 6% saline solutions and tubes filled with coupling agent/vegetable oil to demonstrate the complementary information provided by the two modalities; imaging of brain tissue and bone-cartilage samples to assess the applicability of the technology; and osteoporosis detection to validate the disease diagnostic capability of the dual-modality system. The microwave-induced thermoacoustic and ultrasound microscopic images of these samples were verified against corresponding photographs or micro-CT images.<b>Results</b> The thermoacoustic and ultrasonic images of the copper wire closely matched the physical photograph. The three-dimensional resolutions of the microwave-induced thermoacoustic and ultrasound imaging systems, as estimated from the copper wire experiment, were 178×178×88 μm<sup>3</sup> and 177×177×42 μm<sup>3</sup>, respectively. These measured values align well with theoretical predictions. The dual-modality imaging system successfully combines dielectric property differences captured by thermoacoustic imaging and acoustic impedance variations captured by ultrasound imaging, thereby providing both functional and structural information of the samples. Specifically, the system distinguished between tubes containing saline solutions of different concentrations and those containing vegetable oil, demonstrating strong spatial consistency with physical photographs. The thermoacoustic image contrast among saline solutions corresponded to theoretical dielectric properties, while the ultrasonic contrast between saline and oil reflected their difference in acoustic impedance. The system identified multiple brain tissue structures, including the cortex, hippocampus, superior colliculus, corpus callosum, cingulate cortex, and striatum. The bimodal imaging approach exhibited superior performance, visualizing tissue structures with greater clarity and detail than either modality alone. The brain tissue images were consistent with physical photographs, tissue dielectric properties, and publicly available anatomical atlases. The bimodal system clearly delineated cartilage and epiphyseal lines <i>via</i> thermoacoustic imaging, while ultrasonic imaging revealed bone structures. Thermoacoustic imaging alone differentiated bone sections between normal and osteoporotic groups; however, incorporating prior skeletal contour information from ultrasound significantly enhanced discriminatory power, resulting in intergroup differences with higher statistical significance. The imaging results of bone samples corresponded well with physical photographs, micro-CT images, and theoretical analyses of dielectric properties for cartilage, normal bone, and osteoporotic bone.<b>Conclusion</b> The microwave-induced thermoacoustic and ultrasound dual-modality microscopy system developed in this study demonstrates potential for microscopic detection of complex biological tissues based on dielectric properties. It is expected to provide a new imaging tool for functional assessment of brain tissue and the skeletal system, as well as for studies on disease pathogenesis.]]></description>
<pubDate>2025/9/22 17:53:26</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CHI Zi-Hui,DU Shuang,FANG Qiu-Chao,GUO Xiang-Wen,JIANG Hua-Bei,NIE Yin-Qiang,WU Dan]]></author>
</item>
<item>
<title><![CDATA[Taurine Alleviates Androgenetic Alopecia in Male C57BL/6 Mice by Modulating Hair Follicle Cycle and Related Signaling Pathways]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202505290000001]]></link>
<description><![CDATA[<b>Objective</b> This study aimed to comprehensively investigate the potential protective effects and underlying mechanisms of taurine against dihydrotestosterone (DHT)-induced androgenetic alopecia (AGA) in male C57BL/6 mice, with a focus on hair follicle cycle modulation, cellular proliferation/apoptosis, and key related signaling pathways.<b>Methods</b> Six-week-old female C57BL/6 mice were initially used to assess the hair growth-promoting potential of taurine. After acclimatization, they were randomly assigned to three groups (<i>n</i>=8): control (regular drinking water), taurine (drinking water containing 1% taurine), and minoxidil (topical 2% minoxidil, positive control). For the AGA study, male C57BL/6 mice were randomly divided into five groups (<i>n</i>=8): control (physiological saline), DHT (model group, 1 mg/d DHT), DHT+low-dose taurine (1 mg/d DHT+2 mg/d taurine), DHT+high-dose taurine (1 mg/d DHT+10 mg/d taurine), and DHT+minoxidil (positive control, 1 mg/d DHT+topical 2% minoxidil). One day before treatment initiation, dorsal hair was shaved with scissors, and residual hair was removed using a depilatory cream. DHT and taurine were administered <i>via</i> daily intraperitoneal injection. Hair regrowth was assessed by photographing the depilated area at regular intervals and quantified using a four-point grading system (0-3). Dorsal skin samples were collected on day 14 for histological analysis (H&E staining), immunofluorescence staining (Ki67 for proliferation, TUNEL for apoptosis), ELISA (DHT quantification), RT-qPCR, and Western blot analysis to evaluate the expression of key genes and proteins (androgen receptor (AR), transforming growth factor (TGF)-β1, TGF-β2, Dickkopf-1 (DKK1)).<b>Results</b> In female mice, taurine supplementation significantly accelerated hair growth, with effects comparable to minoxidil. This was evidenced by an earlier transition from pink (telogen) to black (anagen) skin and increased hair growth scores. Histological analysis showed that taurine increased hair follicle count and dermal thickness. Immunofluorescence confirmed enhanced keratinocyte proliferation in the hair matrix. In the DHT-induced AGA model, DHT significantly extended the telogen phase, inhibited hair growth, increased skin DHT content, and induced hair follicle miniaturization. Taurine treatment, particularly at the high dose, effectively counteracted these effects: it promoted the telogen-to-anagen transition and improved hair growth scores. Histomorphometric analysis showed that taurine significantly restored DHT-induced reductions in dermal thickness, hair follicle count, hair bulb depth, and follicle size. Taurine treatment also reduced apoptosis and promoted the proliferation of hair follicle cells, as demonstrated by Ki67 and TUNEL assays. Crucially, RT-qPCR and Western blot analyses revealed that DHT significantly up-regulated the expression of AR, TGF-β1, TGF-β2, and DKK1 at both mRNA and protein levels in dorsal skin. Taurine administration markedly down-regulated the expression of these pathogenic factors, bringing them closer to the levels observed in the control group.<b>Conclusion</b> Taurine demonstrates significant efficacy in alleviating DHT-induced AGA in male C57BL/6 mice. Its protective effects are mediated through multi-faceted mechanisms. (1) Promoting hair follicle cycle progression: it accelerates the transition from telogen to anagen, counteracting DHT-induced prolongation of the telogen phase. (2) Modulating cellular dynamics: it stimulates the proliferation of hair matrix keratinocytes and reduces DHT-induced apoptosis within hair follicle cells. (3) Suppressing androgen-driven pathogenic pathways: it downregulates the expression of critical molecules in the AGA pathway, including AR, the cytokines TGF-β1 and TGF-β2, and the Wnt pathway inhibitor DKK1. Given its favorable safety profile and multi-targeted action, taurine emerges as a promising novel therapeutic candidate or adjunct for treating AGA. Further investigation into its clinical potential and precise molecular mechanisms is warranted. This study provides a robust preclinical foundation for considering taurine supplementation or topical application in hair loss management strategies.]]></description>
<pubDate>2025/9/22 8:44:34</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[GUO Guo-Guo,HE Xiao-Yan,LIU Jin-Jia,WANG Hai-Dong,WANG Ji-Xiang,WU Jin-Qiang,ZHANG Xin-Ting]]></author>
</item>
<item>
<title><![CDATA[Molecular Mapping and Functional Analysis of Phenotype-determining Genes for Mendelian Traits in Pea]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202507080000003]]></link>
<description><![CDATA[Mendel established the laws and laid the foundation of modern genetics through his famous hybridization experiments on seven pairs of classic traits in the garden pea (<i>Pisum sativum</i>). However, the molecular bases underlying these traits have only come into sharp focus in recent years. Leveraging advances in traditional map-based cloning, TILLING, long-read resequencing, population genetics, and GWAS, this article synthesizes current knowledge of ten genes governing seven traits—plant height, seed shape, flower color, seed color, pod color, pod morphology, and flower position—by summarizing each gene’s identity, chromosomal localization, and functional pathway. For plant height, the classical <i>Le</i> locus corresponds to <i>PsGA3ox1</i>, which encodes a gibberellin 3β-hydroxylase. Mutations at <i>Le</i> impede the biosynthesis of the bioactive hormone GA<sub>1</sub>, and the resulting deficiency leads to a dwarf or reduced-stature phenotype. Seed shape is determined by <i>R</i>, identified as <i>PsSBEI</i> (starch-branching enzyme I). Insertion of a transposable element into <i>R</i> restricts amylopectin synthesis, perturbing endosperm starch architecture and resulting in the wrinkled seeds noted by Mendel. Flower color is specified by the coordinated action of <i>A</i> (a bHLH transcription factor) and <i>A2</i> (a WD40 scaffold). Together, they assemble the canonical MYB-bHLH-WD40 (MBW) regulatory complex, which co-activates structural genes in the anthocyanin pathway to determine pigment accumulation and floral hue. Seed color is governed by <i>I</i>, which encodes <i>PsSGR</i> (STAY-GREEN), a magnesium dechelatase that catalyzes a key step in chlorophyll catabolism. Loss-of-function alleles at <i>I</i> block chlorophyll degradation, yielding “stay-green” seeds in which chlorophyll persists beyond normal developmental stages. Pod coloration maps to <i>Gp</i>, corresponding to <i>ChlG</i> (chlorophyll synthase). Either direct loss of <i>ChlG</i> function or readthrough-fusion transcriptional interference caused by a large upstream deletion suppresses chlorophyll biosynthesis in developing pods, resulting in the yellow-pod phenotype. Pod morphology depends on two convergent regulatory pathways. The <i>P</i> gene, <i>PsCLE41</i>, signals through the P-PXY-WOX/NAC axis to promote vascular differentiation and secondary-wall programs, while <i>V</i> encodes <i>PsMYB26</i>, a transcription factor that drives secondary wall thickening in fiber cells. Acting in concert, these modules ensure robust secondary-wall deposition in the fiber layer lining the inner pod wall; disruption of either component compromises wall thickening and leads to pleated or wrinkled pods. Flower position (inflorescence determinacy at the shoot apex) is controlled by <i>FA</i>, identified as <i>PsCIK</i>, which participates in the CLAVATA-WUSCHEL (CLV-WUS) feedback circuit that maintains shoot apical meristem homeostasis. Mutations in <i>FA</i> destabilize this self-regulatory loop and promote terminal flowers at the apex. The expressivity of this determinacy phenotype is further modulated by a recessive modifier, <i>Mfa</i>, which fine-tunes the outcome in the <i>fa</i> background. Across these loci, convergent evidence highlights the central role of structural variation in generating the classical Mendelian phenotypes. Building on this clarified molecular landscape, we outline practical implications for quality improvement and the deliberate “design” of traits. Looking ahead, we envisage a next generation of legume genetic improvement anchored on three mutually reinforcing pillars: high-quality reference genomes to deliver contiguous, structurally faithful assemblies; comprehensive pan-genomes to capture presence/absence variation and structural polymorphism across germplasm; and precise gene editing to target coding, regulatory, and structural features alike. Together, these tools chart a path toward mechanism-based breeding, enabling purposeful, design-driven trait improvement in peas and, by extension, other legumes.]]></description>
<pubDate>2025/9/19 11:41:30</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[GUO Jia-He,LI Shao-Jun]]></author>
</item>
<item>
<title><![CDATA[A Blended Physiology Course Integrating Teaching, Learning, and Research: Development and Practice Within New Medical Education]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202507190000002]]></link>
<description><![CDATA[Driven by the construction of “New Medical Sciences” and the educational digitalization strategy, there is an increasingly urgent demand in medical education for compound talents who possess a solid professional foundation, scientific research literacy, and clinical innovation capabilities. To address the problems existing in traditional physiology courses—including insufficient training of high-order thinking, delayed scientific research initiation, and a single evaluation mechanism—this study, with the concept of outcome-based education (OBE) as the guide and supported by constructivist and inquiry-based learning theories, has constructed and implemented a new “Teaching-Learning-Research Integration” blended online-offline curriculum model for physiology. The curriculum promotes reforms systematically from four dimensions. First, in the online dimension, it upgrades resources such as micro-courses and virtual simulation experiments, and optimizes self-directed learning paths. Second, in the offline dimension, it reconstructs flipped classrooms to strengthen the discussion of scientific research cases and interactive inquiry. Third, it expands in-depth scientific research guidance and builds a stepped scientific research training system through Student Research and Innovation Program (SRIP) projects and discipline competitions. Fourth, it reforms the multi-dimensional evaluation mechanism by integrating process-oriented assessment and scientific research literacy evaluation. The practical results show that students’ mastery of basic physiology knowledge has been significantly improved; the effectiveness of cultivating their scientific research literacy and professional literacy, as well as their overall course satisfaction, have all been enhanced. Meanwhile, the teaching and research capabilities of the teacher team have been synchronously strengthened, achieving the goal of “mutual promotion between teaching and research”. This study confirms the effectiveness and promotion value of the in-depth integration of “Teaching-Learning-Research” in physiology courses. It provides a replicable and transferable model reference for the reform of basic medical courses under the background of “New Medical Sciences” and holds important practical significance for systematically improving the scientific research literacy and innovation capabilities of medical talents.]]></description>
<pubDate>2025/9/19 10:14:32</pubDate>
<category><![CDATA[科教融合]]></category>
<author><![CDATA[CHEN Xiao-Wei,GUO Lei,LI Li-Ping,LIU Hao,XU Jia,XU Shu-Jun,ZHANG Jun-Fang]]></author>
</item>
<item>
<title><![CDATA[Structure and Function of Mitochondrial AAA+ Proteases and Their Roles in Neurological Disorders]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202508030000003]]></link>
<description><![CDATA[Mitochondria are the most crucial energy-generating organelles in eukaryotic cells and serve as signaling hubs that orchestrate metabolism, redox balance, cell-fate decision and multiple forms of cell death. Mitochondria possess their own DNA (mtDNA), which is independent of the nuclear genome, yet encodes only 13 polypeptides, 22 tRNAs, and 2 rRNAs. The remaining >1 150 mitochondrial proteins are encoded by nuclear genes (nDNA), and the two genomes cooperate to preserve cellular homeostasis and proper function. Mitochondrial proteins are localized to the outer mitochondrial membrane (OMM), intermembrane space (IMS), inner mitochondrial membrane (IMM) or matrix, participating in oxidative phosphorylation (OXPHOS), the tricarboxylic acid (TCA) cycle, fission-fusion dynamics, and other processes indispensable for mitochondrial integrity. Mitochondrial quality control (MQC) is exerted largely by mitochondrial proteases, which selectively modulate protein activity and degrade misfolded or superfluous proteins. Among them, a group of mitochondrial ATPases associated with diverse cellular activities (AAA+ proteases) couple ATP binding and hydrolysis to protein unfolding and proteolysis, thereby regulating fusion protein maturation, respiratory-chain assembly, and mtDNA replication/transcription. Mutations or aberrant expression of these mitochondrial AAA+ proteases cripple mitochondrial architecture and function, precipitating a spectrum of severe neurological disorders. This review summarizes current knowledge on three paradigmatic mitochondrial AAA+ proteases, LONP1, YME1L1, and AFG3L2. We highlight their conserved Walker A/B motifs in the ATPase domain and hexameric architecture, yet emphasize divergent sub-mitochondrial topologies: LONP1 is soluble in the matrix, whereas YME1L1 and AFG3L2 are embedded in the IMM with catalytic domains facing IMS and matrix, respectively. These positional differences translate into distinct substrates and proteolytic strategies, enabling a division of labor and mutual complementation that cooperatively safeguards mitochondrial proteostasis. Pathogenic mutations linked to neurological disorders are mapped predominantly to the ATPase and the hydrolase/peptidase domains. Substitutions of the amino acid within these core domains can directly abolish ATP hydrolysis, substrate engagement or peptide cleavage, thereby crippling local MQC networks. Additional variants may disturb transcriptional, translational or post-translational regulation, altering protease stoichiometry and impairing compartmental balance. The subsequent cascade, mtDNA instability, respiratory-chain dysfunction, and aberrant mitochondrial dynamics, propagates stress signals that culminate in neuronal dysfunction and/or neurodegeneration. The mutational and clinical heterogeneity observed across cell types, developmental stages, and genetic backgrounds underscores the context-dependent fine-tuning of these AAA+ proteases. Deciphering how disease-associated variants rewire domain structure, catalytic cycle, and network-level crosstalk will therefore illuminate pathophysiologic mechanisms and guide precision therapeutic strategies.]]></description>
<pubDate>2025/9/16 14:22:48</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LI Ru-Ru,WEI Tao-Tao,ZHANG Ye,ZHU Li]]></author>
</item>
<item>
<title><![CDATA[Three-channel Recognition Model Based on Visible Light Images for Crop Disease Incubation Stage]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202505070000004]]></link>
<description><![CDATA[<b>Objective</b> Early detection of crop diseases is crucial for effective agricultural management and yield protection. While visible light imaging has been widely applied for disease detection due to its accessibility and non-destructive nature, most existing methods primarily focus on identifying diseases during the symptomatic phase, when visual symptoms are already prominent. However, detecting plant diseases during the incubation period—when symptoms are still subtle or invisible—remains a major challenge due to the lack of distinctive visual cues and limited research methodologies. This study aims to address this gap by proposing a novel three-channel recognition model to accurately identify early blight symptoms during the incubation stage in Solanaceae crops, particularly in chili and tomato, using only visible light images.<b>Methods</b> We established a controlled experimental setup in which healthy leaves and leaves inoculated with early blight pathogens were photographed continuously over time. A total of 1 258 visible light images were collected, capturing various stages of disease progression. From these images, lesion regions were manually annotated. To quantitatively characterize early and subtle color changes within the lesion areas, we extracted color moments—first-order (mean), second-order (standard deviation), and third-order (skewness)—from multiple color spaces, including Lab and HSV. By analyzing the temporal variation of these color moments across disease progression stages, we identified the first-order moment of the saturation (S) channel in the HSV color space as the most sensitive indicator of lesion development on inoculated leaves. Using this insight, we defined four disease categories: healthy, incubation stage, early stage, and late stage. Subsequently, a three-channel classification model was constructed by integrating features from three color channels that provided complementary information. Three-channel models were constructed based on R-G-B, L-a-b, and H-S-V color spaces, respectively, to evaluate performance across different crops and to determine which color representation provides the most discriminative power for identifying disease symptoms during the incubation period.<b>Results</b> The proposed models demonstrated strong classification performance. The three-channel model built using the Lab color space achieved a 94.44% accuracy in recognizing the incubation stage of early blight in pepper, effectively distinguishing subtle pre-symptomatic features from healthy tissue. The model based on the HSV color space achieved 100% accuracy in detecting incubation-stage symptoms in tomato, underscoring the discriminative power of S-channel variations in this context. These results confirm the model’s capability to identify early blight before visible lesions become pronounced, which is essential for timely disease intervention.<b>Conclusion</b> This study presents a new technical pathway for early-stage disease detection using visible light images by focusing on subtle color feature changes during the incubation period. The proposed three-channel recognition model effectively identifies early blight in both chili and tomato, offering a non-destructive, low-cost, and easily deployable solution for early warning and precision agriculture. Furthermore, this framework can be generalized to other crops and diseases where early detection plays a critical role in minimizing yield losses and ensuring sustainable production. The method lays a solid foundation for future research in pre-symptomatic plant disease recognition and provides valuable tools for intelligent crop monitoring and precision management systems.]]></description>
<pubDate>2025/9/10 16:23:27</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[PANG Hao,ZHANG Yan]]></author>
</item>
<item>
<title><![CDATA[Ultrasound-targeted Microbubbles Destruction: a New Approach to The Treatment of Neurodegenerative Diseases]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202506040000001]]></link>
<description><![CDATA[Neurodegenerative diseases (NDs) are a group of disorders characterized by the progressive loss of neuronal structure and function, leading to clinical manifestations such as cognitive decline, motor dysfunction, and neuropsychiatric abnormalities. NDs encompass a range of conditions, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS), <i>etc</i>. With the intensifying trends of global population growth and aging, the incidence of NDs continues to rise, yet no curative treatments are currently available. The blood-brain barrier (BBB) plays a crucial role in maintaining central nervous system (CNS) homeostasis by blocking harmful substances in the bloodstream from entering brain tissue. More than 98% of small-molecule drugs and nearly 100% of large-molecule therapeutics fail to cross the BBB and reach brain parenchyma. Ultrasound-targeted microbubble destruction (UTMD) is an emerging interdisciplinary technology integrating materials science and bioengineering, which combines the advantages of microbubble carriers with the physical properties of ultrasound. This innovative approach enables transient and reversible opening of the BBB, and enhancing drug delivery efficiency. Microbubbles (MB) are the core component of the UTMD system, consisting of two fundamental structural elements: a gaseous core and a biocompatible outer shell. The drug-loading capacity of MB has been significantly expanded, evolving from traditional chemotherapeutic agents to encompass nucleic acid drugs, macromolecular antibodies, and even traditional Chinese medicines. Concurrently, their drug-loading strategies have advanced from initial passive physical adsorption to active targeted delivery. UTMD possesses the following 4 biological advantages. (1) UTMD can transiently and reversibly enhance the permeability of cell membranes and blood vessels. The biocompatible shells commonly used in microbubbles can be metabolized by the body, posing no risk of long-term accumulation. (2) UTMD not only significantly improves drug delivery efficiency but also simultaneously serves as an ultrasound contrast agent and therapeutic carrier, achieving the integration of diagnosis and treatment. (3) UTMD technology offers dual advantages of spatial targeting and molecular targeting, allowing for precise drug delivery. (4) UTMD only requires conventional ultrasound equipment, and the raw materials for microbubble preparation are readily available with simple synthesis processes. Whether applied in diagnostics or treatment, the cost remains relatively low. The mechanism by which UTMD opens the BBB is primarily associated with cavitation effect and sonoporation effect. The cavitation effect induces mechanical stretching of both cellular membranes and capillary walls, creating transient, reversible channels that facilitate macromolecular drug passage, to enhance BBB permeability. Meanwhile, the sonoporation effect promotes drug penetration through dual mechanisms: (1) augmenting passive diffusion across biological barriers; (2) potentiating active transport processes. This synergistic action significantly elevates both local drug concentrations and therapeutic efficacy at target sites. The permeability of BBB is predominantly influenced by both microbubble characteristics and ultrasound parameters. Microbubble characteristics and ultrasound parameters are key factors affecting BBB permeability. By adjusting the composition of microbubbles and optimizing ultrasound parameters, effective BBB opening can be achieved while minimizing tissue damage, to regulate the dosage of drugs delivered to the brain parenchyma. Both preclinical investigations and clinical trials have consistently shown that UTMD holds significant therapeutic promise for NDs. This article outlines the fundamental properties of microbubbles and elucidates the potential mechanisms underlying UTMD mediated BBB opening. Furthermore, it systematically reviews recent advances in UTMD technology for the treatment of treating various NDs, aiming to provide a theoretical foundation and future directions for developing novel therapeutic strategies and drugs for NDs.]]></description>
<pubDate>2025/9/10 14:27:25</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HU Huo-Jun,HUANG Yi-Ling,LI Ling-Yan,SHENG De-Qiao,YANG Yi,YOU Cheng-Cheng,ZHENG Ruo-Quan,ZHOU Jun]]></author>
</item>
<item>
<title><![CDATA[An Accurate Density Estimation Method of Brain Glioma Based on Regularized U-net Segmentation Model]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202505010000001]]></link>
<description><![CDATA[<b>Objective</b> In the clinical diagnosis and grading of brain glioma from histopathological slides, whole-slide cell nucleus density estimation is a critical task. This metric is a key biomarker directly correlated with tumor malignancy, proliferative activity, and patient prognosis, as defined by the World Health Organization (WHO) classification system. Glioma density estimation typically relies heavily on the performance of underlying nucleus segmentation. However, segmentation accuracy is challenged by substantial heterogeneity in nucleus morphology and significant staining variations both across slides and within individual specimens. This variability often causes standard semantic segmentation models to overfit the training data, leading to considerable errors in density estimation. Such inaccuracies can compromise downstream pathological assessments, particularly the subjective and time-consuming manual selection of regions of interest (ROI) for grading. To address these limitations, this study aims to develop a precise and robust whole-slide nucleus density estimation method that enhances model generalization and mitigates overfitting, thereby providing an objective, automated tool for glioma analysis.<b>Methods</b> We propose a systematic three-stage pipeline. (1) Preprocessing: whole-slide images (WSIs) of glioma undergo comprehensive preprocessing, including automated data cleaning to discard blurry or artifact-contaminated patches, data augmentation through geometric transformations (e.g., rotation, flipping) to increase dataset diversity, and color normalization. The latter, based on RGB channel ratios, remaps the color space of all patches to a standardized target, reducing domain shifts caused by staining inconsistencies and improving model robustness. A rigorous semi-automated ground-truth annotation protocol is also implemented, where initial binarization assists annotators in accurately labeling even faint or blurry nuclei, ensuring high-quality training data. (2) Segmentation: using the preprocessed patches, we construct a U-net-based segmentation model that incorporates the DropBlock regularization module—here termed U-net+DropBlock. Unlike standard Dropout, which removes individual neurons, DropBlock eliminates contiguous, spatially correlated regions within feature maps. This structural regularization disrupts undesirable spatial dependencies, forcing the network to learn a more distributed and robust feature representation, thereby reducing overfitting. (3) Quantitative analysis: for each segmented patch, density is computed as the ratio of the total nucleus area to the total patch area—a more robust approach than simple nucleus counting, as it accounts for variations in nucleus size. Patch-wise density values are then assembled into a whole-slide density heatmap, offering an intuitive, global overview of tumor cellularity.<b>Results</b> The U-net+DropBlock model was evaluated both quantitatively and qualitatively against state-of-the-art nucleus segmentation methods, including standard U-net and Hover-net. Quantitatively, our model achieved an F1 score of 90.1%, outperforming U-net and Hover-net, which both scored 87.6%. Qualitative analysis confirmed that our method effectively balances precision and recall, substantially reducing the over-segmentation artifacts common with U-net and the under-segmentation issues observed with Hover-net. This enhanced segmentation quality directly improved the accuracy and reliability of the proposed density estimation approach.<b>Conclusion</b> The proposed whole-slide nucleus density estimation method provides a powerful tool for improving the precision and efficiency of glioma diagnosis. By enabling automated, rapid, and objective analysis of cellular density, it overcomes key limitations of manual pathological review. The generated heatmaps allow pathologists to rapidly identify high-density “hotspots” critical for accurate grading and prognostic evaluation, supporting a more standardized and reproducible ROI selection process. This work lays a solid foundation for developing advanced AI-assisted diagnostic systems, paving the way for more precise, efficient, and reproducible glioma assessments in clinical practice.]]></description>
<pubDate>2025/9/9 17:39:37</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[LIU Kai,PAN Min-Hong,XIA Rui-Chen,YAO Jia-Feng,YE Chen,ZHAO Lai-Ding]]></author>
</item>
<item>
<title><![CDATA[Natural Spore and Pollen Microcarriers: Processing and Advanced Drug Delivery]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202507130000001]]></link>
<description><![CDATA[Spores and pollen, as ubiquitous organisms found in nature, possess a remarkable core-shell structure and intricate surface morphology. These tiny particles are notable for their dimensional uniformity, sustainable utilization, environmental friendliness, porosity, amphiphilicity, and strong adhesive properties. In addition, they display excellent biocompatibility and biodegradability, which significantly enhances the stability and targeting of drugs within the body. Spores and pollen can be extracted using methods such as acidic solutions, alkaline solutions, or enzyme treatments to obtain sporopollenin, which is an extremely resilient and chemically inert complex biopolymer. The sporopollenin extracted through this process removes the original bioactive substances, such as cell nuclei, enzymes, and DNA, providing greater drug loading capacity and containing no potential allergens or immunogens, thus further enhancing its drug loading capacity and improving safety in therapeutic applications. Due to these beneficial attributes, spores, pollen and sporopollenin have gained widespread use in a variety of drug delivery systems, such as targeted delivery, sustained drug delivery, toxicity mitigation, flavor masking, vaccine delivery, delivery of labile substances, and other applications. This review introduces the types of natural spores and pollen commonly used in drug delivery systems, including their main components, common effects, and uses in drug delivery systems, and so on. It subsequently summarizes novel optimization methods in their processing, such as physical treatment, surface modification, and chemical modification, which enable higher drug loading efficiency, stability, and targeting, among other benefits. Additionally, this paper reviews the research progress and applications of natural spores, pollen, and sporopollenin in drug delivery systems, while also touching on some innovative research content, such as novel nanomotor microcarriers developed based on pollen. Based on these research findings, we further elaborate on the advantages of spores, pollen, and sporopollenin in drug delivery systems. For example, they have high stability and drug loading capacity, good adhesion, excellent targeting, and are easy to modify functionally. Currently, they show promising prospects in the fields of targeted drug delivery, sustained-release drug delivery, as well as the delivery of drugs that are effective but slightly toxic, and are often used in research on the treatment of diseases such as cancer and inflammation. We have also highlighted the challenges they face in various applications and identified some issues that need to be addressed, including difficulties in large-scale production, the need to improve extraction and purification processes, and the existence of a low but still noteworthy risk of allergies, in order to fully leverage their potential in drug delivery applications. According to current research, although spores, pollen, and sporopollenin face some unresolved issues in clinical drug delivery, they still have great potential overall and are expected to become a new generation of green drug delivery platforms. In the future, further research into their unique physical and chemical properties and structural characteristics will help develop more efficient and stable drug delivery systems to meet diverse treatment needs. We believe that continued exploration of natural spores, pollen, and sporopollenin will drive this emerging field to achieve continuous breakthroughs and progress, ultimately making an important contribution to the cause of human health.]]></description>
<pubDate>2025/9/8 21:25:14</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LIU Jia,SHI Xiu-Yan,WANG Jing-Jing,YUAN Chen-Man]]></author>
</item>
<item>
<title><![CDATA[Regulatory Effects of Oncogenes and Tumor Suppressor Genes on Tumor Immune Microenvironment]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202507070000001]]></link>
<description><![CDATA[In recent years, immunotherapy has become an excellent option for cancer patients, but most patients still face problems such as low response or drug resistance. Therefore, researchers conducted extensive studies on the reasons for the poor efficacy of immunotherapy. Eventually, it was found that the regulatory effect of abnormal expression of oncogenes and tumor suppressor genes on the tumor immune microenvironment is one of the important factors leading to the failure of immunotherapy to achieve the expected efficacy. It is well known that cancer is a kind of disease caused by the interaction between environmental and genetic factors, and the occurrence of cancer is mainly related to genetic alteration. Physiologically, the balance between oncogenes and tumor suppressor genes is crucial for DNA replication and proliferation regulation. However, under certain conditions, such as viral infection, chemical carcinogens or radiation, these genes may be mutated and eventually induce cancer. In addition, the combination of different gene mutations can also lead to significant differences among patients. For example, certain gene mutations are associated with the metastasis of cancer cells, while some are associated with the resistance of cancer cells to the attack of immune cells. Therefore, exploring the effects of different genetic alterations on the tumor microenvironment can help us better solve the problems in the process of clinical treatment and provide a theoretical basis for designing gene-targeted and personalized therapies. This review mainly summarizes the effects of common oncogenes and tumor suppressor gene mutations on immunosuppressive cells, anti-tumor immune effector cells and tumor-associated fibroblasts in the tumor microenvironment. Firstly, when the oncogene <i>KRAS</i>, <i>c</i>-<i>Myc</i> and <i>EGFR</i> are abnormally activated, cancer cell will secrete various cytokines and chemokines, thereby recruiting various immunosuppressive cells to the TME and causing exhaustion of CD8<sup>+</sup> T and NK cells. It can also reprogram CAFs and eventually promote the development of cancer. Furthermore, similar phenomena occur after the inactivation of tumor suppressor genes. For example, cancer cells with inactivated <i>PTEN</i> genes will secrete large amounts of IL-33 and LOX to recruit macrophages and induce TAMs. Cancer cells can secrete a variety of microRNAs into the tumor microenvironment after p53 dysregulation. These mircoRNAs can reprogram CAFs and lead to epithelial-mesenchymal transition. Finally, we summarize the reversing effects of therapeutic interventions targeting mutant oncogenes or tumor suppressor genes (such as KRAS inhibitors, overexpression of p53 by mRNA, PI3Kβ inhibitors) on the immunosuppressive tumor microenvironment. Some of the results of their synergistic effects in combination with immunotherapy are also listed. Compared with monotherapy, the combination of either KRAS inhibitor or <i>p53</i> mRNA nanomedicine with αPD-1 therapy resulted in more durable and potent anti-tumor effects. In summary, this review elucidates the regulatory and remodeling effects of genetic alterations in tumor cells on the tumor immune microenvironment, and analyzes the great potential of gene alteration intervention combined with immunotherapy. We hope it can provide theoretical basis and development strategy for precise cancer immunotherapy.]]></description>
<pubDate>2025/9/8 8:37:46</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[TAN Shu-Yi,ZHANG Jian]]></author>
</item>
<item>
<title><![CDATA[Mechanisms of Immune Evasion by The SARS-CoV-2 JN.1 Variant Against Broadly Neutralizing Antibodies]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202507150000005]]></link>
<description><![CDATA[<b>Objective</b> With the continuous evolution of severe acute respiratory syndromes-coronary virus 2 (SARS-CoV-2) Omicron subvariants, particularly the emergence of BA.2.86 and its descendant JN.1, the efficacy of current neutralizing antibodies has faced substantial challenges. The JN.1 variant, noted for its pronounced immune evasion capacity, has rapidly become the globally dominant strain. Elucidating its escape mechanisms is therefore essential to guide the development of next-generation broad-spectrum vaccines and neutralizing antibody therapeutics. This study aimed to investigate the immune evasion mechanisms of JN.1 against broadly neutralizing antibodies, focusing on the effects of key receptor-binding domain (RBD) mutations on antibody binding and neutralization, thereby providing theoretical support for countering ongoing viral evolution.<b>Methods</b> We employed a multidisciplinary approach to systematically assess the binding and neutralizing activities of three broad-spectrum neutralizing antibodies (XGv074, XGv302, and XGv303) against BA.2.86 and JN.1. Binding affinities (<i>K</i><sub>D</sub> values) of antibodies to variant RBDs were determined using bio-layer interferometry (BLI). Cryo-electron microscopy (cryo-EM) was used to resolve the structure of the BA.2.86 Spike trimer in complex with antibody antigen-binding fragments (Fabs), achieving a resolution of 3.47 ? for the BA.2.86 S-trimer bound to XGv302. Molecular dynamics simulations and binding free-energy decomposition were conducted to quantify the contributions of key mutations at the antibody-RBD interface. Additionally, sequence alignment and structural modeling were performed to evaluate the role of conformational flexibility in the antibody heavy-chain complementarity-determining region 3 (HCDR3) in mediating tolerance to mutations.<b>Results</b> Experimental data showed that XGv074, XGv302, and XGv303 retained neutralizing activity against BA.2.86 but exhibited markedly reduced binding to JN.1, with only XGv074 maintaining weak neutralization (<i>IC</i><sub>50</sub>=2.3 mg/L). Cryo-EM structures revealed that all three antibodies targeted the RBD tip, overlapping with the ACE2-binding region. The JN.1-specific L455S mutation disrupted the hydrophobic interaction network between XGv302 and the RBD (involving key residues such as Y421 and L455), resulting in complete loss of neutralization. Binding free-energy decomposition further identified L455 and Y421 as energetic hotspots (Δ<i>G</i><-3 kcal/mol), with the L455S mutation directly impairing antibody binding. XGv074, owing to greater conformational flexibility in its HCDR3 region, partially tolerated the mutation and retained weak binding. Molecular dynamics simulations showed that the L455S mutation not only eliminated the energetic contribution of this residue but also caused a concurrent decrease in binding free energy of neighboring residues, thereby reducing overall interface stability.<b>Conclusion</b> The JN.1 variant escapes broad-spectrum neutralizing antibodies primarily through the L455S mutation in the RBD, which disrupts energetic hotspots and remodels the antibody-binding interface. Antibody conformational flexibility enhances adaptability to such mutations, providing new insights for broad-spectrum antibody design. These findings highlight the critical roles of epitope energy distribution and antibody flexibility in maintaining neutralization breadth, offering essential guidance for the rational design of next-generation vaccines and antibody therapeutics: specifically targeting conserved energetic hotspots while enhancing CDR flexibility to counter immune evasion driven by viral evolution.]]></description>
<pubDate>2025/8/20 14:57:08</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[FENG Lu-Lu,GUO Meng-Tian,LIU Pan,LIU Tian-Ci,SUN Ming-Chen,XIE Jia-Wen,ZHU Qian-Hui]]></author>
</item>
<item>
<title><![CDATA[The Invariant Neural Representation of Neurons in Pigeon’s Ventrolateral Mesopallium to<sup> </sup>Stereoscopic Shadow Shapes]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202505110000001]]></link>
<description><![CDATA[<b>Objective</b> In nature, objects cast shadows due to illumination, forming the basis for stereoscopic perception. Birds need to adapt to changes in lighting (meaning they can recognize stereoscopic shapes even when shadows look different) to accurately perceive different three-dimensional forms. However, how neurons in the key visual brain area in birds handle these lighting changes remains largely unreported. In this study, pigeons (<i>Columba livia</i>) were used as subjects to investigate how neurons in pigeon’s ventrolateral mesopallium (MVL) represent stereoscopic shapes consistently, regardless of changes in lighting.<b>Methods</b> Visual cognitive training combined with neuronal recording was employed. Pigeons were first trained to discriminate different stereoscopic shapes (concave/convex). We then tested whether and how light luminance angle and surface appearance of the stereoscopic shapes affect their recognition accuracy, and further verify whether the results rely on specify luminance color. Simultaneously, neuronal firing activity of neurons was recorded with multiple electrode array implanted from the MVL during the presentation of difference shapes. The response was finally analyzed how selectively they responded to different stereoscopic shapes and whether their selectivity was affected by the changes of luminance condition (like lighting angle) or surface look. Support vector machine (SVM) models were trained on neuronal population responses recorded under one condition (light luminance angle of 45°) and used to decode responses under other conditions (light luminance angle of 135°, 225°, 315°) to verify the invariance of responses to different luminance conditions.<b>Results</b> Behavioral results from 6 pigeons consistently showed that the pigeons could reliably identify the core 3D shape (over 80% accuracy), and this ability wasn’t affected by changes in light angle or surface appearance. Statistical analysis of 88 recorded neurons from 6 pigeons revealed that 83% (73/88) showed strong selectivity for specific 3D shapes (selectivity index>0.3), and responses to convex shapes were consistently stronger than to concave shapes. These shape-selective responses remained stable across changes in light angle and surface appearance. Neural patterns were consistent under both blue and orange lighting. The decoding accuracy achieves above 70%, suggesting stable responses under different conditions (<i>e.g</i>., different lighting angles or surface appearance).<b>Conclusion</b> Neurons in the pigeon MVL maintain a consistent neural encoding pattern for different stereoscopic shapes, unaffected by illumination or surface appearance. This ensures stable object recognition by pigeons in changing visual environments. Our findings provide new physiological evidence for understanding how birds achieve stable perception (“invariant neural representations”) while coping with variations in the visual field.]]></description>
<pubDate>2025/8/12 20:42:58</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[DENG Yi-Xin,HAN Yong-Hao,LI Zhi-Hui,NIU Xiao-Ke,PENG Yan-Yan,WANG Qing-Yu,ZHANG Meng-Bo]]></author>
</item>
<item>
<title><![CDATA[Prediction of RNA m6A Methylation Sites in Multiple Tissues Based on Dual-branch Residual Network]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202504170000001]]></link>
<description><![CDATA[<b>Objective</b> N6-methyladenosine (m6A), the most prevalent epigenetic modification in eukaryotic RNA, plays a pivotal role in regulating cellular differentiation and developmental processes, with its dysregulation implicated in diverse pathological conditions. Accurate prediction of m6A sites is critical for elucidating their regulatory mechanisms and informing drug development. However, traditional experimental methods are time-consuming and costly. Although various computational approaches have been proposed, challenges remain in feature learning, predictive accuracy, and generalization. Here, we present m6A-PSRA, a dual-branch residual-network-based predictor that fully exploits RNA sequence information to enhance prediction performance and model generalization.<b>Methods</b> m6A-PSRA adopts a parallel dual-branch network architecture to comprehensively extract RNA sequence features <i>via</i> two independent pathways. The first branch applies one-hot encoding to transform the RNA sequence into a numerical matrix while strictly preserving positional information and sequence continuity. This ensures that the biological context conveyed by nucleotide order is retained. A bidirectional long short-term memory network (BiLSTM) then processes the encoded matrix, capturing both forward and backward dependencies between bases to resolve contextual correlations. The second branch employs a <i>k</i>-mer tokenization strategy (<i>k</i>=3), decomposing the sequence into overlapping 3-mer subsequences to capture local sequence patterns. A pre-trained Doc2vec model maps these subsequences into fixed-dimensional vectors, reducing feature dimensionality while extracting latent global semantic information <i>via</i> context learning. Both branches integrate residual networks (ResNet) and a self-attention mechanism: ResNet mitigates vanishing gradients through skip connections, preserving feature integrity, while self-attention adaptively assigns weights to focus on sequence regions most relevant to methylation prediction. This synergy enhances both feature learning and generalization capability.<b>Results</b> Across 11 tissues from humans, mice, and rats, m6A-PSRA consistently outperformed existing methods in accuracy (<i>ACC</i>) and area under the curve (<i>AUC</i>), achieving >90% <i>ACC</i> and >95% <i>AUC</i> in every tissue tested, indicating strong cross-species and cross-tissue adaptability. Validation on independent datasets—including three human cell lines (MOLM1, HEK293, A549) and a long-sequence dataset (m6A_IND, 1 001 nt)—confirmed stable performance across varied biological contexts and sequence lengths. Ablation studies demonstrated that the dual-branch architecture, residual network, and self-attention mechanism each contribute critically to performance, with their combination reducing interference between pathways. Motif analysis revealed an enrichment of m6A sites in guanine (G) and cytosine (C), consistent with known regulatory patterns, supporting the model’s biological plausibility.<b>Conclusion</b> m6A-PSRA effectively captures RNA sequence features, achieving high prediction accuracy and robust generalization across tissues and species, providing an efficient computational tool for m6A methylation site prediction.]]></description>
<pubDate>2025/8/12 12:53:00</pubDate>
<category><![CDATA[技术与方法]]></category>
<author><![CDATA[CHEN Dan,GAO Wei,GUO Xiao-Tian,LI Hui-Min,TAN Xue-Wen]]></author>
</item>
<item>
<title><![CDATA[Transzonal Projections and Follicular Development Abnormalities in Polycystic Ovary Syndrome]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202504250000001]]></link>
<description><![CDATA[Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder affecting a substantial proportion of women of reproductive age. It is frequently associated with ovulatory dysfunction, infertility, and an increased risk of chronic metabolic diseases. A hallmark pathological feature of PCOS is the arrest of follicular development, closely linked to impaired intercellular communication between the oocyte and surrounding granulosa cells. Transzonal projections (TZPs) are specialized cytoplasmic extensions derived from granulosa cells that penetrate the zona pellucida to establish direct contact with the oocyte. These structures serve as essential conduits for the transfer of metabolites, signaling molecules (<i>e.g.</i>, cAMP, cGMP), and regulatory factors (<i>e.g</i>., microRNAs, growth differentiation factors), thereby maintaining meiotic arrest, facilitating metabolic cooperation, and supporting gene expression regulation in the oocyte. The proper formation and maintenance of TZPs depend on the cytoskeletal integrity of granulosa cells and the regulated expression of key connexins, particularly CX37 and CX43. Recent studies have revealed that in PCOS, TZPs exhibit significant structural and functional abnormalities. Contributing factors—such as hyperandrogenism, insulin resistance, oxidative stress, chronic inflammation, and dysregulation of critical signaling pathways (including PI3K/Akt, Wnt/β-catenin, and MAPK/ERK)—collectively impair TZP integrity and reduce their formation. This disruption in granulosa-oocyte communication compromises oocyte quality and contributes to follicular arrest and anovulation. This review provides a comprehensive overview of TZP biology, including their formation mechanisms, molecular composition, and stage-specific dynamics during folliculogenesis. We highlight the pathological alterations in TZPs observed in PCOS and elucidate how endocrine and metabolic disturbances—particularly androgen excess and hyperinsulinemia—downregulate CX43 expression and impair gap junction function, thereby exacerbating ovarian microenvironmental dysfunction. Furthermore, we explore emerging therapeutic strategies aimed at preserving or restoring TZP integrity. Anti-androgen therapies (<i>e.g</i>., spironolactone, flutamide), insulin sensitizers (<i>e.g</i>., metformin), and GLP-1 receptor agonists (<i>e.g</i>., liraglutide) have shown potential in modulating connexin expression and enhancing granulosa-oocyte communication. In addition, agents such as melatonin, AMPK activators, and GDF9/BMP15 analogs may promote TZP formation and improve oocyte competence. Advanced technologies, including ovarian organoid models and CRISPR-based gene editing, offer promising platforms for studying TZP regulation and developing targeted interventions. In summary, TZPs are indispensable for maintaining follicular homeostasis, and their disruption plays a pivotal role in the pathogenesis of PCOS-related folliculogenesis failure. Targeting TZP integrity represents a promising therapeutic avenue in PCOS management and warrants further mechanistic and translational investigation.]]></description>
<pubDate>2025/8/7 11:27:33</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Yu-Hua,CHENG Di,JIANG Xia-Ping,LI Lan-Yu,LI Ming,MO Zhong-Cheng,TAN Yi]]></author>
</item>
<item>
<title><![CDATA[Glycolytic Hyperactivity in Endometriotic Diseases: From Molecular Mechanisms to Precise Interventions]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202504280000002]]></link>
<description><![CDATA[Endometriosis (EM) and adenomyosis (AM) are chronic, estrogen-dependent gynecological disorders that significantly impair the quality of life and reproductive health of millions of women worldwide. Clinically, both conditions are characterized by dysmenorrhea, abnormal uterine bleeding, infertility, and high recurrence rates. Despite decades of research, their pathogenesis remains incompletely understood, and current therapeutic options are limited in both efficacy and long-term safety. Emerging studies have identified glycolytic metabolic reprogramming (GMR)—a shift from mitochondrial oxidative phosphorylation (OXPHOS) to aerobic glycolysis—as a unifying and critical feature in the development and progression of EM and AM. In ectopic lesions, enhanced glycolysis supports cellular proliferation, survival, and adaptation to hypoxic microenvironments. Key glycolytic enzymes, including hexokinase 2 (HK2), phosphofructokinase-1 (PFK1), pyruvate dehydrogenase kinase (PDK), and lactate dehydrogenase A (LDHA), are markedly upregulated, whereas oxidative metabolism is suppressed, reflecting a Warburg-like metabolic phenotype. Notably, single-cell and spatial transcriptomic analyses reveal significant heterogeneity between EM and AM lesions. EM lesions often contain cell clusters co-expressing glycolytic and OXPHOS-related genes, suggesting metabolic flexibility. In contrast, AM tissues exhibit a more uniform, glycolysis-dominant profile, with preferential HK2 expression over HK1—potentially linked to defective repair of the endometrial basal layer. Multiple regulatory layers contribute to this glycolytic shift. Hypoxia-inducible factors (HIFs) act as upstream transcriptional activators in response to oxygen deprivation. Kinase cascades, such as those involving PIM2 and AURKA, enhance glycolytic enzyme activity <i>via</i> phosphorylation. Epigenetic mechanisms—including N6-methyladenosine (m6A) RNA modification and histone H3K18 lactylation—further stabilize glycolytic gene expression and reinforce metabolic reprogramming. These alterations form an integrated regulatory network that sustains high glycolytic flux in ectopic cells. Importantly, GMR profoundly affects the immune microenvironment. Lactate produced by glycolytic stromal cells promotes M2 macrophage polarization and impairs the function of cytotoxic T cells and dendritic cells, leading to immune evasion and chronic inflammation. Meanwhile, immune cells themselves undergo metabolic reprogramming, exhibiting increased dependence on glycolysis and diminished oxidative capacity. This bidirectional metabolic-immune feedback loop facilitates lesion persistence and disease progression. GMR is also closely linked to infertility in EM and AM. In the ovarian microenvironment, glycolytic imbalance leads to lactate accumulation in follicular fluid, negatively affecting oocyte quality and embryo development. In the endometrium, excessive glycolysis disrupts decidualization, angiogenesis, and immune tolerance—processes essential for implantation and pregnancy. Targeting glycolysis offers promising therapeutic potential. Small-molecule inhibitors such as dichloroacetate and meclozine target PDK and HK2, respectively. Natural compounds like cinnamic acid and protoberberine derivatives exhibit both anti-glycolytic and anti-inflammatory effects. Traditional Chinese medicine formulations, including Guizhi Fuling Wan, have shown efficacy in modulating metabolism, vascular remodeling, and fibrosis. Combination therapies, such as atorvastatin with resveratrol, may provide synergistic benefits by inhibiting both glucose uptake and lactate export. In conclusion, glycolytic metabolic reprogramming is a central mechanism linking inflammation, immune dysfunction, lesion progression, and reproductive failure in endometriotic diseases. Future research should focus on identifying metabolic subtypes, developing combined metabolic-immune therapies, and evaluating the safety of these treatments in reproductive-age women. These insights may pave the way toward personalized, mechanism-driven interventions for EM and AM.]]></description>
<pubDate>2025/8/5 20:03:27</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DU Lin,FU Xian-Yun,SHI Wen-Jie,TAO Yi-Dan,WANG Mei-Ling,ZHOU Hao-Xin,ZHOU Shuang-Shuang]]></author>
</item>
<item>
<title><![CDATA[The Role of AMPK in Diabetic Cardiomyopathy and Related Intervention Strategies]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202504090000002]]></link>
<description><![CDATA[Diabetic cardiomyopathy is a distinct form of cardiomyopathy that can lead to heart failure, arrhythmias, cardiogenic shock, and sudden death. It has become a major cause of mortality in diabetic patients. The pathogenesis of diabetic cardiomyopathy is complex, involving increased oxidative stress, activation of inflammatory responses, disturbances in glucose and lipid metabolism, accumulation of advanced glycation end products (AGEs), abnormal autophagy and apoptosis, insulin resistance, and impaired intracellular Ca<sup>2+</sup> homeostasis. Recent studies have shown that adenosine monophosphate-activated protein kinase (AMPK) plays a crucial protective role by lowering blood glucose levels, promoting lipolysis, inhibiting lipid synthesis, and exerting antioxidant, anti-inflammatory, anti-apoptotic, and anti-ferroptotic effects. It also enhances autophagy, thereby alleviating myocardial injury under hyperglycemic conditions. Consequently, AMPK is considered a key protective factor in diabetic cardiomyopathy. As part of diabetes prevention and treatment strategies, both pharmacological and exercise interventions have been shown to mitigate diabetic cardiomyopathy by modulating the AMPK signaling pathway. However, the precise regulatory mechanisms, optimal intervention strategies, and clinical translation require further investigation. This review summarizes the role of AMPK in the prevention and treatment of diabetic cardiomyopathy through drug and/or exercise interventions, aiming to provide a reference for the development and application of AMPK-targeted therapies. First, several classical AMPK activators (<i>e.g.</i>, AICAR, A-769662, O-304, and metformin) have been shown to enhance autophagy and glucose uptake while inhibiting oxidative stress and inflammatory responses by increasing the phosphorylation of AMPK and its downstream target, mammalian target of rapamycin (mTOR), and/or by upregulating the gene expression of glucose transporters GLUT1 and GLUT4. Second, many antidiabetic agents (<i>e.g</i>., teneligliptin, liraglutide, exenatide, semaglutide, canagliflozin, dapagliflozin, and empagliflozin) can promote autophagy, reverse excessive apoptosis and autophagy, and alleviate oxidative stress and inflammation by enhancing AMPK phosphorylation and its downstream targets, such as mTOR, or by increasing the expression of silent information regulator 1 (SIRT1) and peroxisome proliferator-activated receptor-α (PPAR-α). Third, certain anti-anginal (<i>e.g.</i>, trimetazidine, nicorandil), anti-asthmatic (<i>e.g</i>., farrerol), antibacterial (<i>e.g.</i>, sodium houttuyfonate), and antibiotic (<i>e.g.</i>, minocycline) agents have been shown to promote autophagy/mitophagy, mitochondrial biogenesis, and inhibit oxidative stress and lipid accumulation <i>via</i> AMPK phosphorylation and its downstream targets such as protein kinase B (PKB/AKT) and/or PPAR-α. Fourth, natural compounds (<i>e.g</i>., dihydromyricetin, quercetin, resveratrol, berberine, platycodin D, asiaticoside, cinnamaldehyde, and icariin) can upregulate AMPK phosphorylation and downstream targets such as AKT, mTOR, and/or the expression of nuclear factor erythroid 2-related factor 2 (Nrf2), thereby exerting anti-inflammatory, anti-apoptotic, anti-pyroptotic, antioxidant, and pro-autophagic effects. Fifth, moderate exercise (<i>e.g</i>., continuous or intermittent aerobic exercise, aerobic combined with resistance training, or high-intensity interval training) can activate AMPK and its downstream targets (<i>e.g</i>., acetyl-CoA carboxylase (ACC), GLUT4, PPARγ coactivator-1α (PGC-1α), PPAR-α, and forkhead box protein O3 (FOXO3)) to promote fatty acid oxidation and glucose uptake, and to inhibit oxidative stress and excessive mitochondrial fission. Finally, the combination of liraglutide and aerobic interval training has been shown to activate the AMPK/FOXO1 pathway, thereby reducing excessive myocardial fatty acid uptake and oxidation. This combination therapy offers superior improvement in cardiac dysfunction, myocardial hypertrophy, and fibrosis in diabetic conditions compared to liraglutide or exercise alone.]]></description>
<pubDate>2025/8/5 19:53:06</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Xiao-Feng,LIAO Fang-Lian,SHANG Hua-Yu,XIA Zhi,XIANG Han-Yi]]></author>
</item>
<item>
<title><![CDATA[Regulatory Effects of Exercise on The Natural Immune System and Related Molecular Mechanisms]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202505150000001]]></link>
<description><![CDATA[The innate immune system serves as the body’s first line of defense against pathogens and plays a central role in inflammation regulation, immune homeostasis, and tumor immunosurveillance. In recent years, with the growing recognition of the concept “exercise is medicine”, increasing attention has been paid to the immunoregulatory effects of physical activity. Accumulating evidence suggests that regular, moderate-intensity exercise significantly enhances innate immunity by strengthening the skin-mucosal barrier, increasing levels of secretory immunoglobulin A (sIgA), and improving the functional capacity of key immune cells such as natural killer (NK) cells, neutrophils, macrophages, and dendritic cells. It also modulates the complement system and various inflammatory mediators. This review comprehensively summarizes the effects of exercise on each component of the innate immune system and highlights the underlying molecular mechanisms, including activation of AMP-activated protein kinase (AMPK), inhibition of nuclear factor-kappa B (NF-κB), enhancement of mitochondrial function <i>via</i> the PGC-1α/TFAM axis, and initiation of autophagy through the ULK1/mTOR pathway. Emerging mechanisms are also discussed, such as exercise-induced epigenetic modifications (<i>e.g.</i>, histone acetylation and miRNA regulation), modulation of the gut microbiota, and metabolite-mediated immune programming (<i>e.g.</i>, short-chain fatty acids (SCFAs), β-hydroxybutyrate). The effects of exercise on innate immunity vary considerably among individuals, depending on factors such as age, sex, and comorbidities. For example, adolescents exhibit enhanced NK cell mobilization, whereas older adults benefit from reduced chronic inflammation and immune aging. Sex hormones and metabolic conditions (<i>e.g.</i>, obesity, diabetes, chronic obstructive pulmonary disease, cancer) further modulate the immune response to exercise. Based on these insights, we propose a personalized approach to exercise prescription guided by the FITT (frequency, intensity, time, and type) principle, aiming to optimize immune outcomes across diverse populations. Importantly, given the dual role of exercise in immune activation and regulation, caution is warranted: while moderate exercise enhances immune defense, excessive or high-intensity activity may induce transient immunosuppression. In pathological contexts such as infection, autoimmune diseases, or tissue injury, exercise intensity and timing must be carefully adjusted. This review provides practical guidelines for exercise-based immune modulation and underscores the need for dose-response studies and advancements in precision exercise medicine. In conclusion, exercise represents a safe and effective strategy for enhancing innate immune function and mitigating chronic inflammatory diseases.]]></description>
<pubDate>2025/8/4 8:30:48</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LI Xin,NING Ke,WANG Zhuo,ZHAO Shu-Yang]]></author>
</item>
<item>
<title><![CDATA[The Relationship of Transcription Factor BRF1 Expression to Tumor and Cardiomyopathy]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202505280000001]]></link>
<description><![CDATA[TFIIB-related factor 1 (BRF1) is an important transcription factor. It specifically regulates the transcription of RNA polymerase III-dependent genes (RNA Pol III genes). The products of these genes are some small non-coding RNAs, including transfer RNAs (tRNAs) and 5S ribosomal RNAs (5S rRNA). The transcription levels of tRNAs and 5S rRNA vary with changes in intracellular BRF1 amounts. tRNAs and 5S rRNA play a crucial role in determining protein synthesis. Studies have demonstrated that dysregulation of tRNAs and 5S rRNA is closely related to cell growth, proliferation, transformation, and even tumorigenesis. BRF1 is a key factor determining the generation of tRNAs and 5S rRNA. Increasing BRF1 expression enhances cell proliferation and transformation, promoting tumor development. In contrast, repressing BRF1 activity decreases the rates of cell proliferation and transformation, and inhibits tumor growth. High levels of BRF1 are found in the samples of patients suffering from hepatocellular carcinoma, breast cancer, gastric carcinoma, lung cancer, prostate carcinoma, and other cancers. It indicates that high levels of BRF1 are closely related to the occurrence of human cancer and may be a common landmark of tumors. But there is discrepancy in the regulatory mechanisms and signaling pathways of BRF1 overexpression in different cancers. In general, high levels of BRF1 in patients suffering from cancer show short survival period and poor prognosis. However, there is one exception, namely breast cancer. Approximate 80% of cases of breast cancer are estrogen receptor-positive (ER+) and 20% are ER-. The cases with high levels of BRF1 reveal longer survival period and better prognosis after they accepted the hormone treatment by Tamoxifen (Tam), compared to the cases with low level BRF1. It seems like a contradiction. Most of the cases with high levels of BRF1 belong to ER+ status. Tam has been used to treat ER+ cases of breast cancer after diagnosis and surgery. Thus, hormone therapy, such as Tam, is more effective on these patients. This is because, on one hand, that Tam competes with E2 (17β-estradiol) to bind to estrogen receptor α (ERα), but does not dissociate to occupy the receptors, blocking E2 binding to this receptor and inhibiting its biological effects. On other hand, Tam can inhibit the expression of BRF1, leading to a decline of intracellular BRF1 levels. Therefore, the actual levels of BRF1 are lower in the patients with ER+ breast cancer. It appears the prognosis of the high BRF1 expression cases better than that of the low BRF1 expression cases. Myocardial hypertrophy manifests magnification of cardiomyocyte volume rather than number increasing in the postnatal heart. Myocardial hypertrophy is a critical risk factor underlying cardiovascular diseases. No matter how myocardial hypertrophy occur, it will ultimately lead to myocardial dysfunction and heart failure. Hypertrophic growth of cardiomyocytes requires a large amount of protein synthesis to meet its needs of cardiomyocyte growth. Animal models and cell experiments have shown that myocardial hypertrophy stimulates a significant increase in BRF1 expression and transcription of tRNAs and 5S rRNA. Interestingly, elevated levels of BRF1 are found in the myocardium tissues of patients with myocardial hypertrophy. These studies demonstrate that BRF1 indeed plays a critical role in myocardial hypertrophy. In summary, high levels of BRF1 are found in patients suffering from different cancers and myocardial hypertrophy. It implies that BRF1 is a promising biological target of cancer and cardiomyopathy. BRF1 is expected to become a common biomarker for early diagnosis and prognostic observation of different human cancers. It is also an important biomarker for the diagnosis and treatment of cardiomyopathy. BRF1 not only holds an important position in the field of basic medical research but also has great prospects for translational medicine. In the present article, we summarize the progress on studies of BRF1 expressions in cancer and cardiomyopathy, proposes future research directions. It is a new research area. Here, we emphasize the significancy of BRF overexpression in the two huge diseases of human, cancer and cardiomyopathy to raise people"s attention to this field.]]></description>
<pubDate>2025/8/1 9:07:16</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[ZHONG Shuping,CHEN Mei-Ling,LIN Yong-Luan,ZHENG Li-Ling,ZHONG Zheng-Yan]]></author>
</item>
<item>
<title><![CDATA[Nucleation-dependent Polymerization and Liquid-to-solid Phase Transition in Protein Aggregation]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202505070000002]]></link>
<description><![CDATA[Neurodegenerative diseases (NDs) are a wide variety of disorders characterized by the progressive and irreversible loss of neuronal structure and functions leading to cognitive impairments. The common types of NDs include Alzheimer’s disease, amyotrophic lateral sclerosis, Huntington’s disease, and Parkinson’s disease. The sharing pathological hallmarks of these diseases are the aberrant aggregation and amyloid deposition. However, the underlying molecular mechanisms of protein misfolding and aberrant aggregation remain elusive. Amyloid protein is prone to aggregate from its native disordered monomeric state into well-ordered amyloid fibril state <i>via</i> nucleation-dependent polymerization mechanism, in which follows sigmoidal growth kinetics with three steps: lag phase, growth phase, and plateau phase. The formation and subsequent distribution of these pathological amyloid fibrils are closely related to the onset and progression of NDs. Additionally, the aberrant aggregation of these disease-associated proteins proceeds <i>via</i> liquid-liquid phase separation (LLPS) and liquid-to-solid phase transition (LSPT) leading to amyloid fibril formation in the condensed phase. The phase transition from liquid-like droplets or dynamic condensates to solid-like hydrogel or amyloids is intimately linked to the pathogenesis of several NDs. In this review, we discuss two typical pathways of amyloid fibrils formation. One route involves aggregation in the bulk solution environment, proceeding <i>via</i> nucleation and elongation steps to form amyloid fibrils. In this scenario, protein aggregation initiates with the nucleation step to form oligomeric nuclei. Then the nuclei serve as templates for the subsequent elongation step ultimately leading to the formation of amyloid fibrils. When sufficient fibrils have formed during self-assembly, the secondary nucleation is triggered to generate new species of oligomers and fibrillar aggregates. The other route of fibril formation occurs in the condensed phase through LLPS and LSPT to form amyloid aggregates and deposits. The occurrence of a phase separation leads to the liquid-like droplets formation during the early stage of aggregation. Over time, these dynamic biomolecular condensates gradually solidify and ultimately evolve into a hydrogel state enriched by amyloid aggregates through a phase transition process. Evidence indicates that pathological phase transitions are early events in the pathogenesis of several NDs. It should be noted that these two routes are not independent or mutually exclusive. They are interconnected and function cooperatively during aberrant aggregation. The pathological progression of NDs is closely related to the dominant aggregation pathway involved in aberrant aggregation. Moreover, the molecular mechanisms underlying the formation of pathogenic amyloid deposits are intricately linked to the structural and functional characteristics of aggregates. These aggregates may not only directly participate in fibrillization, but also indirectly promote the development of NDs by affecting the normal physiological cellular functions. Therefore, in-depth research on the structural and functional properties of both intermediates and fibrils is of great significance for understanding the molecular mechanisms of protein misfolding and aberrant aggregation. Overall, this paper reviews the amyloid deposition and pathological phase transitions in NDs. By delving into the molecular mechanisms of amyloid fibrillization, the aim is to better understand the pathogenesis of NDs, and to provide valuable insights into the development of therapeutic strategies targeting amyloid aggregation and aberrant phase transition.]]></description>
<pubDate>2025/8/1 9:00:38</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHENG Wan-Ru,FENG Shuang,LIANG Yu-Han,NIU Zheng,YANG Shuo]]></author>
</item>
<item>
<title><![CDATA[Analysis of The Application and Prospects of CRISPR-based RNA Detection Technology in Forensic Science]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202503070000001]]></link>
<description><![CDATA[The emergence of clustered regularly interspaced short palindromic repeat (CRISPR) and CRISPR-associated proteins (Cas) system represents a revolutionary paradigm shift in molecular diagnostics, offering transformative potential for RNA analysis within the rigorous demands of forensic science. Conventional forensic RNA detection methodologies, such as reverse transcription-quantitative polymerase chain reaction (RT-qPCR) or microarray analysis, are significantly hampered by inherent limitations including complex, multi-step protocols requiring sophisticated laboratory infrastructure, pronounced susceptibility to inhibitors prevalent in complex forensic matrices (<i>e.g.</i>, humic acids, heme, indigo dyes), and often inadequate sensitivity for trace or degraded samples typical of crime scenes, thereby failing to meet the critical operational imperatives of forensic practice: rapidity, high specificity, sensitivity, portability, and robustness against interference. This review posits that CRISPR-Cas-based RNA detection technology provides a groundbreaking solution by leveraging the programmable, sequence-specific recognition conferred by the synergistic interaction between a designed guide RNA (gRNA) and Cas effector proteins (<i>e.g</i>., Cas12a, Cas13a, Cas14). Upon target RNA binding, specific Cas enzymes undergo conformational activation, exhibiting collateral cleavage activity―a unique catalytic amplification mechanism where the enzyme non-specifically cleaves surrounding reporter molecules, enabling ultra-high sensitivity. To further enhance detection limits, CRISPR-Cas systems are strategically integrated with isothermal pre-amplification techniques like recombinase polymerase amplification (RPA) or loop-mediated isothermal amplification (LAMP), which efficiently amplify target RNA at constant temperatures, eliminating the need for thermal cyclers. This powerful cascade―isothermal pre-amplification followed by CRISPR-mediated sequence-specific recognition and collateral signal amplification―achieves exceptional sensitivity, often down to the single-molecule (attomolar) level, while drastically reducing analysis time to potentially 30-60 min. Crucially, the compatibility of CRISPR-Cas detection with simple, equipment-free readout systems, such as lateral flow strips (LFS) for visual colorimetric results or portable fluorescence/electrochemical sensors, facilitates true point-of-need (PON) forensic analysis directly at crime scenes, morgues, or field labs. This enables rapid applications like specific body fluid identification (<i>e.g</i>., distinguishing menstrual blood <i>via</i> miRNA, identifying saliva <i>via</i> mRNA), post-mortem interval (PMI) estimation through RNA degradation/expression patterns, donor age inference <i>via</i> age-related RNA markers, tissue identification, and microbial forensics, thereby accelerating investigative leads, minimizing sample degradation risks, and optimizing resource allocation. However, significant challenges impede widespread adoption, including persistent environmental interference inhibiting enzymes, fluctuations in Cas/amplification enzyme activity affecting reproducibility, a critical lack of standardized protocols and validated quality assurance/quality control (QA/QC) frameworks essential for forensic reliability and court admissibility, and current limitations in multiplex detection capability. Consequently, future research must prioritize overcoming multiplexing bottlenecks for comprehensive analysis, enhancing system robustness through Cas protein engineering and optimized reagents, developing fully integrated, sample-to-answer microfluidic or lateral flow devices for user-friendly field deployment, and collaboratively establishing universally accepted validation guidelines, performance standards, and stringent QA/QC procedures. Furthermore, the urgent development of clear ethical guidelines governing the use of this highly sensitive technology, particularly concerning RNA data privacy and potential misuse, is imperative. This review systematically outlines the principles, forensic applications, current limitations, and future trajectories of CRISPR-RNA detection, with the authors’ conviction that focused efforts addressing these challenges will translate this technology into a cornerstone of next-generation forensic practice, driving unprecedented efficiency and innovation in field investigations and laboratory analysis to enhance justice delivery.]]></description>
<pubDate>2025/7/31 16:21:41</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[FANG Yun,SUN Qi-Fan,WANG Xian-Miao,XIE Wei]]></author>
</item>
<item>
<title><![CDATA[Molecular Mechanisms Underlying Sleep Deprivation-induced Acceleration of Alzheimer’s Disease Pathology]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202505210000006]]></link>
<description><![CDATA[Sleep deprivation (SD) has emerged as a significant modifiable risk factor for Alzheimer’s disease (AD), with mounting evidence demonstrating its multifaceted role in accelerating AD pathogenesis through diverse molecular, cellular, and systemic mechanisms. SD is refined within the broader spectrum of sleep-wake and circadian disruption, emphasizing that both acute total sleep loss and chronic sleep restriction destabilize the homeostatic and circadian processes governing glymphatic clearance of neurotoxic proteins. During normal sleep, concentrations of interstitial Aβ and tau fall as cerebrospinal fluid oscillations flush extracellular waste; SD abolishes this rhythm, causing overnight rises in soluble Aβ and tau species in rodent hippocampus and human CSF. Orexinergic neurons sustain arousal, and become hyperactive under SD, further delaying sleep onset and amplifying Aβ production. At the molecular level, SD disrupts Aβ homeostasis through multiple converging pathways, including enhanced production <i>via</i> beta-site APP cleaving enzyme 1 (BACE1) upregulation, coupled with impaired clearance mechanisms involving the glymphatic system dysfunction and reduced Aβ-degrading enzymes (neprilysin and insulin-degrading enzyme). Cellular and histological analyses revealed that these proteinopathies are significantly exacerbated by SD-induced neuroinflammatory cascades characterized by microglial overactivation, astrocyte reactivity, and sustained elevation of pro-inflammatory cytokines (IL-1β, TNF-α, IL-6) through NF-κB signaling and NLRP3 inflammasome activation, creating a self-perpetuating cycle of neurotoxicity. The synaptic and neuronal consequences of chronic SD are particularly profound and potentially irreversible, featuring reduced expression of critical synaptic markers (PSD95, synaptophysin), impaired long-term potentiation (LTP), dendritic spine loss, and diminished neurotrophic support, especially brain-derived neurotrophic factor (BDNF) depletion, which collectively contribute to progressive cognitive decline and memory deficits. Mechanistic investigations identify three core pathways through which SD exerts its neurodegenerative effects: circadian rhythm disruption <i>via </i>BMAL1 suppression, orexin system hyperactivity leading to sustained wakefulness and metabolic stress, and oxidative stress accumulation through mitochondrial dysfunction and reactive oxygen species overproduction. The review critically evaluates promising therapeutic interventions including pharmacological approaches (melatonin, dual orexin receptor antagonists), metabolic strategies (ketogenic diets, and Mediterranean diets rich in omega-3 fatty acids), lifestyle modifications (targeted exercise regimens, cognitive behavioral therapy for insomnia), and emerging technologies (non-invasive photobiomodulation, transcranial magnetic stimulation). Current research limitations include insufficient understanding of dose-response relationships between SD duration/intensity and AD pathology progression, lack of long-term longitudinal clinical data in genetically vulnerable populations (particularly APOE ε4 carriers and those with familial AD mutations), the absence of standardized SD protocols across experimental models that accurately mimic human chronic sleep restriction patterns, and limited investigation of sex differences in SD-induced AD risk. The accumulated evidence underscores the importance of addressing sleep disturbances as part of multimodal AD prevention strategies and highlights the urgent need for clinical trials evaluating sleep-focused interventions in at-risk populations. The review proposes future directions focused on translating mechanistic insights into precision medicine approaches, emphasizing the need for biomarkers to identify SD-vulnerable individuals, chronotherapeutic strategies aligned with circadian biology, and multi-omics integration across sleep, proteostasis and immune profiles may delineate precision-medicine strategies for at-risk populations. By systematically examining these critical connections, this analysis positions sleep quality optimization as a viable strategy for AD prevention and early intervention while providing a comprehensive roadmap for future mechanistic and interventional research in this rapidly evolving field.]]></description>
<pubDate>2025/7/29 23:20:56</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CAI Ming-Yang,DAI Xue-Ling,HUO Qing,SUN Ya-Xuan,YAN Si-Ru]]></author>
</item>
<item>
<title><![CDATA[The Influence of Social Context on Perceptual Decision Making and Its Computational Neural Mechanisms]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202505090000003]]></link>
<description><![CDATA[Perceptual decision making refers to the process by which individuals make choices and judgments based on sensory information, serving as a fundamental ability for human adaptation to complex environments. While traditional research has focused on perceptual decision making in isolated contexts, growing evidence highlights the profound influence of social contexts prevalent in real-world scenarios. As a crucial factor supporting individual survival and development, social context not only provides rich information sources but also shapes perceptual decision making through top-down processing mechanisms, prompting researchers to recognize the inherently social nature of human decisions. Empirical studies have demonstrated that social information, such as others’ choices or group norms, can systematically bias individuals’ perceptual decisions, often manifesting as conformity behaviors. Social influence can also facilitate performance under certain conditions, particularly when individuals can accurately identify and adopt high-quality social information. The impact of social context on perceptual decisions is modulated by a variety of external and internal factors, including group characteristics (<i>e.g</i>., group size, response consistency), attributes of peers (<i>e.g</i>., familiarity, social status, distinctions between human and artificial agents), as well as individual differences such as confidence, personality traits, and developmental stage. The motivations driving social influence encompass three primary mechanisms: improving decision accuracy through informational influence, gaining social acceptance through normative influence, and maintaining positive self-concept. Recent computational approaches have employed diverse theoretical frameworks to provide valuable insights into the cognitive mechanisms underlying social influence in perceptual decision making. Reinforcement learning models demonstrate how social feedback shapes future choices through reward-based updating. Bayesian inference frameworks describe how individuals integrate personal beliefs with social information based on their respective reliabilities, dynamically updating beliefs to optimize decisions under uncertainty. Drift diffusion models offer powerful tools to decompose social influence into distinct cognitive components, allowing researchers to differentiate between changes in perceptual processing and shifts in decision criteria. Collectively, these models establish a comprehensive methodological foundation for disentangling the multiple pathways by which social context shapes perceptual decisions. Neuroimaging and electrophysiological studies provide converging evidence that social context influences perceptual decision making through multi-level neural mechanisms. At early perceptual processing stages, social influence modulates sensory evidence accumulation in parietal cortex and directly alters primary visual cortex activity, while guiding selective attention to stimulus features consistent with social norms through attentional alignment mechanisms. At higher cognitive levels, the reward system (ventral striatum, ventromedial prefrontal cortex) is activated during group-consistent decisions; emotion-processing networks (anterior cingulate cortex, insula, amygdala) regulate experiences of social acceptance and rejection; and mentalizing-related brain regions (dorsomedial prefrontal cortex, temporoparietal junction) support inference of others’ mental states and social information integration. These neural circuits work synergistically to achieve top-down multi-level modulation of perceptual decision making. Understanding the mechanisms by which social context shapes perceptual decision making has broad theoretical and practical implications. These insights inform the optimization of collective decision-making, the design of socially adaptive human-computer interaction systems, and interventions for cognitive disorders such as autism spectrum disorder and anorexia nervosa. Future studies should combine computational modeling and neuroimaging approaches to systematically investigate the multi-level and dynamic nature of social influences on perceptual decision making.]]></description>
<pubDate>2025/7/25 23:03:18</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[JIANG Yi,LIU Yu-Pei,WANG Rui,WANG Yu-Shu,ZHAN Bin]]></author>
</item>
<item>
<title><![CDATA[Non-pharmacological Treatments for Core Cognitive Impairment in Schizophrenia]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202504230000004]]></link>
<description><![CDATA[Schizophrenia is a severe psychiatric disorder characterized by positive symptoms (<i>e.g.</i>, hallucinations), negative symptoms (<i>e.g.</i>, social withdrawal), and cognitive impairments. Among these, cognitive impairment is a core feature that severely compromises patients’ social functioning and long-term prognosis. Antipsychotics, the first-line treatment for schizophrenia, are generally effective in managing positive symptoms. However, their efficacy in alleviating negative symptoms and cognitive deficits remains limited. Moreover, long-term use may lead to metabolic syndrome and extrapyramidal side effects. Consequently, non-pharmacological interventions have garnered increasing attention as alternative or adjunctive strategies for cognitive remediation in schizophrenia. In recent years, techniques grounded in neuroplasticity theory have advanced rapidly. These interventions aim to alleviate cognitive impairments by modulating neural circuits (<i>e.g.</i>, enhancing prefrontal-hippocampal connectivity) and synaptic plasticity (<i>e.g.</i>, modulating the BDNF/TrkB pathway) from multiple dimensions. Such approaches not only enhance cognitive function but also reduce medication-related adverse effects and improve treatment compliance. This article comprehensively reviews the clinical evidence and recent technological advances in non-pharmacological interventions targeting cognitive impairments in schizophrenia. The interventions discussed include cognitive remediation therapy (CRT), repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), electro-acupuncture (EA), aerobic exercise (AE), and light therapy (LT). CRT, the most extensively studied and evidence-based intervention, uses structured cognitive training tasks to enhance neuroplasticity and has consistently demonstrated efficacy in improving executive function and social cognition. Both rTMS and tDCS are non-invasive brain stimulation techniques that modulate cortical excitability and neural network connectivity. While rTMS has shown promise in improving working memory and attention—particularly in patients with prominent negative symptoms—its clinical efficacy remains inconsistent, likely due to variability in stimulation parameters and patient heterogeneity. In contrast, tDCS has demonstrated encouraging effects on working memory and attention with a relatively rapid onset, although optimal stimulation protocols have yet to be standardized. EA, which combines traditional acupuncture with electrical stimulation, has been shown to improve memory function, possibly through upregulation of brain-derived neurotrophic factor (BDNF) and enhanced cerebral blood flow. It may be especially useful in treatment-resistant cases. AE is a low-cost and widely accessible intervention that promotes hippocampal neuroplasticity and BDNF expression, thereby improving memory and attention. It is recommended as a foundational adjunctive therapy, particularly for patients with chronic schizophrenia. LT, although still experimental, has yielded promising results in animal models by modulating neuroinflammation and enhancing neurogenesis via the BDNF/CREB signaling pathway. However, clinical evidence remains limited, necessitating further large-scale trials to validate its efficacy and safety. In addition to reviewing individual interventions, this article highlights the potential of combination strategies—such as CRT combined with AE or rTMS—to produce synergistic cognitive benefits. Future directions include the development of personalized treatment protocols, early intervention during neurodevelopmental windows (<i>e.g.</i>, adolescence), and the integration of biomarkers and neuroimaging to guide therapeutic decisions. This synthesis aims to provide clinicians and researchers with a comprehensive framework for advancing non-pharmacological cognitive rehabilitation in schizophrenia.]]></description>
<pubDate>2025/7/24 7:29:57</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[FENG Jia-Xin,HUANG Min-Fang,LI Yi,LIN Fo-Xiang,WANG Qin-Wen,WANG Zheng-Chun,XIE Yan-Hong]]></author>
</item>
<item>
<title><![CDATA[Oxidative Stress-related Signaling Pathways and Antioxidant Therapy in Alzheimer’s Disease]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202504250000004]]></link>
<description><![CDATA[Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline, functional impairment, and neuropsychiatric symptoms. It represents the most prevalent form of dementia among the elderly population. Accumulating evidence indicates that oxidative stress plays a pivotal role in the pathogenesis of AD. Notably, elevated levels of oxidative stress have been observed in the brains of AD patients, where excessive reactive oxygen species (ROS) can cause extensive damage to lipids, proteins, and DNA, ultimately compromising neuronal structure and function. Amyloid β-protein (Aβ) has been shown to induce mitochondrial dysfunction and calcium overload, thereby promoting the generation of ROS. This, in turn, exacerbates Aβ aggregation and enhances tau phosphorylation, leading to the formation of two pathological features of AD: extracellular Aβ plaque deposition and intracellular neurofibrillary tangles (NFTs). These events ultimately culminate in neuronal death, forming a vicious cycle. The interplay between oxidative stress and these pathological processes constitutes a core link in the pathogenesis of AD. The signaling pathways mediating oxidative stress in AD include Nrf2, RCAN1, PP2A, CREB, Notch1, NF-κB, ApoE, and ferroptosis. Nrf2 signaling pathway serves as a key regulator of cellular redox homeostasis, exerts important antioxidant capacity and protective effects in AD. RCAN1 signaling pathway, as a calcineurin inhibitor, and modulates AD progression through multiple mechanisms. PP2A signaling pathway is involved in regulating tau phosphorylation and neuroinflammation processes. CREB signaling pathway contributes to neuroplasticity and memory formation; activation of CREB improves cognitive function and reduce oxidative stress. Notch1 signaling pathway regulates neuronal development and memory, participates in modulation of Aβ production, and interacts with Nrf2 to co-regulate antioxidant activity. NF-κB signaling pathway governs immune and inflammatory responses; sustained activation of this pathway forms “inflammatory memory”, thereby exacerbating AD pathology. ApoE signaling pathway is associated with lipid metabolism; among its isoforms, ApoE-ε4 significantly increases the risk of AD, leading to elevated oxidative stress, abnormal lipid metabolism, and neuroinflammation. The ferroptosis signaling pathway is driven by iron-dependent lipid peroxidation, and the subsequent release of lipid peroxidation products and ROS exacerbate oxidative stress and neuronal damage. These interconnected pathways form a complex regulatory network that regulates the progression of AD through oxidative stress and related pathological cascades. In terms of therapeutic strategies targeting oxidative stress, among the drugs currently used in clinical practice for AD treatment, memantine and donepezil demonstrate significant therapeutic efficacy and can improve the level of oxidative stress in AD patients. Some compounds with antioxidant effects (such as α-lipoic acid and melatonin) have shown certain potential in AD treatment research and can be used as dietary supplements to ameliorate AD symptoms. In addition, non-drug interventions such as calorie restriction and exercise have been proven to exerted neuroprotective effects and have a positive effect on the treatment of AD. By comprehensively utilizing the therapeutic characteristics of different signaling pathways, it is expected that more comprehensive multi-target combination therapy regimens and combined nanomolecular delivery systems will be developed in the future to bypass the blood-brain barrier, providing more effective therapeutic strategies for AD.]]></description>
<pubDate>2025/7/22 22:24:29</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LIU Hui,PAN Zi-Heng,PENG De-Jian,RAN Tian-Lu,SHEN Yun-Long,TANG Li,ZENG Xin-Yi]]></author>
</item>
<item>
<title><![CDATA[Ubiquitination and Deubiquitination in Oral Squamous Cell Carcinoma: Potential Drug Targets]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202504280000001]]></link>
<description><![CDATA[Oral squamous cell carcinoma (OSCC) is the most common head and neck malignancy worldwide, accounting for more than 90% of all oral cancers, and is characterized by high invasiveness and poor long-term prognosis. Its etiology is multifactorial, involving tobacco use, alcohol consumption, and human papillomavirus (HPV) infection. Oral leukoplakia and erythroplakia are the main precancerous lesions lesions, with oral leukoplakia being the most common. Both OSCC and premalignant lesions are closely associated with aberrant activation of multiple signaling pathways. Post-translational modifications (such as ubiquitination and deubiquitination) play key roles in regulating these pathways by controlling protein stability and activity. Growing evidence indicates that dysregulated ubiquitination/deubiquitination can mediate OSCC initiation and progression <i>via</i> aberrant activation of signaling pathways. The ubiquitination/deubiquitination process mainly involves E3 ligases (E3s) that catalyze substrate ubiquitination, deubiquitinating enzymes (DUBs) that remove ubiquitin chains, and the 26S proteasome complex that degrades ubiquitinated substrates. Abnormal expression or mutation of E3s and DUBs can lead to altered stability of critical tumor-related proteins, thereby driving OSCC initiation and progression. Therefore, understanding the aberrantly activated signaling pathways in OSCC and the ubiquitination/deubiquitination mechanisms within these pathways will help elucidate the molecular mechanisms and improve OSCC treatment by targeting relevant components. Here, we summarize four aberrantly activated signaling pathways in OSCC―the PI3K/AKT/mTOR pathway, Wnt/β-catenin pathway, Hippo pathway, and canonical NF-κB pathway―and systematically review the regulatory mechanisms of ubiquitination/deubiquitination within these pathways, along with potential drug targets. PI3K/AKT/mTOR pathway is aberrantly activated in approximately 70% of OSCC cases. It is modulated by E3s (<i>e.g.</i>, FBXW7 and NEDD4) and DUBs (<i>e.g.</i>, USP7 and USP10): FBXW7 and USP10 inhibit signaling, while NEDD4 and USP7 potentiate it. Aberrant activation of the Wnt/β-catenin pathway leads to β-catenin nuclear translocation and induction of cell proliferation. This pathway is modulated by E3s (<i>e.g.</i>, c-Cbl and RNF43) and DUBs (<i>e.g.</i>, USP9X and USP20): c-Cbl and RNF43 inhibit signaling, while USP9X and USP20 potentiate it. Hippo pathway inactivation permits YAP/TAZ to enter the nucleus and promotes cancer cell metastasis. This pathway is modulated by E3s (<i>e.g.</i>, CRL4<sup>DCAF1</sup> and SIAH2) and DUBs (<i>e.g.</i>, USP1 and USP21): CRL4<sup>DCAF1</sup> and SIAH2 inhibit signaling, while USP1 and USP21 potentiate it. Persistent activation of the canonical NF-κB pathway is associated with an inflammatory microenvironment and chemotherapy resistance. This pathway is modulated by E3s (<i>e.g.</i>, TRAF6 and LUBAC) and DUBs (<i>e.g.</i>, A20 and CYLD): A20 and CYLD inhibit signaling, while TRAF6 and LUBAC potentiate it. Targeting these E3s and DUBs provides directions for OSCC drug research. Small-molecule inhibitors such as YCH2823 (a USP7 inhibitor), GSK2643943A (a USP20 inhibitor), and HOIPIN-8 (a LUBAC inhibitor) have shown promising antitumor activity in preclinical models; PROTAC molecules, by binding to surface sites of target proteins and recruiting E3s, achieve targeted ubiquitination and degradation of proteins insensitive to small-molecule inhibitors, for example, PU7-1-mediated USP7 degradation, offering new strategies to overcome traditional drug limitations. Currently, NX-1607 (a Cbl-b inhibitor) has entered phase I clinical trials, with preliminary results confirming its safety and antitumor activity. Future research on aberrant E3s and DUBs in OSCC and the development of highly specific inhibitors will be of great significance for OSCC precision therapy.]]></description>
<pubDate>2025/7/21 15:02:58</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHANG Han,JIN Xiao-Feng,YING Bin-Bin,ZHAO Meng-Xiang]]></author>
</item>
<item>
<title><![CDATA[Diagnostic Techniques and Risk Prediction for Cardiovascular-kidney-metabolic (CKM) Syndrome]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202504200000001]]></link>
<description><![CDATA[Cardiovascular disease (CVD), chronic kidney disease (CKD), and metabolic disorders are the 3 major chronic diseases threatening human health, which are closely related and often coexist, significantly increasing the difficulty of disease management. In response, the American Heart Association (AHA) proposed a novel disease concept of “cardiovascular-kidney-metabolic (CKM) syndrome” in October 2023, which has triggered widespread concern about the co-treatment of heart and kidney diseases and the prevention and treatment of metabolic disorders around the world. This review posits that effectively managing CKM syndrome requires a new and multidimensional paradigm for diagnosis and risk prediction that integrates biological insights, advanced technology and social determinants of health (SDoH). We argue that the core pathological driver is a “metabolic toxic environment”, fueled by adipose tissue dysfunction and characterized by a vicious cycle of systemic inflammation and oxidative stress, which forms a common pathway to multi-organ injury. The at-risk population is defined not only by biological characteristics but also significantly impacted by adverse SDoH, which can elevate the risk of advanced CKM by a factor of 1.18 to 3.50, underscoring the critical need for equity in screening and care strategies. This review systematically charts the progression of diagnostic technologies. In diagnostics, we highlight a crucial shift from single-marker assessments to comprehensive multi-marker panels. The synergistic application of traditional biomarkers like NT-proBNP (reflecting cardiac stress) and UACR (indicating kidney damage) with emerging indicators such as systemic immune-inflammation index (SII) and Klotho protein facilitates a holistic evaluation of multi-organ health. Furthermore, this paper explores the pivotal role of non-invasive monitoring technologies in detecting subclinical disease. Techniques like multi-wavelength photoplethysmography (PPG) and impedance cardiography (ICG) provide a real-time window into microcirculatory and hemodynamic status, enabling the identification of early, often asymptomatic, functional abnormalities that precede overt organ failure. In imaging, progress is marked by a move towards precise, quantitative evaluation, exemplified by artificial intelligence-powered quantitative computed tomography (AI-QCT). By integrating AI-QCT with clinical risk factors, the predictive accuracy for cardiovascular events within 6 months significantly improves, with the area under the curve (<i>AUC</i>) increasing from 0.637 to 0.688, demonstrating its potential for reclassifying risk in CKM stage 3. In the domain of risk prediction, we trace the evolution from traditional statistical tools to next-generation models. The new PREVENT equation represents a major advancement by incorporating key kidney function markers (eGFR, UACR), which can enhance the detection rate of CKD in primary care by 20%-30%. However, we contend that the future lies in dynamic, machine learning-based models. Algorithms such as XGBoost have achieved an <i>AUC</i> of 0.82 for predicting 365-day cardiovascular events, while deep learning models like KFDeep have demonstrated exceptional performance in predicting kidney failure risk with an <i>AUC</i> of 0.946. Unlike static calculators, these AI-driven tools can process complex, multimodal data and continuously update risk profiles, paving the way for truly personalized and proactive medicine. In conclusion, this review advocates for a paradigm shift toward a holistic and technologically advanced framework for CKM management. Future efforts must focus on the deep integration of multimodal data, the development of novel AI-driven biomarkers, the implementation of refined SDoH-informed interventions, and the promotion of interdisciplinary collaboration to construct an efficient, equitable, and effective system for CKM screening and intervention.]]></description>
<pubDate>2025/7/21 15:01:19</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HONG Xiu-Qin,HOU Song,LIN Hai-Jun,LIU Ying,YANG Yu-Xiang,ZHANG Cai-Li,ZHANG Chi,ZHANG Fu,ZHANG Lin-Shan,ZHU Yan]]></author>
</item>
<item>
<title><![CDATA[tRF Prospect: tRNA-derived Fragment Target Prediction Based on Neural Network Learning]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202502090000001]]></link>
<description><![CDATA[<b>Objective</b> Transfer RNA-derived fragments (tRFs) are a recently characterized and rapidly expanding class of small non-coding RNAs, typically ranging from 13 to 50 nucleotides in length. They are derived from mature or precursor tRNA molecules through specific cleavage events and have been implicated in a wide range of cellular processes. Increasing evidence indicates that tRFs play important regulatory roles in gene expression, primarily by interacting with target messenger RNAs (mRNAs) to induce transcript degradation, in a manner partially analogous to microRNAs (miRNAs). However, despite their emerging biological relevance and potential roles in disease mechanisms, there remains a significant lack of computational tools capable of systematically predicting the interaction landscape between tRFs and their target mRNAs. Existing databases often rely on limited interaction features and lack the flexibility to accommodate novel or user-defined tRF sequences. The primary goal of this study was to develop a machine learning based prediction algorithm that enables high-throughput, accurate identification of tRF:mRNA binding events, thereby facilitating the functional analysis of tRF regulatory networks.<b>Methods</b> We began by assembling a manually curated dataset of 38 687 experimentally verified tRF:mRNA interaction pairs and extracting seven biologically informed features for each pair: (1) AU content of the binding site, (2) site pairing status, (3) binding region location, (4) number of binding sites per mRNA, (5) length of the longest consecutive complementary stretch, (6) total binding region length, and (7) seed sequence complementarity. Using this dataset and feature set, we trained 4 distinct machine learning classifiers—logistic regression, random forest, decision tree, and a multilayer perceptron (MLP)—to compare their ability to discriminate true interactions from non-interactions. Each model’s performance was evaluated using overall accuracy, receiver operating characteristic (ROC) curves, and the corresponding area under the ROC curve (AUC). The MLP consistently achieved the highest <i>AUC</i> among the four, and was therefore selected as the backbone of our prediction framework, which we named tRF Prospect. For biological validation, we retrieved 3 high-throughput RNA-seq datasets from the gene expression omnibus (GEO) in which individual tRFs were overexpressed: AS-tDR-007333 (GSE184690), tRF-3004b (GSE197091), and tRF-20-S998LO9D (GSE208381). Differential expression analysis of each dataset identified genes downregulated upon tRF overexpression, which we designated as putative targets. We then compared the predictions generated by tRF Prospect against those from three established tools—tRFTar, tRForest, and tRFTarget—by quantifying the number of predicted targets for each tRF and assessing concordance with the experimentally derived gene sets.<b>Results</b> The proposed algorithm achieved high predictive accuracy, with an <i>AUC</i> of 0.934. Functional validation was conducted using transcriptome-wide RNA-seq datasets from cells overexpressing specific tRFs, confirming the model’s ability to accurately predict biologically relevant downregulation of mRNA targets. When benchmarked against established tools such as tRFTar, tRForest, and tRFTarget, tRF Prospect consistently demonstrated superior performance, both in terms of predictive precision and sensitivity, as well as in identifying a higher number of true-positive interactions. Moreover, unlike static databases that are limited to precomputed results, tRF Prospect supports real-time prediction for any user-defined tRF sequence, enhancing its applicability in exploratory and hypothesis-driven research.<b>Conclusion</b> This study introduces tRF Prospect as a powerful and flexible computational tool for investigating tRF:mRNA interactions. By leveraging the predictive strength of deep learning and incorporating a broad spectrum of interaction-relevant features, it addresses key limitations of existing platforms. Specifically, tRF Prospect: (1) expands the range of detectable tRF and target types; (2) improves prediction accuracy through multilayer perceptron model; and (3) allows for dynamic, user-driven analysis beyond database constraints. Although the current version emphasizes miRNA-like repression mechanisms and faces challenges in accurately capturing 5"UTR-associated binding events, it nonetheless provides a critical foundation for future studies aiming to unravel the complex roles of tRFs in gene regulation, cellular function, and disease pathogenesis.]]></description>
<pubDate>2025/7/14 8:41:30</pubDate>
<category><![CDATA[技术与方法]]></category>
<author><![CDATA[MO Yong-Zhen,REN Dai-Xi,SHI Lei,XIONG Wei,YANG Mei,YI Jian-Yong,ZENG Zhao-Yang]]></author>
</item>
<item>
<title><![CDATA[THBS4 in Disease: Mechanisms, Biomarkers, and Therapeutic Opportunities]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202505120000004]]></link>
<description><![CDATA[Thrombospondin 4 (THBS4; TSP4), a crucial component of the extracellular matrix (ECM), serves as an important regulator of tissue homeostasis and various pathophysiological processes. As a member of the evolutionarily conserved thrombospondin family, THBS4 is a multidomain adhesive glycoprotein characterized by six distinct structural domains that mediate its diverse biological functions. Through dynamic interactions with various ECM components, THBS4 plays pivotal roles in cell adhesion, proliferation, inflammation regulation, and tissue remodeling, establishing it as a key modulator of microenvironmental organization. The transcription and translation of <i>THBS4</i> gene, as well as the activity of the THBS4 protein, are tightly regulated by multiple signaling pathways and extracellular cues. Positive regulators of THBS4 include transforming growth factor-β (TGF-β), interferon-γ (IFNγ), granulocyte-macrophage colony-stimulating factor (GM-CSF), bone morphogenetic proteins (BMP12/13), and other regulatory factors (such as B4GALNT1, ITGA2/ITGB1, PDGFRβ, <i>etc</i>.), which upregulate THBS4 at the mRNA and/or protein level. Conversely, oxidized low-density lipoprotein (OXLDL) acts as a potent negative regulator of THBS4. This intricate regulatory network ensures precise spatial and temporal control of THBS4 expression in response to diverse physiological and pathological stimuli. Functionally, THBS4 acts as a critical signaling hub, influencing multiple downstream pathways essential for cellular behavior and tissue homeostasis. The best-characterized pathways include: (1) the PI3K/AKT/mTOR axis, which THBS4 modulates through both direct and indirect interactions with integrins and growth factor receptors; (2) Wnt/β-catenin signaling, where THBS4 functions as either an activator or inhibitor depending on the cellular context; (3) the suppression of DBET/TRIM69, contributing to its diverse regulatory roles. These signaling connections position THBS4 as a master regulator of cellular responses to microenvironmental changes. Substantial evidence links aberrant THBS4 expression to a range of pathological conditions, including neoplastic diseases, cardiovascular disorders, fibrotic conditions, neurodegenerative diseases, musculoskeletal disorders, and atopic dermatitis. In cancer biology, THBS4 exhibits context-dependent roles, functioning either as a tumor suppressor or promoter depending on the tumor type and microenvironment. In the cardiovascular system, THBS4 contributes to both adaptive remodeling and maladaptive fibrotic responses. Its involvement in fibrotic diseases arises from its ability to regulate ECM deposition and turnover. The diagnostic and therapeutic potential of THBS4 is particularly promising in oncology and cardiovascular medicine. As a biomarker, THBS4 expression patterns correlate significantly with disease progression and patient outcomes. Therapeutically, targeting THBS4-mediated pathways offers novel opportunities for precision medicine approaches, including anti-fibrotic therapies, modulation of the tumor microenvironment, and enhancement of tissue repair. This comprehensive review systematically explores three key aspects of THBS4<b>research</b> (1) The fundamental biological functions of THBS4 in ECM organization; (2) its mechanistic involvement in various disease pathologies; (3) its emerging potential as both a diagnostic biomarker and therapeutic target. By integrating recent insights from molecular studies, animal models, and clinical investigations, this review provides a framework for understanding the multifaceted roles of THBS4 in health and disease. The synthesis of current knowledge highlights critical research gaps and future directions for exploring THBS4-targeted interventions across multiple disease contexts. Given its unique position at the intersection of ECM biology and cellular signaling, THBS4 represents a promising frontier for the development of novel diagnostic tools and therapeutic strategies in precision medicine.]]></description>
<pubDate>2025/7/11 16:32:37</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[BAI Xiu-Feng,HUANG De-Ying,LI Yan-Hong,LIU Yi]]></author>
</item>
<item>
<title><![CDATA[The Application of Spatial Resolved Metabolomics in Neurodegenerative Diseases]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202502090000002]]></link>
<description><![CDATA[The pathogenesis of neurodegenerative diseases (NDDs) is fundamentally linked to complex and profound alterations in metabolic networks within the brain, which exhibit marked spatial heterogeneity. While conventional bulk metabolomics is powerful for detecting global metabolic shifts, it inherently lacks spatial resolution. This methodological limitation hampers the ability to interrogate critical metabolic dysregulation within discrete anatomical brain regions and specific cellular microenvironments, thereby constraining a deeper understanding of the core pathological mechanisms that initiate and drive NDDs. To address this critical gap, spatial metabolomics, with mass spectrometry imaging (MSI) at its core, has emerged as a transformative approach. It uniquely overcomes the limitations of bulk methods by enabling high-resolution, simultaneous detection and precise localization of hundreds to thousands of endogenous molecules—including primary metabolites, complex lipids, neurotransmitters, neuropeptides, and essential metal ions—directly <i>in situ</i> from tissue sections. This powerful capability offers an unprecedented spatial perspective for investigating the intricate and heterogeneous chemical landscape of NDD pathology, opening new avenues for discovery. Accordingly, this review provides a comprehensive overview of the field, beginning with a discussion of the technical features, optimal application scenarios, and current limitations of major MSI platforms. These include the widely adopted matrix-assisted laser desorption/ionization (MALDI)-MSI, the ultra-high-resolution technique of secondary ion mass spectrometry (SIMS)-MSI, and the ambient ionization method of desorption electrospray ionization (DESI)-MSI, along with other emerging technologies. We then highlight the pivotal applications of spatial metabolomics in NDD research, particularly its role in elucidating the profound chemical heterogeneity within distinct pathological microenvironments. These applications include mapping unique molecular signatures around amyloid β-protein (Aβ) plaques, uncovering the metabolic consequences of neurofibrillary tangles composed of hyperphosphorylated tau protein, and characterizing the lipid and metabolite composition of Lewy bodies. Moreover, we examine how spatial metabolomics contributes to constructing detailed metabolic vulnerability maps across the brain, shedding light on the biochemical factors that render certain neuronal populations and anatomical regions selectively susceptible to degeneration while others remain resilient. Looking beyond current applications, we explore the immense potential of integrating spatial metabolomics with other advanced research methodologies. This includes its combination with three-dimensional brain organoid models to recapitulate disease-relevant metabolic processes, its linkage with multi-organ axis studies to investigate how systemic metabolic health influences neurodegeneration, and its convergence with single-cell and subcellular analyses to achieve unprecedented molecular resolution. In conclusion, this review not only summarizes the current state and critical role of spatial metabolomics in NDD research but also offers a forward-looking perspective on its transformative potential. We envision its continued impact in advancing our fundamental understanding of NDDs and accelerating translation into clinical practice—from the discovery of novel biomarkers for early diagnosis to the development of high-throughput drug screening platforms and the realization of precision medicine for individuals affected by these devastating disorders.]]></description>
<pubDate>2025/7/11 16:22:53</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Huan,HAN Shu-Lei,HOU Hong-Wei,HU Qing-Yuan,LI Qian,XU Lu-Tao]]></author>
</item>
<item>
<title><![CDATA[Adolescent Smoking Addiction Diagnosis Based on TI-GNN]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202503140000003]]></link>
<description><![CDATA[<b>Objective</b> Tobacco-related diseases remain one of the leading preventable public health challenges worldwide and are among the primary causes of premature death. In recent years, accumulating evidence has supported the classification of nicotine addiction as a chronic brain disease, profoundly affecting both brain structure and function. Despite the urgency, effective diagnostic methods for smoking addiction remain lacking, posing significant challenges for early intervention and treatment. To address this issue and gain deeper insights into the neural mechanisms underlying nicotine dependence, this study proposes a novel graph neural network framework, termed TI-GNN. This model leverages functional magnetic resonance imaging (fMRI) data to identify complex and subtle abnormalities in brain connectivity patterns associated with smoking addiction.<b>Methods</b> The study utilizes fMRI data to construct functional connectivity matrices that represent interaction patterns among brain regions. These matrices are interpreted as graphs, where brain regions are nodes and the strength of functional connectivity between them serves as edges. The proposed TI-GNN model integrates a Transformer module to effectively capture global interactions across the entire brain network, enabling a comprehensive understanding of high-level connectivity patterns. Additionally, a spatial attention mechanism is employed to selectively focus on informative inter-regional connections while filtering out irrelevant or noisy features. This design enhances the model’s ability to learn meaningful neural representations crucial for classification tasks. A key innovation of TI-GNN lies in its built-in causal interpretation module, which aims to infer directional and potentially causal relationships among brain regions. This not only improves predictive performance but also enhances model interpretability—an essential attribute for clinical applications. The identification of causal links provides valuable insights into the neuropathological basis of addiction and contributes to the development of biologically plausible and trustworthy diagnostic tools.<b>Results</b> Experimental results demonstrate that the TI-GNN model achieves superior classification performance on the smoking addiction dataset, outperforming several state-of-the-art baseline models. Specifically, TI-GNN attains an accuracy of 0.91, an F1-score of 0.91, and a Matthews correlation coefficient (<i>MCC</i>) of 0.83, indicating strong robustness and reliability. Beyond performance metrics, TI-GNN identifies critical abnormal connectivity patterns in several brain regions implicated in addiction. Notably, it highlights dysregulations in the amygdala and the anterior cingulate cortex, consistent with prior clinical and neuroimaging findings. These regions are well known for their roles in emotional regulation, reward processing, and impulse control—functions that are frequently disrupted in nicotine dependence.<b>Conclusion</b> The TI-GNN framework offers a powerful and interpretable tool for the objective diagnosis of smoking addiction. By integrating advanced graph learning techniques with causal inference capabilities, the model not only achieves high diagnostic accuracy but also elucidates the neurobiological underpinnings of addiction. The identification of specific abnormal brain networks and their causal interactions deepens our understanding of addiction pathophysiology and lays the groundwork for developing targeted intervention strategies and personalized treatment approaches in the future.]]></description>
<pubDate>2025/7/11 16:16:00</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[DONG Fang,LI Xiao-Jiao,MA Yu-Xin,MAI Zhen-Zhen,WANG Juan,WANG Xu-Wen,XUE Ting,YU Da-Hua,YUAN Kai]]></author>
</item>
<item>
<title><![CDATA[The Biological Activity of Human Milk Oligosaccharides]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202502160000001]]></link>
<description><![CDATA[Human milk is universally recognized as the optimal and most natural source of nutrition for newborns, offering benefits that extend far beyond basic energy and macronutrient provision. Among its complex constituents, human milk oligosaccharides (HMOs) represent the third most abundant solid component, surpassed only by lactose and lipids. HMOs are distinguished by their exceptionally high structural diversity—over 200 distinct structures have been identified to date. This structural complexity underlies the extensive biological functions HMOs perform within the infant’s body. HMOs play a pivotal role in promoting healthy growth, development, and overall well-being in infants and young children, functioning as indispensable bioactive molecules. Their key physiological activities include: immunomodulation and allergy prevention by promoting immune tolerance and reducing the risk of allergic diseases; potent anti-inflammatory and antioxidant effects that protect vulnerable infant tissues; support for brain development and cognitive enhancement through multiple mechanisms; anti-pathogenic properties, acting as soluble receptor analogs or “decoy” molecules to competitively block viral, bacterial, and other pathogen adhesion, thereby preventing colonization and infection in the gastrointestinal tract; and functioning as blood group substances. At the translational and application level, HMO research is actively driving cross-disciplinary innovation. Building on a deep understanding of their immunological and neurodevelopmental benefits, certain structurally defined HMOs have been successfully incorporated into infant formula. These HMO-supplemented formulas have received regulatory approval and are now commercially available worldwide, providing a nutritional alternative that more closely resembles human milk for infants who are not exclusively breastfed. This represents a significant step toward narrowing the compositional gap between formula and breast milk. Simultaneously, research into the symbiotic relationship between HMOs and the gut microbiota—particularly their role as selective prebiotic substrates promoting the growth of beneficial bacteria—has catalyzed the development of novel functional foods, dietary supplements, and microbiome-targeted therapies. These include advanced synbiotic formulations that combine specific probiotic strains with HMOs to synergistically optimize gut health and function. Furthermore, the intrinsic qualities of HMOs—including their natural origin, safety profile, biocompatibility, and proven antioxidant properties—have attracted growing interest in the emerging field of high-performance cosmetics. They are increasingly being explored as innovative functional ingredients in skincare products aimed at reducing oxidative stress and supporting skin health. This review aims to systematically synthesize recent advancements in HMO research, offering a comprehensive analysis centered on their complex composition and structural diversity; the molecular and cellular mechanisms underlying their diverse biological functions; their translational potential across sectors such as nutrition, medicine, and consumer care (including cosmetics); and the major challenges that persist in the field. It critically examines both foundational discoveries and recent breakthroughs. By integrating these interconnected themes, the review provides a holistic and up-to-date perspective on the scientific landscape of HMOs, highlighting their essential role in early-life nutrition and their expanding relevance across health and wellness applications. It also outlines promising directions for future research, with the goal of advancing evidence-based innovation in infant health and beyond.]]></description>
<pubDate>2025/7/10 11:17:28</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HUANG Chun-Cui,LI Yan,WANG Hai-Zhu]]></author>
</item>
<item>
<title><![CDATA[Analysis of T7 RNA Polymerase: From Structure-function Relationship to dsRNA Challenge and Biotechnological Applications]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202503170000002]]></link>
<description><![CDATA[T7 RNA polymerase (T7 RNAP) is one of the simplest known RNA polymerases. Its unique structural features make it a critical model for studying the mechanisms of RNA synthesis. This review systematically examines the static crystal structure of T7 RNAP, beginning with an in-depth examination of its characteristic “thumb”, “palm”, and “finger” domains, which form the classic “right-hand-like” architecture. By detailing these structural elements, this review establishes a foundation for understanding the overall organization of T7 RNAP. This review systematically maps the functional roles of secondary structural elements and their subdomains in transcriptional catalysis, progressively elucidating the fundamental relationships between structure and function. Further, the intrinsic flexibility of T7 RNAP and its applications in research are also discussed. Additionally, the review presents the structural diagrams of the enzyme at different stages of the transcription process, and through these diagrams, it provides a detailed description of the complete transcription process of T7 RNAP. By integrating structural dynamics and kinetics analyses, the review constructs a comprehensive framework that bridges static structure to dynamic processes. Despite its advantages, T7 RNAP has a notable limitation: it generates double-stranded RNA (dsRNA) as a byproduct. The presence of dsRNA not only compromises the purity of mRNA products but also elicits nonspecific immune responses, which pose significant challenges for biotechnological and therapeutic applications. The review provides a detailed exploration of the mechanisms underlying dsRNA formation during T7 RNAP catalysis, reviews current strategies to mitigate this issue, and highlights recent progress in the field. A key focus is the semi-rational design of T7 RNAP mutants engineered to minimize dsRNA generation and enhance catalytic performance. Beyond its role in transcription, T7 RNAP exhibits rapid development and extensive application in fields, including gene editing, biosensing, and mRNA vaccines. This review systematically examines the structure-function relationships of T7 RNAP, elucidates the mechanisms of dsRNA formation, and discusses engineering strategies to optimize its performance. It further explores the engineering optimization and functional expansion of T7 RNAP. Furthermore, this review also addresses the pressing issues that currently need resolution, discusses the major challenges in the practical application of T7 RNAP, and provides an outlook on potential future research directions. In summary, this review provides a comprehensive analysis of T7 RNAP, ranging from its structural architecture to cutting-edge applications. We systematically examine: (1) the characteristic right-hand domains (thumb, palm, fingers) that define its minimalistic structure; (2) the structure-function relationships underlying transcriptional catalysis; and (3) the dynamic transitions during the complete transcription cycle. While highlighting T7 RNAP’s versatility in gene editing, biosensing, and mRNA vaccine production, we critically address its major limitation—dsRNA byproduct formation—and evaluate engineering solutions including semi-rationally designed mutants. By synthesizing current knowledge and identifying key challenges, this work aims to provide novel insights for the development and application of T7 RNAP and to foster further thought and progress in related fields.]]></description>
<pubDate>2025/7/9 11:25:25</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HU Zhen-Xin,HUA Yu,LI Qiu-Shi,LIU Yun-Long,NING Wei-Chen,WU Yao,YOU Hui-Ling]]></author>
</item>
<item>
<title><![CDATA[Multi-omics Analysis of NUDT19 Across Cancer Types and Its Functional Role in Leukemia]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202502080000002]]></link>
<description><![CDATA[<b>Objective</b> Recent studies have highlighted the critical role of NUDT19 in the initiation, progression, and prognosis of specific cancer types. However, its involvement in pan-cancer analysis has not been fully characterized. This study aims to systematically explore the expression patterns, clinical significance, and immune-related functions of NUDT19 in various cancer types through multi-omics analysis, further revealing its potential role in cancer, particularly its functional and therapeutic target value in leukemia.<b>Methods</b> To achieve this goal, various bioinformatics approaches were employed to evaluate the expression patterns, clinical significance, and immune-related functions of NUDT19 in tumors and normal tissues. Additionally, we analyzed the mutation characteristics of NUDT19 and its relationship with epigenetic modifications. Using the single-cell analysis tool SingleCellBase, we explored the distribution of NUDT19 across different cell subpopulations in tumors. To validate these findings, qRT-PCR was used to measure NUDT19 expression levels in specific tumor cell lines, and we established acute myeloid leukemia (AML) cell lines (HL-60 and THP-1) to conduct NUDT19 knockdown and overexpression experiments, assessing its effects on leukemia cell proliferation, apoptosis, and invasion.<b>Results</b> Pan-cancer analysis revealed the dysregulated expression of NUDT19 across multiple cancer types, which was closely associated with poor prognosis, clinical staging, and diagnostic markers. Furthermore, NUDT19 was significantly correlated with tumor biomarkers, immune-related genes, and immune cell infiltration in different cancers. Mutation analysis showed that multiple mutations in NUDT19 were significantly associated with epigenetic changes. Single-cell analysis revealed the heterogeneity of NUDT19 expression in cancer cells, suggesting its potentially diverse functional roles in different cell subpopulations. qRT-PCR experiments confirmed the significant upregulation of NUDT19 in various tumor cell lines. In AML cell lines, NUDT19 knockdown led to reduced cell proliferation and invasion, with increased apoptosis, while NUDT19 overexpression significantly enhanced cell proliferation and invasion while reducing apoptosis.<b>Conclusion</b> This study demonstrates the diverse roles of NUDT19 in various cancer types, with a particularly prominent functional role in leukemia. NUDT19 is not only associated with tumor initiation and progression but may also influence cancer progression through the regulation of immune microenvironment and epigenetic mechanisms. Our research highlights the potential of NUDT19 as a therapeutic target, particularly for targeted therapies in malignancies such as leukemia, with significant clinical application prospects.]]></description>
<pubDate>2025/7/9 11:23:28</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[FENG Shuai,LI Xiao-Jin,YANG Tong-Hua,YUAN Zhong-Tao]]></author>
</item>
<item>
<title><![CDATA[Targeting PPARα for The Treatment of Cardiovascular Diseases]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202502280000001]]></link>
<description><![CDATA[Cardiovascular disease (CVD) remains one of the leading causes of mortality among adults globally, with continuously rising morbidity and mortality rates. Metabolic disorders are closely linked to various cardiovascular diseases and play a critical role in their pathogenesis and progression, involving multifaceted mechanisms such as altered substrate utilization, mitochondrial structural and functional dysfunction, and impaired ATP synthesis and transport. In recent years, the potential role of peroxisome proliferator-activated receptors (PPARs) in cardiovascular diseases has garnered significant attention, particularly peroxisome proliferator-activated receptor alpha (PPARα), which is recognized as a highly promising therapeutic target for CVD. PPARα regulates cardiovascular physiological and pathological processes through fatty acid metabolism. As a ligand-activated receptor within the nuclear hormone receptor family, PPARα is highly expressed in multiple organs, including skeletal muscle, liver, intestine, kidney, and heart, where it governs the metabolism of diverse substrates. Functioning as a key transcription factor in maintaining metabolic homeostasis and catalyzing or regulating biochemical reactions, PPARα exerts its cardioprotective effects through multiple pathways: modulating lipid metabolism, participating in cardiac energy metabolism, enhancing insulin sensitivity, suppressing inflammatory responses, improving vascular endothelial function, and inhibiting smooth muscle cell proliferation and migration. These mechanisms collectively reduce the risk of cardiovascular disease development. Thus, PPARα plays a pivotal role in various pathological processes<i> via</i> mechanisms such as lipid metabolism regulation, anti-inflammatory actions, and anti-apoptotic effects. PPARα is activated by binding to natural or synthetic lipophilic ligands, including endogenous fatty acids and their derivatives (<i>e.g</i>., linoleic acid, oleic acid, and arachidonic acid) as well as synthetic peroxisome proliferators. Upon ligand binding, PPARα activates the nuclear receptor retinoid X receptor (RXR), forming a PPARα-RXR heterodimer. This heterodimer, in conjunction with coactivators, undergoes further activation and subsequently binds to peroxisome proliferator response elements (PPREs), thereby regulating the transcription of target genes critical for lipid and glucose homeostasis. Key genes include fatty acid translocase (<i>FAT</i>/<i>CD36</i>), diacylglycerol acyltransferase (<i>DGAT</i>), carnitine palmitoyltransferase I (<i>CPT1</i>), and glucose transporter (<i>GLUT</i>), which are primarily involved in fatty acid uptake, storage, oxidation, and glucose utilization processes. Advancing research on PPARα as a therapeutic target for cardiovascular diseases has underscored its growing clinical significance. Currently, PPARα activators/agonists, such as fibrates (<i>e.g</i>., fenofibrate and bezafibrate) and thiazolidinediones, have been extensively studied in clinical trials for CVD prevention. Traditional PPARα agonists, including fenofibrate and bezafibrate, are widely used in clinical practice to treat hypertriglyceridemia and low high-density lipoprotein cholesterol (HDL-C) levels. These fibrates enhance fatty acid metabolism in the liver and skeletal muscle by activating PPARα, and their cardioprotective effects have been validated in numerous clinical studies. Recent research highlights that fibrates improve insulin resistance, regulate lipid metabolism, correct energy metabolism imbalances, and inhibit the proliferation and migration of vascular smooth muscle and endothelial cells, thereby ameliorating pathological remodeling of the cardiovascular system and reducing blood pressure. Given the substantial attention to PPARα-targeted interventions in both basic research and clinical applications, activating PPARα may serve as a key therapeutic strategy for managing cardiovascular conditions such as myocardial hypertrophy, atherosclerosis, ischemic cardiomyopathy, myocardial infarction, diabetic cardiomyopathy, and heart failure. This review comprehensively examines the regulatory roles of PPARα in cardiovascular diseases and evaluates its clinical application value, aiming to provide a theoretical foundation for further development and utilization of PPARα-related therapies in CVD treatment.]]></description>
<pubDate>2025/7/3 16:14:52</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DAN Ju-Hua,HE Li,LIU Jia-Wei,SU Wen-Hua,WU Jia-Zhen,ZHANG Hao-Zhuo,ZHANG Tong-Tong]]></author>
</item>
<item>
<title><![CDATA[Development of an Analytical Software for Forensic Proteomic SAP Typing]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202502120000001]]></link>
<description><![CDATA[<b>Objective</b> The proteome of biological evidence contains rich genetic information, namely single amino acid polymorphisms (SAPs) in protein sequences. However, due to the lack of efficient and convenient analysis tools, the application of SAP in public security still faces many challenges. This paper aims to meet the application requirements of SAP analysis for forensic biological evidence’s proteome data.<b>Methods</b> The software is divided into three modules. First, based on a built-in database of common non-synonymous single nucleotide polymorphisms (nsSNPs) and SAPs in East Asian populations, the software integrates and annotates newly identified exonic nsSNPs as SAPs, thereby constructing a customized SAP protein sequence database. It then utilizes a pre-installed search engine—either pFind or MaxQuant—to perform analysis and output SAP typing results, identifying both reference and variant types, along with their corresponding imputed nsSNPs. Finally, SAPTyper compares the proteome-based typing results with the individual’s exome-derived nsSNP profile and outputs the comparison report.<b>Results</b> SAPTyper accepts proteomic DDA mass spectrometry raw data (DDA acquisition mode) and exome sequencing results of nsSNPs as input and outputs the report of SAPs result. The pFind and Maxquant search engines were used to test the proteome data of 2 hair shafts of 2 individuals, and both obtained SAP results. It was found that the results of the Maxquant search engine were slightly less than those of pFind. This result shows that SAPTyper can achieve SAP fingding function. Moreover, the pFind search engine was used to test the proteome data of 3 hair shafts from 1 European person and 1 African person in the literature. Among the sites fully matched by the literature method, sites detected by SAPTyper are also included; for semi-matching sites, that is, nsSNPs are heterozygous, both literature method and SAPTyper method had the risk of missing detection for one type of the allele. Comparing the analysis results of SAPTyper with the SAP test results reported in the literature, it was found that some imputed nsSNP sites identified by the literature method but not detected by SAPTyper had a <i>MAF</i> of less than 0.1% in East Asian populations, and therefore they were not included in the common nsSNP database of East Asian populations constructed by this software. Since the database construction of this software is based on the genetic variation information of East Asian populations, it is currently unable to effectively identify representative unique common variation sites in European or African populations, but it can still identify SAP sites shared by these populations and East Asian populations.<b>Conclusion</b> An automated SAP analysis algorithm was developed for East Asian populations, and the software named SAPTyper was developed. This software provides a convenient and efficient analysis tool for the research and application of forensic proteomic SAP and has important application prospects in individual identification and phenotypic inference based on SAP.]]></description>
<pubDate>2025/6/30 21:29:29</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[DING Dong-Sheng,FENG Lei,HU Feng,JI An-Quan,WANG Meng-Jiao,WU Jia-Lei,YANG Zhi-Yuan,YE Jian]]></author>
</item>
<item>
<title><![CDATA[Study on The Detection Method of Fat Infiltration in Muscle Tissue Based on Phase Angle Electrical Impedance Tomography]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202505190000002]]></link>
<description><![CDATA[<b>Objective</b> Fat infiltration has been shown to be closely related to muscle mass loss and a variety of muscle diseases. This study proposes a method based on phase-angle electrical impedance tomography (<i>Φ</i>EIT) to visualize the electrical characteristic response caused by muscle fat infiltration, aiming to provide a new technical means for early non-invasive detection of muscle mass deterioration.<b>Methods</b> This study was divided into two parts. First, a laboratory pork model was constructed to simulate different degrees of fat infiltration by injecting 1 ml or 2 ml of emulsified fat solution into different muscle compartments, and the phase angle images were reconstructed using <i>Φ</i>EIT. Second, a human experiment was conducted to recruit healthy subjects (<i>n</i>=8) from two age groups (20-25 years old and 26-30 years old). The fat content percentage <i>η</i><sub>fat</sub> of the left and right legs was measured by bioelectrical impedance analysis (BIA), and the phase angle images of the left and right calves were reconstructed using <i>Φ</i>EIT. The relationship between the global average phase angle <i>Φ</i><sub>M</sub> and the spatial average phase angle <i>Φ</i><sub>M</sub><i><sub>i</sub></i> of each muscle compartment and fat infiltration was further analyzed.<b>Results</b> In the laboratory pork model, the grayscale value of the image increased with the increase of <i>η</i><sub>fat</sub> and <i>Φ</i><sub>M</sub> showed a downward trend. The results of human experiments showed that at the same fat content percentage, the <i>Φ</i><sub>M</sub><i><sub> </sub></i>of the 26-30-year-old group was about 20%-35% lower than that of the 20-25-year-old group. The fat content percentage was significantly negatively correlated with <i>Φ</i><sub>M</sub>. In addition, the M<sub>2</sub> (soleus) compartment was most sensitive to fat infiltration, and the spatial average phase angles of the M<sub>2</sub> (soleus), M<sub>3</sub> (tibialis posterior and flexor digitorum longus), and M<sub>4</sub> (tibialis anterior, extensor digitorum longus, and peroneus longus) compartments all showed significant inter-group differences.<b>Conclusion</b> <i>Φ</i>EIT imaging can effectively distinguish different degrees of fat infiltration, especially in deep, small or specially located muscles, showing high sensitivity, demonstrating the potential application of this method in local muscle mass monitoring and early non-invasive diagnosis.]]></description>
<pubDate>2025/6/30 21:26:28</pubDate>
<category><![CDATA[技术与方法]]></category>
<author><![CDATA[FENG Hui,SUN Bo,XIAO Wu-Guang,YAO Jia-Feng,ZHAO Tong,ZHU Xiao-Peng]]></author>
</item>
<item>
<title><![CDATA[Lipid Droplet Biogenesis at the Endoplasmic Reticulum: Orchestrating Nucleation, Membrane Budding, and Expansion]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202504270000001]]></link>
<description><![CDATA[Lipid droplets (LDs) are dynamic organelles that are ubiquitous across most organisms, including animals, plants, protists, and microorganisms. Their core consists of neutral lipids, surrounded by a phospholipid monolayer adorned with a specific set of proteins. As critical intracellular hubs of metabolic regulation, lipid droplets play essential roles in maintaining physiological homeostasis and contributing to the progression of various pathological processes. They store neutral lipids for energy production during periods of starvation or for membrane biosynthesis, and they sequester fatty acids to mitigate lipotoxicity. Clinically, dysregulation of lipid droplet function is associated with a wide range of diseases, including metabolic dysfunction-associated steatotic liver disease (MASLD), obesity, type 2 diabetes mellitus (T2DM), neurodegenerative disorders, and cancer. Research into the biological functions of lipid droplets—as dynamic organelles and their links to multiple diseases—has emerged as a cutting-edge focus in cell biology. In recent years, significant advances have been made in understanding lipid droplet biogenesis. Researchers have developed a more refined framework that elucidates how LDs are assembled in the endoplasmic reticulum (ER). Triacylglycerols and sterol esters are synthesized between the inner and outer leaflets of the ER bilayer, and when they exceed the critical nucleation concentration (CNC), they coalesce to form neutral lipid lenses. These then bud from the ER under the coordinated action of key proteins such as Seipin, fat storage-inducing transmembrane protein 2 (FIT2), and the peroxisomal membrane protein Pex30. This budding process is driven by changes in membrane curvature and surface tension, induced by the asymmetric distribution of phospholipids. Nascent lipid droplets recruit lipid-synthesizing enzymes <i>via</i> ER-LD bridging structures, enabling localized lipid production and surface expansion, ultimately resulting in the formation of mature LDs. Biochemical and biophysical approaches have revealed important features of this process, underscoring the critical roles of ER membrane biophysical properties and specific phospholipids. Structural biology and proteomic studies have identified key regulators—particularly Seipin and FIT2—as central players in LD biogenesis. This review systematically summarizes recent advances in the molecular mechanisms of LD biogenesis. It delves into the processes of LD nucleation, membrane budding, and expansion in eukaryotic cells, with a special focus on how core factors such as Seipin and FIT2 dynamically regulate LD morphology. In addition, it examines the mechanisms and pathways by which class I and class II proteins are targeted to LDs, compares LD biogenesis involving different neutral lipid cores, and discusses the disease relevance of specific regulatory proteins. Finally, the review outlines critical unresolved questions in the field of LD biogenesis, offering clear directions for future research and providing a comprehensive framework for deepening our understanding of LD formation and its implications for disease intervention.]]></description>
<pubDate>2025/6/28 9:12:19</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[JI Wei-Ke,XIONG Juan,YU Yue]]></author>
</item>
<item>
<title><![CDATA[Exploration and Practice of Artificial Intelligence Empowering Case-based Teaching in Biochemistry and Molecular Biology]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202505120000002]]></link>
<description><![CDATA[In recent years, the deep integration of artificial intelligence (AI) into medical education has created new opportunities for teaching <i>Biochemistry and Molecular Biology</i>, while also offering innovative solutions to the pedagogical challenges associated with protein structure and function. Focusing on the case of anaplastic lymphoma kinase (<i>ALK</i>) gene mutations in non-small-cell lung cancer (NSCLC), this study integrates AI into case-based learning (CBL) to develop an AI-CBL hybrid teaching model. This model features an intelligent case-generation system that dynamically constructs ALK mutation scenarios using real-world clinical data, closely linking molecular biology concepts with clinical applications. It incorporates AI-powered protein structure prediction tools to accurately visualize the three-dimensional structures of both wild-type and mutant ALK proteins, dynamically simulating functional abnormalities resulting from conformational changes. Additionally, a virtual simulation platform replicates the <i>ALK</i> gene detection workflow, bridging theoretical knowledge with practical skills. As a result, a multidimensional teaching system is established—driven by clinical cases and integrating molecular structural analysis with experimental validation. Teaching outcomes indicate that the three-dimensional visualization, dynamic interactivity, and intelligent analytical capabilities provided by AI significantly enhance students’ understanding of molecular mechanisms, classroom engagement, and capacity for innovative research. This model establishes a coherent training pathway linking “fundamental theory-scientific research thinking-clinical practice”, offering an effective approach to addressing teaching challenges and advancing the intelligent transformation of medical education.]]></description>
<pubDate>2025/6/26 16:49:34</pubDate>
<category><![CDATA[科教融合]]></category>
<author><![CDATA[GUO Jun-Ming,HU Ying-Lu,LIN Yi-Chen,MENG Xiao-Dan]]></author>
</item>
<item>
<title><![CDATA[Molecular Mechanisms of RNA Modification Interactions and Their Roles in Cancer Diagnosis and Treatment]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202502050000001]]></link>
<description><![CDATA[RNA modifications constitute a crucial class of post-transcriptional chemical alterations that profoundly influence RNA stability and translational efficiency, thereby shaping cellular protein expression profiles. These diverse chemical marks are ubiquitously involved in key biological processes, including cell proliferation, differentiation, apoptosis, and metastatic potential, and they exert precise regulatory control over these functions. A major advance in the field is the recognition that RNA modifications do not act in isolation. Instead, they participate in complex, dynamic interactions—through synergistic enhancement, antagonism, competitive binding, and functional crosstalk—forming what is now termed the “RNA modification interactome” or “RNA modification interaction network.” The formation and functional operation of this interactome rely on a multilayered regulatory framework orchestrated by RNA-modifying enzymes—commonly referred to as “writers,” “erasers,” and “readers.” These enzymes exhibit hierarchical organization within signaling cascades, often functioning in upstream-downstream sequences and converging at critical regulatory nodes. Their integration is further mediated through shared regulatory elements or the assembly into multi-enzyme complexes. This intricate enzymatic network directly governs and shapes the interdependent relationships among various RNA modifications. This review systematically elucidates the molecular mechanisms underlying both direct and indirect interactions between RNA modifications. Building upon this foundation, we introduce novel quantitative assessment frameworks and predictive disease models designed to leverage these interaction patterns. Importantly, studies across multiple disease contexts have identified core downstream signaling axes driven by specific constellations of interacting RNA modifications. These findings not only deepen our understanding of how RNA modification crosstalk contributes to disease initiation and progression, but also highlight its translational potential. This potential is exemplified by the discovery of diagnostic biomarkers based on interaction signatures and the development of therapeutic strategies targeting pathogenic modification networks. Together, these insights provide a conceptual framework for understanding the dynamic and multidimensional regulatory roles of RNA modifications in cellular systems. In conclusion, the emerging concept of RNA modification crosstalk reveals the extraordinary complexity of post-transcriptional regulation and opens new research avenues. It offers critical insights into the central question of how RNA-modifying enzymes achieve substrate specificity—determining which nucleotides within specific RNA transcripts are selectively modified during defined developmental or pathological stages. Decoding these specificity determinants, shaped in large part by the modification interactome, is essential for fully understanding the biological and pathological significance of the epitranscriptome.]]></description>
<pubDate>2025/6/23 16:48:37</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[FANG Jia-Wen,LI Lin-Hai,XIAO Bin,XU Ling-Ting,ZHE Chao]]></author>
</item>
<item>
<title><![CDATA[The Critical Roles of GABAergic Interneurons in The Pathological Progression of Alzheimer’s Disease]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202503200000001]]></link>
<description><![CDATA[Alzheimer’s disease (AD), a progressive neurodegenerative disorder and the leading cause of dementia in the elderly, is characterized by severe cognitive decline, loss of daily living abilities, and neuropsychiatric symptoms. This condition imposes a substantial burden on patients, families, and society. Despite extensive research efforts, the complex pathogenesis of AD, particularly the early mechanisms underlying cognitive dysfunction, remains incompletely understood, posing significant challenges for timely diagnosis and effective therapeutic intervention. Among the various cellular components implicated in AD, GABAergic interneurons have emerged as critical players in the pathological cascade, playing a pivotal role in maintaining neural network integrity and function in key brain regions affected by the disease. GABAergic interneurons represent a heterogeneous population of inhibitory neurons essential for sustaining neural network homeostasis. They achieve this by precisely modulating rhythmic oscillatory activity (<i>e.g</i>., theta and gamma oscillations), which are crucial for cognitive processes such as learning and memory. These interneurons synthesize and release the inhibitory neurotransmitter GABA, exerting potent control over excitatory pyramidal neurons through intricate local circuits. Their primary mechanism involves synaptic inhibition, thereby modulating the excitability and synchrony of neural populations. Emerging evidence highlights the significant involvement of GABAergic interneuron dysfunction in AD pathogenesis. Contrary to earlier assumptions of their resistance to the disease, specific subtypes exhibit vulnerability or altered function early in the disease process. Critically, this impairment is not merely a consequence but appears to be a key driver of network hyperexcitability, a hallmark feature of AD models and potentially a core mechanism underlying cognitive deficits. For instance, parvalbumin-positive (PV<sup>+</sup>) interneurons display biphasic alterations in activity. Both suppressing early hyperactivity or enhancing late activity can rescue cognitive deficits, underscoring their causal role. Somatostatin-positive (SST<sup>+</sup>) neurons are highly sensitive to amyloid beta protein (Aβ) dysfunction. Their functional impairment drives AD progression <i>via</i> a dual pathway: compensatory hyperexcitability promotes Aβ generation, while released SST-14 forms toxic oligomers with Aβ, collectively accelerating neuronal loss and amyloid deposition, forming a vicious cycle. Vasoactive intestinal peptide-positive (VIP<sup>+</sup>) neurons, although potentially spared in number early in the disease, exhibit altered firing properties (<i>e.g</i>., broader spikes, lower frequency), contributing to network dysfunction (<i>e.g</i>., in CA1). Furthermore, VIP release induced by 40 Hz sensory stimulation (GENUS) enhances glymphatic clearance of Aβ, demonstrating a direct link between VIP neuron function and modulation of amyloid pathology. Given their central role in network stability and their demonstrable dysfunction in AD, GABAergic interneurons represent promising therapeutic targets. Current research primarily explores three approaches: increasing interneuron numbers (<i>e.g</i>., improving cortical PV<sup>+</sup> interneuron counts and behavior in APP/PS1 mice with the antidepressant citalopram; transplanting stem cells differentiated into functional GABAergic neurons to enhance cognition), enhancing neuronal activity (<i>e.g</i>., using low-dose levetiracetam or targeted activation of specific molecules to boost PV<sup>+</sup> interneuron excitability, restoring neural network γ-oscillations and memory; non-invasive neuromodulation techniques like 40 Hz repetitive transcranial magnetic stimulation (rTMS), GENUS, and minimally invasive electroacupuncture to improve inhibitory regulation, promote memory, and reduce Aβ), and direct GABA system intervention (clinical and animal studies reveal reduced GABA levels in AD-affected brain regions; early GABA supplementation improves cognition in APP/PS1 mice, suggesting a therapeutic time window). Collectively, these findings establish GABAergic interneuron intervention as a foundational rationale and distinct pathway for AD therapy. In conclusion, GABAergic interneurons, particularly the PV<sup>+</sup>, SST<sup>+</sup>, and VIP<sup>+</sup> subtypes, play critical and subtype-specific roles in the initiation and progression of AD pathology. Their dysfunction significantly contributes to network hyperexcitability, oscillatory deficits, and cognitive decline. Understanding the heterogeneity in their vulnerability and response mechanisms provides crucial insights into AD pathogenesis. Targeting these interneurons through pharmacological, neuromodulatory, or cellular approaches offers promising avenues for developing novel, potentially disease-modifying therapies.]]></description>
<pubDate>2025/6/23 11:30:49</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Ke-Han,CHEN Ke,GAO Zi-Xin,YANG Yin,YANG Zheng-Jiang,YAO De-Zhong,YAO Yuan]]></author>
</item>
<item>
<title><![CDATA[Single-cell Protein Localization Method Based on Class Perception Graph Convolutional Network]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202501270000002]]></link>
<description><![CDATA[<b>Objective</b> This study proposes a novel single-cell protein localization method based on a class perception graph convolutional network (CP-GCN) to overcome several critical challenges in protein microscopic image analysis, including the scarcity of cell-level annotations, inadequate feature extraction, and the difficulty in achieving precise protein localization within individual cells. The methodology involves multiple innovative components designed to enhance both feature extraction and localization accuracy.<b>Methods</b> First, a class perception module (CPM) is developed to effectively capture and distinguish semantic features across different subcellular categories, enabling more discriminative feature representation. Building upon this, the CP-GCN network is designed to explore global features of subcellular proteins in multicellular environments. This network incorporates a category feature-aware module to extract protein semantic features aligned with label dimensions and establishes a subcellular relationship mining module to model correlations between different subcellular structures. By doing so, it generates co-occurrence embedding features that encode spatial and contextual relationships among subcellular locations, thereby improving feature representation. To further refine localization, a multi-scale feature analysis approach is employed using the K-means clustering algorithm, which classifies multi-scale features within each subcellular category and generates multi-cell class activation maps (CAMs). These CAMs highlight discriminative regions associated with specific subcellular locations, facilitating more accurate protein localization. Additionally, a pseudo-label generation strategy is introduced to address the lack of annotated single-cell data. This strategy segments multicellular images into single-cell images and assigns reliable pseudo-labels based on the CAM-predicted regions, ensuring high-quality training data for single-cell analysis. Under a transfer learning framework, the model is trained to achieve precise single-cell-level protein localization, leveraging both the extracted features and pseudo-labels for robust performance.<b>Results</b> Experimental validation on multiple single-cell test datasets demonstrates that the proposed method significantly outperforms existing approaches in terms of robustness and localization accuracy. Specifically, on the Kaggle 2021 dataset, the method achieves superior mean average precision (mAP) metrics across 18 subcellular categories, highlighting its effectiveness in diverse protein localization tasks. Visualization of the generated CAM results further confirms the model’s capability to accurately localize subcellular proteins within individual cells, even in complex multicellular environments.<b>Conclusion</b> The integration of the CP-GCN network with a pseudo-labeling strategy enables the proposed method to effectively capture heterogeneous cellular features in protein images and achieve precise single-cell protein localization. This advancement not only addresses key limitations in current protein image analysis but also provides a scalable and accurate solution for subcellular protein studies, with potential applications in biomedical research and diagnostic imaging. The success of this method underscores the importance of combining advanced deep learning architectures with innovative training strategies to overcome data scarcity and improve localization performance in biological image analysis. Future work could explore the extension of this framework to other types of microscopic imaging and its application in large-scale protein interaction studies.]]></description>
<pubDate>2025/6/22 14:06:04</pubDate>
<category><![CDATA[技术与方法]]></category>
<author><![CDATA[TANG Hao-Yang,WANG Meng-Meng,YANG Si-Cong,YAO Xin-Yue]]></author>
</item>
<item>
<title><![CDATA[Exercise Improves Metaflammation: The Potential Regulatory Role of BDNF]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202505080000002]]></link>
<description><![CDATA[Metaflammation is a crucial mechanism in the onset and advancement of metabolic disorders, primarily defined by the activation of immune cells and increased concentrations of pro-inflammatory substances. The function of brain-derived neurotrophic factor (BDNF) in modulating immune and metabolic processes has garnered heightened interest, as BDNF suppresses glial cell activation and orchestrates inflammatory responses in the central nervous system <i>via</i> its receptor tyrosine kinase receptor B (TrkB), while also diminishing local inflammation in peripheral tissues by influencing macrophage polarization. Exercise, as a non-pharmacological intervention, is extensively employed to enhance metabolic disorders. A crucial mechanism underlying its efficacy is the significant induction of BDNF expression in central (hypothalamus, hippocampus, prefrontal cortex, and brainstem) and peripheral (liver, adipose tissue, intestines, and skeletal muscle) tissues and organs. This induction subsequently regulates inflammatory responses, ameliorates metabolic conditions, and decelerates disease progression. Consequently, BDNF is considered a pivotal molecule in the motor-metabolic regulation axis. Despite prior suggestions that BDNF may have a role in the regulation of exercise-induced inflammation, systematic data remains inadequate. Since that time, the field continues to lack structured descriptions and conversations pertinent to it. As exercise physiology research has advanced, the academic community has increasingly recognized that exercise is a multifaceted activity regulated by various systems, with its effects contingent upon the interplay of elements such as type, intensity, and frequency of exercise. Consequently, it is imperative to transcend the prior study paradigm that concentrated solely on localized effects and singular mechanisms and transition towards a comprehensive understanding of the systemic advantages of exercise. A multitude of investigations has validated that exercise confers health advantages for individuals with metabolic disorders, encompassing youngsters, adolescents, middle-aged individuals, and older persons, and typically enhances health <i>via</i> BDNF secretion. However, exercise is a double-edged sword; the relationship between exercise and health is not linearly positive. Insufficient exercise is ineffective, while excessive exercise can be detrimental to health. Consequently, it is crucial to scientifically develop exercise prescriptions, define appropriate exercise loads, and optimize health benefits to regulate bodily metabolism. BDNF mitigates metaflammation <i>via</i> many pathways during exercise. Initially, BDNF suppresses pro-inflammatory factors and facilitates the production of anti-inflammatory factors by modulating bidirectional transmission between neural and immune cells, therefore diminishing the inflammatory response. Secondly, exercise stimulates the PI3K/Akt, AMPK, and other signaling pathways <i>via</i> BDNF, enhancing insulin sensitivity, reducing lipotoxicity, and fostering mitochondrial production, so further optimizing the body’s metabolic condition. Moreover, exercise-induced BDNF contributes to the attenuation of systemic inflammation by collaborating with several organs, enhancing hepatic antioxidant capacity, regulating immunological response, and optimizing “gut-brain” axis functionality. These processes underscore the efficacy of exercise as a non-pharmacological intervention for enhancing anti-inflammatory and metabolic health. Despite substantial experimental evidence demonstrating the efficacy of exercise in mitigating inflammation and enhancing BDNF levels, numerous limitations persist in the existing studies. Primarily, the majority of studies have concentrated on molecular biology and lack causal experimental evidence that explicitly confirms BDNF as a crucial mediator in the exercise regulation of metaflammation. Furthermore, the outcomes of current molecular investigations are inadequately applicable to clinical practice, and a definitive pathway of “exercise-BDNF-metaflammation” remains unestablished. Moreover, the existing research methodology, reliant on animal models or limited human subject samples, constrains the broad dissemination of the findings. Future research should progressively transition from investigating isolated and localized pathways to a comprehensive multilevel and multidimensional framework that incorporates systems biology and exercise physiology. Practically, there is an immediate necessity to undertake extensive, double-blind, randomized controlled longitudinal human studies utilizing multi-omics technologies (<i>e.g</i>., transcriptomics, proteomics, and metabolomics) to investigate the principal signaling pathways of BDNF-mediated metaflammation and to elucidate the causal relationships and molecular mechanisms involved. Establishing a more comprehensive scientific evidence system aims to furnish a robust theoretical framework and practical guidance for the mechanistic interpretation, clinical application, and pharmaceutical development of exercise in the prevention and treatment of metabolic diseases.]]></description>
<pubDate>2025/6/22 14:04:28</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DAI Yu-Xi,HE Yu-Xiu,WANG Wei-Huan]]></author>
</item>
<item>
<title><![CDATA[N-glycosylation Modifications of Immunoglobulins G in Systemic Lupus Erythematosus]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202501140000001]]></link>
<description><![CDATA[Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown etiology, primarily characterized by systemic inflammation and hyperactivation of both B and T lymphocytes. Key immunological features include increased consumption of complement components, sustained overproduction of type I interferons (IFN-I), and persistent production of a broad spectrum of autoantibodies, such as anti-dsDNA antibodies. However, the use of autoantibodies as biomarkers for the early detection of SLE is associated with a high false-positive rate, suggesting that antibody characteristics evolve during disease progression. N-glycosylation is a critical post-translational modification of antibodies that significantly influences their structure and receptor-binding properties, thereby modulating biological activities and functions. In particular, glycosylation patterns affect the antibody’s affinity for Fc gamma receptors (FcγRs), subsequently regulating various antibody-mediated immune responses. Numerous studies have investigated the impact of individual monosaccharides—such as sialic acid, fucose, and N-acetylglucosamine, which constitute N-glycans—on the immunological functions of antibodies. This review systematically summarizes the aberrant immunoglobulin G (IgG) N-glycosylation patterns observed in SLE patients, with a focus on correlations between disease progression or complications and quantitative alterations in individual glycan components. We first review how different types of N-glycosylation modifications affect the biological activity and functional properties of IgG, particularly regarding the effects of specific monosaccharides—such as sialic acid, fucose, and galactose—on FcγR binding affinity and the resulting downstream immune functions. We then summarize the differential expression of IgG N-glycans and glycosyltransferase genes between SLE patients and healthy controls, and outline the associations between glycosylation changes and SLE-related pathological responses. In response to the inconsistencies and limitations in current research, we propose potential explanations from the perspectives of study methodologies, participant characteristics, and variations in N-glycan structures, aiming to provide a constructive reference for future studies. Given the close relationship between antibody glycosylation and SLE, this review highlights the potential of IgG N-glycosylation patterns as promising biomarkers for early diagnosis and disease monitoring. In terms of therapy, we discuss how IgG glycosylation can enhance the efficacy of intravenous immunoglobulin (IVIg) treatment and introduce emerging therapeutic strategies that aim to modulate endogenous IgG N-glycans as a novel glycan-based approach for SLE management. In summary, N-glycans are essential structural components of antibodies that regulate immune responses by modulating antibody-receptor interactions. Aberrant glycosylation is closely associated with the pathogenesis of autoimmune diseases, including SLE. However, due to the structural diversity of N-glycans and the complexity of glycosylation processes, the precise roles of IgG N-glycosylation in SLE pathophysiology remain incompletely understood. Moreover, therapeutic strategies targeting IgG glycosylation are still in early development and have not yet reached clinical application. Continued progress in glycan analysis technologies and other biological tools, along with interdisciplinary collaboration, will be essential for advancing this field.]]></description>
<pubDate>2025/6/19 14:50:24</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[BIAN Zheng,HUANG Chun-Cui,LI Yan,LIU Yao-Zhou]]></author>
</item>
<item>
<title><![CDATA[The Improvement of Motor Symptoms in Parkinson’s Disease by Exerkines and The Underlying Mechanisms]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202503150000004]]></link>
<description><![CDATA[Parkinson’s disease (PD), the second most common neurodegenerative disease after Alzheimer’s disease, manifests a variety of motor symptoms, such as bradykinesia, resting tremor, rigidity, postural balance disorder, and also presents non-motor symptoms, including cognitive decline, depression, constipation, and sleep disorders. Currently, treatment for PD primarily encompasses pharmacological interventions, with levodopa being the first-line therapy, and non-pharmacological approaches such as deep brain stimulation (DBS). However, both approaches exhibit therapeutic limitations, with potential adverse reactions emerging from long-term use. Levodopa is associated with dyskinesia, while DBS may lead to mental confusion, cognitive decline, and depression. Exercise, as an effective adjuvant strategy for drug treatment of PD, can significantly improve PD motor disorders. Recently, studies have found that the mechanisms of exercise improving PD motor symptoms are associated with exerkines. Exerkine refers to signalling moieties secreted in response to acute and/or chronic exercise. This review mainly summarizes the improvement of PD motor disorders by various exerkines and the underlying mechanisms. Firstly, exercise can trigger the secretion of brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) in the substantia nigra (SN) and the striatum, potentially improving PD. Recent evidence has suggested that both BDNF and GDNF could improve motor symptoms of PD <i>via</i> restoring the number of dopaminergic neurons in the SN and striatum, increasing striatal dopamine contents, and reducing α-synuclein (α-syn) accumulation in the SN. In addition, BDNF also alleviates motor symptoms of PD by enhancing long-term potentiation and increasing the spine density of spiny projection neurons in the striatum, while GDNF by inhibiting neuroinflammation in the SN <i>via</i> suppressing the activation of microglia, reducing interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) expressions, reducing the phosphorylation of inhibitor of nuclear factor kappa Bα (IκBα), and increasing the anti-inflammatory factors IL-10 and transforming growth factor-β (TGF-β). Secondly, exercise, a main trigger for irisin secretion from skeletal muscle, can improve PD motor symptoms by stimulating the irisin/adenosine monophosphate-activated protein kinase (AMPK)/Sirtuin-1 (SIRT1) pathway. Specifically, irisin alleviates motor symptoms in PD through multiple mechanisms, including inhibiting excessive mitochondrial fission by reducing the expressions of dynamin-related protein 1 (Drp1) and mitochondrial fission protein 1 (Fis1), alleviating the apoptosis of dopaminergic neurons by increasing B-cell lymphoma 2 (Bcl-2) expression and reducing Bcl-2-associated X protein (Bax) and caspase 3 expressions, and restoring the number of dopaminergic neurons. Thirdly, new biomarkers of PD (cathepsin B and Fetuin-A) also play roles in PD development. Cathepsin B can promote the clearance of pathogenic α-syn in PD by enhancing the function of lysosomes, including strengthening the lysosomal degradation capacity, elevating the transport rate, and increasing the activity of lysosomal glucocerebrosidase (GCase). Fetuin-A has been demonstrated to improve PD by restoring the number and the morphology of Purkinje cells, which are the only efferent neurons in the cerebellar cortex and play an important role in maintaining motor coordination. This review aims to facilitate a deep understanding of the mechanism by which exercise improves PD motor symptoms and provide a theoretical basis for promotion of exercise in PD.]]></description>
<pubDate>2025/6/19 11:12:07</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LIU Yu,PENG Jin,WANG Xiao-Hui]]></author>
</item>
<item>
<title><![CDATA[<b>Review:</b>Effects of Different Modes in Hypoxic Training on Metabolic Improvements in Obese Individuals : a Systematic Review With Meta-analysis on Randomized Controlled Trail]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202504300000004]]></link>
<description><![CDATA[This paper aimed to systematically evaluate the effects of hypoxic training at different fraction of inspired oxygen (FiO<sub>2</sub>) on body composition, glucose metabolism, and lipid metabolism in obese individuals, and to determine the optimal oxygen concentration range to provide scientific evidence for personalized and precise hypoxic exercise prescriptions. A systematic search was conducted in the Cochrane Library, PubMed, Web of Science, Embase, and CNKI databases for randomized controlled trials and pre-post intervention studies published up to March 31, 2025, involving hypoxic training interventions in obese populations. Meta-analysis was performed using RevMan 5.4 software to assess the effects of different fraction of inspired oxygen (FiO<sub>2</sub>≤14% <i>vs</i>. FiO<sub>2</sub>>14%) on BMI, body fat percentage, waist circumference, fasting blood glucose, insulin, HOMA-IR, triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C), with subgroup analyses based on oxygen concentration. A total of 22 studies involving 292 participants were included. Meta-analysis showed that hypoxic training significantly reduced BMI (mean difference (<i>MD</i>)=-2.29,95%<i>CI</i>: -3.42 to -1.17, <i>P</i><0.000 1), body fat percentage (<i>MD</i>=-2.32, 95%<i>CI</i>: -3.16 to -1.47, <i>P</i><0.001), waist circumference (<i>MD</i>=-3.79, 95%<i>CI</i>: -6.73 to -0.85, <i>P</i>=0.01), fasting blood glucose (<i>MD</i>=-3.58, 95%<i>CI</i>: -6.23 to -0.93, <i>P</i>=0.008), insulin (<i>MD</i>=-1.60, 95%<i>CI</i>: -2.98 to -0.22, <i>P</i>=0.02), TG (<i>MD</i>=-0.18, 95%<i>CI</i>: -0.25 to -0.12, <i>P</i><0.001), and LDL-C (<i>MD</i>=-0.25, 95%<i>CI</i>: -0.39 to -0.11, <i>P</i>=0.000 3). Greater improvements were observed under moderate hypoxic conditions with FiO<sub>2</sub>>14%. Changes in HOMA-IR (<i>MD</i>=-0.74, 95%<i>CI</i>: -1.52 to 0.04, <i>P</i>=0.06) and HDL-C (<i>MD</i>=-0.09, 95%<i>CI</i>: -0.21 to 0.02, <i>P</i>=0.11) were not statistically significant. Hypoxic training can significantly improve body composition, glucose metabolism, and lipid metabolism indicators in obese individuals, with greater benefits observed under moderate hypoxia (FiO>14%). As a key parameter in hypoxic exercise interventions, the precise setting of oxygen concentration is crucial for optimizing intervention outcomes.]]></description>
<pubDate>2025/6/13 10:17:21</pubDate>
<category><![CDATA[运动代谢效应与促健康机制研究专刊]]></category>
<author><![CDATA[LI Xiao-Shi,WANG Jie-Ping,WANG Ru,WANG Ru-Wen,YU Feng-Zhi,ZHANG Yi-Yin]]></author>
</item>
<item>
<title><![CDATA[Network Pharmacology and Experimental Verification Unraveled The Mechanism of Pachymic Acid in The Treatment of Neuroblastoma]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202504090000001]]></link>
<description><![CDATA[<b>Objective</b> Traditional Chinese medicine (TCM) constitutes a valuable cultural heritage and an important source of antitumor compounds. <i>Poria </i>(<i>Poria cocos </i>(Schw.) Wolf), the dried sclerotium of a polyporaceae fungus, was first documented in <i>Shennong</i>’<i>s Classic of Materia Medica</i> and has been used therapeutically and dietarily in China for millennia. Traditionally recognized for its diuretic, spleen-tonifying, and sedative properties, modern pharmacological studies confirm that <i>Poria</i> exhibits antioxidant, anti-inflammatory, antibacterial, and antitumor activities. Pachymic acid (PA; a triterpenoid with the chemical structure 3β-acetyloxy-16α-hydroxy-lanosta-8,24(31)-dien-21-oic acid), isolated from <i>Poria</i>, is a principal bioactive constituent. Emerging evidence indicates PA exerts antitumor effects through multiple mechanisms, though these remain incompletely characterized. Neuroblastoma (NB), a highly malignant pediatric extracranial solid tumor accounting for 15% of childhood cancer deaths, urgently requires safer therapeutics due to the limitations of current treatments. Although PA shows multi-mechanistic antitumor potential, its efficacy against NB remains uncharacterized. This study systematically investigated the potential molecular targets and mechanisms underlying the anti-NB effects of PA by integrating network pharmacology-based target prediction with experimental validation of multi-target interactions through molecular docking, dynamic simulations, and <i>in vitro</i> assays, aimed to establish a novel perspective on PA’s antitumor activity and explore its potential clinical implications for NB treatment by integrating computational predictions with biological assays.<b>Methods</b> This study employed network pharmacology to identify potential targets of PA in NB, followed by validation using molecular docking, molecular dynamics (MD) simulations, MM/PBSA free energy analysis, RT-qPCR and Western blot experiments. Network pharmacology analysis included target screening <i>via </i>TCMSP, GeneCards, DisGeNET, SwissTargetPrediction, SuperPred, and PharmMapper. Subsequently, potential targets were predicted by intersecting the results from these databases <i>via</i> Venn analysis. Following target prediction, topological analysis was performed to identify key targets using Cytoscape software. Molecular docking was conducted using AutoDock Vina, with the binding pocket defined based on crystal structures. MD simulations were performed for 100 ns using GROMACS, and RMSD, RMSF, SASA, and hydrogen bonding dynamics were analyzed. MM/PBSA calculations were carried out to estimate the binding free energy of each protein-ligand complex. <i>In vitro</i> validation included RT-qPCR and Western blot, with GAPDH used as an internal control.<b>Results</b> The CCK-8 assay demonstrated a concentration-dependent inhibitory effect of PA on NB cell viability. GO analysis suggested that the anti-NB activity of PA might involve cellular response to chemical stress, vesicle lumen, and protein tyrosine kinase activity. KEGG pathway enrichment analysis suggested that the anti-NB activity of PA might involve the PI3K/AKT, MAPK, and Ras signaling pathways. Molecular docking and MD simulations revealed stable binding interactions between PA and the core target proteins AKT1, EGFR, SRC, and HSP90AA1. RT-qPCR and Western blot analyses further confirmed that PA treatment significantly decreased the mRNA and protein expression of AKT1, EGFR, and SRC while increasing the HSP90AA1 mRNA and protein levels.<b>Conclusion</b> It was suggested that PA may exert its anti-NB effects by inhibiting AKT1, EGFR, and SRC expression, potentially modulating the PI3K/AKT signaling pathway. These findings provide crucial evidence supporting PA’s development as a therapeutic candidate for NB.]]></description>
<pubDate>2025/6/13 8:56:37</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[DAI Xin-Wen,GUO Si-Lin,LIAO Si-Cong,LIU Hang,PAN Xin-Yun,SHEN Ping,XIAO Yu-Bo,XIE Yuan-Jie,ZHU Yu-Xin]]></author>
</item>
<item>
<title><![CDATA[<b>Research:</b>Hypoxia Exercise Mediates The miR-27/PPARγ Pathway to Improve Lipid Metabolism in Obese Rats at Target Genes and Protein Levels]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202505210000004]]></link>
<description><![CDATA[<b>Objective</b> To explore the sequential effects of hypoxic exercising on miR-27/PPARγ and lipid metabolism target gene and protein expression levels in the obesity rats’ liver.<b>Methods</b> 13-week-old male diet-induced obesity rats were randomly divided into three groups (<i>n</i>＝10): normal oxygen concentration quiet group (N), hypoxia quiet group (H), hypoxic exercise group (HE). Exercise training on the horizontal animal treadmill for 1 h/d, 5 d/week for a total of 4 week, and the intensity of horizontal treadmill training was 20 m/min (hypoxic concentration was 13.6%). Comparison of the weights of perirenal fat and epididymal fat in rats across different groups and calculation of Lee’s index based on body weight and body length of rats in each group were done. And the serum concentrations of total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) levels were detected. RT-PCR and Western Blot were used to detect the levels of miR-27, PPARγ, CYP7A1 and CD36.<b>Results</b> Hypoxic exercise decreased the expression levels of miR-27 in the obese rats’ liver, however, the expression level of PPARγ was gradually increased. The expression levels of miR-27 in HE group were significantly lower than N group (<i>P</i><0.05). The expression levels of <i>PPARγ</i> mRNA in N group were significantly lower than H group (<i>P</i><0.05), especially lower than HE group (<i>P</i><0.01). The protein expression of PPARγ protein in N group was significantly lower than that other groups (<i>P</i><0.01). The expression of lipid metabolism-related genes and proteins increased in the obese rats’ liver. The expression of <i>CYP7A1</i> mRNA in N group was significantly lower than H group (<i>P</i><0.05), especially lower than HE group (<i>P</i><0.01). The expression of CYP7A1 protein in the obese rats’ liver in N group was extremely lower than H group and HE group (<i>P</i><0.01). The protein expression of CD36 in N group was significantly lower than that in HE group (<i>P</i><0.05). Hypoxia exercise improved the related physiological and biochemical indexes of lipid metabolism disorder. The perirenal fat weight of obese rats in HE group was extremely lower than N group and H group (<i>P</i><0.01), and the perirenal fat weight in N group was significantly higher than H group (<i>P</i><0.05). The epididymal fat weight in N group was significantly higher than H group (<i>P</i><0.05), and extremely higher than HE group (<i>P</i><0.01). The Lee’s index in HE group was extremely lower than N group and H group (<i>P</i><0.01). The serum concentration of TC in obese rats in HE group was extremely lower than N group and H group (<i>P</i><0.01). The serum concentration of TG in HE group was extremely lower than N group and H group (<i>P</i><0.01). The serum concentration of LDL-C in N group was extremely higher than HE group (<i>P</i><0.01). The serum concentration of HDL-C in N group was extremely lower than H group (<i>P</i><0.01).<b>Conclusion</b> Hypoxia and hypoxia exercise may negatively regulate the levels of PPARγ by inhibiting miR-27 in the obese rats’ liver, thereby affecting the expression of downstream target genes CYP7A1 and CD36, and promoting cholesterol, fatty acid oxidation and HDL-C transport in the liver, and ultimately the lipid levels in obese rats were improved. The effect of hypoxia exercise on improving blood lipid is better than simple hypoxia intervention.]]></description>
<pubDate>2025/6/13 8:52:29</pubDate>
<category><![CDATA[运动代谢效应与促健康机制研究专刊]]></category>
<author><![CDATA[CHENG Qian,HAN Fang-Zheng,KONG Wei,QU Yi,SHAO Jie,ZHAI Teng,ZHU Lei]]></author>
</item>
<item>
<title><![CDATA[Effects of Non-invasive Light Flicker on Functional Properties of Primary Visual Cortex in Adult Mice]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202503140000002]]></link>
<description><![CDATA[<b>Objective</b> As the central hub of the classical visual pathway, the primary visual cortex not only encodes and processes visual information but also establishes dense neural circuit connections with higher-order cognitive brain regions. Numerous studies have shown that 40 Hz flicker stimulation can induce γ oscillations in the brain and significantly improve learning and cognitive impairments in patients with neurodegenerative diseases. Moreover, flickering light phenomena naturally occur in daily environments. Given that the primary visual cortex serves as the brain’s first cortical hub for receiving visual input, it is essential to comprehensively understand how non-invasive light flicker stimulation modulates its information processing mechanisms. This study systematically investigates the effects of non-invasive light flicker stimulation at different frequencies on the functional properties of neurons in the primary visual cortex of adult mice, aiming to uncover how such stimulation modulates this region and, consequently, affects overall brain function.<b>Methods</b> Three groups of adult mice (approximately 12 weeks old) were exposed to light flicker stimulation at frequencies of 20 Hz, 40 Hz, and 60 Hz, respectively, for a duration of two months. A control group was exposed to the same light intensity without flickering. Following the stimulation period, <i>in vivo</i> multi-channel electrophysiological recordings were conducted. During these recordings, anesthetized mice were presented with various types of moving sinusoidal light gratings to assess the effects of different flicker frequencies on the functional properties of neurons in the primary visual cortex.<b>Results</b> The experimental results demonstrate that two months of light flicker stimulation at 20 Hz, 40 Hz, and 60 Hz enhances the orientation tuning capabilities of neurons in the primary visual cortex. Specifically, 40 Hz and 60 Hz stimulation improved contrast sensitivity, whereas 20 Hz had no significant effect. Further analysis revealed that all three frequencies reduced neuronal response variability (as measured by the Fano factor), increased the signal-to-noise ratio, and decreased noise correlation (<i>r</i><sub>sc</sub>) between neurons.<b>Conclusion</b> Non-invasive light flicker stimulation enhances orientation tuning (<i>e.g</i>., orientation bias index) and contrast sensitivity (<i>e.g</i>., contrast threshold and <i>C</i><sub>50</sub>) in neurons of the primary visual cortex. This enhancement is likely due to improved information processing efficiency, characterized by reduced neuronal variability and increased signal-to-noise ratio. These findings suggest that the primary visual cortex can achieve precise and efficient information encoding in complex lighting environments by selectively adapting to different flicker frequencies and optimizing receptive field properties. This study provides new experimental evidence on how various types of light flicker influence visual perception and offers insights into the mechanisms through which specific frequencies enhance brain function.]]></description>
<pubDate>2025/6/12 19:00:55</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[LI Xue-Qi,XU Guang-Wei,ZHOU Yi-Feng]]></author>
</item>
<item>
<title><![CDATA[Mechanisms and Molecular Networks of Hypoxia-regulated Tumor Cell Dormancy]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202502170000004]]></link>
<description><![CDATA[Dormant tumor cells constitute a population of cancer cells that reside in a non-proliferative or low-proliferative state, typically arrested in the G0/G1 phase and exhibiting minimal mitotic activity. These cells are commonly observed across multiple cancer types, including breast, lung, and ovarian cancers, and represent a central cellular component of minimal residual disease (MRD) following surgical resection of the primary tumor. Dormant cells are closely associated with long-term clinical latency and late-stage relapse. Due to their quiescent nature, dormant cells are intrinsically resistant to conventional therapies—such as chemotherapy and radiotherapy—that preferentially target rapidly dividing cells. In addition, they display enhanced anti-apoptotic capacity and immune evasion, rendering them particularly difficult to eradicate. More critically, in response to microenvironmental changes or activation of specific signaling pathways, dormant cells can re-enter the cell cycle and initiate metastatic outgrowth or tumor recurrence. This ability to escape dormancy underscores their clinical threat and positions their effective detection and elimination as a major challenge in contemporary cancer treatment. Hypoxia, a hallmark of the solid tumor microenvironment, has been widely recognized as a potent inducer of tumor cell dormancy. However, the molecular mechanisms by which tumor cells sense and respond to hypoxic stress—initiating the transition into dormancy—remain poorly defined. In particular, the lack of a systems-level understanding of the dynamic and multifactorial regulatory landscape has impeded the identification of actionable targets and constrained the development of effective therapeutic strategies. Accumulating evidence indicates that hypoxia-induced dormancy tumor cells are accompanied by a suite of adaptive phenotypes, including cell cycle arrest, global suppression of protein synthesis, metabolic reprogramming, autophagy activation, resistance to apoptosis, immune evasion, and therapy tolerance. These changes are orchestrated by multiple converging signaling pathways—such as PI3K-AKT-mTOR, Ras-Raf-MEK-ERK, and AMPK—that together constitute a highly dynamic and interconnected regulatory network. While individual pathways have been studied in depth, most investigations remain reductionist and fail to capture the temporal progression and network-level coordination underlying dormancy transitions. Systems biology offers a powerful framework to address this complexity. By integrating high-throughput multi-omics data—such as transcriptomics and proteomics—researchers can reconstruct global regulatory networks encompassing the key signaling axes involved in dormancy regulation. These networks facilitate the identification of core regulatory modules and elucidate functional interactions among key effectors. When combined with dynamic modeling approaches—such as ordinary differential equations—these frameworks enable the simulation of temporal behaviors of critical signaling nodes, including phosphorylated AMPK (p-AMPK), phosphorylated S6 (p-S6), and the p38/ERK activity ratio, providing insights into how their dynamic changes govern transitions between proliferation and dormancy. Beyond mapping trajectories from proliferation to dormancy and from shallow to deep dormancy, such dynamic regulatory models support topological analyses to identify central hubs and molecular switches. Key factors—such as NR2F1, mTORC1, ULK1, HIF-1α, and DYRK1A—have emerged as pivotal nodes within these networks and represent promising therapeutic targets. Constructing an integrative, systems-level regulatory framework—anchored in multi-pathway coordination, omics-layer integration, and dynamic modeling—is thus essential for decoding the architecture and progression of tumor dormancy. Such a framework not only advances mechanistic understanding but also lays the foundation for precision therapies targeting dormant tumor cells during the MRD phase, addressing a critical unmet need in cancer management.]]></description>
<pubDate>2025/6/12 18:30:47</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[FENG Jin-Qiu,FU Jia,GAO Ze-Qi,WANG Ping,ZHAO Mao]]></author>
</item>
<item>
<title><![CDATA[<b>Research:</b>Effect of Carbohydrate Intake Order on Metabolic Profiles of Endurance Exercise Mice in a High-temperature Environment]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202504300000005]]></link>
<description><![CDATA[<b>Objective</b> The primary objective of this study was to investigate the effects of carbohydrate intake order on post-exercise recovery and metabolic regulation under heat stress, particularly in models of exercise induced fatigue. Given the increasing significance of optimizing nutritional strategies to support performance in extreme environmental conditions, this study aimed to provide experimental evidence that contributes to a better understanding of how the sequence in which carbohydrates are consumed impacts exercise recovery, metabolic homeostasis, and fatigue alleviation in a high-temperature environment.<b>Methods</b> A mouse model of exercise-induced fatigue was established under high-temperature (35°C) to simulate heat stress. The subjects were divided into 3 distinct groups based on their carbohydrate intake order: the “mixed intake” group (HOT_MIX), where all macronutrients (carbohydrates, proteins, and fats) were consumed in a balanced ratio; the “carbohydrate-first intake” group (HOT_CHO), where carbohydrates were consumed first followed by other macronutrients; the “carbohydrate-later intake” group (HOT_PRO), where proteins and fats were consumed prior to carbohydrates. Each group underwent a 7 d intervention period with daily intake according to their designated group. Exercise performance was assessed using rotarod retention time test, and biomarkers of muscle damage, such as lactate dehydrogenase (LDH), creatine kinase (CK), lactate (LD), alanine aminotransferase (ALT), and non-esterified fatty acids (NEFA), were measured. Furthermore, targeted metabolomics analyses were conducted to investigate metabolic shifts in response to different dietary strategies, and KEGG pathway enrichment analysis was employed to explore the biological mechanisms underlying these changes.<b>Results</b> The findings demonstrated that the HOT_PRO group exhibited a significantly improved performance in the rotarod test, with a longer retention time compared to both the HOT_MIX and HOT_CHO groups (<i>P</i><0.05). Additionally, this group showed significantly reduced levels of muscle damage markers such as LDH and CK, indicating that the carbohydrate-later intake strategy helped alleviate exercise-induced muscle injury. Metabolomic profiling of the HOT_PRO group showed marked increases in alanine, creatine, and flavin adenine dinucleotide (FAD), indicating shifts in amino acid metabolism and oxidative metabolism. Conversely, metabolites such as spermidine, cholesterol sulfate, cholesterol, and serine were significantly reduced in the HOT_PRO group, pointing to alterations in lipid and sterol metabolism. Further analysis of the differential metabolites revealed that these changes were primarily associated with key metabolic pathways, including glycine-serine-threonine metabolism, primary bile acid biosynthesis, taurine and hypotaurine metabolism, and steroid hormone biosynthesis. These pathways are essential for energy production, antioxidant defense, and muscle recovery, suggesting that the carbohydrate-later feeding strategy may promote metabolic homeostasis and improve exercise recovery by enhancing these critical metabolic processes.<b>Conclusion</b> The results of this study support the hypothesis that consuming carbohydrates after proteins and fats during exercise recovery enhances metabolic homeostasis and accelerates recovery under heat stress. This strategy effectively modulates energy, amino acid, and lipid-related pathways, which are crucial for improving endurance performance and mitigating fatigue in high-temperature environments. The findings suggest that carbohydrate-later intake could be a promising nutritional strategy for athletes and individuals exposed to heat during physical activity. Furthermore, the study provides valuable insights into how different nutrient timing strategies can impact exercise recovery and metabolic regulation, paving the way for more personalized and effective nutritional interventions in extreme environmental conditions.]]></description>
<pubDate>2025/6/12 9:32:01</pubDate>
<category><![CDATA[运动代谢效应与促健康机制研究专刊]]></category>
<author><![CDATA[QIU Jun,WANG Huan-Yu,WANG Ru,WANG Ru-Wen,ZHOU Guo-Dong]]></author>
</item>
<item>
<title><![CDATA[<b>Review:</b>Exercise-induced Mitohormesis in Counteracting Age-related Sarcopenia]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202505060000001]]></link>
<description><![CDATA[Sarcopenia, an age-related degenerative skeletal muscle disorder characterized by progressive loss of muscle mass, diminished strength, and impaired physical function, poses substantial challenges to global healthy aging initiatives. The pathogenesis of this condition is fundamentally rooted in mitochondrial dysfunction, manifested through defective energy metabolism, disrupted redox equilibrium, imbalanced dynamics, and compromised organelle quality control. This comprehensive review elucidates the central role of exercise-induced mitochondrial hormesis as a critical adaptive mechanism counteracting sarcopenia. Mitohormesis represents an evolutionarily conserved stress response wherein sublethal mitochondrial perturbations, particularly transient low-dose reactive oxygen species (ROS) generated during muscle contraction, activate cytoprotective signaling cascades rather than inflicting macromolecular damage. The mechanistic foundation of this process involves ROS functioning as essential signaling molecules that activate the Keap1 nuclear factor erythroid 2 related factor 2 (Nrf2) antioxidant response element pathway. This activation drives transcriptional upregulation of phase II detoxifying enzymes including superoxide dismutase (SOD) and glutathione peroxidase (GPx), thereby enhancing cellular redox buffering capacity. Crucially, Nrf2 engages in bidirectional molecular crosstalk with peroxisome proliferator activated receptor gamma coactivator 1 alpha (PGC-1α), the principal regulator orchestrating mitochondrial biogenesis through coordinated induction of nuclear respiratory factors 1 and 2 (NRF1/2) along with mitochondrial transcription factor A (Tfam), collectively facilitating mitochondrial DNA replication and respiratory complex assembly. Concurrently, exercise-induced alterations in cellular energy status, specifically diminished ATP to AMP ratios, potently activate AMP activated protein kinase (AMPK). This energy-sensing kinase phosphorylates PGC-1α while concomitantly stimulating NAD dependent deacetylase sirtuin 1 (SIRT1) activity, which further potentiates PGC-1α function through post-translational deacetylation. The integrated AMPK/PGC-1α/SIRT1 axis coordinates mitochondrial biogenesis, optimizes network architecture through regulation of fusion proteins mitofusin 1 (Mfn1), mitofusin 2 (Mfn2) and optic atrophy protein 1 (OPA1), and enhances clearance of damaged organelles via selective activation of mitophagy receptors BCL2 interacting protein 3 (Bnip1) and FUN14 domain containing 1 (FNDC1). Exercise further stimulates the mitochondrial unfolded protein response (UPRmt), increasing molecular chaperones such as heat shock protein 60 (HSP60) and HSP10 to preserve proteostasis. Within the mitochondrial matrix, SIRT3 fine-tunes metabolic flux through deacetylation of electron transport chain components, improving phosphorylation efficiency while attenuating pathological ROS emission. Distinct exercise modalities differentially engage these pathways. Aerobic endurance training primarily activates AMPK/PGC-1α signaling and UPRmt to expand mitochondrial volume and oxidative capacity. Resistance training exploits mechanical tension to acutely stimulate mechanistic target of rapamycin complex 1 (mTORC1) mediated protein synthesis while modulating dynamin related protein 1 (Drp1) phosphorylation dynamics to support mitochondrial network reorganization. High intensity interval training generates potent metabolic oscillations that rapidly amplify AMPK/PGC-1α and Nrf2 activation, demonstrating particular efficacy in insulin-resistant phenotypes. Strategically designed concurrent training regimens synergistically integrate these adaptations. Mitochondrial-nuclear communication through tricarboxylic acid cycle metabolites and mitochondrially derived peptides such as mitochondrial open reading frame of 12s rRNA-c (MOTS-c) coordinates systemic metabolic reprogramming, with exercise-responsive myokines including fibroblast growth factor 21 (FGF-21) mediating inter-tissue signaling to reduce inflammation and enhance insulin sensitivity. This integrated framework provides the scientific foundation for precision exercise interventions targeting mitochondrial pathophysiology in sarcopenia, incorporating biomarker monitoring and exploring pharmacological potentiators including nicotinamide riboside and MOTS-c mimetics. Future investigations should delineate temporal dynamics of mitohormesis signaling and epigenetic regulation to optimize therapeutic approaches for age-related muscle decline.]]></description>
<pubDate>2025/6/11 10:09:51</pubDate>
<category><![CDATA[运动代谢效应与促健康机制研究专刊]]></category>
<author><![CDATA[BO Hai,LIU Tao,MA Mei,ZHANG Yong,ZHANG Zi-Yi]]></author>
</item>
<item>
<title><![CDATA[Prediction of Protein Thermodynamic Stability Based on Artificial Intelligence]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202412250000002]]></link>
<description><![CDATA[In recent years, the application of artificial intelligence (AI) in the field of biology has witnessed remarkable advancements. Among these, the most notable achievements have emerged in the domain of protein structure prediction and design, with AlphaFold and related innovations earning the 2024 Nobel Prize in Chemistry. These breakthroughs have transformed our ability to understand protein folding and molecular interactions, marking a pivotal milestone in computational biology. Looking ahead, it is foreseeable that the accurate prediction of various physicochemical properties of proteins—beyond static structure—will become the next critical frontier in this rapidly evolving field. One of the most important protein properties is thermodynamic stability, which refers to a protein’s ability to maintain its native conformation under physiological or stress conditions. Accurate prediction of protein stability, especially upon single-point mutations, plays a vital role in numerous scientific and industrial domains. These include understanding the molecular basis of disease, rational drug design, development of therapeutic proteins, design of more robust industrial enzymes, and engineering of biosensors. Consequently, the ability to reliably forecast the stability changes caused by mutations has broad and transformative implications across biomedical and biotechnological applications. Historically, protein stability was assessed via experimental methods such as differential scanning calorimetry (DSC) and circular dichroism (CD), which, while precise, are time-consuming and resource-intensive. This prompted the development of computational approaches, including empirical energy functions and physics-based simulations. However, these traditional models often fall short in capturing the complex, high-dimensional nature of protein conformational landscapes and mutational effects. Recent advances in machine learning (ML) have significantly improved predictive performance in this area. Early ML models used handcrafted features derived from sequence and structure, whereas modern deep learning models leverage massive datasets and learn representations directly from data. Deep neural networks (DNNs), graph neural networks (GNNs), and attention-based architectures such as transformers have shown particular promise. GNNs, in particular, excel at modeling spatial and topological relationships in molecular structures, making them well-suited for protein modeling tasks. Furthermore, attention mechanisms enable models to dynamically weigh the contribution of specific residues or regions, capturing long-range interactions and allosteric effects. Nevertheless, several key challenges remain. These include the imbalance and scarcity of high-quality experimental datasets, particularly for rare or functionally significant mutations, which can lead to biased or overfitted models. Additionally, the inherently dynamic nature of proteins—their conformational flexibility and context-dependent behavior—is difficult to encode in static structural representations. Current models often rely on a single structure or average conformation, which may overlook important aspects of stability modulation. Efforts are ongoing to incorporate multi-conformational ensembles, molecular dynamics simulations, and physics-informed learning frameworks into predictive models. This paper presents a comprehensive review of the evolution of protein thermodynamic stability prediction techniques, with emphasis on the recent progress enabled by machine learning. It highlights representative datasets, modeling strategies, evaluation benchmarks, and the integration of structural and biochemical features. The aim is to provide researchers with a structured and up-to-date reference, guiding the development of more robust, generalizable, and interpretable models for predicting protein stability changes upon mutation. As the field moves forward, the synergy between data-driven AI methods and domain-specific biological knowledge will be key to unlocking deeper understanding and broader applications of protein engineering.]]></description>
<pubDate>2025/6/5 15:59:15</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[GUO Yu,LONG Jian-Gang,LU Zhuo-Yang,TAO Lin-Jie,XU Fan-Ding]]></author>
</item>
<item>
<title><![CDATA[<b>Review:</b>Molecular Mechanisms of Exercise in Promoting Health: a Multi-omics Analysis of Metabolic Biomarkers]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202504300000006]]></link>
<description><![CDATA[The molecular mechanisms underlying the health-promoting effects of exercise remain to be fully elucidated. As a bridge between genetics, exercise and phenotype, metabolites can be detected in high throughput through metabolomics, offering valuable insights into mechanism elucidation and disease prediction. Metabolic homeostasis is intricately regulated by various factors, including enzyme activity and transporters. Integration of multiple omics technologies such as genomics, transcriptomics, and proteomics enables the comprehensive elucidation of the metabolic network modulated by exercise interventions and facilitates the identification of key metabolic markers. This review summarizes the current research advancements, biological functions, discovery methods, and applications of exercise-induced multi omics metabolic markers, furnishing a theoretical foundation for understanding the mechanisms of exercise-induced health benefits and enabling precision interventions. Relevant literatures from 2000 to 2025 were systematically retrieved from databases including PubMed, CNKI and other databases with the keywords such as “multi-omics”, “metabolic biomarkers”, “exercise”, “health”. Subsequently, the identified literature was meticulously screened to meet the specified criteria and was subsequently incorporated into the study. (1) Exercise induces profound alterations in metabolite levels within the body, with particular emphasis on markers associated with sugar, lipid, and protein metabolism being extensively investigated. As an intensity marker, lactate is implicated in the regulation of fat browning (UCP-1), angiogenesis (VEGF), mitochondrial function (PGC-1α) and metabolic homeostasis (HIF-1α/CES2). Following resistance training, pyruvate levels increase, and an aberrant pyruvate to lactate ratio (approximately 10) may indicate mitochondrial dysfunction. Supplementation with pyruvate has been shown to reduce weight and lipid levels. Ketone bodies regulate metabolism by inhibiting lipolytic enzyme activity and promoting insulin secretion. Plasma ketone body concentrations rise after high-intensity exercise, with levels positively associated with central fatigue. Carnitine levels elevate post-endurance training, and supplementation with carnitine has been linked to increased lean body mass and enhanced cognitive function in older individuals. Serum alanine levels rise following resistance training and, as a precursor of carnosine, supplementation can elevate carnosine concentration by 80%, exerting antioxidant and neuroprotective effects. Creatine, a pivotal molecule in phosphogen energy supply, exhibits a 93% increase in plasma levels post-marathon, with its metabolism intricately related to AMPK activation. (2) Metabolites play a crucial role in disease prediction, particularly in the context of cardiovascular disease where 18 metabolites including glycoprotein acetyl and ketone bodies have been shown to enhance the performance of prediction models. Similarly, in diabetes research, acylcarnitine and other metabolites can improve prediction model efficacy. The combination of multiple metabolites has been found to substantially enhance predictive capabilities for various conditions such as cancer, aging, and other risks, surpassing the predictive power of traditional indicators. (3) Genomics investigations have unveiled the genetic underpinnings of exercise-related metabolites. VO<sub>2</sub>max, a significant exercise phenotype with heritability estimates ranging from 0.59 to 0.66, exhibits a negative correlation with the susceptibility to diabetes and cardiovascular disease. SNPs associated with VO<sub>2</sub>max, such as variants in the <i>FSHR</i> gene, are positively linked to serum creatinine levels. Reduced creatinine levels have been associated with an elevated risk of T2DM. These findings suggest that creatinine serves as a potential marker of exercise metabolism. (4) Transcriptomic studies have elucidated the molecular mechanisms by which exercise modulates metabolites. Acute exercise induces rapid alterations in the expression profiles of 9 132 transcripts. Exercise elicits upregulation of genes involved in the fructose/mannose metabolic pathway (such as <i>SORD</i>, <i>PFKFB3</i>), suggesting these metabolites may serve as pivotal mediators in the beneficial effects of exercise on Parkinson’s disease. Altitude training enhances the expression of the <i>PHOSPHO1</i> gene, which encodes an enzyme facilitating choline synthesis. Choline deficiency has been linked to insulin resistance. Choline supplementation has been shown to augment the effects of resistance training, underscoring the significance of choline as a key marker in exercise-mediated metabolic health promotion. (5) Proteomic analyses have unveiled the key mechanisms through which exercise modulates metabolism. Endurance training induces significant alterations in myofibrillar expression, with 237 slow muscles and 172 fast muscles proteins showing differential regulation, of which 65% are associated with metabolism, including ACSL1 and ECHS1. Various training modalities elicit distinct phosphorylation modifications, exemplified by the negative correlation between LDHA3 phosphorylation and lactate levels. Endurance training upregulates SLC25A15 expression in adipose tissue, enhancing arginine synthesis. The post-exercise elevation of plasma GPLD1 levels mimics the neuroprotective effects of exercise on the brain. These findings present novel targets for investigating exercise-related metabolic markers. The application of multi omics technologies has expedited the identification and mechanistic analysis of both established and novel sports-related metabolic markers like lactate. Integrated multi omics strategies (<i>e.g</i>., genome-metabolome) enable the simultaneous examination of metabolic markers and their regulatory mechanisms, facilitating the discovery of exercise-related genetic markers and pivotal regulatory proteins. However, challenges persist, including inadequate data integration and a lack of standardization. Future endeavors should focus on developing dynamic monitoring tools, integrating state-of-the-art approaches such as single-cell/spatial omics, and leveraging AI algorithms for optimized analysis to construct precise predictive models for maximizing health benefits in exercise.]]></description>
<pubDate>2025/6/5 15:34:15</pubDate>
<category><![CDATA[运动代谢效应与促健康机制研究专刊]]></category>
<author><![CDATA[LIU Yang,ZHANG Sai]]></author>
</item>
<item>
<title><![CDATA[<b>Research:</b>The Role and Mechanism of Aerobic Exercise in Enhancing Insulin Sensitivity by Reducing Circulating Glutamate]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202504270000002]]></link>
<description><![CDATA[<b>Objective</b> To explore the role and potential mechanism of circulating glutamate in enhancing insulin sensitivity by aerobic exercise. This research may provide a novel strategy for preventing metabolic diseases through precise exercise interventions.<b>Methods</b> To investigate the effects of elevated circulating glutamate on insulin sensitivity and its potential mechanisms, 18 male C57BL/6 mice aged 6 to 8 weeks were randomly divided into 3 groups: a control group (C), a group receiving 500 mg/kg glutamate supplementation (M), and a group receiving 1 000 mg/kg glutamate supplementation (H). The intervention lasted for 12 weeks, with treatments administered 6 d per week. Following the intervention, an insulin tolerance test (ITT) and a glucose tolerance test (GTT) were conducted. Circulating glutamate levels were measured using a commercial kit, and the activity of the skeletal muscle InsR/IRS1/PI3K/AKT signaling pathway was analyzed <i>via</i> Western blot. To further investigate the role of circulating glutamate in enhancing insulin sensitivity through aerobic exercise, 30 male C57BL/6 mice were randomly assigned to 3 groups: a control group (CS), an exercise intervention group (ES), and an exercise combined with glutamate supplementation group (EG). The ES group underwent treadmill-based aerobic exercise, while the EG group received glutamate supplementation at a dosage of 1 000 mg/kg in addition to aerobic exercise. The intervention lasted for 10 weeks, with sessions occurring 6 d per week, and the same procedures were followed afterward. To further elucidate the mechanism by which glutamate modulates the InsR/IRS1/PI3K/AKT signaling pathway, C2C12 myotubes were initially subjected to graded glutamate treatment (0, 0.5, 1, 3, 5, 10 mmol/L) to determine the optimal concentration for cellular intervention. Subsequently, the cells were divided into 3 groups: a control group (C), a glutamate intervention group (G), and a glutamate combined with MK801 (an NMDA receptor antagonist) intervention group (GK). The G group was treated with 5 mmol/L glutamate, while the GK group received 50 μmol/L MK801 in addition to 5 mmol/L glutamate. After 24 h of intervention, the activity of the InsR/IRS1/PI3K/AKT signaling pathway was analyzed using Western blot.<b>Results</b> Compared to the mice in group C, the circulating glutamate levels, the area under curve (<i>AUC</i>) of ITT, and the <i>AUC</i> of GTT in the mice of group H were significantly increased. Additionally, the expression levels of p-InsRβ, IRS1, p-AKT, and p-mTOR proteins in skeletal muscle were significantly downregulated. Compared to the mice in group CS, the circulating glutamate levels, the <i>AUC</i> of ITT, and the <i>AUC</i> of GTT in the mice of group ES were significantly reduced. Additionally, the expression levels of p-InsRβ, IRS1, p-AKT, and p-mTOR proteins in skeletal muscle of group ES mice were significantly upregulated. There were no significant changes observed in the mice of group EG. Compared to the cells in group 0 mmol/L, the expression levels of p-InsRβ, p-IRS1, p-PI3K, and p-AKT proteins in cells of group 5 mmol/L were significantly downregulated. Compared to the cells in group C, the expression levels of p-InsRβ, p-IRS1, p-PI3K, and p-AKT proteins in the cells of group G were significantly downregulated. No significant changes were observed in the cells of group GK.<b>Conclusion</b> Long-term aerobic exercise can improve insulin sensitivity by lowering circulating levels of glutamate. This effect may be associated with the upregulation of the InsR/IRS1/AKT signaling pathway activity in skeletal muscle. Furthermore, glutamate can weaken the activity of the InsR/IRS1/PI3K/AKT signaling pathway in skeletal muscle, potentially by binding to NMDAR expressed in skeletal muscle.]]></description>
<pubDate>2025/6/5 14:57:19</pubDate>
<category><![CDATA[运动代谢效应与促健康机制研究专刊]]></category>
<author><![CDATA[FAN Ruo-Bing,SUN Qin,WANG Huan-Yu,WANG Ru,XING Xiao-Rui]]></author>
</item>
<item>
<title><![CDATA[<b>Research:</b>Effects of Exercise Training on The Behaviors and HPA Axis in Autism Spectrum Disorder Rats Through The Gut Microbiota]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202503310000002]]></link>
<description><![CDATA[<b>Objective</b> The study explores the influence of voluntary wheel running on the behavioral abnormalities and the activation state of the hypothalamic-pituitary-adrenal (HPA) axis in autism spectrum disorder (ASD) rats through gut microbiota.<b>Methods</b> SD female rats were selected and administered either 400 mg/kg of valproic acid (VPA) solution or an equivalent volume of saline <i>via</i> intraperitoneal injection on day 12.5 of pregnancy. The resulting offspring were divided into 2 groups: the ASD model group (PASD, <i>n</i>=35) and the normal control group (PCON, <i>n</i>=16). Behavioral assessments, including the three-chamber social test, open field test, and Morris water maze, were conducted on postnatal day 23. After behavioral testing, 8 rats from each group (PCON, PASD) were randomly selected for serum analysis using enzyme-linked immunosorbent assay (ELISA) to measure corticotropin-releasing hormone (CRH), adrenocorticotropic hormone (ACTH), and corticosterone (CORT) concentration, to evaluate the functional state of the HPA axis in rats. On postnatal day 28, the remaining 8 rats in the PCON group were designated as the control group (CON, <i>n</i>=8), and the remaining 27 rats in the PASD group were randomly divided into 4 groups: ASD non-intervention group (ASD, <i>n</i>=6), ASD exercise group (ASDE, <i>n</i>=8), ASD fecal microbiota transplantation group (FMT, <i>n</i>=8), and ASD sham fecal microbiota transplantation group (sFMT, <i>n</i>=5). The rats in the ASD group and the CON group were kept under standard conditions, while the rats in the ASDE group performed 6 weeks of voluntary wheel running intervention starting on postnatal day 28. The rats in the FMT group were gavaged daily from postnatal day 42 with 1 ml/100 g fresh fecal suspension from ASDE rats which had undergone exercise for 2 weeks, 5 d per week, continuing for 4 weeks. The sFMT group received an equivalent volume of saline. After the interventions were completed, behavioral assessments and HPA axis markers were measured for all groups.<b>Results</b> Before the intervention, the ASD model group exhibited significantly reduced social ability, social novelty preference, spontaneous activity, and exploratory interest, as well as impaired spatial learning, memory, and navigation abilities compared to the normal control group (<i>P</i><0.05). Serum concentration of corticotropin-releasing hormone (CRH), adrenocorticotropic hormone (ACTH), and corticosterone (CORT) in the PASD group were significantly higher than those in the PCON group (<i>P</i><0.05). Following 6 weeks of voluntary wheel running, the ASDE group showed significant improvements in social ability, social novelty preference, spontaneous activity, exploratory interest, spatial learning, memory, and navigation skills compared to the ASD group (<i>P</i><0.05), with a significant decrease in serum CORT concentration (<i>P</i><0.05), and a downward trend in CRH and ACTH concentration. After 4 weeks of fecal microbiota transplantation in the exercise group, the FMT group showed marked improvements in social ability, social novelty preference, spontaneous activity, exploratory interest, as well as spatial learning, memory, and navigation abilities compared to both the ASD and sFMT groups (<i>P</i><0.05). In addition, serum ACTH and CORT concentration were significantly reduced (<i>P</i><0.05), and CRH concentration also showed a decreasing trend.<b>Conclusion</b> Exercise may improve ASD-related behaviors by suppressing the activation of the HPA axis, with the gut microbiota likely playing a crucial role in this process.]]></description>
<pubDate>2025/5/30 22:05:01</pubDate>
<category><![CDATA[运动代谢效应与促健康机制研究专刊]]></category>
<author><![CDATA[CHEN Xue-Mei,HOU Xiao-Hui,LI Yin-Hua,YANG Zhao-Ming,ZHONG Jiu-Gen]]></author>
</item>
<item>
<title><![CDATA[<b>Review:</b>Neuroplasticity Mechanisms of Exercise-induced Brain Protection]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202503310000004]]></link>
<description><![CDATA[Neuroscience is a significant frontier discipline within the natural sciences and has become an important interdisciplinary frontier scientific field. Brain is one of the most complex organs in the human body, and its structural and functional analysis is considered the “ultimate frontier” of human self-awareness and exploration of nature. Driven by the strategic layout of “China Brain Project”, Chinese scientists have conducted systematic research focusing on “understanding the brain, simulating the brain, and protecting the brain”. They have made breakthrough progress in areas such as the principles of brain cognition, mechanisms and interventions for brain diseases, brain-like computation, and applications of brain-machine intelligence technology, aiming to enhance brain health through biomedical technology and improve the quality of human life. Due to limited understanding and comprehension of neuroscience, there are still many important unresolved issues in the field of neuroscience, resulting in a lack of effective measures to prevent and protect brain health. Therefore, in addition to actively developing new generation drugs, exploring non pharmacological treatment strategies with better health benefits and higher safety is particularly important. Epidemiological data shows that, exercise is not only an indispensable part of daily life but also an important non-pharmacological approach for protecting brain health and preventing neurodegenerative diseases, forming an emerging research field known as motor neuroscience. Basic research in motor neuroscience primarily focuses on analyzing the dynamic coding mechanisms of neural circuits involved in motor control, breakthroughs in motor neuroscience research depend on the construction of dynamic monitoring systems across temporal and spatial scales. Therefore, high spatiotemporal resolution detection of movement processes and movement-induced changes in brain structure and neural activity signals is an important technical foundation for conducting motor neuroscience research and has developed a set of tools based on traditional neuroscience methods combined with novel motor behavior decoding technologies, providing an innovative technical platform for motor neuroscience research. The protective effect of exercise in neurodegenerative diseases provides broad application prospects for its clinical translation. Applied research in motor neuroscience centers on deciphering the regulatory networks of neuroprotective molecules mediated by exercise. From the perspectives of exercise promoting neurogenesis and regeneration, enhancing synaptic plasticity, modulating neuronal functional activity, and remodeling the molecular homeostasis of the neuronal microenvironment, it aims to improve cognitive function and reduce the incidence of Parkinson’s disease and Alzheimer’s disease. This has also advanced research into the molecular regulatory networks mediating exercise-induced neuroprotection and facilitated the clinical application and promotion of exercise rehabilitation strategies. Multidimensional analysis of exercise-regulated neural plasticity is the theoretical basis for elucidating the brain-protective mechanisms mediated by exercise and developing intervention strategies for neurological diseases. Thus,real-time analysis of different neural signals during active exercise is needed to study the health effects of exercise throughout the entire life cycle and enhance lifelong sports awareness. Therefore, this article will systematically summarize the innovative technological developments in motor neuroscience research, review the mechanisms of neural plasticity that exercise utilizes to protect the brain, and explore the role of exercise in the prevention and treatment of major neurodegenerative diseases. This aims to provide new ideas for future theoretical innovations and clinical applications in the field of exercise-induced brain protection.]]></description>
<pubDate>2025/5/30 16:32:29</pubDate>
<category><![CDATA[运动代谢效应与促健康机制研究专刊]]></category>
<author><![CDATA[CHEN Wei,HOU Li-Juan,LI Ke,MAO Lan-Qun,WANG Yin-Hao,WEI Tian-He,YANG Zi-Zheng,ZHAO Xu-Dong]]></author>
</item>
<item>
<title><![CDATA[The Role of Golgi Apparatus Homeostasis in Regulating Cell Death and Major Diseases]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202502100000002]]></link>
<description><![CDATA[The Golgi apparatus (GA) is a key membranous organelle in eukaryotic cells, acting as a central component of the endomembrane system. It plays an irreplaceable role in the processing, sorting, trafficking, and modification of proteins and lipids. Under normal conditions, the GA cooperates with other organelles, including the endoplasmic reticulum (ER), lysosomes, mitochondria, and others, to achieve the precise processing and targeted transport of nearly one-third of intracellular proteins, thereby ensuring normal cellular physiological functions and adaptability to environmental changes. This function relies on Golgi protein quality control (PQC) mechanisms, which recognize and handle misfolded or aberrantly modified proteins by retrograde transport to the ER, proteasomal degradation, or lysosomal clearance, thus preventing the accumulation of toxic proteins. In addition, Golgi-specific autophagy (Golgiphagy), as a selective autophagy mechanism, is also crucial for removing damaged or excess Golgi components and maintaining its structural and functional homeostasis. Under pathological conditions such as oxidative stress and infection, the Golgi apparatus suffers damage and stress, and its homeostatic regulatory network may be disrupted, leading to the accumulation of misfolded proteins, membrane disorganization, and trafficking dysfunction. When the capacity and function of the Golgi fail to meet cellular demands, cells activate a series of adaptive signaling pathways to alleviate Golgi stress and enhance Golgi function. This process reflects the dynamic regulation of Golgi capacity to meet physiological needs. To date, 7 signaling pathways related to the Golgi stress response have been identified in mammalian cells. Although these pathways have different mechanisms, they all help restore Golgi homeostasis and function and are vital for maintaining overall cellular homeostasis. It is noteworthy that the regulation of Golgi homeostasis is closely related to multiple programmed cell death pathways, including apoptosis, ferroptosis, and pyroptosis. Once Golgi function is disrupted, these signaling pathways may induce cell death, ultimately participating in the occurrence and progression of diseases. Studies have shown that Golgi homeostatic imbalance plays an important pathological role in various major diseases. For example, in Alzheimer’s disease (AD) and Parkinson’s disease (PD), Golgi fragmentation and dysfunction aggravate the abnormal processing of amyloid β-protein (Aβ) and Tau protein, promoting neuronal loss and advancing neurodegenerative processes. In cancer, Golgi homeostatic imbalance is closely associated with increased genomic instability, enhanced tumor cell proliferation, migration, invasion, and increased resistance to cell death, which are important factors in tumor initiation and progression. In infectious diseases, pathogens such as viruses and bacteria hijack the Golgi trafficking system to promote their replication while inducing host defensive cell death responses. This process is also a key mechanism in host-pathogen interactions. This review focuses on the role of the Golgi apparatus in cell death and major diseases, systematically summarizing the Golgi stress response, regulatory mechanisms, and the role of Golgi-specific autophagy in maintaining homeostasis. It emphasizes the signaling regulatory role of the Golgi apparatus in apoptosis, ferroptosis, and pyroptosis. By integrating the latest research progress, it further clarifies the pathological significance of Golgi homeostatic disruption in neurodegenerative diseases, cancer, and infectious diseases, and reveals its potential mechanisms in cellular signal regulation.]]></description>
<pubDate>2025/5/30 9:42:19</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHENG Xin-Yue,YAO Feng-Hua,YAO Yong-Ming,ZHANG Hui]]></author>
</item>
<item>
<title><![CDATA[<b>Review:</b>Intergenerational Effects on Metabolic Health: Perspectives on Maternal Nutrition and Exercise During Pregnancy]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202503300000003]]></link>
<description><![CDATA[With the increasing prevalence of overweight and obesity among children and adolescents in China, pediatric metabolic syndrome has emerged as a significant public health challenge. The Developmental Origins of Health and Disease (DOHaD) theory underscores the critical influence of early environmental factors on lifelong metabolic health. Consequently, maternal nutritional status and physical activity during pregnancy have become key modifiable factors that have attracted considerable attention in recent years. Research indicates exposure to a maternal high-fat diet (HFD) during pregnancy has long-term effects on offspring health, which may be transmitted through placental transit disorder, inflammation, and oxidative stress. Similarly, a high-protein diet (HPD) during pregnancy exhibits a dose- and time-dependent biphasic effect: excessive intake may lead to fetal growth restriction and an increased risk of preterm birth, whereas moderate supplementation may instead reduce the susceptibility of offspring to obesity. Interestingly, caloric restriction (CR) during pregnancy presents a double-edged sword: while it may impair the development of metabolic organs in offspring, moderate CR in metabolically compromised mothers can ameliorate maternal metabolic dysfunction and reprogram oocyte DNA methylation, significantly lowering the risk of metabolic disorders in offspring. Notably, metabolic abnormalities induced by a low-protein diet (LPD) during pregnancy demonstrate lifecycle-accumulative effects and transgenerational inheritance, with offspring exhibiting obesity phenotypes during weaning, insulin resistance in adulthood, and hepatic decompensation in old age, mediated through oocyte epigenetic reprogramming. Additionally, maintaining an optimal micronutrient balance is crucial for the metabolic homeostasis of offspring, as both deficiency and excess can lead to detrimental outcomes. Maternal exercise has been established as a safe and effective non-pharmacological intervention that confers multigenerational metabolic benefits through diverse biological pathways. Maternal metabolic dysregulation represents a critical determinant of offspring metabolic disorders. Regular exercise during gestation exerts protective effects by attenuating maternal systemic inflammation and reducing the incidence of pregnancy-related complications, thereby effectively mitigating fetal overgrowth and metabolic dysfunction. This dual benefit for both mother and offspring underscores the pivotal role of gestational physical activity in promoting long-term metabolic health. The placenta, serving as the exclusive interface for maternal-fetal communication, mediates exercise-induced metabolic programming through enhanced secretion of key regulatory factors (including SOD3, Apelin, ADPN, and Irisin) and promotes the development of vascular networks, collectively optimizing nutrient transport efficiency. The intrauterine period represents a crucial window for epigenetic reprogramming, during which maternal exercise modulates DNA methylation patterns of critical metabolic genes (<i>e.g</i>., <i>Ppargc-1α</i>, <i>Prdm16</i>, <i>Klf4</i>, and <i>Slc23a2</i>) in offspring, thereby enhancing their capacity to resist metabolic disorders. Notably, the regulatory effects of maternal exercise extend beyond the gestational period. Postnatally, exercise-induced modifications in the bioactive components of breast milk and gut microbiota composition contribute to the sustained maintenance of metabolic homeostasis in offspring, establishing a continuum of metabolic protection from prenatal to postnatal stages. This review explores the potential of maternal combined nutrition-exercise interventions, suggesting that such strategies may synergistically enhance transgenerational health benefits through interactions within the metabolic-epigenetic network, thereby outperforming single interventions. Additionally, it examines current research limitations, including controversies surrounding transgenerational mechanisms, sex-specific responses, and undefined dynamic thresholds, while providing directions for future investigations. These findings pave the way for a theoretical foundation for early-life health interventions, potentially offering a more effective strategy for combatting intergenerational metabolic disorders.]]></description>
<pubDate>2025/5/30 9:40:17</pubDate>
<category><![CDATA[运动代谢效应与促健康机制研究专刊]]></category>
<author><![CDATA[DUAN Rui,LI Jie,SHI Hai-Wang]]></author>
</item>
<item>
<title><![CDATA[rTMS Improves Cognitive Function and Brain Network Connectivity in Patients With Alzheimer’s Disease]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202501090000001]]></link>
<description><![CDATA[<b>Objective</b> Repetitive transcranial magnetic stimulation (rTMS) has demonstrated efficacy in enhancing neurocognitive performance in Alzheimer’s disease (AD), but the neurobiological mechanisms linking synaptic pathology, neural oscillatory dynamics, and brain network reorganization remain unclear. This investigation seeks to systematically evaluate the therapeutic potential of rTMS as a non-invasive neuromodulatory intervention through a multimodal framework integrating clinical assessments, molecular profiling, and neurophysiological monitoring.<b>Methods</b> In this prospective double-blind trial, 12 AD patients underwent a 14-day protocol of 20 Hz rTMS, with comprehensive multimodal assessments performed pre- and post-intervention. Cognitive functioning was quantified using the mini-mental state examination (MMSE) and Montreal cognitive assessment (MOCA), while daily living capacities and neuropsychiatric profiles were respectively evaluated through the activities of daily living (ADL) scale and combined neuropsychiatric inventory (NPI)-Hamilton depression rating scale (HAMD). Peripheral blood biomarkers, specifically Aβ1-40 and phosphorylated tau (p-tau181), were analyzed to investigate the effects of rTMS on molecular metabolism. Spectral power analysis was employed to investigate rTMS-induced modulations of neural rhythms in AD patients, while brain network analyses incorporating topological properties were conducted to examine stimulus-driven network reorganization. Furthermore, systematic assessment of correlations between cognitive scale scores, blood biomarkers, and network characteristics was performed to elucidate cross-modal therapeutic associations.<b>Results</b> Clinically, MMSE and MOCA scores improved significantly (<i>P</i><0.05). Biomarker showed that Aβ1-40 level increased (<i>P</i><0.05), contrasting with p-tau181 reduction (<i>P</i><0.05). Moreover, the levels of Aβ1-40 were positively correlated with MMSE and MOCA scores. Significant post-intervention alterations were observed in oscillatory power, with marked reductions in delta (<i>P</i><0.05) and theta bands (<i>P</i><0.05), contrasted by gamma band power elevation (<i>P</i><0.05). No significant changes were observed in alpha and beta band electroencephalogram (EEG) powers (<i>P</i>>0.05). Network analysis revealed frequency-specific reorganization: clustering coefficients were significantly enhanced in delta, theta, and alpha bands (<i>P</i><0.05), while global efficiency improvement was exclusively detected in the delta band (<i>P</i><0.05). The alpha band demonstrated concurrent increases in average nodal degree (<i>P</i><0.05) and characteristic path length reduction (<i>P</i><0.05). Further research findings indicate that the changes in the clinical scale HAMD scores before and after rTMS stimulation are negatively correlated with the changes in the blood biomarkers Aβ1-40 and p-tau181. Additionally, the changes in the clinical scales MMSE and MoCA scores are negatively correlated with the changes in the node degree of the alpha frequency band and negatively correlated with the clustering coefficient of the delta frequency band. However, the changes in MMSE scores are positively correlated with the changes in global efficiency of both the delta and alpha frequency bands.<b>Conclusion</b> 20 Hz rTMS targeting dorsolateral prefrontal cortex (DLPFC) significantly improves cognitive function and enhances the metabolic clearance of β-amyloid and tau proteins in AD patients. This neurotherapeutic effect is mechanistically associated with rTMS-mediated frequency-selective neuromodulation, which enhances the connectivity of oscillatory networks through improved neuronal synchronization and optimized topological organization of functional brain networks. These findings not only support the efficacy of rTMS as an adjunctive therapy for AD but also underscore the importance of employing multiple assessment methods—including clinical scales, blood biomarkers, and EEG——in understanding and monitoring the progression of AD. This research provides a significant theoretical foundation and empirical evidence for further exploration of rTMS applications in AD treatment.]]></description>
<pubDate>2025/5/28 20:58:28</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[GAO Jiao-Jiao,GUO Miao-Miao,JI Yong,LIU Lin,WANG Pan,WANG Tian,XU Gui-Zhi]]></author>
</item>
<item>
<title><![CDATA[<b>Review:</b>Comparative Analysis of Exercise-induced Transcriptomic Responses in Human and Mouse Homologous Genes: Divergence and Convergence Based on The GEPREP Database]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202505060000002]]></link>
<description><![CDATA[Exercise, as a non-pharmacological intervention, holds a pivotal role in metabolic regulation, neuroplasticity, and immune homeostasis maintenance. However, human exercise studies are constrained by ethical limitations in tissue sampling, especially for key organs such as muscles and the brain. Meanwhile, rodent models like mice exhibit physiological differences in exercise patterns and metabolic rates from human. Despite these challenges, approximately 70% of human and mouse genes are conserved, providing a molecular basis for cross-species comparisons. This paper leverages the GEPREP database, which integrates human and mouse exercise transcriptomic data from multiple platforms, to conduct a comprehensive cross-species analysis of exercise-induced gene expression patterns. We employ a stringent data standardization process, including the conversion of orthologous genes and the filtering of low-expressing genes, to ensure the accuracy and reliability of the analysis. A mixed-effects model is utilized to assess differential gene expression across multiple cohorts, identifying genes that are significantly upregulated or downregulated in response to exercise. The analysis reveals a complex pattern of gene expression, with a significant number of genes showing conserved responses between humans and mice, particularly in acute aerobic exercise, where genes such as <i>ATF3</i>, <i>PPARGC1A</i>, and <i>ANKRD1</i> are commonly upregulated. These genes are implicated in muscle stress response, metabolic regulation, and muscle adaptation, highlighting the shared molecular pathways activated by exercise across species. However, the study also uncovers substantial species-specific differences in gene expression, especially in chronic aerobic exercise, where the number of divergently regulated genes increases. These differences suggest that while some fundamental biological processes are conserved, the specific regulatory mechanisms and gene expression patterns can vary significantly between humans and mice. Functional enrichment analysis further reveals that conserved genes are involved in muscle development, inflammation regulation, and energy metabolism, while species-specific genes are associated with ion transport, extracellular matrix (ECM) organization, and muscle contraction, indicating the multifaceted impact of exercise on skeletal muscle function. The findings emphasize the importance of considering species-specific differences when interpreting results from animal models and translating them to human health applications. The study highlights the need for a more nuanced understanding of the molecular underpinnings of exercise-induced adaptations and underscores the value of cross-species comparative analyses in uncovering the evolutionary and functional basis of these responses. Future research should focus on integrating multi-omics data and expanding the analysis to include other tissues to provide a more comprehensive view of the systemic effects of exercise. Additionally, the development of species-specific gene editing models and the validation of key genes in exercise physiology will further enhance our understanding of the evolutionary logic behind exercise interventions. This study not only provides valuable insights into the molecular mechanisms of exercise-induced adaptations but also underscores the necessity of validating findings from animal models in human cohorts to ensure the reliability and applicability of translational research in exercise science. By addressing these aspects, the study aims to bridge the gap between basic research and clinical applications, ultimately contributing to the development of personalized exercise prescriptions and interventions that can effectively promote health and prevent diseases.]]></description>
<pubDate>2025/5/28 9:43:32</pubDate>
<category><![CDATA[运动代谢效应与促健康机制研究专刊]]></category>
<author><![CDATA[SUN Qian,TAO Wei-Chu,WANG Ru,XU Bing-Xiang]]></author>
</item>
<item>
<title><![CDATA[<b>Research:</b>4 Weeks of HIIT Modulates Metabolic Homeostasis of Hippocampal Pyruvate-lactate Axis in CUMS Rats Improving Their Depression-like Behavior]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202410290000001]]></link>
<description><![CDATA[<b>Objective</b> To investigate the role of 4-week high-intensity interval training (HIIT) in modulating the metabolic homeostasis of the pyruvate-lactate axis in the hippocampus of rats with chronic unpredictable mild stress (CUMS) to improve their depressive-like behavior.<b>Methods</b> Forty-eight SPF-grade 8-week-old male SD rats were randomly divided into 4 groups: the normal quiet group (C), the CUMS quiet group (M), the normal exercise group (HC), and the CUMS exercise group (HM). The M and HM groups received 8 weeks of CUMS modeling, while the HC and HM groups were exposed to 4 weeks of HIIT starting from the 5th week (3 min (85%-90%) <i>S</i><sub>max</sub>+1 min (50%-55%) <i>S</i><sub>max</sub>, 3-5 cycles, <i>S</i><sub>max</sub> is the maximum movement speed). A lactate analyzer was used to detect the blood lactate concentration in the quiet state of rats in the HC and HM groups at week 4 and in the 0, 2, 4, 8, 12, and 24 h after exercise, as well as in the quiet state of rats in each group at week 8. Behavioral indexes such as sucrose preference rate, number of times of uprightness and number of traversing frames in the absenteeism experiment, and other behavioral indexes were used to assess the depressive-like behavior of the rats at week 4 and week 8. The rats were anesthetized on the next day after the behavioral test in week 8, and hippocampal tissues were taken for assay. LC-MS non-targeted metabolomics, target quantification, ELISA and Western blot were used to detect the changes in metabolite content, lactate and pyruvate concentration, the content of key metabolic enzymes in the pyruvate-lactate axis, and the protein expression levels of monocarboxylate transporters (MCTs).<b>Results</b> 4-week HIIT intervention significantly increased the sucrose preference rate, the number of uprights and the number of traversed frames in the absent field experiment in CUMS rats; non-targeted metabolomics assay found that 21 metabolites were significantly changed in group M compared to group C, and 14 and 11 differential metabolites were significantly dialed back in the HC and HM groups, respectively, after the 4-week HIIT intervention; the quantitative results of the targeting showed that, compared to group C, lactate concentration in the hippocampal tissues of M group, compared with group C, lactate concentration in hippocampal tissue was significantly reduced and pyruvate concentration was significantly increased, and 4-week HIIT intervention significantly increased the concentration of lactate and pyruvate in hippocampal tissue of HM group; the trend of changes in blood lactate concentration was consistent with the change in lactate concentration in hippocampal tissue; compared with group C, the LDHB content of group M was significantly increased, the content of PKM2 and PDH, as well as the protein expression level of MCT2 and MCT4 were significantly reduced. The 4-week HIIT intervention upregulated the PKM2 and PDH content as well as the protein expression levels of MCT2 and MCT4 in the HM group.<b>Conclusion</b> The 4-week HIIT intervention upregulated blood lactate concentration and PKM2 and PDH metabolizing enzymes in hippocampal tissues of CUMS rats, and upregulated the expression of MCT2 and MCT4 transport carrier proteins to promote central lactate uptake and utilization, which regulated metabolic homeostasis of the pyruvate-lactate axis and improved depressive-like behaviors.]]></description>
<pubDate>2025/5/26 11:23:41</pubDate>
<category><![CDATA[运动代谢效应与促健康机制研究专刊]]></category>
<author><![CDATA[BAO Chun-Hui,HAN Yu-Mei,LIANG Jia-Ren,TIAN Jun-Sheng,WU Shuang-Shuang,XIANG Huan,ZHANG Zi-Wei,ZHOU Shi]]></author>
</item>
<item>
<title><![CDATA[<b>Review:</b>Exercise Modulates Protein Acylation to Improve Cardiovascular Diseases]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202409300000003]]></link>
<description><![CDATA[The pathogenesis of cardiovascular diseases (CVD) is complex, and dynamic imbalances in protein acylation modification are significantly associated with the development of CVD. In recent years, most studies on exercise-regulated protein acylation modifications to improve cardiovascular function have focused on acetylation and lactylation. Protein acylation modifications are usually affected by exercise intensity. High-intensity exercise directly affects oxidative stress and cellular energy supply, such as changes in ATP and NAD<sup>+</sup> levels; moderate-intensity exercise is often accompanied by improvements in aerobic metabolism, such as fatty acid β-oxidation and TCA cycle, which modulate mitochondrial biogenesis. The above processes may affect the acylation status of relevant regulatory enzymes and functional proteins, thereby altering their function and activity and triggering signaling cascades to adapt to exercise’s metabolic demands and stresses. Exercise regulates the levels of acylation modifications of H3K9, H3K14, H3K18, and H3K23, which are involved in regulating the transcriptional expression of genes involved in oxidative stress, glycolysis, inflammation, and hypertrophic response by altering chromatin structure and function. Exercise can regulate the acylation modification of non-histone-specific sites in the cardiovascular system involved in mitochondrial function, glycolipid metabolism, fibrosis, protein synthesis, and other biological processes, and participates in the regulation of protein activity and function by altering the stability, localization, and interaction of proteins, and ultimately works together to achieve the improvement of cardiovascular phenotypes and biological functions. Exercise affects acyl donor concentration, acyltransferase, and deacetylase expression and activity by influencing acyl donor concentration, acyltransferase, and deacetylase. Exercise regulates the abundance of acyl donors such as acetyl coenzyme A, propionyl coenzyme A, butyryl coenzyme A, succinyl coenzyme A, and lactoyl coenzyme A by promoting glucose and lipid metabolism and improving intestinal bacterial flora, which in turn affects protein acylation modification, accelerates oxidative decarboxylation of pyruvic acid in the body, and activates the energy-sensing molecule, adenosine monophosphate-activated protein kinase (AMPK), to improve cardiovascular function. Exercise may affect protein acylation modifications in the cardiovascular system by regulating the activity and expression of adenoviral E1A binding protein of 300 kDa (p300)/cyclic adenosine monophosphate response element-binding protein (CBP), general control nonderepressible 5-related N-acetyltransferases (GNAT), and alanyl-transfer t-RNA synthetase (AARS), which in turn improves cardiovascular function. The relationship between exercise and cardiovascular deacetylases has attracted much attention, with SIRT1 and SIRT3 of the silence information regulator (SIRT) family of proteins being the most studied. Exercise may exert transient or long-term stable cardiovascular protective benefits by promoting the enzymatic activity and expression of SIRT1, SIRT3, and HDAC2, inhibiting the enzymatic activity and expression of HDAC4, and mediating the deacylation of metabolic regulation-related enzymes, cytokines, and molecules of signaling pathways. This review introduces the role of protein acylation modification on CVD and the effect of exercise-mediated protein acylation modification on CVD. Based on the existing studies, it analyzes the possible mechanisms of exercise-regulated protein acylation modification to improve CVD from the perspectives of acylation modification donors, acyltransferases, and deacetylases. Deciphering the regulation of cardiovascular protein acylation and modification by exercise and exploring the essential clues to improve cardiovascular disease can enrich the theoretical basis for exercise to promote cardiovascular health. However, it is also significant for developing new cardiovascular disease prevention and treatment targets.]]></description>
<pubDate>2025/5/26 11:15:17</pubDate>
<category><![CDATA[运动代谢效应与促健康机制研究专刊]]></category>
<author><![CDATA[HUANG Wen-Hua,LI Feng-Yi,ZHANG Jing]]></author>
</item>
<item>
<title><![CDATA[The Regulatory Mechanisms of Dopamine Homeostasis in Behavioral Functions Under Microgravity]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202504080000002]]></link>
<description><![CDATA[As China accelerates its efforts in deep space exploration and long-duration space missions, including the operationalization of the Tiangong Space Station and the development of manned lunar missions, safeguarding astronauts’ physiological and cognitive functions under extreme space conditions becomes a pressing scientific imperative. Among the multifactorial stressors of spaceflight, microgravity emerges as a particularly potent disruptor of neurobehavioral homeostasis. Dopamine (DA) plays a central role in regulating behavior under space microgravity by influencing reward processing, motivation, executive function and sensorimotor integration. Changes in gravity disrupt dopaminergic signaling at multiple levels, leading to impairments in motor coordination, cognitive flexibility, and emotional stability. Microgravity exposure induces a cascade of neurobiological changes that challenge dopaminergic stability at multiple levels: from the transcriptional regulation of DA synthesis enzymes and the excitability of DA neurons, to receptor distribution dynamics and the efficiency of downstream signaling pathways. These changes involve downregulation of tyrosine hydroxylase in the substantia nigra, reduced phosphorylation of DA receptors, and alterations in vesicular monoamine transporter expression, all of which compromise synaptic DA availability. Experimental findings from space analog studies and simulated microgravity models suggest that gravitational unloading alters striatal and mesocorticolimbic DA circuitry, resulting in diminished motor coordination, impaired vestibular compensation, and decreased cognitive flexibility. These alterations not only compromise astronauts’ operational performance but also elevate the risk of mood disturbances and motivational deficits during prolonged missions. The review systematically synthesizes current findings across multiple domains: molecular neurobiology, behavioral neuroscience, and gravitational physiology. It highlights that maintaining DA homeostasis is pivotal in preserving neuroplasticity, particularly within brain regions critical to adaptation, such as the basal ganglia, prefrontal cortex, and cerebellum. The paper also discusses the dual-edged nature of DA plasticity: while adaptive remodeling of synapses and receptor sensitivity can serve as compensatory mechanisms under stress, chronic dopaminergic imbalance may lead to maladaptive outcomes, such as cognitive rigidity and motor dysregulation. Furthermore, we propose a conceptual framework that integrates homeostatic neuroregulation with the demands of space environmental adaptation. By drawing from interdisciplinary research, the review underscores the potential of multiple intervention strategies including pharmacological treatment, nutritional support, neural stimulation techniques, and most importantly, structured physical exercise. Recent rodent studies demonstrate that treadmill exercise upregulates DA transporter expression in the dorsal striatum, enhances tyrosine hydroxylase activity, and increases DA release during cognitive tasks, indicating both protective and restorative effects on dopaminergic networks. Thus, exercise is highlighted as a key approach because of its sustained effects on DA production, receptor function, and brain plasticity, making it a strong candidate for developing effective measures to support astronauts in maintaining cognitive and emotional stability during space missions. In conclusion, the paper not only underscores the centrality of DA homeostasis in space neuroscience but also reflects the authors’ broader academic viewpoint: understanding the neurochemical substrates of behavior under microgravity is fundamental to both space health and terrestrial neuroscience. By bridging basic neurobiology with applied space medicine, this work contributes to the emerging field of gravitational neurobiology and provides a foundation for future research into individualized performance optimization in extreme environments.]]></description>
<pubDate>2025/5/22 15:38:00</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HOU Li-Juan,LI Ke,LIU Ran,MAO Lan-Qun,WANG Hua-Lin,YANG Xin,ZHAO Xu-Dong]]></author>
</item>
<item>
<title><![CDATA[<b>Research:</b>Mechanism of Aerobic Exercise in Delaying Brain Aging in Aging Mice by Regulating Tryptophan Metabolism]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202504210000002]]></link>
<description><![CDATA[<b>Objective</b> To explore the molecular mechanism of aerobic exercise to improve hippocampal neuronal degeneration by regulating tryptophan metabolic pathway.<b>Methods</b> 60 SPF-grade C57BL/6J male mice were divided into a young group (2 months old, <i>n</i>=30) and a senile group (12 months old, <i>n</i>=30), and each group was further divided into a control group (C/A group, <i>n</i>=15) and an exercise group (CE/AE group, <i>n</i>=15). An aerobic exercise program was used for 8 weeks. Learning memory ability was assessed by Y-maze, and anxiety-depression-like behavior was detected by absent field experiment. Hippocampal Trp levels were measured by GC-MS. Nissl staining was used to observe the number and morphology of hippocampal neurons, and electron microscopy was used to detect synaptic ultrastructure. ELISA was used to detect the levels of hippocampal Trp, 5-HT, Kyn, KATs, KYNA, KMO, and QUIN; Western blot was used to analyze the activities of TPH2, IDO1, and TDO enzymes.<b>Results</b> Group A mice showed significant decrease in learning and memory ability (<i>P</i><0.05) and increase in anxiety and depressive behaviors (<i>P</i><0.05); all of AE group showed significant improvement (<i>P</i><0.05). Hippocampal Trp levels decreased in group A (<i>P</i><0.05) and increased in AE group (<i>P</i><0.05). Nidus vesicles were reduced and synaptic structures were degraded in group A (<i>P</i><0.05), and both were significantly improved in group AE (<i>P</i><0.05). The levels of Trp, 5-HT, KATs, and KYNA were decreased (<i>P</i><0.05) and the levels of Kyn, KMO, and QUIN were increased (<i>P</i><0.05) in group A. The activity of TPH2 was decreased (<i>P</i><0.05), and the activities of IDO1 and TDO were increased (<i>P</i><0.05). The AE group showed the opposite trend.<b>Conclusion</b> The aging process significantly reduces the learning memory ability and increases the anxiety-depression-like behavior of mice, and leads to the reduction of the number of nidus vesicles and degenerative changes of synaptic structure in the hippocampus, whereas aerobic exercise not only effectively enhances the spatial learning memory ability and alleviates the anxiety-depression-like behavior of aging mice, but also improves the morphology and structure of neurons in hippocampal area, which may be achieved by the mechanism of regulating the tryptophan metabolic pathway.]]></description>
<pubDate>2025/5/22 14:33:39</pubDate>
<category><![CDATA[运动代谢效应与促健康机制研究专刊]]></category>
<author><![CDATA[HUANG Xiao-Han,JIN Yu,LI Xue,WEI Chang-Ling,ZHANG De-Man,ZHANG Yuan-Ting,ZHENG Min-Yan]]></author>
</item>
<item>
<title><![CDATA[Analysis of The Characteristics of Brain Functional Activity in Gross Motor Tasks in Children With Autism Based on Functional Near-infrared Spectroscopy Technology]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202504160000002]]></link>
<description><![CDATA[<b>Objective</b> Based on functional near-infrared spectroscopy (fNIRS), we investigated the brain activity characteristics of gross motor tasks in children with autism spectrum disorder (ASD) and motor dysfunctions (MDs) to provide a theoretical basis for further understanding the mechanism of MDs in children with ASD and designing targeted intervention programs from a central perspective.<b>Methods</b> According to the inclusion and exclusion criteria, 48 children with ASD accompanied by MDs were recruited into the ASD group and 40 children with typically developing (TD) into the TD group. The fNIRS device was used to collect the information of blood oxygen changes in the cortical motor-related brain regions during single-handed bag throwing and tiptoe walking, and the differences in brain activation and functional connectivity between the two groups of children were analyzed from the perspective of brain activation and functional connectivity.<b>Results</b> Compared to the TD group, in the object manipulative motor task (one-handed bag throwing), the ASD group showed significantly reduced activation in both left sensorimotor cortex (SMC) and right secondary visual cortex (V2) (<i>P</i><0.05), whereas the right pre-motor and supplementary motor cortex (PMC&SMA) had significantly higher activation (<i>P</i><0.01) and showed bilateral brain region activity; in terms of brain functional integration, there was a significant decrease in the strength of brain functional connectivity (<i>P</i><0.05) and was mainly associated with dorsolateral prefrontal cortex (DLPFC) and V2. In the body stability motor task (tiptoe walking), the ASD group had significantly higher activation in motor-related brain regions such as the DLPFC, SMC, and PMC&SMA (<i>P</i><0.05) and showed bilateral brain region activity; in terms of brain functional integration, the ASD group had lower strength of brain functional connectivity (<i>P</i><0.05) and was mainly associated with PMC&SMA and V2.<b>Conclusion</b> Children with ASD exhibit abnormal brain functional activity characteristics specific to different gross motor tasks in object manipulative and body stability, reflecting insufficient or excessive compensatory activation of local brain regions and impaired cross-regions integration, which may be a potential reason for the poorer gross motor performance of children with ASD, and meanwhile provides data support for further unraveling the mechanisms underlying the occurrence of MDs in the context of ASD and designing targeted intervention programs from a central perspective.]]></description>
<pubDate>2025/5/22 13:37:22</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[DONG Gui-Jun,LEI Hong,LI Ke-Feng,LIANG Qi,WANG Feng-Jiao,WEI Meng-Zhao,YANG Shi-Yu,ZONG Wen-Hao]]></author>
</item>
<item>
<title><![CDATA[The Near-infraredII Emission of Gold Clusters and Their Applications in Biomedicine]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202503230000001]]></link>
<description><![CDATA[Optical imaging is highly valued for its superior temporal and spatial resolution. This is particularly important in near-infrared II (NIR-II, 1 000-3 000 nm) imaging, which offers advantages such as reduced tissue absorption, minimal scattering, and low autofluorescence. These characteristics make NIR-II imaging especially suitable for deep tissue visualization, where high contrast and minimal background interference are critical for accurate diagnosis and monitoring. Currently, inorganic fluorescent probes—such as carbon nanotubes, rare earth nanoparticles, and quantum dots—offer high brightness and stability. However, they are hindered by ambiguous structures, larger sizes, and potential accumulation toxicity <i>in vivo</i>. In contrast, organic fluorescent probes, including small molecules and polymers, demonstrate higher biocompatibility but are limited by shorter emission wavelengths, lower quantum yields, and reduced stability. Recently, gold clusters have emerged as a promising class of nanomaterials with potential applications in biocatalysis, fluorescence sensing, biological imaging, and more. Water-soluble gold clusters are particularly attractive as fluorescent probes due to their remarkable optical properties, including strong photoluminescence, large Stokes shifts, and excellent photostability. Furthermore, their outstanding biocompatibility—attributed to good aqueous stability, ultra-small hydrodynamic size, and high renal clearance efficiency—makes them especially suitable for biomedical applications. Gold clusters hold significant potential for NIR-II fluorescence imaging. Atomic-precision gold clusters, typically composed of tens to hundreds of gold atoms and measuring only a few nanometers in diameter, possess well-defined three-dimensional structures and clear spatial coordination. This atomic-level precision enables fine-tuned structural regulation, further enhancing their fluorescence properties. Variations in cluster size, surface ligands, and alloying elements can result in distinct physicochemical characteristics. The incorporation of different atoms can modulate the atomic and electronic structures of gold clusters, while diverse ligands can influence surface polarity and steric hindrance. As such, strategies like alloying and ligand engineering are effective in enhancing both fluorescence and catalytic performance, thereby meeting a broader range of clinical needs. In recent years, gold clusters have attracted growing attention in the biomedical field. Their application in NIR-II imaging has led to significant progress in vascular, organ, and tumor imaging. The resulting high-resolution, high signal-to-noise imaging provides powerful tools for clinical diagnostics. Moreover, biologically active gold clusters can aid in drug delivery and disease diagnosis and treatment, offering new opportunities for clinical therapeutics. Despite the notable achievements in fundamental research and clinical translation, further studies are required to address challenges related to the standardized synthesis and complex metabolic behavior of gold clusters. Resolving these issues will help accelerate their clinical adoption and broaden their biomedical applications.]]></description>
<pubDate>2025/5/21 7:16:57</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LI Zhen-Hua,LIU Chang-Long,MA Hui-Zhen,WANG Hao,ZHANG Xiao-Dong]]></author>
</item>
<item>
<title><![CDATA[Fast Object Perception in The Subcortical Pathway: a Commentary on Wang <i>et al</i>.’s Paper in <i>Human Brain Mapping </i>(2023)]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202502200000001]]></link>
<description><![CDATA[The subcortical visual pathway is generally thought to be involved in dangerous information processing, such as fear processing and defensive behavior. A recent study, published in <i>Human Brain Mapping</i>, shows a new function of the subcortical pathway involved in the fast processing of non-emotional object perception. Rapid object processing is a critical function of visual system. Topological perception theory proposes that the initial perception of objects begins with the extraction of topological property (TP). However, the mechanism of rapid TP processing remains unclear. The researchers investigated the subcortical mechanism of TP processing with transcranial magnetic stimulation (TMS). They find that a subcortical magnocellular pathway is responsible for the early processing of TP, and this subcortical processing of TP accelerates object recognition. Based on their findings, we propose a novel training approach called subcortical magnocellular pathway training (SMPT), aimed at improving the efficiency of the subcortical M pathway to restore visual and attentional functions in disorders associated with subcortical pathway dysfunction.]]></description>
<pubDate>2025/5/19 14:18:10</pubDate>
<category><![CDATA[动态与评论]]></category>
<author><![CDATA[HU Li-Ping,MA Hao-Yun,WEI Yu-Yin]]></author>
</item>
<item>
<title><![CDATA[A New Risk of Cardiovascular Disease —— Micro-nanoplastics]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202502090000003]]></link>
<description><![CDATA[In recent years, with the large-scale use of plastic products, the degree of plastic pollution has increased, becoming a serious global problem. Microplastics and nanoplastics (MNPs), as emerging environmental pollutants, are widely found in organisms and the environment. These plastic particles enter the human body through 3 exposure pathways: breathing, the food chain’s bioaccumulation and transfer, and skin contact, thereby exerting toxic effects. The physical attributes of MNPs, including their shape, size, and surface characteristics, are not static but rather undergo dynamic transformations in response to changing environmental conditions. These changes can significantly influence their behavior and interactions within different ecosystems. When considering MNPs as carriers of chemicals, two primary mechanisms can be distinguished. (1) MNPs have the capacity to adsorb pollutants from their surrounding environment. These pollutants may encompass a wide range of substances, such as heavy metals, organic compounds, and other contaminants that are commonly found in water, soil, or air. (2) MNPs may also carry chemical agents that are artificially introduced during their commercial production process. For example, flame retardants and pigments are often added to plastics to enhance their performance or appearance. These artificially added chemicals can remain associated with MNPs throughout their lifecycle and may contribute to their overall toxicological impact. Cardiovascular diseases (CVDs) are a general term for diseases of the heart, arteries, veins, and capillaries, and are one of the main causes of disability and death. CVDs have higher incidence, mortality, and recurrence rates, and more complications, which reduce the quality of life and happiness of patients, the phenomenon is gradually showing a trend of early onset, therefore early-stage prevention for CVDs is of critical importance. This article reviews the properties of MNPs and their potential threats to the cardiovascular system, aiming to explore how MNPs cause CVDs through certain physiological effects, toxicity mechanisms, and related pathways. Our review primarily focus on elucidating several critical mechanisms through which MNPs exert their adverse effects. Specifically, the review examines how the enhancement of oxidative stress can trigger the expression of pro-inflammatory factors, which in turn leads to the formation of a chronic inflammatory microenvironment within biological systems. Additionally, MNPs possess the capacity to adsorb toxic metals and organic substances from their surroundings. Furthermore, the review summarizes that sewage irrigation and atmospheric deposition are significant factors contributing to the co-pollution of heavy metals with MNPs in environmental settings. The interaction between heavy metals and MNPs has been shown to have detrimental effects on agricultural productivity, as it can inhibit crop growth and simultaneously increase the absorption rate of heavy metals in plants. When these contaminated plants enter the food chain, the accumulated heavy metals can ultimately be ingested by humans. This process poses a potential risk for inducing acute coronary syndrome and other CVDs, thereby underscoring the importance of understanding and mitigating the impact of MNPs on human health. In addition, our review also gives examples of the long-term effects of MNPs on cardiovascular function and the adverse consequences such as arrhythmia and atherosclerosis, the limitations of the current studies of MNPs affecting cardiovascular system health and future directions are also explored.]]></description>
<pubDate>2025/5/19 12:44:59</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Zhong,GAO Fan,YANG Ming]]></author>
</item>
<item>
<title><![CDATA[Immunotherapy for Lung Cancer]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202501200000001]]></link>
<description><![CDATA[Lung cancer is the most common malignant tumor worldwide, ranking first in both incidence and mortality rates. According to the latest statistics from the International Agency for Research on Cancer (IARC), approximately 2.5 million new cases and around 1.8 million deaths from lung cancer occurred in 2022, placing a tremendous burden on global healthcare systems. The high mortality rate of lung cancer is closely linked to its subtle early symptoms, which often lead to diagnosis at advanced stages. This not only complicates treatment but also results in substantial economic losses. Current treatment options for lung cancer include surgery, radiotherapy, chemotherapy, targeted drug therapy, and immunotherapy. Among these, immunotherapy has emerged as the most groundbreaking advancement in recent years, owing to its unique antitumor mechanisms and impressive clinical benefits. Unlike traditional therapies such as radiotherapy and chemotherapy, immunotherapy activates or enhances the patient’s immune system to recognize and eliminate tumor cells. It offers advantages such as more durable therapeutic effects and relatively fewer toxic side effects. The main approaches to lung cancer immunotherapy include immune checkpoint inhibitors, tumor-specific antigen-targeted therapies, adoptive cell therapies, cancer vaccines, and oncolytic virus therapies. Among these, immune checkpoint inhibitors and tumor-specific antigen-targeted therapies have received approval from the U.S. Food and Drug Administration (FDA) for clinical use in lung cancer, significantly improving outcomes for patients with advanced non-small cell lung cancer. Although other immunotherapy strategies are still in clinical trials, they show great potential in improving treatment precision and efficacy. This article systematically reviews the latest research progress in lung cancer immunotherapy, including the development of novel immune checkpoint molecules, optimization of treatment strategies, identification of predictive biomarkers, and findings from recent clinical trials. It also discusses the current challenges in the field and outlines future directions, such as the development of next-generation immunotherapeutic agents, exploration of more effective combination regimens, and the establishment of precise efficacy prediction systems. The aim is to provide a valuable reference for the continued advancement of lung cancer immunotherapy.]]></description>
<pubDate>2025/5/18 10:40:11</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HOU Xiao-Jun,LI Feng-Qi,LI Pei-Yang,LI Xue-Ren,LIU Hui-Min,MU Xin,PENG Shou-Chun]]></author>
</item>
<item>
<title><![CDATA[Tumor Microenvironment Polyamines Inhibit T Cell Antitumor Activity]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202501150000001]]></link>
<description><![CDATA[Tumor immunotherapy has emerged as the fourth major therapeutic modality, following surgery, radiotherapy, and chemotherapy. Unlike traditional treatments that primarily target tumor cells directly, immunotherapy harnesses the body’s immune system to recognize and eliminate cancer cells. Over the past decade, various immunotherapeutic strategies have been developed, including immune checkpoint inhibitors (ICIs), chimeric antigen receptor (CAR) T cell therapy, cancer vaccines, and cytokine-based therapies. However, the immunosuppressive tumor microenvironment (TME) poses a significant obstacle to the effectiveness of these treatments. Polyamines—including putrescine, spermidine, and spermine—are polycationic metabolites that often accumulate abnormally in the TME and act as critical immunoregulatory molecules. T cells play a central role in antitumor immunity, yet their function is frequently influenced by immunoregulatory factors within the TME. Elevated polyamine levels in the TME have been implicated in dampening antitumor T cell responses, thereby facilitating tumor immune evasion. Polyamines in the TME originate from both tumor cells and tumor-associated immune cells. Tumor cells often overexpress the oncogene <i>Myc</i>, which drives the upregulation of polyamine biosynthetic enzymes, resulting in excessive intracellular polyamine production. Additionally, M2-polarized tumor-associated macrophages (M2-TAMs) contribute to polyamine accumulation by upregulating arginase-I (Arg-I), an enzyme that catalyzes the conversion of arginine into ornithine—a key precursor in the polyamine biosynthetic pathway. These combined sources lead to sustained polyamine enrichment in the TME, contributing to immune dysfunction and supporting tumor progression. Moreover, polyamines indirectly affect T cell activity by modulating macrophage polarization and directly suppress tumor cell apoptosis, further promoting an immunosuppressive environment. This review highlights the multifaceted roles of polyamines in modulating tumor-infiltrating T cell function, with a particular focus on their influence on CD4+ T cell differentiation, CD8+ T cell cytotoxicity, and immune checkpoint molecule expression. Recent studies suggest that polyamines suppress CD4+ T cell activation and differentiation by modulating the MAPK/ERK signaling pathway. Additionally, polyamines can impair T cell receptor (TCR) signaling and promote immune evasion through the upregulation of PD-L1 expression on tumor cells. These effects collectively contribute to weakened antitumor T cell responses. Polyamine blocking therapy (PBT), which primarily targets polyamine biosynthesis and transport, has emerged as a novel adjunctive immunotherapeutic strategy in cancer treatment. By reducing polyamine levels in the TME, PBT restores T cell effector functions and alleviates immunosuppression. Notably, studies have demonstrated that combining PBT with ICIs produces synergistic antitumor effects and may overcome resistance to ICI monotherapy. Although research has revealed the inhibitory effects of polyamines on T cell immune function, the underlying regulatory mechanisms remain to be fully elucidated. Moreover, due to compensatory mechanisms employed by tumor cells to maintain polyamine homeostasis, multi-targeted approaches may be necessary to achieve safe and effective therapeutic outcomes. Future PBT strategies may benefit from the integration of multi-omics technologies and the development of nanocarrier-based drug delivery systems, which could collectively enhance their specificity, efficacy, and applicability in cancer immunotherapy. This review systematically elucidates the immunomodulatory effects of polyamines on T cell function within the TME and provides theoretical support and novel insights for the advancement of tumor immunotherapeutic strategies.]]></description>
<pubDate>2025/5/15 10:41:55</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[AI Yuan-Bao,HUANG Xue-Mei,LIU Sen]]></author>
</item>
<item>
<title><![CDATA[<b>Review:</b>Regulation of Immune Function by Exercise-induced Metabolic Remodeling]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202504100000002]]></link>
<description><![CDATA[Exercise-induced metabolic remodeling is a fundamental adaptive process whereby the body reorganizes systemic and cellular metabolism to meet the dynamic energy demands posed by physical activity. Emerging evidence reveals that such remodeling not only enhances energy homeostasis but also profoundly influences immune function through complex molecular interactions involving glucose, lipid, and protein metabolism. This review presents an in-depth synthesis of recent advances, elucidating how exercise modulates immune regulation <i>via</i> metabolic reprogramming, highlighting key molecular mechanisms, immune-metabolic signaling axes, and the authors’ academic perspective on the integrated “exercise-metabolism-immunity” network. In the domain of glucose metabolism, regular exercise improves insulin sensitivity and reduces hyperglycemia, thereby attenuating glucose toxicity-induced immune dysfunction. It suppresses the formation of advanced glycation end-products (AGEs) and interrupts the AGEs-RAGE-inflammation positive feedback loop in innate and adaptive immune cells. Importantly, exercise-induced lactate, traditionally viewed as a metabolic byproduct, is now recognized as an active immunomodulatory molecule. At high concentrations, lactate can suppress immune function through pH-mediated effects and GPR81 receptor activation. At physiological levels, it supports regulatory T cell survival, promotes macrophage M2 polarization, and modulates gene expression <i>via</i> histone lactylation. Additionally, key metabolic regulators such as AMPK and mTOR coordinate immune cell energy balance and phenotype; exercise activates the AMPK-mTOR axis to favor anti-inflammatory immune cell profiles. Simultaneously, hypoxia-inducible factor-1α (HIF-1α) is transiently activated during exercise, driving glycolytic reprogramming in T cells and macrophages, and shaping the immune landscape. In lipid metabolism, exercise alleviates adipose tissue inflammation by reducing fat mass and reshaping the immune microenvironment. It promotes the polarization of adipose tissue macrophages from a pro-inflammatory M1 phenotype to an anti-inflammatory M2 phenotype. Moreover, exercise alters the secretion profile of adipokines—raising adiponectin levels while reducing leptin and resistin—thereby influencing systemic immune balance. At the circulatory level, exercise improves lipid profiles by lowering pro-inflammatory free fatty acids (particularly saturated fatty acids) and triglycerides, while enhancing high-density lipoprotein (HDL) function, which has immunoregulatory properties such as endotoxin neutralization and macrophage cholesterol efflux. Regarding protein metabolism, exercise triggers the expression of heat shock proteins (HSPs) that act as intracellular chaperones and extracellular immune signals. Exercise also promotes the secretion of myokines (<i>e.g</i>., IL-6, IL-15, irisin, FGF21) from skeletal muscle, which modulate immune responses, facilitate T cell and macrophage function, and support immunological memory. Furthermore, exercise reshapes amino acid metabolism, particularly of glutamine, arginine, and branched-chain amino acids (BCAAs), thereby influencing immune cell proliferation, biosynthesis, and signaling. Leucine-mTORC1 signaling plays a key role in T cell fate, while arginine metabolism governs macrophage polarization and T cell activation. In summary, this review underscores the complex, bidirectional relationship between exercise and immune function, orchestrated through metabolic remodeling. Future research should focus on causative links among specific metabolites, signaling pathways, and immune phenotypes, as well as explore the epigenetic consequences of exercise-induced metabolic shifts. This integrated perspective advances understanding of exercise as a non-pharmacological intervention for immune regulation and offers theoretical foundations for individualized exercise prescriptions in health and disease contexts.]]></description>
<pubDate>2025/5/15 8:22:02</pubDate>
<category><![CDATA[运动代谢效应与促健康机制研究专刊]]></category>
<author><![CDATA[LI Zi-Yan,WANG Hui-Guo,WANG Yu,XIE Xian-Yan,YANG Gao-Yuan,ZHU Lin]]></author>
</item>
<item>
<title><![CDATA[<b>Review:</b>The Mechanism of Exercise Regulating Intestinal Flora in The Prevention and Treatment of Depression]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202504300000001]]></link>
<description><![CDATA[Depression, a prevalent mental disorder with significant socioeconomic burdens, underscores the urgent need for safe and effective non-pharmacological interventions. Recent advances in microbiome research have revealed the pivotal role of gut microbiota dysbiosis in the pathogenesis of depression. Concurrently, exercise, as a cost-effective and accessible intervention, has demonstrated remarkable efficacy in alleviating depressive symptoms. This comprehensive review synthesizes current evidence on the interplay among exercise, gut microbiota modulation, and depression, elucidating the mechanistic pathways through which exercise ameliorates depressive symptoms <i>via</i> the microbiota-gut-brain (MGB) axis. Depression is characterized by gut microbiota alterations, including reduced alpha and beta diversity, depletion of beneficial taxa (<i>e.g</i>., <i>Bifidobacterium</i>, <i>Lactobacillus</i>, and <i>Coprococcus</i>), and overgrowth of pro-inflammatory and pathogenic bacteria (<i>e.g</i>., <i>Morganella</i>, <i>Klebsiella</i>, and Enterobacteriaceae). Metagenomic analyses reveal disrupted metabolic functions in depressive patients, such as diminished synthesis of short-chain fatty acids (SCFAs), impaired tryptophan metabolism, and dysregulated bile acid conversion. For instance,<i> Bifidobacterium longum</i> deficiency correlates with reduced synthesis of neuroactive metabolites like homovanillic acid, while decreased <i>Coprococcus</i> abundance limits butyrate production, exacerbating neuroinflammation. Furthermore, elevated levels of indole derivatives from <i>Clostridium</i> species inhibit serotonin (5-HT) synthesis, contributing to depressive phenotypes. These dysbiotic profiles disrupt the MGB axis, triggering systemic inflammation, neurotransmitter imbalances, and hypothalamic-pituitary-adrenal (HPA) axis hyperactivity. Exercise exerts profound effects on gut microbiota composition, diversity, and metabolic activity. Longitudinal studies demonstrate that sustained aerobic exercise increases alpha diversity, enriches SCFA-producing genera (<i>e.g</i>., <i>Faecalibacterium prausnitzii</i>, <i>Roseburia,</i> and <i>Akkermansia</i>), and suppresses pathobionts (<i>e.g.</i>, <i>Desulfovibrio</i> and<i> Streptococcus</i>). For example, a meta-analysis of 25 trials involving 1 044 participants confirmed that exercise enhances microbial richness and restores the Firmicutes/Bacteroidetes ratio, a biomarker of metabolic health. Notably, endurance training promotes <i>Veillonella </i>proliferation, which converts lactate into propionate, enhancing energy metabolism and delaying fatigue. Exercise also strengthens intestinal barrier integrity by upregulating tight junction proteins (<i>e.g</i>., ZO-1, occludin), thereby reducing lipopolysaccharide (LPS) translocation and systemic inflammation. However, excessive exercise may paradoxically diminish microbial diversity and exacerbate intestinal permeability, highlighting the importance of moderate intensity and duration. Exercise ameliorates depressive symptoms through multifaceted interactions with the gut microbiota, primarily <i>via</i> 4 interconnected pathways. First, exercise mitigates neuroinflammation by elevating anti-inflammatory SCFAs such as butyrate, which suppresses NF-κB signaling to attenuate microglial activation and oxidative stress in the hippocampus. Animal studies demonstrate that voluntary wheel running reduces hippocampal TNF-α and IL-17 levels in stress-induced depression models, while fecal microbiota transplantation (FMT) from exercised mice reverses depressive behaviors by modulating the TLR4/NF-κB pathway. Second, exercise regulates neurotransmitter dynamics by enriching GABA-producing <i>Lactobacillus</i> and <i>Bifidobacterium</i>, thereby counteracting neuronal hyperexcitability. Aerobic exercise also enhances the abundance of <i>Lactobacillus plantarum</i> and<i> Streptococcus thermophilus</i>, which facilitate 5-HT and dopamine synthesis. Clinical trials reveal that 12 weeks of moderate exercise increases fecal <i>Coprococcus</i> and <i>Blautia</i> abundance, correlating with improved 5-HT bioavailability and reduced depression scores. Third, exercise normalizes HPA axis hyperactivity by reducing cortisol levels and restoring glucocorticoid receptor sensitivity. In rodent models, chronic stress-induced corticosterone elevation is reversed by probiotic supplementation (<i>e.g</i>., <i>Lactobacillus</i>), which enhances endocannabinoid signaling and hippocampal neurogenesis. Furthermore, exercise upregulates brain-derived neurotrophic factor (BDNF) <i>via</i> microbial metabolites like butyrate, promoting histone acetylation and synaptic plasticity. FMT experiments confirm that exercise-induced microbiota elevates prefrontal BDNF expression, reversing stress-induced neuronal atrophy. Fourth, exercise reshapes microbial metabolic crosstalk, diverting tryptophan metabolism toward 5-HT synthesis instead of neurotoxic kynurenine derivatives. Butyrate inhibits indoleamine 2,3-dioxygenase (IDO), a key enzyme in the kynurenine pathway linked to depression. Concurrently, exercise-induced <i>Akkermansia</i> enrichment enhances mucin production, fortifies the gut barrier, and reduces LPS-driven neuroinflammation. Collectively, these mechanisms underscore exercise as a potent modulator of the microbiota-gut-brain axis, offering a holistic approach to alleviating depression through microbial and neurophysiological synergy. Current evidence supports exercise as a potent adjunct therapy for depression, with personalized regimens (<i>e.g</i>., aerobic, resistance, or yoga) tailored to individual microbiota profiles. However, challenges remain in optimizing exercise prescriptions (intensity, duration, and type) and integrating them with probiotics, prebiotics, or FMT for synergistic effects. Future research should prioritize large-scale randomized controlled trials to validate causality, multi-omics approaches to decipher MGB axis dynamics, and mechanistic studies exploring microbial metabolites as therapeutic targets. The authors advocate for a paradigm shift toward microbiota-centric interventions, emphasizing the bidirectional relationship between physical activity and gut ecosystem resilience in mental health management. In conclusion, this review underscores exercise as a multifaceted modulator of the gut-brain axis, offering novel insights into non-pharmacological strategies for depression. By bridging microbial ecology, neuroimmunology, and exercise physiology, this work lays a foundation for precision medicine approaches targeting the gut microbiota to alleviate depressive disorders.]]></description>
<pubDate>2025/5/14 14:35:28</pubDate>
<category><![CDATA[运动代谢效应与促健康机制研究专刊]]></category>
<author><![CDATA[CUI Yi-Cong,MA Xin-Dong,MIN Lei-Zi,WANG Jing-Tong,WANG Qing-Yuan,WANG Rui]]></author>
</item>
<item>
<title><![CDATA[Prediction of Potential Regulatory Pathways Involving The Notch Signaling Pathway and Its Associated Non-coding RNAs in Alzheimer’s Disease Based on Database Analysis]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202502280000002]]></link>
<description><![CDATA[Alzheimer’s disease (AD) is a chronic, progressive, and irreversible neurodegenerative disorder that typically begins with a subtle onset and progresses slowly. Pathologically, it is characterized by two hallmark features: the extracellular accumulation of amyloid β-protein (Aβ), forming senile plaques, and the intracellular hyperphosphorylation of tau protein, resulting in neurofibrillary tangles (NFTs). These pathological changes are accompanied by substantial neuronal and synaptic loss, particularly in critical brain regions such as the cerebral cortex and hippocampus. Clinically, AD presents as a gradual decline in memory, language abilities, and spatial orientation, significantly impairing the quality of life of affected individuals. With the aging population steadily increasing in China, the incidence of AD is rising, making it a major public health concern that requires urgent attention. The growing societal and economic burden of AD underscores the pressing need to identify effective diagnostic biomarkers and develop novel therapeutic strategies. Among the various molecular signaling pathways involved in neurological disorders, the Notch signaling pathway is especially noteworthy due to its evolutionary conservation and regulatory roles in cell proliferation, differentiation, development, and apoptosis. In the central nervous system, Notch signaling is essential for neurodevelopment and synaptic plasticity and has been implicated in several neurodegenerative processes. Although some studies suggest that Notch signaling may influence AD-related pathology, its precise role in AD remains poorly understood. In particular, the interaction between Notch signaling and non-coding RNAs (ncRNAs)—key regulators of gene expression—has received limited attention. NcRNAs, including long non-coding RNAs (lncRNAs) and microRNAs (miRNAs), are known to exert extensive regulatory functions at both transcriptional and post-transcriptional levels. Dysregulation of these molecules has been widely associated with various diseases, including cancers, cardiovascular conditions, and neurodegenerative disorders. Notably, interactions between ncRNAs and major signaling pathways such as Notch can produce widespread biological effects. While such interactions have been increasingly reported in several disease models, comprehensive studies investigating the regulatory relationship between Notch signaling and ncRNAs in the context of AD remain scarce. Given the capacity of ncRNAs to modulate signaling cascades and form complex regulatory networks, a deeper understanding of their crosstalk with the Notch pathway could provide novel insights into AD pathogenesis and reveal potential targets for diagnosis and treatment. In this study, we investigated the regulatory landscape involving the Notch signaling pathway and associated ncRNAs in AD using bioinformatics approaches. By integrating data from multiple public databases, we systematically identified significantly dysregulated Notch pathway-related genes and their interacting ncRNAs in AD. Based on this analysis, we constructed a lncRNA-miRNA-mRNA regulatory network to elucidate the potential mechanisms linking Notch signaling to ncRNA-mediated gene regulation in AD pathogenesis. Furthermore, we explored the internal relationships and molecular mechanisms within this network and assessed the feasibility and clinical relevance of these molecules as early diagnostic biomarkers and potential therapeutic targets for AD. This study aims to deepen our understanding of the molecular basis of AD and offer novel strategies for its diagnosis and treatment.]]></description>
<pubDate>2025/5/11 14:09:41</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[KOU Xian-Juan,LIU Xing-Ran,Lü Meng-Lin]]></author>
</item>
<item>
<title><![CDATA[<b>Review:</b>Role and Mechanism of Lactate Metabolism/Lactylation in The Improvement of Central Nervous System Diseases by Exercise Intervention]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202503280000002]]></link>
<description><![CDATA[Central nervous system diseases (CNSDs) refer to a range of disorders resulting from structural or functional impairments of the brain and spinal cord, including stroke, Alzheimer’s disease (AD), Parkinson’s disease, spinal cord injury (SCI), and brain tumors. As a leading cause of disability and the second leading cause of death worldwide, CNSDs involve complex pathological mechanisms that profoundly affect patients’ physical and mental health as well as their quality of life. Therefore, identifying potential therapeutic targets and developing targeted intervention strategies for the prevention and treatment of CNSDs is of great significance. Recent studies have revealed that lactate can transmit energy between cells <i>via </i>the “lactate shuttle” mechanism and act as an endogenous signaling molecule, exerting diverse biological functions in CNSDs. Lactylation, a novel type of post-translational modification that uses lactate and lysine residues as substrates, plays a critical role in regulating gene transcription, immune responses, and cellular metabolism under both physiological and pathological conditions. Studies have confirmed that lactate participates in the onset and progression of CNSDs through both lactate metabolism and lactylation. In AD, lactate promotes Aβ plaque formation and impairs synaptic plasticity and cognitive function. Lactylation contributes to AD pathogenesis by regulating Aβ accumulation, Tau protein phosphorylation, neuroinflammation, pyroptosis, and ferroptosis. In ischemic stroke (IS), lactate suppresses neuroinflammation and alleviates ischemic injury. Lactylation is involved in the regulation of neuroinflammation, endothelial cell apoptosis, and neuronal ferroptosis, contributing to IS progression. In SCI, lactate promotes the phenotypic transition of astrocytes from the A1 to the A2 type, thereby mitigating neural injury. Lactylation alleviates neurological dysfunction by modulating neuroinflammation, axonal regeneration, mitochondrial function, and microglial proliferation. In glioblastoma (GBM), lactate promotes M2 polarization of microglia, facilitating tumor cell growth and dissemination. Lactylation further accelerates GBM progression by enhancing tumor cell migration, proliferation, immune evasion, and drug resistance. These findings suggest that lactate may serve as a potential therapeutic target for the prevention and treatment of CNSDs. However, its precise role in CNSDs remains unclear, and the specific mechanisms by which lactate metabolism and lactylation influence disease progression warrant further investigation. Moreover, studies have confirmed that exercise, as a key non-pharmacological intervention, holds great promise in the prevention, treatment, and rehabilitation of CNSDs. Specifically, exercise can regulate lactate metabolism and lactylation, which in turn suppresses neuroinflammation, enhances synaptic plasticity, promotes neurogenesis and angiogenesis, improves mitochondrial function in the hippocampus, and facilitates the release of neuroprotective factors, ultimately contributing to the improvement of CNSDs. This review summarizes the roles of lactate metabolism and lactylation in CNSDs, as well as the potential mechanisms by which exercise regulates lactate metabolism and lactylation to improve CNSDs, providing a theoretical basis for the benefits of exercise on brain health.]]></description>
<pubDate>2025/5/10 3:40:34</pubDate>
<category><![CDATA[运动代谢效应与促健康机制研究专刊]]></category>
<author><![CDATA[CHEN Xiao-An,TANG Shao-Kai]]></author>
</item>
<item>
<title><![CDATA[The Functional Diversity and Regulatory Mechanism of Clathrin Plaques]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202502110000001]]></link>
<description><![CDATA[Clathrin-mediated endocytosis (CME) is a critical process by which cells internalize macromolecular substances and initiate vesicle trafficking, serving as the foundation for many cellular activities. Central to this process are clathrin-coated structures (CCSs), which consist of clathrin-coated pits (CCPs) and clathrin plaques. While clathrin-coated pits are well-established in the study of endocytosis, clathrin plaques represent a more recently discovered but equally important component of this system. These plaques are large, flat, and extended clathrin-coated assemblies found on the cytoplasmic membrane. They are distinct from the more typical clathrin-coated pits in terms of their morphology, larger surface area, and longer lifespan. Recent research has revealed that clathrin plaques play roles that go far beyond endocytosis, contributing to diverse cellular processes such as cellular adhesion, mechanosensing, migration, and pathogen invasion. Unlike traditional clathrin-coated pits, which are transient and dynamic structures involved primarily in the internalization of molecules, clathrin plaques are more stable and extensive, often persisting for extended periods. Their extended lifespan suggests that they serve functions beyond the typical endocytic role, making them integral to various cellular processes. For instance, clathrin plaques are involved in the regulation of intercellular adhesion, allowing cells to better adhere to one another or to the extracellular matrix, which is crucial for tissue formation and maintenance. Furthermore, clathrin plaques act as mechanosensitive hubs, enabling the cell to sense and respond to mechanical stress, a feature that is essential for processes like migration, tissue remodeling, and even cancer progression. Recent discoveries have also highlighted the role of clathrin plaques in cellular signaling. These plaques can serve as scaffolds for signaling molecules, orchestrating the activation of various pathways that govern cellular behavior. For example, the recruitment of actin-binding proteins such as F-actin and vinculin to clathrin plaques can influence cytoskeletal dynamics, helping cells adapt to mechanical changes in their environment. This recruitment also plays a pivotal role in regulating cellular migration, which is crucial for developmental processes. Additionally, clathrin plaques influence receptor-mediated signal transduction by acting as platforms for the assembly of signaling complexes, thereby affecting processes such as growth factor signaling and cellular responses to extracellular stimuli. Despite the growing body of evidence that supports the involvement of clathrin plaques in a wide array of cellular functions, much remains unknown about the precise molecular mechanisms that govern their formation, maintenance, and turnover. For example, the factors that regulate the recruitment of clathrin and other coat proteins to form plaques, as well as the signaling molecules that coordinate plaque dynamics, remain areas of active research. Furthermore, the complex interplay between clathrin plaques and other cellular systems, such as the actin cytoskeleton and integrin-based adhesion complexes, needs further exploration. Studies have shown that clathrin plaques can respond to mechanical forces, with recent findings indicating that they act as mechanosensitive structures that help the cell adapt to changing mechanical environments. This ability underscores the multifunctional nature of clathrin plaques, which, in addition to their role in endocytosis, are involved in cellular processes such as mechanotransduction and adhesion signaling. In summary, clathrin plaques represent a dynamic and versatile component of clathrin-mediated endocytosis. They play an integral role not only in the internalization of macromolecular cargo but also in regulating cellular adhesion, migration, and signal transduction. While much has been learned about their structural and functional properties, significant questions remain regarding the molecular mechanisms that regulate their formation and their broader role in cellular physiology. This review highlights the evolving understanding of clathrin plaques, emphasizing their importance in both endocytosis and a wide range of other cellular functions. Future research is needed to fully elucidate the mechanisms by which clathrin plaques contribute to cellular processes and to better understand their implications for diseases, including cancer and tissue remodeling. Ultimately, clathrin plaques are emerging as crucial hubs that integrate mechanical, biochemical, and signaling inputs, providing new insights into cellular function and the regulation of complex cellular behaviors.]]></description>
<pubDate>2025/5/6 18:10:28</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Zhi-Ming,JIANG Zhao-Hong,ZHAO Yi-Ge,ZHOU Qian-Yi]]></author>
</item>
<item>
<title><![CDATA[<b>Review:</b>Small Intestine Lipid Absorption and Health: The Improvement Effect of Exercise Under The Challenge of High-fat Diet]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202503310000001]]></link>
<description><![CDATA[The two core causes of obesity in modern lifestyle are high-fat diet (HFD) and insufficient physical activity. HFD can lead to disruption of gut microbiota and abnormal lipid metabolism, further exacerbating the process of obesity. The small intestine, as the “first checkpoint” for the digestion and absorption of dietary lipids into the body, plays a pivotal role in lipid metabolism. The small intestine is involved in the digestion, absorption, transport, and synthesis of dietary lipids. The absorption of lipids in the small intestine is a crucial step, as overactive absorption leads to a large amount of lipids entering the bloodstream, which affects the occurrence of obesity. HFD can lead to insulin resistance, disruption of gut microbiota, and inflammatory response in the body, which can further induce lipid absorption and metabolism disorders in the small intestine, thereby promoting the occurrence of chronic metabolic diseases such as obesity. Long term HFD can accelerate pathological structural remodeling and lipid absorption dysfunction of the small intestine: after high-fat diet, the small intestine becomes longer and heavier, with excessive villi elongation and microvilli elongation, thereby increasing the surface area of lipid absorption and causing lipid overload in the small intestine. In addition, overexpression of small intestine uptake transporters, intestinal mucosal damage induced “intestinal leakage”, dysbiosis of intestinal microbiota, ultimately leading to abnormal lipid absorption and chronic inflammation, accelerating lipid accumulation and obesity. Exercise, as one of the important means of simple, economical, and effective proactive health interventions, has always been highly regarded for its role in improving lipid metabolism homeostasis. The effect of exercise on small intestine lipid absorption shows a dose-dependent effect. Moderate to low-intensity aerobic exercise can improve the intestinal microenvironment, regulate the structure and lipid absorption function of the small intestine, promote lipid metabolism and health, while vigorous exercise, excessive exercise, and long-term high-intensity training can cause intestinal discomfort, leading to the destruction of intestinal structure and related symptoms, affecting lipid absorption. Long term regular exercise can regulate the diversity of intestinal microbiota, inhibit inflammatory signal transduction such as NF-κB, enhance intestinal mucosal barrier function, and improve intestinal lipid metabolism disorders, further enhancing the process of small intestinal lipid absorption. Exercise also participates in the remodeling process of small intestinal epithelial cells, regulating epithelial structural homeostasis by activating cell proliferation related pathways such as Wnt/β-catenin. Exercise can regulate the expression of lipid transport proteins CD36, FATP, and NPC1L1, and regulate the function of small intestine lipid absorption. However, the research on the effects of long-term exercise on small intestine structure, villus structure, absorption surface area, and lipid absorption related proteins is not systematic enough, the results are inconsistent, and the relevant mechanisms are not clear. In the future, experimental research can be conducted on the dose-response relationship of different intensities and forms of exercise, exploring the mechanisms of exercise improving small intestine lipid absorption and providing theoretical reference for scientific weight loss. It should be noted that the intestine is an organ that is sensitive to exercise response. How to determine the appropriate range, threshold, and form of exercise intensity to ensure beneficial regulation of intestinal lipid metabolism induced by exercise should become an important research direction in the future.]]></description>
<pubDate>2025/4/30 11:30:47</pubDate>
<category><![CDATA[运动代谢效应与促健康机制研究专刊]]></category>
<author><![CDATA[DAI Yu-Xi,HE Yu-Xiu,WANG Wei-Huan]]></author>
</item>
<item>
<title><![CDATA[Predicting Hepatocellular Carcinoma Using Brightness Change Curves Derived From Contrast-enhanced Ultrasound Images]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202412110000003]]></link>
<description><![CDATA[<b>Objective</b> The primary objective of this study was to develop an advanced, light-weighted classification network capable of distinguishing HCC from other non-HCC malignancies by leveraging the automatic analysis of brightness changes in CEUS images. The ultimate goal was to create a user-friendly and cost-efficient computer-aided diagnostic tool that could assist radiologists in making more accurate and efficient clinical decisions.<b>Methods</b> This retrospective study encompassed a total of 161 patients, comprising 131 diagnosed with HCC and 30 with non-HCC malignancies. To achieve accurate tumor detection, the YOLOX network was employed to identify the region of interest (ROI) on both B-mode ultrasound and CEUS images. A custom-developed algorithm was then utilized to extract brightness change curves from the tumor and adjacent liver parenchyma regions within the CEUS images. These curves provided critical data for the subsequent analysis and classification process. To analyze the extracted brightness change curves and classify the malignancies, we developed and compared several models. These included one-dimensional convolutional neural networks (1D-ResNet, 1D-ConvNeXt, and 1D-CNN), as well as traditional machine-learning methods such as support vector machine (SVM), ensemble learning (EL), K-nearest neighbor (KNN), and decision tree (DT). The diagnostic performance of each method in distinguishing HCC from non-HCC malignancies was rigorously evaluated using four key metrics: Area under the receiver operating characteristic (AUC), accuracy (ACC), sensitivity (SE), and specificity (SP).<b>Results</b> The evaluation of the machine-learning methods revealed AUC values of 0.70 for SVM, 0.56 for ensemble learning, 0.63 for KNN, and 0.72 for the decision tree. These results indicated moderate to fair performance in classifying the malignancies based on the brightness change curves. In contrast, the deep learning models demonstrated significantly higher AUCs, with 1D-ResNet achieving an AUC of 0.72, 1D-ConvNeXt reaching 0.82, and 1D-CNN obtaining the highest AUC of 0.84. Moreover, under the five-fold cross-validation scheme, the 1D-CNN model outperformed other models in both accuracy and specificity. Specifically, it achieved accuracy improvements of 3.8% to 10.0% and specificity enhancements of 6.6% to 43.3% over competing approaches. The superior performance of the 1D-CNN model highlighted its potential as a powerful tool for accurate classification.<b>Conclusion</b> The 1D-CNN model proved to be the most effective in differentiating HCC from non-HCC malignancies, surpassing both traditional machine-learning methods and other deep learning models. This study successfully developed a user-friendly and cost-efficient computer-aided diagnostic solution that would significantly enhances radiologists" diagnostic capabilities. By improving the accuracy and efficiency of clinical decision-making, this tool has the potential to positively impact patient care and outcomes. Future work may focus on further refining the model and exploring its integration with multimodal ultrasound data to maximize its accuracy and applicability.]]></description>
<pubDate>2025/4/30 8:46:05</pubDate>
<category><![CDATA[技术与方法]]></category>
<author><![CDATA[CHEN Ying-Ying,HUANG Liang-Hui,JIANG Shang-Lin,WANG Xue-Hua,ZENG Ya-Guang,ZHENG Wei]]></author>
</item>
<item>
<title><![CDATA[Repetitive Transcranial Magnetic Stimulation Ameliorates Cognitive Dysfunction in Alzheimer’s Disease Mice by Inhibiting Ferroptosis and Maintaining Cytoplasmic Calcium Homeostasis]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202501150000002]]></link>
<description><![CDATA[<b>Objective</b> Repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, offers a non-pharmacological therapeutic option for the management of Alzheimer’s disease (AD). Studies have demonstrated that ferroptosis plays a pivotal role in the pathological onset and progression of AD, and the inhibition of neuronal ferroptosis can significantly ameliorate cognitive impairments associated with AD. The imbalance of calcium ion (Ca<sup>2+</sup>) homeostasis is intimately associated with the pathology of AD and serves as a catalyst for the induction of ferroptosis through various pathways. This study is designed to investigate whether rTMS can ameliorate AD by inhibiting neuronal ferroptosis or maintaining calcium homeostasis, ultimately establishing a theoretical and experimental framework for the utilization of rTMS in AD treatment.<b>Methods</b> APP/PS1 AD mice were subjected to both 0.5 Hz low-frequency and 20 Hz high-frequency rTMS treatments, and the efficacy of these treatments was evaluated using novel object recognition and Morris water maze tests. ELISA was employed to quantify the levels of glutathione (GSH), malondialdehyde (MDA), superoxide dismutase (SOD), Fe<sup>2+</sup> within the hippocampi of mice from each group. HT-22 cells were induced to undergo ferroptosis <i>via</i> Erastin treatment, and subsequent to high- and low-frequency magnetic stimulation, cell viability was assessed using CCK-8 assay, while intracellular calcium ion concentration fluctuations were monitored using Fluo-4 AM.<b>Results</b> The findings revealed that, when compared to normal mice, AD mice displayed a notable decline in cognitive function, accompanied by a substantial increase in ferroptosis levels and intracellular calcium ion concentrations. Both high-frequency and low-frequency applications of rTMS were found to significantly ameliorate cognitive impairments in AD mice, while also effectively mitigating the abnormal augmentation of neuronal ferroptosis and intracellular calcium ion levels.<b>Conclusion</b> The present study underscores that both high-frequency and low-frequency rTMS exhibit efficacy in alleviating cognitive dysfunction in AD mice, potentially through the modulation of ferroptosis and intracellular calcium ion homeostasis.]]></description>
<pubDate>2025/4/27 11:21:06</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[DING Chong,FU Rui,REN Zi-Hao,ZHANG Meng,ZHANG Ze]]></author>
</item>
<item>
<title><![CDATA[<b>Research:</b>Aerobic Exercise Improves Cognitive Function of Aging Mice by Regulating Intestinal Flora-metabolite Network]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202503270000002]]></link>
<description><![CDATA[<b>Objective</b> This study aimed to explore the effects of aerobic exercise on cognitive function in aging mice and to elucidate the underlying molecular mechanisms by which aerobic exercise ameliorates cognitive decline through the regulation of gut microbiota-metabolite network. By providing novel insights into the interplay between exercise, gut microbiota, and cognitive health, this research seeks to offer a robust theoretical foundation for developing anti-aging strategies and personalized exercise interventions targeting aging-related cognitive dysfunction.<b>Methods</b> Using naturally aged C57BL/6 mice as the experimental model, this study employed a multi-omics approach combining 16S rRNA sequencing and wide-targeted metabolomics analysis. A total of 18 mice were divided into 3 groups: young control (YC, 4-month-old), old control (OC, 21-month-old), and old+exercise (OE, 21-month-old with 12 weeks of moderate-intensity treadmill training) groups. Behavioral assessments, including the Morris water maze (MWM) test, were conducted to evaluate cognitive function. Histopathological examinations of brain tissue sections provided morphological evidence of neuronal changes. Fecal samples were collected for gut microbiota and metabolite profiling <i>via</i> 16S rRNA sequencing and ultra-performance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry (UPLC-QTOF-MS). Data were analyzed using a combination of statistical and bioinformatics tools to identify differentially abundant microbial taxa and metabolites and to construct interaction networks between them.<b>Results</b> Behavioral tests revealed that 12 weeks of aerobic exercise significantly improved spatial learning and memory capacity of aged mice, as evidenced by reduced escape latency and increased target area exploration and platform crossings in the MWM. Histopathological analysis demonstrated that exercise mitigated aging-related neuronal damage in the hippocampus, enhancing neuronal density and morphology. 16S rRNA sequencing indicated that exercise increased gut microbiota α-diversity and enriched beneficial bacterial genera, including <i>Bifidobacterium</i>, <i>Parabacteroides</i>, and <i>Rikenella</i>. Metabolomics analysis identified 32 differentially regulated metabolites between OC and OE groups, with 94 up-regulated and 30 down-regulated in the OE group when compared with OC group. These metabolites were primarily involved in energy metabolism reprogramming (<i>e.g</i>., L-homocitrulline), antioxidant defense (<i>e.g</i>., L-carnosine), neuroprotection (<i>e.g</i>., lithocholic acid), and DNA repair (<i>e.g</i>., ADP-ribose). Network analysis further revealed strong positive correlations between specific bacteria and metabolites, such as <i>Parabacteroides</i> with ADP-ribose and <i>Bifidobacterium</i> with lithocholic acid, suggesting potential neuroprotective pathways mediated by the gut microbiota-metabolite axis.<b>Conclusion</b> This study provides comprehensive evidence that aerobic exercise elicits cognitive benefits in aging mice by modulating the gut microbiota-metabolite network. These findings highlight three key mechanisms: (1) the proliferation of beneficial gut bacteria enhances metabolic reprogramming to boost DNA repair pathways; (2) elevated neuroinflammation-inhibiting factors reduce neurodegenerative changes; and (3) enhanced antioxidant defenses maintain neuronal homeostasis. These results underscore the critical role of the “microbiota-metabolite-brain” axis in mediating the cognitive benefits of aerobic exercise. This study not only advances our understanding of the gut-brain axis in aging but also offers a scientific basis for developing personalized exercise and probiotic-based interventions targeting aging-related cognitive decline. Future research should further validate these mechanisms in non-human primates and human clinical trials to establish the translational potential of exercise-induced gut microbiota-metabolite modulation for combating neurodegenerative diseases.]]></description>
<pubDate>2025/4/26 17:39:22</pubDate>
<category><![CDATA[运动代谢效应与促健康机制研究专刊]]></category>
<author><![CDATA[CHEN Ning,LIANG Ji-Ling,WANG An-Feng,WU Tong,ZHANG Hu]]></author>
</item>
<item>
<title><![CDATA[<b>Research:</b>Four Weeks of HIIT Modulates Lactate-mediated Synaptic Plasticity to Improve Depressive-like Behavior in CUMS Rats]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202503270000001]]></link>
<description><![CDATA[<b>Objective</b> This study aimed to investigate the effects of 4-week high-intensity interval training (HIIT) on synaptic plasticity in the prefrontal cortex (PFC) of rats exposed to chronic unpredictable mild stress (CUMS), and to explore its potential mechanisms.<b>Methods</b> A total of 48 male Sprague-Dawley rats were randomly divided into 4 groups: control (C), model (M), control plus HIIT (HC), and model plus HIIT (HM). Rats in groups M and HM underwent 8 weeks of CUMS to establish depression-like behaviors, while groups HC and HM received HIIT intervention beginning from the 5th week for 4 consecutive weeks. The HIIT protocol consisted of repeated intervals of 3 min at high speed (85%-90% maximal training speed, <i>S</i><sub>max</sub>) alternated with one minute at low speed (50%-55% <i>S</i><sub>max</sub>), with 3 to 5 sets per session, conducted 5 d per week. Behavioral assessments and tail-vein blood lactate levels were measured at the end of the 4th and 8th weeks. After the intervention, rat PFC tissues were collected for Golgi staining to analyze synaptic morphology. Enzyme-linked immunosorbent assays (ELISA) were employed to detect brain-derived neurotrophic factor (BDNF), monocarboxylate transporter 1 (MCT1), lactate, and glutamate levels in the PFC, as well as serotonin (5-HT) levels in serum. Additionally, Western blot analysis was conducted to quantify the expression of synaptic plasticity-related proteins, including c-Fos, activity-regulated cytoskeleton-associated protein (Arc), and N-methyl-D-aspartate receptor 1 (NMDAR1).<b>Results</b> Compared to the control group (C), the CUMS-exposed rats (group M) exhibited significant reductions in sucrose preference rates, number of grid crossings, frequency of upright postures, and entries into and duration spent in open arms of the elevated plus maze, indicating marked depressive-like behaviors. Additionally, the group M showed significantly reduced dendritic spine density in the PFC, along with elevated levels of c-Fos, Arc, NMDAR1 protein expression, and increased concentrations of lactate and glutamate. Conversely, BDNF and MCT1 contents in the PFC and 5-HT levels in serum were significantly decreased. Following HIIT intervention, rats in the group HM displayed considerable improvement in behavioral indicators compared with the group M, accompanied by significant elevations in PFC MCT1 and lactate concentrations. Furthermore, HIIT notably normalized the expression levels of c-Fos, Arc, NMDAR1, as well as glutamate and BDNF contents in the PFC. Synaptic spine density also exhibited significant recovery.<b>Conclusion</b> Four weeks of HIIT intervention may alleviate depressive-like behaviors in CUMS rats by increasing lactate levels and reducing glutamate concentration in the PFC, thereby downregulating the overexpression of NMDAR, attenuating excitotoxicity, and enhancing synaptic plasticity.]]></description>
<pubDate>2025/4/26 17:37:12</pubDate>
<category><![CDATA[运动代谢效应与促健康机制研究专刊]]></category>
<author><![CDATA[BAO Chun-Hui,HAN Yu-Mei,LIANG Jia-Ren,TIAN Jun-Sheng,XIANG Huan,YANG Yong-Hong,ZHANG Zi-Wei,ZHOU Shi]]></author>
</item>
<item>
<title><![CDATA[<b>Review:</b>The Mechanisms of Neurotransmitters and Their Receptors in Exercise Central Fatigue]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202502080000001]]></link>
<description><![CDATA[Exercise fatigue is a complex physiological and psychological phenomenon that includes peripheral fatigue in the muscles and central fatigue in the brain. Peripheral fatigue refers to the loss of force caused at the distal end of the neuromuscular junction, whereas central fatigue involves decreased motor output from the primary motor cortex, which is associated with modulations at anatomical sites proximal to nerves that innervate skeletal muscle. The central regulatory failure reflects a progressive decline in the central nervous system’s capacity to recruit motor units during sustained physical activity. Emerging evidence highlights the critical involvement of central neurochemical regulation in fatigue development, particularly through neurotransmitter-mediated modulation. Alterations in neurotransmitter release and receptor activity could influence excitatory and inhibitory signal pathways, thus modulating the perception of fatigue and exercise performance. Increased serotonin (5-HT) could increase perception of effort and lethargy, reduce motor drive to continue exercising, and contribute to exercise fatigue. Decreased dopamine (DA) and noradrenaline (NE) neurotransmission can negatively impact arousal, mood, motivation, and reward mechanisms and impair exercise performance. Furthermore, the serotonergic and dopaminergic systems interact with each other; a low 5-HT/DA ratio enhances motor motivation and improves performance, and a high 5-HT/DA ratio heightens fatigue perception and leads to decreased performance. The expression and activity of neurotransmitter receptors would be changed during prolonged exercise to fatigue, affecting the transmission of nerve signals. Prolonged high-intensity exercise causes excess 5-HT to overflow from the synaptic cleft to the axonal initial segment and activates the 5-HT1A receptor, thereby inhibiting the action potential of motor neurons and affecting the recruitment of motor units. During exercise to fatigue, the DA secretion is decreased, which blocks the binding of DA to D1 receptor in the caudate putamen and inhibits the activation of the direct pathway of the basal ganglia to suppress movement, meanwhile the binding of DA to D2 receptor is restrained in the caudate putamen, which activates the indirect pathway of the basal ganglia to influence motivation. Furthermore, other neurotransmitters and their receptors, such as adenosine (ADO), glutamic acid (Glu), and γ-aminobutyric acid (GABA) also play important roles in regulating neurotransmitter balance and fatigue. The occurrence of central fatigue is not the result of the action of a single neurotransmitter system, but a comprehensive manifestation of the interaction between multiple neurotransmitters. This review explores the important role of neurotransmitters and their receptors in central motor fatigue, reveals the dynamic changes of different neurotransmitters such as 5-HT, DA, NE, and ADO during exercise, and summarizes the mechanisms by which these neurotransmitters and their receptors regulate fatigue perception and exercise performance through complex interactions. Besides, this study presents pharmacological evidence that drugs such as agonists, antagonists, and reuptake inhibitors could affect exercise performance by regulating the metabolic changes of neurotransmitters. Recently, emerging interventions such as dietary bioactive components intake and transcranial electrical stimulation may provide new ideas and strategies for the prevention and alleviation of exercise fatigue by regulating neurotransmitter levels and receptor activity. Overall, this work offers new theoretical insights into the understanding of exercise central fatigue, and future research should further investigate the relationship between neurotransmitters and their receptors and exercise fatigue.]]></description>
<pubDate>2025/4/26 17:35:18</pubDate>
<category><![CDATA[运动代谢效应与促健康机制研究专刊]]></category>
<author><![CDATA[CAO Meng,FENG Du-Shuo,GUAN Lu-Lu,QI Bo-Te,TAN Jing-Wang,ZOU Yu]]></author>
</item>
<item>
<title><![CDATA[The Role of Skeletal Muscle Satellite Cells-mediated Muscle Regeneration in The Treatment of Age-related Sarcopenia]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202501160000006]]></link>
<description><![CDATA[Age-related sarcopenia is a progressive, systemic skeletal muscle disorder associated with aging. It is primarily characterized by a significant decline in muscle mass, strength, and physical function, rather than being an inevitable consequence of normal aging. Despite ongoing research, there is still no globally unified consensus among physicians regarding the diagnostic criteria and clinical indicators of this condition. Nonetheless, regardless of the diagnostic standards applied, the prevalence of age-related sarcopenia remains alarmingly high. With the global population aging at an accelerating rate, its incidence is expected to rise further, posing a significant public health challenge. Age-related sarcopenia not only markedly increases the risk of physical disability but also profoundly affects patients’ quality of life, independence, and overall survival. As such, the development of effective prevention and treatment strategies to mitigate its dual burden on both societal and individual health has become an urgent and critical priority. Skeletal muscle regeneration, a vital physiological process for maintaining muscle health, is significantly impaired in age-related sarcopenia and is considered one of its primary underlying causes. Skeletal muscle satellite cells (MSCs), also known as muscle stem cells, play a pivotal role in generating new muscle fibers and maintaining muscle mass and function. A decline in both the number and functionality of MSCs is closely linked to the onset and progression of sarcopenia. This dysfunction is driven by alterations in intrinsic MSC mechanisms—such as Notch, Wnt/β-Catenin, and mTOR signaling pathways—as well as changes in transcription factors and epigenetic modifications. Additionally, the MSC microenvironment, including both the direct niche formed by skeletal muscle fibers and their secreted cytokines, and the indirect niche composed of extracellular matrix proteins and various cell types, undergoes age-related changes. Mitochondrial dysfunction and chronic inflammation further contribute to MSC impairment, ultimately leading to the development of sarcopenia. Currently, there are no approved pharmacological treatments for age-related sarcopenia. Nutritional intervention and exercise remain the cornerstone of therapeutic strategies. Adequate protein intake, coupled with sufficient energy provision, is fundamental to both the prevention and treatment of this condition. Adjuvant therapies, such as dietary supplements and caloric restriction, offer additional therapeutic potential. Exercise promotes muscle regeneration and ameliorates sarcopenia by acting on MSCs through various mechanisms, including mechanical stress, myokine secretion, distant cytokine signaling, immune modulation, and epigenetic regulation. When combined with a structured exercise regimen, adequate protein intake has been shown to be particularly effective in preventing age-related sarcopenia. However, traditional interventions may be inadequate for patients with limited mobility, poor overall health, or advanced sarcopenia. Emerging therapeutic strategies—such as miRNA mimics or inhibitors, gut microbiota transplantation, and stem cell therapy—present promising new directions for MSC-based interventions. This review comprehensively examines recent advances in MSC-mediated muscle regeneration in age-related sarcopenia and systematically discusses therapeutic strategies targeting MSC regulation to enhance muscle mass and strength. The goal is to provide a theoretical foundation and identify future research directions for the prevention and treatment of this increasingly prevalent condition.]]></description>
<pubDate>2025/4/17 14:50:37</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[JI Wei-Xiu,Lü Jia-Lin,MA Yi-Fan,ZHAO Yun-Gang]]></author>
</item>
<item>
<title><![CDATA[Neuroimaging Mechanism of The Modified Electro-convulsive Therapy on The Anti-depressive Effects and Cognitive Impairment]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407020000003]]></link>
<description><![CDATA[Modified electro-convulsive therapy (MECT) is one of the most potent treatments for major depressive disorder (MDD). However, it remains a second-line option due to significant side effects, such as transient memory loss. The relationship between therapeutic efficacy and cognitive impairment warrants further investigation to develop improved treatment regimens. In this review, we examine recent evidence from magnetic resonance imaging (MRI) studies aiming to identify structural and functional brain changes specifically associated with both the antidepressant effects and the amnesic outcomes of MECT. MECT induces widespread alterations across multiple brain systems. Increases in gray matter volume (GMV) have been observed in the prefrontal, temporal, and parietal cortices, as well as in subcortical regions such as the hippocampus (HP), amygdala, and striatum. Strengthening of myelination has also been reported along the dorsolateral prefrontal-limbic pathways. Functional changes include increased spontaneous neural activity in prefrontal areas, reorganization of intrinsic connectivity within the default mode network (DMN), and altered functional connectivity (FC) among the DMN, salience network (SN), and central executive network (CEN). Correlational studies have identified structural and functional alterations linked to antidepressant efficacy, including right hippocampal volume enlargement, prefrontal cortical thickening, reduced iron deposition in the striatum, decreased FC within certain DMN nodes, and enhanced effective connectivity from the dorsolateral prefrontal cortex (DLPFC) to the right angular gyrus. In contrast, the amnesic effects have been associated with increased volumes in the left hippocampus and bilateral dentate gyrus; enhanced FC in the left angular gyrus and left posterior cingulate cortex (PCC); increased FC between the right ventral anterior insula and DLPFC; and reduced FC in the left thalamus and bilateral precuneus. Changes in the hippocampus appear to correlate with both antidepressant efficacy and memory impairment. Clinical studies have found no significant correlation between the severity of memory impairment and the reduction in depressive symptoms, suggesting that the therapeutic and adverse effects may arise from distinct regional or subregional mechanisms. Supporting this hypothesis, recent findings show that increased right hippocampal volume is significantly associated with reduced depression scores, whereas increased volume in the left dentate gyrus correlates with declines in delayed recall performance. Additionally, enhanced connectivity between the anterior hippocampus and middle occipital gyrus (MOG) has been linked to mood improvement, while decreased FC between the mid-hippocampus and angular gyrus has been associated with impairments in memory integration. In conclusion, current evidence suggests that the antidepressant and memory-impairing effects of MECT may localize to distinct hippocampal subregions. These effects likely result from differential modulation of local neural activity and functional connectivity, leading to divergent behavioral outcomes. Given that both effects may originate in deep and spatially constrained structures such as the hippocampus, small-sample studies and conventional methodologies may fail to differentiate them effectively. Future research should employ large-scale, longitudinal designs utilizing high-field MRI and multimodal neuroimaging to characterize MECT-induced structure-function coupling in the hippocampus and its integration at the network level. Additionally, multiscale analyses spanning molecular, circuit, and network dimensions would be beneficial.]]></description>
<pubDate>2025/4/16 16:32:44</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[GAO Shu-Gui,SHEN Ruo-Bing,SHEN Wen-Wen]]></author>
</item>
<item>
<title><![CDATA[Research on a COPD Diagnosis Method Based on Electrical Impedance Tomography Imaging]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202410310000001]]></link>
<description><![CDATA[<b>Objective</b> This paper proposes a novel real-time bedside pulmonary ventilation monitoring method for the diagnosis of chronic obstructive pulmonary disease (COPD), based on electrical impedance tomography (EIT). Four indicators—center of ventilation (CoV), global inhomogeneity index (GI), regional ventilation delay inhomogeneity (RVDI), and the ratio of forced expiratory volume in one second to forced vital capacity (FEV<sub>1</sub>/FVC)—are calculated to enable the spatiotemporal assessment of COPD.<b>Methods</b> A simulation of the respiratory cycles of COPD patients was first conducted, revealing significant differences in certain indicators compared to healthy individuals. The effectiveness of these indicators was then validated through experiments. A total of 93 subjects underwent multiple pulmonary function tests (PFTs) alongside simultaneous EIT measurements. Ventilation heterogeneity under different breathing patterns—including forced exhalation, forced inhalation, and quiet tidal breathing—was compared. EIT images and related indicators were analyzed to distinguish healthy individuals across different age groups from COPD patients.<b>Results</b> Simulation results demonstrated significant differences in CoV, GI, FEV<sub>1</sub>/FVC, and RVDI between COPD patients and healthy individuals. Experimental findings indicated that, in terms of spatial heterogeneity, the <i>GI</i> values of COPD patients were significantly higher than those of the other two groups, while no significant differences were observed among healthy individuals. Regarding temporal heterogeneity, COPD patients exhibited significantly higher <i>RVDI</i> values than the other groups during both quiet breathing and forced inhalation. Moreover, during forced exhalation, the distribution of <i>FEV</i><sub>1</sub>/<i>FVC</i> values further highlighted the temporal delay heterogeneity of regional lung function in COPD patients, distinguishing them from healthy individuals of various ages.<b>Conclusion</b> EIT technology effectively reveals the spatiotemporal heterogeneity of regional lung function, which holds great promise for the diagnosis and management of COPD.]]></description>
<pubDate>2025/4/15 13:48:12</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CHEN Bai,LI Fang,LIU Kai,WU Yang,YAO Jia-Feng,ZHOU Tong]]></author>
</item>
<item>
<title><![CDATA[PES1 Repression Triggers Ribosomal Biogenesis Impairment and Cellular Senescence Through p53 Pathway Activation]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202501080000001]]></link>
<description><![CDATA[<b>Objective</b> The nucleolar protein PES1 (Pescadillo homolog 1) plays critical roles in ribosome biogenesis and cell cycle regulation, yet its involvement in cellular senescence remains poorly understood. This study aimed to comprehensively investigate the functional consequences of PES1 suppression in cellular senescence and elucidate the molecular mechanisms underlying its regulatory role.<b>Methods</b> Initially, we assessed PES1 expression patterns in two distinct senescence models: replicative senescent mouse embryonic fibroblasts (MEFs) and doxorubicin-induced senescent human hepatocellular carcinoma HepG2 cells. Subsequently, PES1 expression was specifically downregulated using siRNA-mediated knockdown in these cell lines as well as additional relevant cell types. Cellular proliferation and senescence were assessed by EdU incorporation and SA-β-gal staining assays, respectively. The expression of senescence-associated proteins (p53, p21, and Rb) and SASP factors (IL-6, IL-1β, and IL-8) were analyzed by Western blot or qPCR. Furthermore, Northern blot and immunofluorescence were employed to evaluate pre-rRNA processing and nucleolar morphology.<b>Results</b> PES1 expression was significantly downregulated in senescent MEFs and HepG2 cells. PES1 knockdown resulted in decreased EdU-positive cells and increased SA-β-gal-positive cells, indicating proliferation inhibition and senescence induction. Mechanistically, PES1 suppression activated the p53-p21 pathway without affecting Rb expression, while upregulating IL-6, IL-1β, and IL-8 production. Notably, PES1 depletion impaired pre-rRNA maturation and induced nucleolar stress, as evidenced by aberrant nucleolar morphology.<b>Conclusion</b> Our findings demonstrate that PES1 deficiency triggers nucleolar stress and promotes p53-dependent (but Rb-independent) cellular senescence, highlighting its crucial role in maintaining nucleolar homeostasis and regulating senescence-associated pathways.]]></description>
<pubDate>2025/4/14 13:49:51</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CHENG Long,JIN Rui,LI Yu-Fang,NIU Chang,WU Feng-Yun,YE Qi-Nong,ZHANG Chang-Jian]]></author>
</item>
<item>
<title><![CDATA[Construction Strategies and Challenges of Vascularized Brain Organoids]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202411250000002]]></link>
<description><![CDATA[Brain organoids are three-dimensional (3D) neural cultures that self-organize from pluripotent stem cells (PSCs) cultured <i>in vitro</i>. Compared with traditional two-dimensional (2D) neural cell culture systems, brain organoids demonstrate a significantly enhanced capacity to faithfully replicate key aspects of the human brain, including cellular diversity, 3D tissue architecture, and functional neural network activity. Importantly, they also overcome the inherent limitations of animal models, which often differ from human biology in terms of genetic background and brain structure. Owing to these advantages, brain organoids have emerged as a powerful tool for recapitulating human-specific developmental processes, disease mechanisms, and pharmacological responses, thereby providing an indispensable model for advancing our understanding of human brain development and neurological disorders. Despite their considerable potential, conventional brain organoids face a critical limitation: the absence of a functional vascular system. This deficiency results in inadequate oxygen and nutrient delivery to the core regions of the organoid, ultimately constraining long-term viability and functional maturation. Moreover, the lack of early neurovascular interactions prevents these models from fully recapitulating the human brain microenvironment. In recent years, the introduction of vascularization strategies has significantly enhanced the physiological relevance of brain organoid models. Researchers have successfully developed various vascularized brain organoid models through multiple innovative approaches. Biological methods, for example, involve co-culturing brain organoids with endothelial cells to induce the formation of static vascular networks. Alternatively, co-differentiation strategies direct both mesodermal and ectodermal lineages to generate vascularized tissues, while fusion techniques combine pre-formed vascular organoids with brain organoids. Beyond biological approaches, tissue engineering techniques have played a pivotal role in promoting vascularization. Microfluidic systems enable the creation of dynamic, perfusable vascular networks that mimic blood flow, while 3D printing technologies allow for the precise fabrication of artificial vascular scaffolds tailored to the organoid’s architecture. Additionally, <i>in vivo</i> transplantation strategies facilitate the formation of functional, blood-perfused vascular networks through host-derived vascular infiltration. The incorporation of vascularization has yielded multiple benefits for brain organoid models. It alleviates hypoxia within the organoid core, thereby improving cell survival and supporting long-term culture and maturation. Furthermore, vascularized organoids recapitulate critical features of the neurovascular unit, including the early structural and functional characteristics of the blood-brain barrier. These advancements have established vascularized brain organoids as a highly relevant platform for studying neurovascular disorders, drug screening, and other applications. However, achieving sustained, long-term functional perfusion while preserving vascular structural integrity and promoting vascular maturation remains a major challenge in the field. In this review, we systematically outline the key stages of human neurovascular development and provide a comprehensive analysis of the various strategies employed to construct vascularized brain organoids. We further present a detailed comparative assessment of different vascularization techniques, highlighting their respective strengths and limitations. Additionally, we summarize the principal challenges currently faced in brain organoid vascularization and discuss the specific technical obstacles that persist. Finally, in the outlook section, we elaborate on the promising applications of vascularized brain organoids in disease modeling and drug testing, address the main controversies and unresolved questions in the field, and propose potential directions for future research.]]></description>
<pubDate>2025/4/11 10:03:06</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[BAO Shuang-Qing,CHEN Meng-Meng,HU Nan,LI Xiao-Hong]]></author>
</item>
<item>
<title><![CDATA[A Muscle Fatigue Assessment Method of Electrical Impedance Tomography for Police Extreme Training Based on TK-Noser Regularization Algorithm]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202501100000001]]></link>
<description><![CDATA[<b>Objective</b> This study proposes a fatigue detection method for police extreme training based on electrical impedance imaging technology to prevent muscle damage caused by overstrain during intense physical training.<b>Methods</b> First, based on the mechanism of human anaerobic exercise, lactic acid was identified as a key indicator of muscle fatigue, demonstrating that measuring muscle lactic acid effectively reflects localized fatigue. Second, a numerical simulation model of the human calf was established, and the internal tissue structure of the calf was analyzed to determine the stages of lactic acid diffusion and change. Then, the reconstruction performance of electrical impedance tomography (EIT) in visualizing lactic acid diffusion was compared under three different regularization algorithms, and the most suitable regularization method for subsequent experiments was selected. Finally, a controlled experiment simulating lactate diffusion was conducted to verify the imaging capability of the TK-Noser regularization algorithm in complex imaging fields.<b>Results</b> Simulation results indicate that both the TK-Noser and TV regularization algorithms achieve superior imaging performance, effectively suppressing artifacts in the visualization of lactic acid diffusion inside muscle tissue. The average <i>ICC/RMSE</i> values reached 0.754/0.303 and 0.772/0.320, respectively, while the average <i>SSIM/PSNR</i> values were 0.677/61 dB and 0.488/60 dB, respectively. In the lactate diffusion experiment, the average <i>ICC/SSIM</i> of the EIT reconstruction results based on the TK-Noser regularization algorithm reached 0.701/0.572, respectively. Additionally, compared with the TV regularization algorithm, the TK-Noser algorithm better preserved the shape and structural integrity of the imaging target, with an <i>SSIM</i> value 21.2% higher than that of the TV regularization results. This enhancement ensures the stability of the experimental results and significantly improves the capability of electrical impedance imaging technology in monitoring lactate diffusion within complex fields.<b>Conclusion</b> The proposed method offers real-time convenience and non-invasiveness, making it a promising approach for dynamic monitoring of muscle lactate levels in police officers during extreme physical training.]]></description>
<pubDate>2025/4/11 8:39:58</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[LIU Jun-Feng,LIU Kai,LIU Tao,SHI Shu-Sheng,YAO Jia-Feng]]></author>
</item>
<item>
<title><![CDATA[The Application of Quantum Dots in Disease Diagnosis and Treatment]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202411290000001]]></link>
<description><![CDATA[Quantum dots (QDs), nanoscale semiconductor crystals, have emerged as a revolutionary class of nanomaterials with unique optical and electrochemical properties, making them highly promising for applications in disease diagnosis and treatment. Their tunable emission spectra, long-term photostability, high quantum yield, and excellent charge carrier mobility enable precise control over light emission and efficient charge utilization, which are critical for biomedical applications. This article provides a comprehensive review of recent advancements in the use of quantum dots for disease diagnosis and therapy, highlighting their potential and the challenges involved in clinical translation. Quantum dots can be classified based on their elemental composition and structural configuration. For instance, IB-IIIA-VIA group quantum dots and core-shell structured quantum dots are among the most widely studied types. These classifications are essential for understanding their diverse functionalities and applications. In disease diagnosis, quantum dots have demonstrated remarkable potential due to their high brightness, photostability, and ability to provide precise biomarker detection. They are extensively used in bioimaging technologies, enabling high-resolution imaging of cells, tissues, and even individual biomolecules. As fluorescent markers, quantum dots facilitate cell tracking, biosensing, and the detection of diseases such as cancer, bacterial and viral infections, and immune-related disorders. Their ability to provide real-time, <i>in vivo</i> tracking of cellular processes has opened new avenues for early and accurate disease detection. In the realm of disease treatment, quantum dots serve as versatile nanocarriers for targeted drug delivery. Their nanoscale size and surface modifiability allow them to transport therapeutic agents to specific sites, improving drug bioavailability and reducing off-target effects. Additionally, quantum dots have shown promise as photosensitizers in photodynamic therapy (PDT). When exposed to specific wavelengths of light, quantum dots interact with oxygen molecules to generate reactive oxygen species (ROS), which can selectively destroy malignant cells, vascular lesions, and microbial infections. This targeted approach minimizes damage to healthy tissues, making PDT a promising strategy for treating complex diseases. Despite these advancements, the translation of quantum dots from research to clinical application faces significant challenges. Issues such as toxicity, stability, and scalability in industrial production remain major obstacles. The potential toxicity of quantum dots, particularly to vital organs, has raised concerns about their long-term safety. Researchers are actively exploring strategies to mitigate these risks, including surface modification, coating, and encapsulation techniques, which can enhance biocompatibility and reduce toxicity. Furthermore, improving the stability of quantum dots under physiological conditions is crucial for their effective use in biomedical applications. Advances in surface engineering and the development of novel encapsulation methods have shown promise in addressing these stability concerns. Industrial production of quantum dots also presents challenges, particularly in achieving consistent quality and scalability. Recent innovations in synthesis techniques and manufacturing processes are paving the way for large-scale production, which is essential for their widespread adoption in clinical settings. This article provides an in-depth analysis of the latest research progress in quantum dot applications, including drug delivery, bioimaging, biosensing, photodynamic therapy, and pathogen detection. It also discusses the multiple barriers hindering their clinical use and explores potential solutions to overcome these challenges. The review concludes with a forward-looking perspective on the future directions of quantum dot research, emphasizing the need for further studies on toxicity mitigation, stability enhancement, and scalable production. By addressing these critical issues, quantum dots can realize their full potential as transformative tools in disease diagnosis and treatment, ultimately improving patient outcomes and advancing biomedical science.]]></description>
<pubDate>2025/4/11 8:37:28</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[KE Zhi-Jian,QI Li-Li,SHEN Ji-Sheng,WANG Jin-Bo,WANG Qi-Chao]]></author>
</item>
<item>
<title><![CDATA[<b>Review:</b>Lactate Transferase Function of Alanyl-transfer t-RNA Synthetase and Its Relationship With Exercise]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202502270000001]]></link>
<description><![CDATA[Lactylation (Kla), a protein post-translational modification characterized by the covalent conjugation of lactyl groups to lysine residues in proteins, is widely present in living organisms. Since its discovery in 2019, it has attracted much attention for its role in regulating major pathological processes such as tumorigenesis, neurodegenerative diseases, and cardiovascular diseases. By mediating core biological processes such as signal transduction, epigenetic regulation, and metabolic homeostasis, lactylation contributes to disease progression. However, the lactylation donor lactyl-CoA has a low intracellular concentration, and the specific enzyme catalyzing lactylation is not yet clear, which has become an urgent issue in lactate research. A groundbreaking study in 2024 found that alanyl-transfer t-RNA synthetase 1/2 (AARS1/2), members of the aminoacyl-tRNA synthetase (aaRS) family, can act as protein lysine lactate transferases, modifying histones and metabolic enzymes directly with lactate as a substrate, without relying on the classical substrate lactyl-CoA, promoting a new stage in lactate research. Although exercise significantly increases lactate levels in the body and can induce changes in lactylation in multiple tissues and cells, the regulation of lactylation by exercise is not entirely consistent with lactate levels. Research has found that high-intensity exercise can induce upregulation of lactate at 37 lysine sites in 25 proteins of adipose tissue, while leading to downregulation of lactate at 27 lysine sites in 22 proteins. The level of lactate is not the only factor regulating lactylation through exercise. We speculate that the lactate transferase AARS1/2 play an important role in the process of lactylation regulated by exercise, and AARS1/2 should also be regulated by exercise. This review introduces the molecular biology characteristics, subcellular localization, and multifaceted biological functions of AARS, including its canonical roles in alanylation and editing, as well as its newly identified lactate transferase activity. We detail the discovery of AARS1/2 as lactylation catalysts and the specific process of them as lactate transferases catalyzing protein lactylation. Furthermore, we discuss the pathophysiological significance of AARS in tumorigenesis, immune dysregulation, and neuropathy, with a focus on exploring the expression regulation and possible mechanisms of AARS through exercise. The expression of AARS in skeletal muscle regulated by exercise is related to exercise time and muscle fiber type; the skeletal muscle AARS2 upregulated by long-term and high-intensity exercise catalyzes the lactylation of key metabolic enzymes such as pyruvate dehydrogenase E1 alpha subunit (PDHA1) and carnitine palmitoyltransferase 2 (CPT2), reducing exercise capacity and providing exercise protection; physiological hypoxia caused by exercise significantly reduces the ubiquitination degradation of AARS2 by inhibiting its hydroxylation, thereby maintaining high levels of AARS2 protein and exerting lactate transferase function; exercise induced lactate production can promote the translocation of AARS1 cytoplasm to the nucleus, exert lactate transferase function upon nuclear entry, regulate histone lactylation, and participate in gene expression regulation; exercise induced lactate production promotes direct interactions between AARS and star molecules such as p53 and cGAS, and is widely involved in the occurrence and development of tumors and immune diseases. Elucidating the regulatory mechanism of exercise on AARS can provide new ideas for improving metabolic diseases and promote health through exercise.]]></description>
<pubDate>2025/4/11 8:33:53</pubDate>
<category><![CDATA[运动代谢效应与促健康机制研究专刊]]></category>
<author><![CDATA[LI Feng-Yi,SUN Ying-Ying,XING Zheng,ZHANG Jing]]></author>
</item>
<item>
<title><![CDATA[Interplay Between Interferon Stimulatory Pathways and Organellar Dynamics]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202411250000001]]></link>
<description><![CDATA[Interferon stimulating factor STING, a transmembrane protein residing in the endoplasmic reticulum, is extensively involved in the sensing and transduction of intracellular signals and serves as a crucial component of the innate immune system. STING is capable of directly or indirectly responding to abnormal DNA originating from diverse sources within the cytoplasm, thereby fulfilling its classical antiviral and antitumor functions. Structurally, STING is composed of 4 transmembrane helices, a cytoplasmic ligand binding domain (LBD), and a C terminal tail structure (CTT). The transmembrane domain (TM), which is formed by the transmembrane helical structures, anchors STING to the endoplasmic reticulum, while the LBD is in charge of binding to cyclic dinucleotides (CDNs). The classical second messenger, cyclic guanosine monophosphate-adenosine monophosphate (cGAMP), represents a key upstream molecule for STING activation. Once cGAMP binds to LBD, STING experiences conformational alterations, which subsequently lead to the recruitment of Tank-binding kinase 1 (TBK1) <i>via</i> the CTT domain. This, in turn, mediates interferon secretion and promotes the activation and migration of dendritic cells, T cells, and natural killer cells. Additionally, STING is able to activate nuclear factor-κB (NF-κB), thereby initiating the synthesis and release of inflammatory factors and augmenting the body’s immune response. In recent years, an increasing number of studies have disclosed the non-classical functions of STING. It has been found that STING plays a significant role in organelle regulation. STING is not only implicated in the quality control systems of organelles such as mitochondria and endoplasmic reticulum but also modulates the functions of these organelles. For instance, STING can influence key aspects of organelle quality control, including mitochondrial fission and fusion, mitophagy, and endoplasmic reticulum stress. This regulatory effect is not unidirectional; rather, it is subject to organelle feedback regulation, thereby forming a complex interaction network. STING also exerts a monitoring function on the nucleus and ribosomes, which further enhances the role of the cGAS-STING pathway in infection-related immunity. The interaction mechanism between STING and organelles is highly intricate, which, within a certain range, enhances the cells’ capacity to respond to external stimuli and survival pressure. However, once the balance of this interaction is disrupted, it may result in the occurrence and development of inflammatory diseases, such as aseptic inflammation and autoimmune diseases. Excessive activation or malfunction of STING may trigger an over-exuberant inflammatory response, which subsequently leads to tissue damage and pathological states. This review recapitulates the recent interactions between STING and diverse organelles, encompassing its multifarious functions in antiviral, antitumor, organelle regulation, and immune regulation. These investigations not only deepen the comprehension of molecular mechanisms underlying STING but also offer novel concepts for the exploration of human disease pathogenesis and the development of potential treatment strategies. In the future, with further probing into STING function and its regulatory mechanisms, it is anticipated to pioneer new approaches for the treatment of complex diseases such as inflammatory diseases and tumors.]]></description>
<pubDate>2025/4/10 10:49:54</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DAI Xin-Gui,DUAN Yu,LI Jin-Ru,YAO Yong-Ming]]></author>
</item>
<item>
<title><![CDATA[Regulation Mechanism of Eukaryotic Translation Initiation Factor 5A in Epithelial-mesenchymal Transition]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202412230000002]]></link>
<description><![CDATA[Eukaryotic translation initiation factor 5A (eIF5A) is the only known protein in eukaryotes that contains a hydroxyputrescine lysine modification. Only the modified form of eIF5A is biologically active and is widely involved in protein translation, mRNA degradation, autophagy, and other intracellular processes. Epithelial-mesenchymal transition (EMT) is a process in which epithelial cells transform into mesenchymal phenotype cells through a highly regulated program. It plays a key role in embryonic development, tissue regeneration, and wound healing. Based on its biological functions, EMT can be classified into three types: I, II, and III. Type III EMT is the core mechanism underlying malignant tumor cell invasion and metastasis. This EMT mechanism involves the canonical pathway induced by transforming growth factor-β (TGF-β) and is regulated by various growth factors (TRAF6, EGF, IGF, HGF, VEGF), transcription factors (Twist, Slug, NF-κB, E12/E47, SIP1, ZEB1, <i>etc</i>.), and signaling pathways such as Wnt/β-catenin and PEAK1. eIF5A can influence tumor cell proliferation, invasion, and metastasis by regulating EMT-related signaling pathways. The known signaling pathways through which eIF5A regulates EMT include the canonical Smad signaling pathway and non-canonical pathways such as Rho/Rac1, Twist, STAT3, and MAT1. Additionally, certain miRNA family members, such as miR-30b, miR-599, and miR-203, can bind to the 3"-UTR of eIF5A2, inhibiting its expression and subsequently suppressing the EMT process in cancer cells, including gastric cancer and colorectal cancer. GC7, an inhibitor targeting the key enzyme DHPS involved in eIF5A modification, has been shown to reverse the EMT mechanism in oral squamous cell carcinoma, lung cancer, and breast cancer by regulating cytokine-mediated signaling pathways, including HIF-1α, STAT3/c-MYC, and Twist. However, to date, no inhibitors directly targeting eIF5A have been developed. In recent years, the mechanism of eIF5A activation catalyzed by DHPS and DOHH has become increasingly clear. As the only protein involved in lysine deoxyhydroxymethylation, DHPS may play a more critical role than eIF5A in the overall signal transduction process. Through in-depth analysis of the DHPS protein structure and its active site, researchers have shifted their approach to DHPS inhibitor development from substrate analog inhibitors (such as GC7, CNI-1493, DHSI-15, <i>etc</i>.) to allosteric inhibitors (11g, 26d, 8m, GL-1, <i>etc</i>.). GC7 is not suitable for clinical trials due to its lack of specificity and low bioavailability, and the therapeutic potential of novel allosteric inhibitors has yet to be clarified. Therefore, there is a significant gap in the development of covalent drugs targeting DHPS for cancer treatment in clinical settings. This paper reviews the research progress on eIF5A in regulating EMT, focusing on the molecular mechanisms by which eIF5A influences tumor cell invasion and migration. It also discusses the characteristics and current limitations of inhibitors targeting the hypusine pathway, aiming to provide insights for studying tumor metastasis mechanisms and drug discovery.]]></description>
<pubDate>2025/4/9 15:11:00</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LIU Sen,PENG Can-Ming,WANG Juan-Ping]]></author>
</item>
<item>
<title><![CDATA[Adhesion Mechanisms of Aquatic Fouling Organisms Mediated by Biomacromolecules]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202501210000002]]></link>
<description><![CDATA[Aquatic organisms can secrete biomacromolecules through specialized organs, tissues, or structures, enabling adhesion to underwater material surfaces and leading to severe biofouling issues. This phenomenon adversely impacts aquatic ecosystem health and human activities. Biofouling has emerged as an emerging global environmental challenge. Adhesion serves as the foundation of biofouling, representing a critical step toward a comprehensive understanding of the adhesion mechanisms of aquatic organisms. Biomacromolecules, including proteins, lipids, and carbohydrates, are the primary functional components in the adhesive substances of aquatic fouling organisms. Research indicates that these biomacromolecules exhibit diversity in types and characteristics across different aquatic organisms, yet their adhesion mechanisms show unifying features. Despite significant progress, there remains a lack of comprehensive reviews on the adhesion mechanisms mediated by biomacromolecules in aquatic fouling organisms, particularly on the roles of lipids and carbohydrates. Through a comprehensive analysis of existing literature, this review systematically summarizes the mechanistic roles of three classes of macromolecules in aquatic biofouling adhesion processes. Proteins demonstrate central functionality in interfacial adhesion and cohesion through specialized functional amino acids, conserved structural domains, and post-translational modifications. Lipids enhance structural stability via hydrophobic barrier formation and antioxidative protection mechanisms. Carbohydrates contribute to adhesion persistence through cohesive reinforcement and enzymatic resistance of adhesive matrices. Building upon these mechanisms, this review proposes four prospective research directions: optimization of protein-mediated adhesion functionality, elucidation of lipid participation in adhesion dynamics, systematic characterization of carbohydrate adhesion modalities, and investigation of macromolecular synergy in composite adhesive systems. The synthesized knowledge provides critical insights into underwater adhesion mechanisms of aquatic fouling organisms and establishes a theoretical foundation for developing mechanism-driven antifouling strategies. This work advances fundamental understanding of bioadhesion phenomena while offering practical guidance for next-generation antifouling technology development.]]></description>
<pubDate>2025/4/4 12:56:17</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HE Dan,LI Shi-Guo,ZHAN Ai-Bin]]></author>
</item>
<item>
<title><![CDATA[Astrocytes in The Central Nervous System Regulate Myelination and Remyelination Through Multiple Mechanisms]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202411300000001]]></link>
<description><![CDATA[In the central nervous system (CNS), the myelin sheath, a specialized membrane structure that wraps around axons, is formed by oligodendrocytes through a highly coordinated spatiotemporal developmental program. The process begins with the directed differentiation of neural precursor cells into oligodendrocyte precursor cells (OPCs), followed by their migration, proliferation, differentiation, and maturation, ultimately leading to the formation of a multi-segmental myelin sheath structure. Recent single-cell sequencing research has revealed that this process involves the temporal regulation of over 200 key genes, with a regulatory network composed of transcription factors such as Sox10 and Olig2 playing a central role. The primary function of the myelin sheath is to accelerate nerve signal transmission and protect nerve fibers from damage. Its insulating properties not only increase nerve conduction speed by 50-100 times but also ensure the long-term functional integrity of the nervous system by maintaining axonal metabolic homeostasis and providing mechanical protection. The pathological effects of myelin sheath injury exhibit a cascade amplification pattern: acute demyelination leads to action potential conduction block, while chronic lesions may cause axonal damage and neuronal death in severe or long-term cases, ultimately resulting in irreversible neurological dysfunction with neurodegenerative characteristics. Multiple sclerosis (MS) is a neurodegenerative disease characterized by chronic inflammatory demyelination of the CNS. Clinically, the distribution of lesions in MS exhibits spatial heterogeneity, which is closely related to differences in the regenerative capacity of oligodendrocytes within the local microenvironment. Emerging evidence suggests that astrocytes form a dynamic “neural-immune-metabolic interface” and play a multidimensional regulatory role in myelin development and regeneration by forming heterogeneous populations composed of different subtypes. During embryonic development, astrocytes induce the targeted differentiation of OPCs in the ventricular region through the Wnt/β-catenin pathway. In the mature stage, they secrete platelet-derived growth factor AA (PDGF-AA) to establish a chemical gradient that guides the precise migration of OPCs along axonal bundles. Notably, astrocytes also provide crucial metabolic support by supplying energy substrates for high-energy myelin formation through the lactate shuttle mechanism. In addition, astrocytes play a dual role in myelin regulation. During the acute injury phase, reactive astrocytes establish a triple defense system within 72 h: upregulating glial fibrillary acidic protein (GFAP) to form scars that isolate lesions, activating the JAK-STAT3 regeneration pathway in oligodendrocytes <i>via</i> leukemia inhibitory factor (LIF), and releasing tumor necrosis factor-stimulated gene-6 (TSG-6) to inhibit excessive microglial activation. However, in chronic neurodegenerative diseases, the phenotypic transformation of astrocytes contributes to microenvironmental deterioration. The secretion of chondroitin sulfate proteoglycans (CSPGs) inhibits OPC migration <i>via</i> the RhoA/ROCK pathway, while the persistent release of reactive oxygen species (ROS) leads to mitochondrial dysfunction and the upregulation of complement C3-mediated synaptic pruning. This article reviews the mechanisms by which astrocytes regulate the development and regeneration of myelin sheaths in the CNS, with a focus on analyzing the multifaceted roles of astrocytes in this process. It emphasizes that astrocytes serve as central hubs in maintaining myelin homeostasis by establishing a metabolic microenvironment and signaling network, aiming to provide new therapeutic strategies for neurodegenerative diseases such as multiple sclerosis.]]></description>
<pubDate>2025/4/4 12:46:28</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[Lü Tao,LUO Fu-Cheng,XING Wen-Xiao]]></author>
</item>
<item>
<title><![CDATA[Mitochondial-located miRNAs in The Regulation of mtDNA Expression]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202501090000002]]></link>
<description><![CDATA[Mitochondria, functioning not only as the central hub of cellular energy metabolism but also as semi-autonomous organelles, orchestrate cellular fate decisions through their endogenous mitochondrial DNA (mtDNA), which encodes core components of the electron transport chain. Emerging research has identified microRNAs localized within mitochondria, termed mitochondria-located microRNAs (mitomiRs). Recent studies have revealed that mitomiRs are transcribed from nuclear DNA (nDNA), processed and matured in the cytoplasm, and subsequently transported into mitochondria. mitomiRs regulate mtDNA through diverse mechanisms, including modulation of mtDNA expression at the translational level and direct binding to mtDNA to influence transcription. Aberrant expression of mitomiRs leads to mitochondrial dysfunction and contributes to the pathogenesis of metabolic diseases. Restoring mitomiR expression to physiological levels using mitomiRs mimics or inhibitors has been shown to improve mitochondrial function and alleviate related diseases. Consequently, the regulatory mechanisms of mitomiRs have become a major focus in mitochondrial research. Given that mitomiRs are located in mitochondria, targeted delivery strategies designed for mtDNA can be adapted for the delivery of mitomiRs mimics or inhibitors. However, numerous intracellular and extracellular barriers remain, highlighting the need for more precise and efficient delivery systems in the future. The regulation of mtDNA expression mediated by mitomiRs not only expands our understanding of miRNA functions in post-transcriptional gene regulation but also provides promising molecular targets for the treatment of mitochondrial-related diseases. This review systematically summarizes recent research progress on mitomiRs in regulating mtDNA expression and discusses the underlying mechanisms of mitomiRs-mtDNA interactions. Additionally, it provides new perspectives on precision therapeutic strategies, with a particular emphasis on mitomiRs-based regulation of mitochondrial function in mitochondrial-related diseases.]]></description>
<pubDate>2025/4/4 12:43:16</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Le-Rong,LONG Jian-Gang,PENG Yun-Hua,WANG Peng-Xiao,WANG Zhen]]></author>
</item>
<item>
<title><![CDATA[Drug Delivery Systems for Pancreatic Cancers Treatment]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202501180000002]]></link>
<description><![CDATA[Pancreatic cancers (PCs) is a common malignant tumor with poor prognosis in the digestive system. Its main treatment methods include surgery, radiotherapy, chemotherapy, and targeted therapy. The early diagnosis rate of hidden onset of PCs is low, and most patients have already lost the opportunity to undergo surgery when diagnosed with PCs. Chemotherapy is still the main treatment for advanced PCs, but the use of chemotherapy drugs in PCs can easily lead to drug resistance. The most significant feature that distinguishes PCs from other tumors is its rich and dense matrix, which not only hinders drug penetration but also impedes the infiltration of immune cells. The above reasons have led to a very low survival rate of PCs patients. Therefore, drug delivery systems are very important in the diagnosis and treatment of PCs. They can improve drug delivery, enhance biological barrier penetration, reduce side effects, and combine multiple treatment methods. Therefore, the treatment prospects of PCs are very broad. Currently, drug delivery systems widely applied in PCs primarily include nanodrug delivery systems, tumor microenvironment-targeted drug delivery system, immunotherapy drug delivery system, gene therapy drug delivery system, and combination therapy drug delivery system that synergize multiple therapeutic modalities. Emerging drug delivery systems (DDSs) have revolutionized PCs treatment by addressing these challenges through multiple mechanisms. Nanoformulations improve drug solubility, prolong circulation time, and reduce systemic toxicity <i>via </i>passive/active targeting. Smart DDSs responsive to PCs-specific stimuli enable extracellular matrix degradation, tumor-associated fibroblasts reprogramming, and vascular normalization to enhance drug accessibility. Last but not least, carrier systems loaded with myeloid-derived suppressor cell inhibitors or T cell activators can reverse immunosuppression and potentiate immunotherapy efficacy. Advanced platforms co-deliver chemotherapeutics with immunomodulators, gene-editing tools, or sonodynamic agents to achieve synergistic antitumor effects. These platforms aim to address critical challenges in PCs treatment, such as enhancing drug bioavailability, overcoming stromal barriers, reprogramming immunosuppressive niches, and achieving multi-mechanistic antitumor effects. This article provides a systematic summary and prospective analysis of the current development status, latest cutting-edge advances, opportunities, and challenges of the above-mentioned drug delivery systems in the field of PCs therapy.]]></description>
<pubDate>2025/4/3 15:04:39</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CUI Li-Gang,LIANG Xiao-Long,SHI Wan-Rui]]></author>
</item>
<item>
<title><![CDATA[Study on Kinetic and Static Tasks With Different Resistance Coefficients in Post-stroke Rehabilitation Training Based on Functional Near-infrared Spectroscopy]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202412190000001]]></link>
<description><![CDATA[<b>Objective</b> Functional near-infrared spectroscopy (fNIRS), a novel non-invasive technique for monitoring cerebral activity, can be integrated with upper limb rehabilitation robots to facilitate the real-time assessment of neurological rehabilitation outcomes. The rehabilitation robot is designed with 3 training modes: passive, active, and resistance. Among these, the resistance mode has been demonstrated to yield superior rehabilitative outcomes for patients with a certain level of muscle strength. The control modes in the resistance mode can be categorized into dynamic and static control. However, the effects of different control modes in the resistance mode on the motor function of patients with upper limb hemiplegia in stroke remain unclear. Furthermore, the effects of force, an important parameter of different control modes, on the activation of brain regions have rarely been reported. This study investigates the effects of dynamic and static resistance modes under varying resistance levels on cerebral functional alterations during motor rehabilitation in post-stroke patients.<b>Methods</b> A cohort of 20 stroke patients with upper limb dysfunction was enrolled in the study, completing preparatory adaptive training followed by 3 intensity-level tasks across 2 motor paradigms. The bilateral prefrontal cortices (PFC), bilateral primary motor cortices (M1), bilateral primary somatosensory cortices (S1), and bilateral premotor and supplementary motor cortices (PM) were examined in both the resting and motor training states. The lateralization index (LI), phase locking value (PLV), network metrics were employed to examine cortical activation patterns and topological properties of brain connectivity.<b>Results</b> The data indicated that both dynamic and static modes resulted in significantly greater activation of the contralateral M1 area and the ipsilateral PM area when compared to the resting state. The static patterns demonstrated a more pronounced activation in the contralateral M1 in comparison to the dynamic patterns. The results of brain network analysis revealed significant differences between the dynamic and resting states in the contralateral PFC area and contralateral M1 area (<i>F</i>=4.709, <i>P</i>=0.038), as well as in the contralateral PM area and ipsilateral M1 area (<i>F</i>=4.218, <i>P</i>=0.049). Moreover, the findings indicated a positive correlation between the activation of the M1 region and the increase in force in the dynamic mode, which was reversed in the static mode.<b>Conclusion</b> Both dynamic and static resistance training modes have been demonstrated to activate the corresponding brain functional regions. Dynamic resistance modes elicit greater oxygen changes and connectivity to the region of interest (ROI) than static resistance modes. Furthermore, the effects of increasing force differ between the two modes. In patients who have suffered a stroke, dynamic modes may have a more pronounced effect on the activation of exercise-related functional brain regions.]]></description>
<pubDate>2025/4/1 10:51:16</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[DOU Jia-Xuan,FU Ling-Di,LIANG Zhen-Hu,TANG Min,YIN Li-Yong,YING Ting-Ting]]></author>
</item>
<item>
<title><![CDATA[Self-face Advantage Processing and Its Mechanisms]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202501150000003]]></link>
<description><![CDATA[Self-face is a unique and highly distinctive stimulus, not shared with others, and serves as a reliable marker of self-awareness. Compared to other faces, self-face processing exhibits several advantages, including the self-face recognition advantage, self-face attention advantage, and self-face positive processing advantage. The self-face recognition advantage manifests as faster and more accurate identification across different orientations and spatial frequency components, supported by enhanced early event-related potential (ERP) components, such as N170. Attentional biases toward self-face are evident in target detection during spatial tasks and the attentional blink effect in temporal paradigms. However, measurement sensitivity, perceptual load, and task demands contribute to some mixed findings. Positive biases further characterize the self-face processing advantage, with individuals perceiving their faces as more attractive or trustworthy than objective representations. These biases even extend to self-similar others, influencing social behaviors such as trust and voting preferences. Self-face processing advantages have been observed at an unconscious level and are regulated by several factors, including self-esteem, cultural differences, and multisensory integration. Cultural and individual differences play a crucial role in shaping self-face advantages. Individuals from Western cultures, which emphasize independent self-construal, exhibit stronger self-face biases compared to those from East Asian collectivist contexts. Self-esteem also modulates self-face advantages: high-self-esteem individuals generally maintain their self-face recognition advantage despite interference, exhibit attentional prioritization of self-faces, and demonstrate enhanced positive associations with subliminal self-faces. In contrast, low-self-esteem individuals display recognition vulnerabilities to social cues, show context-dependent attentional divergence (prioritizing others’ faces in task-oriented settings while prioritizing self-face in free-viewing tasks), and exhibit reversed positive associations with subliminal self-faces. Multisensory integration, such as synchronized visual-tactile cues, enhances self-face advantages and induces perceptual plasticity. This phenomenon is exemplified by the enfacement illusion, in which synchronous visual and tactile inputs update the mental representation of the self-face, leading to assimilation with another face. Neuroanatomically, self-face processing is predominantly lateralized to the right hemisphere and involves a network of brain regions, including the occipital lobe, temporal lobe, frontal lobe, insula, and cingulate gyrus. Disruptions in these networks are linked to self-face processing deficits in socio-cognitive disorders. For instance, autism spectrum disorder (ASD) and schizophrenia are associated with attenuated self-face advantages and abnormal neural activity in regions such as the right inferior frontal gyrus, insula, and posterior cingulate cortex. These findings suggest that self-face processing could serve as a potential biomarker for the early diagnosis and intervention of such disorders. In recent years, researchers have proposed various theoretical explanations for self-face processing and its advantage effects. However, some studies have reported no significant behavioral or neural advantages of self-faces over familiar faces, leaving the specificity of self-face a subject of debate. Further elucidation of self-face specificity requires the adoption of a face association paradigm, which controls for facial familiarity and helps determine whether qualitative differences exist between self-faces and familiar faces. Given the close relationship between self-face processing advantages and socio-cognitive disorders (e.g., ASD, schizophrenia), a deeper understanding of self-face specificity has the potential to provide critical insights into the early identification, classification, and intervention of these disorders. This research holds both theoretical significance and substantial social value.]]></description>
<pubDate>2025/3/26 10:58:10</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[TANG Xiao-Xia,WANG Li,ZHANG Shu-Jia,ZHANG Ying]]></author>
</item>
<item>
<title><![CDATA[<b>Review:</b>Effect of Exercise Intervention on Bone Mineral Density in Postmenopausal Osteoporosis Womana Network Meta-analysis]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202411270000003]]></link>
<description><![CDATA[Postmenopausal osteoporosis (PMOP) is a chronic metabolic bone disease caused by a decrease in estrogen levels. With the acceleration of population aging process, the public health burden caused by it is becoming increasingly severe. The prevalence rate of osteoporosis in people over 65 years old in China is as high as 32%, which is especially prominent after menopause, which is about 5 times that of elderly men. About 40% of postmenopausal women are at risk of osteoporotic fractures, with a disability rate of up to 50% and a fatality rate of about 20%. The prevention and treatment of osteoporosis has become a major public health issue of global concern, and it is particularly urgent to develop reasonable and effective prevention and treatment programs and explore their scientific basis. Exercise is an important non-drug means for the prevention and treatment of PMOP, it can improve estrogen levels and the expression of bone formation transcription factors, and inhibit the levels of proinflammatory factors and bone resorption markers, macroscopically manifested by the improvement of bone microstructure and bone density. However, the effectiveness of exercise in improving bone mineral density (BMD) remains controversial. Some studies revealed significant changes of bone to mechanical stimulation, while others showed no significant effect of mechanical training, this heterogeneity in bone adapt to mechanical stimulation is particularly evident in postmenopausal women. Although the evidence that a wide range of exercise programs can improve osteoporosis, the optimal solution to address bone mineral loss remains unclear. The most effective exercise type, dosage and personalized adaptation are still being determined. This study will fully consider the differences in gender and hormone levels, searching and screening randomized controlled trials of PubMed, CNKI and other databases regarding exercise improving bone mineral density in women with PMOP. Strictly following the PRISMA guidelines to reviewed and compared the effects of different types of exercise modalities on BMD at different sites in women with PMOP by network Meta-analysis, to provide theoretical guidance to maintain or improve BMD in women with PMOP.]]></description>
<pubDate>2025/3/25 11:49:34</pubDate>
<category><![CDATA[运动代谢效应与促健康机制研究专刊]]></category>
<author><![CDATA[CHEN Zhuo,HAO Ying,SUN Meng-Ying,YANG Ning-Ning,ZHOU Xiao-Bin]]></author>
</item>
<item>
<title><![CDATA[Terms Related to The Study of Biomacromolecular Condensates]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202412300000002]]></link>
<description><![CDATA[Biomolecular condensates are formed through phase separation of biomacromolecules such as proteins and RNAs. These condensates exhibit liquid-like properties that can futher transition into more stable material states. They form complex internal structures <i>via</i> multivalent weak interactions, enabling precise spatiotemporal regulations. However, the use of inconsistent and non-standardized terminology has become increasingly problematic, hindering academic exchange and the dissemination of scientific knowledge. Therefore, it is necessary to discuss the terminology related to biomolecular condensates in order to clarify concepts, promote interdisciplinary cooperation, enhance research efficiency, and support the healthy development of this field.]]></description>
<pubDate>2025/3/24 16:23:17</pubDate>
<category><![CDATA[学术讨论]]></category>
<author><![CDATA[FANG Xiao-Feng,LI Dan,LI Pi-Long,LIN Yi,LIU Cong,RUAN Ke,SHI Yun-Yu,WANG Zheng,ZHANG Hong,ZHANG Ming-Jie]]></author>
</item>
<item>
<title><![CDATA[Communication Between Mitochondria and Nucleus With Retrograde Signals]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202412230000003]]></link>
<description><![CDATA[Mitochondria, the primary energy-producing organelles of the cell, also serve as signaling hubs and participate in diverse physiological and pathological processes, including apoptosis, inflammation, oxidative stress, neurodegeneration, and tumorigenesis. As semi-autonomous organelles, mitochondrial functionality relies on nuclear support, with mitochondrial biogenesis and homeostasis being stringently regulated by the nuclear genome. This interdependency forms a bidirectional signaling network that coordinates cellular energy metabolism, gene expression, and functional states. During mitochondrial damage or dysfunction, retrograde signals are transmitted to the nucleus, activating adaptive transcriptional programs that modulate nuclear transcription factors, reshape nuclear gene expression, and reprogram cellular metabolism. This mitochondrion-to-nucleus communication, termed “mitochondrial retrograde signaling”, fundamentally represents a mitochondrial “request” to the nucleus to maintain organellar health, rooted in the semi-autonomous nature of mitochondria. Despite possessing their own genome, the “fragmented” mitochondrial genome necessitates reliance on nuclear regulation. This genomic incompleteness enables mitochondria to sense and respond to cellular and environmental stressors, generating signals that modulate the functions of other organelles, including the nucleus. Evolutionary transfer of mitochondrial genes to the nuclear genome has established mitochondrial control over nuclear activities <i>via </i>retrograde communication. When mitochondrial dysfunction or environmental stress compromises cellular demands, mitochondria issue retrograde signals to solicit nuclear support. Studies demonstrate that mitochondrial retrograde signaling pathways operate in pathological contexts such as oxidative stress, electron transport chain (ETC) impairment, apoptosis, autophagy, vascular tension, and inflammatory responses. Mitochondria-related diseases exhibit marked heterogeneity but invariably result in energy deficits, preferentially affecting high-energy-demand tissues like muscles and the nervous system. Consequently, mitochondrial dysfunction underlies myopathies, neurodegenerative disorders, metabolic diseases, and malignancies. Dysregulated retrograde signaling triggers proliferative and metabolic reprogramming, driving pathological cascades. Mitochondrial retrograde signaling critically influences tumorigenesis and progression. Tumor cells with mitochondrial dysfunction exhibit compensatory upregulation of mitochondrial biogenesis, excessive superoxide production, and ETC overload, collectively promoting metastatic tumor development. Recent studies reveal that mitochondrial retrograde signaling—mediated by altered metabolite levels or stress signals—induces epigenetic modifications and is intricately linked to tumor initiation, malignant progression, and therapeutic resistance. For instance, mitochondrial dysfunction promotes oncogenesis through mechanisms such as epigenetic dysregulation, accumulation of mitochondrial metabolic intermediates, and mitochondrial DNA (mtDNA) release, which activates the cytosolic cGAS-STING signaling pathway. In normal cells, miR-663 mediates mitochondrion-to-nucleus retrograde signaling under reactive oxygen species (ROS) regulation. Mitochondria modulate miR-663 promoter methylation, which governs the expression and supercomplex stability of nuclear-encoded oxidative phosphorylation (OXPHOS) subunits and assembly factors. However, dysfunctional mitochondria induce oxidative stress, elevate methyltransferase activity, and cause miR-663 promoter hypermethylation, suppressing miR-663 expression. Mitochondrial dysfunction also triggers retrograde signaling in primary mitochondrial diseases and contributes to neurodegenerative disorders such as Parkinson’s disease (PD) and Alzheimer’s disease (AD). Current therapeutic strategies targeting mitochondria in neurological diseases focus on 5 main approaches: alleviating oxidative stress, inhibiting mitochondrial fission, enhancing mitochondrial biogenesis, mitochondrial protection, and insulin sensitization. In AD patients, mitochondrial morphological abnormalities and enzymatic defects, such as reduced pyruvate dehydrogenase and α-ketoglutarate dehydrogenase activity, are observed. Platelets and brains of AD patients exhibit diminished cytochrome c oxidase (COX) activity, correlating with mitochondrial dysfunction. To model AD-associated mitochondrial pathology, researchers employ cybrid technology, transferring mtDNA from AD patients into enucleated cells. These cybrids recapitulate AD-related mitochondrial phenotypes, including reduced COX activity, elevated ROS production, oxidative stress markers, disrupted calcium homeostasis, activated stress signaling pathways, diminished mitochondrial membrane potential, apoptotic pathway activation, and increased Aβ42 levels. Furthermore, studies indicate that Aβ aggregates in AD and α-synuclein aggregates in PD trigger mtDNA release from damaged microglial mitochondria, activating the cGAS-STING pathway. This induces a reactive microglial transcriptional state, exacerbating neurodegeneration and cognitive decline. Targeting the cGAS-STING pathway may yield novel therapeutics for neurodegenerative diseases like AD, though translation from bench to bedside remains challenging. Such research not only deepens our understanding of disease mechanisms but also informs future therapeutic strategies. Investigating the triggers, core molecular pathways, and regulatory networks of mitochondrial retrograde signaling advances our comprehension of intracellular communication and unveils novel pathogenic mechanisms underlying malignancies, neurodegenerative diseases, and type 2 diabetes mellitus. This review summarizes established mitochondrial-nuclear retrograde signaling axes, their roles in interorganellar crosstalk, and pathological consequences of dysregulated communication. Targeted modulation of key molecules and proteins within these signaling networks may provide innovative therapeutic avenues for these diseases.]]></description>
<pubDate>2025/3/21 11:59:34</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[QUAN Lei,ZHANG Wen-Long,ZHAO Yun-Gang]]></author>
</item>
<item>
<title><![CDATA[Application of Nanomaterials in The Prevention and Treatment of Radiation-induced Injury]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202412060000002]]></link>
<description><![CDATA[Radiation-induced injury is a key factor in determining the prognosis of patients undergoing radiotherapy, highlighting the significant clinical importance of developing drugs for radiation prevention and treatment. Especially in oncology, radiation-induced injury remains a pivotal determinant of therapeutic outcomes, because of its direct correlation with normal tissue damage during radiotherapy. Efforts to mitigate or treat such injury are thus paramount in enhancing the overall safety and efficacy of cancer treatment. Novel nanomedicines with prolonged systemic circulation, versatile drug-loading capacities, enhanced tissue retention, and stimuli responsiveness exhibit unique advantages in the treatment and prevention of radiation-induced diseases, as they can be designed based on the specific microenvironment of radiation-damaged tissues, which offers innovative solutions to address the limitations of conventional radioprotectors such as short half-life, poor tissue targeting, and systemic side effects. This review thus aims to provide an overview of recent advance in the design and application of nanomaterials for radiation prevention and treatment. Generally, ionizing radiation damages cells either by inducing DNA double-strand breaks or through the generation of reactive oxygen species (ROS). The resulting oxidative stress would disrupt the structural integrity of cell membranes, proteins, and nucleic acids, leading to apoptosis, chronic inflammation, and systemic effects across multiple systems, including hematopoietic system, gastrointestinal tract, skin, lungs, brain, and heart. Radiation protection strategies focus on scavenging ROS, stimulating cellular repair and regeneration, inducing tissue hypoxia, and inhibiting apoptotic pathways. Recent advances in nanomedicine have introduced novel approaches for targeted and efficient radiation protection and treatment. For radiation-induced hematopoietic injury, nanoparticles can been designed to promote red and white blood cell regeneration while reducing oxidative stress. To address radiation-induced gastrointestinal injuries, nanomaterials enable localized antioxidant delivery and extended intestinal retention, effectively relieving radiation enteritis by scavenging ROS and modulating gut microbiota. For radiation-induced skin injuries, self-assembling peptide hydrogels that mimic the extracellular matrix can serve as effective scaffolds for wound healing. These hydrogels exhibit excellent antioxidant properties, stimulating angiogenesis, and accelerating the recovery of radiation dermatitis. In cases of radiation-induced brain damage, nanoparticles were designed to cross the blood-brain barrier to rescue neuronal damage and protect cognitive function. This review provides an in-depth insight into the mechanisms underlying radiation-induced injuries and highlights how nanomaterial were construtced according to the specific injury. Therefore, nanotechnology endowers durgs with transformative potential for preventing and treating radiation-induced injuries. Despite significant progress in nanomedicine, there are still challenges in long-term biocompatibility, precise targeting of damaged tissues, and scalable manufacturing. In addition, an in-depth understanding of the interactions between nanomaterials and biological systems remains to be covered. Future efforts should focus on optimizing design strategies, enhancing clinical translatability, and ensuring long-term safety, ultimately improving patient outcomes. Besides, expanding research into other radiation-induced diseases, such as radiation-induced ophthalmic disorders and hepatic injuries, may diversify therapeutic options.]]></description>
<pubDate>2025/3/18 20:58:19</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LIU Wei,LIU Ya,LONG Wei,WANG Qing-Qing]]></author>
</item>
<item>
<title><![CDATA[The Role of Mitochondrial Quality Control in Glycolipid Metabolism and Metabolic Diseases]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202410300000002]]></link>
<description><![CDATA[The liver, skeletal muscle, and adipose tissue are central energy-metabolizing organs and insulin-sensitive tissues, playing a crucial role in maintaining glucose homeostasis. As the powerhouse of the cell, mitochondria not only regulate insulin secretion but also oversee the oxidative phosphorylation and β-oxidation of fatty acids, processes vital for the metabolism of carbohydrates and fats, as well as the synthesis of ATP. The mitochondrial quality control system is of paramount importance for sustaining mitochondrial homeostasis, achieved through mechanisms such as protein homeostasis, mitochondrial dynamics, mitophagy, and biogenesis. Evidence suggests that dysfunctional mitochondria may significantly contribute to insulin resistance and ectopic fat storage in the liver, offering new insights into the strong correlation between mitochondrial dysfunction and the development of obesity, diabetes mellitus type 2 (T2DM), and non-alcoholic fatty liver disease (NAFLD). This manuscript aims to delve into the precise mechanisms by which imbalances in mitochondrial quality control lead to metabolic disorders in the liver, skeletal muscle, and adipose tissue, the 3 major insulin-sensitive organs. In the liver, mitochondrial dysfunction can lead to disturbances in glucose and lipid metabolism, resulting in insulin resistance and fat accumulation—a key factor in the development of NAFLD. In skeletal muscle, reduced mitochondrial function can decrease ATP production, weakening the muscle’s ability to uptake glucose, thereby exacerbating insulin resistance. In adipose tissue, mitochondrial dysfunction can impair adipocyte function, leading to lipotoxicity and inflammatory responses,which further contribute to insulin resistance and the onset of metabolic syndrome. Moreover, the interorgan crosstalk among these 3 tissues is essential for overall metabolic homeostasis. For instance, hepatic gluconeogenesis and glucose utilization in skeletal muscle are both influenced by the health status of their respective mitochondrial populations. The conversion between different types of adipose tissue and the ability to store lipids depend on normal mitochondrial function to avert ectopic fat accumulation in other organs. In summary, this manuscript emphasizes the critical role of mitochondrial quality control in maintaining the metabolic stability of the liver, skeletal muscle, and adipose tissue. It elucidates the specific mechanisms by which mitochondrial dysfunction in these organs contributes to the development of metabolic diseases, providing a foundation for future research and the development of therapeutic strategies targeting mitochondrial dysfunction.]]></description>
<pubDate>2025/3/10 10:57:36</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[FENG Jia-Jia,GUO Meng,Lü Bin,OUYANG Zheng]]></author>
</item>
<item>
<title><![CDATA[Mitochondrial Function and Regulation in Spermatogenesis and Activation of <i>Caenorhabditis elegans</i>]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202412240000003]]></link>
<description><![CDATA[Mitochondria play a pivotal role in spermatogenesis and sperm activation in <i>Caenorhabditis elegans</i>, serving as the primary ATP supplier for cell division and differentiation while also acting as a key regulator of zinc ion homeostasis, membrane dynamics, and apoptotic signaling. This review systematically summarizes the essential mitochondrial mechanisms at different stages of sperm development, highlighting their multifaceted contributions beyond energy metabolism. Mitochondria are crucial for maintaining the health and stability of the gonads by regulating key apoptotic execution proteins that facilitate the proper elimination of damaged or unnecessary germ cells. Additionally, mitochondria dynamically adjust their energy supply to meet the metabolic demands of different stages of germline development. During early spermatogenesis, mitochondria provide ATP to fuel mitotic and meiotic divisions, support cellular differentiation, and regulate H<sup>+</sup> and Zn<sup>2+</sup> exchange to maintain cytoplasmic homeostasis, thereby ensuring the proper maturation and functionality of sperm cells. As spermatogenesis progresses, mitochondria participate in processing and sorting essential sperm proteins, such as major sperm protein (MSP), and contribute to the formation of membranous organelles (MOs), which are critical for subsequent activation events. During sperm activation, mitochondria play a dual role in ensuring a successful transition from immotile spermatids to fully functional spermatozoa. First, they provide ATP to facilitate pseudopod formation, MO fusion, and ion channel regulation, all of which are essential for sperm motility and fertilization potential. Second, mitochondria regulate the quality and quantity of functional mitochondria within sperm cells through mitopherogenesis—a recently discovered process in which mitochondrial vesicles are selectively released, ensuring that only healthy mitochondria are retained. This quality-control mechanism optimizes mitochondrial function, which is crucial for sustaining sperm motility and longevity. Beyond their traditional role in energy metabolism, mitochondria may also contribute to protein synthesis during spermatogenesis and activation. Recent evidence suggests that mitochondrial ribosomes actively translate specific proteins required for sperm function, challenging the long-standing belief that spermatozoa do not engage in <i>de novo</i> protein synthesis after differentiation. This emerging perspective raises important questions about the role of mitochondria in regulating sperm activation at the molecular level, particularly in modulating oxidative phosphorylation (OXPHOS) protein composition to optimize ATP production. In summary, mitochondria serve as both the central energy hub and a crucial regulatory factor in sperm activation, metabolic homeostasis, and reproductive success. Their involvement extends beyond ATP generation to include apoptotic regulation, ion homeostasis, vesicle-mediated mitochondrial quality control, and potential contributions to protein synthesis. Understanding these mitochondrial functions in <i>C. elegans</i> not only deepens our knowledge of nematode reproductive biology, but also provides valuable insights into broader mechanisms governing mitochondrial regulation in germline cells across species. These findings open new avenues for future research into the interplay between mitochondria, energy metabolism, and sperm function, with potential implications for reproductive health and fertility studies.]]></description>
<pubDate>2025/3/7 16:40:58</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHANG Zhan-Xin,MIAO Long,WANG Peng]]></author>
</item>
<item>
<title><![CDATA[The Mesencephalic Locomotor Region for Locomotion Control]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202409060000001]]></link>
<description><![CDATA[Locomotion, a fundamental motor function encompassing various forms such as swimming, walking, running, and flying, is essential for animal survival and adaptation. The mesencephalic locomotor region (MLR), located at the midbrain-hindbrain junction, is a conserved brain area critical for controlling locomotion. This review highlights recent advances in understanding the MLR’s structure and function across species, from lampreys to mammals and birds, with a particular focus on insights gained from optogenetic studies in mammals. The goal is to uncover universal strategies for MLR-mediated locomotor control. Electrical stimulation of the MLR in species such as lampreys, salamanders, cats, and mice initiates locomotion and modulates speed and patterns. For example, in lampreys, MLR stimulation induces swimming, with increased intensity or frequency enhancing propulsive force. Similarly, in salamanders, graded stimulation transitions locomotor outputs from walking to swimming. Histochemical studies reveal that effective MLR stimulation sites colocalize with cholinergic neurons, suggesting a conserved neurochemical basis for locomotion control. In mammals, the MLR comprises two key nuclei: the cuneiform nucleus (CnF) and the pedunculopontine nucleus (PPN). Both nuclei contain glutamatergic and GABAergic neurons, with the PPN additionally housing cholinergic neurons. Optogenetic studies in mice by selectively activating glutamatergic neurons have demonstrated that the CnF and PPN play distinct roles in motor control: the CnF drives rapid escape behaviors, while the PPN regulates slower, exploratory movements. This functional specialization within the MLR allows animals to adapt their locomotion patterns and speed in response to environmental demands and behavioral objectives. Similar to findings in lampreys, the CnF and PPN in mice transmit motor commands to spinal effector circuits by modulating the activity of brainstem reticular formation neurons. However, they achieve this through distinct reticulospinal pathways, enabling the generation of specific behaviors. Further insights from monosynaptic rabies viral tracing reveal that the CnF and PPN integrate inputs from diverse brain regions to produce context-appropriate behaviors. For instance, glutamatergic neurons in the PPN receive signals from other midbrain structures, the basal ganglia, and medullary nuclei, whereas glutamatergic neurons in the CnF rarely receive inputs from the basal ganglia but instead are strongly influenced by the periaqueductal grey and inferior colliculus within the midbrain. These differential connectivity patterns underscore the specialized roles of the CnF and PPN in motor control, highlighting their unique contributions to coordinating locomotion. Birds exhibit exceptional flight capabilities, yet the avian MLR remains poorly understood. Comparative studies suggest that the pedunculopontine tegmental nucleus (PPTg) in birds is homologous to the mammalian PPN, which contains cholinergic neurons, while the intercollicular nucleus (ICo) or nucleus isthmi pars magnocellularis (ImC) may correspond to the CnF. These findings provide important clues for identifying the avian MLR and elucidating its role in flight control. However, functional validation through targeted experiments is urgently needed to confirm these hypotheses. Optogenetics and other advanced techniques in mice have greatly advanced MLR research, enabling precise manipulation of specific neuronal populations. Future studies should extend these methods to other species, particularly birds, to explore unique locomotor adaptations. Comparative analyses of MLR structure and function across species will deepen our understanding of the conserved and evolved features of motor control, revealing fundamental principles of locomotion regulation throughout evolution. By integrating findings from diverse species, we can uncover how the MLR has been adapted to meet the locomotor demands of different environments, from aquatic to aerial habitats.]]></description>
<pubDate>2025/3/7 15:03:45</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[GUO Xing-Chen,LI Wen-Fen,SUN Ying-Yu,WEI Xin-Shuo,XIE Yan]]></author>
</item>
<item>
<title><![CDATA[Role of Peripheral 5-hydroxytryptamine in Toll-like Receptor 4-mediated Diabetes Mellitus Type 2]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202412180000001]]></link>
<description><![CDATA[In recent years, the prevalence of diabetes has continued to rise, with diabetes mellitus type 2 (T2DM) being the most common form. T2DM is characterized by chronic low-grade inflammation and disruptions in insulin metabolism. Toll-like receptor 4 (TLR4) is a key pattern recognition receptor that, upon activation, upregulates pro-inflammatory cytokines <i>via</i> the nuclear factor κB (NF-κB) pathway, thereby contributing to the pathogenesis of T2DM. Peripheral 5-hydroxytryptamine (5-HT), primarily synthesized by enterochromaffin (EC) cells in the gut, interacts with 5-hydroxytryptamine receptors (5-HTRs) in key insulin-target tissues, including the liver, adipose tissue, and skeletal muscle. This interaction influences hepatic gluconeogenesis, fat mobilization, and the browning of white adipose tissue. Elevated peripheral 5-HT levels may disrupt glucose and lipid metabolism, thereby contributing to the onset and progression of T2DM. Within mitochondria, 5-HT undergoes degradation and inactivation through the enzymatic action of monoamine oxidase A (MAO-A), leading to the generation of reactive oxygen species (ROS). Excessive ROS production and accumulation can induce oxidative stress, which may further contribute to the pathogenesis of T2DM. Platelets serve as the primary reservoir for 5-HT in the bloodstream. The activation of the TLR4 signaling pathway on the platelet surface, coupled with reduced expression of the 5-HT transporter on the cell membrane, leads to elevated serum 5-HT levels, potentially accelerating the progression of T2DM. Therefore, inhibition of TLR4 and reduction of peripheral 5-HT levels could represent promising therapeutic strategies for T2DM. This review explores the synthesis, transport, and metabolism of peripheral 5-HT, as well as its role in TLR4-mediated T2DM, with the aim of providing novel insights into the clinical diagnosis, treatment, and evaluation of T2DM.]]></description>
<pubDate>2025/3/5 11:36:35</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHANG Xiao-Tong,YANG Bo,ZHANG Ping,ZHANG Yi-Ying]]></author>
</item>
<item>
<title><![CDATA[Application of Engineered Exosomes in Tumor-targeted Therapy]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202410100000001]]></link>
<description><![CDATA[Tumors are the second leading cause of death worldwide. Exosomes are a type of extracellular vesicle secreted from multivesicular bodies, with particle sizes ranging from 40 to 160 nm. They regulate the tumor microenvironment, proliferation, and progression by transporting proteins, nucleic acids, and other biomolecules. Compared with other drug delivery systems, exosomes derived from different cells possess unique cellular tropism, enabling them to selectively target specific tissues and organs. This homing ability allows them to cross biological barriers that are otherwise difficult for conventional drug delivery systems to penetrate. Due to their biocompatibility and unique biological properties, exosomes can serve as drug delivery systems capable of loading various anti-tumor drugs. They can traverse biological barriers, evade immune responses, and specifically target tumor tissues, making them ideal carriers for anti-tumor therapeutics. This article systematically summarizes the methods for exosome isolation, including ultracentrifugation, ultrafiltration, size-exclusion chromatography (SEC), immunoaffinity capture, and microfluidics. However, these methods have certain limitations. A combination of multiple isolation techniques can improve isolation efficiency. For instance, combining ultrafiltration with SEC can achieve both high purity and high yield while reducing processing time. Exosome drug loading methods can be classified into post-loading and pre-loading approaches. Pre-loading is further categorized into active and passive loading. Active loading methods, including electroporation, sonication, extrusion, and freeze-thaw cycles, involve physical or chemical disruption of the exosome membrane to facilitate drug encapsulation. Passive loading relies on drug concentration gradients or hydrophobic interactions between drugs and exosomes for encapsulation. Pre-loading strategies also include genetic engineering and co-incubation methods. Additionally, we review approaches to enhance the targeting, retention, and permeability of exosomes. Genetic engineering and chemical modifications can improve their tumor-targeting capabilities. Magnetic fields can also be employed to promote the accumulation of exosomes at tumor sites. Retention time can be prolonged by inhibiting monocyte-mediated clearance or by combining exosomes with hydrogels. Engineered exosomes can also reshape the tumor microenvironment to enhance permeability. This review further discusses the current applications of exosomes in delivering various anti-tumor drugs. Specifically, exosomes can encapsulate chemotherapeutic agents such as paclitaxel to reduce side effects and increase drug concentration within tumor tissues. For instance, exosomes loaded with doxorubicin can mitigate cardiotoxicity and minimize adverse effects on healthy tissues. Furthermore, exosomes can encapsulate proteins to enhance protein stability and bioavailability or carry immunogenic cell death inducers for tumor vaccines. In addition to these applications, exosomes can deliver nucleic acids such as siRNA and miRNA to regulate gene expression, inhibit tumor proliferation, and suppress invasion. Beyond their therapeutic applications, exosomes also serve as tumor biomarkers for early cancer diagnosis. The detection of exosomal miRNA can improve the sensitivity and specificity of diagnosing prostate and pancreatic cancers. Despite their promising potential as drug delivery systems, challenges remain in the standardization and large-scale production of exosomes. This article explores the future development of engineered exosomes for targeted tumor therapy. Plant-derived exosomes hold potential due to their superior biocompatibility, lower toxicity, and abundant availability. Furthermore, the integration of exosomes with artificial intelligence may offer novel applications in diagnostics, therapeutics, and personalized medicine.]]></description>
<pubDate>2025/3/5 11:34:41</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[JIANG Yu-Huan,JIN Yi-Xin,MU Xing-Yu,SONG Jia-Lu,WANG Jing]]></author>
</item>
<item>
<title><![CDATA[Therapeutic Study on The Inhibition of Neuroinflammation in Ischemic Stroke by Induced Regulatory T Cells]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202501130000002]]></link>
<description><![CDATA[<b>Objective</b> Neuroinflammation plays a crucial role in both the onset and progression of ischemic stroke, exerting a significant impact on the recovery of the central nervous system. Excessive neuroinflammation can lead to secondary neuronal damage, further exacerbating brain injury and impairing functional recovery. As a result, effectively modulating and reducing neuroinflammation in the brain has become a key therapeutic strategy for improving outcomes in ischemic stroke patients. Among various approaches, targeting immune regulation to control inflammation has gained increasing attention. This study aims to investigate the role of<i> in vitro </i>induced regulatory T cells (Treg cells) in suppressing neuroinflammation after ischemic stroke, as well as their potential therapeutic effects. By exploring the mechanisms through which Tregs exert their immunomodulatory functions, this research is expected to provide new insights into stroke treatment strategies.<b>Methods</b> Naive CD4<sup>+</sup> T cells were isolated from mouse spleens using a negative selection method to ensure high purity, and then they were induced <i>in vitro </i>to differentiate into Treg cells by adding specific cytokines. The anti-inflammatory effects and therapeutic potential of Treg cells transplantation in a mouse model of ischemic stroke was evaluated. In the middle cerebral artery occlusion (MCAO) model, after Treg cells transplantation, their ability to successfully migrate to the infarcted brain region and their impact on neuroinflammation levels were examined. To further investigate the role of Treg cells in stroke recovery, the changes in cytokine expression and their effects on immune cell interactions was analyzed. Additionally, infarct size and behavioral scores were measured to assess the neuroprotective effects of Treg cells. By integrating multiple indicators, the comprehensive evaluation of potential benefits of Treg cells in the treatment of ischemic stroke was performed.<b>Results</b> Treg cells significantly regulated the expression levels of both pro-inflammatory and anti-inflammatory cytokines <i>in vitro</i> and<i> in vivo</i>, effectively balancing the immune response and suppressing excessive inflammation. Additionally, Treg cells inhibited the activation and activity of inflammatory cells, thereby reducing neuroinflammation. In the MCAO mouse model, Treg cells were observed to accumulate in the infarcted brain region, where they significantly reduced the infarct size, demonstrating their neuroprotective effects. Furthermore, Treg cell therapy notably improved behavioral scores, suggesting its role in promoting functional recovery, and increased the survival rate of ischemic stroke mice, highlighting its potential as a promising therapeutic strategy for stroke treatment.<b>Conclusion</b> <i>In vitro</i> induced Treg cells can effectively suppress neuroinflammation caused by ischemic stroke, demonstrating promising clinical application potential. By regulating the balance between pro-inflammatory and anti-inflammatory cytokines, Treg cells can inhibit immune responses in the nervous system, thereby reducing neuronal damage. Additionally, they can modulate the immune microenvironment, suppress the activation of inflammatory cells, and promote tissue repair. The therapeutic effects of Treg cells also include enhancing post-stroke recovery, improving behavioral outcomes, and increasing the survival rate of ischemic stroke mice. With their ability to suppress neuroinflammation, Treg cell therapy provides a novel and effective strategy for the treatment of ischemic stroke, offering broad application prospects in clinical immunotherapy and regenerative medicine.]]></description>
<pubDate>2025/2/28 16:13:08</pubDate>
<category><![CDATA[研究快报]]></category>
<author><![CDATA[CAI Lin-Tao,CHEN Li-Qi,GONG Han,KANG Tian-Fang,MA Ai-Qing,OUYANG Jia-Cheng,PAN Fan,PAN Hong]]></author>
</item>
<item>
<title><![CDATA[Study on Brain Functional Network Characteristics of Parkinson’s Disease Patients Based on Beta Burst Period]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407130000002]]></link>
<description><![CDATA[<b>Objective</b> The central symptom of Parkinson’s disease (PD) is impaired motor function. Beta-band electrical activity in the motor network of the basal ganglia is closely related to motor function. In this study, we combined scalp electroencephalography (EEG), brain functional network, and clinical scales to investigate the effects of beta burst-period neural electrical activity on brain functional network characteristics, which may serve as a reference for clinical diagnosis and treatment.<b>Methods</b> Thirteen PD patients were included in the PD group, and 13 healthy subjects were included in the healthy control group. Resting-state EEG data were collected from both groups, and beta burst and non-burst periods were extracted. A phase synchronization network was constructed using weighted phase lag indices, and the topological feature parameters of phase synchronization network were compared between the two groups across different periods and four frequency bands. Additionally, the correlation between changes in network characteristics and clinical symptoms was analyzed.<b>Results</b> During the beta burst period, the topological characteristic parameters of phase synchronization network in all four frequency bands were significantly higher in PD patients compared to healthy controls. The average clustering coefficient of the phase synchronization network in the beta band during the beta burst period was negatively correlated with UPDRS-III scores. In the low gamma band during the non-burst period, the average clustering coefficient of phase synchronization network was positively correlated with UPDRS and UPDRS-III scores, while UPDRS-III scores were positively correlated with global efficiency and average degree.<b>Conclusion</b> The brain functional network features of PD patients were significantly enhanced during the beta burst period. Moreover, the beta-band brain functional network characteristics during the beta burst period were negatively correlated with clinical scale scores, whereas low gamma-band functional network features during the non-burst period were positively correlated with clinical scale scores. These findings indicate that motor function impairment in PD patients is associated with the beta burst period. This study provides valuable insights for the diagnosis of PD.]]></description>
<pubDate>2025/2/28 11:13:03</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[HAO Yu-Jie,LIU Shuo,LOU Xu,WANG Lei,YANG Shuo]]></author>
</item>
<item>
<title><![CDATA[Mechanisms of Gut Microbiota Influencing Reproductive Function <i>via</i> The Gut-Gonadal Axis]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202411060000002]]></link>
<description><![CDATA[Reproductive system diseases are among the primary contributors to the decline in social fertility rates and the intensification of aging, posing significant threats to both physical and mental health, as well as quality of life. Recent research has revealed the substantial potential of the gut microbiota in improving reproductive system diseases. Under healthy conditions, the gut microbiota maintains a dynamic balance, whereas dysfunction can trigger immune-inflammatory responses, metabolic disorders, and other issues, subsequently leading to reproductive system diseases through the gut-gonadal axis. Reproductive diseases, in turn, can exacerbate gut microbiota imbalance. This article reviews the impact of the gut microbiota and its metabolites on both male and female reproductive systems, analyzing changes in typical gut microorganisms and their metabolites related to reproductive function. The composition, diversity, and metabolites of gut bacteria, such as <i>Bacteroides</i>, <i>Prevotella</i>, and <i>Firmicutes</i>, including short-chain fatty acids, 5-hydroxytryptamine, γ-aminobutyric acid, and bile acids, are closely linked to reproductive function. As reproductive diseases develop, intestinal immune function typically undergoes changes, and the expression levels of immune-related factors, such as Toll-like receptors and inflammatory cytokines (including IL-6, TNF-α, and TGF-β), also vary. The gut microbiota and its metabolites influence reproductive hormones such as estrogen, luteinizing hormone, and testosterone, thereby affecting folliculogenesis and spermatogenesis. Additionally, the metabolism and absorption of vitamins can also impact spermatogenesis through the gut-testis axis. As the relationship between the gut microbiota and reproductive diseases becomes clearer, targeted regulation of the gut microbiota can be employed to address reproductive system issues in both humans and animals. This article discusses the regulation of the gut microbiota and intestinal immune function through microecological preparations, fecal microbiota transplantation, and drug therapy to treat reproductive diseases. Microbial preparations and drug therapy can help maintain the intestinal barrier and reduce chronic inflammation. Fecal microbiota transplantation involves transferring feces from healthy individuals into the recipient’s intestine, enhancing mucosal integrity and increasing microbial diversity. This article also delves into the underlying mechanisms by which the gut microbiota influences reproductive capacity through the gut-gonadal axis and explores the latest research in diagnosing and treating reproductive diseases using gut microbiota. The goal is to restore reproductive capacity by targeting the regulation of the gut microbiota. While the gut microbiota holds promise as a therapeutic target for reproductive diseases, several challenges remain. First, research on the association between gut microbiota and reproductive diseases is insufficient to establish a clear causal relationship, which is essential for proposing effective therapeutic methods targeting the gut microbiota. Second, although gut microbiota metabolites can influence lipid, glucose, and hormone synthesis and metabolism <i>via</i> various signaling pathways—thereby indirectly affecting ovarian and testicular function—more in-depth research is required to understand the direct effects of these metabolites on germ cells or granulosa cells. Lastly, the specific efficacy of gut microbiota in treating reproductive diseases is influenced by multiple factors, necessitating further mechanistic research and clinical studies to validate and optimize treatment regimens.]]></description>
<pubDate>2025/2/28 11:03:22</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HU Xu-Qi,MAO Hai-Guang,QI Li-Li,SUN Qiu-Zhen,WANG Jin-Bo,WANG Meng-Ting,ZHAO Ya-Qi]]></author>
</item>
<item>
<title><![CDATA[Research on BP Neural Network Method for Identifying Cell Suspension Concentration Based on GHz Electrochemical Impedance Spectroscopy]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202410180000001]]></link>
<description><![CDATA[<b>Objective</b> The rapid advancement of bioanalytical technologies has heightened the demand for high-throughput, label-free, and real-time cellular analysis. Electrochemical impedance spectroscopy (EIS) operating in the GHz frequency range (GHz-EIS) has emerged as a promising tool for characterizing cell suspensions due to its ability to rapidly and non-invasively capture the dielectric properties of cells and their microenvironment. Although GHz-EIS enables rapid and label-free detection of cell suspensions, significant challenges remain in interpreting GHz impedance data for complex samples, limiting the broader application of this technique in cellular research. To address these challenges, this study presents a novel method that integrates GHz-EIS with deep learning algorithms, aiming to improve the precision of cell suspension concentration identification and quantification. This method provides a more efficient and accurate solution for the analysis of GHz impedance data.<b>Methods</b> The proposed method comprises two key components: dielectric property dataset construction and Backpropagation (BP) Neural Network modeling. Yeast cell suspensions at varying concentrations were prepared and separately introduced into a coaxial sensor for impedance measurement. The dielectric properties of these suspensions were extracted using a GHz-EIS dielectric property extraction method applied to the measured impedance data. A dielectric properties dataset incorporating concentration labels was subsequently established and divided into training and testing subsets. A BP neural network model employing specific activation functions (ReLU and Leaky ReLU) was then designed. The model was trained and tested using the constructed dataset, and optimal model parameters were obtained through this process. This BP neural network enables automated extraction and analytical processing of dielectric properties, facilitating precise recognition of cell suspension concentrations through data-driven training.<b>Results</b> Through comparative analysis with conventional centrifugal methods, the recognized concentration values of cell suspensions showed high consistency, with relative errors consistently below 5%. Notably, high-concentration samples exhibited even smaller deviations, further validating the precision and reliability of the proposed methodology. To benchmark the recognition performance against different algorithms, two typical approaches—Support Vector Machines (SVM) and K-Nearest Neighbor (KNN)—were selected for comparison. The proposed method demonstrated superior performance in quantifying cell concentrations. Specifically, the BP neural network achieved a mean absolute percentage error (MAPE) of 2.06% and an R2 value of 0.997 across the entire concentration range, demonstrating both high predictive accuracy and excellent model fit.<b>Conclusion</b> This study demonstrates that the proposed method enables accurate and rapid determination of unknown sample concentrations. By combining GHz-EIS with BP neural network algorithms, efficient identification of cell concentrations is achieved, laying the foundation for the development of a convenient online cell analysis platform and showing significant application prospects. Compared to typical recognition approaches, the proposed method exhibits superior capabilities in recognizing cell suspension concentrations. Furthermore, this methodology not only accelerates research in cell biology and precision medicine but also paves the way for future EIS biosensors capable of intelligent, adaptive analysis in dynamic biological research.]]></description>
<pubDate>2025/2/27 16:40:06</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[LIU Xia-Yi,RAN Qi-Hang,SUN Bo,TAO A-Long,WANG Zhi-Long,YAO Jia-Feng,ZHANG An,ZHAO Tong]]></author>
</item>
<item>
<title><![CDATA[The Mechanism of Blue Light in Inactivating Microorganisms and Its Applications in The Food and Medical Fields]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202410170000001]]></link>
<description><![CDATA[Blue light inactivation technology, particularly at the 405 nm wavelength, has demonstrated distinct and multifaceted mechanisms of action against both Gram-positive and Gram-negative bacteria, offering a promising alternative to conventional antibiotic therapies. For Gram-positive pathogens such as <i>Bacillus cereus</i>, <i>Listeria monocytogenes</i>, and methicillin-resistant<i> Staphylococcus aureus</i> (MRSA), the bactericidal effects are primarily mediated by endogenous porphyrins (<i>e.g</i>., protoporphyrin III, coproporphyrin III, and uroporphyrin III), which exhibit strong absorption peaks between 400-430 nm. Upon irradiation, these porphyrins are photoexcited to generate cytotoxic reactive oxygen species (ROS), including singlet oxygen, hydroxyl radicals, and superoxide anions, which collectively induce oxidative damage to cellular components. Early studies by Endarko <i>et al</i>. revealed that (405±5) nm blue light at 185 J/cm2 effectively inactivated <i>L. monocytogenes</i> without exogenous photosensitizers, supporting the hypothesis of intrinsic photosensitizer involvement. Subsequent work by Masson-Meyers <i>et al</i>. demonstrated that 405 nm light at 121 J/cm2 suppressed MRSA growth by activating endogenous porphyrins, leading to ROS accumulation. Kim <i>et al</i>. further elucidated that ROS generated under 405 nm irradiation directly interact with unsaturated fatty acids in bacterial membranes, initiating lipid peroxidation. This process disrupts membrane fluidity, compromises structural integrity, and impairs membrane-bound proteins, ultimately causing cell death. In contrast, Gram-negative bacteria such as <i>Salmonella</i>, <i>Escherichia coli</i>, <i>Helicobacter pylori</i>, <i>Pseudomonas aeruginosa</i>, and <i>Acinetobacter baumannii</i> exhibit more complex inactivation pathways. While endogenous porphyrins remain central to ROS generation, studies reveal additional photodynamic contributors, including flavins (<i>e.g</i>., riboflavin) and bacterial pigments. For instance, <i>H. pylori</i> naturally accumulates protoporphyrin and coproporphyrin mixtures, enabling efficient 405 nm light-mediated inactivation without antibiotic resistance concerns. Kim <i>et al</i>. demonstrated that 405 nm light at 288 J/cm2 inactivates <i>Salmonella</i> by inducing genomic DNA oxidation (<i>e.g</i>., 8-hydroxy-deoxyguanosine formation) and disrupting membrane functions, particularly efflux pumps and glucose uptake systems. Huang <i>et al.</i> highlighted the enhanced efficacy of pulsed 405 nm light over continuous irradiation for <i>E. coli</i>, attributing this to increased membrane damage and optimized ROS generation through frequency-dependent photodynamic effects. Environmental factors such as temperature, pH, and osmotic stress further modulate susceptibility, sublethal stress conditions (<i>e.g</i>., high salinity or acidic environments) weaken bacterial membranes, rendering cells more vulnerable to subsequent ROS-mediated damage. The 405 nm blue light inactivates drug-resistant <i>Pseudomonas aeruginosa</i> through endogenous porphyrins, pyocyanin, and pyoverdine, with the inactivation efficacy influenced by bacterial growth phase and culture medium composition. Intriguingly, repeated 405 nm exposure (20 cycles) failed to induce resistance in <i>A. baumannii</i>, with transient tolerance linked to transient overexpression of antioxidant enzymes (<i>e.g</i>., superoxide dismutase) or stress-response genes (<i>e.g.</i>, oxyR). For Gram-positive bacteria, porphyrin abundance dictates sensitivity, whereas in Gram-negative species, membrane architecture and accessory pigments modulate outcomes. Critically, ROS-mediated damage is nonspecific, targeting DNA, proteins, and lipids simultaneously, thereby minimizing resistance evolution. The 405 nm blue light technology, as a non-chemical sterilization method, shows promise in medical and food industries. It enhances infection control through photodynamic therapy and disinfection, synergizing with red light for anti-inflammatory treatments (<i>e.g.</i>, acne). In food processing, it effectively inactivates pathogens (<i>e.g</i>., <i>E. coli</i>, <i>S. aureus</i>) without altering food quality. Despite efficacy against multidrug-resistant <i>A. baumannii</i>, challenges include device standardization, limited penetration in complex materials, and optimization of photosensitizers/light parameters. Interdisciplinary research is needed to address these limitations and scale applications in healthcare, food safety, and environmental decontamination.]]></description>
<pubDate>2025/2/27 11:26:21</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[BI Ruo-Hong,LIU Xiao-Fei,Lü Yi,WU Rong-Qian]]></author>
</item>
<item>
<title><![CDATA[PDGF-C: an Emerging Target in The Treatment of Organ Fibrosis]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202411070000001]]></link>
<description><![CDATA[Fibrosis, the pathological scarring of vital organs, is a severe and often irreversible condition that leads to progressive organ dysfunction. It is particularly pronounced in organs like the liver, kidneys, lungs, and heart. Despite its clinical significance, the full understanding of its etiology and complex pathogenesis remains incomplete, posing substantial challenges to diagnosing, treating, and preventing the progression of fibrosis. Among the various molecular players involved, platelet-derived growth factor-C (PDGF-C) has emerged as a crucial factor in fibrotic diseases, contributing to the pathological transformation of tissues in several key organs. PDGF-C is a member of the PDGFs family of growth factors and is synthesized and secreted by various cell types, including fibroblasts, smooth muscle cells, and endothelial cells. It acts through both autocrine and paracrine mechanisms, exerting its biological effects by binding to and activating the PDGF receptors (PDGFRs), specifically PDGFRα and PDGFRβ. This binding triggers multiple intracellular signaling pathways, such as JAK/STAT, PI3K/AKT and Ras-MAPK pathways. which are integral to the regulation of cell proliferation, survival, migration, and fibrosis. Notably, PDGF-C has been shown to promote the proliferation and migration of fibroblasts, key effector cells in the fibrotic process, thus accelerating the accumulation of extracellular matrix components and the formation of fibrotic tissue. Numerous studies have documented an upregulation of PDGF-C expression in various fibrotic diseases, suggesting its significant role in the initiation and progression of fibrosis. For instance, in liver fibrosis, PDGF-C stimulates hepatic stellate cell activation, contributing to the excessive deposition of collagen and other extracellular matrix proteins. Similarly, in pulmonary fibrosis, PDGF-C enhances the migration of fibroblasts into the damaged areas of lungs, thereby worsening the pathological process. Such findings highlight the pivotal role of PDGF-C in fibrotic diseases and underscore its potential as a therapeutic target for these conditions. Given its central role in the pathogenesis of fibrosis, PDGF-C has become an attractive target for therapeutic intervention. Several studies have focused on developing inhibitors that block the PDGF-C/PDGFR signaling pathway. These inhibitors aim to reduce fibroblast activation, prevent the excessive accumulation of extracellular matrix components, and halt the progression of fibrosis. Preclinical studies have demonstrated the efficacy of such inhibitors in animal models of liver, kidney, and lung fibrosis, with promising results in reducing fibrotic lesions and improving organ function. Furthermore, several clinical inhibitors, such as Olaratumab and Seralutinib, are ongoing to assess the safety and efficacy of these inhibitors in human patients, offering hope for novel therapeutic options in the treatment of fibrotic diseases. In conclusion, PDGF-C plays a critical role in the development and progression of fibrosis in vital organs. Its ability to regulate fibroblast activity and influence key signaling pathways makes it a promising target for therapeutic strategies aiming at combating fibrosis. Ongoing research into the regulation of PDGF-C expression and the development of PDGF-C/PDGFR inhibitors holds the potential to offer new insights and approaches for the diagnosis, treatment, and prevention of fibrotic diseases. Ultimately, these efforts may lead to the development of more effective and targeted therapies that can mitigate the impact of fibrosis and improve patient outcomes.]]></description>
<pubDate>2025/2/21 22:40:04</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHENG Yi-Jing,KUANG Yuan-Yuan,LI Xue,LIN Yan,REN Ke-Xin,SONG Zi-Yi,WANG Chang-Xin,YANG Chao]]></author>
</item>
<item>
<title><![CDATA[Research on Magnetic Stimulation Intervention Technology for Alzheimer’s Disease Guided by Heart Rate Variability]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202411080000002]]></link>
<description><![CDATA[<b>Objective</b> Non-invasive magnetic stimulation technology has been widely used in the treatment of Alzheimer’s disease (AD), but there is a lack of convenient and timely methods for evaluating and providing feedback on the effectiveness of the stimulation, which can be used to guide the adjustment of the stimulation protocol. This study aims to explore the possibility of heart rate variability (HRV) in diagnosing AD and guiding AD magnetic stimulation intervention techniques.<b>Methods</b> In this study, we used a 40 Hz, 10 mT pulsed magnetic field to expose AD mouse models to whole-body exposure for 18 d, and detected the behavioral and electroencephalographic signals before and after exposure, as well as the instant electrocardiographic signals after exposure every day.<b>Results</b> Using one-way ANOVA and Pearson correlation coefficient analysis, we found that some HRV indicators could identify AD mouse models as accurately as behavioral and electroencephalogram(EEG) changes (<i>P</i><0.05) and significantly distinguish the severity of the disease (<i>P</i><0.05), including rMSSD, pNN6, LF/HF, SD1/SD2, and entropy arrangement. These HRV indicators showed good correlation and statistical significance with behavioral and EEG changes (<i>r</i>>0.3, <i>P</i><0.05); HRV indicators were significantly modulated by the magnetic field exposure before and after the exposure, both of which were observed in the continuous changes of electrocardiogram (ECG) (<i>P</i><0.05), and the trend of the stimulation effect was more accurately observed in the continuous changes of ECG.<b>Conclusion</b> HRV can accurately reflect the pathophysiological changes and disease degree, quickly evaluate the effect of magnetic stimulation, and has the potential to guide the pattern of magnetic exposure, providing a new idea for the study of personalized electromagnetic neuroregulation technology for brain diseases.]]></description>
<pubDate>2025/2/21 22:36:16</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CHEN Shu-Ting,FAN Chun-Meng,GENG Du-Yan,XU Gui-Zhi,ZHENG Wei-Ran]]></author>
</item>
<item>
<title><![CDATA[<i>In situ</i> Analytical Techniques for Membrane Protein Interactions]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202409190000003]]></link>
<description><![CDATA[Membrane proteins are integral components of cellular membranes, accounting for approximately 30% of the mammalian proteome and serving as targets for 60% of FDA-approved drugs. They are critical to both physiological functions and disease mechanisms. Their functional protein-protein interactions form the basis for many physiological processes, such as signal transduction, material transport, and cell communication. Membrane protein interactions are characterized by membrane environment dependence, spatial asymmetry, weak interaction strength, high dynamics, and a variety of interaction sites. Therefore, <i>in situ</i> analysis is essential for revealing the structural basis and kinetics of these proteins. This paper introduces currently available <i>in situ</i> analytical techniques for studying membrane protein interactions and evaluates the characteristics of each. These techniques are divided into two categories: label-based techniques (<i>e.g.</i>, co-immunoprecipitation, proximity ligation assay, bimolecular fluorescence complementation, resonance energy transfer, and proximity labeling) and label-free techniques (<i>e.g.</i>, cryo-electron tomography, <i>in situ</i> cross-linking mass spectrometry, Raman spectroscopy, electron paramagnetic resonance, nuclear magnetic resonance, and structure prediction tools). Each technique is critically assessed in terms of its historical development, strengths, and limitations. Based on the authors’ relevant research, the paper further discusses the key issues and trends in the application of these techniques, providing valuable references for the field of membrane protein research. Label-based techniques rely on molecular tags or antibodies to detect proximity or interactions, offering high specificity and adaptability for dynamic studies. For instance, proximity ligation assay combines the specificity of antibodies with the sensitivity of PCR amplification, while proximity labeling enables spatial mapping of interactomes. Conversely, label-free techniques, such as cryo-electron tomography, provide near-native structural insights, and Raman spectroscopy directly probes molecular interactions without perturbing the membrane environment. Despite advancements, these methods face several universal challenges: (1) indirect detection, relying on proximity or tagged proxies rather than direct interaction measurement; (2) limited capacity for continuous dynamic monitoring in live cells; and (3) potential artificial influences introduced by labeling or sample preparation, which may alter native conformations. Emerging trends emphasize the multimodal integration of complementary techniques to overcome individual limitations. For example, combining <i>in situ</i> cross-linking mass spectrometry with proximity labeling enhances both spatial resolution and interaction coverage, enabling high-throughput subcellular interactome mapping. Similarly, coupling fluorescence resonance energy transfer with nuclear magnetic resonance and artificial intelligence (AI) simulations integrates dynamic structural data, atomic-level details, and predictive modeling for holistic insights. Advances in AI, exemplified by AlphaFold’s ability to predict interaction interfaces, further augment experimental data, accelerating structure-function analyses. Future developments in cryo-electron microscopy, super-resolution imaging, and machine learning are poised to refine spatiotemporal resolution and scalability. In conclusion, <i>in situ</i> analysis of membrane protein interactions remains indispensable for deciphering their roles in health and disease. While current technologies have significantly advanced our understanding, persistent gaps highlight the need for innovative, integrative approaches. By synergizing experimental and computational tools, researchers can achieve multiscale, real-time, and perturbation-free analyses, ultimately unraveling the dynamic complexity of membrane protein networks and driving therapeutic discovery.]]></description>
<pubDate>2025/2/19 17:29:46</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[GUO Jing-Xing,GUO Jun-Hui,KANG Zi-Yuan,LI Chao,LI Qi-Chang,XIE Hao,YU Tong,ZHANG Xue-Hua]]></author>
</item>
<item>
<title><![CDATA[Role of ATG12 in The Development of Disease]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202412050000003]]></link>
<description><![CDATA[Autophagy, a highly conserved cellular degradation mechanism, maintains intracellular homeostasis by removing damaged organelles and abnormal proteins. Its dysregulation is closely associated with various diseases. Autophagy-related protein 12 (ATG12), a core member of the ubiquitin-like protein family, covalently binds to ATG5 through a ubiquitin-like conjugation system to form the ATG12-ATG5-ATG16L1 complex. This complex directly regulates the formation and maturation of autophagosomes, making ATG12 a key molecule in the initiation of autophagy. Recent studies have revealed that ATG12 functions extend far beyond the classical autophagy context. It promotes apoptosis by binding to anti-apoptotic proteins of the Bcl-2 family (<i>e.g.</i>, Bcl-2 and Mcl-1) and enhances host antiviral immunity by regulating the NF-κB and interferon signaling pathways. Moreover, ATG12 deficiency can lead to mitochondrial biogenesis impairment, energy metabolism disorders, and substrate-dependent metabolic shifts, underscoring its pivotal role in cellular metabolic homeostasis. At the disease level, dysregulation of ATG12 expression is closely linked to tumorigenesis and cancer progression. By modulating the dynamic balance between autophagy and apoptosis, ATG12 influences cancer cell proliferation, metastasis, and chemoresistance. Notably, ATG12 is abnormally overexpressed in multiple cancers, including breast, liver, and gastric cancer, highlighting its potential as a therapeutic target. Furthermore, in neurodegenerative diseases such as Parkinson’s disease, ATG12 mitigates protein toxicity by enhancing mitochondrial autophagy. In cardiovascular diseases, it alleviates ischemia-reperfusion injury by regulating cardiomyocyte autophagy and apoptosis, demonstrating its broad regulatory role across various pathological conditions. Genetic studies further underscore the clinical significance of ATG12. Polymorphisms in the <i>ATG12</i> gene (<i>e.g.</i>, rs26537 and rs26538) have been significantly associated with the risk of head and neck squamous cell carcinoma, hepatocellular carcinoma, and atrophic gastritis. Notably, the risk allele of rs26537 enhances <i>ATG12</i> promoter activity, leading to its overexpression and promoting tumorigenesis. These findings provide a molecular basis for individualized risk assessment and targeted interventions based on <i>ATG12</i> genotype. Despite significant progress, many aspects of ATG12 biology remain unclear. The precise regulatory mechanisms of its post-translational modifications (<i>e.g.</i>, ubiquitination and acetylation) are yet to be fully elucidated. Additionally, the molecular pathways underlying its non-canonical functions, such as metabolic regulation and immune modulation, require further investigation. Moreover, the functional heterogeneity of ATG12 in different tumor microenvironments and its role in drug resistance warrant in-depth exploration. Future research should integrate advanced technologies such as cryo-electron microscopy, single-cell sequencing, and organoid models to decipher the intricate regulatory network of ATG12. Additionally, developing small-molecule inhibitors or gene-editing tools targeting its protein interaction interfaces (<i>e.g.</i>, the ATG12-ATG3 binding domain) may help overcome current therapeutic challenges. Through interdisciplinary collaboration and clinical translation, ATG12 holds promise as a next-generation molecular target for precision intervention in autophagy-related diseases. This review summarizes the structure and function of ATG12, its role in autophagy initiation, its physiological functions, and its involvement in disease pathogenesis. Furthermore, it discusses future research directions and potential challenges, emphasizing ATG12’s potential as a biomarker and therapeutic target in autophagy-related diseases.]]></description>
<pubDate>2025/2/17 15:49:15</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LIU Wei,TANG Jing-Feng,TIAN Rui,ZHOU Ce-Fan]]></author>
</item>
<item>
<title><![CDATA[Effect of The Hydrophilic Amino Acids on Self-assembly Behavior of Short Bola-like Peptides]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202412040000002]]></link>
<description><![CDATA[<b>Objective</b> Bola-like short peptides exhibit novel self-assembly properties due to the formation of peptide dimers <i>via</i> hydrogen bonding interactions between their C-terminals. In this configuration, hydrophilic amino acids are distributed at both terminals, making these peptides behave similarly to Bola peptides. The electrostatic repulsive interactions arising from the hydrophilic amino acids at each terminal can be neutralized, thereby greatly promoting the lateral association of β-sheets. Consequently, assemblies with significantly larger widths are typically the dominant nanostructures for Bola-like peptides. To investigate the effect of hydrophilic amino acids on the self-assembly behavior of Bola-like peptides, the peptides Ac-RI<sub>3</sub>-CONH<sub>2</sub> and Ac-HI<sub>3</sub>-CONH<sub>2</sub> were designed and synthesized using the Bola-like peptide Ac-KI<sub>3</sub>-CONH<sub>2</sub> as a template. Their self-assembly behavior was systematically examined.<b>Methods</b> Atomic force microscopy (AFM) and transmission electron microscopy (TEM) were employed to characterize the morphology and size of the assemblies. The secondary structures of the assemblies were analyzed using circular dichroism (CD) and Fourier transform infrared (FTIR) spectroscopy. Small-angle neutron scattering (SANS) was used to obtain detailed structural information at a short-length scale. Based on these experimental results, the effects of hydrophilic amino acids on the self-assembly behavior of Bola-like short peptides were systematically analyzed, and the underlying formation mechanism was explored.<b>Results</b> The aggregation process primarily involved three steps. First, peptide dimers were formed through hydrogen bonding interactions between their C-terminals. Within these dimers, the hydrophilic amino acids K, R, and H were positioned at both terminals, enabling the peptides to self-assemble in a manner similar to Bola peptides. Next, β-sheets were formed <i>via</i> hydrogen bonding interactions along the peptide backbone. Finally, self-assemblies were generated through the lateral association of β-sheets. The results demonstrated that both Ac-KI<sub>3</sub>-CONH<sub>2</sub> and Ac-RI<sub>3</sub>-CONH<sub>2</sub> could self-assemble into double-layer nanotubes with diameters of approximately 200 nm. These nanotubes were formed by the edge fusion of helical ribbons, which initially emerged from twisted ribbons. Notably, the primary assemblies of these peptides exhibited opposite chirality: nanofibers formed by Ac-KI<sub>3</sub>-CONH<sub>2</sub> displayed left-handed chirality, whereas those formed by Ac-RI<sub>3</sub>-CONH<sub>2</sub> exhibited right-handed chirality. This reversal in torsional direction was primarily attributed to the different abilities of K and R to form hydrogen bonds with water. In contrast, Ac-HI<sub>3</sub>-CONH<sub>2</sub> formed narrower twisted ribbons with a significantly reduced width of approximately 30 nm, which was attributed to the strong steric hindrance caused by the imidazole rings. The multilayer height of these ribbons was mainly due to the unique structure of the imidazole rings, which can function as both hydrogen bond donors and acceptors, thereby promoting aggregate growth in the vertical direction.<b>Conclusion</b> The final morphology of the self-assemblies resulted from a delicate balance of various non-covalent interactions. By altering the types of hydrophilic amino acid residues in Bola-like short peptides, the relative strength of non-covalent interactions that drive assembly formation can be effectively regulated, allowing precise control over the morphology and chirality of the assemblies. This study provides a simple and effective approach for constructing diverse self-assemblies and lays a theoretical foundation for the development of functional biomaterials.]]></description>
<pubDate>2025/2/14 16:06:13</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CHEN Xi-Ya,GAO Xin-Xin,HAN Yu,ZHAO Yu-Rong,ZHOU Yi-Lin]]></author>
</item>
<item>
<title><![CDATA[Hepatocyte Nuclear Factor 4α Transcriptionally Activates <i>TM4SF5</i> Through The DR1 Motif]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202409200000004]]></link>
<description><![CDATA[<b>Objective</b> Hepatocyte nuclear factor 4-alpha (HNF4A) is a critical transcription factor in the liver and pancreas. Dysfunctions of HNF4A lead to maturity onset diabetes of the young 1 (MODY1). Notably, MODY1 patients with <i>HNF4A</i> pathogenic mutations exhibit decreased responses to arginine and reduced plasma triglyceride levels, but the mechanisms remain unclear. This study aims to investigate the potential target genes transcriptionally regulated by HNF4A and explore its role in these metabolic pathways.<b>Methods</b> A stable 293T cell line expressing the <i>HNF1A</i> reporter was overexpressed with HNF4A. RNA sequencing (RNA-seq) was performed to analyze transcriptional differences. Transcription factor binding site prediction was then conducted to identify HNF4A binding motifs in the promoter regions of relevant target genes.<b>Results</b> RNA-seq results revealed a significant upregulation of transmembrane 4 L six family member 5 (<i>TM4SF5</i>) mRNA in HNF4A-overexpressing cells. Transcription factor binding predictions suggested the presence of five potential HNF4A binding motifs in the <i>TM4SF5</i> promoter. Finally, we confirmed that the DR1 site in the -57 to -48 region of the <i>TM4SF5</i> promoter is the key binding motif for HNF4A.<b>Conclusion</b> This study identified <i>TM4SF5</i> as a target gene of HNF4A and determined the key binding motif involved in its regulation. Given the role of TM4SF5 as an arginine sensor in mTOR signaling activation and triglyceride secretion, which closely aligns with phenotypes observed in MODY1 patients, our findings provide novel insights into the possible mechanisms by which HNF4A regulates triglyceride secretion in the liver and arginine-stimulated insulin secretion in the pancreas.]]></description>
<pubDate>2025/2/12 15:44:52</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[FENG Han,GUO Yi-Ming,ZHANG Xiao-Fei,ZHENG Li]]></author>
</item>
<item>
<title><![CDATA[The Role and Mechanism of Circadian Rhythm Regulation in Skin Tissue Regeneration]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202410310000002]]></link>
<description><![CDATA[Circadian rhythm is an endogenous biological clock mechanism that enables organisms to adapt to the earth’s alternation of day and night. It plays a fundamental role in regulating physiological functions and behavioral patterns, such as sleep, feeding, hormone levels and body temperature. By aligning these processes with environmental changes, circadian rhythm plays a pivotal role in maintaining homeostasis and promoting optimal health. However, modern lifestyles, characterized by irregular work schedules and pervasive exposure to artificial light, have disrupted these rhythms for many individuals. Such disruptions have been linked to a variety of health problems, including sleep disorders, metabolic syndromes, cardiovascular diseases, and immune dysfunction, underscoring the critical role of circadian rhythm in human health. Among the numerous systems influenced by circadian rhythm, the skin—a multifunctional organ and the largest by surface area—is particularly noteworthy. As the body’s first line of defense against environmental insults such as UV radiation, pollutants, and pathogens, the skin is highly affected by changes in circadian rhythm. Circadian rhythm regulates multiple skin-related processes, including cyclic changes in cell proliferation, differentiation, and apoptosis, as well as DNA repair mechanisms and antioxidant defenses. For instance, studies have shown that keratinocyte proliferation peaks during the night, coinciding with reduced environmental stress, while DNA repair mechanisms are most active during the day to counteract UV-induced damage. This temporal coordination highlights the critical role of circadian rhythms in preserving skin integrity and function. Beyond maintaining homeostasis, circadian rhythm is also pivotal in the skin’s repair and regeneration processes following injury. Skin regeneration is a complex, multi-stage process involving hemostasis, inflammation, proliferation, and remodeling, all of which are influenced by circadian regulation. Key cellular activities, such as fibroblast migration, keratinocyte activation, and extracellular matrix remodeling, are modulated by the circadian clock, ensuring that repair processes occur with optimal efficiency. Additionally, circadian rhythm regulates the secretion of cytokines and growth factors, which are critical for coordinating cellular communication and orchestrating tissue regeneration. Disruptions to these rhythms can impair the repair process, leading to delayed wound healing, increased scarring, or chronic inflammatory conditions. The aim of this review is to synthesize recent information on the interactions between circadian rhythms and skin physiology, with a particular focus on skin tissue repair and regeneration. Molecular mechanisms of circadian regulation in skin cells, including the role of core clock genes such as <i>Clock</i>, <i>Bmal1</i>, <i>Per</i> and <i>Cry</i>. These genes control the expression of downstream effectors involved in cell cycle regulation, DNA repair, oxidative stress response and inflammatory pathways. By understanding how these mechanisms operate in healthy and diseased states, we can discover new insights into the temporal dynamics of skin regeneration. In addition, by exploring the therapeutic potential of circadian biology in enhancing skin repair and regeneration, strategies such as topical medications that can be applied in a time-limited manner, phototherapy that is synchronized with circadian rhythms, and pharmacological modulation of clock genes are expected to optimize clinical outcomes. Interventions based on the skin’s natural rhythms can provide a personalized and efficient approach to promote skin regeneration and recovery. This review not only introduces the important role of circadian rhythms in skin biology, but also provides a new idea for future innovative therapies and regenerative medicine based on circadian rhythms.]]></description>
<pubDate>2025/1/22 19:55:54</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[JIN Zhen-Kai,LI Kun,MA Xiao-Meng,WANG Min,ZHANG Lin-Lin,ZHAO Ya-Qi]]></author>
</item>
<item>
<title><![CDATA[Application of Non-invasive Deep Brain Stimulation in Parkinson’s Disease Treatment]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202410210000002]]></link>
<description><![CDATA[Parkinson’s disease (PD) is a common neurodegenerative disorder that significantly impacts patients’ independence and quality of life, imposing a substantial burden on both individuals and society. Although dopaminergic replacement therapies provide temporary relief from various symptoms, their long-term use often leads to motor complications, limiting overall effectiveness. In recent years, non-invasive deep brain stimulation (DBS) techniques have emerged as promising therapeutic alternatives for PD, offering a means to modulate deep brain regions with high precision without invasive procedures. These techniques include temporal interference stimulation (TIs), low-intensity transcranial focused ultrasound stimulation (LITFUS), transcranial magneto-acoustic stimulation (TMAS), non-invasive optogenetic modulation, and non-invasive magnetoelectric stimulation. They have demonstrated significant potential in alleviating various PD symptoms by modulating neural activity within specific deep brain structures affected by the disease. Among these approaches, TIs and LITFUS have received considerable attention. TIs generate low-frequency interference by applying two slightly different high-frequency electric fields, targeting specific brain areas to alleviate symptoms such as tremors and bradykinesia. LITFUS, on the other hand, uses low-intensity focused ultrasound to non-invasively stimulate deep brain structures, showing promise in improving both motor function and cognition in PD patients. The other three techniques, while still in early research stages, also hold significant promise for deep brain modulation and broader clinical applications, potentially complementing existing treatment strategies. Despite these promising findings, significant challenges remain in translating these techniques into clinical practice. The heterogeneous nature of PD, characterized by variable disease progression and individualized treatment responses, necessitates flexible protocols tailored to each patient’s unique needs. Additionally, a comprehensive understanding of the mechanisms underlying these treatments is crucial for refining protocols and maximizing their therapeutic potential. Personalized medicine approaches, such as the integration of neuroimaging and biomarkers, will be pivotal in customizing stimulation parameters to optimize efficacy. Furthermore, while early-stage clinical trials have reported improvements in certain symptoms, long-term efficacy and safety data are limited. To validate these techniques, large-scale, multi-center, randomized controlled trials are essential. Parallel advancements in device design, including the development of portable and cost-effective systems, will improve patient access and adherence to treatment protocols. Combining non-invasive DBS with other interventions, such as pharmacological treatments and physical therapy, could also provide a more comprehensive and synergistic approach to managing PD. In conclusion, non-invasive deep brain stimulation techniques represent a promising frontier in the treatment of Parkinson’s disease. While they have demonstrated considerable potential in improving symptoms and restoring neural function, further research is needed to refine protocols, validate long-term outcomes, and optimize clinical applications. With ongoing technological and scientific advancements, these methods could offer PD patients safer, more effective, and personalized treatment options, ultimately improving their quality of life and reducing the societal burden of the disease.]]></description>
<pubDate>2025/1/21 16:40:43</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LIU Yu,LU Zi-Jun,Lü Jiao-Jiao,WANG Wei,ZHANG Yu-Feng]]></author>
</item>
<item>
<title><![CDATA[ESCRT Mechanism-mediated Repair of Plasma Membrane Damage Induced by Regulatory Cell Death]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202408140000001]]></link>
<description><![CDATA[The plasma membrane (PM) plays an essential role in maintaining cell homeostasis, therefore, timely and effective repair of damage caused by factors such as mechanical rupture, pore-forming toxins, or pore-forming proteins is crucial for cell survival. PM damage induces membrane rupture and stimulates an immune response. However, damage resulting from regulated cell death processes, including pyroptosis, ferroptosis, and necroptosis, cannot be repaired by simple sealing mechanisms and thus, requires specialized repair machinery. Recent research has identified a PM repair mechanism of regulated cell death-related injury, mediated by the endosomal sorting complexes required for transport (ESCRT) machinery. Here, we review recent progress in elucidating the ESCRT machinery-mediated repair mechanism of PM injury, with particular focus on processes related to regulated cell death. This overview, along with continued research in this field, may provide novel insights into therapeutic targets for diseases associated with dysregulation of regulated cell death pathways.]]></description>
<pubDate>2025/1/21 10:36:23</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DENG Le,FENG Tian-Yang,GUO Miao-Miao,LI Li,XU Gou]]></author>
</item>
<item>
<title><![CDATA[PANoptosis: a New Target for Cardiovascular Diseases]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202410120000001]]></link>
<description><![CDATA[The innate immune system detects cellular stressors and microbial infections, activating programmed cell death (PCD) pathways to eliminate intracellular pathogens and maintain homeostasis. Among these pathways, pyroptosis, apoptosis, and necroptosis represent the most characteristic forms of PCD. Although initially regarded as mechanistically distinct, emerging research has revealed significant crosstalk among their signaling cascades. Consequently, the concept of PANoptosis has been proposed—an inflammatory cell death pathway driven by caspases and receptor-interacting protein kinases (RIPKs), and regulated by the PANoptosome, which integrates key features of pyroptosis, apoptosis, and necroptosis. The core mechanism of PANoptosis involves the assembly and activation of the PANoptosome, a macromolecular complex composed of three structural components: sensor proteins, adaptor proteins, and effector proteins. Sensors detect upstream stimuli and transmit signals downstream, recruiting critical molecules via adaptors to form a molecular scaffold. This scaffold activates effectors, triggering intracellular signaling cascades that culminate in PANoptosis. The PANoptosome is regulated by upstream molecules such as interferon regulatory factor 1 (IRF1), transforming growth factor beta-activated kinase 1 (TAK1), and adenosine deaminase acting on RNA 1 (ADAR1), which function as molecular switches to control PANoptosis. Targeting these switches represents a promising therapeutic strategy. Furthermore, PANoptosis is influenced by organelle functions, including those of the mitochondria, endoplasmic reticulum, and lysosomes, highlighting organelle-targeted interventions as effective regulatory approaches. Cardiovascular diseases (CVDs), the leading global cause of morbidity and mortality, are profoundly impacted by PCD. Extensive crosstalk among multiple cell death pathways in CVDs suggests a complex regulatory network. As a novel cell death modality bridging pyroptosis, apoptosis, and necroptosis, PANoptosis offers fresh insights into the complexity of cell death and provides innovative strategies for CVD treatment. This review summarizes current evidence linking PANoptosis to various CVDs, including myocardial ischemia/reperfusion injury, myocardial infarction, heart failure, arrhythmogenic cardiomyopathy, sepsis-induced cardiomyopathy, cardiotoxic injury, atherosclerosis, abdominal aortic aneurysm, thoracic aortic aneurysm and dissection, and vascular toxic injury, thereby providing critical clinical insights into CVD pathophysiology. However, the current understanding of PANoptosis in CVDs remains incomplete. First, while PANoptosis in cardiomyocytes and vascular smooth muscle cells has been implicated in CVD pathogenesis, its role in other cell types—such as vascular endothelial cells and immune cells (e.g., macrophages)—warrants further investigation. Second, although pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) are known to activate the PANoptosome in infectious diseases, the stimuli driving PANoptosis in CVDs remain poorly defined. Additionally, methodological challenges persist in identifying PANoptosome assembly in CVDs and in establishing reliable PANoptosis models. Beyond the diseases discussed, PANoptosis may also play a role in viral myocarditis and diabetic cardiomyopathy, necessitating further exploration. In conclusion, elucidating the role of PANoptosis in CVDs opens new avenues for drug development. Targeting this pathway could yield transformative therapies, addressing unmet clinical needs in cardiovascular medicine.]]></description>
<pubDate>2025/1/20 11:20:27</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Xin-Nong,GUO Xiao-Chen,LIU Na-Wen,YANG Ying-Xi,ZHANG Jun-Ping]]></author>
</item>
<item>
<title><![CDATA[Promotion of Angiogenesis by Colorectal Cancer Cell LoVo Derived-exosomes Through Transferring pEGFR]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406300000002]]></link>
<description><![CDATA[<b>Objective</b> This study sought to investigate the impact of exosomes derived from LoVo cells (LoVo-Exos) in colorectal cancer (CRC) on tumor angiogenesis, as well as to elucidate the potential molecular mechanisms underlying their pro-angiogenic effects.<b>Methods</b> LoVo-Exos were isolated <i>via</i> ultracentrifugation, and their internalization into recipient human umbilical vein endothelial cells (HUVECs) was visualized using confocal microscopy. The influence of LoVo-Exos on angiogenesis was assessed through an <i>in vitro</i> tube formation assay. Additionally, the pro-angiogenic effects of LoVo-Exos were evaluated <i>in vivo</i> using a matrix gluing assay in mice. To investigate the molecular mechanisms through which LoVo-Exos facilitate angiogenesis, Western blot analysis was employed to examine the transfer of pEGFR by LoVo-Exos into recipient cells. Both Western blot and ELISA were utilized to assess the expression levels of key signaling proteins within the EGFR-ERK pathway, as well as the expression of downstream angiogenic core molecules. Furthermore, the impact of EGFR knockdown and ERK inhibitor treatment on angiogenesis was evaluated, with subsequent analysis of the expression of downstream angiogenic core molecules following these interventions.<b>Results</b> Confocal microscopy demonstrated the internalization of LoVo-Exos into HUVECs. <i>In vitro</i> angiogenesis assays further indicated that LoVo-Exos significantly enhanced the formation of tubular structures in HUVECs. Additionally, macroscopic examination of subcutaneous matrix plug formation in mice revealed a substantial increase in vascular-like structures within the matrix plugs following the administration of LoVo-Exos, compared to the PBS control group. Hematoxylin and eosin (HE) staining revealed the presence of erythrocyte-filled microvessels within the matrix plugs combined with LoVo-Exos. Furthermore, immunohistochemical analysis demonstrated the expression of the endothelial cell marker CD31 in these matrix plugs. The presence of CD31-positive cells in the LoVo-Exos-treated matrix plugs was associated with a significant enhancement in the formation of luminal structures. These findings suggest that LoVo-Exos facilitate the <i>in vivo</i> development of vascular-like structures. Subsequent investigations demonstrated that LoVo-Exos facilitated the delivery of pEGFR to HUVEC, thereby enhancing angiogenesis. Conversely, LoVo-Exos with EGFR knockdown exhibited a diminished capacity to promote angiogenesis, an effect that was further attenuated by the ERK phosphorylation inhibitor U0126. Western blot analysis assessing the activation of the EGFR-ERK signaling pathway in HUVEC indicated that LoVo-Exos augmented angiogenesis through the activation of this pathway. Furthermore, analysis of the impact of LoVo-Exos on the expression of downstream angiogenic core molecules revealed an increase in interleukin-8 (IL-8) secretion in HUVEC. The enhancement observed was diminished in LoVo-Exos following EGFR knockdown, and this reduction was counteracted by the ERK phosphorylation inhibitor U0126.<b>Conclusion</b> The underlying mechanism may involve the delivery of pEGFR in LoVo-Exos to HUVECs, leading to increased IL-8 secretion <i>via</i> the EGFR-ERK signaling pathway, thereby enhancing the angiogenic potential of HUVECs. This finding may offer new insights into the mechanisms underlying cancer metastasis.]]></description>
<pubDate>2025/1/8 15:45:47</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CHENG Ya-Jie,FANG Jin,WANG Rui,ZHOU Xue-Tong]]></author>
</item>
<item>
<title><![CDATA[Ca<sup>2+</sup> Release From The Endoplasmic Reticulum Mediates Electric Field Guided Cell Migration of <i>Dictyostelium discoideum</i>]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202411120000001]]></link>
<description><![CDATA[<b>Objective</b> As a second messenger in intracellular signal transduction, Ca<sup>2+</sup> plays an important role in cell migration. Previous studies have demonstrated that extracellular Ca<sup>2+</sup> influx can promote electric field-guided cell migration, known as electrotaxis. However, the effect of intracellular Ca<sup>2+</sup> flow on electrotaxis is unclear. Therefore, in this study, we investigate the effect of Ca<sup>2+</sup> flux on the electrotaxis of <i>Dictyostelium discoideum</i>.<b>Methods</b> The electrotaxis of <i>Dictyostelium discoideum</i> was investigated by applying a direct current (DC) electric field. Cell migration was recorded using a real-time imaging system. Calcium channel inhibitors, the extracellular Ca<sup>2+</sup> chelator EGTA, Ca<sup>2+</sup>-free DB buffer, and caffeine were applied to investigate the impact of intra- and extracellular Ca<sup>2+</sup> flow on electrotaxis. The involvement of G proteins and ERK2 in directed cell migration mediated by endoplasmic reticulum Ca<sup>2+</sup> release was explored using mutants.<b>Results</b> <i>Dictyostelium discoideum</i> migrated toward the cathode in the electric field in a voltage-dependent manner. The intracellular Ca<sup>2+</sup> concentration of the cells was significantly increased in the electric field. Inhibition of both extracellular Ca<sup>2+</sup> influx and intracellular Ca<sup>2+</sup> release suppressed cell electrotaxis migration. Inhibition of endoplasmic reticulum Ca<sup>2+</sup> release induced by caffeine significantly impaired the electrotaxis of <i>Dictyostelium discoideum</i>. Deletion of <i>Gα2, Gβ, Gγ, </i>and<i> Erk2</i> notably reduced the electrotaxis of the cells. Enhancing Ca<sup>2+</sup> release mediated by caffeine restored the electrotaxis of the <i>Gα2</i><sup>-</sup><i>, Gβ</i><sup> -</sup><i>, </i>and<i> Erk2</i><sup>-</sup> mutant cells partially or completely, but did not restore electrotaxis in the <i>Gγ</i><sup>-</sup><i> </i>mutant cells.<b>Conclusion</b> Ca<sup>2+</sup> release from the endoplasmic reticulum regulates electrotaxis migration in <i>Dictyostelium discoideum</i> and is involved in the regulation of cell electrotaxis by G proteins and ERK2.]]></description>
<pubDate>2025/1/8 15:32:21</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[GAO Run-Chi,WANG Yi-Fan,YUAN Shu-Qin,ZHAO San-Jun]]></author>
</item>
<item>
<title><![CDATA[Aging and Regeneration of Hypothalamic Neural Stem Cells]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202409160000002]]></link>
<description><![CDATA[Hypothalamic neural stem cells (htNSCs) are a type of glial-like neural stem cell located in the hypothalamus, possessing unique biological characteristics. They not only have the capacity to proliferate and differentiate but can also migrate into the parenchymal regions of the hypothalamus, further developing into neurons and successfully integrating into neural circuits. HtNSCs play multiple key physiological roles in the adult hypothalamus, including contributing to the formation of the blood-hypothalamic barrier (BHB), which is crucial for maintaining the stability of the hypothalamic environment. Through the BHB, htNSCs facilitate the effective diffusion of small molecules between the blood, cerebrospinal fluid, and hypothalamic parenchyma, thereby ensuring the proper transmission of nutrients and signaling molecules. In addition, htNSCs can sense fluctuations in blood glucose levels and regulate the release of neuropeptides accordingly, thus influencing the body’s energy metabolism and endocrine balance. However, as the body ages, the function of htNSCs gradually declines. Studies have shown that the aging of htNSCs has significant adverse effects on energy metabolism, sex hormone secretion, and overall hypothalamic function. During the aging process, the proliferative and differentiative capacities of htNSCs diminish, leading to reduced neuronal replenishment and subsequently impairing the hypothalamus’s ability to regulate energy balance. Furthermore, aging htNSCs may secrete inflammatory factors that disrupt the endocrine functions of the hypothalamus, thereby affecting sex hormone secretion. This impact extends beyond the hypothalamus itself and may exert widespread effects on the entire endocrine system through pathways such as the hypothalamic-pituitary-gonadal axis. Fortunately, research has found that transplanting young htNSCs can effectively alleviate neurological and skeletal muscle dysfunction associated with aging. This transplantation therapy replenishes active htNSCs, restoring normal hypothalamic function and thereby improving the body’s energy metabolism and neuromuscular function. These findings offer new perspectives and potential therapeutic strategies for anti-aging interventions. In recent years, the role of htNSCs in regulating energy metabolism and promoting aging has attracted significant attention from researchers. Studies have shown that the aging of htNSCs is closely linked to the development of various diseases. For instance, in obesity and metabolic syndrome, htNSC dysfunction may lead to disturbances in energy metabolism. Moreover, the aging of htNSCs has also been associated with the onset of neurodegenerative diseases. Therefore, in-depth research into the mechanisms underlying htNSC aging is crucial for understanding the pathogenesis of these conditions. This article briefly reviews the classification of htNSCs, the impacts of their aging on bodily functions, their relationship with related diseases, and the regulatory mechanisms that promote htNSC regeneration. Some strategies aimed at promoting htNSC regeneration and counteracting their aging appear to influence the overall aging phenotype of organisms. For example, studies have shown that modulating specific signaling pathways or gene expression can promote htNSC regeneration, thereby delaying the aging process. Additionally, certain natural products or pharmacological agents may also influence htNSC aging. Further research on htNSC aging will enhance our understanding of the hypothalamus’s role in systemic aging and elucidate the reasons behind gender differences in aging patterns. Moreover, these studies may offer novel approaches and therapeutic targets for improving energy metabolism disorders and treating diseases associated with gonadal hormone abnormalities. In summary, htNSCs play a vital role in the physiological functions of the hypothalamus and the aging process. Further investigation into the mechanisms and regulatory pathways of htNSC aging will aid in the development of new anti-aging therapies and provide innovative strategies for the treatment of related diseases.]]></description>
<pubDate>2025/1/8 11:39:08</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[ZHANG Xiu-Feng,ZHANG Yu]]></author>
</item>
<item>
<title><![CDATA[Neuromolecular Mechanisms of Transcranial Electrical Stimulation for The Improvement of Alzheimer’s Disease]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202409200000001]]></link>
<description><![CDATA[Alzheimer’s disease (AD) is one of the most common and severe dementias, severely affecting the physical and mental health and quality of life of patients and imposing a heavy burden on society. Recently, transcranial electrical stimulation (tES) has shown great potential for improving cognitive function in AD. Transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS) are the two main forms of tES. The present review mainly summarizes the neuromolecular mechanisms of tDCS and tACS for the improvement of AD. Both techniques show similarities in exerting neuroprotective effects, improving cerebral blood flow to alleviate cerebrovascular dysfunction, affecting the state and function of astrocytes, affecting the levels of amyloid β-protein (Aβ) and phosphorylated tau (p-tau) proteins, and affecting neuroplasticity. Specifically, tDCS improves neuronal status, inhibits neuronal apoptosis, improves cholinergic neurons and reduces oxidative stress, <i>etc</i>., and further exerts neuroprotective effects, but tACS mainly maintains the normal function of cholinergic neurons to exert the effects. For the alleviation of cerebrovascular dysfunction, tDCS has particular advantages in optimizing the neural vascular unit and improving the blood-brain barrier. For astrocytes, tDCS attenuates inflammatory responses by inhibiting their activation. In contrast, the effect of tACS on the activation state of microglial cells is still controversial for enhancement in AD mice and inhibition in patients. For Aβ levels, the effects of tDCS in AD patients are also inconclusive, but in AD rodents, tDCS may regulate molecular pathways related to Aβ production and degradation, thereby removing Aβ. In addition, tACS reduces p-tau levels in AD patients, but tDCS shows a trend toward reduction. In short, the effect of tES on Aβ and p-tau needs further investigation. Regarding neuroplasticity, tDCS improves cortical and synaptic plasticity, but tACS improves only synaptic plasticity. However, both techniques do not affect the molecular level associated with plasticity. On the other hand, this review has summarized some interesting findings of tES in non-AD rodents that may be relevant to the pathological mechanisms of AD. For neuroprotection, tDCS can promote neurogenesis, GABAergic and glutamatergic neurotransmission, modulate neuroprotection-related signaling pathways, reduce oxidative stress, and protect hippocampal neurons. In addition, tDCS inhibits conversion of microglia to the M1 phenotype and promotes conversion to the M2 phenotype, thereby reducing neuroinflammation. Importantly, tDCS induces changes in molecular indices associated with synaptic plasticity. These findings in non-AD rodents provide a reference for understanding the potential effect and possible mechanism of tES in AD and for exploring new approaches to treat other diseases with similar pathological features. In addition, tES has shown some effects in AD rodents, such as tACS improving plasticity, that have not been studied in non-AD rodents. These effects suggest the particular complexity of the pathological mechanisms of AD, which should be considered when applying the results of tES studies in non-AD rodents to AD rodents. In conclusion, this review provides a comprehensive overview of the neuromolecular mechanisms of tES in AD research and highlights its promise as a non-invasive brain stimulation technique in the treatment of AD. Furthermore, tES will play an indispensable role in the treatment of neuropsychiatric disorders and in the study of brain function.]]></description>
<pubDate>2025/1/6 16:42:03</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Zhuang-Fei,FU Yu,YUAN Yuan]]></author>
</item>
<item>
<title><![CDATA[The Role of NEAT1 in Bone and Cartilage Metabolism and Bone Diseases]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202411040000001]]></link>
<description><![CDATA[In the process of maintaining the steady state of bone tissue, the transcription network and signal pathway of the body play a vital role. These complex regulatory mechanisms need precise coordination to ensure the balance between bone formation and bone absorption. Once this balance is broken, it may lead to pathological changes of bone and cartilage, and then lead to various bone diseases. Therefore, it is of great significance to understand these regulatory mechanisms for the prevention and treatment of bone diseases. In recent years, with the deepening of research, more and more lncRNA has been found to be closely related to bone health. Among them, nuclear paraspeckle assembly transcript 1 (NEAT1), as an extremely abundant RNA molecule in mammalian nuclei, has attracted extensive attention. NEAT1 is mainly transcribed from a specific site in human chromosome 11 by RNA polymerase II (RNaseP), which can form two different subtypes NEAT1_1 and NEAT1_2. These two subtypes are different in intracellular distribution and function, but they participate in many biological processes together. Studies have shown that NEAT1 plays a specific role in the process of cell growth and stress response. For example, it can regulate the development of osteoblasts (OB), osteoclasts (OC) and chondrocytes by balancing the differentiation of bone marrow mesenchymal stem cells (BMSCs), thus maintaining the steady state of bone metabolism. This discovery reveals the important role of NEAT1 in bone development and remodeling. In addition, NEAT1 is closely related to a variety of bone diseases. In patients with bone diseases such as osteoporosis (OP), osteoarthritis (OA) and osteosarcoma (OS), the expression level of NEAT1 is different. These differential expressions may be closely related to the pathogenesis and progression of bone diseases. By regulating the level of NEAT1, it can affect a variety of signal transduction pathways, and then affect the development of bone diseases. For example, some studies show that by regulating the expression level of NEAT1, the activity of osteoclasts can be inhibited, and the proliferation and differentiation of osteoblasts can be promoted, thus improving the symptoms of osteoporosis. It is worth noting that NEAT1 can also be used as a key sensor for the prevention and treatment of bone diseases. When exercising or receiving some natural products, the expression level of NEAT1 will change, thus reflecting the response of bones to external stimuli. This feature makes NEAT1 an important target for studying the prevention and treatment strategies of bone diseases. However, although the role of NEAT1 in bone biology and bone diseases has been initially recognized, its specific mechanism and regulatory relationship are still controversial. For example, the expression level, mode of action and interaction with other molecules of NEAT1 in different bone diseases still need further in-depth study. This paper reviews the role of NEAT1 in maintaining bone and cartilage metabolism, and discusses its expression and function in various bone diseases. By combing the existing research results and controversial points, this paper aims to provide new perspectives and ideas for the prevention and treatment of bone diseases, and provide useful reference and enlightenment for future research.]]></description>
<pubDate>2025/1/3 17:12:31</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHANG Yi-Xing,HUANG Rui-Qi,WEN Rui-Ming,XU Ke,YI Xue-Jie]]></author>
</item>
<item>
<title><![CDATA[Effects of E2F Family on Musculoskeletal System Development and Related Diseases]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202410260000002]]></link>
<description><![CDATA[The E2F family consists of transcription factors that mediate the induction of the E2 gene by adenovirus E1a and play a vital role in regulating cell cycle progression, cell proliferation, and cell apoptosis. Given its primary functions in cell proliferation and differentiation, early studies on the E2F family focused on its relationship with cancer. However, as research has expanded, the E2F family has been found to play an independent role in the development of the musculoskeletal system and the mechanisms of related diseases. The E2F family can influence the progression of musculoskeletal diseases by regulating the cell cycle and proliferation of stem cells, osteoblasts, osteoclasts, chondrocytes, and myoblasts, acting as a target gene for various downstream pathways and microRNAs. This review is divided into two parts: the first elaborates on the physiological roles of the E2F family in bone metabolism, skeletal muscle, and cartilage development, while the second summarizes its roles in the pathological processes of osteosarcoma, rheumatoid arthritis, osteoporosis, and muscle-related diseases. During musculoskeletal system development, the E2F family affects bone metabolism by regulating stem cell differentiation, promoting osteoclast differentiation and metabolism, and increasing osteoblast activity or inhibiting osteoblast differentiation. It also regulates mitosis in cartilage, influencing chondrocyte proliferation and differentiation. Additionally, the E2F family is essential for skeletal muscle development, controlling muscle differentiation and myogenesis. In the pathological mechanisms of musculoskeletal diseases, most E2F family members act as downstream targets of various microRNAs, regulating osteosarcoma progression. Some members function independently through their ability to control cell proliferation. The E2F family also contributes to osteoporosis progression by promoting pathological increases in osteoclast activity and affecting osteoblast function. In rheumatoid arthritis and osteoarthritis, E2F family members aggravate inflammation by increasing inflammatory factors through multiple pathways. Moreover, the E2F family plays a crucial role in muscle-related diseases, influencing skeletal muscle regeneration after injury and affecting symptoms of muscular dystrophies. This review provides a comprehensive overview of the physiological roles of the E2F family in the musculoskeletal system and its mechanisms of action in related diseases. By offering a systematic summary and analysis, this article aims to provide a foundation for future research as well as insights for disease diagnosis and treatment.]]></description>
<pubDate>2024/12/31 11:54:00</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[WANG Zhuo,WANG Shu-Wan]]></author>
</item>
<item>
<title><![CDATA[Predicting Postoperative Motor Function in High-risk Glioma Based on The Morphology Change of Motor Fiber Tracts]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202411230000001]]></link>
<description><![CDATA[<b>Objective</b> Gliomas in the motor functional area can damage the corticospinal tract (CST), leading to motor dysfunction. Currently, there is a lack of unified methods for evaluating the extent of CST damage, especially in patients with high surgical risk where the minimum distance from the lesion to the CST is less than 10 mm. This study aims to further clarify the classification method and clinical significance of CST morphological changes in these patients.<b>Methods</b> This retrospective study analyzed 109 high-risk functional area glioma patients who underwent neurosurgical treatment with preoperative diffusion tensor imaging (DTI) imaging and intraoperative neurostimulation guidance between 2014 and 2024. All patients had a lesion-to-tract distance (<i>LTD</i>) of less than 10 mm between the CST and the lesion. Preoperative DTI evaluation of CST involvement-induced morphological changes were reviewed. Patients were divided into 3 groups: 17 cases (15.6%) with symmetric CST morphology compared to the healthy side (CST symmetry), 48 cases (44.0%) with significant CST morphology changes compared to the healthy side (CST deformation), and 44 cases (40.4%) with CST overlap with the tumor (CST overlap). Then we classified patients according to preoperative assessment of tumor-induced morphological changes, and analyze postoperative motor function for each category.<b>Results</b> Postoperative pathology showed a significantly higher proportion of high-grade gliomas (HGG) in the CST overlap group compared to the other two groups (<i>P</i>=0.001). Logistic regression analysis showed that CST overlap was a predictor of HGG (<i>P</i>=0.000). The rate of total tumor resection in the CST deformation group and overlap group was lower than in the CST symmetric group (<i>P</i>=0.008). There was a total of 41 postoperative hemiplegic patients, with 4 cases (23.5%) in the CST symmetric group, 11 cases (22.9%) in the CST deformation group, and 26 cases (59.1%) in the CST overlap group. CST overlap with the tumor predicted postoperative hemiplegia (<i>P</i>=0.016). Two-way ANOVA analysis of the affected/healthy side and CST morphology groups showed significant main effects of CST grouping and healthy-affected side (<i>P</i>=0.017 and <i>P</i>=0.010), with no significant interaction (<i>P</i>=0.31). The fractional anisotropy (<i>FA</i>) value in the CST overlap group and the affected side was lower. A decrease in the <i>FA</i> value on the affected side predicted postoperative hemiplegia (sensitivity 69.2%, specificity 71.9%).<b>Conclusion</b> We have established a method to predict postoperative hemiplegia in high-risk motor functional area glioma patients based on preoperative CST morphological changes. CST overlap leads to a decrease in CST <i>FA</i> values. This method can be used for precise patient management and aid in accurate preoperative surgical planning.]]></description>
<pubDate>2024/12/31 9:38:34</pubDate>
<category><![CDATA[技术与方法]]></category>
<author><![CDATA[LIN Song,MA Qiang,WANG Xi-Jie,YU Song-Lin,YU Tao,ZHAO Chu-Yue,ZUO Zhen-Tao]]></author>
</item>
<item>
<title><![CDATA[Applications of EEG Biomarkers in The Assessment of Disorders of Consciousness]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202409200000003]]></link>
<description><![CDATA[Disorders of consciousness (DOC) are pathological conditions characterized by severely suppressed brain function and the persistent interruption or loss of consciousness. Accurate diagnosis and evaluation of DOC are prerequisites for precise treatment. Traditional assessment methods are primarily based on behavioral scales, which are inherently subjective and rely on observable behaviors. Moreover, traditional methods have a high misdiagnosis rate, particularly in distinguishing minimally conscious state (MCS) from vegetative state/unresponsive wakefulness syndrome (VS/UWS). This diagnostic uncertainty has driven the exploration of objective, reliable, and efficient assessment tools. Among these tools, electroencephalography (EEG) has garnered significant attention for its non-invasive nature, portability, and ability to capture real-time neurodynamics. This paper systematically reviews the application of EEG biomarkers in DOC assessment. These biomarkers are categorized into 3 main types: resting-state EEG features, task-related EEG features, and features derived from transcranial magnetic stimulation-EEG (TMS-EEG). Resting-state EEG biomarkers include features based on spectrum, microstates, nonlinear dynamics, and brain network metrics. These biomarkers provide baseline representations of brain activity in DOC patients. Studies have shown their ability to distinguish different levels of consciousness and predict clinical outcomes. However, because they are not task-specific, they are challenging to directly associate with specific brain functions or cognitive processes. Strengthening the correlation between resting-state EEG features and consciousness-related networks could offer more direct evidence for the pathophysiological mechanisms of DOC. Task-related EEG features include event-related potentials, event-related spectral modulations, and phase-related features. These features reveal the brain’s responses to external stimuli and provide dynamic information about residual cognitive functions, reflecting neurophysiological changes associated with specific cognitive, sensory, or behavioral tasks. Although these biomarkers demonstrate substantial value, their effectiveness rely on patient cooperation and task design. Developing experimental paradigms that are more effective at eliciting specific EEG features or creating composite paradigms capable of simultaneously inducing multiple features may more effectively capture the brain activity characteristics of DOC patients, thereby supporting clinical applications. TMS-EEG is a technique for probing the neurodynamics within thalamocortical networks without involving sensory, motor, or cognitive functions. Parameters such as the perturbational complexity index (PCI) have been proposed as reliable indicators of consciousness, providing objective quantification of cortical dynamics. However, despite its high sensitivity and objectivity compared to traditional EEG methods, TMS-EEG is constrained by physiological artifacts, operational complexity, and variability in stimulation parameters and targets across individuals. Future research should aim to standardize experimental protocols, optimize stimulation parameters, and develop automated analysis techniques to improve the feasibility of TMS-EEG in clinical applications. Our analysis suggests that no single EEG biomarker currently achieves an ideal balance between accuracy, robustness, and generalizability. Progress is constrained by inconsistencies in analysis methods, parameter settings, and experimental conditions. Additionally, the heterogeneity of DOC etiologies and dynamic changes in brain function add to the complexity of assessment. Future research should focus on the standardization of EEG biomarker research, integrating features from resting-state, task-related, and TMS-EEG paradigms to construct multimodal diagnostic models that enhance evaluation efficiency and accuracy. Multimodal data integration (<i>e.g</i>., combining EEG with functional near-infrared spectroscopy) and advancements in source localization algorithms can further improve the spatial precision of biomarkers. Leveraging machine learning and artificial intelligence technologies to develop intelligent diagnostic tools will accelerate the clinical adoption of EEG biomarkers in DOC diagnosis and prognosis, allowing for more precise evaluations of consciousness states and personalized treatment strategies.]]></description>
<pubDate>2024/12/31 9:31:01</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Long,LIU Jia,MING Dong,WANG Zhong-Peng,XU Min-Peng]]></author>
</item>
<item>
<title><![CDATA[Inhibition of HDAC3 Promotes Psoriasis Development in Mice Through Regulating Th17]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202409180000002]]></link>
<description><![CDATA[<b>Objective</b> To investigate the influence of histone deacetylase 3 (HDAC3) on the occurrence, development of psoriasis-like inflammation in mice, and the relative immune mechanisms.<b>Methods</b> Healthy C57BL/6 mice aged 6-8 weeks were selected and randomly divided into 3 groups: control group (Control), psoriasis model group (IMQ), and HDAC3 inhibitor RGFP966-treated psoriasis model group (IMQ+RGFP966). One day prior to the experiment, the back hair of the mice was shaved. After a one-day stabilization period, the mice in Control group was treated with an equal amount of vaseline, while the mice in IMQ group was treated with imiquimod (62.5 mg/d) applied topically on the back to establish a psoriasis-like inflammation model. The mice in IMQ+RGFP966 group received intervention with a high dose of the HDAC3-selective inhibitor RGFP966 (30 mg/kg) based on the psoriasis-like model. All groups were treated continuously for 5 d, during which psoriasis-like inflammation symptoms (scaling, erythema, skin thickness), body weight, and mental status were observed and recorded, with photographs taken for documentation. After euthanasia, hematoxylin-eosin (HE) staining was used to assess the effect of RGFP966 on the skin tissue structure of the mice, and skin thickness was measured. The mRNA and protein expression levels of HDAC3 in skin tissues were detected using reverse transcription real-time quantitative polymerase chain reaction (RT-qPCR) and Western blot (WB), respectively. Flow cytometry was employed to analyze neutrophils in peripheral blood and lymph nodes, CD4<sup>+</sup> T lymphocytes, CD8<sup>+</sup> T lymphocytes in peripheral blood, and IL-17A secretion by peripheral blood CD4<sup>+</sup> T lymphocytes. Additionally, spleen CD4<sup>+</sup> T lymphocyte expression of HDAC3, CCR6, CCR8, and IL-17A secretion levels were analyzed. Immunohistochemistry was used to detect the localization and expression levels of HDAC3, IL-17A, and IL-10 in skin tissues.<b>Results</b> Compared with the Control group, the IMQ group exhibited significant psoriasis-like inflammation, characterized by erythema, scaling, and skin wrinkling. Compared with the IMQ group, RGFP966 exacerbated psoriasis-like inflammatory symptoms, leading to increased hyperkeratosis. The psoriasis area and severity index (PASI) skin symptom scores were higher in the IMQ group than those in the Control group, and the scores were further elevated in the IMQ+RGFP966 group compared to the IMQ group. Skin thickness measurements showed a trend of IMQ+RGFP966>IMQ>Control. The numbers of neutrophils in the blood and lymph nodes increased sequentially in the Control, IMQ, and IMQ+RGFP966 groups, with a similar trend observed for CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocytes in the blood. In skin tissues, compared with the Control group, the mRNA and protein levels of HDAC3 decreased in the IMQ group, but RGFP966 did not further reduce these expressions. HDAC3 was primarily located in the nucleus. Compared with the Control group, the nuclear HDAC3 content decreased in the skin tissues of the IMQ group, and RGFP966 further reduced nuclear HDAC3. Compared with the Control and IMQ groups, RGFP966 treatment decreased HDAC3 expression in splenic CD4<sup>+</sup> and CD8<sup>+</sup> T cells. RGFP966 treatment increased the expression of CCR6 and CCR8 in splenic CD4<sup>+</sup> T cells and enhanced IL-17A secretion by peripheral blood and splenic CD4<sup>+</sup> T lymphocytes. Additionally, compared with the IMQ group, RGFP966 reduced IL-10 protein levels and upregulated IL-17A expression in skin tissues.<b>Conclusion</b> RGFP966 exacerbates psoriatic-like inflammatory responses by inhibiting HDAC3, increasing the secretion of the cytokine IL-17A, and upregulating the expression of chemokines CCR8 and CCR6.]]></description>
<pubDate>2024/12/24 10:26:14</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CHEN Hao,LI Wen-Ting,QIN An-Qi,TIAN Feng,XIA Yang-Chen,XU Fan,ZHANG Ai-Hong,ZHANF Xin-Rui,ZHENG Quan-Hui,ZHU Yi-Ran]]></author>
</item>
<item>
<title><![CDATA[Structural Elucidation and Catalytic Mechanisms of PKS and NRPS Thioesterase Domains]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407010000006]]></link>
<description><![CDATA[Polyketides (PKs) and non-ribosomal peptides are the most important drug-leads for human, animal, and plant diseases. The conserved modular architectures and biosynthetic assembly line of polyketide synthases (PKS) and non-ribosomal peptide synthases (NRPS) endow PKs and NRPs with extremely diverse structures and activities and bring infinite possibilities to edit and modify the backbone structure of PKs and NRPs by adding, removing, inactivating and replacing PKS/NRPS modules or domains. The biosynthetic machinery of microbial polyketide natural products has evolved delicately with specific recognition and efficient catalysis of upstream intermediates by downstream enzymes/domains. Therefore, manipulations of PKS/NRPS and their related tailoring enzymes usually lead to attenuated production or abolished accumulation of intermediates with modified structures. As the terminal domain of most PKS and NRPS, thioesterases (TEs) play crucial roles in substrate selection during the chain release of these bioactive natural products, serving as pivotal bottleneck steps in their late-stage biosynthesis. TEs mainly perform chain hydrolysis or ester transfer reactions by nucleophilic attack of foreign nucleophiles such as H<sub>2</sub>O. Meanwhile, TEs also undergo nucleophilic attack by intramolecular oxygen atom, nitrogen atom, or carbon atom to achieve macrolactonization, macrolactamization, or Claisen condensation, respectively. There are two main classes of TEs involved in natural product biosynthesis. Type I TEs (TEIs) are commonly found in type I <i>cis</i>-AT PKS, <i>trans</i>-AT PKS, NRPS, and fungal PKS/NRPS, which are mainly located at the end module of synthase. In addition to TEIs, there is also a class of free type II TE (TEIIs), which catalyzes the release of incomplete or incorrectly extended intermediates during PKs and NRPs biosynthesis. Besides, a distinct class of free TE was identified in the chain release of polyether backbones, such as monensin and nanchangmycin. Since 2001, more than 20 crystal structures of TEs from diverse PKSs and NRPSs have been solved. The structural elucidation of TEs has unlocked the mystery of their structural and functional interaction, laid the foundation for the TE classification and mechanistic insight into the substrate selectivity and catalytic efficiency of TE, which further promotes the understanding of the chain release mechanism of natural products and better served the rational design of TE. Previous articles have systematically reviewed the structure, function, and regulatory mechanism of different TE families. Horsman <i>et al</i>. also reviewed the diversity, structure, and mechanism of TEs in PKSs and NRPSs. They put forward an insightful view that TEs might act as logic gates for substrate loading and chain releasing during the biosynthesis of natural products. It provides an important perspective for studying the evolution and functional prediction of TEs. This review summarizes the structural characteristics of various TE, focusing on the structural consistency of thioesterase to the catalytic mechanism. Additionally, this review follows the progress and limitations on the catalytic mechanism and computational simulation of type I TE, providing a detailed analysis of the chemical essence of thioesterase-catalyzed chain release reactions. This review aims to deliver revealing suggestions for the structural elucidation and mechanistic insights of TE, as well as its rational design for improved chain release of unnatural products.]]></description>
<pubDate>2024/12/21 7:51:21</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[BAI Lin-Quan,LIU Hao,LU Chen-Yang,SHI Ting,ZHOU Yu-Cong]]></author>
</item>
<item>
<title><![CDATA[The Adoption of Non-invasive Photobiomodulation in The Treatment of Epilepsy]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202409100000003]]></link>
<description><![CDATA[Epilepsy is a chronic neurological disease caused by abnormal synchronous discharge of the brain, which is characterized by recurrent and transient neurological abnormalities, mainly manifested as loss of consciousness and limb convulsions, and can occur in people of all ages. At present, anti-epileptic drugs (AEDs) are still the main means of treatment, but their efficacy is limited by the problem of drug resistance, and long-term use can cause serious side effects, such as cognitive dysfunction and vital organ damage. Although surgical resection of epileptic lesions has achieved certain results in some patients, the high cost and potential risk of neurological damage limit its scope of application. Therefore, the development of safe, accurate and personalized non-invasive treatment strategies has become one of the key directions of epilepsy research. In recent years, photobiomodulation (PBM) has gained significant attention as a promising non-invasive therapeutic approach. PBM uses light of specific wavelengths to penetrate tissues and interact with photosensitive molecules within cells, thereby modulating cellular metabolic processes. Research has shown that PBM can enhance mitochondrial function, promote ATP production, improve meningeal lymphatic drainage, reduce neuroinflammation, and stimulate the growth of neurons and synapses. These biological effects suggest that PBM not only holds the potential to reduce the frequency of seizures but also to improve the metabolic state and network function of neurons, providing a novel therapeutic avenue for epilepsy treatment. Compared to traditional treatment methods, PBM is non-invasive and avoids the risks associated with surgical interventions. Its low risk of significant side effects makes it particularly suitable for patients with drug-resistant epilepsy, offering new therapeutic options for those who have not responded to conventional treatments. Furthermore, PBM’s multi-target mechanism enables it to address a variety of complex etiologies of epilepsy, demonstrating its potential in precision medicine. In contrast to therapies targeting a single pathological mechanism, PBM’s multifaceted approach makes it highly adaptable to different types of epilepsy, positioning it as a promising supplementary or alternative treatment. Although animal studies and preliminary clinical trials have shown positive outcomes with PBM, its clinical application remains in the exploratory phase. Future research should aim to elucidate the precise mechanisms of PBM, optimize light parameters, such as wavelength, dose, and frequency, and investigate potential synergistic effects with other therapeutic modalities. These efforts will be crucial for enhancing the therapeutic efficacy of PBM and ensuring its safety and consistency in clinical settings. This review summarizes the types of epilepsy, diagnostic biomarkers, the advantages of PBM, and its mechanisms and potential applications in epilepsy treatment. The unique value of PBM lies not only in its multi-target therapeutic effects but also in its adaptability to the diverse etiologies of epilepsy. The combination of PBM with traditional treatments, such as pharmacotherapy and neuroregulatory techniques, holds promise for developing a more comprehensive and multidimensional treatment strategy, ultimately alleviating the treatment burden on patients. PBM has also shown beneficial effects on neural network plasticity in various neurodegenerative diseases. The dynamic remodeling of neural networks plays a critical role in the pathogenesis and treatment of epilepsy, and PBM’s multi-target mechanism may promote brain function recovery by facilitating neural network remodeling. In this context, optimizing optical parameters remains a key area of research. By adjusting parameters such as wavelength, dose, and frequency, researchers aim to further enhance the therapeutic effects of PBM while maintaining its safety and stability. Looking forward, interdisciplinary collaboration’ particularly in the fields of neuroscience, optical engineering, and clinical medicine’ will drive the development of PBM technology and facilitate its transition from laboratory research to clinical application. With the advancement of portable devices, PBM is expected to provide safer and more effective treatments for epilepsy patients and make a significant contribution to personalized medicine, positioning it as a critical component of precision therapeutic strategies.]]></description>
<pubDate>2024/12/18 13:04:16</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CAO Li,CHEN Chang-Chun,CHEN Lei,CHEN Si,JIANG Hui,LI Ao-Yun,LU Zhan-Chuang]]></author>
</item>
<item>
<title><![CDATA[The Function of <i>FoxA</i> Gene in Evolution, Development, and Disease]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202409030000001]]></link>
<description><![CDATA[The <i>FoxA</i> genes belong to a conserved family of transcription factors, that play a crucial role in regulating embryonic development, cellular differentiation, and disease pathogenesis. Initially identified as hepatocyte nuclear factor 3α (<i>Hnf3α</i>), FoxA is pivotal in activating liver-specific genes and contributing to liver morphogenesis. Studies have shown that FoxA proteins interact with specific DNA sequences and nucleosome-bound DNA, altering the local chromatin structure to regulate gene expression. The unique ability has earned them the designation of “pioneer factors”. The FoxA family comprises three members: FoxA1, FoxA2, and FoxA3. FoxA1 is predominantly expressed in endoderm-derived organs such as the lungs, liver, pancreas, and prostate, where it regulates hormone metabolism, cell cycle, and cell proliferation. FoxA2 is primarily expressed in the floor plate of the vertebrate spinal cord, where it plays a key role in establishing the dorsal-ventral patterning of the neural tube. FoxA3 is mainly expressed in the testes, where it regulates germ cell formation. <i>FoxA</i> genes exhibit functional diversity in embryonic development across different species, offering insights into their evolutionary roles. For instance, zebrafish embryos with mutations in the <i>foxa2</i><sup>-/-</sup> gene can survive, providing an opportunity to study embryonic development mechanisms. Currently, a growing body of research suggests that <i>FoxA</i> genes are involved in early embryonic development, cancer, and metabolism-related diseases. This paper summarizes the discovery, expression patterns, and biological functions of the <i>FoxA</i> genes while identifying key scientific questions that remain unresolved. It aims to provide readers a solid scientific basis for understanding the molecular mechanisms through which <i>FoxA</i> genes regulate embryonic development and contribute to cancer pathogenesis.]]></description>
<pubDate>2024/12/18 13:01:30</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[WANG Jing-Han,YANG Li-Xin]]></author>
</item>
<item>
<title><![CDATA[The Discovery of microRNA and Its Significance: The Enlightenment of The Nobel Prize in Physiology or Medicine of 2024]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202411130000001]]></link>
<description><![CDATA[The 2024 Nobel Prize in Physiology or Medicine was awarded to American scientists Victor Ambros and Gary Ruvkun in recognition of their discovery of microRNA (miRNA) and its role in regulating gene expression at the post-transcriptional level. miRNA is a type of small non-coding RNA (ncRNA) that regulates gene expression by binding to messenger RNA (mRNA). It exists not only in model organisms such as <i>Caenorhabditis elegans </i>(<i>C. elegans</i>) but also plays an important role in multicellular organisms, including humans, participating in regulating key life activities such as the cell cycle, cell death, and tissue differentiation. miRNAs have also been found in viruses, where they are involved in the process of viral infection. The discovery of miRNA has not only opened up a new research field in ncRNA but also challenged the classic “central dogma” of molecular biology. This dogma traditionally transcribes the linear transmission of genetic information: from DNA to mRNA, then translated into proteins, which ultimately carry out biological functions. However, due to the competitive binding of miRNAs with mRNA and other ncRNAs in cells, such as long non-coding RNA (lncRNA) and circular RNA (circRNA), a vast and complex gene expression regulatory network, known as the competing endogenous RNA (ceRNA) network, has emerged. The complexity and sophistication of the ceRNA regulatory network offer new perspectives for transcriptome research, aid in the exploration of gene functions and regulatory mechanisms at a deeper level, and then enable a more comprehensive understanding of various biological phenomena. Moreover, a complex interaction and regulatory network exists between miRNA and other ncRNAs. miRNA and other ncRNAs may also be generated through the splicing of the same genes, which have complex transcripts capable of simultaneously producing multiple types of ncRNAs, including miRNA, lncRNA, circRNA, <i>etc</i>., all of which are involved in a variety of biological processes. Meanwhile, miRNA itself is encoded by genes in the genome, and its expression is also regulated by other coding or ncRNAs. Together with mRNA and other ncRNAs, miRNA finely regulates the life activities of cells and affects the physiological and pathological functions of the body. The dysregulation of miRNA expression is closely linked to the onset and progression of many diseases, particularly cancers, cardiovascular diseases, and neurodegenerative disordors. Furthermore, miRNA provides new molecular markers and targets for the diagnosis and treatment of these diseases. In terms of disease diagnosis, miRNA can stably exist in body fluids and serve as a biomarker for many diseases. The research and development of miRNA drugs is currently advancing rapidly. At present, the research and development of miRNA drugs mainly includes endogenous miRNA analogs and inhibitors targeting endogenous miRNA. Although challenges such as stability, immunogenicity, and permeability remain, advances in chemical modification and delivery technologies are gradually overcoming these obstacles, promoting the clinical translation of miRNA-based drugs. This article summarizes the discovery, mechanism of action, and biological functions of miRNAs, as well as their interaction networks with other ncRNAs, and explores the future prospects of miRNA applications.]]></description>
<pubDate>2024/12/17 16:25:06</pubDate>
<category><![CDATA[2024年诺贝尔奖解读]]></category>
<author><![CDATA[LI Wen-Chao,QU Hong-Ke,XIAO Cheng-Feng,XIONG Wei,ZENG Zhao-Yang]]></author>
</item>
<item>
<title><![CDATA[Mass Spectrometry-based Cell Imaging]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407290000001]]></link>
<description><![CDATA[Cell models can simulate a variety of life states and disease developments, including single cells, two-dimensional (2D) cell cultures, three-dimensional (3D) multicellular spheroids, and organoids. They are essential tools for addressing complex biochemical questions. With continuous advancements in biological and cellular analysis technologies, in vitro cellular models designed to answer scientific questions have evolved rapidly. Early in vitro models primarily relied on 2D systems, which failed to accurately replicate the complex cellular compositions and microenvironmental interactions observed in vivo, let alone support sophisticated investigations into cellular biological functions. Subsequent improvements in cell culture techniques led to the development of 3D culture-based models, such as cellular spheroids. The advent of pluripotent stem cell technology further advanced the development of organoid systems, which closely mimic human organ development. Compared to traditional 2D models, both 3D cellular models and organoids offer significant advantages, including personalization and enhanced physiological relevance, making them particularly suitable for exploring molecular mechanisms of disease progression, discovering novel cellular and biomolecular functions, and conducting related studies. The imaging analysis of common cellular models primarily employs labeling-based methods for <i>in situ</i> imaging of targeted genes, proteins, and small-molecule metabolites, enabling further research on cell types, states, metabolism, and drug efficacy. However, these approaches have drawbacks such as poor labeling specificity and complex experimental procedures. By using cells as experimental models, mass spectrometry technology combined with morphological analysis can reveal quantitative changes and spatial distributions of various biological substances at the spatiotemporal level, including metabolites, proteins, lipids, peptides, drugs, environmental pollutants, and metals. This allows for the investigation of cell-cell interactions, tumor microenvironments, and cellular bioinformational heterogeneity. The application of these cutting-edge imaging technologies generates vast amounts of cellular data, necessitating the development of rapid, efficient, and highly accurate image data algorithms for precise segmentation and identification of single cells, multi-organelle structures, rare cell subpopulations, and complex cellular morphologies. A critical focus lies in creating deep learning models and algorithms that enhance the accuracy of cellular visualization. At the same time, establishing more robust data integration tools is essential not only for analyzing and interpreting outputs but also for effectively uncovering the biological significance of spatially resolved mass spectrometry data. Developing a cell imaging platform with high versatility, operational stability, and specificity to enable data interoperability will significantly enhance its utility in clinical research, thereby advancing investigations into disease molecular mechanisms and supporting precision diagnostics and therapeutics. In contrast to genomic, transcriptomic, and proteomic information, the metabolome can rapidly respond to external stimuli and cellular physiological changes within a short timeframe. This rapid and precise reflection of ongoing cellular state alterations has positioned spatial metabolomics as a pivotal approach for exploring the molecular mechanisms underlying physiological and pathological processes in cells, tissues, and organisms. In this review, we summarize research on cell imaging based on mass spectrometry technologies, including the selection and preparation of cell models, morphological analysis of cell models, spatial omics techniques based on mass spectrometry, mass cytometry, and their applications. We also discuss the current challenges and propose future directions for development in this field.]]></description>
<pubDate>2024/12/8 9:37:44</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LUO Qian,WANG Xin,ZHAO Chao,ZHOU Peng]]></author>
</item>
<item>
<title><![CDATA[Structural and Spatial Analysis of The Recognition Relationship Between Influenza A Virus Neuraminidase Antigenic Epitopes and Antibodies]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407100000002]]></link>
<description><![CDATA[<b>Objective</b> This study leverages structural data from antigen-antibody complexes of the influenza A virus neuraminidase (NA) protein to investigate the spatial recognition relationship between the antigenic epitopes and antibody paratopes.<b>Methods</b> Structural data on NA protein antigen-antibody complexes were comprehensively collected from the SAbDab database, and processed to obtain the amino acid sequences and spatial distribution information on antigenic epitopes and corresponding antibody paratopes. Statistical analysis was conducted on the antibody sequences, frequency of use of genes, amino acid preferences, and the lengths of complementarity determining regions (CDR). Epitope hotspots for antibody binding were analyzed, and the spatial structural similarity of antibody paratopes was calculated and subjected to clustering, which allowed for a comprehensively exploration of the spatial recognition relationship between antigenic epitopes and antibodies. The specificity of antibodies targeting different antigenic epitope clusters was further validated through bio-layer interferometry (BLI) experiments.<b>Results</b> The collected data revealed that the antigen-antibody complex structure data of influenza A virus NA protein in SAbDab database were mainly from H3N2, H7N9 and H1N1 subtypes. The hotspot regions of antigen epitopes were primarily located around the catalytic active site. The antibodies used for structural analysis were primarily derived from human and murine sources. Among murine antibodies, the most frequently used V-J gene combination was IGHV1-12*01/IGHJ2*01, while for human antibodies, the most common combination was IGHV1-69*01/IGHJ6*01. There were significant differences in the lengths and usage preferences of heavy chain CDR amino acids between antibodies that bind within the catalytic active site and those that bind to regions outside the catalytic active site. The results revealed that structurally similar antibodies could recognize the same epitopes, indicating a specific spatial recognition between antibody and antigen epitopes. Structural overlap in the binding regions was observed for antibodies with similar paratope structures, and the competitive binding of these antibodies to the epitope was confirmed through BLI experiments.<b>Conclusion</b> The antigen epitopes of NA protein mainly ditributed around the catalytic active site and its surrounding loops. Spatial complementarity and electrostatic interactions play crucial roles in the recognition and binding of antibodies to antigenic epitopes in the catalytic region. There existed a spatial recognition relationship between antigens and antibodies that was independent of the uniqueness of antibody sequences, which means that antibodies with different sequences could potentially form similar local spatial structures and recognize the same epitopes.]]></description>
<pubDate>2024/12/4 10:35:01</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[BI Lei,CHEN Zheng-Shan,CHI Xiang-Yang,CUI Yue,FAN Pu,FANG Ting,LI Ze-Ya,SU Chun-Yi,YU Chang-Ming,ZHANG Guan-Ying,ZHU Zheng]]></author>
</item>
<item>
<title><![CDATA[A Multimodal Fusion Drug Molecular Attribute Prediction Method Based on Bert and GCN]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407060000003]]></link>
<description><![CDATA[<b>Objective</b> Molecular property prediction plays a crucial role in drug development, especially in virtual screening and compound optimization. The advancement of artificial intelligence (AI) technologies has led to the emergence of numerous deep learning-based methods, which have demonstrated significant potential in improving molecular property prediction. Nonetheless, acquiring labeled molecular data can be both costly and time-consuming. The scarcity of labeled data poses a substantial challenge for supervised machine learning models to effectively generalize across the vast chemical space. In order to overcome the above limitations, in this work, we proposed a novel Bert and GCN-based multimodal fusion method (called BGMF) to predict molecular property.<b>Methods</b> BGMF can extract comprehensive molecular representation from atomic sequences, molecular fingerprint sequences, and molecular graph data and combine them through pre-training and fine-tuning. Specifically, our method consists of the following three main parts. (1) Molecular feature extraction; (2) Bert-GCN based pre-training; (3) fine-tuning. During molecular feature extraction, the Morgan algorithm is employed to generate the molecular fingerprints, transforming input SMILES strings of drugs into molecular fingerprint sentences. Simultaneously, atom sentences are created based on the atom indices within the molecule, Consequently, drug molecule are represented as both molecular fingerprint sentences and atom sentences. In the pre-training section, BGMF utilizes a self-supervised learning strategy, specifically masked molecular fingerprint and masked atom recovery, on a large dataset of unlabeled data using the Bert model. Here, molecular graph data is incorporated by merging graph convolutional neural networks with the Bert model, effectively combining the global “word” features of drug molecules with the local topological features of molecular graphs. We have also developed a dual decoder for atomic and molecular fingerprints to amplify molecular feature expression. Finally, in the fine-tuning stage, the addition of a pooling layer and task-specific fully connected neural networks allows the pre-trained module to be applied to a variety of downstream tasks for molecular property prediction.<b>Results</b> To validate the effectiveness of our BGMF, we conduct several experiments on 43 molecular attribute prediction tasks across 5 datasets. In comparison with other recent state-of-the-art methods, our BGMF achieves the best results in terms of area under the ROC curve (AUC). We also verified the generalization performance of the BGMF model by constructing independent test dataset, showing that the BGMF model has the best generalization performance. Additionally, we conduct the ablation studies to demonstrate the effect of atomic sequence, molecular fingerprint sequence, GCN based molecular graph module, and pre-training module on the overall performance of the model.<b>Conclusion</b> In this paper, we propose a novel method for drug molecular attribute prediction named BGMF which integrating the molecular graph data into tasks of molecular fingerprint recovery and masked atom recovery by combining graph convolutional neural network with the Bert model. The molecular fingerprint representations generated by BGMF were visualized using t-SNE, revealing that the BGMF model effectively captures the intrinsic structure and features of molecular fingerprints.]]></description>
<pubDate>2024/12/4 10:08:41</pubDate>
<category><![CDATA[技术与方法]]></category>
<author><![CDATA[FENG Yue-Hua,JIN Yan-Chun,YAN Xiao-Ying,ZHANG Shao-Wu]]></author>
</item>
<item>
<title><![CDATA[Intelligent Protein Engineering]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202409120000001]]></link>
<description><![CDATA[Proteins are essential fundamental substance for life processes, performing a variety of key roles in organisms, such as constructing cell structures, participating in metabolism and energy transformation, regulating physiological functions, providing immune protection, and transmitting signals. The diverse functions of proteins are achieved through their unique amino acid sequences and corresponding three-dimensional structures. Protein engineering involves altering or designing protein sequences and structures to achieve specific functions, and these efforts enhance our knowledge of proteins and offer powerful tools and technical support for research in biomedicine, biomaterials, bioengineering, and related fields. In recent years, with the advancements in algorithms, the accumulation of big data, and improvements in hardware computational power, artificial intelligence technology has rapidly developed and gradually been applied in the field of protein engineering, leading to the emergence of intelligent protein engineering. By utilizing biological big data such as genomics, proteomics, protein structure databases, and establishing various advanced deep learning models based on the data, intelligent protein engineering can achieve efficient, precise, and predictable protein design and modification. This article primarily focuses on four aspects of intelligent protein engineering, including structure design, backbone-free sequence design, backbone-based sequence design, and other auxiliary design approaches, summarizing the latest progress in the artificial intelligence technologies employed in these fields, and compiling the practical results achieved in recent years using intelligent protein engineering technology. As an emerging technology and method, intelligent protein engineering demonstrates significant potential and prospects, bringing substantial impacts on future scientific research and technological innovation, and providing new solutions and tools for addressing global challenges.]]></description>
<pubDate>2024/12/3 10:11:05</pubDate>
<category><![CDATA[2024年诺贝尔奖解读]]></category>
<author><![CDATA[WANG Kai-Yue,YE Sheng]]></author>
</item>
<item>
<title><![CDATA[The Refinement and Innovation of The UV Cross-linking and Immunoprecipitation]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202409110000001]]></link>
<description><![CDATA[RNA-binding proteins (RBPs) are ubiquitous components within cells, fulfilling essential functions in a myriad of biological processes. These proteins interact with RNA molecules to regulate gene expression at various levels, including transcription, splicing, transport, localization, translation, and degradation. Understanding the intricate network of RBP-RNA interactions is crucial for deciphering the complex regulatory mechanisms that govern cellular function and organismal development. Ultravidet (UV) cross-linking and immunoprecipitation (CLIP) stands out as a powerful approach designed to map the precise locations where RBPs bind to RNA. By using UV light to create covalent bonds between proteins and RNA, followed by immunoprecipitation to isolate the protein-RNA complexes, researchers can identify the direct targets of specific RBPs. The advent of high-throughput sequencing technologies has revolutionized CLIP, enabling the identification of not only the types but also the exact sequences of RNA bound by RBPs on a genome-wide scale. The evolution of CLIP has led to the development of specialized variants, each with unique features that address specific challenges and expand the scope of what can be studied. High-throughput sequencing CLIP (HITS-CLIP) was one of the first advancements, significantly increasing the throughput and resolution of RNA-protein interaction mapping. Photoactivatable-ribonucleoside-enhanced CLIP (PAR-CLIP) introduced the use of photoactivatable ribonucleosides to enhance cross-linking efficiency and specificity, reducing background noise and improving the detection of low-abundance RNA-protein interactions. Individual-nucleotide resolution CLIP (iCLIP) further refined the technique, achieving unprecedented precision by resolving individual nucleotides involved in RBP binding, which is particularly valuable for studying the fine details of RNA structure and function. Despite the remarkable progress, there remains room for improvement in CLIP technology. Researchers continue to seek methods to increase sensitivity, reduce technical variability, and improve the reproducibility of results. Advances in sample preparation, data analysis algorithms, and computational tools are critical for addressing these challenges. Moreover, the application of CLIP to more diverse biological systems, including non-model organisms and clinical samples, requires the development of tailored protocols and the optimization of existing ones. Looking forward, the field of RNA biology is poised to benefit greatly from ongoing innovations in CLIP technology. The exploration of non-canonical RNA-protein interactions, such as those involving long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs), promises to reveal new layers of cellular regulation and may lead to the discovery of novel therapeutic targets. Furthermore, integrating CLIP data with other omics approaches, such as proteomics and metabolomics, will provide a more comprehensive understanding of the dynamic interplay between RNA and its binding partners within the cell. In conclusion, the continuous refinement and expansion of CLIP techniques have not only deepened our knowledge of RNA biology but have also opened up new avenues for investigating the molecular underpinnings of health and disease. As the technology matures, it is expected to play an increasingly pivotal role in both basic and applied research, contributing to the advancement of medical science and biotechnology.]]></description>
<pubDate>2024/12/2 12:08:36</pubDate>
<category><![CDATA[新技术讲座]]></category>
<author><![CDATA[LU Cheng-Jiang,Buhe Nashun,WANG Gang,YANG Ming,ZHAO Jia-Min]]></author>
</item>
<item>
<title><![CDATA[Geographical Inference Study of Dust Samples From Four Cities in China Based on ITS2 Sequencing]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407070000001]]></link>
<description><![CDATA[<b>Objective</b> In the realm of forensic science, dust is a valuable type of trace evidence with immense potential for intricate investigations. With the development of DNA sequencing technologies, there is a heightened interest among researchers in unraveling the complex tapestry of microbial communities found within dust samples. Furthermore, striking disparities in the microbial community composition have been noted among dust samples from diverse geographical regions, heralding new possibilities for geographical inference based on microbial DNA analysis. The pivotal role of microbial community data from dust in geographical inference is significant, underscoring its critical importance within the field of forensic science. This study aims to delve deeply into the nuances of fungal community composition across the urban landscapes of Beijing, Fuzhou, Kunming, and Urumqi in China. It evaluates the accuracy of biogeographic inference facilitated by the internal transcribed spacer 2 (ITS2) fungal sequencing while concurrently laying a robust foundation for the operational integration of environmental DNA into geographical inference mechanisms.<b>Methods</b> ITS2 region of the fungal genomes was amplified using universal primers known as 5.8S-Fun/ITS4-Fun, and the resulting DNA fragments were sequenced on the Illumina MiSeq FGx platform. Non-metric multidimensional scaling analysis (NMDS) was employed to visually represent the differences between samples, while analysis of similarities (ANOSIM) and permutational multivariate analysis of variance (PERMANOVA) were utilized to statistically evaluate the dissimilarities in community composition across samples. Furthermore, using Linear Discriminant Analysis Effect Size (LEfSe) analysis to identify and filter out species that exhibit significant differences between various cities. In addition, we leveraged SourceTracker to predict the geographic origins of the dust samples.<b>Results</b> Among the four cities of Beijing, Fuzhou, Kunming and Urumqi, Beijing has the highest species richness. The results of species annotation showed that there were significant differences in the species composition and relative abundance of fungal communities in the four cities. NMDS analysis revealed distinct clustering patterns of samples based on their biogeographic origins in multidimensional space. Samples from the same city exhibited clear clustering, while samples from different cities showed separation along the first axis. The results from ANOSIM and PERMANOVA confirmed the significant differences in fungal community composition between the four cities, with the most pronounced distinctions observed between Fuzhou and Urumqi. Notably, the biogeographic origins of all known dust samples were successfully predicted.<b>Conclusion</b> Significant differences are observed in the fungal species composition and relative abundance among the cities of Beijing, Fuzhou, Kunming, and Urumqi. Employing fungal ITS2 sequencing on dust samples from these urban areas enables accurate inference of biogeographical locations. The high feasibility of utilizing fungal community data in dust for biogeographical inferences holds particular promise in the field of forensic science.]]></description>
<pubDate>2024/11/24 23:03:07</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[Deng Ye,FENG Kai,FENG Yao-Sen,KANG Ke-Lai,PENG Jia-Jin,WANG Le,ZHANG Wen-Jun]]></author>
</item>
<item>
<title><![CDATA[The Effects of Facilitation and Inhibition During Multimodal Somatosensory Integration]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202408050000001]]></link>
<description><![CDATA[The somatosensory system, including modalities such as touch, temperature, and pain, is essential for perceiving and interacting with the environment. When individuals encounter different somatosensory modalities, they interact through a process called multimodal somatosensory integration. This integration is essential for accurate perception, motor coordination, pain management, and adaptive behavior. Disruptions in this process can lead to a variety of sensory disorders and complicate rehabilitation efforts. However, research on the behavioral patterns and neural mechanisms underlying multimodal somatosensory integration remains limited. According to previous studies, multimodal somatosensory integration can result in facilitative or inhibitory effects depending on factors like stimulus type, intensity, and spatial proximity. Facilitative effects are observed primarily when stimuli from the same sensory modality (<i>e.g.</i>, two touch or temperature stimuli) are presented simultaneously, leading to amplified perceptual strength and quicker reaction times. Additionally, certain external factors, such as cooling, can increase sensitivity to other sensory inputs, further promoting facilitative integration. In contrast, inhibitory effects may also emerge when stimuli from different sensory modalities interact, particularly between touch and pain. Under such conditions, one sensory input (<i>e.g.</i>, vibration or non-noxious temperature stimulation) can effectively reduce the perceived intensity of the other, often resulting in reduced pain perception. These facilitative and inhibitory interactions are critical for efficient processing in a multi-stimulus environment and play a role in modulating the experience of somatosensory inputs in both normal and clinical contexts. The neural mechanisms underlying multimodal somatosensory integration are multi-tiered, encompassing peripheral receptors, the spinal cord, and various cortical structures. Facilitative integration relies on the synchronous activation of peripheral receptors, which transmit enhanced signals to higher processing centers. At the cortical level, areas such as the primary and secondary somatosensory cortex, through multimodal neuron responses, facilitate combined representation and amplification of sensory signals. In particular, the thalamus is a significant relay station where multisensory neurons exhibit superadditive responses, contributing to facilitation by enhancing signal strength when multiple inputs are present. Inhibitory integration, on the other hand, is mediated by mechanisms within the spinal cord, such as gating processes that limit transmission of competing sensory signals, thus diminishing the perceived intensity of certain inputs. At the cortical level, lateral inhibition within the somatosensory cortex plays a key role in reducing competing signals from non-target stimuli, enabling prioritized processing of the most relevant sensory input. This layered neural architecture supports the dynamic modulation of sensory inputs, balancing facilitation and inhibition to optimize perception. Understanding the neural pathways involved in somatosensory integration has potential clinical implications for diagnosing sensory disorders and developing therapeutic strategies. Future research should focus on elucidating the specific neural circuitry and mechanisms that contribute to these complex interactions, providing insights into the broader implications of somatosensory integration on behavior and cognition. In summary, this review highlights the importance of multimodal somatosensory integration in enhancing sensory perception. It also underscores the need for further exploration into the neural underpinnings of these processes to advance our understanding of sensory integration and its applications in clinical settings.]]></description>
<pubDate>2024/11/24 21:10:02</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[KONG Ya-Zhuo,ZHANG Ming,ZHANG Yu]]></author>
</item>
<item>
<title><![CDATA[Exercise Regulates Structural Plasticity and Neurogenesis of Hippocampal Neurons and Improves Memory Impairment in High-fat Diet-induced Obese Mice]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202409110000002]]></link>
<description><![CDATA[<b>Objective</b> Obesity has been identified as one of the most important risk factors for cognitive dysfunction. Physical exercise can ameliorate learning and memory deficits by reversing synaptic plasticity in the hippocampus and cortex in diseases such as Alzheimer’s disease. In this study, we aimed to determine whether 8 weeks of treadmill exercise could alleviate hippocampus-dependent memory impairment in high-fat diet-induced obese mice and investigate the potential mechanisms involved.<b>Methods</b> A total of sixty 6-week-old male C57BL/6 mice, weighing between 20-30 g, were randomly assigned to 3 distinct groups, each consisting of 20 mice. The groups were designated as follows: control (CON), high-fat diet (HFD), and high-fat diet with exercise (HFD-Ex). Prior to the initiation of the treadmill exercise protocol, the HFD and HFD-Ex groups were fed a high-fat diet (60% fat by kcal) for 20 weeks. The mice in the HFD-Ex group underwent treadmill exercise at a speed of 8 m/min for the first 10 min, followed by 12 m/min for the subsequent 50 min, totally 60 min of exercise at a 0° slope, 5 d per week, for 8 weeks. We employed Y-maze and novel object recognition tests to assess hippocampus-dependent memory and utilized immunofluorescence, Western blot, Golgi staining, and ELISA to analyze axon length, dendritic complexity, number of spines, the expression of c-fos, doublecortin (DCX), postsynaptic density-95 (PSD95), synaptophysin (Syn), interleukin-1β (IL-1β), and the number of major histocompatibility complex II (MHC-II) positive cells.<b>Results</b> Mice with high-fat diet-induced obesity exhibit hippocampus-dependent memory impairment, and treadmill exercise can prevent memory decline in these mice. The expression of DCX was significantly decreased in the HFD-induced obese mice compared to the control group (<i>P</i><0.001). Treadmill exercise increased the expression of c-fos (<i>P</i><0.001) and DCX (<i>P</i>=0.001) in the hippocampus of the HFD-induced obese mice. The axon length (<i>P</i><0.001), dendritic complexity (<i>P</i><0.001), the number of spines (<i>P</i><0.001) and the expression of PSD95 (<i>P</i><0.001) in the hippocampus were significantly decreased in the HFD-induced obese mice compared to the control group. Treadmill exercise increased the axon length (<i>P</i>=0.002), dendritic complexity (<i>P</i><0.001), the number of spines (<i>P</i><0.001) and the expression of PSD95 (<i>P</i>=0.001) of the hippocampus in the HFD-induced obese mice. Our study found a significant increase in MHC-II positive cells (<i>P</i><0.001) and the concentration of IL-1β (<i>P</i><0.001) in the hippocampus of HFD-induced obese mice compared to the control group. Treadmill exercise was found to reduce the number of MHC-II positive cells (<i>P</i><0.001) and the concentration of IL-1β (<i>P</i><0.001) in the hippocampus of obese mice induced by a HFD.<b>Conclusion</b> Treadmill exercise led to enhanced neurogenesis and neuroplasticity by increasing the axon length, dendritic complexity, dendritic spine numbers, and the expression of PSD95 and DCX, decreasing the number of MHC-II positive cells and neuroinflammation in HFD-induced obese mice. Therefore, we speculate that exercise may serve as a non-pharmacologic method that protects against HFD-induced hippocampus-dependent memory dysfunction by enhancing neuroplasticity and neurogenesis in the hippocampus of obese mice.]]></description>
<pubDate>2024/11/24 21:06:35</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CHENG Ran,LIAO Jing-Wen,MU Lian-Wei,SHU Lin-Jie,WANG Chao-Ge,YAN Meng-Si]]></author>
</item>
<item>
<title><![CDATA[2，3，5，4""-Tetrahydroxystilbene-2-O-β-glucoside Alleviates PCOS-like Characteristics by Upregulating The Expression of CYP19A1 in Granular Cells of Sinus Follicles to Inhibit Inflammatory Response]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407240000001]]></link>
<description><![CDATA[<b>Objective</b> To investigate whether 2,3,5,4"-tetrahydroxystilbene-2-O-β-glucoside (TSG) ameliorated polycystic ovary syndrome (PCOS)-like characteristics by inhibiting inflammation.<b>Methods</b> PCOS models were established by injecting subcutaneously with dehydroepiandrosterone into female Sprague-Dawley rats, followed by receiving intraperitoneal injection of TSG. The granular cells (GCs) KGN were transfected with small interfering RNAs (si-NC and si-CYP19A1). The cells were preincubated with lipopolysaccharide (LPS) and then treated with or without TSG. The estrous cycle was monitored using vaginal exfoliated cells. The morphology of ovarian follicles was analyzed by H&E staining. ELISA was used to analyze estradiol (E2), testosterone (T), follicle stimulating hormone (FSH), luteinizing hormone (LH), IL-6, TNF-α, AGEs, CRP and Omentin-1 levels in serum. Immunohistochemistry was performed to analyze PCNA and CYP19A1 expressions in the GCs of ovaries. Tunel staining was executed to detect the apoptosis of GCs. Quantitative polymerase chain reaction (qPCR) and Western blot were implemented to measure the expression of CYP19A1 in the ovaries and transfected cells. qPCR was used to analyze the expression of IL-6 and TNF-α in the transfected cells treated with LPS and TSG.<b>Results</b> The estrous cycles were restored in TSG group. Compared with model group, the sinus follicles were reduced and corpus luteums were increased in TSG group. TSG group showed increased E2, and decreased T and LH, compared with model group. Pro-inflammatory factors (IL-6, TNF-α, CRP and AGEs) were decreased, and anti-inflammatory factor (Omentin-1) was increased in TSG group compared with those in model group. TSG could partially inhibit decrease of PNCA-positive GCs and increase of Tunel-positive GCs caused by PCOS. The CYP19A1 expression of GCs in TSG group was upregulated compared with model group. The expressions of IL-6 and TNF-α in si-CYP19A1 cells were increased compared with si-NC cells. Compared with cells (si-NC and si-CYP19A1) treated without LPS, the expressions of IL-6 and TNF-α cells were increased, and the expression of CYP19A1 was downregulated in LPS-preincubated cells. Compared with cells treated with LPS, the expression of IL-6 and TNF-α were decreased, and the expression of CYP19A1 was increased in cells treated with LPS and TSG. Compared with si-NC cells treated with LPS and TSG, the expressions of IL-6 and TNF-α cells were increased in the si-CYP19A1 cells treated with LPS and TSG.<b>Conclusion</b> TSG could alleviate PCOS-like characteristics by increasing the expression of CYP19A1 in GCs to inhibit inflammatory response.]]></description>
<pubDate>2024/11/19 16:32:53</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CHENG Di,LI Ming,LIU Pin-Yue,MO Zhong-Cheng,PAN Xin-Yun,WEI Le,XU Bo,YAO Jian-Feng]]></author>
</item>
<item>
<title><![CDATA[Mitochondria: The Target of Ionizing Radiation Damage]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202409080000001]]></link>
<description><![CDATA[In recent years, due to the development of radiotherapy technology and nuclear energy, people have paid more and more attention to the various effects of ionizing radiation on organisms. Ionizing radiation can induce protein, DNA and other biological macromolecules to damage, resulting in apoptosis, senescence, cancer and a series of changes. For a long time, it has been believed that the main target of ionizing radiation damage is DNA in the nucleus. However, it has been reported in recent years that ionizing radiation has both direct and indirect effects, and the theory of ROS damage in the indirect effects believes that ionizing radiation has target uncertainty, so it is not comprehensive enough to evaluate only the DNA damage in the nucleus. It has been reported that ionizing radiation can cause damage to organelles as well as damage to cells. Mitochondria are important damaged organelles because mitochondria occupy as much as 30% of the entire cell volume in the cytoplasm, which contains DNA and related enzymes that are closely related to cellular ATP synthesis, aerobic respiration and other life activities. What is more noteworthy is that mitochondria are the only organelles in which DNA exists in the human body, which makes researchers pay attention to various damage to mitochondrial DNA caused by ionizing radiation (such as double-strand breaks, base mismatching, and fragment loss). Although these damages also occur in the nucleus, mitochondrial DNA is more severely damaged than nuclear DNA due to its lack of histone protection, so mitochondria are important targets of ionizing radiation damage in addition to the nucleus. Mitochondrial DNA is not protected by histones and has little repair ability. When exposed to ionizing radiation, common deletions occur at an increased frequency and are passed on to offspring. For large-scale mitochondrial DNA damage, mitochondria indirectly compensate for the amount of damaged DNA by increasing the number of DNA copies and maintaining the normal function of mitochondrial DNA. Mitochondria are in a state of oxidative stress after exposure to ionizing radiation, and this oxidative stress will promote the change in mitochondrial function. When mitochondria are damaged, the activity of proteins related to aerobic respiration decreases, and oxidative respiration is inhibited to a certain extent. At the same time, a large amount of active superoxide anions are continuously produced to stimulate mitochondrial oxidative stress, and the signal of such damage is transmitted to the surrounding mitochondria, resulting in a cascade of damage reaction, which further activates the signalling pathway between mitochondria and nucleus. The cell nucleus is also in a state of oxidative stress, and finally, the level of free radicals is high, causing secondary damage to the genetic material DNA of mitochondria and nucleus. In this paper, the damage effects of ionizing radiation on mitochondria are reviewed, to provide a new idea for radiation protection.]]></description>
<pubDate>2024/11/12 11:44:50</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DANG Xu-Hong,TIAN Lian-Chen,YUAN Ya-Yi]]></author>
</item>
<item>
<title><![CDATA[Contribution of Transmembrane Protein 68 to Triglyceride Synthesis and Lipid Droplet Formation Differs From Diacylglycerol Acyltransferase]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407010000005]]></link>
<description><![CDATA[<b>Objective</b> To characterize transmembrane protein 68 (TMEM68) in an alternative triacylglycerol (TAG) biosynthesis pathway, and determine the interplay between TMEM68 and the canonical TAG synthesis enzyme acyl-CoA:diacylglycerol acyltransferase (DGAT).<b>Methods</b> Effects of exogenous fatty acid and monoacylglycerol on TAG synthesis and lipid droplet (LD) formation in TMEM68 overexpression and knockout cells treated with DGAT inhibitor or not were investigated by comparing LD morphology, Oil Red O staining, and measurement of TAG levels. LDs were stained with fluorescence dye and observed by confocal fluorescence microscopy. TAG levels were determined with an enzyme-based triglyceride assay kit. Colocalization of TMEM68 and DGAT1 was detected by co-expression and confocal fluorescence microscopy and their interaction was determined by co-immunoprecipitation. RT-qPCR and immunoblotting assay were used to detect the expression of DGAT1.<b>Results</b> The synthesis of TAG catalyzed by TMEM68 was independent of DGAT activity. Surplus exogenous fatty acids and monoacylglycerol promoted TAG synthesis mainly through DGAT in human neuroblastoma cells. The LDs formed by TMEM68 were different in morphology from those by DGAT. In addition, TMEM68 and DGAT1 colocalized in the same endoplasmic reticulum (ER) compartment but did not interact physically. TMEM68 overexpression reduced the expression of DGAT1, the major DGAT enzyme involved in TAG synthesis, while TMEM68 knockout had little impact.<b>Conclusion</b> The TMEM68-mediated TAG synthesis pathway has distinct features from the canonical DGAT pathway, however, TMEM68 and DGAT may coregulate intracellular TAG levels.]]></description>
<pubDate>2024/11/6 14:54:16</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CHANG Ping-An,FU Yang-Yang,HUANG Fei-Fei,PANG Hui-Min,YU Qing,ZENG Fan-Si]]></author>
</item>
<item>
<title><![CDATA[Research on The Construction and Application of Multiple Fluorescence Amplification System for Three Kinds of Stains]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202408260000001]]></link>
<description><![CDATA[<b>Objective</b> A multiplex amplification system was constructed based on the capillary electrophoresis platform for simultaneous detection of saliva, semen, and vaginal secretions using tissue-specific RNA markers. The aim of this study is to identify the tissue origin of suspicious body fluid stains found at crime scenes and determine whether the body fluid stains at the crime scene are one or several types among saliva, semen, and vaginal secretions.<b>Methods</b> Thirty saliva samples, forty semen samples, and forty vaginal secretion samples (half from 2015 and half from 2024) were collected from healthy adult volunteers. Through primer designing, system formulation, and PCR condition optimization, a multiplex fluorescent amplification system was constructed. The specificity, sensitivity, and detection ability for mixed samples of this system were investigated, and it was tested using real crime scene materials. In the primer design stage, to reduce the requirements for RNA template quality, the amplification products were set within 80-300 bp. In the system formulation stage, dominant and subordinate primers were mainly considered. By reducing the concentration of dominant primers and increasing that of subordinate primers, a capillary electrophoresis spectrum with an appropriate peak height ratio was finally obtained. Additionally, gradient experiments were designed to adjust the concentrations of PCR reagents and PCR amplification conditions, and multiple versions of DNA amplification enzymes were optimized to achieve the best experimental results.<b>Results</b> Through statistical analysis, there was no significant difference in the capillary electrophoresis of the 3 types of body fluid samples from the two years (2015 and 2024), demonstrating that the sample preservation method in this study can preserve samples for a relatively long time. The composite amplification system constructed in this study exhibited high specificity for all 3 types of body fluid, with no cross-reactions between the markers of each type of body fluid. The minimum detection thresholds for the 3 types of body fluid reached 0.002 9, 0.001 5, and 0.42 mg/L, respectively. This system also had a high degree of discrimination for mixed samples, especially for semen-saliva mixtures, where each body fluid marker could still be successfully detected when the concentration ratio of semen to saliva was 100:1. Meanwhile, in the two actual cases presented in this article, the application of this composite amplification system performed outstandingly.<b>Conclusion</b> The composite amplification detection system constructed in this study can achieve the correct screening of saliva, semen, and vaginal secretions, overcoming the problems such as low specificity and sensitivity of marker tests and unbalanced RFU values of each marker in previous studies. The specificity and sensitivity meet the practical work requirements, and the operation is simple. It provides an analytical and identification method for body fluid stains in actual case and is applicable to the identification of the tissue origin of biological evidence at crime scenes involving sexual assault, indecent assault, and other criminal acts. In the future, more types of body fluid markers will be screened to expand the types of body fluids detected by the system, and body fluid-specific cSNP and cInDel genetic markers will be introduced to infer the sources (individuals and types) of mixed and complex stains more accurately.]]></description>
<pubDate>2024/11/6 14:47:13</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[BAI Yi-Fan,CHEN Jing,LIU Hong-Di,WANG Chong,YANG Rui-Qin,ZHAO He-Miao]]></author>
</item>
<item>
<title><![CDATA[Heterogeneity of Adipose Tissue From a Single-cell Transcriptomics Perspective]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202409190000001]]></link>
<description><![CDATA[Adipose tissue is a critical energy reservoir in animals and humans, with multifaceted roles in endocrine regulation, immune response, and providing mechanical protection. Based on anatomical location and functional characteristics, adipose tissue can be categorized into distinct types, including white adipose tissue (WAT), brown adipose tissue (BAT), beige adipose tissue, and pink adipose tissue. Traditionally, adipose tissue research has centered on its morphological and functional properties as a whole. However, with the advent of single-cell transcriptomics, a new level of complexity in adipose tissue has been unveiled, showing that even under identical conditions, cells of the same type may exhibit significant variation in morphology, structure, function, and gene expression——phenomena collectively referred to as cellular heterogeneity. Single-cell transcriptomics, including techniques like single-cell RNA sequencing (scRNA-seq) and single-nucleus RNA sequencing (snRNA-seq), enables in-depth analysis of the diversity and heterogeneity of adipocytes at the single-cell level. This high-resolution approach has not only deepened our understanding of adipocyte functionality but also facilitated the discovery of previously unidentified cell types and gene expression patterns that may play key roles in adipose tissue function. This review delves into the latest advances in the application of single-cell transcriptomics in elucidating the heterogeneity and diversity within adipose tissue, highlighting how these findings have redefined the understanding of cell subpopulations within different adipose depots. Moreover, the review explores how single-cell transcriptomic technologies have enabled the study of cellular communication pathways and differentiation trajectories among adipose cell subgroups. By mapping these interactions and differentiation processes, researchers gain insights into how distinct cellular subpopulations coordinate within adipose tissues, which is crucial for maintaining tissue homeostasis and function. Understanding these mechanisms is essential, as dysregulation in adipose cell interactions and differentiation underlies a range of metabolic disorders, including obesity and diabetes mellitus type 2. Furthermore, single-cell transcriptomics holds promising implications for identifying therapeutic targets; by pinpointing specific cell types and gene pathways involved in adipose tissue dysfunction, these technologies pave the way for developing targeted interventions aimed at modulating specific adipose subpopulations. In summary, this review provides a comprehensive analysis of the role of single-cell transcriptomic technologies in uncovering the heterogeneity and functional diversity of adipose tissues.]]></description>
<pubDate>2024/11/6 14:43:28</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Si-Si,DUAN Xin-Yue,DUAN Ye-Hui,GONG Yu,GUO Qiu-Ping,LI Feng-Na,LI Qi-Long,WANG Yong-Lang]]></author>
</item>
<item>
<title><![CDATA[The Ferroptosis-inducing Compounds in Triple Negative Breast Cancer]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407260000001]]></link>
<description><![CDATA[Ferroptosis, a programmed cell death modality discovered and defined in the last decade, is primarily induced by iron-dependent lipid peroxidation. At present, it has been found that ferroptosis is involved in various physiological functions such as immune regulation, growth and development, aging, and tumor suppression. Especially its role in tumor biology has attracted extensive attention and research. Breast cancer is one of the most common female tumors, characterized by high heterogeneity and complex genetic background. Triple negative breast cancer (TNBC) is a special type of breast cancer, which lacks conventional breast cancer treatment targets and is prone to drug resistance to existing chemotherapy drugs and has a low cure rate after progression and metastasis. There is an urgent need to find new targets or develop new drugs. With the increase of studies on promoting ferroptosis in breast cancer, it has gradually attracted attention as a treatment strategy for breast cancer. Some studies have found that certain compounds and natural products can act on TNBC, promote their ferroptosis, inhibit cancer cells proliferation, enhance sensitivity to radiotherapy, and improve resistance to chemotherapy drugs. To promote the study of ferroptosis in TNBC, this article summarized and reviewed the compounds and natural products that induce ferroptosis in TNBC and their mechanisms of action. We started with the exploration of the pathways of ferroptosis, with particular attention to the System X<sub>c</sub><sup>-</sup>-cystine-GPX4 pathway and iron metabolism. Then, a series of compounds, including sulfasalazine (SAS), metformin, and statins, were described in terms of how they interact with cells to deplete glutathione (GSH), thereby inhibiting the activity of glutathione peroxidase 4 (GPX4) and preventing the production of lipid peroxidases. The disruption of the cellular defense against oxidative stress ultimately results in the death of TNBC cells. We have also our focus to the realm of natural products, exploring the therapeutic potential of traditional Chinese medicine extracts for TNBC. These herbal extracts exhibit multi-target effects and good safety, and have shown promising capabilities in inducing ferroptosis in TNBC cells. We believe that further exploration and characterization of these natural compounds could lead to the development of a new generation of cancer therapeutics. In addition to traditional chemotherapy, we discussed the role of drug delivery systems in enhancing the efficacy and reducing the toxicity of ferroptosis inducers. Nanoparticles such as exosomes and metal-organic frameworks (MOFs) can improve the solubility and bioavailability of these compounds, thereby expanding their therapeutic potential while minimizing systemic side effects. Although preclinical data on ferroptosis inducers are relatively robust, their translation into clinical practice remains in its early stages. We also emphasize the urgent need for more in-depth and comprehensive research to understand the complex mechanisms of ferroptosis in TNBC. This is crucial for the rational design and development of clinical trials, as well as for leveraging ferroptosis to improve patient outcomes. Hoping the above summarize and review could provide references for the research and development of lead compounds for the treatment for TNBC.]]></description>
<pubDate>2024/11/6 14:41:23</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CUI Xiang,FENG Da-Li,GAO Zhi-Qiang,WANG Jun,WANG Xin-Die,ZHANG Peng-Fei,ZHOU Su,ZOU Li-Li]]></author>
</item>
<item>
<title><![CDATA[Heterogeneity of Adipose Tissue From a Single-cell Transcriptomics Perspective]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202409190000001]]></link>
<description><![CDATA[Adipose tissue is a critical energy reservoir in animals and humans, with multifaceted roles in endocrine regulation, immune response, and providing mechanical protection. Based on anatomical location and functional characteristics, adipose tissue can be categorized into distinct types, including white adipose tissue (WAT), brown adipose tissue (BAT), beige adipose tissue, and pink adipose tissue. Traditionally, adipose tissue research has centered on its morphological and functional properties as a whole. However, with the advent of single-cell transcriptomics, a new level of complexity in adipose tissue has been unveiled, showing that even under identical conditions, cells of the same type may exhibit significant variation in morphology, structure, function, and gene expression——phenomena collectively referred to as cellular heterogeneity. Single-cell transcriptomics, including techniques like single-cell RNA sequencing (scRNA-seq) and single-nucleus RNA sequencing (snRNA-seq), enables in-depth analysis of the diversity and heterogeneity of adipocytes at the single-cell level. This high-resolution approach has not only deepened our understanding of adipocyte functionality but also facilitated the discovery of previously unidentified cell types and gene expression patterns that may play key roles in adipose tissue function. This review delves into the latest advances in the application of single-cell transcriptomics in elucidating the heterogeneity and diversity within adipose tissue, highlighting how these findings have redefined the understanding of cell subpopulations within different adipose depots. Moreover, the review explores how single-cell transcriptomic technologies have enabled the study of cellular communication pathways and differentiation trajectories among adipose cell subgroups. By mapping these interactions and differentiation processes, researchers gain insights into how distinct cellular subpopulations coordinate within adipose tissues, which is crucial for maintaining tissue homeostasis and function. Understanding these mechanisms is essential, as dysregulation in adipose cell interactions and differentiation underlies a range of metabolic disorders, including obesity and diabetes mellitus type 2. Furthermore, single-cell transcriptomics holds promising implications for identifying therapeutic targets; by pinpointing specific cell types and gene pathways involved in adipose tissue dysfunction, these technologies pave the way for developing targeted interventions aimed at modulating specific adipose subpopulations. In summary, this review provides a comprehensive analysis of the role of single-cell transcriptomic technologies in uncovering the heterogeneity and functional diversity of adipose tissues.]]></description>
<pubDate>2024/11/6 11:52:10</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Si-Si,DUAN Xin-Yue,DUAN Ye-Hui,GONG Yu,GUO Qiu-Ping,LI Feng-Na,LI Qi-Long,WANG Yong-Lang]]></author>
</item>
<item>
<title><![CDATA[Neurological Insights into Attentional Deficits in High Trait Anxiety: a Commentary on Hu <i>et al</i>.’s Paper in <i>Cerebral Cortex</i> (2023)]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407080000001]]></link>
<description><![CDATA[In a recent publication, Hu <i>et al</i>. (2023) have reported that individuals with high trait anxiety exhibit attentional deficits characterized by reduced inhibition of distractors and delayed attentional selection of targets, indicating impaired top-down attentional control. This commentary underscores their significant contributions to the cognitive theory of anxiety. Based on their findings, we propose a novel training approach called attentional inhibition training (AIT), aimed at improving top-down attentional control to alleviate symptoms of anxiety. Furthermore, we explore the potential application of non-invasive transcranial magnetic stimulation (TMS) for rapidly enhancing attentional control function.]]></description>
<pubDate>2024/10/30 20:34:41</pubDate>
<category><![CDATA[动态与评论]]></category>
<author><![CDATA[LIANG Jian-Hui,LIU Dong-Qiang,MA Hao-Yun]]></author>
</item>
<item>
<title><![CDATA[6-Week Caloric Restriction Improves Lipopolysaccharide-induced Septic Cardiomyopathy by Modulating SIRT3]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406020000001]]></link>
<description><![CDATA[<b>Objective</b> The aim of this study was to investigate the prophylactic effects of caloric restriction (CR) on lipopolysaccharide (LPS)-induced septic cardiomyopathy (SCM) and to elucidate the mechanisms underlying the cardioprotective actions of CR. This research aims to provide innovative strategies and theoretical support for the prevention of SCM.<b>Methods</b> A total of forty-eight 8-week-old male C57BL/6 mice, weighing between 20-25 g, were randomly assigned to 4 distinct groups, each consisting of 12 mice. The groups were designated as follows: CON (control), LPS, CR, and CR+LPS. Prior to the initiation of the CR protocol, the CR and CR+LPS groups underwent a 2-week acclimatization period during which individual food consumption was measured. The initial week of CR intervention was set at 80% of the baseline intake, followed by a reduction to 60% for the subsequent 5 weeks. After 6-week CR intervention, all 4 groups received an intraperitoneal injection of either normal saline or LPS (10 mg/kg). Twelve hours post-injection, heart function was assessed, and subsequently, heart and blood samples were collected. Serum inflammatory markers were quantified using enzyme-linked immunosorbent assay (ELISA). The serum myocardial enzyme spectrum was analyzed using an automated biochemical instrument. Myocardial tissue sections underwent hematoxylin and eosin (HE) staining and immunofluorescence (IF) staining. Western blot analysis was used to detect the expression of protein in myocardial tissue, including inflammatory markers (TNF-α, IL-9, IL-18), oxidative stress markers (iNOS, SOD2), pro-apoptotic markers (Bax/Bcl-2 ratio, CASP3), and SIRT3/SIRT6.<b>Results</b> Twelve hours after LPS injection, there was a significant decrease in ejection fraction (<i>EF</i>) and fractional shortening (<i>FS</i>) ratios, along with a notable increase in left ventricular end-systolic diameter (<i>LVESD</i>). Morphological and serum indicators (AST, LDH, CK, and CK-MB) indicated that LPS injection could induce myocardial structural disorders and myocardial injury. Furthermore, 6-week CR effectively prevented the myocardial injury. LPS injection also significantly increased the circulating inflammatory levels (IL-1β, TNF-α) in mice. IF and Western blot analyses revealed that LPS injection significantly up-regulating the expression of inflammatory-related proteins (TNF-α, IL-9, IL-18), oxidative stress-related proteins (iNOS, SOD2) and apoptotic proteins (Bax/Bcl-2 ratio, CASP3) in myocardial tissue. 6-week CR intervention significantly reduced circulating inflammatory levels and downregulated the expression of inflammatory, oxidative stress-related proteins and pro-apoptotic level in myocardial tissue. Additionally, LPS injection significantly downregulated the expression of SIRT3 and SIRT6 proteins in myocardial tissue, and CR intervention could restore the expression of SIRT3 proteins.<b>Conclusion</b> A 6-week CR could prevent LPS-induced septic cardiomyopathy, including cardiac function decline, myocardial structural damage, inflammation, oxidative stress, and apoptosis. The mechanism may be associated with the regulation of SIRT3 expression in myocardial tissue.]]></description>
<pubDate>2024/10/29 22:52:23</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CHEN Ming-Hua,LI Ting-Ting,SUN Zhong-Guang,WANG Xiao-Wen,ZHANG Hui,ZHANG Ming-Chen]]></author>
</item>
<item>
<title><![CDATA[Application and Evaluation of Neuromodulation in Major Depressive Disorder]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202405280000003]]></link>
<description><![CDATA[Depression, also known as major depressive disorder (MDD), is an emotional disorder characterized by low mood, decreased interest, and lack of energy, which imposes a heavy burden on families and society. Neuromodulation technology has made significant progress in improving depressive symptoms by using invasive or non-invasive methods, such as electricity and magnetism, to regulate neural activity in specific areas of the brain. Determining objective evaluation indicators can provide reliable basis for the development of neural regulation strategies and efficacy evaluation in MDD. This article systematically reviews the latest application progress of non-invasive neural regulation techniques such as transcranial magnetic stimulation (TMS), transcranial electrical stimulation (TES), and transcranial ultrasound stimulation (TUS), as well as invasive neural regulation techniques such as deep brain stimulation (DBS), optogenetics, and chemical genetics in MDD. The focus is on exploring behavioral, neuroimaging, and neurophysiological evaluation indicators of neural regulation, providing direction for the development of precise and personalized neural regulation schemes and assessment tools for MDD in the future.]]></description>
<pubDate>2024/10/26 15:02:50</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[GUO Jiang-Zi-Hui,JIE Hui-Cong,LI Yu-Qing,LIU Tiao-Tiao,ZHENG Xu-Yuan]]></author>
</item>
<item>
<title><![CDATA[Dynamic Characteristics and Application Prospects of Potential Addiction Biomarkers and Their Quantification Analysis of mRNA in Peripheral Blood Immunocyte]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202312250000001]]></link>
<description><![CDATA[Drug addiction is a worldwide issue that threaten social stability and development. It has been proved to be a chronic, relapsing disease that results from the prolonged effects of drugs on the various neural networks. Over time, plenty of attention has been paid to find new approaches to enhance the sensitivity and accuracy of assessment on addiction. In recent years, researchers found that the expression of neurotransmitters and their receptors in some peripheral blood immunocyte may reflect their expression in the brain. By analyzing the changes of addiction-related neural biomarkers in peripheral blood immunocyte, it is potential to enhance the accuracy and the susceptibility of assessments on addiction and treatment effectiveness, and in turn help to reduce drug relapse. In this review, we summarize the potential biomarkers related to addiction in peripheral blood immunocyte and changing trend of their mRNA expression level in patients using different types of drugs and with different addiction states, and discuss their application prospects and future research directions. Previous studies have found various types of potential addiction biomarkers, including neurotransmitter receptor proteins, hormones, small molecule metabolites, ΔFosB microRNA and other transcriptional (post) regulators. Considering the correlation with addiction and the richness of existing research, this article mainly introduces neurotransmitter receptor proteins closely related to addiction, including dopamine receptors, opioid receptors, cannabinoid receptors, and N-methyl-D-aspartate (NMDA) receptors. The expression levels of these potential biomarkers often change correspondingly at different stages. For example, mRNA expression of dopamine D3 receptor was increased in opioid addicted and methadone-maintained patients, but no change was observed in the heroin abstinent group. In addition, changing patterns of the biomarkers induced by different types of drugs were also various. Although both opioid addiction and alcohol addiction could induce the change of mRNA expression of dopamine D4 receptor, it was decreased in the opioid addiction patients while increased in the alcohol addiction patients. On the basis of the available evidence, dopamine receptors (especially D4 receptors) are most potent at the indicative action across drugs and stages, while cannabinoid receptors mainly specifically reflect different stages of cannabis addiction status. In addition, the mRNA level of the GluN3B subunit showed a steady increase in different stages of opioid addiction and showed a decreased response to methadone treatment, suggesting that it has high potential as a biomarker of heroin addiction. Besides, the mRNA level of D4 receptor showed a clear reverse trend in the stage of alcohol addiction and alcohol withdrawal, which also reflected the potential of D4 receptor mRNA in the state of alcohol addiction. Considering evidences about serum levels changing in patients with drug addiction, immune response induced by drugs may be one possible mechanism of changes in the expression levels of transmitter receptors in the peripheral blood of drug addiction patients. Finally, the current research on biomarkers in peripheral blood for addiction is still relatively fragmented, and lack systematic mechanism exploration. Future studies could further combine animal studies and clinical studies to systematically demonstrate the role of relevant biomarkers and underlying mechanisms. In addition, there are often interactions between multiple biomarker proteins in mediating drug addiction, especially in the process of addiction development. Thus, the overall observation of the dynamic changing of different biomarkers in the addiction process may be helpful to enhance the accuracy of assessment of addiction states. At the same time, when applying peripheral blood biomarkers, corresponding standards should be formulated based on experimental evidences, so as to enhance the pertinence and effectiveness of peripheral blood biomarkers in the diagnosis and treatment of addiction.]]></description>
<pubDate>2024/10/25 17:12:52</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DANG Wang-Jie,DUAN Hai-Jun,DUAN Wen-Jing,HAN Jing,REN Wei,WANG Yi-Fan,WU Mei-Lin]]></author>
</item>
<item>
<title><![CDATA[Breakthrough of AlphaFold Structure Prediction and Its Impact and Challenges on Protein Research]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202408160000003]]></link>
<description><![CDATA[In recent years, deep learning-based methods have achieved significant breakthroughs in protein structure prediction. The open-source release of AlphaFold 2 (AF2) in 2021 enabled high-precision prediction of three-dimensional structures for both individual proteins and protein complexes, allowing researchers to rapidly obtain reliable structural information and greatly accelerating advancements in protein structure and function studies. The release of AlphaFold 3 (AF3) in 2024 took this further by achieving accurate predictions of three-dimensional structures for protein-nucleic acid and protein-small molecule complexes. With improved algorithms and a more efficient model, AF3 significantly enhanced prediction accuracy, especially demonstrating outstanding performance in antigen-antibody and protein-small molecule complexes. The success of AlphaFold has not only brought revolutionary progress to structural biology but also showcased immense application potential in fields such as drug development, protein design, and molecular function research, driving innovation in biomedical studies. This article will review the development history of AlphaFold and related protein structure prediction methods, summarize their key technologies and current applications, and, by considering their limitations, provide an outlook on future research directions and applications.]]></description>
<pubDate>2024/10/25 16:20:22</pubDate>
<category><![CDATA[2024年诺贝尔奖解读]]></category>
<author><![CDATA[GONG Wei-Bin]]></author>
</item>
<item>
<title><![CDATA[The Biological Characteristics and Functions of TRIM13 and Its Relationship With The Development of Diseases]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407170000001]]></link>
<description><![CDATA[Tripartite motif-containing protein 13 (TRIM13) is a crucial member of the TRIM protein family, distinguished by its unique transmembrane domain that anchors it to the endoplasmic reticulum (ER). As an E3 ubiquitin ligase, TRIM13 influences multiple key signaling pathways through ubiquitination regulation, playing significant roles in modulating ER function, immune responses, metabolic disorders, inflammatory diseases, and tumor suppression. TRIM13 possesses the common RING, B-box, and coiled-coil domains of the TRIM family, along with its distinctive transmembrane domain. Its E3 ubiquitin ligase activity serves as the structural basis for its diverse biological functions. TRIM13 acts as a non-canonical ER-phagy receptor to participate in regulating ER stress responses, recruiting LC3 through interaction with SQSTM1/p62 to initiate autophagy-mediated degradation of damaged ER, which is crucial for maintaining ER homeostasis and cellular function under stress conditions. TRIM13 is involved in inflammatory and antiviral immune responses by modulating key molecules in signaling pathways such as MDA5, NF-κB, and STING, highlighting its potential in regulating innate immunity and inflammatory responses. TRIM13 is associated with various pathological conditions, particularly in cancer and metabolic diseases. In multiple cancers, including non-small cell lung cancer, hepatocellular carcinoma, and acute myeloid leukemia, TRIM13 exhibits tumor-suppressive effects, with its expression levels closely associated with patient prognosis, suggesting its potential as a biomarker or therapeutic target in oncology. In diabetic nephropathy, TRIM13 improves renal function by promoting CHOP ubiquitination and inhibiting interstitial collagen synthesis, demonstrating its protective role in kidney disease. In atherosclerosis, TRIM13 is involved in regulating cholesterol metabolism and inflammatory pathways, indicating its significance in cardiovascular disorders. Recent studies have also implicated TRIM13 in neurodegenerative disorders and metabolic syndromes, with its role in regulating protein quality control and ER stress responses, suggesting potential involvement in diseases characterized by protein misfolding and aggregation, such as Alzheimer’s and Parkinson’s diseases. Additionally, TRIM13’s participation in lipid metabolism and insulin signaling pathways points to its possible influence on obesity and diabetes. Despite significant advancements in TRIM13 research, the precise molecular mechanisms underlying its functions in various physiological and pathological processes remain to be elucidated. In this article, we review the structural characteristics and functions of TRIM13 protein, with particular emphasis on its roles in ER-phagy, inflammatory responses, and tumor suppression, as well as its potential significance in various diseases. Future studies should focus on revealing the specific core mechanisms of TRIM13 function and exploring its unique role in ER function regulation. A deeper understanding of TRIM13 protein and its regulatory mechanisms in development of diseases may provide novel targets and strategies for disease diagnosis and treatment.]]></description>
<pubDate>2024/10/18 15:56:38</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DONG Yue-Hong,JIANG Miao,JIANG Li-Na,NIU Chun-Yu,YAO Yong-Ming,ZHAO Zi-Gang]]></author>
</item>
<item>
<title><![CDATA[The Rde of Tumor-infiltrating B Lymphocytes in Tumor Immunity and Clinical Application Prospects]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202408300000001]]></link>
<description><![CDATA[In recent years, tumor-infiltrating B lymphocytes (TIL-B) play a complex and important role in tumorigenesis and tumor development. TIL-B contains various subpopulations, which can be broadly classified into subpopulations of tumor-suppressing B cells, such as antigen-presenting B cells and plasma cells; and subpopulations of tumor-promoting B cells, such as regulatory B cells (Bregs). The anti-tumor mechanisms of TIL-B contain many aspects, including the secretion of specific antibodies such as IgG and IgA; activation of T cells through antigen presentation; release of cytokines that affect tumor cell growth; direct killing of target cells through the Fas/FasL and perforin pathways; and enhancement of anti-tumor immunity through interactions with T cells. The pro-tumor mechanism of TIL-B also includes many aspects, such as Bregs can inhibit anti-tumor immunity by secreting cytokines, inducing the production of regulatory T cells (Tregs), and inhibiting the interaction between T cells and antigen presenting cells (APCs). Atypical memory (AtM) B cells and leucine-tRNA-synthase-2 (LARS2) -expressing B cells (LARS B) can also promote tumor progression by secreting cytokines such as TNF-α and TGF-β. Based on the above mechanisms, a variety of tumor therapies are now available. Firstly, the anti-tumor effect of TIL-B can be enhanced. Immune checkpoint blockade therapy is a classical immunotherapy method, and TIM-1 is a key checkpoint and has achieved certain efficacy. In addition, the development of suitable novel antibodies, safe and effective TIL-B vaccines are also promising therapeutic methods. Adoptive metastatic B-cell therapy, direct activation of B-cells, chemotherapy and targeted drugs is limited because of the high technical requirements, high toxicity and uncertainty of efficacy. In the future, it is expected that further research will gradually expand the scope of its application to achieve more effective treatment for tumor patients. Selective depletion of B cells is an immunotherapy based on the inhibition of Bregs subpopulations to achieve anti-tumor effects. The next step is to develop more efficacious targeted drugs by understanding the phenotypic and functional differences of Bregs. Finally, TIL-B can be involved in the treatment and prognosis of tumors as a predictive tumor immune marker. The efficacy of treatment can be simply assessed by observing TIL-B distribution and density in tumor. Stress-responsive memory B cells and tumor-associated atypical B cells (TAAB) have clearly shown to be associated with shorter and longer survival in cancer patients, thus being used as biomarkers of immunotherapeutic response in human cancers. This paper reviews the current status of TIL-B research, summarizes its mechanism of action in tumor immunity, analyses current therapeutic strategies and prognostic assessment methods. Future focus on understanding the functional heterogeneity and molecular regulatory mechanisms of TIL-B is essential for optimising tumor immunotherapy strategies. The systematic study of TIL-B characteristics and mechanisms of action in different tumor types can help provide a theoretical basis and potential targets for the development of new tumor therapeutic strategies.]]></description>
<pubDate>2024/10/18 15:26:52</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CAO Chun-Yu,CHEN Jin-Xiu,DONG Xiang,HUANG Ming,WU Hong-Yan,ZHANG Yu-Le]]></author>
</item>
<item>
<title><![CDATA[Targeting CSPGs/PTPσ: a Novel Approach for Multiple Sclerosis Treatment]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407020000004]]></link>
<description><![CDATA[Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS) characterized by progressive demyelination and neuroinflammation, leading to axonal damage and neuronal degeneration. It is the most prevalent non-traumatic cause of neurological disability in young adults, affecting millions of people worldwide. MS manifests with a wide range of symptoms, including motor dysfunction, sensory deficits, and cognitive impairment, which can severely impact the quality of life. Despite extensive research, the exact pathogenesis of MS remains unclear, and currently available treatments primarily focus on reducing inflammation and relapse rates rather than reversing neurological damage. Thus, one of the major therapeutic challenges is to develop strategies that can not only suppress the aberrant immune response but also enhance endogenous myelin regeneration and neurorepair, ultimately halting or even reversing disease progression. Recent studies have highlighted the critical role of chondroitin sulfate proteoglycans (CSPGs), a family of inhibitory extracellular matrix (ECM) molecules, in regulating CNS repair processes. CSPGs accumulate at the sites of demyelinated lesions and form a dense, inhibitory matrix that impedes the migration and differentiation of oligodendrocyte precursor cells (OPCs), thereby preventing effective myelin regeneration. CSPGs exert their inhibitory effects through several cell surface receptors, including leukocyte common antigen-related receptor (LAR), Nogo receptors (NgR1 and NgR3), and protein tyrosine phosphatase σ (PTPσ). Among these, PTPσ is a predominant receptor that mediates the biological activities of CSPGs <i>via</i> its phosphatase domains, which regulate downstream signaling pathways involved in cell proliferation, differentiation, and cytoskeletal organization. The CSPGs/PTPσ axis has been identified as a major molecular pathway contributing to the inhibition of remyelination in MS. The upregulation of CSPGs and PTPσ in MS lesions has been associated with a failure of OPCs to remyelinate damaged axons effectively. Preclinical studies have shown that pharmacological inhibition or genetic ablation of PTPσ can alleviate the inhibitory effects of CSPGs on OPC migration and differentiation. For instance, systemic administration of the PTPσ inhibiting peptide intracellular sigma peptide (ISP) has been shown to enhance OPC differentiation, promote remyelination, and restore motor function in animal models of MS, highlighting the potential of targeting CSPGs/PTPσ as a therapeutic approach for MS. Furthermore, CSPGs and their receptors have been implicated in modulating other biological processes such as immune cell infiltration, synaptic plasticity, and axonal regeneration, which are relevant to the pathogenesis of MS and other neurodegenerative diseases. CSPGs are known to activate downstream signaling pathways, such as the Rho/ROCK, Akt, and ERK pathways, which regulate cytoskeletal dynamics and gene expression in OPCs, ultimately affecting their ability to mature into myelinating oligodendrocytes. Additionally, CSPGs can interact with the N-cadherin/β-catenin pathway, influencing cell adhesion and signaling in OPCs, thereby modulating myelin repair capacity. Given the multifaceted roles of CSPGs/PTPσ in CNS pathology, targeting this pathway represents a promising therapeutic strategy. This article aims to provide a comprehensive overview of the biological properties of CSPGs and PTPσ, focusing on their roles in the inhibition of myelin regeneration. Specifically, it discusses how CSPGs/PTPσ signaling modulates various aspects of OPC biology, including autophagy regulation and immune modulation. Moreover, the review explores potential therapeutic strategies aimed at disrupting CSPGs/PTPσ interactions, such as the use of small-molecule inhibitors, neutralizing antibodies, or gene therapies. In summary, a deeper understanding of CSPGs/PTPσ-mediated signaling in OPCs and other cell types within MS lesions may reveal novel therapeutic targets for promoting remyelination and functional recovery. This review provides a detailed analysis of current findings and highlights the need for further research to translate these findings into effective treatments for MS patients.]]></description>
<pubDate>2024/10/18 14:57:48</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Wen-Li,LUO Fu-Cheng,WANG Jing-Tong]]></author>
</item>
<item>
<title><![CDATA[Research on High-precision and High-speed Bioimpedance Spectroscopy Detection Method for Tumour Identification]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407190000001]]></link>
<description><![CDATA[<b>Objective</b> Cancer is a global public health issue that has attracted much attention. Detecting and treating cancer at an earlier time point is the key to improving cancer survival rates. However, due to factors such as high equipment cost, slow detection speed, and poor detection accuracy, the promotion of early cancer screening is limited. Therefore, this paper proposes a high-precision and high-speed bioimpedance spectroscopy detection method for tumor identification based on multi-frequency synchronous bioimpedance spectroscopy technology.<b>Methods</b> First, based on the multi-frequency synchronization technology, this paper built a multi-frequency synchronous bioimpedance spectrum detection system, realized the high-speed detection of bioimpedance spectrum, designed concentric circle sensors to reduce the influence of biological tissue anisotropy on impedance detection, and improved the discrimination of bioimpedance spectrum between different tissues. Secondly, a gastric wall tissue model was established, and the degree of anisotropy influence on traditional four-electrode sensors and concentric circle sensors was studied through simulation. Finally, through pork tissue detection experiments and clinical gastric cancer tissue detection experiments, it was verified that the multi-frequency synchronous bioimpedance spectroscopy detection system using concentric circle sensors has higher detection accuracy.<b>Results</b> The experimental results show that when using concentric circle sensors, the average overlap rate of detection results is 13.4%, which is 41.7% lower than that of traditional electrodes, and the average discrete coefficient (<i>C</i><sub>v</sub>) is 7.6%, which is 54.0% lower than that of traditional electrodes. The multi-frequency synchronous bioimpedance spectrum detection system takes about 20 ms to perform a detection, and the detection method proposed in this paper has higher detection accuracy and detection speed. Finally, the concentric circle electrodes were selected to conduct clinical experiments on human gastric cancer tissue, and normal tissue and tumor tissue were successfully distinguished.<b>Conclusion</b> The high-precision and high-speed bioimpedance spectroscopy detection method for tumor identification proposed in this paper can effectively reduce the influence of anisotropy of biological tissues and obtain higher-precision and higher-speed detection results.]]></description>
<pubDate>2024/10/18 14:55:14</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[HU Song-Pei,LIU Kai,PAN Min-Hong,WANG Zhong-Wei,YAO Jia-Feng,ZOU Bin]]></author>
</item>
<item>
<title><![CDATA[Research and Application of Transcranial Focused Ultrasound Simulation Methods]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202405280000002]]></link>
<description><![CDATA[Transcranial focused ultrasound (tFUS) technology achieves precise stimulation or treatment of the area of interest in the head by directing ultrasound beams to penetrate the human skull to form an intracranial focal point, with the advantages of eliminating the need for craniotomy and the absence of ionizing radiation. High-intensity tFUS treats brain diseases such as essential tremor or brain tumors through thermal effects, while low-intensity tFUS can safely and reversibly open the blood-brain barrier or conduct neuromodulation studies through mechanical effects. However, in practical applications, ultrasound waves undergo strong phase distortion and energy attenuation due to the strong acoustic attenuation properties and inhomogeneous structure of the skull. Acoustic simulation models the interaction between ultrasound and media based on acoustic fluctuation equations to predict the propagation properties of sound waves in different media. Therefore, acoustic simulation is commonly used to predict the intracranial acoustic field for single-element tFUS or to perform phase correction for each element of multi-element tFUS to ensure accurate focusing of intracranial ultrasound. According to the different methods of solving the acoustic fluctuation equations, the commonly used acoustic simulation methods in tFUS can be categorized into numerical and semi-analytical methods. The numerical methods include k-space pseudo-spectral method, time-domain finite difference method and finite element method, <i>etc</i>., and the semi-analytical methods include ray-tracing method and hybrid angular spectrum method. Simulation tools based on numerical methods synthesize various forms of wave propagation in media, such as nonlinear effects, scattering and diffraction, and are widely used in academic research. The k-Wave toolbox based on the k-space pseudo-spectral method and various programs based on the time-domain finite-difference method are the most widely used simulation tools in the current tFUS accurate simulation and experimental research. Although the finite element method has the advantage of dealing with complex boundary conditions, the excessive consumption of computational resources limits its direct application in complex 3D simulations. Compared to numerical methods, semi-analytical-based simulations cannot accurately model full-wave effects, but their computational speed makes them more suitable for clinical scenarios where simulation time is critical. Ray-tracing, developed by Insightec, is currently the only phase-correction method that has been used in clinical applications. Based on geometric acoustic principles, ray tracing enables near real-time tFUS phase correction. At the same time, the hybrid angular spectroscopy method shows higher accuracy in precise targeting than the conventional ray tracing method. In addition, the hybrid application of different simulation methods significantly improves the simulation efficiency and accuracy, <i>e.g</i>., the boundary element method can be coupled with the finite element method to limit the computational area to the region involving only the skull, which drastically reduces the computational load. In recent years, the acoustic simulation for tFUS has continued to make progress, but there is still a huge room for improvement in terms of computational efficiency and accuracy, and the optimal use of computational resources and the combination of multiple simulation techniques may be the direction of the future development of simulation technology. In this paper, the research on simulation techniques based on numerical, semi-analytical and hybrid methods commonly used in the field of tFUS in recent years is reviewed and sorted out, and the research and application of various simulation methods are summarized and prospected.]]></description>
<pubDate>2024/10/14 22:27:01</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Guo-Wei,HE Feng,MING Dong,WANG Xue,XU Min-Peng,ZHANG Hao]]></author>
</item>
<item>
<title><![CDATA[Non-invasive Photobiomodulation Therapy Techniques in Alzheimer’s Disease]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202404290000001]]></link>
<description><![CDATA[As the aging population in China continues to grow, the country’s public health sector faces an urgent need to address the significant social challenges posed by Alzheimer’s disease (AD). The available clinical treatments for AD are extremely limited, and the effectiveness of these drugs often diminishes after a period of use. Despite substantial global investment in drug research and development, the progress of clinical trials for AD treatments has been exceedingly slow. Over the past 30 years, only seven AD drugs have been approved by the U.S. Food and Drug Administration (FDA). Traditional drug therapies are expensive and can only slow the progression of AD, without halting the progressive degeneration of neurons. Therefore, exploring and developing emerging treatment methods for AD is imperative. Photobiomodulation (PBM) is a non-invasive therapeutic approach that uses red or near-infrared light to stimulate cellular metabolism and biological responses. PBM has the potential to improve brain metabolism and blood circulation, repair damaged neurons in the brain, and stimulate dendritic and neuronal growth, making it a promising non-invasive neurotherapeutic method that could complement drug treatments. This paper discusses the pathological characteristics and pathogenic mechanisms of AD, as well as the challenges faced by existing treatment strategies. It also reviews the research on PBM treatment in AD cellular and animal models and clinical studies, summarizes the history of phototherapy and the current state of advanced PBM phototherapy device development, and finally offers a perspective on the future development of advanced photonic technologies and therapeutic devices for PBM treatment of AD.]]></description>
<pubDate>2024/10/14 22:23:07</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HOSSEIN Chamkouri,CHEN Lei,CHEN Peng,CHEN Si,GUO Yan-Guang,NIU Chao-Shi,SI Jian-Min,WANG Yun-Le,WEI Shuang-Hong]]></author>
</item>
<item>
<title><![CDATA[Structural Characteristics and Signal Transduction Mechanisms of Bacterial Two-component Systems]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202405210000001]]></link>
<description><![CDATA[The two-component system (TCS) is a signaling mechanism extensively found in prokaryotes, playing a pivotal role in bacterial environmental sensing and adaptive responses. Comprising histidine kinase (HK) and response regulator (RR) components, TCS ensures appropriate bacterial reactions to various stimuli. Understanding its structural composition, signal transduction mechanisms, and applications in synthetic biology underscores its significance in both basic research and biotechnological applications. At its core, TCS operates through a sequence of events initiated by the detection of environmental cues. When the HK senses specific signals such as temperature changes, osmolarity shifts, or the presence of ligands, it undergoes autophosphorylation at a conserved histidine residue within its kinase domain. Subsequently, this phosphoryl group is transferred to a conserved aspartate residue on the RR’s receiver domain. This phosphotransfer event activates the RR, inducing a conformational change that alters its activity, often leading to changes in gene expression or other cellular responses. The specificity and fidelity of signal transduction in TCS are critical for bacteria to differentiate between various environmental cues and mount appropriate responses. This specificity is achieved through mechanisms such as unique signal molecule recognition by HKs and precise phosphotransfer from HKs to RRs. Moreover, the directional transfer of phosphoryl groups ensures tightly regulated signaling cascades, contributing to the overall robustness of bacterial response systems. Beyond its natural role, the versatility of TCS has been harnessed by engineers in synthetic biology to create tools like biosensors. By integrating TCS components into synthetic circuits, researchers can develop customized biosensors capable of highly sensitive and specific detection of environmental signals or biomolecules. These engineered biosensors find applications across diverse fields including environmental monitoring, medical diagnostics, and industrial biotechnology. The robustness of TCS-driven biosensors is particularly advantageous in synthetic biology. The modular design of TCS allows for the construction of sensor systems sensitive to a broad range of signals, adaptable to different cellular contexts. This adaptability is crucial for optimizing sensor performance under varying conditions, ensuring reliable and reproducible results. Safety considerations are paramount in synthetic biology, where TCS-based systems offer inherent safety features due to their reliance on natural signaling pathways and components. Well-characterized interactions between HKs and RRs minimize risks such as unintended cross-talk or interference with endogenous cellular processes, enhancing reliability in bioengineering applications requiring predictable and controllable cellular responses. Looking ahead, ongoing research aims to expand the capabilities of TCS-based biosensors through innovative engineering approaches. Advances in synthetic biology techniques, including genome editing and high-throughput screening, facilitate rapid design and optimization of novel sensor systems. These efforts promise next-generation biosensors with enhanced functionalities such as multiplexed sensing and real-time monitoring in complex biological environments. In summary, the TCS stands as a cornerstone of bacterial signal transduction, facilitating precise environmental sensing and adaptive responses. Its structural simplicity, coupled with robust signaling mechanisms and programmability, underpins its utility in synthetic biology for developing advanced biosensors and other bioengineering applications. By leveraging these capabilities, researchers are poised to address critical challenges in healthcare, environmental sustainability, and industrial biotechnology, shaping the future of biologically inspired technologies.]]></description>
<pubDate>2024/10/14 22:19:35</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LUO Bo-Yu,TENG Yue]]></author>
</item>
<item>
<title><![CDATA[Quercetin Inhibits Lipid Droplet Formation in ox-LDL-induced Foam Cells Through FOXO1-mediated Autophagy]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407160000001]]></link>
<description><![CDATA[<b>Objective</b> The aim of this study was to investigate the effect and mechanism of quercetin on lipid droplet formation in foam cells induced by oxidized low-density lipoprotein (ox-LDL).<b>Methods</b> Mouse RAW264.7 cells were induced by 50 mg/L ox-LDL to construct a foam cell model. After different quercetin concentrations were treated for different time, the optimal quercetin concentration and time were screened by CCK8 assay. Based on the constructed foam cell model, the formation of fat droplets was observed by oil red O staining after quercetin treatment with or without AS1842856 (FOXO1 inhibitor). Apoptosis was detected by flow cytometry. The protein expression of FOXO1 in each group was detected by Western blot. Autophagosome formation was observed by acridine orange staining. The mRNA and protein expression levels of Beclin1, LC3II and P62 were detected by qRT-PCR and Western blot.<b>Results</b> After being treated with 100 μmol/L quercetin for 12 h, the formation of fat droplets and apoptosis of foam cells were inhibited (<i>P</i><0.05). Compared with control group, there was an increase in fat droplet formation and apoptosis (<i>P</i><0.05), a decrease in autophagosome (<i>P</i><0.05), a decrease in FOXO1 protein expression (<i>P</i><0.05), a decrease in Beclin1 and LC3II protein and mRNA expression levels (<i>P</i><0.05), and the expression levels of P62 protein and mRNA were found to be increased (<i>P</i><0.05) in model group. Compared with model group, quercetin treatment up-regulated FOXO1 protein expression (<i>P</i><0.05), induced autophagosome formation (<i>P</i><0.05), promoted the protein and mRNA expression levels of Beclin1 and LC3II (<i>P</i><0.05), and inhibited the protein and mRNA expression levels of P62 (<i>P</i><0.05). In addition, treatment with the FOXO1 inhibitor AS1842856 reversed quercetin’s effect on OX-LDL-induced foam cells.<b>Conclusion</b> Quercetin induced autophagy by upregulating FOXO1 expression and inhibited fat droplet formation induced by OX-LDL.]]></description>
<pubDate>2024/10/8 21:21:44</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[DING Xiao-Ming,JIANG Yue-Wen,MOU Yan-Jie,SUN Qin-Guo,XU Hong-Jie,ZENG jiang-Qin]]></author>
</item>
<item>
<title><![CDATA[Translational Research of Electromagnetic Fields on Diseases Related With Bone Remodeling: Review and Prospects]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406180000003]]></link>
<description><![CDATA[Electromagnetic fields can regulate the fundamental biological processes involved in bone remodeling. As a non-invasive physical therapy, electromagnetic fields with specific parameters have demonstrated therapeutic effects on bone remodeling diseases, such as fractures and osteoporosis. Electromagnetic fields can be generated by the movement of charged particles or induced by varying currents. Based on whether the strength and direction of the electric field change over time, electromagnetic fields can be classified into static and time-varying fields. The treatment of bone remodeling diseases with static magnetic fields primarily focuses on fractures, often using magnetic splints to immobilize the fracture site while studying the effects of static magnetic fields on bone healing. However, there has been relatively little research on the prevention and treatment of osteoporosis using static magnetic fields. Pulsed electromagnetic fields, a type of time-varying field, have been widely used in clinical studies for treating fractures, osteoporosis, and non-union. However, current clinical applications are limited to low-frequency, and research on the relationship between frequency and biological effects remains insufficient. We believe that different types of electromagnetic fields acting on bone can induce various “secondary physical quantities”, such as magnetism, force, electricity, acoustics, and thermal energy, which can stimulate bone cells either individually or simultaneously. Bone cells possess specific electromagnetic properties, and in a static magnetic field, the presence of a magnetic field gradient can exert a certain magnetism on the bone tissue, leading to observable effects. In a time-varying magnetic field, the charged particles within the bone experience varying Lorentz forces, causing vibrations and generating acoustic effects. Additionally, as the frequency of the time-varying field increases, induced currents or potentials can be generated within the bone, leading to electrical effects. When the frequency and power exceed a certain threshold, electromagnetic energy can be converted into thermal energy, producing thermal effects. In summary, external electromagnetic fields with different characteristics can generate multiple physical quantities within biological tissues, such as magnetic, electric, mechanical, acoustic, and thermal effects. These physical quantities may also interact and couple with each other, stimulating the biological tissues in a combined or composite manner, thereby producing biological effects. This understanding is key to elucidating the electromagnetic mechanisms of how electromagnetic fields influence biological tissues. In the study of electromagnetic fields for bone remodeling diseases, attention should be paid to the biological effects of bone remodeling under different electromagnetic wave characteristics. This includes exploring innovative electromagnetic source technologies applicable to bone remodeling, identifying safe and effective electromagnetic field parameters, and combining basic research with technological invention to develop scientifically grounded, advanced key technologies for innovative electromagnetic treatment devices targeting bone remodeling diseases. In conclusion, electromagnetic fields and multiple physical factors have the potential to prevent and treat bone remodeling diseases, and have significant application prospects.]]></description>
<pubDate>2024/10/8 21:18:25</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LI An-Lin,LIU Jun-Yu,SHANG Peng,WANG Sheng-Hang,YANG Jian-Cheng,ZENG Yu-Hong,ZHANG Hao,ZHANG Zhe-Yuan]]></author>
</item>
<item>
<title><![CDATA[The Emerged Perspective on Improving Insulin Resistance Through Exercise: Metabolic Reprogramming Induces Trained Immunity Tolerance]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202408120000001]]></link>
<description><![CDATA[In recent years, it has been discovered that innate immunity also exhibits immune memory characteristics, referred to as trained immunity. This refers to the ability of innate immune cells to acquire a memory-like capacity after being attacked by pathogens, thereby demonstrating enhanced reactivity upon secondary stimulation from the same or different stimuli. Existing research indicates that high-fat diet stimulates innate immune cells to undergo trained immunity, thereby significantly boosting their immune response to secondary metabolic disorders. This process serves as a crucial mechanism underlying the development of insulin resistance-associated metabolic diseases. Breaking the vicious cycle between insulin resistance and trained immunity by inducing innate immune cells to establish immune tolerance and inhibiting excessive inflammatory reactions caused by various secondary metabolic disorders of insulin resistance represents a novel strategy for early prevention and treatment of related metabolic diseases. As is widely known, exercise intervention serves as an effective means to improve insulin resistance-related metabolic diseases. It promotes metabolic homeostasis by exerting anti-inflammatory effects, yet the underlying mechanism of these anti-inflammatory effects remains unclear. Numerous studies suggest that after a high-fat diet generates innate immune memory, exercise intervention may alleviate excessive inflammatory reactions caused by secondary metabolic disorders due to insulin resistance by inducing immune tolerance in innate immune cells, and promote early prevention and treatment of related metabolic diseases. Therefore, targeting innate immune cell immune tolerance to explore the anti-inflammatory mechanism of exercise intervention in insulin resistance holds exciting and vast prospects. Metabolic reprogramming refers to the process in which cells undergo systematic adjustments and transformations in their energy requirements and metabolic patterns to adapt to changes in the external environment and meet their own needs for proliferation and differentiation under specific physiological and pathological conditions. Numerous studies have shown that metabolic reprogramming plays a crucial role in tumor biology, immunology, stem cell research, and the occurrence and development of various diseases. Increasing evidence suggests that metabolic reprogramming is also a key mechanism for innate immune cells to respond to external stimuli and perform immune functions. The process of immune tolerance is also driven by metabolic reprogramming. Studying the mechanisms of innate immune cell immune tolerance from the perspective of metabolic reprogramming is expected to provide new directions for the prevention and treatment of chronic inflammation and related metabolic diseases. Meanwhile, exercise has been proven to regulate metabolic reprogramming in various cells. It may induce immune tolerance in activated innate immune cells by inhibiting glycolysis and enhancing their oxidative phosphorylation levels, thereby mitigating excessive inflammatory reactions and achieving early prevention and treatment of insulin resistance-related metabolic diseases. Itaconate, an intermediate product of the tricarboxylic acid cycle, represents a newly discovered central regulatory point for balancing the trained immunity and immunity tolerance in innate immune cells. Additionally, exercise modulates IRG1/itaconate signaling. Therefore, conducting an in-depth exploration of the interrelationships between trained immunity, immunity tolerance, metabolic reprogramming, and IRG1/itaconate signaling in exercise intervention for insulin resistance, as well as summarizing the immune tolerance mechanism of exercise in improving insulin resistance, can provide theoretical support for the preventive and therapeutic effects of exercise in insulin resistance and related metabolic diseases. This can also offer new insights for the development of simulated drugs tailored for individuals with exercise intolerance.]]></description>
<pubDate>2024/10/8 21:14:50</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[AI Lei,GAO Wen-Yue,LIU Yan-Song,LUO Wei,WANG Yu-Hang]]></author>
</item>
<item>
<title><![CDATA[The Relationship Between Intestinal Flora and Intestinal Mucosal Immune Senescence]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406110000001]]></link>
<description><![CDATA[Aging has been identified as one of the risk factors for chronic disease, and the onset and development of many chronic diseases are closely related to gut immune dysfunction in the elderly. Aging profoundly affects the intestinal immune system and the homeostasis of intestinal flora. We have reviewed the changes in intestinal mucosal immune function that occur with aging, including Toll-like receptors (TLRs), T cells, B cells and inflammatory cytokines such as IL-6, TNF-α and IFN-γ. Age-related changes in typical gut microbiota and their metabolites were discussed. Aging leads to changes in the composition and diversity of the gut microbiota. With advancing age, intestinal bacteria such as <i>Bacteroides</i>, <i>Bifidobacterium</i> and <i>Clostridium butyricum </i>undergo<i> </i>significant alterations. These changes lead to a decline in the metabolites produced by the gut flora, including short chain fatty acids (SCFAs), bile, indole and indole derivatives. As a result, the homeostasis of the gut microbiota becomes disrupted, leading to an imbalance in the intestinal microbial ecosystem. The interaction between the intestinal flora and its metabolites and the intestinal immune system has been studied and a high correlation between the intestinal flora and the immune function of the intestinal mucosa has been proposed. Under normal circumstances, a healthy immune system and gut flora are mutually reinforcing and promote the health of the host. However, with age, the integrity of intestinal mucosa and the homeostasis of intestinal flora are disrupted, resulting in a decline in the immune response and regulatory capacity and an inability to respond effectively to various exogenous insults. Meanwhile, the ongoing damage to the immune system further exacerbates the imbalance in the gut flora. Changes in the gut flora of the elderly affect the diversity and levels of key immune molecules such as defensins and immunoglobulin A (IgA). Abnormal expression of immune molecules in the gut also leads to changes in the composition of the gut microbiome, affecting gut health and potentially increasing the risk of disease. The metabolites of intestinal flora interact with intestinal receptors, activate relevant signalling pathways, directly regulate immune cells and control the immune system, influence the intestinal barrier and intestinal immune functions, and exert immunoregulatory effects on the intestine. As the relationship between gut flora and immune aging becomes clearer, future research can explore strategies for targeted regulation of gut flora for anti-aging and immune enhancement. In this paper, we further explore the regulation of gut flora and gut immune function by dietary intervention and fecal microbiota transplantation (FMT) to achieve the goal of delaying immune aging. Dietary intervention promotes the growth of beneficial bacteria by adjusting the structure of the elderly’s diet and supplementing with microbial preparations, maintaining the intestinal barrier and reducing chronic inflammation. FMT involves the transplantation of faeces from healthy individuals into recipients to improve mucosal integrity and promote microbial diversity. This paper has discussed the complex mechanism between aging, gut flora and immune response, highlighted the research progress of gut flora anti-aging methods, with the aim of providing a reference for research on targeted gut flora regulation to promote gut mucosal immune function for health promotion and anti-aging.]]></description>
<pubDate>2024/10/5 22:50:20</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[GUO Wen-Wen,KE Zhi-Jian,MAO Hai-Guang,QI Li-Li,WANG Jin-Bo,WANG Meng-Ting]]></author>
</item>
<item>
<title><![CDATA[Apolipoprotein E and Alzheimer’s Disease: Risk, Mechanisms, and Treatment]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202408290000001]]></link>
<description><![CDATA[Alzheimer’s disease (AD) is the most common form of dementia, and its prevalence is rapidly increasing with the aging population. Among the growing number of genetic risk factors, apolipoprotein E (ApoE) is the most prevalent and strongest risk factor, accounting for nearly three-quarters of AD cases. ApoE is a key protein involved in lipids and cholesterol metabolism in the central nervous system. There are three subtypes of ApoE: ApoE2, ApoE3, and ApoE4, among which ApoE4 is a high-risk factor for the incidence of AD. ApoE4 not only affects lipid efflux and distribution in glial cells, but also affects the lipid metabolism in neurons, resulting in the imbalance of lipid homeostasis. ApoE plays a role in the processing of amyloid precursor protein (APP), which is associated with the early production of amyloid β-(Aβ) protein and plaque deposition. ApoE4 also reduces the solubility of Tau protein, which contributes to promoting the aberrant phosphorylation and the aggregation of Tau, and resulting in neurofibrillary tangles (NFTs). Moreover, brain regions expressing ApoE4 are more susceptible to Tau diffusion. Furthermore, ApoE4 has been demonstrated to activate the NF-κB inflammatory pathway, convert microglia and astrocytes into the pro-inflammatory phenotypes, secrete pro-inflammatory factors and oxidative mediators, and induce neuroinflammation. Altogether, ApoE participates in AD neuropathology through multiple pathways such as Aβ plaque, Tau pathology, neuroinflammation, neuroplasticity and blood-brain barrier, which all jointly promotes the progression of the disease. It has been demonstrated that anti-ApoE4 antibodies can reduce the formation of Aβ plaques and neuroinflammation. The repurposing of metformin, rapamycin, enoxaparin, DHA, and tamoxifen have been shown to reduce the expression of ApoE4 protein and ameliorate AD pathology. Gene therapies utilising antisense oligonucleotides (ASO) and double-stranded interfering small RNA (siRNA) has been proved to be effective technologies to reduce ApoE4 expression and mitigate AD pathology. Adeno-associated virus (AAV)-mediated ApoE2 has been demonstrated to neutralize the negative effects of ApoE4 by expressing ApoE2 in the ventricular membrane. Traditional Chinese medicine resveratrol and waterside delivered by ApoE-modified liposome nanodrug delivery system can improve the BBB penetration of drugs and provid a new method for the treatment of AD. In addition, targeting the interaction of ApoE with low-density lipoprotein receptor (LDLR) and low density lipoprotein-related protein 1 (LRP1) receptors can indirectly regulate the expression level of ApoE, which provids a new perspective for the treatment of AD. This article aims to elucidate the roles of ApoE and its isoforms in the pathogenesis of AD and summarize the potential therapeutic strategies against ApoE with the hope of providing novel insights for the ApoE-based therapies combat AD.]]></description>
<pubDate>2024/10/5 22:20:14</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Shi-Yu,FANG Tian-Yuan,LI Li-Ping,LI Wan-Yi,LIN Zhi-Cheng,LIU Zhi-Tao,XIE Kai,XU Shu-Jun,YING Jia-Qin,ZHANG Chu-Xia,ZHOU Yu-Yu]]></author>
</item>
<item>
<title><![CDATA[EEG Study Based on Bipolar Concentric Ring Laplacian Electrodes]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407100000001]]></link>
<description><![CDATA[<b>Objective</b> Electroencephalography (EEG) serves as a non-invasive electrophysiological monitoring technique employed to record brain electrical activity. Nonetheless, traditional EEG electrodes are susceptible to reference activation influences and exhibit limited spatial resolution. Laplacian electrodes, devoid of reference dependencies, possess the potential to amplify the spatial resolution of EEG recordings. Anchored in the utilization of bipolar concentric ring Laplacian electrodes, this study delves into the autonomous referencing attributes intrinsic to Laplacian electrodes. Furthermore, it conducts a comparison of spatial resolution disparities between Laplacian electrodes and their conventional counterparts.<b>Methods</b> A three-dimensional (3D) hemispherical tank experiment was conducted utilizing 21 Ag/AgCl bipolar concentric ring Laplacian electrodes to simulate whole-brain signal acquisitions. A sinusoidal signal with an amplitude of 400 mVpp@13 Hz was employed for detection. The positions of the ground electrodes in the Laplacian electrode array were varied, alongside the reference electrode positions in the case of the traditional electrodes. Subsequently, the spatial distribution of the 13 Hz source frequency component was extracted and subjected to comprehensive analysis.<b>Results</b> With varying ground electrode positions, the spatial distribution of the signal-to-noise ratio (SNR) among Laplacian electrodes maintains remarkable consistency, yielding a correlation coefficient of 0.94. In contrast, for traditional electrodes, the correlation coefficient for SNR distribution under distinct reference electrode positions barely reaches 0.07. While Laplacian electrodes exhibit independence from reference electrodes, traditional counterparts display a notable susceptibility to changes in reference electrode positions. Comparing amplitude’s 3 dB attenuation area ratio, Laplacian electrodes showcase a mere 2.1% reduction, a significantly favorable outcome when juxtaposed with the 6.9% reduction evident in traditional electrodes. Similarly, the SNR’s 3 dB attenuation area ratio for Laplacian electrodes is a mere 1.0%, contrasting with the considerably higher figure of 30.1% for traditional electrodes.<b>Conclusion</b> Laplacian electrodes remain impervious to reference electrode influence, displaying distinctive reference-independent attributes, in addition to boasting a heightened spatial resolution. These characteristics imbue them with the capacity to achieve heightened precision in localizing brain electrical activities, thus constituting a cornerstone for the integration of Laplacian electrodes into brain-computer interfaces (BCIs).]]></description>
<pubDate>2024/10/5 22:13:45</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[HE Feng,SHI Tian-Ning,XU Min-Peng,XUE Jia-Xing,YING Bing-Jie,ZHENG Chun-Hou]]></author>
</item>
<item>
<title><![CDATA[A Fitting Method for Photoacoustic Pump-probe Imaging Based on Phase Correction]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202408240000002]]></link>
<description><![CDATA[<b>Objective</b> Photoacoustic pump-probe imaging can effectively eliminate the interference of blood background signal in traditional photoacoustic imaging, and realize the imaging of weak phosphorescence molecules and their triplet lifetimes in deep tissues. However, background differential noise in photoacoustic pump-probe imaging often leads to large fitting results of phosphorescent molecule concentration and triplet lifetime. Therefore, this paper proposes a novel triplet lifetime fitting method for photoacoustic pump-probe imaging. By extracting the phase of the triplet differential signal and the background noise, the fitting bias caused by the background noise can be effectively corrected.<b>Methods</b> The advantages and feasibility of the proposed algorithm are verified by numerical simulation, phantom and <i>in vivo</i> experiments, respectively.<b>Results</b> In the numerical simulation, under the condition of noise intensity being 10% of the signal amplitude, the new method can optimize the fitting deviation from 48.5% to about 5%, and has a higher exclusion coefficient (0.88>0.79), which greatly improves the fitting accuracy. The high specificity imaging ability of photoacoustic pump imaging for phosphorescent molecules has been demonstrated by phantom experiments. <i>In vivo</i> experiments have verified the feasibility of the new fitting method proposed in this paper for fitting phosphoometric lifetime to monitor oxygen partial pressure content during photodynamic therapy of tumors in nude mice.<b>Conclusion</b> This work will play an important role in promoting the application of photoacoustic pump-probe imaging in biomedicine.]]></description>
<pubDate>2024/10/5 22:11:35</pubDate>
<category><![CDATA[技术与方法]]></category>
<author><![CDATA[HE Bin,LIU Run-Xiang,WANG Bo,XIE Zhuo-Jun,XUE Ping,ZHONG Hong-Wen]]></author>
</item>
<item>
<title><![CDATA[Perspectives: Nanozyme and Abiogenesis]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202409250000001]]></link>
<description><![CDATA[Nanozymes, a groundbreaking discovery by Chinese scientists, represent a novel and remarkable property of nanomaterials. They not only exhibit catalytic activity comparable to natural enzymes, but also boast exceptional stability, tunable reactivity, and the ability to catalyze reactions under mild conditions. The identification of nanozymes has unveiled the biocatalytic potential of inorganic nanomaterials. In parallel, inorganic minerals have long been regarded as pivotal catalysts in the origin of life, driving the synthesis of early biomolecules. These minerals not only facilitate redox reactions that convert simple inorganic compounds into organic molecules but also enable chiral selection, the synthesis of biomacromolecules, and radioprotective functions <i>via </i>their surface structures. Recent advances suggest that inorganic nanomaterials can delicately catalyze the formation of biomolecules, aid in macromolecular assembly, and provide radiation shielding. Furthermore, nanominerals are found in abundance across Earth and extraterrestrial environments. This paper seeks to explore the potential of nanozymes as catalytic agents in the processes that gave rise to life, integrating the catalytic roles of inorganic minerals with the unique attributes of nanozymes, which will provide a new perspective for research of origin of life.]]></description>
<pubDate>2024/10/5 10:26:21</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[FAN Ke-Long,FENG Jing,HOU Yin-Yin,LIANG Zi-Mo,MA Long,YAN Xi-Yun]]></author>
</item>
<item>
<title><![CDATA[Hydrogen Sulfide Prevents ATP-induced Neurotoxicity <i>via</i> Inhibiting The NLRP1/caspase-1/ gasdermin D-mediated Pyroptosis Pathway]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202403210000002]]></link>
<description><![CDATA[<b>Objective</b> Stroke is a leading cause of death and disability worldwide, with ischemic stroke accounting for 80%-85% of cases. Despite the prevalence, effective treatments remain scarce. The compelling evidence suggest that high concentrations of ATP in the brain post-stroke can trigger irreversible neuronal damage and necrosis, contributing to a range of neurocellular dysfunctions. Pyroptosis, a recently identified form of programmed cell death, is characterized by caspase-1 activation and the action of the Gasdermin D (GSDMD) protein family, leading to cell perforation and inflammatory death.<b>Methods</b> In this study, human neuroblastoma SH-SY5Y cells were used to investigate the mechanisms of ATP-induced neurotoxicity and the protective effects of hydrogen sulfide (H<sub>2</sub>S) against this toxicity through the antagonization of pyroptosis. We employed CCK-8 and LDH assays to assess cell viability. YO-PRO-1 fluorescent dyes and flow cytometry were conducted for detecting changes in cell membrane permeability. Western blot analysis was used to measure protein levels associated with cellular dysfunction.<b>Results</b> Our results indicate that high concentrations of ATP enhance cytotoxicity and increase cell membrane permeability in SH-SY5Y cells, that are mitigated by the H<sub>2</sub>S donor NaHS. Furthermore, ATP was found to promote the activation of the NOD-like receptor pyrin domain-containing 1 (NLRP-1), caspase-1, and the cleavage of GSDMD, with NaHS significantly attenuating these effects.<b>Conclusion</b> Our research suggests that H<sub>2</sub>S protects SH-SY5Y cells from ATP-induced neurotoxicity through a mechanism mediated by the NLRP1, caspase-1, and GSDMD pathway.]]></description>
<pubDate>2024/10/2 12:12:28</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[FAN Zhi-Ru,LI Dong-Liang,LI Man-Li,LI Ying-Hong,REN Yan-Kai,YANG Kun-Li,ZHANG Si-Yu]]></author>
</item>
<item>
<title><![CDATA[Early Identification and Visualization of Tomato Early Blight Using Hyperspectral Imagery]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202405140000002]]></link>
<description><![CDATA[<b>Objective</b> Tomatoes are one of the highest-yielding and most widely cultivated economic crops globally, playing a crucial role in agricultural production and providing significant economic benefits to farmers and related industries. However, early blight in tomatoes is known for its rapid infection, widespread transmission, and severe destructiveness, which significantly impacts both the yield and quality of tomatoes, leading to substantial economic losses for farmers. Therefore, accurately identifying early symptoms of tomato early blight is essential for the scientific prevention and control of this disease. Additionally, visualizing affected areas can provide precise guidance for farmers, effectively reducing economic losses. This study combines hyperspectral imaging technology with machine learning algorithms to develop a model for the early identification of symptoms of tomato early blight, facilitating early detection of the disease and visual localization of affected areas.<b>Methods</b> To address noise interference present in hyperspectral images, robust principal component analysis (RPCA) is employed for effective denoising, enhancing the accuracy of subsequent analyses. To avoid insufficient information representation caused by the subjective selection of regions of interest, the Otsu’s thresholding method is utilized to extract tomato leaves effectively from the background, with the average spectrum of the entire leaf taken as the primary object of study. Furthermore, a comprehensive spectral preprocessing workflow is established by integrating multivariate scatter correction (MSC) and standardization methods, ensuring the reliability and effectiveness of the data. Based on the processed spectral data, a discriminant model utilizing a linear kernel function support vector machine (SVM) is constructed, focusing on characteristic wavelengths to improve the model"s discriminative capability.<b>Results</b> Compared to full-spectrum modeling, this approach results in an 8.33% increase in accuracy on the test set. After optimizing the parameters of the SVM model, when <i>C</i>=1.64, the accuracies of the training set and test set reach 91.67% and 94.44%, respectively, demonstrating a 1.19% increase in training set accuracy compared to the unoptimized model, while maintaining the same accuracy on the test set, effectively alleviating issues of underfitting.<b>Conclusion</b> This study successfully establishes an early discriminant model for tomato early blight using hyperspectral imaging and achieves visualization of early symptoms. Experimental results indicate that the SVM discriminant model based on characteristic wavelengths and a linear kernel function can effectively identify early symptoms of tomato early blight. Visualization of these symptoms in terms of disease probability allows for a more intuitive detection of early diseases and timely implementation of corresponding control measures. This visual analysis not only enhances the efficiency of disease identification but also provides farmers with more straightforward and practical information, aiding them in formulating more reasonable prevention strategies. These research findings provide valuable references for the early identification and visualization of plant diseases, holding significant practical implications for monitoring, identifying, and scientifically preventing crop diseases. Future research could further explore how to apply this model to disease detection in other crops and how to integrate IoT technology to create intelligent disease monitoring systems, enhancing the scientific and efficient management of crops.]]></description>
<pubDate>2024/10/2 9:50:33</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[BAO Hao,HUANG Li,PANG Hao,ZHANG Yan]]></author>
</item>
<item>
<title><![CDATA[Research and Application of Scalp Surface Laplacian Technique]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202408010000004]]></link>
<description><![CDATA[Electroencephalography (EEG) is a non-invasive, high temporal-resolution technique for monitoring brain activity. However, affected by the volume conduction effect, EEG has a low spatial resolution and is difficult to locate brain neuronal activity precisely. The surface Laplacian (SL) technique obtains the Laplacian EEG (LEEG) by estimating the second-order spatial derivative of the scalp potential. LEEG can reflect the radial current activity under the scalp, with positive values indicating current flow from the brain to the scalp (“source”) and negative values indicating current flow from the scalp to the brain (“sink”). It attenuates signals from volume conduction, effectively improving the spatial resolution of EEG, and is expected to contribute to breakthroughs in neural engineering. This paper provides a systematic overview of the principles and development of SL technology. Currently, there are two implementation paths for SL technology: current source density algorithms (CSD) and concentric ring electrodes (CRE). CSD performs the Laplace transform of the EEG signals acquired by conventional disc electrodes to indirectly estimate the LEEG. It can be mainly classified into local methods, global methods, and realistic Laplacian methods. The global method is the most commonly used approach in CSD, which can achieve more accurate estimation compared with the local method, and it does not require additional imaging equipment compared with the realistic Laplacian method. CRE employs new concentric ring electrodes instead of the traditional disc electrodes, and measures the LEEG directly by differential acquisition of the multi-ring signals. Depending on the structure, it can be divided into bipolar CRE, quasi-bipolar CRE, tripolar CRE, and multi-pole CRE. The tripolar CRE is widely used due to its optimal detection performance. While ensuring the quality of signal acquisition, the complexity of its preamplifier is relatively acceptable. Here, this paper introduces the study of the SL technique in resting rhythms, visual-related potentials, movement-related potentials, and sensorimotor rhythms. These studies demonstrate that SL technology can improve signal quality and enhance signal characteristics, confirming its potential applications in neuroscientific research, disease diagnosis, visual pathway detection, and brain-computer interfaces. CSD is frequently utilized in applications such as neuroscientific research and disease detection, where high-precision estimation of LEEG is required. And CRE tends to be used in brain-computer interfaces, that have stringent requirements for real-time data processing. Finally, this paper summarizes the strengths and weaknesses of SL technology and envisages its future development. SL technology boasts advantages such as reference independence, high spatial resolution, high temporal resolution, enhanced source connectivity analysis, and noise suppression. However, it also has shortcomings that can be further improved. Theoretically, simulation experiments should be conducted to investigate the theoretical characteristics of SL technology. For CSD methods, the algorithm needs to be optimized to improve the precision of LEEG estimation, reduce dependence on the number of channels, and decrease computational complexity and time consumption. For CRE methods, the electrodes need to be designed with appropriate structures and sizes, and the low-noise, high common-mode rejection ratio preamplifier should be developed. We hope that this paper can promote the in-depth research and wide application of SL technology.]]></description>
<pubDate>2024/10/2 8:06:25</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[GUO Si-Ying,LI Xin-Yi,LUO Rui-Xin,MING Dong,XU Min-Peng,ZHAO Yu-He,ZHENG Chun-Hou]]></author>
</item>
<item>
<title><![CDATA[Early Swimming Alleviates Stereotypic Behavior in <i>Shank3</i> Knockout Rats by Regulating Striatal Cell Autophagy]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407130000003]]></link>
<description><![CDATA[<b>Objective</b> To explore the mechanism of exercise intervention in improving autism-like behaviors in <i>Shank3</i> gene knockout (<i>Shank3</i><sup>-/-</sup>) induced autism spectrum disorder (ASD) rat models from an autophagy perspective through 8-week swimming intervention.<b>Methods</b> Based on genotype identification and exercise intervention, rats were divided into four groups (<i>n</i>=15): wild-type control group (WC), <i>Shank3</i><sup>-/-</sup> control group (KC), wild-type swimming group (WS), and <i>Shank3</i><sup>-/-</sup> swimming group (KS). KS and WS groups underwent 8 weeks of swimming exercise, 5 d/week, gradually increasing to and maintaining 40 min/session. Behavioral experiments, including self-grooming test, marble burying test, and hole-board test, were conducted 24 h after the final swimming intervention. Tissue sampling was performed 12 h after behavioral testing. Transmission electron microscopy was used to observe autophagosome numbers in the striatum region. Immunofluorescence staining was employed to observe the expression levels of microtubule-associated protein 1 light chain 3 (LC3) and selective autophagy adaptor protein (p62). Quantitative real-time polymerase chain reaction (qPCR) and Western blot were used to detect protein and mRNA expression of Beclin1, LC3, p62, autophagy-related protein 5 (Atg5), autophagy-related 16-like protein 1 (Atg16L), and lysosome-associated membrane protein 1 (LAMP1) in striatal.<b>Results</b> Compared with the WC group, rats in the KC group exhibited significantly higher self-grooming frequency and duration (<i>P</i>0.05), increased marble burying behavior (<i>P</i>0.01), and elevated frequencies in both hole-board exploration and single-hole exploration (<i>P</i>0.05). Following 8 weeks of swimming intervention, the KS group demonstrated significantly reduced self-grooming duration, marble burying behavior, and single-hole exploration frequency compared to the KC group. Furthermore, compared to the WC group, the KC group displayed abundant autophagosomes in the striatum region, along with significantly elevated protein and mRNA expression levels of Atg5, Atg16L, p62, and LC3II/LC3I ratio (<i>P</i>0.05), increased Beclin1 protein levels (<i>P</i>0.05), and markedly decreased LAMP1 protein and mRNA expression levels (<i>P</i>0.05). Following the 8-week swimming intervention, the KS group exhibited significantly reduced protein and mRNA expression levels of Atg5, Atg16L, p62, and LC3II/LC3I ratio (<i>P</i>0.05), decreased Beclin1 protein levels (<i>P</i>0.05), and significantly elevated LAMP1 protein and mRNA expression levels (<i>P</i>0.05) compared to the KC group.<b>Conclusion</b> Early 8-week swimming can alleviate stereotyped behaviors in <i>Shank3</i><sup>-/-</sup> rats by regulating striatal cell autophagy.]]></description>
<pubDate>2024/10/2 8:03:25</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[BA Yi,LIU Niu,WANG Shi-Jiao,XUE Ya-Qi,ZHEN Zhi-Ping]]></author>
</item>
<item>
<title><![CDATA[The Neurobiological Mechanisms of Runner’s High]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406280000001]]></link>
<description><![CDATA[“Runner’s high” refers to a momentary sense of pleasure that suddenly appears during running or other exercise activities, characterized by anti-anxiety, pain relief, and other symptoms. The neurobiological mechanism of “runner’s high” is unclear. This review summarizes human and animal models for studying “runner’s high”, analyzes the neurotransmitters and neural circuits involved in runner’s high, and elucidates the evidence and shortcomings of researches related to “runner’s high”. This review also provides prospects for future research. Research has found that exercise lasting more than 30 min and with an intensity exceeding 70% of the maximum heart rate can reach a “runner’s high”. Human experiments on “runner’s high” mostly use treadmill exercise intervention, and evaluate it through questionnaire surveys, measurement of plasma AEA, miRNA and other indicators. Animal experiments often use voluntary wheel running intervention, and evaluate it through behavioral experiments such as conditional place preference, light dark box experiments (anxiety), hot plate experiments (pain sensitivity), and measurement of plasma AEA and other indicators. Dopamine, endogenous opioid peptides, endogenous cannabinoids, brain-derived neurotrophic factor, and other substances increase after exercise, which may be related to the “runner’s high”. However, attention should be paid to the functional differences of these substances in the central and peripheral regions, as well as in different brain regions. Moreover, current studies have not identified the targets of the neurotransmitters or neural factors mentioned above, and further in-depth researches are needed. The mesolimbic dopamine system, prefrontal cortex-nucleus accumbens projection, ventral hippocampus-nucleus accumbens projection, red nucleus-ventral tegmental area projection, cerebellar-ventral tegmental area projection, and brain-gut axis may be involved in the regulation of runner’s high, but there is a lack of direct evidence to prove their involvement. There are still many issues that need to be addressed in the research on the neurobiological mechanisms of “runner’s high”. (1) Most studies on “runner’s high” involve one-time exercise, and the characteristics of changes in “runner’s high” during long-term exercise still need to be explored. (2) The using of scales to evaluate subjects lead to the lacking of objective indicators. However, some potential biomarkers (such as endocannabinoids) have inconsistent characteristics of changes after one-time and long-term exercise. (3) The neurotransmitters involved in the formation of the “runner’s high” all increase in the peripheral and/or central nervous system after exercise. Attention should be paid to whether peripheral substances can enter the blood-brain barrier and the binding effects of neurotransmitters to different receptors are completely different in different brain regions. (4) Most of the current evidence show that some brain regions are activated after exercise. Is there a functional circuit mediating “runner’s high” between these brain regions? (5) Although training at a specific exercise intensity can lead to “runner’s high”, most runners have not experienced “runner’s high”. Can more scientific training methods or technological means be used to make it easier for people to experience the “runner’s high” and thus be more willing to engage in exercise? (6) The “runner’s high” and “addiction” behaviors are extremely similar, and there are evidences that exercise can reverse addictive behaviors. However, why is there still a considerable number of people in the sports population and even athletes who smoke or use addictive drugs instead of pursuing the “pleasure” brought by exercise? Solving the problems above is of great significance for enhancing the desire of exercise, improving the clinical application of neurological and psychiatric diseases through exercise, and enhancing the overall physical fitness of the population.]]></description>
<pubDate>2024/9/27 14:41:10</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LI Yan,LIANG Jia-Qi,SU Wan-Tang,WANG Yun-Teng,ZHAO Li]]></author>
</item>
<item>
<title><![CDATA[Teaching Reform of “Structural Biology” Course Based on The Ability Cultivation]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202408270000001]]></link>
<description><![CDATA[As a rapidly developing frontier discipline, structural biology has penetrated into every field of life science research. The course of “Structural Biology” plays an important role in expanding the knowledge system of undergraduate students and promoting students’ scientific spirit and innovation. For the high-quality training of highly skilled talents, we aimed to promote the original innovation of students, the ability of thinking, and the ability of engineering practice. The trinity education concept, including shape of the value, passing on knowledge, and ability cultivation, was applied. During the reform, we explored a step-by-step course content and searched for factors involved in ideological and political education. Based on the problem-based learning (PBL) method, a hybrid teaching model was designed to cultivate the problem-thinking and problem-solving skills of students. Meanwhile, a number of evaluation systems for students and teachers were established, which may be generally adopted for the course of “Structural Biology”. The survey data suggested that the exploration has a good effect on teaching and training and is conducive to the cultivation of research-oriented, comprehensive, innovative talents under the background of “New Engineering”.]]></description>
<pubDate>2024/9/26 11:11:27</pubDate>
<category><![CDATA[科教融合]]></category>
<author><![CDATA[GAO Xiang,GUO Ting-Ting,LI Ying-Jie,WANG Lu-Shan,WANG Ming-Yu,WU Da-Lei]]></author>
</item>
<item>
<title><![CDATA[Role of SPINK in Dermatologic Diseases and Potential Therapeutic Targets]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202405310000001]]></link>
<description><![CDATA[Serine protease inhibitor Kazal-type (SPINK) is a skin keratinizing protease inhibitor, which was initially found in animal serum and is widely present in plants, animals, bacteria, and viruses, and they act as key regulators of skin keratinizing proteases and are involved in the regulation of keratinocyte proliferation and inflammation, primarily through the inhibition of deregulated tissue kinin-releasing enzymes (KLKs) in skin response. This process plays a crucial role in alleviating various skin problems caused by hyperkeratinization and inflammation, and can greatly improve the overall condition of the skin. Specifically, the different members of the SPINK family, such as SPINK5, SPINK6, SPINK7, and SPINK9, each have unique biological functions and mechanisms of action. The existence of these members demonstrates the diversity and complexity of skin health and disease. First, <i>SPINK5</i> mutations are closely associated with the development of various skin diseases, such as Netherton’s syndrome and atopic dermatitis, and SPINK5 is able to inhibit the activation of the STAT3 signaling pathway, thereby effectively preventing the metastasis of melanoma cells, which is important in preventing the invasion and migration of malignant tumors. Secondly, SPINK6 is mainly distributed in the epidermis and contains lysine and glutamate residues, which can act as a substrate for epidermal transglutaminase to maintain the normal structure and function of the skin. In addition, SPINK6 can activate the intracellular ERK1/2 and AKT signaling pathways through the activation of epidermal growth factor receptor and protease receptor-2 (EphA2), which can promote the migration of melanoma cells, and SPINK6 further deepens its role in stimulating the migration of malignant tumor cells by inhibiting the activation of STAT3 signaling pathway. This process further deepens its potential impact in stimulating tumor invasive migration. Furthermore, SPINK7 plays a role in the pathology of some inflammatory skin diseases, and is likely to be an important factor contributing to the exacerbation of skin diseases by promoting aberrant proliferation of keratinocytes and local inflammatory responses. Finally, SPINK9 can induce cell migration and promote skin wound healing by activating purinergic receptor 2 (P2R) to induce phosphorylation of epidermal growth factor and further activating the downstream ERK1/2 signaling pathway. In addition, SPINK9 also plays an antimicrobial role, preventing the interference of some pathogenic microorganisms. Taken as a whole, some members of the SPINK family may be potential targets for the treatment of dermatological disorders by regulating multiple biological processes such as keratinization metabolism and immuno-inflammatory processes in the skin. The development of drugs such as small molecule inhibitors and monoclonal antibodies has great potential for the treatment of dermatologic diseases, and future research on SPINK will help to gain a deeper understanding of the physiopathologic processes of the skin. Through its functions and regulatory mechanisms, the formation and maintenance of the skin barrier and the occurrence and development of inflammatory responses can be better understood, which will provide novel ideas and methods for the prevention and treatment of skin diseases.]]></description>
<pubDate>2024/9/26 10:49:04</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DENG Hao,HU Li-Ling,LIU Wei,TAN Xiao,XIA Yong-Hang]]></author>
</item>
<item>
<title><![CDATA[Structure and Function of GPR126/ADGRG6]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406210000001]]></link>
<description><![CDATA[GPR126, also known as ADGRG6, is one of the most deeply studied aGPCRs. Initially, GPR126 was thought to be a receptor associated with muscle development and was primarily expressed in the muscular and skeletal systems. With the deepening of research, it was found that GPR126 is expressed in multiple mammalian tissues and organs, and is involved in many biological processes such as embryonic development, nervous system development, and extracellular matrix interactions. Compared with other aGPCRs proteins, GPR126 has a longer N-terminal domain, which can bind to ligands one-to-one and one-to-many. Its N-terminus contains five domains, a CUB (complement C1r/C1s, Uegf, Bmp1) domain, a PTX (Pentraxin) domain, a SEA (Sperm protein, Enterokinase, and Agrin) domain, a hormone binding (HormR) domain, and a conserved GAIN domain. The GAIN domain has a self-shearing function, which is essential for the maturation, stability, transport and function of aGPCRs. Different SEA domains constitute different GPR126 isomers, which can regulate the activation and closure of downstream signaling pathways through conformational changes. GPR126 has a typical aGPCRs seven-transmembrane helical structure, which can be coupled to Gs and Gi, causing cAMP to up- or down-regulation, mediating transmembrane signaling and participating in the regulation of cell proliferation, differentiation and migration. GPR126 is activated in a tethered-stalk peptide agonism or orthosteric agonism, which is mainly manifested by self-proteolysis or conformational changes in the GAIN domain, which mediates the rapid activation or closure of downstream pathways by tethered agonists. In addition to the tethered short stem peptide activation mode, GPR126 also has another allosteric agonism or tunable agonism mode, which is specifically expressed as the GAIN domain does not have self-shearing function in the physiological state, NTF and CTF always maintain the binding state, and the NTF binds to the ligand to cause conformational changes of the receptor, which somehow transmits signals to the GAIN domain in a spatial structure. The GAIN domain can cause the 7TM domain to produce an activated or inhibited signal for signal transduction, For example, type IV collagen interacts with the CUB and PTX domains of GPR126 to activate GPR126 downstream signal transduction. GPR126 has homology of 51.6%-86.9% among different species, with 10 conserved regions between different species, which can be traced back to the oldest metazoans as well as unicellular animals.In terms of diseases, GPR126 dysfunction involves the pathological process of bone, myelin, embryo and other related diseases, and is also closely related to the occurrence and development of malignant tumors such as breast cancer and colon cancer. However, the biological function of GPR126 in various diseases and its potential as a therapeutic target still needs further research. This paper focuses on the structure, interspecies differences and conservatism, signal transduction and biological functions of GPR126, which provides ideas and references for future research on GPR126.]]></description>
<pubDate>2024/9/20 21:58:15</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CAO Shu-Zhu,DENG Xing-Mei,JIA Si-Qi,SUN Zhi-Hua,TANG Guo-Chao,WU Ting-Ting,ZHANG Hui,ZHU De-Xin]]></author>
</item>
<item>
<title><![CDATA[Review: Research and Prospect for Nanoscale Resolution Microscopy]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202408130000002]]></link>
<description><![CDATA[Fluorescence microscopy is a vital tool in life science research, but the diffraction nature of light limits further observation of cells. Super-resolution imaging techniques provide deeper insights into cellular structures, including stimulated emission depletion microscopy (STED), structured illumination microscopy (SIM), and single-molecule localization microscopy (SMLM). Each of these methods offers unique advantages and principles that push the boundaries of spatial resolution beyond conventional diffraction limits. Among these techniques, SMLM stands out for its exceptional resolution, offering nanometer resolution and becoming a powerful tool for obtaining high-resolution images. SMLM is particularly valuable for studying the spatial distribution and interactions of organelles and macromolecular complexes. Following the award of the Nobel Prize in Chemistry in 2014, super-duper resolution imaging techniques were listed as one of <i>Nature</i>’s seven technologies to watch in 2024. The development of these techniques remains an important area of research. We introduce the development of multi-color SMLM, three-dimensional (3D) SMLM, and nanoscale resolution microscopes. We describe several methods to achieve multi-color SMLM. Sequential imaging and Exchange-PAINT require image targets in sequence, excitation or emission spectral demixing can obtain multi-color images simultaneously based on spectral difference between fluorescent dyes, dual-channel spectroscopic SMLM to achieve simultaneous imaging and spectral analysis of each molecule, and techniques based on binding kinetics of PAINT achieve multi-color by designing the blinking behavior of targets with engineered binding frequency and duration in DNA-PAINT. We then discuss various approaches for 3D imaging. Point spread function (PSF) engineering techniques manipulate the shape and properties of the PSF to improve 3D localization accuracy. Multi-plane imaging methods capture images from different focal planes and reconstruct them to obtain 3D information. Interferometry methods use single molecule interference to achieve high precision in axial localization, providing another way for high resolution 3D nanoscopy. Finally, we highlight advances in new nanoscale resolution microscopes based on modulated illumination patterns, including minimal photon fluxes (MINFLUX), repetitive optical selective exposure (ROSE), ROSE-Z, SIMFLUX, SIMPLE, and ModLoc. MINFLUX is known for its ability to achieve ultra-high resolution by detecting minimal photon fluxes from single molecules using a doughnut-shaped excitation spot to spatially modulate excitation intensities. Typically, we focus on ROSE and ROSE-Z, which outperform other techniques, using a resonant mirror to eliminate localization errors caused by fluorescence blinking. Recently, resolution enhancement by sequential imaging (RESI) and one nanometre expansion (ONE) was introduced to achieve resolution down to the ?ngstr?m scale. Nanoscopy serves as a new role between super resolution microscopy and structural biology and will lead to more discoveries in complex biological systems. Overall, this article provides a comprehensive overview of current advances in super-resolution imaging techniques, highlighting their contributions to overcoming the diffraction limit and enabling detailed observation of nanoscale biological structures, and provides an outlook on promising new techniques and applications. Through detailed descriptions of the principles, benefits, and applications of multi-color and 3D techniques, the article highlights new nanoscale imaging techniques that are expanding our ability to visualize and understand the intricate details of molecular and cellular processes. We hope that this article can be a primer resource for both newcomers and seasoned practitioners of SMLM.]]></description>
<pubDate>2024/9/20 21:40:38</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[GU Lu-Sheng,JI Wei,PAN Tian-Ying]]></author>
</item>
<item>
<title><![CDATA[Structure and Function of GPR126/ADGRG6]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406210000001]]></link>
<description><![CDATA[GPR126, also known as ADGRG6, is one of the most deeply studied aGPCRs. Initially, GPR126 was thought to be a receptor associated with muscle development and was primarily expressed in the muscular and skeletal systems. With the deepening of research, it was found that GPR126 is expressed in multiple mammalian tissues and organs, and is involved in many biological processes such as embryonic development, nervous system development, and extracellular matrix interactions. Compared with other aGPCRs proteins, GPR126 has a longer N-terminal domain, which can bind to ligands one-to-one and one-to-many. Its N-terminus contains five domains, a CUB (complement C1r/C1s, Uegf, Bmp1) domain, a PTX (Pentraxin) domain, a SEA (Sperm protein, Enterokinase, and Agrin) domain, a hormone binding (HormR) domain, and a conserved GAIN domain. The GAIN domain has a self-shearing function, which is essential for the maturation, stability, transport and function of aGPCRs. Different SEA domains constitute different GPR126 isomers, which can regulate the activation and closure of downstream signaling pathways through conformational changes. GPR126 has a typical aGPCRs seven-transmembrane helical structure, which can be coupled to Gs and Gi, causing cAMP to up- or down-regulation, mediating transmembrane signaling and participating in the regulation of cell proliferation, differentiation and migration. GPR126 is activated in a tethered-stalk peptide agonism or orthosteric agonism, which is mainly manifested by self-proteolysis or conformational changes in the GAIN domain, which mediates the rapid activation or closure of downstream pathways by tethered agonists. In addition to the tethered short stem peptide activation mode, GPR126 also has another allosteric agonism or tunable agonism mode, which is specifically expressed as the GAIN domain does not have self-shearing function in the physiological state, NTF and CTF always maintain the binding state, and the NTF binds to the ligand to cause conformational changes of the receptor, which somehow transmits signals to the GAIN domain in a spatial structure. The GAIN domain can cause the 7TM domain to produce an activated or inhibited signal for signal transduction, For example, type IV collagen interacts with the CUB and PTX domains of GPR126 to activate GPR126 downstream signal transduction. GPR126 has homology of 51.6%-86.9% among different species, with 10 conserved regions between different species, which can be traced back to the oldest metazoans as well as unicellular animals.In terms of diseases, GPR126 dysfunction involves the pathological process of bone, myelin, embryo and other related diseases, and is also closely related to the occurrence and development of malignant tumors such as breast cancer and colon cancer. However, the biological function of GPR126 in various diseases and its potential as a therapeutic target still needs further research. This paper focuses on the structure, interspecies differences and conservatism, signal transduction and biological functions of GPR126, which provides ideas and references for future research on GPR126.]]></description>
<pubDate>2024/9/20 15:44:37</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CAO Shu-Zhu,DENG Xing-Mei,JIA Si-Qi,SUN Zhi-Hua,TANG Guo-Chao,WU Ting-Ting,ZHANG Hui,ZHU De-Xin]]></author>
</item>
<item>
<title><![CDATA[Review: Advances of Volume Electron Microscopy]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407160000002]]></link>
<description><![CDATA[Volume electron microscopy (vEM) imaging technology was rapidly developed in recent years. It has been the advanced technology to solve high-resolution three-dimensional structures of biological samples. Much wonderful work has revealed the fine structure and interactions of intracellular organelles, the ultrastructure of tissues, and even the three-dimensional structure of entire small biological organisms. With the continuous improvement of resolution, scale and throughput, vEM is becoming more and more widely used in medicine, life sciences, clinical diagnostics and other fields. As a result, this technology has been rated by <i>Nature</i> as one of the seven most noteworthy frontier technologies to watch in 2023. However, the development and application of vEM-related technologies started late in China and need to be further promoted. We write this review to introduce all related vEM technologies, covering the development history of vEM, technology classification, sample preparation, data collection, image processing, <i>etc.</i>, which is convenient for people in various fields to understand, learn, apply and further develop this technology.]]></description>
<pubDate>2024/9/20 15:36:12</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[CHEN Lian-Wan,CHEN Xi,HAN Hua,LI Lin-Lin,LI Xi-Xia,SUN Fei,ZHANG Yan]]></author>
</item>
<item>
<title><![CDATA[Review: Wnt/β-catenin Signaling Cascades in Cardiovascular Diseases]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407020000002]]></link>
<description><![CDATA[Cardiovascular diseases are a group of disorders of the heart and blood vessels, primarily including coronary heart disease, stroke, and other diseases. It is the world’s leading cause of death, and its incidence is increasing yearly. Hypertension is a major risk factor for cardiovascular disease. Wnt signaling comprises a series of highly conservative cascading events controlling fundamental biological processes. Wnt signaling pathways include the canonical Wnt pathway (or Wnt/β-catenin pathway), the non-canonical planar cell-polarity pathway, and the non-canonical calcium-dependent pathways. Abnormal Wnt signaling promotes cell proliferation and differentiation, cardiac malformations, various malignancies, so drugs targeting Wnt signaling play a great therapeutic potential. Wnt/β-catenin pathway is involved in the occurrence and development of cardiovascular diseases such as atherosclerosis and stroke by regulating cell proliferation, migration, apoptosis, blood-brain barrier permeability, inflammation, oxidative stress, and immune response. Based on the latest research progress, this review summarizes the role of Wnt/β-catenin signaling in cardiovascular diseases, in order to provide new ideas for the prevention and treatment of cardiovascular diseases.]]></description>
<pubDate>2024/9/18 23:22:06</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[LIU Yan-Ping,QI Yan-Fei,XU Wen-Qing,YAN Xiao-Xue]]></author>
</item>
<item>
<title><![CDATA[Review: The Application of Lipid Nanoparticle-delivered mRNA in Disease Prevention and Treatment]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407120000003]]></link>
<description><![CDATA[In recent years, nucleic acid therapy, as a revolutionary therapeutic tool, has shown great potential in the treatment of genetic diseases, infectious diseases and cancer. Lipid nanoparticles (LNPs) are currently the most advanced mRNA delivery carriers, and their emergence is an important reason for the rapid approval and use of COVID-19 mRNA vaccines and the development of mRNA therapy. Currently, mRNA therapeutics using LNP as a carrier have been widely used in protein replacement therapy, vaccines and gene editing. Conventional LNP is composed of four components: ionizable lipids, phospholipids, cholesterol, and polyethylene glycol (PEG) lipids, which can effectively load mRNA to improve the stability of mRNA and promote the delivery of mRNA to the cytoplasm. However, in the face of the complexity and diversity of clinical diseases, the structure, properties and functions of existing LNPs are too homogeneous, and the lack of targeted delivery capability may result in the risk of off-targeting. LNPs are flexibly designed and structurally stable vectors, and the adjustment of the types or proportions of their components can give them additional functions without affecting the ability of LNPs to deliver mRNAs. For example, by replacing and optimizing the basic components of LNP, introducing a fifth component, and modifying its surface, LNP can be made to have more precise targeting ability to reduce the side effects caused by treatment, or be given additional functions to synergistically enhance the efficacy of mRNA therapy to respond to the clinical demand for nucleic acid therapy. It is also possible to further improve the efficiency of LNP delivery of mRNA through machine learning-assisted LNP iteration. This review can provide a reference method for the rational design of engineered lipid nanoparticles delivering mRNA to treat diseases.]]></description>
<pubDate>2024/9/16 11:06:13</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[HUANG Yuan-Yu,LI Lu-Wei,LIANG Xing-Jie,SUN Wei-Lun,WENG Yu-Hua,YANG Hai-Yin,ZHANG Jin-Chao,ZHOU Ti-Qiang]]></author>
</item>
<item>
<title><![CDATA[Review: Mitochondrial Regulation of Tumor-associated Macrophages]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406280000003]]></link>
<description><![CDATA[Tumor immune microenvironment is an important microecology for tumor development, where tumor-associated macrophages are the most abundant immune cells in the tumor immune microenvironment, with high plasticity and heterogeneity. Under the regulation of various environmental factors, tumor-associated macrophages can differentiate into different subgroups. Though complex and variable, all these environmental factors ultimately regulate tumor-associated macrophages by influencing the temporal and spatial heterogeneity of these cells’ internal components, structure, and functions. Mitochondrion are important organelles, responsible for energy production, metabolism, and centers of multiple signal transduction. More and more studies have found that mitochondria can regulate cell functions through various mechanisms such as morphological change, metabolic reprogramming, intermediate metabolites or mitochondrial genetic material. Mitochondrial disorders are involved in many diseases and pathological processes. Here, we review the mechanisms by which mitochondria regulate the polarization of macrophages and thus reshape the tumor immune microenvironment. Further, we discuss and prospect the current status of macrophage mitochondria-related tumor immunotherapy.]]></description>
<pubDate>2024/9/13 18:33:13</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[CAI Xiu-E,LI Jiang,SU Shi-Cheng]]></author>
</item>
<item>
<title><![CDATA[Science and Education: Application of Hexose Equal Division in The Teaching of Glycolysis]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202408130000001]]></link>
<description><![CDATA[Glycolysis is a fundamental topic in the biochemistry curriculum, pivotal for understanding glucose metabolism, and it stands as a challenging subject in various life science disciplines, including microbiology, marine biology, zoology, cell biology, and bioengineering. The process of glycolysis encompasses 10 successive reactions, involving numerous enzymes and intermediate metabolites, making it a complex pathway that both consumes and generates energy (ATP). Over the past decades, and continuing to the present, the standard pedagogical approach has been to explain glycolysis step by step, a method known as the sequential teaching method, which has not yielded optimal educational outcomes. In this paper, we introduce an innovative teaching strategy that frames the overall reaction of glycolysis as the division of one molecule (6C) of glucose into two molecules (3C) of pyruvate. To achieve the equal division of the hexose molecule, a phosphate group is added to both the head (C1) and tail (C6) of the hexose carbon chain, resulting in the formation of fructose 1,6-bisphosphate. A critical chemical bond breakage at the center of the molecule (C3-C4) then occurs, yielding two molecules of phosphorylated aldose. The subsequent five reactions involve a series of steps, including the transfer of phosphate groups, culminating in the production of pyruvate from phosphorylated aldose. This novel education approach, which begins with the concept of “equal division of the hexose carbon chain”, is termed the “hexose equal division” teaching method. Graduate (<i>n</i>=63) and undergraduate (<i>n</i>=39) students were enrolled in a teaching research study where glycolysis was taught using the “hexose equal division” method, followed by a questionnaire survey. The results showed that before receiving the “hexose equal division” teaching, students found it challenging to grasp and retain the steps of glycolysis, with the reactions being prone to be forgotten after memorization. However, after employing the “hexose equal division” teaching method, the majority of graduate students reported that glycolysis steps became more comprehensible and easier to recall compared to the “sequential teaching method” used during their undergraduate studies. This same approach was applied to undergraduate students, and a statistical analysis revealed no significant difference (<i>P</i>>0.05) in outcome between the two groups. Consequently, the “hexose equal division” teaching method has been shown to enhance students" understanding of the glycolysis mechanism, aid in memorization, and encourage independent thinking, thus leading to improved learning outcomes.]]></description>
<pubDate>2024/9/12 15:02:37</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[HE Rong-Qiao,ZHU Li]]></author>
</item>
<item>
<title><![CDATA[Review: Effects of 40 Hz Rhythmic Stimulation on Alzheimer’s Disease and Cognitive Function]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202408240000001]]></link>
<description><![CDATA[Alzheimer’s disease (AD), characterized by cognitive decline and neurodegeneration, currently relies on pharmacological treatments that are limited in efficacy and often accompanied by side effects. As the number of AD patients increases, so does the economic burden on both the global healthcare system and families of patients, further worsening the quality of life for patients in their later years. Therefore, it is crucial to find new and more effective therapeutic approaches. This necessity has sparked a growing interest in non-invasive therapies, such as 40 Hz rhythmic stimulation, which aims to modulate brain activity to potentially reverse pathological changes and alleviate symptoms. This review provides an overview of the effects of 40 Hz stimulation on AD pathology and symptoms, its impact on cognitive functions in healthy individuals, the underlying mechanisms of action, and strategies to enhance the treatment’s compliance and effectiveness. Research has demonstrated that 40 Hz rhythmic stimulation, particularly through auditory and visual modalities, can influence core AD pathologies. In mouse models of AD, this stimulation has been shown to reduce amyloid-beta protein (Aβ) plaques and phosphorylated tau protein levels, hallmarks of AD pathology. These effects are thought to stem from enhanced waste clearance mechanisms, facilitated by the stimulation of the glymphatic system and the activation of microglia. Clinical applications in AD patients have shown promising results, with improvements noted in cognitive functions and behavioral symptoms. These findings suggest that 40 Hz rhythmic stimulation could offer a non-pharmacological option to mitigate the pathological progression and symptomatic expression of AD. In healthy individuals, the cognitive outcomes of 40 Hz stimulation appear more variable. Some studies indicate potential enhancements in memory and attention, proposing that 40 Hz stimulation may bolster cognitive resilience and processing efficiency in a non-diseased brain. However, these effects are not consistently replicated across studies, indicating that individual differences and specific stimulation parameters may significantly influence outcomes. The beneficial effects of 40 Hz rhythmic stimulation are believed to be primarily due to neural entrainment, where neural circuits synchronize their activity to the external frequency. This entrainment may restore the balance between excitatory and inhibitory neural activity, which is often disrupted in AD mice and AD patients. By reinforcing natural brain rhythms, 40 Hz stimulation may enhance neural connectivity and function, facilitating cognitive and memory processes that are deteriorated in AD. Neural entrainment at 40 Hz has been demonstrated to aid in restoring neural network function, enhancing the glymphatic system, improving cerebral blood flow, and providing neuroprotection. These mechanisms are thought to work synergistically to regulate brain activity, potentially leading to a reduction in lesions and an improvement in cognitive performance. To optimize the therapeutic benefits of 40 Hz stimulation, several factors need to be considered. Treatment protocols should be tailored to individual needs, accounting for variability in disease progression and personal health status. Enhancing patient compliance involves simplifying treatment regimens and using portable, user-friendly devices that can be easily incorporated into daily routines. Ongoing research should focus on refining stimulation parameters and delivery methods to maximize efficacy and minimize potential side effects. In conclusion, while 40 Hz rhythmic stimulation represents a promising avenue for treating AD and enhancing cognitive functions, further research is required to fully elucidate its mechanisms, refine its application, and ensure its practicality and efficacy in broad clinical and everyday settings.]]></description>
<pubDate>2024/9/11 21:17:56</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[HE Sheng,SHI Li-Nan,ZHAO Na]]></author>
</item>
<item>
<title><![CDATA[Reivew: Frontiers in <i>in situ</i> Cryo-electron Microscopy and Visual Proteomics]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407170000003]]></link>
<description><![CDATA[In recent years, with the continuous development of <i>in situ</i> cryo-electron microscopy (cryo-EM) and artificial intelligence (AI) technologies, the research of structural biology has undergone a paradigm shift. Structural analysis is no longer confined to isolated and purified biomolecules, and determination of high-resolution <i>in situ</i> structures directly within cells and tissues becomes feasible. Furthermore, structural analysis of the molecular landscapes of subcellular regions can be performed to gain a deeper understanding of the molecular mechanisms of living activities in the native functional context. Through determining <i>in situ</i> structures of various protein complexes within the cell, it is feasible to visualize the proteome with spatial and quantitative information, which is often referred to as visual proteomics. Emerging <i>in situ</i> structural methods represented by cryo-electron tomography (cryo-ET) hold the promise to elucidate the three-dimensional interaction networks of the intracellular proteome and understand their activities in a systematic manner. To advance <i>in situ</i> cryo-EM/ET and visual proteomics in China, this review summarizes the new research paradigms and technological advances, showcases the superiority of new concepts and technologies with representative examples, and discusses the future prospects in the field.]]></description>
<pubDate>2024/9/10 15:51:17</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[LI Kuan-Ying,SUN Fei,WANG Wen-Xue,XUE Liang,ZHU Yun]]></author>
</item>
<item>
<title><![CDATA[Review: Cancer Stem Cells and Immune Microenvironment Regulation]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406070000001]]></link>
<description><![CDATA[Cancer stem cells (CSCs), a small subset of cells in the tumor bulk with the ability of self-renewal and differentiation, are the key to tumor occurrence, metastasis, drug resistance and relapse. CSCs are resided in a specific microenvironment, and their number maintenance, self-renewal and differentiation are precisely regulated by the microenvironment, and the immune microenvironment is one of the most critical microenvironments for CSCs. In recent years, tumor immunotherapy has achieved great success, but drug resistance and recurrence are frequently occurred after immunotherapy. Compared with non-CSC tumor cells, CSCs harbor stronger immune escape ability, and their roles in tumor immune escape are increasingly followed. In this review, we described the discovery history and lineage sources of CSCs, focused on immune cells in the CSC microenvironment, such as tumor-infiltrating lymphocytes, tumor-associated macrophages, and tumor-associated dendritic cells, and analyzed the mechanism of CSC-immune cell interaction. Intervention strategies targeting CSCs and their immune microenvironment are also described. With the development and application of advanced technologies such as CSC-immune cell co-culture, single-cell sequencing and lineage tracing, the immune escape of CSCs can be suppressed by targeting the interaction between CSCs and immune cells or reversing the immunosuppressive microenvironment, which is expected to provide potential solutions to the problems of drug resistance and relapse in tumor immunotherapy.]]></description>
<pubDate>2024/9/10 15:44:40</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[FAN Zu-Sen,JIN Shui-Ling,ZHAO Qi,ZHU Ping-Ping]]></author>
</item>
<item>
<title><![CDATA[The Role of KLF15 in Metabolic Regulation]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202403150000004]]></link>
<description><![CDATA[With changes in human lifestyle, chronic diseases caused by metabolic disorders, such as obesity, type 2 diabetes, and non-alcoholic fatty liver disease, have become serious public health issues threatening human health. These diseases not only significantly increase the disease burden on humans but also put immense pressure on global healthcare systems. Therefore, understanding and exploring the molecular mechanisms leading to these diseases, especially the role of metabolic regulators, is crucial for developing effective prevention and treatment strategies. KLF15, one of the highly conserved members of the KLF family, has gained widespread attention due to its expression and regulatory roles in various metabolically active organs. Recent studies have shown that KLF15 regulates glucose, lipid, and amino acid metabolism in adipose tissue, skeletal muscle, and liver, and is closely related to the acquisition, transport, and utilization of nutrients. The role of KLF15 in glucose metabolism is primarily reflected in its regulation of gluconeogenesis and glucose uptake. KLF15 influences blood glucose levels by regulating the expression of key gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PEPCK). Research has shown that KLF15 knockout (KO) mice exhibit severe hypoglycemia and reduced liver glycogen content after 18 h of fasting. Additionally, KLF15 interacts with muscle enhancer factor 2 (MEF2A) to activate the GLUT4 promoter, significantly enhancing glucose uptake in skeletal muscle and adipose tissue. In insulin-resistant individuals, KLF15 expression is reduced, affecting insulin sensitivity by regulating genes related to lipid metabolism and mitochondrial function. In terms of lipid metabolism, KLF15 expression significantly increases during adipocyte differentiation, regulating the expression of genes such as <i>C/EBPβ</i>, <i>C/EBPδ</i>, and <i>PPARγ</i>. KLF15 KO mice show reduced lipogenesis and increased lipolysis, highlighting its importance in fat storage and energy balance. In brown adipose tissue (BAT), KLF15 regulates genes involved in lipid uptake and thermogenesis, such as <i>CD36</i>,<i> Slc25a20</i>, and <i>Cpt1a</i>. KLF15 KO mice fail to maintain body temperature during fasting-induced cold exposure, demonstrating the critical role of KLF15 in BAT metabolism and energy balance. Specifically, KLF15 forms positive feedback loops with adipogenic transcription factors such as glucocorticoid receptor (GR), PPARγ, and C/EBP, promoting adipocyte differentiation and maturation. In BAT, KLF15 is crucial not only for regulating lipid uptake but also for promoting non-shivering thermogenesis by regulating thermogenic genes, thereby helping to maintain body temperature in cold environments. In protein metabolism, KLF15 regulates key enzymes involved in branched chain amino acid (BCAA) metabolism, such as BCAT2 and ALT, which are essential for gluconeogenesis and maintaining blood glucose levels. KLF15 KO mice show reduced expression of these enzymes, leading to impaired amino acid catabolism. KLF15 regulates muscle protein synthesis and degradation through the mTOR pathway and E3 ubiquitin ligases (<i>e.g</i>., Atrogin-1 and MuRF1), indicating its significance in muscle protein metabolism and stress response, especially in glucocorticoid-induced muscle atrophy. Studies have shown that KLF15 expression in muscle tissue is regulated by GR. Glucocorticoids regulate KLF15 expression through GR, which in turn affects the mTOR signaling pathway, inhibiting protein synthesis and promoting protein degradation. This mechanism is particularly significant in glucocorticoid-induced muscle atrophy. KLF15 also responds significantly to exercise, particularly acute endurance exercise and long-term aerobic training. Acute endurance exercise increases KLF15 expression in muscle and adipose tissue, enhancing lipid synthesis and protein catabolism. In contrast, chronic exercise reduces KLF15 expression, improving insulin sensitivity and mitigating diabetes-induced myopathy. However, further research is needed to explore the effects of different forms of exercise on KLF15 and its specific roles in various tissues. In conclusion, KLF15 plays a crucial role in maintaining overall metabolic balance. It regulates glucose, lipid, amino acid, and protein metabolism, responding to nutritional status and exercise to maintain energy homeostasis. The role of KLF15 in glucose metabolism involves regulating gluconeogenesis and glucose uptake, in lipid metabolism through regulating fat synthesis and breakdown, and in protein metabolism through influencing branched-chain amino acid metabolism and muscle protein synthesis and degradation. Future research should continue to delve into the specific mechanisms of KLF15 in different metabolic pathways, especially its regulatory roles under various exercise forms and nutritional states, to provide new perspectives and theoretical foundations for treating metabolic diseases.]]></description>
<pubDate>2024/9/10 14:31:21</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHANG Bo,DUAN Zi-Qiang,LI Meng-Huan,WAN Gen-Meng,YANG Yang,YI Xue-Jie]]></author>
</item>
<item>
<title><![CDATA[Review: Nanodrug Delivery System: a Promising Targeting Strategy for Treatment of Pancreatic Ductal Adenocarcinoma]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407090000001]]></link>
<description><![CDATA[Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant solid tumor of the digestive system, characterized by rapid progression and difficulties of early diagnosis. Five-year survival rate of the patients is less than 9%. With the acceleration of global population aging and lifestyle change, the incidence of PDAC has been increasing annually. Currently, surgical treatment and chemotherapy remain the standard treatment options for PDAC patients. Early symptoms of PDAC are so undetectable that most patients miss the optimal opportunity for radical surgical resection. Even among those who undergo surgery, the high recurrence rate remains a major problem. PDAC is known for its unique tumor microenvironment. The cellular and non-cellular components in the tumor microenvironment account for as much as 90% of the tumor stroma, presenting many potential targets for PDAC therapy. Activated pancreatic stellate cells within PDAC tissue express specific proteins and secrete various cytokines and metabolites, which directly contribute to the proliferation, invasion, and metastasis of PDAC cells. These elements are critical in extracellular matrix production, connective tissue hyperplasia, immune tolerance, and drug resistance. Immune cells, such as macrophages and neutrophils, exert immunosuppressive and tumor-promoting roles in PDAC progression. The extracellular matrix, which serve as a natural physical barrier, induces interstitial hypertension and reduces blood supply, thereby hindering the delivery of drugs to the tumor. Additionally, it helps the metastasis and differentiation of PDAC cells, reducing the efficacy of clinical chemotherapy and immunotherapy. Although chemotherapeutic agents like gemcitabine have been used in the clinical treatment of PDAC for more than 20 years, the curative effect is obstructed by their poor stability in the bloodstream, low cellular uptake, and poor targeting. While small-molecule inhibitors targeting mutations such as <i>KRAS</i><sup>G12C</sup>, <i>BRCA</i>, and <i>NTRK</i> fusion have shown great potential for molecular targeted treatments and gene therapies of PDAC, their broader application is limited by side effects and restricted scope of patients. The advancement of nanotechnology brings new strategies for PDAC treatment. By virtue of unique size characteristics and actual versatility, different drug-delivery nanosystems contribute to overcome the dense stromal barrier, prolong the circulation time of therapeutics and realize precise PDAC treatment by targeted drug delivery. Clinical nanodrugs such as albumin-bound paclitaxel (nab-paclitaxel) and irinotecan liposome greatly improve the pharmacokinetics of conventional chemotherapeutics and promote drug accumulation inside the tumor, thereby are applying to the first-line treatment of PDAC. It is noteworthy that none nanodrugs with active targeting design have been approved for clinical treatment yet, though many are in clinical trials. In this review, we discuss promising targeting strategies based on different nanodrug delivery systems for treatment of PDAC. One major nanostrategy focuses on the tumor cell targeting and its applications in chemotherapy, molecular targeting therapy, gene therapy, and immunotherapy of PDAC. Another nanostrategy targets the tumor microenvironment, which highlights the nanosystems specifically regulating pancreatic stellate cells, immune cells and the extracellular matrix. Recent progress of developing new nanotheraputics for breakthrough in the fight of PDAC are elaborated in this review. We also provide our perspectives on the challenges and opportunities in the field.]]></description>
<pubDate>2024/9/10 12:37:44</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[LI Yi-Ye,NIE Guang-Jun,WANG Zhi-Qin,ZHANG Ji-Miao]]></author>
</item>
<item>
<title><![CDATA[Review: Adenine Base Editor and Its Clinical Application]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407260000002]]></link>
<description><![CDATA[The mutations in human disease-causing genes are predominantly caused by point mutations, with more than half of them being transitions between guanine (G) and adenine (A). Precise and efficient in situ repair of these mutations is the most ideal approach for the treatment of genetic diseases. Given that most point mutations are transitions between G and A, adenine base editors (ABEs) based on the CRISPR/Cas9 system, which convert A to G, are particularly important for repairing these mutations in the treatment of human genetic diseases. In recent years, ABEs have been continuously optimized, with both activity and fidelity being improved. Here we summarize the progress of ABEs, especially those key mutants developed during the process of ABE optimization. It also reflects on the existing defects in current ABEs. Additionally, the article reviews the clinical applications (including preclinical studies) of ABE. Overall, the article aims to provide references for the discovery and optimization of new ABEs and their applications.]]></description>
<pubDate>2024/9/10 12:35:10</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[CHEN Lei,GU Feng,WANG Hui-Ling]]></author>
</item>
<item>
<title><![CDATA[Application of Recombinant Collagen in Biomedicine]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202405290000001]]></link>
<description><![CDATA[Collagen is a major structural protein in the matrix of animal cells and the most widely distributed and abundant functional protein in mammals. Collagen’s good biocompatibility, biodegradability and biological activity make it a very valuable biomaterial. According to the source of collagen, it can be broadly categorized into two types: one is animal collagen; the other is recombinant collagen. Animal collagen is mainly extracted and purified from animal connective tissues by chemical methods, such as acid, alkali and enzyme methods, <i>etc</i>. Recombinant collagen refers to collagen produced by gene splicing technology, where the amino acid sequence is first designed and improved according to one’s own needs, and the gene sequence of improved recombinant collagen is highly consistent with that of human beings, and then the designed gene sequence is cloned into the appropriate vector, and then transferred to the appropriate expression vector. The designed gene sequence is cloned into a suitable vector, and then transferred to a suitable expression system for full expression, and finally the target protein is obtained by extraction and purification technology. Recombinant collagen has excellent histocompatibility and water solubility, can be directly absorbed by the human body and participate in the construction of collagen, remodeling of the extracellular matrix, cell growth, wound healing and site filling, <i>etc</i>., which has demonstrated significant effects, and has become the focus of the development of modern biomedical materials. This paper firstly elaborates the structure, type, and tissue distribution of human collagen, as well as the associated genetic diseases of different types of collagen, then introduces the specific process of producing animal source collagen and recombinant collagen, explains the advantages of recombinant collagen production method, and then introduces the various systems of expressing recombinant collagen, as well as their advantages and disadvantages, and finally briefly introduces the application of animal collagen, focusing on the use of animal collagen in the development of biopharmaceutical materials. In terms of application, it focuses on the use of animal disease models exploring the application effects of recombinant collagen in wound hemostasis, wound repair, corneal therapy, female pelvic floor dysfunction (FPFD), vaginal atrophy (VA) and vaginal dryness, thin endometritis (TE), chronic endometritis (CE), bone tissue regeneration <i>in vivo</i>, cardiovascular diseases, breast cancer (BC) and anti-aging. The mechanism of action of recombinant collagen in the treatment of FPFD and CE was introduced, and the clinical application and curative effect of recombinant collagen in skin burn, skin wound, dermatitis, acne and menopausal urogenital syndrome (GSM) were summarized. From the exploratory studies and clinical applications, it is evident that recombinant collagen has demonstrated surprising effects in the treatment of all types of diseases, such as reducing inflammation, promoting cell proliferation, migration and adhesion, increasing collagen deposition, and remodeling the extracellular matrix. At the end of the review, the challenges faced by recombinant collagen are summarized: to develop new recombinant collagen types and dosage forms, to explore the mechanism of action of recombinant collagen, and to provide an outlook for the future development and application of recombinant collagen.]]></description>
<pubDate>2024/9/10 12:29:44</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHENG Ning-Wen,HU Huan,LI Yun-Lan,LIU Qian,WANG Jian,WANG Li-Wen,ZHANG Hong,ZHANG Xin-Yue]]></author>
</item>
<item>
<title><![CDATA[Cytotoxicity Studies of Light-oxygen-voltage (LOV) Domain Photosensitizers]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202404280000001]]></link>
<description><![CDATA[<b>Objective</b> At present, the most commonly used photosensitizers in photodynamic therapy are still chemical photosensitizers, such as porphyrin and methylene blue, in order to specifically target cellular tissues, and thus poison cells, chemical photosensitizers need to use antibody conjugation or a transgenically encoded tag with affinity for the modified photosensitizing ligand, <i>e.g</i>. FlAsH, ReAsh or Halo Tag. Gene-encoded photosensitizers can directly poison cells by targeting specific cell compartments or organelles. However, currently developed gene-encoded photosensitizers have low reactive oxygen species production and low cytotoxicity, so it is necessary to continue to develop and obtain photosensitizers with higher reactive oxygen species production for the treatment of microbial infections and tumors.<b>Methods</b> In this study, we developed a photosensitizer LovPSO2 based on the light-oxygen-voltage (LOV) structural domain of phototropin-1B-like from <i>Oryza sativa</i> <i>japonica</i>. LovPSO2 was expressed in <i>E. coli</i> BL21(DE3) and purified to obtain protein samples, the purified protein samples were added 3 μmol/L singlet oxygen probe of SOSG and 5 μmol/L superoxide anion probe of DHE after fixed to <i>A</i><sub>445</sub>=0.063±0.003, respectively, then measured every 2 min of singlet oxygen production for 10 min and every 1 min of superoxide anion production for 5 min under blue light irradiation at 445 nm, 70 μmol·m<sup>-2</sup>·s<sup>-1</sup>.<b>Results</b> The results showed that LovPSO2 could produce a large amount of singlet oxygen under blue light irradiation at 445 nm, 70 μmol·m<sup>-2</sup>·s<sup>-1</sup>, and its singlet oxygen quantum yield was 0.61, but its superoxide anion yield was low, so in order to improve the superoxide anion yield of LovPSO2, a mutant with a relatively high superoxide anion yield was obtained by further development and design on its basis LovPRO2. The stability of proteins is crucial for research in drug development and drug delivery, among others. Temperature and light are the key factors affecting the production of reactive oxygen species (ROS) by photosensitive proteins and their stability, while the temperature in cell culture and mammals <i>in vivo</i> is about 37°C, and the temperature inside tumor cells is about 42-45°C. Therefore, we further analyzed the photostability of miniSOG, SOPP3, LovPSO2, and LovPRO2 and their thermostability at 37℃ and 45℃. The analysis of proteins thermostability showed that LovPSO2 and LovPRO2 had better thermostability at 37℃ and 45℃, respectively. Analysis of the photostability of the proteins showed that LovPRO2 had better photostability. In addition, to further determine the phototoxic effects of photosensitizers, LovPSO2 and LovPRO2 were expressed in <i>E. coli</i> BL21(DE3) and HeLa cells, respectively. The results showed that LovPSO2 and LovPRO2 had better phototoxicity to <i>E. coli</i> BL21(DE3) under blue light irradiation, and the cellular phototoxicity lethality was as high as 90% after 30 min of continuous light irradiation, but the phototoxicity was weaker in HeLa cells. The reason for this result may be that the intracellular environment exacerbated the photobleaching of FMN encapsulated by LovPSO2 and LovPRO2, respectively, which attenuated the damage of reactive oxygen species to animal cellular tissues, limiting its use as a mechanistic tool to study oxidative stress.<b>Conclusion</b> LovPSO2 and LovPRO2 can be used as antibacterial photosensitizers, which have broader application prospects in the food and medical fields.]]></description>
<pubDate>2024/9/10 12:24:36</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[SHA Na,WAN Ben,XU Shuang,ZHAO Kai-Hong]]></author>
</item>
<item>
<title><![CDATA[The Role and Mechanism of Lactate Produced by Exercise in The Nervous System]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202401060000001]]></link>
<description><![CDATA[Lactate, with a chemical formula of C<sub>3</sub>H<sub>6</sub>O<sub>3</sub>, is an intermediate product of glucose metabolism in the body and a raw material for hepatic gluconeogenesis. Under physiological resting conditions, the body mainly relies on aerobic oxidation of sugar and fat for energy supply, so the blood lactate concentration is lower. However, during exercise, the enhanced glycolysis in skeletal muscles leads to the significant release of lactate into the bloodstream, causing a marked increase in blood lactate concentration. Traditionally, lactate has been regarded as a metabolic waste product of glycolysis and a contributor to exercise-induced fatigue. Nevertheless, recent studies have revealed that, in humans, lactate is a major vehicle for carbohydrate carbon distribution and metabolism, serving not only as an energy substance alongside glucose but also as a vital component in various biological pathways involved in cardiac energetics, muscle adaptation, brain function, growth and development, and inflammation therapy. Two primary pathways can elevate lactate levels in neurons during exercise. One is peripheral skeletal muscle-derived lactate, which can enter the bloodstream and cross the blood-brain barrier into the brain with the assistance of monocarboxylate transporters (MCTs) from the solute carrier family 16 (SLC16). The other is the central brain-derived pathway. During exercise, neuronal activity is enhanced, promoting the secretion of neuroactive substances such as glutamate, norepinephrine, and serotonin in the brain. This activates astrocytes to break down glycogen into lactate and stimulates glutamate from the presynaptic terminal into the synaptic cleft. It upregulates the glucose transport protein-1 (GLUT-1) expression, allowing astrocytes to convert glucose into lactate through glycolysis. The lactate is produced <i>via</i> peripheral pathways and central pathways during exercise are transported by astrocyte membrane monocarboxylate transporters MCT1 and MCT4 to the extracellular space, where neurons take it up through neuronal cell membrane MCT2. The lactate in neurons can serve as an alternative energy source of glucose for neuronal functional activities, meeting the increased energy demands of synaptic activity during exercise, and maintaining energy balance and normal physiological function in the brain. Additionally, acting as a signaling molecule lactate can enhance synaptic plasticity through the SIRT1/PGC-1α/FNDC5 and ERK1/2 signaling pathways, lactate can promote angiogenesis by upregulating VEGF-A expression through the PI3K/Akt and ERK1/2 signaling pathways, stimulate neurogenesis <i>via</i> the Akt/PKB signaling pathway, and reduce neuroinflammation through activation of the “lactate timer”. Overall, lactate contributes to the protection of neurons, the promotion of learning and memory, the enhancement of synaptic plasticity, and the reduction of neuroinflammation in the nervous system. While lactate may serve as a potential mediator for information exchange between the peripheral and central nervous systems during exercise, further experimental research is needed to elucidate its action mechanisms in the nervous system. In addition, future studies should utilize advanced neurophysiological and molecular biology techniques to uncover the importance of lactate in maintaining brain function and preventing neurological diseases. Accordingly, this article first reviews the historical research on lactate, then summarizes the metabolic characteristics and neuronal sources of lactate, and finally explores the role and mechanisms of exercise-induced lactate in the nervous system, aiming to provide new perspectives and targets for understanding the mechanisms underlying exercise promotion of brain health.]]></description>
<pubDate>2024/9/5 16:42:24</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[BO Shu-Min,CHENG Yang,MA Jing]]></author>
</item>
<item>
<title><![CDATA[The Ameliorate Effect of Piezo1 Signaling Pathway on Diabetes Mellitus Type 2 in Exercise Intervention]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202405160000001]]></link>
<description><![CDATA[Diabetes mellitus type 2 (T2DM) is one of the most common metabolic diseases in the world and has a significant impact on the health of patients. As a key factor in cellular mechanical transduction, Piezo1 protein plays a crucial role in regulating the basic life activities of the body. By participating in energy metabolism, it not only promotes the improvement of basic metabolic rate, but also helps to maintain the stability of the internal environment of the body. The activation of Piezo1 pathway has a significant effect on the release of insulin by islet beta cells, and also plays an important role in the production of adipose tissue after food intake. This study reviews the effects of exercise intervention on the expression and function of Piezo1 protein, as well as its role in metabolic regulation and insulin level regulation in T2DM patients. The study showed that a modest exercise intervention activated Piezo1 signaling pathway, which improved insulin sensitivity and improved sugar metabolism. In addition, the activation of Piezo1 pathway is closely related to the metabolic regulation of adipose tissue, helping to regulate the differentiation and maturation of adipose cells, thereby affecting the metabolic function of adipose tissue. Based on a comprehensive analysis of existing literature, Piezo1 pathway is found to play a complex role in the pathogenesis of T2DM. Exercise intervention, as a non-drug therapy, provides a new strategy for the treatment of T2DM by activating Piezo1 signaling pathway. However, the exact mechanism of action of Piezo1 pathway in T2DM still needs further investigation. Future studies should focus on the interaction between the Piezo1 pathway and T2DM, and how to regulate the Piezo1 pathway to optimize treatment for T2DM. The effects of exercise intervention on Piezo1 protein and its role in metabolic regulation and insulin level regulation of T2DM patients were comprehensively analyzed in this paper, aiming to provide a new perspective for further research and development of therapeutic strategies for metabolic diseases such as diabetes and obesity.]]></description>
<pubDate>2024/9/5 16:40:16</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DONG Zi-Xuan,MA Zhan-Ke]]></author>
</item>
<item>
<title><![CDATA[Exercise Ameliorates Chronic Restraint Stress-induced Anxiety <i>via</i> PVN CRH Neurons]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406030000001]]></link>
<description><![CDATA[<b>Objective</b> To investigate the role of paraventricular nucleus (PVN) corticotropin releasing hormone (CRH) neurons in chronic restraint stress (CRS)-induced anxiety-like behavior. And whether exercise relieves chronic restraint stress-induced anxiety through PVN CRH neurons.<b>Methods</b> Twenty 8-week-old male C57BL/6J mice were randomly divided into control (Ctrl) group and chronic restraint stress (CRS) group. The open field test (OFT) and elevated plus maze (EPM) were used to evaluate anxiety-like behavior of the mice. Food intake was recorded after CRS. Immunofluorescence staining was used to label the expression of c-Fos expression in PVN and calculate the co-expression of c-Fos and CRH neurons. We used chemogenetic activation of PVN CRH neurons to observed the anxiety-like behavior. 8-week treadmill training (10-16 m/min, 60 min/d, 6 d/week) were used to explore the role of exercise in ameliorating CRS-induced anxiety behavior and how PVN CRH neurons involved in it.<b>Results</b> Compared with Ctrl group, CRS group exhibited significant anxiety-like behavior. In OFT, the mice in CRS groups spent less time in center area (<i>P</i><0.001). In EPM, the time in open arm in CRS group were significantly decreased (<i>P</i><0.001). Besides, food intake was also suppressed in CRS group compared with Ctrl group (<i>P</i><0.05). Compared with Ctrl group, CRS significantly increase c-Fos expression in PVN and most of CRH neurons co-express c-Fos (<i>P</i><0.001). Chemogenetic activation of PVN CRH neurons induced anxiety-like behavior (<i>P</i><0.05) and inhibited feeding behavior (<i>P</i><0.01). Exercise relieves chronic restraint stress-induced anxiety (<i>P</i><0.001) and relieved the anorexia caused by chronic restraint stress (<i>P</i><0.05). Aerobic exercise inhibited the CRS labeled c-Fos in PVN CRH neurons (<i>P</i><0.001). Furthermore, ablation of PVN CRH neurons attenuated CRS induced anxiety-like behavior.<b>Conclusion</b> CRS activated PVN CRH neurons, induced anxiety-like behavior and reduced food intake. 8-week exercise attenuated CRS-induced anxiety-like behavior through inhibiting PVN CRH neuron. Ablation of CRH PVN neurons ameliorated CRS-induced anxiety-like behavior. These finding reveals a potential neural mechanism of exercise-relieving CRS-induced anxiety-like behavior. This provides a new idea and theoretical basis for the treatment of anxiety and related mental disorders.]]></description>
<pubDate>2024/9/5 16:38:29</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CHEN Cong-Cong,CHEN Jing,LAI Yu-Lin,ZHANG Kai-Na,ZOU Yang]]></author>
</item>
<item>
<title><![CDATA[The Role and Mechanism of Lactate Produced by Exercise in The Nervous System]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202401060000001]]></link>
<description><![CDATA[Lactate, with a chemical formula of C<sub>3</sub>H<sub>6</sub>O<sub>3</sub>, is an intermediate product of glucose metabolism in the body and a raw material for hepatic gluconeogenesis. Under physiological resting conditions, the body mainly relies on aerobic oxidation of sugar and fat for energy supply, so the blood lactate concentration is lower. However, during exercise, the enhanced glycolysis in skeletal muscles leads to the significant release of lactate into the bloodstream, causing a marked increase in blood lactate concentration. Traditionally, lactate has been regarded as a metabolic waste product of glycolysis and a contributor to exercise-induced fatigue. Nevertheless, recent studies have revealed that, in humans, lactate is a major vehicle for carbohydrate carbon distribution and metabolism, serving not only as an energy substance alongside glucose but also as a vital component in various biological pathways involved in cardiac energetics, muscle adaptation, brain function, growth and development, and inflammation therapy. Two primary pathways can elevate lactate levels in neurons during exercise. One is peripheral skeletal muscle-derived lactate, which can enter the bloodstream and cross the blood-brain barrier into the brain with the assistance of monocarboxylate transporters (MCTs) from the solute carrier family 16 (SLC16). The other is the central brain-derived pathway. During exercise, neuronal activity is enhanced, promoting the secretion of neuroactive substances such as glutamate, norepinephrine, and serotonin in the brain. This activates astrocytes to break down glycogen into lactate and stimulates glutamate from the presynaptic terminal into the synaptic cleft. It upregulates the glucose transport protein-1 (GLUT-1) expression, allowing astrocytes to convert glucose into lactate through glycolysis. The lactate is produced <i>via</i> peripheral pathways and central pathways during exercise are transported by astrocyte membrane monocarboxylate transporters MCT1 and MCT4 to the extracellular space, where neurons take it up through neuronal cell membrane MCT2. The lactate in neurons can serve as an alternative energy source of glucose for neuronal functional activities, meeting the increased energy demands of synaptic activity during exercise, and maintaining energy balance and normal physiological function in the brain. Additionally, acting as a signaling molecule lactate can enhance synaptic plasticity through the SIRT1/PGC-1α/FNDC5 and ERK1/2 signaling pathways, lactate can promote angiogenesis by upregulating VEGF-A expression through the PI3K/Akt and ERK1/2 signaling pathways, stimulate neurogenesis <i>via</i> the Akt/PKB signaling pathway, and reduce neuroinflammation through activation of the “lactate timer”. Overall, lactate contributes to the protection of neurons, the promotion of learning and memory, the enhancement of synaptic plasticity, and the reduction of neuroinflammation in the nervous system. While lactate may serve as a potential mediator for information exchange between the peripheral and central nervous systems during exercise, further experimental research is needed to elucidate its action mechanisms in the nervous system. In addition, future studies should utilize advanced neurophysiological and molecular biology techniques to uncover the importance of lactate in maintaining brain function and preventing neurological diseases. Accordingly, this article first reviews the historical research on lactate, then summarizes the metabolic characteristics and neuronal sources of lactate, and finally explores the role and mechanisms of exercise-induced lactate in the nervous system, aiming to provide new perspectives and targets for understanding the mechanisms underlying exercise promotion of brain health.]]></description>
<pubDate>2024/9/5 15:12:48</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[BO Shu-Min,CHENG Yang,MA Jing]]></author>
</item>
<item>
<title><![CDATA[Synergistic Effect and Mechanism of FUT8 Inhibitor 2FF With DOX for Cancer Treatment]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406300000003]]></link>
<description><![CDATA[<b>Objective</b> Chemotherapy is one of the important therapeutic approaches for cancer treatment. However, the emergence of multidrug resistance and side effects significantly limit its application. To address these challenges, chemotherapy is often combined with other drugs or therapies. Among the 13 human fucosyltransferases (FUTs) identified, FUT8 (alpha-(1,6)-fucosyltransferase) is the only enzyme responsible for core fucosylation. Core fucosylation plays an important role in cancer occurrence, metastasis and chemotherapy resistance, making the suppression of FUT8 a potential strategy for reversing multidrug resistance. This study aims to evaluate the feasibility of combining the small molecule FUT8 inhibitor 2FF (2-deoxy-2-fluoro-L-fucose) with the clinical chemotherapeutic drug doxorubicin (DOX) for treating malignant tumors.<b>Methods</b> The human hepatocellular carcinoma cell line HepG2 and mouse colon cancer cell line CT26 cells were treated with 2FF, DOX or their combination and core fucosylation levels were assessed using Lectin Blot. HepG2 and CT26 cells were exposed to 50 μmol/L 2FF for 72 h, followed by treatment with a gradient concentration of DOX for 24 h. Cell viability and <i>IC</i><sub>50</sub> values were determined <i>via</i> the CCK-8 assay. Transwell invasion assays were conducted to evaluate the combited effect of 2FF and DOX on the invasion ability of HepG2 cells. Flow cytometry was performed to analyze the impact of 2FF, DOX and their combination on membrane PD-L1 expression of HepG2 cells. To assess the <i>in vivo</i> effect, 6 to 8 week old female BALB/c mice (20-25 g), were subcutaneously injected with 1×10<sup>6</sup> CT26 cells into the right axilla (four groups, six mice in each group). After the average tumor volume reached 100 mm<sup>3</sup>, mice were treated with DOX, 2FF, their combination, or saline (mock group) every other day. DOX was administanted intraperitoneally (2 mg/kg), 2FF intravenously (5 mg/kg), and the combination group, received the both treatment. Tumor size was measured every other day using a vernier caliper.<b>Results</b> This study demonstrated that DOX upregulates the core fucosylation level in HepG2 and CT26 cells,while 2FF effectively inhibits this DOX-induced effect. Furthermone, 2FF enhanced the sensitivity of HepG2 and CT26 cells to DOX. The combination of 2FF and DOX synergistically inhibited the invasion ability of HepG2 cells, and enhanced the anti-tumor efficacy of CT26 subcutaneous tumor model in BALB/c mice. However the combination thertment led to weight loss in mice. In addition, DOX increased the cell surface PD-L1 expression in HepG2 cells, which was effectively suppressed by 2FF.<b>Conclusion</b> The FUT8 inhibitor 2FF effectively suppresses DOX-induced upregulation of core fucosylation and PD-L1 levels in tumor cells, and 2FF synergistically enhances the anticancer efficacy of DOX.]]></description>
<pubDate>2024/9/4 16:03:12</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[XIE Zhi-Dong,ZHANG Xiao-Lian]]></author>
</item>
<item>
<title><![CDATA[Application of CRISPR/Cas System in Precision Medicine for Triple-negative Breast Cancer]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202404070000003]]></link>
<description><![CDATA[Triple-negative breast cancer (TNBC) represents a distinctive subtype, characterized by the absence of estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2 (HER2). Due to its high inter-tumor and intra-tumor heterogeneity, TNBC poses significant chanllenges for personalized diagnosis and treatment. The advant of clustered regular interspaced short palindromic repeats (CRISPR) technology has profoundly enhanced our understanding of the structure and function of the TNBC genome, providing a powerfal tool for investigating the occurrence and development of diseases. This review focuses on the application of CRISPR/Cas technology in the personalized diagnosis and treatment of TNBC. We begin by discussing the unique attributes of TNBC and the limitations of current diagnostic and treatment approaches: conventional diagnostic methods provide limited insights into TNBC, while traditional chemotherapy drugs are aften associated with low efficacy and severe side effects. The CRISPR/Cas system, which activates Cas enzymes through complementary guide RNAs (gRNAs) to selectively degrad specific nucleic acids, has emerged as a robust tool for TNBC research. This technology enables precise gene editing, allowing for a deepor understanding of TNBC heterogeneity by marking and tracking diverse cell clones. Additionally, CRISPR facilitates high-throughput screening to promptly identify genes involved in TNBC growth, metastasis, and drug resistance, thus revecling new therapeutic targets and strategies. In TNBC diagnostics, CRISPR/Cas was applied to develop molecular diagnostic systems based on Cas9, Cas12, and Cas13, each employing distinct detection principles. These systems can sensitively and specifically detect a variety of TNBC biomarkers, including cell-specific DNA/RNA and circulating tumor DNA (ctDNA). In the realm of precision therapy, CRISPR/Cas has been utilized to identify key genes implicated in TNBC progression and treatment resistance. CRISPR based screening has uncovered potential therapeutic targets, while its gene-editing capabilities have tacilitated the development of combination therapies with traditional chemotherapy drugs, enhancing their efficacy. Despite its promise, the clinical translation of CRISPR/Cas technology remains in its early stages. Several clinical trials cure underway to assess its safety and efficacy in the treatment of various genetic diseases and cancers. Challenges such as off-target effects, editing efficiency, and delivery methods remain to be addreised. The integration of CRISPR/Cas with other technologies, such as 3D cell culture systems, human induced pluripotent stem cells (hiPSCs), and artificial intelligence (AI), is expected to further advance precision medicine for TNBC. These technological convergences can offer deeper insights into disease mechanisms and facilitate the development of personalized treatment strategies. In conclusion, the CRISPR/Cas system holds immense potential in the precise diagnosis and treatment of TNBC. As the technology progresses and becomes more costs effective, its clinical relevance will grow, and the translation of CRISPR/Cas system data into clinical applications will pave the way for optimal diagnosis and treatment strategies for TNBC patients. However, technical hurdles and ethical considerations require ongoing research and regulation to ensure safety and efficacy.]]></description>
<pubDate>2024/9/4 15:49:49</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HE Ping-Ping,HU Mi,LIN Hui-Ling,OUYANG Xin-Ping,OUYANG Yu-Xin,PENG Mao,TANG Wan-Ying]]></author>
</item>
<item>
<title><![CDATA[Review: Current Research and Development of Antigenic Epitope Prediction Tools]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407300000002]]></link>
<description><![CDATA[Adaptive immunity is a critical component of the human immune system, playing an essential role in identifying antigens and orchestrating a tailored immune response. This review delves into the significant strides made in the development of epitope prediction tools, their integration into vaccine design, and their pivotal role in enhancing immunotherapy strategies. The review emphasizes the transformative potential of these tools in refining our understanding and application of immune responses. Adaptive immunity distinguishes itself from innate immunity by its ability to recognize specific antigens and remember past infections, leading to quicker and more effective responses upon subsequent exposures. This facet of immunity involves complex interactions between various cell types, primarily B cells and T cells, which recognize distinct epitopes presented by antigens. Epitopes are small sequences or configurations on antigens that are recognized by the immune receptors on B cells and T cells, acting as the focal points of immune recognition and response. Epitopes can be broadly classified into two types: linear (or sequential) epitopes and conformational (or discontinuous) epitopes. Linear epitopes consist of a sequence of amino acids in a protein that are recognized by B cells and T cells in their primary structure form. Conformational epitopes, on the other hand, are formed by spatially distinct amino acids that come together in the tertiary structure of the protein, often recognized by the immune system only when the protein folds into its native conformation. The role of epitopes in the immune response is critical as they are the primary triggers for the activation of B cells and T cells. When an epitope is recognized, it can stimulate B cells to produce antibodies, mobilize helper T cells to secrete cytokines, or prompt cytotoxic T cells to kill infected cells. These actions form the basis of the adaptive immune response, tailored to eliminate specific pathogens or infected cells effectively. The prediction of B cell and T cell epitopes has evolved with advances in computational biology, leading to the development of several sophisticated tools that utilize a variety of algorithms to predict the likelihood of epitope regions on antigens. Tools employing machine learning methods, such as support vector machines (SVMs), XGBoost, random forest, analyze large datasets of known epitopes to classify new sequences as potential epitopes based on their similarity to known data. Moreover, deep learning has emerged as a powerful method in epitope prediction, leveraging neural networks capable of learning high-dimensional data from vast amounts of immunological inputs to identify patterns that may not be evident to other predictive models. Deep learning models, such as convolutional neural networks (CNNs), recurrent neural networks (RNNs) and ESM protein language model have demonstrated superior accuracy in mapping the nonlinear relationships inherent in protein structures and epitope interactions. The application of epitope prediction tools in vaccine design is transformative, enabling the development of epitope-based vaccines that can elicit targeted immune responses against specific parts of the pathogen. These vaccines, by focusing the immune response on highly specific regions of the pathogen, can offer high efficacy and reduced side effects. Similarly, in cancer immunotherapy, epitope prediction tools help identify tumor-specific antigens that can be targeted to develop personalized immunotherapeutic strategies, thereby enhancing the precision of cancer treatments. The future of epitope prediction technology appears promising, with ongoing advancements anticipated to enhance the precision and efficiency of these tools further. The integration of broader immunological data, such as patient-specific immune profiles and pathogen variability, along with advances in AI and machine learning, will likely drive the development of more adaptive, robust, and clinically relevant prediction models. This will not only improve the effectiveness of vaccines and immunotherapies but also contribute to our broader understanding of immune mechanisms, potentially leading to breakthroughs in the treatment and prevention of multiple diseases. In conclusion, the development and refinement of epitope prediction tools stand as a cornerstone in the advancement of immunological research and therapeutic design, highlighting a path toward more precise and personalized medicine. The ongoing integration of computational models with experimental immunology holds the promise of revolutionizing our approach to combating infectious diseases and cancer.]]></description>
<pubDate>2024/9/4 15:34:50</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[CAO Zhi-Wei,LI Zi-Hao,MAO Tian-Tian,QIU Tian-Yi,WANG Yuan]]></author>
</item>
<item>
<title><![CDATA[The Current Status of Research on The Association Between <i>TMEM43</i> Gene and Hearing Loss]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202403240000001]]></link>
<description><![CDATA[Transmembrane proteins (TMEM) are a type of membrane protein. Most proteins in this family are located in the phospholipid bilayer of the cell membrane, while a smaller portion is found in the membranes of cellular organelles. Transmembrane protein 43 (TMEM43) is a member of the TMEM protein family and is encoded by the <i>TMEM43</i> gene. This protein consists of 400 amino acids and has 4 transmembrane domains and 1 membrane-associated domain. TMEM43 is localized to various biological membranes within the cell, such as the cell membrane and nuclear membrane, where it forms transmembrane channels for various ions. Additionally, TMEM43 is expressed in many species, showing high genetic similarity, especially with the four transmembrane domains being highly conserved. Current studies on the <i>TMEM43</i> gene are still in its early stages, mainly focusing on its association with arrhythmogenic right ventricular cardiomyopathy (ARVC) and cancer. However, recent studies suggest that pathogenic mutations in <i>TMEM43</i> may cause auditory neuropathy spectrum disorder (ANSD). Patients with <i>TMEM43</i> p.Ser372Ter exhibited late-onset progressive ANSD. Impact of <i>TMEM43</i> pathogenic mutations on individual hearing was likely mediated through effects on gap junction (GJ) structures on glia-like supporting cells (GLS), cell membranes. The <i>TMEM43</i> p.Arg372Ter pathogenic mutation primarily affected the structure and function of TMEM43 protein, leading to premature termination of protein translation and the production of a truncated protein. Abnormal TMEM43 protein significantly reduced K<sup>+</sup> influx in GLS cells, disrupting the endolymphatic K<sup>+</sup> circulation and cochlear microenvironment homeostasis. When K<sup>+</sup> circulation was obstructed, the endocochlear potential (EP) became abnormal, impairing the physiological function of hair cells and potentially leading to hearing impairment. However, it is important to note that studies on the mechanism is limited, and more experimental evidence is needed to confirm this hypothesis. Currently, there is a significant gap in research on TMEM43 and hearing loss, with many issues remaining unresolved. While TMEM43 has been studied in relation to hearing loss in humans, zebrafish, mice, and rats, the research is still preliminary. Detailed investigations into the molecular pathogenic mechanisms, the impact of mutations on hearing damage, and related therapeutic strategies are needed. Additionally, as a newly identified hearing loss-related gene, the mutation frequency and incidence of hearing disorders associated with <i>TMEM43</i> have not been effectively quantified. For example, the ClinVar database listed 829 mutation sites for the <i>TMEM43</i> gene, with only three mutations related to auditory neuropathy: c.605A>T (p.Asn202Ile), c.889T>A (p.Phe297Ile), and c.1114C>T (p.Arg372Ter). Aside from the aforementioned <i>TMEM43</i> c.1114C>T (p.Arg372Ter) mutation observed in patients, the other two mutations were experimentally induced and have not been found in patients. Consequently, these mutations have been classified as unknown significance. We reviewed the current understanding of TMEM43 and hearing loss, analyzed its role in ear development and sound conduction, and explored the impact of <i>TMEM43</i> gene variations on hearing loss, aiming to provide new insights for future research and precision medicine related to TMEM43.]]></description>
<pubDate>2024/9/3 11:49:52</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CUI Rong-Jie,LI Yun-Long]]></author>
</item>
<item>
<title><![CDATA[Research: A Prognostic Model Based on Colony Stimulating Factors-related Genes in Triple-negative Breast Cancer]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406300000004]]></link>
<description><![CDATA[<b>Objective</b> Triple-negative breast cancer (TNBC) is the breast cancer subtype with the worst prognosis, and lacks effective therapeutic targets. Colony stimulating factors (CSFs) are cytokines that can regulate the production of blood cells and stimulate the growth and development of immune cells, playing an important role in the malignant progression of TNBC. This article aims to construct a novel prognostic model based on the expression of colony stimulating factors-related genes (CRGs), and analyze the sensitivity of TNBC patients to immunotherapy and drug therapy.<b>Methods</b> We downloaded CRGs from public databases and screened for differentially expressed CRGs between normal and TNBC tissues in the TCGA-BRCA database. Through LASSO Cox regression analysis, we constructed a prognostic model and stratified TNBC patients into high-risk and low-risk groups based on the colony stimulating factors-related genes risk score (CRRS). We further analyzed the correlation between CRRS and patient prognosis, clinical features, tumor microenvironment (TME) in both high-risk and low-risk groups, and evaluated the relationship between CRRS and sensitivity to immunotherapy and drug therapy.<b>Results</b> We identified 842 differentially expressed CRGs in breast cancer tissues of TNBC patients and selected 13 CRGs for constructing the prognostic model. Kaplan-Meier survival curves, time-dependent receiver operating characteristic curves, and other analyses confirmed that TNBC patients with high CRRS had shorter overall survival, and the predictive ability of CRRS prognostic model was further validated using the GEO dataset. Nomogram combining clinical features confirmed that CRRS was an independent factor for the prognosis of TNBC patients. Moreover, patients in the high-risk group had lower levels of immune infiltration in the TME and were sensitive to chemotherapeutic drugs such as 5-fluorouracil, ipatasertib, and paclitaxel.<b>Conclusion</b> We have developed a CRRS-based prognostic model composed of 13 differentially expressed CRGs, which may serve as a useful tool for predicting the prognosis of TNBC patients and guiding clinical treatment. Moreover, the key genes within this model may represent potential molecular targets for future therapies of TNBC.]]></description>
<pubDate>2024/9/2 16:36:15</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[DENG Xi-Yun,FU Shu-Jun,GUO Yu-Xuan,HE Guang-Chun,LONG Jun,WANG Jie,WANG Yi-An,WANG Zhi-Yu,XIAO Pei-Yao,ZHENG Chan-Juan]]></author>
</item>
<item>
<title><![CDATA[Review: The Regulatory Role of microRNA in Neocortical Layer Formation]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407120000001]]></link>
<description><![CDATA[Laminar organization is a hallmark of the mammalian neocortex, where the orderly arrangement of diverse neurons stereotypically forms into six distinct layers. The laminar structure provides a basis for the formation of precise neural circuits responsible for high-level cognitive functions. A deeper understanding of the mechanisms underlying neocortical layer formation and cell assembly in the brain will provide a more comprehensive insight into mammalian and even human physiology and behavior. It will also enable the development of novel diagnostic and therapeutic strategies for neurological disorders. To achieve this, it is imperative to elucidate the molecular regulatory networks that determine the fate of neurons in the neocortex. MicroRNAs (miRNAs) are small non-coding RNAs of 18-25 nucleotides in length that play important roles in the gene expression network. A large number of studies have reported that miRNAs are involved in various developmental processes within the nervous system. This review summarizes the progress of research on miRNAs that have been identified in recent years with regard to neocortical layer formation. We start with a comparative analysis of different Cre-line mediated conditional knockout mice for Dicer, a gene indispensable for the synthesis of almost all miRNAs. The results indicate that miRNAs are essential for the formation of neocortical layers, including the determination of the fate of projection neurons and the migration of these cells. Next, we summarize the regulatory roles of miRNAs in the coordinated execution of a series of developmental events that contribute to neocortical layer formation. First, the temporal patterning of neocortical neural progenitors is regulated by miRNAs. Two types of temporally opposite expression gradients and functionally antagonistic miRNAs modulate the competence of neural progenitors by changing their relative expression levels during neurogenesis, thereby shifting the progressive generation of neocortical neurons. Second, it is described that miRNAs influence lamination by regulating the fate of intermediate progenitor cells (IPCs). In particular, several miRNAs that are specifically expressed in multiple gyrencephalic species have been identified in recent years and are involved in regulating the generation of IPCs as well as the generation of upper layer neurons. Third, the regulatory roles of miRNAs in the migration of cortical projection neurons, including the multipolar to bipolar transition and other processes, were presented. Fourth, we described miRNAs that are expressed in postmitotic neurons but play roles in the further specification of different cortical projection neuron subtype identities, in particular the role of several miRNAs in the Mirg cluster in establishing different subtype identities of projection neurons in layer V, promoting corticospinal motor neuron (CSMN) identity but inhibiting callosal projection neuron (CPN) identity. Finally, we discussed current challenges in the study of miRNAs in neocortical layer formation and looked forward to future directions that deserve further exploration, such as the functions of a large number of newly discovered miRNAs, or whether miRNAs regulate the layer-dependent pattern of other neuronal cells with layer distribution features; the contribution of miRNAs in the rapid evolution of the neocortex, especially in the formation of characteristic structures in the primate neocortex; and the use of miRNAs as an entry point to explore finer regulatory networks.]]></description>
<pubDate>2024/9/2 14:46:16</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[DOU Xin-Yi,SHU Peng-Cheng]]></author>
</item>
<item>
<title><![CDATA[The Mechanisms of Quercetin in Improving Alzheimer’s Disease]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407020000005]]></link>
<description><![CDATA[Alzheimer’s disease (AD) is a prevalent neurodegenerative condition characterized by progressive cognitive decline and memory loss. As the incidence of AD continues to rise annually, researchers have shown keen interest in the active components found in natural plants and their neuroprotective effects against AD. Quercetin, a flavonol widely present in fruits and vegetables, has multiple biological effects including anticancer, anti-inflammatory, and antioxidant. Oxidative stress plays a central role in the pathogenesis of AD, and the antioxidant properties of quercetin are essential for its neuroprotective function. Quercetin can modulate multiple signaling pathways related to AD, such as Nrf2-ARE, JNK, p38 MAPK, PON2, PI3K/Akt, and PKC, all of which are closely related to oxidative stress. Furthermore, quercetin is capable of inhibiting the aggregation of β-amyloid protein (Aβ) and the phosphorylation of tau protein, as well as the activity of β-secretase 1 and acetylcholinesterase, thus slowing down the progression of the disease.The review also provides insights into the pharmacokinetic properties of quercetin, including its absorption, metabolism, and excretion, as well as its bioavailability challenges and clinical applications. To improve the bioavailability and enhance the targeting of quercetin, the potential of quercetin nanomedicine delivery systems in the treatment of AD is also discussed. In summary, the multifaceted mechanisms of quercetin against AD provide a new perspective for drug development. However, translating these findings into clinical practice requires overcoming current limitations and ongoing research. In this way, its therapeutic potential in the treatment of AD can be fully utilized.]]></description>
<pubDate>2024/8/31 23:32:43</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Huan,HOU Hong-Wei,LI Jie,MU Wen-Jun,TIAN Yu-Shan,YIN Chang-Feng,ZHANG Yu-Meng]]></author>
</item>
<item>
<title><![CDATA[High Expression of INF2 Predicts Poor Prognosis and Promotes Hepatocellular Carcinoma Progression]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202404090000003]]></link>
<description><![CDATA[<b>Objective</b> INF2 is a member of the formins family. Abnormal expression and regulation of INF2 have been associated with the progression of various tumors, but the expression and role of INF2 in hepatocellular carcinoma (HCC) remain unclear. HCC is a highly lethal malignant tumor. Given the limitations of traditional treatments, this study explored the expression level, clinical value and potential mechanism of INF2 in HCC in order to seek new therapeutic targets.<b>Methods</b> In this study, we used public databases to analyze the expression of INF2 in pan-cancer and HCC, as well as the impact of INF2 expression levels on HCC prognosis. Quantitative real time polymerase chain reaction (RT-qPCR), Western blot, and immunohistochemistry were used to detect the expression level of INF2 in liver cancer cells and human HCC tissues. The correlation between INF2 expression and clinical pathological features was analyzed using public databases and clinical data of human HCC samples. Subsequently, the effects of INF2 expression on the biological function and Drp1 phosphorylation of liver cancer cells were elucidated through <i>in vitro</i> and <i>in vivo</i> experiments. Finally, the predictive value and potential mechanism of INF2 in HCC were further analyzed through database and immunohistochemical experiments.<b>Results</b> INF2 is aberrantly high expression in HCC samples and the high expression of INF2 is correlated with overall survival, liver cirrhosis and pathological differentiation of HCC patients. The expression level of INF2 has certain diagnostic value in predicting the prognosis and pathological differentiation of HCC. <i>In vivo</i> and <i>in vitro</i> HCC models, upregulated expression of INF2 triggers the proliferation and migration of the HCC cell, while knockdown of INF2 could counteract this effect. INF2 in liver cancer cells may affect mitochondrial division by inducing Drp1 phosphorylation and mediate immune escape by up-regulating PD-L1 expression, thus promoting tumor progression.<b>Conclusion</b> INF2 is highly expressed in HCC and is associated with poor prognosis. High expression of INF2 may promote HCC progression by inducing Drp1 phosphorylation and up-regulation of PD-L1 expression, and targeting INF2 may be beneficial for HCC patients with high expression of INF2.]]></description>
<pubDate>2024/8/31 22:33:11</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[LI Hong,LIN Man,SHI Jia-Xin,WANG Jie,WANG Hai-Biao,YE Fu-Sang,YE Meng]]></author>
</item>
<item>
<title><![CDATA[Review: Regulation and Function of Protein Histidine Phosphorylation]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406240000001]]></link>
<description><![CDATA[Protein phosphorylation modification is one of the key regulatory mechanisms in cellular signaling transduction and metabolic processes. The phosphorylation state of target proteins is regulated by specific protein kinases and phosphatases, which add or remove phosphate groups. Histidine phosphorylation (pHis) plays a crucial role in both prokaryotes and eukaryotes life activities and is linked to various pathological processes. Unlike the stable phosphorylation of proteins <i>via</i> phosphate ester bonds, histidine phosphorylation is linked through phosphoramide bonds, making it highly sensitive to high temperatures and low pH. This sensitivity has historically impeded progress in identifying and studying histidine phosphorylation. In recent years, the development of new techniques in phosphoproteomics and the emergence of pHis-specific antibodies have promoted the identification and functional research of pHis-modified substrates. For the first time, more than 700 pHis-modified proteins have been identified in mammalian cells, and pHis-modified substrates such as focal adhesion kinase (FAK) and phosphoglycerate mutase 1 (PGAM1) have been found to promote tumor development. This article mainly reviewed the key mechanisms and functions of histidine kinases and histidine phosphatases in regulating the histidine phosphorylation of specific substrates, and highlights their significant roles in human physiological and pathological processes, aiming to provide guidance for further research into the biological functions of histidine phosphorylation.]]></description>
<pubDate>2024/8/31 22:28:44</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[LIU Xiao-Ran,XING Mei-Ning,YING Wan-Tao]]></author>
</item>
<item>
<title><![CDATA[Effect Analysis of Different Interventions to Improve Neuroinflammation in The Treatment of Alzheimer’s Disease]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202408010000003]]></link>
<description><![CDATA[Alzheimer’s disease (AD) is a central neurodegenerative disease characterized by progressive cognitive decline and memory impairment in clinical. Currently, there are no effective treatments for AD. In recent years, a variety of therapeutic approaches from different perspectives have been explored to treat AD. Although the drug therapies targeted at the clearance of amyloid β-protein (Aβ) had made a breakthrough in clinical trials, there were associated with adverse events. Neuroinflammation plays a crucial role in the onset and progression of AD. Continuous neuroinflammatory was considered to be the third major pathological feature of AD, which could promote the formation of extracellular amyloid plaques and intracellular neurofibrillary tangles. At the same time, these toxic substances could accelerate the development of neuroinflammation, form a vicious cycle, and exacerbate disease progression. Reducing neuroinflammation could break the feedback loop pattern between neuroinflammation, Aβ plaque deposition and Tau tangles, which might be an effective therapeutic strategy for treating AD. Traditional Chinese herbs such as <i>Polygonum multiflorum</i> and <i>Curcuma</i> were utilized in the treatment of AD due to their ability to mitigate neuroinflammation. Non-steroidal anti-inflammatory drugs such as ibuprofen and indomethacin had been shown to reduce the level of inflammasomes in the body, and taking these drugs was associated with a low incidence of AD. Biosynthetic nanomaterials loaded with oxytocin were demonstrated to have the capability to anti-inflammatory and penetrate the blood-brain barrier effectively, and they played an anti-inflammatory role <i>via</i> sustained-releasing oxytocin in the brain. Transplantation of mesenchymal stem cells could reduce neuroinflammation and inhibit the activation of microglia. The secretion of mesenchymal stem cells could not only improve neuroinflammation, but also exert a multi-target comprehensive therapeutic effect, making it potentially more suitable for the treatment of AD. Enhancing the level of TREM2 in microglial cells using gene editing technologies, or application of TREM2 antibodies such as Ab-T1, hT2AB could improve microglial cell function and reduce the level of neuroinflammation, which might be a potential treatment for AD. Probiotic therapy, fecal flora transplantation, antibiotic therapy, and dietary intervention could reshape the composition of the gut microbiota and alleviate neuroinflammation through the gut-brain axis. However, the drugs of sodium oligomannose remain controversial. Both exercise intervention and electromagnetic intervention had the potential to attenuate neuroinflammation, thereby delaying AD process. This article focuses on the role of drug therapy, gene therapy, stem cell therapy, gut microbiota therapy, exercise intervention, and brain stimulation in improving neuroinflammation in recent years, aiming to provide a novel insight for the treatment of AD by intervening neuroinflammation in the future.]]></description>
<pubDate>2024/8/28 23:30:38</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Shi-Yu,CHU Chao-Yang,SHAN Jiang-Hui,FANG Tian-Yuan,LI Li-Ping,LIN Zhi-Cheng,LIU Zhi-Tao,WANG Qing-Juan,XIAO Biao,XIE Kai,ZHANG Chu-Xia,ZHOU Yu-Yu]]></author>
</item>
<item>
<title><![CDATA[Review: Development and Therapeutic Applications of Precise Gene Editing Technology]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407100000004]]></link>
<description><![CDATA[The advent of gene editing represents one of the most transformative breakthroughs in life science, making genome manipulation more accessible than ever before. While traditional CRISPR/Cas-based gene editing, which involves double-strand DNA breaks (DSBs), excels at gene disruption, it is less effective for accurate gene modification. The limitation arises because DSBs are primarily repaired <i>via</i> non-homologous end joining (NHEJ), which tends to introduce indels at the break site. While homology-directed repair (HDR) can achieve precise editing when a donor DNA template is provided, the reliance on DSBs often results in unintended genome damage. HDR is restricted to specific cell cycle phases, limiting its application. Currently, gene editing has evolved to unprecedented levels of precision without relying on DSB and HDR. The development of innovative systems, such as base editing, prime editing, and CRISPR-associated transposases (CASTs), now allow for precise editing ranging from single nucleotides to large DNA fragments. Base editors (BEs) enable the direct conversion of one nucleotide to another, and prime editors (PEs) further expand gene editing capabilities by allowing for the insertion, deletion, or alteration of small DNA fragments. The CAST system, a recent innovation, allows for the precise insertion of large DNA fragments at specific genomic locations. In recent years, the optimization of these precise gene editing tools has led to significant improvements in editing efficiency, specificity, and versatility, with advancements such as the creation of base editors for nucleotide transversions, enhanced prime editing systems for more efficient and precise modifications, and refined CAST systems for targeted large DNA insertions, expanding the range of applications for these tools. Concurrently, these advances are complemented by significant improvements in <i>in vivo</i> delivery methods, which have paved the way for therapeutic application of precise gene editing tools. Effective delivery systems are critical for the success of gene therapies, and recent developments in both viral and non-viral vectors have improved the efficiency and safety of gene editing. For instance, adeno-associated viruses (AAVs) are widely used due to their high transfection efficiency and low immunogenicity, though challenges such as limited cargo capacity and potential for immune responses remain. Non-viral delivery systems, including lipid nanoparticles (LNPs), offer an alternative with lower immunogenicity and higher payload capacity, although their transfection efficiency can be lower. The therapeutic potential of these precise gene editing technologies is vast, particularly in treating genetic disorders. Preclinical studies have demonstrated the effectiveness of base editing in correcting genetic mutations responsible for diseases such as cardiomyopathy, liver disease, and hereditary hearing loss. These technologies promise to treat symptoms and potentially cure the underlying genetic causes of these conditions. Meanwhile, challenges remain, such as optimizing the safety and specificity of gene editing tools, improving delivery systems, and overcoming off-target effects, all of which are critical for their successful application in clinical settings. In summary, the continuous evolution of precise gene editing technologies, combined with advancements in delivery systems, is driving the field toward new therapeutic applications that can potentially transform the treatment of genetic disorders by targeting their root causes.]]></description>
<pubDate>2024/8/28 22:58:27</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[LI Zhen-Hua,WANG Jian,YANG Xiao,ZHANG Yi-Meng]]></author>
</item>
<item>
<title><![CDATA[Enzyme-directed Immobilization Strategies for Biosensor Applications]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406170000004]]></link>
<description><![CDATA[Immobilized enzyme-based enzyme electrode biosensors, characterized by high sensitivity and efficiency, strong specificity, and compact size, demonstrate broad application prospects in life science research, disease diagnosis and monitoring, <i>etc</i>. Immobilization of enzyme is a critical step in determining the performance (stability, sensitivity, and reproducibility) of the biosensors. Random immobilization (physical adsorption, covalent cross-linking, <i>etc.</i>) can easily bring about problems, such as decreased enzyme activity and relatively unstable immobilization. Whereas, directional immobilization utilizing amino acid residue mutation, affinity peptide fusion, or nucleotide-specific binding to restrict the orientation of the enzymes provides new possibilities to solve the problems caused by random immobilization. In this paper, the principles, advantages and disadvantages and the application progress of enzyme electrode biosensors of different directional immobilization strategies for enzyme molecular sensing elements by specific amino acids (lysine, histidine, cysteine, unnatural amino acid) with functional groups introduced based on site-specific mutation, affinity peptides (gold binding peptides, carbon binding peptides, carbohydrate binding domains) fused through genetic engineering, and specific binding between nucleotides and target enzymes (proteins) were reviewed, and the application fields, advantages and limitations of various immobilized enzyme interface characterization techniques were discussed, hoping to provide theoretical and technical guidance for the creation of high-performance enzyme sensing elements and the manufacture of enzyme electrode sensors.]]></description>
<pubDate>2024/8/28 21:53:00</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[GONG Wei-Li,HUANG Xiao-Zhen,LIU Qing-Ai,MA Yao-Hong,SHAO Yue,WANG Bing-Lian,WANG Xing-Bao,XUE Yun-Long,YU Yi,ZHANG Li-He]]></author>
</item>
<item>
<title><![CDATA[Review: Microenvironment Remodeling and Immunotherapy of Hepatocellular Carcinoma]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407220000002]]></link>
<description><![CDATA[Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the digestive tract system, which is induced by multiple factors, involving multiple genes and complicated mechanism. Its incidence and mortality rank fourth and second respectively in China, and accounting for more than 85% of primary liver cancers. Tumor immune microenvironment (TIME), plays a critical role in determining the tumor progression and treatment outcomes, making it become a hotspot in current studies. Summarising the previous studies, it is found that the progression of HCC is significantly influenced by the TIME and its complex interactions. TIME consists of various cellular and non-cellular components, such as myeloid-derived suppressor cells (MDSCs), tumor-associated macrophages (TAMs), tumor-associated neutrophils (TANs), regulatory T cells (Tregs), innate lymphoid cells (ILCs), as well as growth factors, proteolytic enzymes, and extracellular matrix proteins. Due to long-term exposure to bacterial components carried by the portal vein, food-derived antigens, and a large amount of foreign antigenic substances, the microenvironment of liver exhibits a certain degree of immune suppression to resist excessive inflammation caused by the non-pathogenic intestinal environment. Besides, the inhibitory immune microenvironment shaped by tumor cells which induces changes in the phenotype and function of immune cells, and attenuates the cytotoxic capabilities of immune system. Meanwhile, the regulation of immune cell metabolism is crucial for anti-tumor immune response. Abnormal metabolites of liver cancer microenvironment and intestinal flora metabolites regulate the remodeling of immune microenvironment and the progression in liver cancer. Normally, the cancer immune cycle functions effectively to remove tumor cells, while the immunosuppressive, exhausted T cells and metabolic disorders of the TIME leads to defects in the cancer immunity cycle and promotes to tumor progression. Furthermore, during the processes of rapid proliferation and differentiation, tumor cells alter their metabolic status through “metabolic reprogramming”, allowing them to compete with anti-tumor immune cells for vital nutrients including glucose, lipids, and nucleotides. At the same time, the abnormal consumption of metabolites leads to local hypoxia, lower pH levels, and the accumulation of metabolic products, which in turn suppress the proliferation and effector functions of immune cells, ultimately facilitating immune evasion and tumor progression. According to the above, local immune imbalance and metabolic disorders in the liver collectively shape the unique microenvironment of HCC, resulting in the accumulation of immunosuppressive cytokines, extracellular matrix and abnormal metabolites. These factors induce abnormal tumor angiogenesis, recruitment of immunosuppressive cells, reduce T-cell infiltration, and diminish anti-tumor function, which accelerates the progression of HCC and immune escape. Currently, there are still remarkable limitations in the clinical treatment methods and outcomes for HCC, while immunotherapy offers a new strategy. The advantages of immunotherapy demonstrate relatively higher specificity and fewer side effects compared to traditional treatment methods such as surgery, radiotherapy, and chemotherapy. Up to now, more and more evidence has been uncovered that liver cancer immunotherapy is closely related to TIME. Targeting the TIME of HCC provides a new perspective into a deeper understanding of the mechanisms of immunotherapy resistance and the development of new immunotherapy approaches. However, single immunotherapy has not shown satisfactory results in improving the prognosis of HCC patients. At present, dual immune checkpoint inhibitors or their combination with existing therapies are being widely explored in clinical studies, hoping to overcome the limitations of HCC therapy. Therefore, this review summarizes the composition of immunosuppressive microenvironment in liver cancer and metabolic regulation, and further discusses clinical therapeutic strategies by targeting microenvironment remodeling for the treatment of liver cancer, which provides new avenues for tumor immunotherapy.]]></description>
<pubDate>2024/8/28 21:40:01</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[CHEN Yun,HAN Yue-Qing,LIU Jia-Fu,ZHANG Yu-Han]]></author>
</item>
<item>
<title><![CDATA[The Use of Speech in Screening for Cognitive Decline in Older Adults]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407170000002]]></link>
<description><![CDATA[Alzheimer’s disease (AD) is a chronic neurodegenerative disorder that severely affects the health of the elderly, marked by its incurability, high prevalence, and extended latency period. The current approach to AD prevention and treatment emphasizes early detection and intervention, particularly during the pre-AD stage of mild cognitive impairment (MCI), which provides an optimal “window of opportunity” for intervention. Clinical detection methods for MCI, such as cerebrospinal fluid monitoring, genetic testing, and imaging diagnostics, are invasive and costly, limiting their broad clinical application. Speech, as a vital cognitive output, offers a new perspective and tool for computer-assisted analysis and screening of cognitive decline. This is because elderly individuals with cognitive decline exhibit distinct characteristics in semantic and audio information, such as reduced lexical richness, decreased speech coherence and conciseness, and declines in speech rate, voice rhythm, and hesitation rates. The objective presence of these semantic and audio characteristics lays the groundwork for computer-based screening of cognitive decline. Speech information is primarily sourced from databases or collected through tasks involving spontaneous speech, semantic fluency, and reading, followed by analysis using computer models. Spontaneous language tasks include dialogues/interviews, event descriptions, narrative recall, and picture descriptions. Semantic fluency tasks assess controlled retrieval of vocabulary items, requiring participants to extract information at the word level during lexical search. Reading tasks involve participants reading a passage aloud. Summarizing past research, the speech characteristics of the elderly can be divided into two major categories: semantic information and audio information. Semantic information focuses on the meaning of speech across different tasks, highlighting differences in vocabulary and text content in cognitive impairment. Overall, discourse pragmatic disorders in AD can be studied along three dimensions: cohesion, coherence, and conciseness. Cohesion mainly examines the use of vocabulary by participants, with a reduction in the use of nouns, pronouns, verbs, and adjectives in AD patients. Coherence assesses the ability of participants to maintain topics, with a decrease in the number of subordinate clauses in AD patients. Conciseness evaluates the information density of participants, with AD patients producing shorter texts with less information compared to normal elderly individuals. Audio information focuses on acoustic features that are difficult for the human ear to detect. There is a significant degradation in temporal parameters in the later stages of cognitive impairment; AD patients require more time to read the same paragraph, have longer vocalization times, and produce more pauses or silent parts in their spontaneous speech signals compared to normal individuals. Researchers have extracted audio and speech features, developing independent systems for each set of features, achieving an accuracy rate of 82% for both, which increases to 86% when both types of features are combined, demonstrating the advantage of integrating audio and speech information. Currently, deep learning and machine learning are the main methods used for information analysis. The overall diagnostic accuracy rate for AD exceeds 80%, and the diagnostic accuracy rate for MCI also exceeds 80%, indicating significant potential. Deep learning techniques require substantial data support, necessitating future expansion of database scale and continuous algorithm upgrades to transition from laboratory research to practical product implementation.]]></description>
<pubDate>2024/8/28 20:47:02</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[GAO Lin-Lin,GUI Wen-Jun,HU Qiao-Xia,LOU Qiong,WANG Qin-Wen,WANG Si-Wen,YIN Xiao-Xiao]]></author>
</item>
<item>
<title><![CDATA[Brain Aperiodic Dynamics]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406170000002]]></link>
<description><![CDATA[Brain’s neural activities encompass both periodic rhythmic oscillations and aperiodic neural fluctuations. Among them, rhythmic oscillations manifest as spectral peaks of neural signals, directly reflecting the synchronized activities of the brain neural population and being intimately tied to cognitive and behavioral states. Conversely, aperiodic fluctuations exhibit a power-law decaying spectral trend, unveiling the multiscale dynamics of brain neural activity. In recent years, researchers have made notable progress in the study of brain aperiodic dynamics. These studies demonstrate that aperiodic activity bears significant physiological relevance, correlating with various physiological states such as external stimuli, drug induction, sleep states, and aging. It serves as a reflection of the brain’s sensory capacity, consciousness level, and cognitive ability. In clinical research, the aperiodic exponent emerges as a significant potential biomarker, capable of reflecting the progression and trends of brain diseases while being intricately intertwined with the excitation-inhibition balance of neural system. The physiological mechanisms underlying aperiodic dynamics span multiple neural scales, with neural activities at the levels of individual neurons, neuronal ensembles, and neural networks each expletively influencing the frequency, oscillatory patterns, and spatiotemporal characteristics of aperiodic activities. Currently, aperiodic dynamics boasts broad application prospects, not only providing a fresh perspective for investigating brain neural dynamics but also holding immense potential as neural markers in neuromodulation technologies or brain-computer interface technologies. This paper summarizes methods for extracting characteristic parameters of aperiodic activity, comparatively analyzes its physiological relevance and potential as a biomarker in brain diseases, summarizes its physiological mechanisms, and finally, based on these findings, elaborates on the research prospects of aperiodic dynamics.]]></description>
<pubDate>2024/8/28 19:51:31</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HU Zhi-Cai,LI Gui-Ping,LIU Shan,WANG Jiang,YU Hai-Tao,ZHANG Zhen]]></author>
</item>
<item>
<title><![CDATA[Brain Aperiodic Dynamics]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406170000002]]></link>
<description><![CDATA[Brain’s neural activities encompass both periodic rhythmic oscillations and aperiodic neural fluctuations. Among them, rhythmic oscillations manifest as spectral peaks of neural signals, directly reflecting the synchronized activities of the brain neural population and being intimately tied to cognitive and behavioral states. Conversely, aperiodic fluctuations exhibit a power-law decaying spectral trend, unveiling the multiscale dynamics of brain neural activity. In recent years, researchers have made notable progress in the study of brain aperiodic dynamics. These studies demonstrate that aperiodic activity bears significant physiological relevance, correlating with various physiological states such as external stimuli, drug induction, sleep states, and aging. It serves as a reflection of the brain’s sensory capacity, consciousness level, and cognitive ability. In clinical research, the aperiodic exponent emerges as a significant potential biomarker, capable of reflecting the progression and trends of brain diseases while being intricately intertwined with the excitation-inhibition balance of neural system. The physiological mechanisms underlying aperiodic dynamics span multiple neural scales, with neural activities at the levels of individual neurons, neuronal ensembles, and neural networks each expletively influencing the frequency, oscillatory patterns, and spatiotemporal characteristics of aperiodic activities. Currently, aperiodic dynamics boasts broad application prospects, not only providing a fresh perspective for investigating brain neural dynamics but also holding immense potential as neural markers in neuromodulation technologies or brain-computer interface technologies. This paper summarizes methods for extracting characteristic parameters of aperiodic activity, comparatively analyzes its physiological relevance and potential as a biomarker in brain diseases, summarizes its physiological mechanisms, and finally, based on these findings, elaborates on the research prospects of aperiodic dynamics.]]></description>
<pubDate>2024/8/27 17:19:11</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HU Zhi-Cai,LI Gui-Ping,LIU Shan,WANG Jiang,YU Hai-Tao,ZHANG Zhen]]></author>
</item>
<item>
<title><![CDATA[Alternative Polyadenylation in Mammalian]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407060000002]]></link>
<description><![CDATA[With the rapid development of sequencing technologies, the detection of alternative polyadenylation (APA) in mammals has become more precise. APA precisely regulates gene expression by altering the length and position of the poly(A) tail, and is involved in various biological processes such as disease occurrence and embryonic development. The research on APA in mammals mainly focuses on the following aspects: (1) identifying APA based on transcriptome data and elucidating their characteristics; (2) investigating the relationship between APA and gene expression regulation to reveal its important role in life regulation; (3) exploring the intrinsic connections between APA and disease occurrence, embryonic development, differentiation, and other life processes to provide new perspectives and methods for disease diagnosis and treatment, as well as uncovering embryonic development regulatory mechanisms. In this review, the classification, mechanisms and functions of APA were elaborated in detail and the methods for APA identifying and APA data resources based on various transcriptome data were systematically summarized. Moreover, we epitomized and provided an outlook on research on APA, emphasizing the role of sequencing technologies in driving studies on APA in mammals. In the future, with the further development of sequencing technology, the regulatory mechanisms of APA in mammals will become clearer.]]></description>
<pubDate>2024/8/27 13:52:05</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHI Hong-Xia,XING Yong-Qiang,YANG Wu-Ri-Tu,ZHANG Yu,ZUO Yong-Chun]]></author>
</item>
<item>
<title><![CDATA[Nucleic Acid-driven Protein Degradation: Frontiers of Lysosomal Targeted Degradation Technology]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202404300000001]]></link>
<description><![CDATA[Distinct from the complementary inhibition mechanism through binding to the target with three-dimensional conformation of small molecule inhibitors, targeted protein degradation technology takes tremendous advantage of endogenous protein degradation pathway inside cells to degrade plenty of “undruggable” target proteins, which provides a novel route for the treatment of many serious diseases, mainly including proteolysis-targeting chimeras, lysosome-targeting chimeras, autophagy-targeting chimeras, antibody-based proteolysis-targeting chimeras, <i>etc.</i> Unlike proteolysis-targeting chimeras first found in 2001, which rely on ubiquitin-proteasome system to mainly degrade intracellular proteins of interest, lysosome-targeting chimeras identified in 2020, which was act as the fastly developing technology, utilize cellular lysosomal pathway through endocytosis mediated by lysosome-targeting receptor to degrade both extracellular and membrane proteins. As an emerging biomedical technology, nucleic acid-driven lysosome-targeting chimeras utilize nucleic acids as certain components of chimera molecule to replace with ligand to lysosome-targeting receptor or protein of interest, exhibiting broad application prospects and potential clinical value in disease treatment and drug development. This review mainly introduced present progress of nucleic acid-driven lysosome-targeting chimeras technology, including its basic composition, its advantages compared with antibody or glycopeptide-based lysosome-targeting chimeras, and focused on its chief application, in terms of the type of lysosome-targeting receptors. Most research about the development of nucleic acid-driven lysosome-targeting chimeras focused on those which utilized cation-independent mannose-6-phosphonate receptor as the lysosome-targeting receptor. Both mannose-6-phosphonate-modified glycopeptide and nucleic aptamer targeting cation-independent mannose-6-phosphonate receptor, even double-stranded DNA molecule moiety can be taken advantage as the ligand to lysosome-targeting receptor. The same as classical lysosome-targeting chimeras, asialoglycoprotein receptor can also be used for advance of nucleic acid-driven lysosome-targeting chimeras. Another new-found lysosome-targeting receptor, scavenger receptor, can bind dendritic DNA molecules to mediate cellular internalization of complex and lysosomal degradation of target protein, suggesting the successful application of scavenger receptor-mediated nucleic acid-driven lysosome-targeting chimeras. In addition, this review briefly overviewed the history of lysosome-targeting chimeras, including first-generation and second-generation lysosome-targeting chimeras through cation-independent mannose-6-phosphonate receptor-mediated and asialoglycoprotein receptor-mediated endocytosis respectively, so that a clear timeline can be presented for the advance of chimera technique. Meantime, current deficiency and challenge of lysosome-targeting chimeras was also mentioned to give some direction for deep progress of lysosome-targeting chimeras. Finally, according to faulty lysosomal degradation efficiency, more cellular mechanism where lysosome-targeting chimeras perform degradation of protein of interest need to be deeply explored. In view of current progress and direction of nucleic acid-driven lysosome-targeting chimeras, we discussed its current challenges and development direction in the future. Stability of natural nucleic acid molecule and optimized chimera construction have a great influence on the biological function of lysosome-targeting chimeras. Discovery of novel lysosome-targeting receptors and nucleic aptamer with higher affinity to the target will greatly facilitate profound advance of chimera technique. In summary, nucleic acid-driven lysosome-targeting chimeras have many superiorities, such as lower immunogenicity, expedient synthesis of chimera molecules and so on, in contrast to classical lysosome-targeting chimeras, making it more valuable. Also, the chimera technology provides new ideas and methods for biomedical research, drug development and clinical treatment, and can be used more widely through further research and optimization.]]></description>
<pubDate>2024/8/27 13:46:30</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[FAN Yu-Chuan,GUO Shuai,HUANG Yuan-Yu,LI Yong,LI Yu,WENG Yu-Hua,YIN Han]]></author>
</item>
<item>
<title><![CDATA[Role of SWI/SNF Chromatin Remodeling Complex in Tumor Drug Resistance]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406140000001]]></link>
<description><![CDATA[Tumor drug resistance is an important problem in the failure of chemotherapy and targeted drug therapy, which is a complex process involving chromatin remodeling. SWI/SNF is one of the most studied ATP-dependent chromatin remodeling complexes in tumorigenesis, which plays an important role in the coordination of chromatin structural stability, gene expression, and post-translation modification. However, its mechanism in tumor drug resistance has not been systematically combed. SWI/SNF can be divided into 3 types according to its subunit composition: BAF, PBAF, and ncBAF. These 3 subtypes all contain two mutually exclusive ATPase catalytic subunits (SMARCA2 or SMARCA4), core subunits (SMARCC1 and SMARCD1), and regulatory subunits (ARID1A, PBRM1, and ACTB, <i>etc</i>.), which can control gene expression by regulating chromatin structure. The change of SWI/SNF complex subunits is one of the important factors of tumor drug resistance and progress. SMARCA4 and ARID1A are the most widely studied subunits in tumor drug resistance. Low expression of SMARCA4 can lead to the deletion of the transcription inhibitor of the <i>BCL2L1</i> gene in mantle cell lymphoma, which will result in transcription up-regulation and significant resistance to the combination therapy of ibrutinib and venetoclax. Low expression of SMARCA4 and high expression of SMARCA2 can activate the FGFR1-pERK1/2 signaling pathway in ovarian high-grade serous carcinoma cells, which induces the overexpression of anti-apoptosis gene <i>BCL2</i> and results in carboplatin resistance. <i>SMARCA4</i> deletion can up-regulate epithelial-mesenchymal transition (EMT) by activating <i>YAP1</i> gene expression in triple-negative breast cancer. It can also reduce the expression of Ca<sup>2+</sup> channel IP3R3 in ovarian and lung cancer, resulting in the transfer of Ca<sup>2+</sup> needed to induce apoptosis from endoplasmic reticulum to mitochondria damage. Thus, these two tumors are resistant to cisplatin. It has been found that verteporfin can overcome the drug resistance induced by <i>SMARCA4</i> deletion. However, this inhibitor has not been applied in clinical practice. Therefore, it is a promising research direction to develop SWI/SNF ATPase targeted drugs with high oral bioavailability to treat patients with tumor resistance induced by low expression or deletion of <i>SMARCA4</i>. <i>ARID1A</i> deletion can activate the expression of ANXA1 protein in HER2+ breast cancer cells or down-regulate the expression of progesterone receptor B protein in endometrial cancer cells. The drug resistance of these two tumor cells to trastuzumab or progesterone is induced by activating AKT pathway. <i>ARID1A</i> deletion in ovarian cancer can increase the expression of MRP2 protein and make it resistant to carboplatin and paclitaxel. <i>ARID1A</i> deletion also can up-regulate the phosphorylation levels of EGFR, ErbB2, and RAF1 oncogene proteins.The ErbB and VEGF pathway are activated and EMT is increased. As a result, lung adenocarcinoma is resistant to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). Although great progress has been made in the research on the mechanism of SWI/SNF complex inducing tumor drug resistance, most of the research is still at the protein level. It is necessary to comprehensively and deeply explore the detailed mechanism of drug resistance from gene, transcription, protein, and metabolite levels by using multi-omics techniques, which can provide sufficient theoretical basis for the diagnosis and treatment of poor tumor prognosis caused by mutation or abnormal expression of SWI/SNF subunits in clinical practice.]]></description>
<pubDate>2024/8/27 13:42:53</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DUAN Feng-Sen,GUO Bing-Qian,LUO Yuan,MEI Zhu-Song,PENG Jie,WANG Guang-Yun,WANG Lu,YANG Zhao-Ting,YE Qiao,ZHU Gui-Zhen]]></author>
</item>
<item>
<title><![CDATA[Optimization of Ovarian Tissue Vitrification Using Hydrogel Encapsulation and Magnetic Induction Nanowarming]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407010000007]]></link>
<description><![CDATA[<b>Objective</b> For prepubertal and urgently treated malignant tumor patients, ovarian tissue cryopreservation and transplantation represent more appropriate fertility preservation methods. Current clinical practices often involve freezing ovarian tissue with high concentrations of cryoprotectants (CPAs) and thawing with water baths. These processes lead to varying degrees of toxicity and devitrification damage to ovarian tissue. Therefore, this paper proposes optimized methods for vitrification of ovarian tissues based on sodium alginate hydrogel encapsulation and magnetic induction nanowarming technology.<b>Methods</b> Firstly, the study investigated the effects of sodium alginate concentration, the sequence of hydrogel encapsulation and CPAs loading on vitrification efficiency of encapsulated ovarian tissue. Additionally, the capability of sodium alginate hydrogel encapsulation to reduce the required concentration of CPAs was validated. Secondly, a platform combining water bath and magnetic induction nanowarming was established to rewarm ovarian tissue under various concentrations of magnetic nanoparticles and magnetic field strengths. The post-warming follicle survival rate, antioxidant capacity, and ovarian tissue integrity were evaluated to assess the efficacy of the method.<b>Results</b> The study found that ovarian tissue encapsulated with 2% sodium alginate hydrogel exhibited the highest follicle survival rate after vitrification. The method of loading CPAs prior to encapsulation proved more suitable for ovarian tissue cryopreservation, effectively reducing the required concentration of CPAs by 50%. A combination of 8 g/L Fe<sub>3</sub>O<sub>4</sub> nanoparticles and an alternating magnetic field of 300 Gs showed optimal warming effectiveness for ovarian tissue. Combining water bath rewarming with magnetic induction nanowarming yielded the highest follicle survival rate, enhanced antioxidant capacity, and preserved tissue morphology.<b>Conclusion</b> Sodium alginate hydrogel encapsulation of ovarian tissue reduces the concentration of CPAs required during the freezing process. The combination of magnetic induction nanowarming with water bath provides an efficient method ovarian tissue rewarming. This study offers novel approaches to optimize ovarian tissues vitrification.]]></description>
<pubDate>2024/8/27 13:39:37</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CAO Yu-Kun,LI Zheng,YE Na,ZHOU Xin-Li]]></author>
</item>
<item>
<title><![CDATA[Review: Pathological Consequences of Altered Palmitoylation in Neurodegenerative Disorders and Its Potential as a Therapeutic Target]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406200000001]]></link>
<description><![CDATA[Protein palmitoylation, a prevalent and dynamic form of S-acylation modification, plays a critical role in maintaining the functionality of the nervous system. This reversible process involves the attachment of palmitic acid to cysteine residues in proteins, anchoring them to cellular membranes and regulating their spatial distribution. The functioning of palmitoylation is crucial for normal neuronal activities, influencing key processes such as signal transduction, synaptic function, and protein trafficking. Recent research has increasingly underscored the significance of specific zinc finger Asp-His-His-Cys motif-containing (ZDHHC) S-acyltransferases in neuronal development and synaptic plasticity. These enzymes, which catalyze the palmitoylation of proteins, have emerged as pivotal regulators of brain function. Dysregulation of palmitoylation by these enzymes is now recognized as a potential contributor to the pathogenesis of various neurodegenerative diseases. This review provides an in-depth analysis of the expression patterns and functional diversity of ZDHHC enzymes across different brain regions and cell types. ZDHHC enzymes exhibit significant sequence variability and demonstrate region-specific and cell type-dependent expression. Such heterogeneity suggests that these enzymes may have specialized roles in different areas of the nervous system, making them crucial modulators of neuronal function and synaptic transmission. The review also explores the regulatory mechanisms of protein palmitoylation and their implications in neurodegenerative disease onset and progression. Altered palmitoylation can lead to the destabilization and subsequent aggregation of these proteins, exacerbating neurodegenerative processes. Abnormal palmitoylation of α-synuclein can either promote or inhibit its aggregation in Parkinson’s disease pathology. Proteins related to these key pathological factors, including amyloid precursor protein (APP) and beta-secretase 1 (BACE1), are also influenced by palmitoylation, contributing to the formation of amyloid plaques through the aggregation of Aβ. Additionally, ZDHHC13 and ZDHHC17, which are abundantly and widely expressed in the brain, play crucial roles in this process. For instance, reduced interaction between ZDHHC17 and huntingtin could significantly contribute to the pathogenesis of Huntington’s disease. Thus, modulating the palmitoylation status of these proteins presents a promising therapeutic strategy to prevent their toxic aggregation and mitigate neuronal damage. Actually, regulating palmitoylation has shown potential for therapeutic interventions in neurodegenerative diseases, with studies demonstrating that modulation of palmitoylation can restore neuronal function and improve disease symptoms. Regulating palmitoylation holds significant promise for therapeutic strategies in neurodegenerative diseases, as modulation of this process can restore neuronal function and ameliorate disease symptoms. However, progress is hindered by the lack of high-resolution structural data and comprehensive targeting maps for specific ZDHHC enzymes. Additionally, current detection methods for palmitoylation, which focus on labeling and analyzing palmitic acid and cysteine residues, are often complex and time-consuming, and may produce inconsistent palmitoyl-proteomic profiles. These methodological challenges underscore the need for more robust and efficient detection technologies. A deeper understanding of palmitoylation’s role in neurological diseases, coupled with the development of improved detection methods, is essential for advancing our knowledge of the molecular underpinnings of these conditions and for the creation of innovative therapeutic strategies aimed at combating neurodegenerative diseases.]]></description>
<pubDate>2024/8/26 16:00:27</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[JIA Jian-Ping,LIU Wen-Ying,WANG Shu-Heng]]></author>
</item>
<item>
<title><![CDATA[Review: Gasdermins, The Executor of Pyroptosis]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407010000001]]></link>
<description><![CDATA[Pyroptosis is a form of lytic programmed cell death executed by a family of pore-forming proteins named gasdermin (GSDM). Pyroptosis plays crucial roles in host defense against pathogen infection and eliminating abnormal and harmful cells, while excessive pyroptosis causes inflammatory diseases including cytokine storm and septic shock. Mammalian GSDMs, except for pejvakin (PJVK), adopt an autoinhibited two-domain architecture, in which the N-terminal cytotoxic domain (GSDM-N) is restrained in an inactive state by the intramolecular interaction with the C-terminal inhibitory domain (GSDM-C). These two-domain proteins are activated by upstream protease cleavage within the interdomain linkers. The unleashed GSDM-N binds to acidic phospholipids in the cytoplasmic leaf of plasma membranes and undergoes dramatic conformational changes and oligomerization, then assembling into transmembrane pores for pyroptosis induction. GSDM pores lead to membrane rupture, cell swelling, and cytosol release, thereby mobilizing proinflammatory responses. GSDMs are evolutionarily conserved and have been discovered across all kingdoms of life, including bacteria, fungi, invertebrates such as cnidarians and mollusks, and all vertebrates. Proteolytic cleavage to liberate the pore-forming activity of GSDM-N appears to be a universal mechanism for most GSDMs activation, despite low sequence homology among the GSDMs from diverse species. However, recent studies discover that there exist noncanonical GSDMs lack of functional C-terminal inhibitory domains in some lower eukaryotic species. These noncanonical GSDMs are activated by unprecedent mechanisms independent of proteolytic cleavage.<i> Tricho</i>GSDM, present in the basal metazoan <i>Trichoplax adhaerens</i>, is a pore-forming domain-only protein and exists as a disulfides-linked autoinhibited dimer. Reduction of the disulfides by the conserved cytoplasmic antioxidant system, including glutathione (GSH) and thioredoxin (Trx), generates pore-forming active monomers capable of inducing lytic cell death. In filamentous fungus <i>Neurospora crassa</i>, polymorphic regulator of cell death-1 (<i>rcd-1</i>) encodes two GSDM-like proteins RCD-1-1 and RCD-1-2 in incompatible haplostrains, which trigger pyroptosis-like cell death in nonself discrimination (allorecognition) upon encountering during somatic cell fusion. RCD-1-1 and RCD-1-2 are both monomers and structurally similar to mammalian GSDM-N domains, lacking autoinhibitory fragments. They alone could bind acidic phospholipids, and associate with cell membrane in a resting state. Coexistence of RCD-1-1 and RCD-1-2 leads to formation of RCD-1-1/RCD-1-2 heterodimers through molecular mating, which further oligomerize into membrane-inserted pores, causing rapid lytic cell death. These findings reveal mechanistic diversities in GSDM activation and indicate versatile functions of GSDMs. Due to the highly proinflammatory nature of pyroptosis, the pore-forming activities of GSDMs have been illustrated to be precisely regulated at multiple levels. GSDMD transcription and expression is characterized to be induced by interferon regulatory factors 2 (IRF2). mRNA alternative splicing of <i>GSDMB</i> generates various isoforms, some of which exhibit potent pore-forming activity whereas the others bear none. Additionally, different types of post-translational modifications have been identified on GSDMs, playing distinct regulatory roles. For examples, itaconation of GSDMD, succinylation of GSDMD and GSDME, and phosphorylation of GSDMA, GSDMD and GSDME, negatively regulate GSDM pore formation, thereby inhibiting pyroptosis. Conversely, palmitoylation of GSDMD and GSDME, and ubiquitination of GSDMD promote the pore-forming activities and pyroptosis. Moreover, some proteases can cleave within the GSDM-N domains to block their pore-forming activities. On the other hand, bacterial pathogens evolve specific effectors to hijack host pyroptotic defense pathway through targeting upstream caspases, GSDMs or plasma membrane phospholipids. Given the crucial roles of GSDMD in immune defense and pathological inflammation, a few small-molecule inhibitors have been found to directly inhibit GSDMD activity. Since the identification of GSDMs as the executioners of pyroptosis, the GSDM family has attracted broad attention in immunology researches. Significant progress has been made to greatly advance our knowledge about how GSDMs action, and what are the immunological functions of pyroptosis. Investigations of GSDM-targeting therapies are emerging as a promising translational direction. In this paper, we review recent progress in the field of pyroptosis researches, with focus on various molecular mechanisms underlying GSDMs activation and regulation. The biological implication and future direction of pyroptosis research are also discussed.]]></description>
<pubDate>2024/8/26 15:56:01</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[DING Jing-Jin,HOU Yan-Jie]]></author>
</item>
<item>
<title><![CDATA[Review: Nanopore Protein Sequencing]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407020000006]]></link>
<description><![CDATA[The success of the Human Genome Project has significantly deepened our understanding of genomics and catalyzed a growing focus on proteomics, as researchers aim to decipher the complex relationship between genes and proteins. Given the central role of proteins in regulating physiological processes—including DNA replication, metabolic reactions, signal transduction, pH balance, and cellular structure—developing advanced protein sequencing technologies is critical. Proteins are fundamental to nearly all biological activities, making their detailed study essential for understanding cellular functions and disease mechanisms. The Edman degradation method, developed in the 1950s, was a breakthrough in sequencing short peptides. However, its limitations in read length (fewer than 50 amino acids) and slow cycle time fall short of modern demands. Mass spectrometry has since emerged as the gold standard in protein sequencing due to its high accuracy, throughput, and reproducibility. The method is enhanced by a robust sample preparation workflow and advances in mass spectrometry technology. Despite these strengths, mass spectrometry faces limitations in dynamic range, sensitivity, read length, and sequence coverage, hindering complete <i>de novo</i> protein sequencing. These technological gaps underscore the need for innovative methods to provide more detailed and accurate protein sequence data. In the past decade, new protein sequencing methods, including tunneling current, fluorescence fingerprinting, and real-time dynamic fluorescence, have shown significant developmental potential. However, these methods are not yet ready for widespread application, as each still faces technical hurdles. Meanwhile, advances in nanopore DNA sequencing have sparked interest in applying nanopore technology to protein sequencing, particularly owing to its speed, convenience, and cost-effectiveness. Unlike DNA sequencing, protein sequencing presents greater challenges due to proteins’ complex three-dimensional structures, heterogeneous electrical charges, difficulties in directional movement, and diverse amino acid compositions, further complicated by post-translational modifications. Researchers have made significant strides in addressing these challenges, such as using unfolding enzymes, high temperatures, high voltage, and deformers to unravel protein structures, and employing charged sequences and electroosmotic flow to control peptide translocation. The latest strategies for nanopore protein sequencing can be broadly categorized into three approaches: strand sequencing, enzyme-assisted nanopore sequencing, and nanopore fingerprinting. In strand sequencing, dragging a protein-oligonucleotide conjugate through a nanopore with the aid of protein motors generates stepped current signals produced by the peptide strand. In enzyme-assisted nanopore sequencing, 20 proteinogenic amino acids and various post-translational modifications have been distinguished using nanopores, and sequencing of short peptides has also been demonstrated. In nanopore fingerprinting, polypeptide fragments resulting from protease digestion of a protein can be identified through nanopore sensing. Despite these advances, further improvements in protein engineering, data processing, identification accuracy, and read length are needed to make these strategies practically useful. This review provides an overview of the current major approaches to nanopore protein sequencing, emphasizing the strategies, recent advances, breakthroughs and challenges in nanopore protein sequencing. As nanopore technology continues to evolve, it is expected to offer more efficient and accurate sequencing solutions in proteomics, potentially leading to new technological breakthroughs in biochemistry and biomedicine.]]></description>
<pubDate>2024/8/26 15:53:01</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[LI Zi-Yi,LIU Lei,WU Hai-Chen,YI Ya-Kun]]></author>
</item>
<item>
<title><![CDATA[Review: Mass Spectrometry Based Single-cell Proteomics]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407010000003]]></link>
<description><![CDATA[In recent years, the development of single-cell sequencing technology has significantly advanced our understanding of single-cell genomics and transcriptomics. However, the study of proteomics, directly related to single-cell life processes, has been limited by slow technological progress. With advancements in sample preparation techniques and chromatography-mass spectrometry instruments, the analytical sensitivity of single-cell proteomics (SCP) has markedly improved. In this review, we thoroughly examine the development of SCP and its applications in life sciences. Regarding sample preparation, various methods such as gentle acoustic dispensing, microfluidic chips, and laser microdissection have been developed for single-cell sorting, gradually transitioning from multi-step to one-step processing, thereby reducing sample loss. In mass spectrometry, both label-free quantification and methods based on isotopic and isobaric labeling have been extensively explored, each with their own technical strengths and weaknesses. SCP has unveiled new biological insights in early embryonic cell development, stem cell differentiation, and spatial heterogeneity of liver tissues. Finally, we summarize the current challenges facing SCP technology, including detection throughput, cost, and data analysis complexity, while envisioning its future directions and emphasizing its broad potential in basic research and clinical applications.]]></description>
<pubDate>2024/8/25 22:19:26</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[XIE Jing-Sheng,YE Zi-Lu]]></author>
</item>
<item>
<title><![CDATA[Research: Engineering The Neck Hinge Reshapes The Processive Movement of Kinesin-3]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406260000002]]></link>
<description><![CDATA[<b>Objective</b> In kinesin-3, the neck coil correlates with the following segments to form an extended neck that contains a characteristic hinge diverse from a proline in KIF13B to a long flexible linker in KIF1A. The function of this neck hinge for controlling processive movement, however, remains unclear.<b>Methods</b> We made a series of modifications to the neck hinges of KIF13B and KIF1A and tested their movement using a single-molecule motility assay.<b>Results</b> In KIF13B, the insertion of flexible residues before or after the proline differentially impacts the processivity or velocity, while the removal of this proline increases the both. In KIF1A, the deletion of entire flexible neck hinge merely enhances the processivity. The engineering of these hinge-truncated necks of kinesin-3 into kinesin-1 similarly boosts the processive movement of kinesin-1.<b>Conclusion</b> The neck hinge in kinesin-3 controls its processive movement and proper modifications tune the motor motility, which provides a novel strategy to reshape the processive movement of kinesin motors.]]></description>
<pubDate>2024/8/25 22:16:36</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[FENG Wei,LI Dong,LIANG Xin,REN Jin-Qi,SONG Yin-Long]]></author>
</item>
<item>
<title><![CDATA[Review: Multilayered Regulation of The Eukaryotic DNA Replication]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407010000002]]></link>
<description><![CDATA[DNA replication is a fundamental DNA metabolism process in living organisms. In human cells, thousands of DNA replication origins are activated simultaneously within the chromatin environment to initiate the replication process and eventually complete genome duplication. This process is regulated by the chromatin environment and coordinated with other chromatin metabolism events, ensuring accurate inheritance of genomic and epigenetic information. With the rapid development of research techniques and the massive accumulation of research data, the systematic understanding of DNA replication in eukaryotic cells, especially in mammals, within complex chromatin environments is a future research trend. Here, we review the multilayered regulatory modes of DNA replication from initiation to termination in the chromatin environment, offering insights for future research.]]></description>
<pubDate>2024/8/25 20:05:53</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[HU Jia-Zhi,LIU Xu-Hao,LIU Yang,ZHANG-DING Zheng-Rong]]></author>
</item>
<item>
<title><![CDATA[Perspectives: Three New Understandings of Oxidative Stress]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407220000001]]></link>
<description><![CDATA[Life is inseparable from oxygen. The redox state in cells directly regulates the functions of biomacromolecules and mediates cell signal transduction and many physiological and pathological processes such as aging, neurodegenerative diseases, cardiovascular diseases, metabolic diseases, and tumors. In view of The Free Radical Theory of Aging proposed in the 1950s, oxidative stress has long been confused with oxidative damage and is regarded as bad. Antioxidation once became synonymous of “anti-aging”. Here in combination the relevant research work of our laboratory and the frontiers of the redox biology field, we propose three new understandings of “oxidative stress”. (1) Oxidative stress is not equal to oxidative damage and has important physiological functions. (2) Oxidative stress is not related to all physiological and pathological processes without specificity, while redox regulation is specific and redox modification of biomacromolecules is the mechanism. (3) Non-targeting antioxidants do not work well, the redox balance has precise properties, 5R principle should be considered for antioxidant pharmacology and the new era of precision redox medicine has begun. Future challenges are reflected in three major aspects: basic research on redox biology and medicine, the specific molecular mechanisms of oxidative stress in physiological and pathological processes and environmental stress, and precise redox intervention against aging and diseases. Multidisciplinary basic research, in-depth cooperation between basic research and clinical research and international collaboration must be enhanced to achieve breakthroughs in the understanding of redox in life processes, breakthroughs in redox mechanisms, and breakthroughs in precision intervention!]]></description>
<pubDate>2024/8/25 20:02:08</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[CHEN Chang]]></author>
</item>
<item>
<title><![CDATA[Hypoglycemic Effect and Mechanism of ICK Pattern Peptides]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202405150000001]]></link>
<description><![CDATA[Diabetes is a very complex endocrine disease whose common feature is the increase in blood glucose concentration. Persistent hyperglycemia can lead to blindness, kidney and heart disease, neurodegeneration, and many other serious complications that have a significant impact on human health and quality of life. The number of people with diabetes is increasing yearly. The global diabetes prevalence in 20-79 year olds in 2021 was estimated to be 10.5% (536.6 million), and it will rise to 12.2% (783.2 million) in 2045. The main modes of intervention for diabetes include medication, dietary management, and exercise conditioning. Medication is the mainstay of treatment. Marketed diabetes drugs such as metformin and insulin, as well as GLP-1 receptor agonists, are effective in controlling blood sugar levels to some extent, but the preventive and therapeutic effects are still unsatisfactory. Peptide drugs have many advantages such as low toxicity, high target specificity, and good biocompatibility, which opens up new avenues for the treatment of diabetes and other diseases. Currently, insulin and its analogs are by far the main life-saving drugs in clinical diabetes treatment, enabling effective control of blood glucose levels, but the risk of hypoglycemia is relatively high and treatment is limited by the route of delivery. New and oral anti-diabetic drugs have always been a market demand and research hotspot. Inhibitor cystine knot (ICK) peptides are a class of multifunctional cyclic peptides. In structure, they contain three conserved disulfide bonds (C3-C20, C7-C22, and C15-C32) form a compact “knot” structure, which can resist degradation of digestive protease. Recent studies have shown that ICK peptides derived from legume, such as PA1b, Aglycin, Vglycin, Iglycin, Dglycin, and aM<sub>1</sub>, exhibit excellent regulatory activities on glucose and lipid metabolism at the cellular and animal levels. Mechanistically, ICK peptides promote glucose utilization by muscle and liver through activation of IR/AKT signaling pathway, which also improves insulin resistance. They can repair the damaged pancrease through activation of PI3K/AKT/Erk signaling pathway, thus lowering blood glucose. The biostability and hypoglycemic efficacy of the ICK peptides meet the requirements for commercialization of oral drugs, and in theory, they can be developed into natural oral anti-diabetes peptide drugs. In this review, the structural properties, activity and mechanism of ICK pattern peptides in regulating glucose and lipid metabolism were summaried, which provided a reference for the development of new oral peptides for diabetes.]]></description>
<pubDate>2024/8/25 19:46:15</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Lin-Fang,GUO Ye-Ning,HU Kang-Hong,HUANG Hui-Zhong,YAO Chen-Guang,ZHANG Jia-Fan]]></author>
</item>
<item>
<title><![CDATA[Review: Target Residence of CRISPR/Cas in Genome Editing]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406280000002]]></link>
<description><![CDATA[The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) is widely used for targeted genomic and epigenomic modifications, transcriptional regulation and real-time cell imaging, and has already demonstrated great potential for applications in agriculture, industry and medicine. The promise of the technology depends upon the five intrinsic properties of CRISPR/Cas: targeting, target unwinding, target cutting, target residence, and collateral cleavage. Here, mainly using <i>Streptococcus pyogenes</i> CRISPR/Cas9 as example, we will focus on the target residence of CRISPR/Cas in applications of the CRISPR/Cas technology, summarize the recent progress, and discuss the effect of CRISPR/Cas target binding and residence on DNA double strand break repair pathway choices and the opportunities that CRISPR/Cas target residence presents to optimize the CRISPR/Cas technology.]]></description>
<pubDate>2024/8/25 19:42:43</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[CHEN Ruo-Dan,FENG Yi-Li,XIE An-Yong]]></author>
</item>
<item>
<title><![CDATA[Review: Structural Basis of Photosystem I and Its Photosynthesis Regulation in Green Plants]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406260000003]]></link>
<description><![CDATA[Photosynthesis is one of the most important chemical reactions on earth. Oxygenic photosynthetic organisms convert solar energy into chemical energy and release oxygen, thus sustaining almost all life on this planet. Oxygenic phototrophs possess two photosystems, namely photosystem I (PSI) and photosystem II (PSII). Both photosystems are multi-subunit protein complexes embedded in the thylakoid membrane and bind numerous pigment molecules, thereby can efficiently harvest light energy and transfer it to the reaction center. PSI is one of the most efficient nano-photochemical machineries in nature. Its complex structure and sophisticated regulatory mechanisms are crucial for the high photosynthetic efficiency of oxygenic phototrophs. Eukaryotic PSI consists of a core complex where charge separation occurs and a peripheral antenna system that increases the light absorption cross section of the core. The PSI core possesses approximately 12-15 protein subunits, most of them are conserved during evolution, with only several small transmembrane subunits emerging or disappearing. The peripheral antenna system usually contains a number of light-harvesting complexes (LHCs). In contrast to the core, the protein composition and arrangement of LHC antennae vary considerably among different species of photosynthetic organisms. Previous results showed that in angiosperm plants (such as <i>Pisum sativum</i> and <i>Zea mays</i>), the PSI core binds four LHC proteins arranged as an arc-shaped belt, whereas in green algae, the PSI core is associated with more LHCs, presumably a result of adaption to the low-light aquatic environment. In addition, structures of several green algal PSI complexes indicated that green algae can dynamically regulate their light-harvesting capability by adjusting the size of PSI antennae, thereby better adapting to the changing natural environment. In addition to the light harvesting and energy conversion, PSI is also involved in several photosynthetic regulatory processes, including state transitions and cycle electron flow/transfer (CEF/CET). State transitions represent a short-term regulatory mechanism that balances the energy distribution between the two photosystems. During the process of state transitions, when PSII is preferentially excited, a portion of the PSII antenna, the major light-harvesting complex II (LHCII), is phosphorylated, and these phosphorylated LHCIIs bind to the PSI core, forming the PSI-LHCI-LHCII complex. This process is reversible, and when PSI is preferentially excited, LHCII is dephosphorylated, detaches from the PSI and binds to the PSII. Previous reports revealed that although higher plants and green algae possess a similar process of state transitions, their PSI-LHCI-LHCII complexes exhibit specific characteristics in addition to common conserved features. CEF is another important regulatory process in which the PSI participates. In NDH (NAD(P)H dehydrogenase-like complex) dependent CEF, PSI can form supercomplex with NDH to improve the electron transfer efficiency. Previous reports suggested that the PSI bound to NDH and the PSI not bound to NDH possess different LHC compositions, and the exact protein identity and location were recently unraveled based on high-resolution structures. In the past two decades, a number of structures of PSI and PSI-containing complexes have been determined. These structural data provide important information concerning the protein assembly and pigment arrangement of these complexes, allowing for a deeper understanding of the structure and function of green plant PSI. In this review, we summarize the research progresses on the structure of green plant PSIs and PSI-containing complexes involved in photosynthetic regulation, primarily based on the results obtained in our laboratory, and discuss the current state of knowledge concerning the antenna arrangement and the regulatory mechanisms of plant PSI.]]></description>
<pubDate>2024/8/24 22:16:39</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[LI Mei,SU Xiao-Dong]]></author>
</item>
<item>
<title><![CDATA[Review: DNA Barcode-based High-throughput Mesoscale Connectomics]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406300000001]]></link>
<description><![CDATA[Connectomics, a research field in neuroscience studying the synaptic connectivity patterns between neurons across different brain regions, is crucial for understanding neural computations underlying complex functions such as emotion, learning, and cognition. Specifically, micrometer-resolution mesoscale connectomics has become the most widely used technology in rodent neuroscience due to its unique advantages, and it also has the potential to transform brain research in non-human primates. Traditional mesoscale connectome techniques typically use fluorescence labeling and optical imaging to perform anterograde or retrograde tracing of neural circuits. To achieve single-cell resolution, methods for sparse labeling of neurons have been developed. However, it remains challenging to trace neurons in high throughput in individual animals and integrate multi-omics data across modalities. In the past decade, high-throughput mesoscale connectome technologies based on DNA barcoding have made significant progress. These technologies have provided novel tools to map single cell connectome, with higher throughput, lower cost, and multi-omics compatibility. Here we review several mature mesoscale connectome technologies based on DNA barcoding, discussing their principles, applications, advantages and disadvantages. We also propose future directions for barcoding-based connectomics.]]></description>
<pubDate>2024/8/24 22:09:38</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[HU Peng-Kai,HUANG Long-Wen]]></author>
</item>
<item>
<title><![CDATA[<i>Wdr63</i> Deletion Aggravates Ulcerative Colitis Likely by Affecting Th17/Treg Balance and Gut Microbiota]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202404080000001]]></link>
<description><![CDATA[<b>Objective</b> Ulcerative colitis is a prevalent immunoinflammatory disease. Th17/Treg cell imbalance and gut microbiota dysregulation are key factors in ulcerative colitis pathogenesis. The actin cytoskeleton contributes to regulating the proliferation, differentiation, and migration of Th17 and Treg cells. <i>Wdr63</i>, a gene containing the WD repeat domain, participates in the structure and functional modulation of actin cytoskeleton. Recent research indicates that WDR63 may serve as a regulator of cell migration and metastasis <i>via</i> actin polymerization inhibition. This article aims to explore the effect of <i>Wdr63</i> deletion on Th17/Treg cells and ulcerative colitis.<b>Methods</b> We constructed <i>Wdr63</i><sup>-/-</sup> mice, induced colitis in mice using dextran sulfate sodium salt, collected colon tissue for histopathological staining, collected mesenteric lymph nodes for flow cytometry analysis, and collected healthy mouse feces for microbial diversity detection.<b>Results</b> Compared with wild-type colitis mice,<i> Wdr63</i><sup>-/-</sup> colitis mice had a more pronounced shortening of colonic tissue, higher scores on disease activity index and histological damage index, Treg cells decreased and Th17 cells increased in colonic tissue and mesenteric lymph nodes, a lower level of anti-inflammatory cytokine IL-10, and a higher level of pro-inflammatory cytokine IL-17A. In addition, WDR63 has shown positive effects on maintaining intestinal microbiota homeostasis. It maintains the balance of Bacteroidota and Firmicutes, promoting the formation of beneficial intestinal bacteria linked to immune inflammation.<b>Conclusion</b> <i>Wdr63</i> deletion aggravates ulcerative colitis in mice, WDR63 inhibits colonic inflammation likely by regulating Th17/Treg balance and maintains intestinal microbiota homeostasis.]]></description>
<pubDate>2024/8/24 21:04:40</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CAO Yang-Yang,FAN Zhi-Peng,YANG Qiu-Bo,ZHU Hao,ZHU Meng-Yuan]]></author>
</item>
<item>
<title><![CDATA[Review: The Implementation, Clinical Progress and Technical Challenges of Implantable Brain-Computer Interface Systems]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406280000004]]></link>
<description><![CDATA[The breakthrough progress of implantable brain-computer interfaces (iBCIs) technology in the field of clinical trials has attracted widespread attention from both academia and industry. The development and advancement of this technology have provided new solutions for the rehabilitation of patients with movement disorders. However, challenges from many aspects make it difficult for iBCIs to further implement and transform technologies. This paper illustrates the key challenges restricting the large-scale development of iBCIs from the perspective of system implementation, then discusses the latest clinical application progress in depth, aiming to provide new ideas for researchers. For the system implementation part, we have elaborated the front-end signal collector, signal processing and decoder, then the effector. The most important part of the front-end module is the neural electrode, which can be divided into two types: piercing and attached. These two types of electrodes are newly classified and described. In the signal processing and decoder section, we have discussed the experimental paradigm together with signal processing and decoder for the first time and believed that the experimental paradigm acts as a learning benchmark for decoders that play a pivotal role in iBCIs systems. In addition, the characteristics and roles of the effectors commonly used in iBCIs systems, including cursors and robotic arms, are analyzed in detail. In the clinical progress section, we have divided the latest clinical progress into two categories: functional rehabilitation and functional replacement from the perspective of the application scenarios of iBCIs. Functional rehabilitation and functional replacement are two different types of application, though the boundary between the two is not absolute. To this end, we have first introduced the corresponding clinical trial progress from the three levels: application field, research team, and clinical timeline, and then conducted an in-depth discussion and analysis of their functional boundaries, in order to provide guidance for future research. Finally, this paper mentions that the key technical challenges in the development of iBCIs technology come from multiple aspects. First of all, from the signal acquisition level, high-throughput and highly bio-compatible neural interface designing is essential to ensure long-term stable signal acquisition. The electrode surface modification method and electrode packaging were discussed. Secondly, in terms of decoding performance, real-time, accurate, and robust algorithms have a decisive impact on improving the reliability of iBCIs systems. The third key technology is from the perspective of practicality, we believe that the signal transmission mode of wireless communication is the trend of the future, but it still needs to overcome challenges such as data transmission rate and battery life. Finally, we believe that issues such as ethics, privacy, and security need to be addressed through legal, policy, and technological innovation. In summary, the development of iBCIs technology requires not only the unremitting efforts of scientific researchers, but also the participation and support of policymakers, medical professionals, technology developers, and all sectors of society. Through interdisciplinary collaboration and innovation, iBCIs technology will achieve wider clinical applications in the future and make important contributions to improving the quality of life of patients.]]></description>
<pubDate>2024/8/24 20:02:18</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[GUO Hao-Yue,LI Xiao-Jian,MA Liang,QIU Wen-Can,YANG Jun-Jie]]></author>
</item>
<item>
<title><![CDATA[Review: Optimization of Prime Editing System and Its Application in Large DNA Fragment Editing]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406250000002]]></link>
<description><![CDATA[Gene editing technology utilizes artificial nucleases to insert, replace, or delete specific sequences in desired genomic regions. The discovery of CRISPR/Cas9 nucleases was a milestone in the development of advanced gene editing tools, which revolutionized the field due to their simplicity and versatility. However, the limited precision of Cas9 nucleases remains a notable obstacle. Recently, derivative technologies such as prime editing have earned considerable attention for their enhanced efficiency and precision. The prime editing system consists of two components: the SpCas9 nickase (H840A) fused with reverse transcriptase (MLV-RT) and an engineered prime editing guide RNA (pegRNA). This system can irreversibly introduce various types of genetic changes into the genome, including 12 possible types of point mutations, as well as insertions, deletions and their combinations, without the need for DNA double-strand breaks (DSBs) or donor DNA templates. Prime editing offers several advantages in terms of editing accuracy, versatility, PAM constraints, and off-target effects. The editing results of prime editing system is highly accurate and can be tailored to specific needs. In addition, the system can be edited near or far from PAM sites, making it less constrained by PAM site restrictions. Moreover, it demonstrates high genome-wide specificity. The system also supports a variety of edits, demonstrating immense potential, especially in large DNA fragment editing—an area that relied heavily on CRISPR/Cas9 nucleases before. The development of prime editing, especially bi-direction prime editor, shed new light on large DNA fragment manipulations, including deletions, insertions, replacements, gene integration, as well as chromosomal translocations, inversions, and tandem duplications. Despite the significant progress made with prime editing technology, its application still faces challenges, especially low editing efficiency, which limits its potential in broader research and clinical settings. Consequently, researchers are exploring strategies to enhance the efficiency of prime editing. This review highlights several approaches to improving prime editing efficiency. These include optimizing pegRNA by refining PBS and RT parameters, increasing pegRNA stability and expression levels, and developing automated pegRNA design software. Additionally, efforts are being made to optimize the prime editing system proteins, such as screening for Cas9 and reverse transcriptase variants and performing codon optimization. The final aspect is the regulation of endogenous factors, including the inhibition of mismatch repair mechanisms and the modulation of chromatin environment. These approaches significantly enhance the practicality of prime editing in research and clinical contexts. In conclusion, prime editing represents a major advancement in the field of gene editing, offering powerful tools and methods for both basic research and clinical applications. This review will introduce the discovery, improvement and applications of prime editors, with a focus on prime editing mediated large DNA fragment manipulations. Hopefully, these insights will serve as valuable references for future research and applications of prime editing technology.]]></description>
<pubDate>2024/8/24 15:17:39</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[JIAO Yao-Ge,YAO Shao-Hua]]></author>
</item>
<item>
<title><![CDATA[Review: Immunotherapy for Colorectal Cancer]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407010000004]]></link>
<description><![CDATA[Improving the prognosis of patients with colorectal cancer (CRC) holds important clinical and social significance. Immunotherapy is an emerging therapy approach for cancers, which mainly include immune checkpoint inhibitors (ICI), immune vaccine and adoptive cell therapy. ICI have achieved good clinical translation in treatment of metastatic CRC with deficient DNA mismatch repair/high microsatellite instability (dMMR/MSI-H) status. The application of some ICI, such as PD-1 inhibitors pembrolizumab and nivolumab, in this type patients have been approved by the FDA. In addition,numerous positive results are acquired in clinical trials of neoadjuvant therapy for resectable dMMR/MSI-H CRC. These results greatly bolstered the exploration enthusiasm of CRC immunotherapy. However, the proficient DNA mismatch repair/microsatellite stability (pMMR/MSS) CRC, which accounting for the vast majority in related patients, hardly benefit from ICI therapy. Various combination strategies, mainly including ICI combined with traditional chemotherapy, radiotherapy, or targeted therapy, have been attempted to alter the “cold tumors” microenvironment characteristics of pMMR/MSS CRC in clinical trials, whereas no breakthrough results were reached. Theoretically, tumor vaccines are ideal choice to break down the barrier of insufficient immune infiltration in solid tumors. However, the outcomes of related clinical trials in CRC patents are not satisfactory, and partially due to the weak specificity of the applied tumor-associated antigens. Clinical studies of adoptive cell therapy in CRC are also actively underway. The favorable efficacy of tumor-infiltrating lymphocyte, cytokine-induced killer (CIK) and dendritic cell-CIK in CRC have been confirmed, while the CAR-T and TCR-T therapies need more exploration based on screening more suitable antigens and optimizing engineering design. In this review, we made a summary based on the mainline of clinical studies related to diverse immunotherapies, so as to clarify the progress of CRC immunotherapy and provide bases for exploration of better treatment options.]]></description>
<pubDate>2024/8/24 14:12:20</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[NIE He,WANG Hui,XU Hao-Ran,ZHAN Qiang,ZHANG Qing-Lin,ZHAO Xiao-Yi]]></author>
</item>
<item>
<title><![CDATA[Review: GisSPA: a New Method for <i>in situ</i> Protein Structural Analysis Based on Cryo-EM Single-particle-like Non-tilting Imaging Data]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406300000005]]></link>
<description><![CDATA[Compared to <i>in vitro</i> purified protein complexes, protein complexes in a working state within cells are often more complete, and their three-dimensional structures are in a fully physiological conformation. This is crucial for understanding the structural basis of important functions that protein complexes play in life activities and can also provide more precise target information for drug design. The direct <i>in situ</i> structural analysis of protein complexes within cells is known as <i>in situ</i> structural analysis of proteins, and cryo-electron tomography (cryo-ET) is the key technology for <i>in situ</i> structural analysis. However, cryo-ET has limitations such as low data acquisition throughput for tilt series, cumbersome data processing, and special sample requirements to achieve near-atomic resolution. These issues have become bottlenecks limiting the resolution and practical application of <i>in situ</i> structural analysis. In recent years, a method based on the analysis of non-tilted images has developed rapidly, allowing high-throughput, high-resolution structural analysis of protein complexes within cells. This review will discuss the principles of this method, compare its advantages and disadvantages with traditional tomography, and provide an outlook on <i>in situ</i> structural analysis of proteins. It is hoped that this review will assist structural biologists in better choosing suitable tools.]]></description>
<pubDate>2024/8/24 14:08:24</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[CAO Duan-Fang,ZHANG Xin-Zheng,ZHAO Ming-Jie]]></author>
</item>
<item>
<title><![CDATA[Etiology and Management of Astronaut Low Back Pain Induced by Space Flight or Simulated Microgravity]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202405080000002]]></link>
<description><![CDATA[It has been demonstrated that long-term space flights have a significantly greater impact on the cardiovascular, skeletal, and nervous systems of astronauts. The structural and functional alterations in the skeletal and muscular systems resulting from exposure to weightlessness can lead to the development of low back pain, significantly impairing the ability of astronauts to perform tasks and respond to emergencies. Both space flight and simulated microgravity have been shown to result in low back pain among astronauts, with the following factors identified as primary contributors to this phenomenon. The occurrence of intervertebral disc (IVD) edema results in the stimulation of type IV mechanoreceptors, which subsequently activate nociceptive afferents. The protrusion of an IVD causes compression of the spinal nerve roots. Furthermore, the elongation of the vertebral column and/or the diminished lumbar curvature of the spine exert traction on the dorsal root nerves. Paravertebral muscle degeneration leads to the inhibition of decreased nociceptive activity of the wide-dynamic range neurons of the spinal dorsal horn. Moreover, endogenous pain descending facilitation triggered by conditioning stimulation can be enhanced <i>via</i> the thalamic mediodorsal nuclei, while endogenous pain descending inhibition triggered by conditioning stimulation can be weakened <i>via</i> the thalamic ventromedial nuclei. Psychological factors may contribute to the development of low back pain. The mechanisms governing the generation, maintenance, and alleviation of low back pain in weightlessness differ from those observed in normal gravitational environments. This presents a significant challenge for space medicine research. Therefore, the elucidation of the occurrence and development mechanism of low back pain in weightlessness is important for the prevention and treatment during space flight. To reduce the incidence of low back pain during long-term missions on the space station, astronauts may choose to wear specialized space clothing that can provide axial physiological loads, designed to stimulate both musculature and skeletal structures, mitigating potential increases in vertebral column length, diminished lumbar curvature, and intervertebral disc edema and/or muscular atrophy. Additionally, assuming a “fetal tuck position” described as the knees to chest position may increase lumbar IVD hydrostatic pressure, subsequently reducing disc volume, rectifying diminished lumbar curvature, and alleviating dorsal root nerve tensions. Moreover, this position may reduce type IV mechanoreceptor facilitation and nerve impulse propagation from the sinuvertebral nerves of the annulus fibrosus. Elongated posterior soft tissues (apophyseal joint capsules and ligaments) with spinal flexion may potentially stimulate type I and II mechanoreceptors. It is also recommended to exercise the paraspinal muscles to prevent and alleviate the decrease in their cross-sectional area and maintain their structure and function. Photobiomodulation has been proved to be an effective means of activating the pain descending inhibition pathway of the central nervous system. In addition, astronauts should be encouraged to participate in mission-related activities and strive to avoid psychological problems caused by the long-term confinement in a small space station. The article presents a concise review of potential causes and targeted treatment strategies for low back pain induced by space flight or simulated microgravity in recent years. Its objective is to further elucidate the mechanisms underlying the occurrence and development of low back pain in weightless environments while providing scientific evidence to inform the development of guidelines for preventing, treating, and rehabilitating low back pain during long-term space flights.]]></description>
<pubDate>2024/8/16 15:28:44</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LEI Jing,LIU Yan-Feng,YOU Hao-Jun]]></author>
</item>
<item>
<title><![CDATA[Applications of Vaterite in Drug Loading and Controlled Release]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407080000002]]></link>
<description><![CDATA[Currently, the drug delivery system (DDS) based on nanomaterials has become a hot interdisciplinary research topic. One of the core issues is drug loading and controlled release, in which the key lever is carriers. Vaterite, as an inorganic porous nano-material, is one metastable structure of calcium carbonate, full of micro or nano porous. Recently, vaterite has attracted more and more attention, due to its significant advantages, such as rich resources, easy preparations, low cost, simple loading procedures, good biocompatibility and many other good points. Vaterite, gained from suitable preparation strategies, can not only possess the good drug carrying performance, like high loading capacity and stable loading efficiency, but also improve the drug release ability, showing the better drug delivery effects, such as targeting release, pH sensitive release, photothermal controlled release, magnetic assistant release, optothermal controlled release. At the same time, the vaterite carriers, with good safety itself, can protect proteins, enzymes, or other drugs from degradation or inactivation, help imaging or visualization with loading fluorescent drugs <i>in vitro</i> and <i>in vivo</i>, and play synergistic effects with other therapy approaches, like photodynamic therapy, sonodynamic therapy, and thermochemotherapy. Latterly, some renewed reports in drug loading and controlled release have led to their widespread applications in diverse fields, from cell level to clinical studies. This review introduces the basic characteristics of vaterite and briefly summarizes its research history, followed by synthesis strategies. We subsequently highlight recent developments in drug loading and controlled release, with an emphasis on the advantages, quantity capacity, and comparations. Furthermore, new opportunities for using vaterite in cell level and animal level are detailed. Finally, the possible problems and development trends are discussed.]]></description>
<pubDate>2024/8/14 19:06:08</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HUANG Zheng-Yu,LI Qing-Ning,PAN Ming-Yu,PAN Qing,SONG Xiao-Hui,XU Jian-Feng]]></author>
</item>
<item>
<title><![CDATA[Preparation of Phenolic Acid-sodium Hyaluronate Copolymers and <i>in vitro</i> Antioxidant Activity Assessment]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202310300000002]]></link>
<description><![CDATA[<b>Objective</b> Sodium hyaluronate (HA) was used as the research object to modify it with phenolic acid in order to obtain the molecular structure with better antioxidant activity or even new activity.<b>Methods</b> In this study, 5 kinds of phenolic acid-sodium hyaluronate was prepared by free radical-mediated grafting method, and the grafts with the highest grafting degree were selected to optimize the synthesis conditions. Then, grafts structure and physicochemical properties were analyzed. The grafts were characterized by IR, UV, <sup>1</sup>H NMR, FESEM and TGA spectra. The<i> in vitro</i> antioxidant capacity of grafts was determined by the scavenging ability of DPPH·, ABTS<sup>+</sup>· and O<sup>2-·</sup>.<b>Results</b> Among 5 kinds of phenolic acid-sodium hyaluronate, the grafting rate of ferulic acid-sodium hyaluronate copolymer (FA-HA) was highest , which was chosen as experimental sample in the following tests. Firstly, the reaction conditions were investigated and the highest grafting rate was (16.59±0.31) mg/g at the optimal preparation conditions. Then, FA-HA structure and physicochemical properties were analyzed. Data from UV, IR, <sup>1</sup>H NMR analyses, TGA showed that FA were successfully grafted to HA. Compared with HA, the results of gel permeation chrematography (GPC) showed that the molecular mass distribution of FA-HA copolymer decreased from 34.4 to 31.5 ku, but the uniformity of molecular distribution was improved. FESEM results showed that the structure of copolymer exhibited a closely connected lamellar structure with a relatively smooth surface. TGA results showed that thermal stability of FA-HA had a little decline. The antioxidant performance <i>in vitro</i> results showed that, during 0.25-10 g/L, FA-HA can eliminate (83.76±4.86)% DPPH·, (76.95±5.06)% ABTS<sup>+</sup>· and (83.08±2.51)% O<sup>2-·</sup> respectively at 10 g/L. which were higher than that of native HA and FA.<b>Conclusion</b> FA and HA were successfully grafted together by free radical grafting, and the grafted FA-HA had better antioxidant activity<i> in vitro</i>, which provided a theoretical basis for further research and development of phenolic acid-HA grafts.]]></description>
<pubDate>2024/8/13 22:14:24</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[GONG Jin-Song,HAN Ting-Ting,JIANG Min,LI Qing-Na,SHI Jin-Song,WANG Xiao-Na,YANG Su-Zhen,ZHANG Xiao-Yue]]></author>
</item>
<item>
<title><![CDATA[Review: Optical-neural Stimulation in Non-human Primates: Modulating Brain Function and Behavior]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202407090000003]]></link>
<description><![CDATA[Optical-neural stimulation, which encompasses cutting-edge techniques such as optogenetics and infrared neurostimulation, employs distinct mechanisms to modulate brain function and behavior. These advanced neuromodulation techniques offer accurate manipulation of targeted areas, even selectively modulating specific neurons, in the brain. This makes it possible to investigate the cause-and-effect connections between neural activity and behavior, allowing for a better comprehension of the intricate brain dynamics towards complex environments. Non-human primates serve as an essential animal model for investigating these complex functions in brain research, bridging the gap between the basic research and clinical applications. One of the earliest optical studies utilizing optogenetic neuromodulation in monkeys was conducted in 2009. Since then, the optical-neural stimulations have been effectively applied in non-human primates. This review summarises recent research that employed optogenetics or infrared neurostimulation techniques to regulate brain function and behavior in non-human primates. The current state of optical-neural stimulations discussed here demonstrates their efficacy in advancing the understanding of brain systems. Nevertheless, there are still challenges that need to be addressed before they can fully achieve their potential.]]></description>
<pubDate>2024/8/9 22:49:56</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[CHEN Yi-Bing,WANG Huan,YANG Yan]]></author>
</item>
<item>
<title><![CDATA[Review: The Neural Network Representation of Pain in Humans]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202406220000001]]></link>
<description><![CDATA[Pain is an unpleasant sensory and emotional experience involving multi-level neural processing, with a highly complex neural activity pattern. Recent advancements in non-invasive brain functional imaging techniques have enhanced our understanding of the neural mechanisms underlying pain processing in humans at the whole-brain level. Functional magnetic resonance imaging (fMRI), in particular, plays an important role due to its high spatial resolution and has driven significant advancements in this field. This review focused on fMRI studies of pain in humans. We first summarized research that explored brain responses to pain and showing that pain processing involves neural activities across multiple brain regions, constituting the pain matrix, which includes the somatosensory cortex, thalamus, insula, anterior cingulate cortex, and other areas. However, modulating the activity of a single brain region has limited effects on pain experiences, suggesting that pain processing entails communications among multiple brain regions. Thus, we reviewed research investigating interactions between brain regions, finding that multiple neural pathways spanning the whole brain are involved in pain processing. Beyond interactions between pairs of regions, understanding how these interactions construct a pain-related network is crucial for fully comprehending the neural representation of pain. Two main approaches are used to describe neural networks across the whole brain. The first one is theory-driven, such as graph theory. Using this method, researchers explored how network properties evolve during pain processing and identified a tightly connected network that emerges during pain, encompassing the somatosensory, salience, and fronto-parietal networks, forming a pain-related super-system. As pain is modulated or diminishes, this system becomes less connected. The second approach relies on data-driven methods, such as methods based on independent component analysis or principal component analysis, and machine learning. These methods are not constrained by pre-defined brain networks. Advancements in machine learning have provided valuable insights, enabling researchers to develop pain biomarkers with promising clinical potential. Theory-driven and data-driven approaches provide complementary insights into our understanding of the neural mechanisms of pain. In recent years, two rapidly advancing and promising techniques have further enhanced the precision and comprehensiveness of pain neural network. One is ultra-high-field magnetic resonance imaging, and the other is simultaneous brain-spinal imaging. Ultra-high-field magnetic resonance imaging has overcome previous spatial resolution limitations in fMRI. In subcortical regions, it helps distinguish neural activities of different nuclei. In cortical regions, high resolution enables the differentiation of neural activities across cortical layers, thereby providing a more in-depth and detailed understanding of the neural mechanisms of pain. Simultaneous brain-spinal imaging technology enables the exploration of brain-spinal networks involved in pain processing, making it possible to construct a comprehensive neural network representation of pain throughout the entire central nervous system. Based on current findings, we suggested that in the clinical treatment of pain using neuromodulation techniques, the selection of stimulation targets could be guided by the pain neural network. Targeting hubs within the pain network could significantly impact the network and may efficiently influence pain experiences. Finally, we discussed the limitations of current research on the neural representation of pain and proposed future directions, including exploring pain-specific representation, systematically comparing experimental and clinical pain, and examining individualized neural representations.]]></description>
<pubDate>2024/8/4 13:26:00</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[TU Yi-Heng,YI Yang-Yang]]></author>
</item>
<item>
<title><![CDATA[Role of Innate Trained Immunity in Diseases]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202405300000001]]></link>
<description><![CDATA[The innate immune system can be boosted in response to subsequent triggers by pre-exposure to microbes or microbial products, known as “trained immunity”. Compared to classical immune memory, innate trained immunity has several different features. Firstly, the molecules involved in trained immunity differ from those involved in classical immune memory. Innate trained immunity mainly involves innate immune cells (<i>e.g.</i>, myeloid immune cells, natural killer cells, innate lymphoid cells) and their effector molecules (<i>e.g</i>., pattern recognition receptor (PRR), various cytokines), as well as some kinds of non-immune cells (<i>e.g</i>., microglial cells). Secondly, the increased responsiveness to secondary stimuli during innate trained immunity is not specific to a particular pathogen, but influences epigenetic reprogramming in the cell through signaling pathways, leading to the sustained changes in genes transcriptional process, which ultimately affects cellular physiology without permanent genetic changes (<i>e.g</i>., mutations or recombination). Finally, innate trained immunity relies on an altered functional state of innate immune cells that could persist for weeks to months after initial stimulus removal. An appropriate inducer could induce trained immunity in innate lymphocytes, such as exogenous stimulants (including vaccines) and endogenous stimulants, which was firstly discovered in bone marrow derived immune cells. However, mature bone marrow derived immune cells are short-lived cells, that may not be able to transmit memory phenotypes to their offspring and provide long-term protection. Therefore, trained immunity is more likely to be relied on long-lived cells, such as epithelial stem cells, mesenchymal stromal cells and non-immune cells such as fibroblasts. Epigenetic reprogramming is one of the key molecular mechanisms that induces trained immunity, including DNA modifications, non-coding RNAs, histone modifications and chromatin remodeling. In addition to epigenetic reprogramming, different cellular metabolic pathways are involved in the regulation of innate trained immunity, including aerobic glycolysis, glutamine catabolism, cholesterol metabolism and fatty acid synthesis, through a series of intracellular cascade responses triggered by the recognition of PRR specific ligands. In the view of evolutionary, trained immunity is beneficial in enhancing protection against secondary infections with an induction in the evolutionary protective process against infections. Therefore, innate trained immunity plays an important role in therapy against diseases such as tumors and infections, which has signature therapeutic effects in these diseases. In organ transplantation, trained immunity has been associated with acute rejection, which prolongs the survival of allografts. However, trained immunity is not always protective but pathological in some cases, and dysregulated trained immunity contributes to the development of inflammatory and autoimmune diseases. Trained immunity provides a novel form of immune memory, but when inappropriately activated, may lead to an attack on tissues, causing autoinflammation. In autoimmune diseases such as rheumatoid arthritis and atherosclerosis, trained immunity may lead to enhance inflammation and tissue lesion in diseased regions. In Alzheimer’s disease and Parkinson’s disease, trained immunity may lead to over-activation of microglial cells, triggering neuroinflammation even nerve injury. This paper summarizes the basis and mechanisms of innate trained immunity, including the different cell types involved, the impacts on diseases and the effects as a therapeutic strategy to provide novel ideas for different diseases.]]></description>
<pubDate>2024/8/2 12:40:35</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHENG Chuang,HE Jing,LIU Xiao-Wen,MOU Xiao-Qin,TAN Chao,WANG Jun,WANG Yue-Qing,ZHENG Xi,ZOU Li-Li]]></author>
</item>
<item>
<title><![CDATA[Severity Assessment Parameters and Diagnostic Technologies of Obstructive Sleep Apnea]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202405160000002]]></link>
<description><![CDATA[Obstructive sleep apnea (OSA) is an increasingly widespread sleep-breathing disordered disease, and is an independent risk factor for many high-risk chronic diseases such as hypertension, coronary heart disease, stroke, arrhythmias and diabetes, which is potentially fatal. The key to the prevention and treatment of OSA is early diagnosis and treatment, so the assessment and diagnostic technologies of OSA have become a research hotspot. This paper reviews the research progresses of severity assessment parameters and diagnostic technologies of OSA, and discusses their future development trends. In terms of severity assessment parameters of OSA, apnea hypopnea index (AHI), as the gold standard, together with the percentage of duration of apnea hypopnea (AH%), lowest oxygen saturation (LSpO<sub>2</sub>), heart rate variability (HRV), oxygen desaturation index (ODI) and the emerging biomarkers, constitute a multi-dimensional evaluation system. Specifically, the AHI, which measures the frequency of sleep respiratory events per hour, does not fully reflect the patients’ overall sleep quality or the extent of their daytime functional impairments. To address this limitation, the AH%, which measures the proportion of the entire sleep cycle affected by apneas and hypopneas, deepens our understanding of the impact on sleep quality. The LSpO<sub>2</sub> plays a critical role in highlighting the potential severe hypoxic episodes during sleep, while the HRV offers a different perspective by analyzing the fluctuations in heart rate thereby revealing the activity of the autonomic nervous system. The ODI provides a direct and objective measure of patients’ nocturnal oxygenation stability by calculating the number of desaturation events per hour, and the biomarkers offers novel insights into the diagnosis and management of OSA, and fosters the development of more precise and tailored OSA therapeutic strategies. In terms of diagnostic techniques of OSA, the standardized questionnaire and Epworth sleepiness scale (ESS) is a simple and effective method for preliminary screening of OSA, and the polysomnography (PSG) which is based on recording multiple physiological signals stands for gold standard, but it has limitations of complex operations, high costs and inconvenience. As a convenient alternative, the home sleep apnea testing (HSAT) allows patients to monitor their sleep with simplified equipment in the comfort of their own homes, and the cardiopulmonary coupling (CPC) offers a minimal version that simply analyzes the electrocardiogram (ECG) signals. As an emerging diagnostic technology of OSA, machine learning (ML) and artificial intelligence (AI) adeptly pinpoint respiratory incidents and expose delicate physiological changes, thus casting new light on the diagnostic approach to OSA. In addition, imaging examination utilizes detailed visual representations of the airway’s structure and assists in recognizing structural abnormalities that may result in obstructed airways, while sound monitoring technology records and analyzes snoring and breathing sounds to detect the condition subtly, and thus further expands our medical diagnostic toolkit. As for the future development directions, it can be predicted that interdisciplinary integrated researches, the construction of personalized diagnosis and treatment models, and the popularization of high-tech in clinical applications will become the development trends in the field of OSA evaluation and diagnosis.]]></description>
<pubDate>2024/7/25 17:52:36</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[FU Zhuo-Zhi,LI Mei-Xi,LIN Hai-Jun,WU Ya-Cen,YANG Yu-Xiang,YIN Ping-Ping,ZHANG Fu]]></author>
</item>
<item>
<title><![CDATA[Erk Signaling Pathway in Striatal D2-MSNs: an Essential Pathway for Exercise-induced Improvement in Parkinson’s Disease]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202405110000001]]></link>
<description><![CDATA[Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the progressive loss of dopamine (DA) neurons in the substantia nigra pars compacta (SNpc), primarily manifesting as motor dysfunctions such as resting tremor, muscle rigidity, and bradykinesia. According to the classical model of basal ganglia motor control, approximately half of the medium spiny neurons (MSNs) in the striatum are D1-MSNs, which constitute the direct pathway. These neurons express D<sub>1</sub>-dopamine receptor (D<sub>1</sub>R) and substance P, and they mainly participate in the selection, initiation, and execution of movements. The other half are D2-MSNs, which constitute the indirect pathway. These neurons express D<sub>2</sub>-dopamine receptor (D<sub>2</sub>R) and adenosine 2A receptors and are involved in inhibiting unnecessary movements or terminating ongoing movements, thereby adjusting movement sequences to perform more precise motor behaviors. The direct pathway in the striatum modulates the activity of motor cortex neurons by exciting D1-MSNs through neurotransmitters such as glutamate (Glu), allowing the motor cortex to send signals more freely to the motor system, thus facilitating the generation and execution of specific motor behaviors. Studies using D1-Cre and D2-Cre mice with neurons labeled for D<sub>1</sub>R and D<sub>2</sub>R have shown that both types of neurons are involved in the execution of movements, with D1-MSNs participating in movement initiation and D2-MSNs in inhibiting actions unrelated to the target movement. These findings suggest that the structural and functional plasticity of D1-MSNs and D2-MSNs in the basal ganglia circuitry enables motor learning and behavioral regulation. Additionally, when SNpc DA neurons begin to degenerate, D1-MSNs are initially affected but do not immediately cause motor impairments. In contrast, when D2-MSNs undergo pathological changes, they are first activated by upstream projecting neurons, leading to the inhibition of most motor behaviors and resulting in motor dysfunction. Therefore, it is hypothesized that motor impairments such as bradykinesia and initiation difficulties are more closely related to the functional activity of D2-MSNs. The extracellular signal-regulated kinase (Erk)/mitogen-activated protein kinase (MAPK) signaling pathway has been identified as a critical modulator in the pathophysiology of PD. Recent findings indicate that Erk/MAPK signaling pathway can mediate DA and Glu signaling in the central nervous system, maintaining normal functional activity of striatal MSNs and influencing the transmission of motor control signals. Within this complex regulatory network, the Erk/MAPK signaling pathway plays a key role in transmitting motor information to downstream neurons, regulating normal movements, avoiding unnecessary movements, and finely tuning motor behaviors. Our laboratory’s previous research found that 4 weeks of aerobic exercise intervention improved motor dysfunction in PD mice by inhibiting the Erk1/2 signaling upstream of striatal MSNs, primarily involving the Erk1/2 signaling in D2-MSNs rather than D1-MSNs. This review summarizes the neurobiological mechanisms of Erk/MAPK signaling pathway in D2-MSNs for the prevention and treatment of motor dysfunction in PD. By exploring the role of this signaling pathway in regulating motor abnormalities and preventing motor dysfunction in the central nervous system of PD, this review provides new theoretical perspectives for related mechanistic research and therapeutic strategies.]]></description>
<pubDate>2024/7/25 14:58:50</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Wei,GAO Bo,GE Yi-Tong,LAI Yi-Ning]]></author>
</item>
<item>
<title><![CDATA[Acute Inflammatory Pain Induces Sex-different Brain Alpha Activity in Anesthetized Rats Through Optically Pumped Magnetometer Magnetoencephalography]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202405070000001]]></link>
<description><![CDATA[<b>Objective</b> Magnetoencephalography (MEG), a non-invasive neuroimaging technique, meticulously captures the magnetic fields emanating from brain electrical activity. Compared with MEG based on superconducting quantum interference devices (SQUID), MEG based on optically pump magnetometer (OPM) has the advantages of higher sensitivity, better spatial resolution and lower cost. However, most of the current studies are clinical studies, and there is a lack of animal studies on MEG based on OPM technology. Pain, a multifaceted sensory and emotional phenomenon, induces intricate alterations in brain activity, exhibiting notable sex differences. Despite clinical revelations of pain-related neuronal activity through MEG, specific properties remain elusive, and comprehensive laboratory studies on pain-associated brain activity alterations are lacking. The aim of this study was to investigate the effects of inflammatory pain (induced by Complete Freund’s Adjuvant (CFA)) on brain activity in a rat model using the MEG technique, to analysis changes in brain activity during pain perception, and to explore sex differences in pain-related MEG signaling.<b>Methods</b> This study utilized adult male and female Sprague-Dawley rats. Inflammatory pain was induced <i>via </i>intraplantar injection of CFA (100 μl, 50% in saline) in the left hind paw, with control groups receiving saline. Pain behavior was assessed using von Frey filaments at baseline and 1 h post-injection. For MEG recording, anesthetized rats had an OPM positioned on their head within a magnetic shield, undergoing two 15-minute sessions: a 5-minute baseline followed by a 10-minute mechanical stimulation phase. Data analysis included artifact removal and time-frequency analysis of spontaneous brain activity using accumulated spectrograms, generating spectrograms focused on the 4-30 Hz frequency range.<b>Results</b> MEG recordings in anesthetized rats during resting states and hind paw mechanical stimulation were compared, before and after saline/CFA injections. Mechanical stimulation elevated alpha activity in both male and female rats pre- and post-saline/CFA injections. Saline/CFA injections augmented average power in both sexes compared to pre-injection states. Remarkably, female rats exhibited higher average spectral power 1 h after CFA injection than after saline injection during resting states. Furthermore, despite comparable pain thresholds measured by classical pain behavioral tests post-CFA treatment, female rats displayed higher average power than males in the resting state after CFA injection.<b>Conclusion</b> These results imply an enhanced perception of inflammatory pain in female rats compared to their male counterparts. Our study exhibits sex differences in alpha activities following CFA injection, highlighting heightened brain alpha activity in female rats during acute inflammatory pain in the resting state. Our study provides a method for OPM-based MEG recordings to be used to study brain activity in anaesthetized animals. In addition, the findings of this study contribute to a deeper understanding of pain-related neural activity and pain sex differences.]]></description>
<pubDate>2024/7/24 15:45:28</pubDate>
<category><![CDATA[技术与方法]]></category>
<author><![CDATA[CHEN Xiao-Wei,LIN Hui-Dan,LIN Xiang-Hong,MIAO Meng-Meng,PAN Chen,REN Yu-Xuan,WU Wen-Wei,ZHANG Yu]]></author>
</item>
<item>
<title><![CDATA[Insights on Peripheral Blood Biomarkers for Parkinson’s Disease]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202404220000001]]></link>
<description><![CDATA[Parkinson’s disease (PD) is a common neurodegenerative disorder with profound impact on patients’ quality of life and long-term health, and early detection and intervention are particularly critical. In recent years, the search for precise and reliable biomarkers has become one of the key strategies to effectively address the clinical challenges of PD. In this paper, we systematically evaluated potential biomarkers, including proteins, metabolites, epigenetic markers, and exosomes, in the peripheral blood of PD patients. Protein markers are one of the main directions of biomarker research in PD. In particular, α-synuclein and its phosphorylated form play a key role in the pathological process of PD. It has been shown that aggregation of α-synuclein may be associated with pathologic protein deposition in PD and may be a potential marker for early diagnosis of PD. In terms of metabolites, uric acid, as a metabolite, plays an important role in oxidative stress and neuroprotection in PD. It has been found that changes in uric acid levels may be associated with the onset and progression of PD, showing its potential as an early diagnostic marker. Epigenetic markers, such as DNA methylation modifications and miRNAs, have also attracted much attention in Parkinson’s disease research. Changes in these markers may affect the expression of PD-related genes and have an important impact on the onset and progression of the disease, providing new research perspectives for the early diagnosis of PD. In addition, exosomes, as a potential biomarker carrier for PD, are able to carry a variety of biomolecules involved in intercellular communication and pathological regulation. Studies have shown that exosomes may play an important role in the pathogenesis of PD, and their detection in blood may provide a new breakthrough for early diagnosis. It has been shown that exosomes may play an important role in the pathogenesis of PD, and their detection in blood may provide new breakthroughs in early diagnosis. In summary, through in-depth evaluation of biomarkers in the peripheral blood of PD patients, this paper demonstrates the important potential of these markers in the early diagnosis of PD and in the study of pathological mechanisms. Future studies will continue to explore the clinical application value of these biomarkers to promote the early detection of PD and individualized treatment strategies.]]></description>
<pubDate>2024/7/24 15:36:04</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Zi-Xuan,DENG Yu-Lin,LI Yu-Meng,LIU Jing-Kai]]></author>
</item>
<item>
<title><![CDATA[Research: Proteomic Analysis of Alveolar Macrophages in Pulmonary Fibrosis Microenvironment]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202404030000003]]></link>
<description><![CDATA[<b>Objective</b> Alveolar macrophages (AMs) are critical for maintaining the homeostasis of pulmonary microenvironment. They process surfactants to ensure alveoli patency, and also serve as the first line of immune defense against pathogen invasion. Available studies have shown that monocyte-derived AMs continuously release pro-inflammatory cytokines and chemokines, recruiting other immune cells to the damaged area during pulmonary fibrosis. These monocyte-derived AMs maintains and amplifies inflammation, playing a negative role in pulmonary fibrosis progression. Current researches have predominantly focused on the gene expression levels of AMs in pulmonary fibrosis microenvironment, with less emphasis on the function and regulation of proteins. This study aims to investigate the differentially expressed proteins (DEPs) of AMs under normal physiological conditions and after pulmonary fibrosis, in order to gain a more comprehensive understanding of the role of AMs in the progression of pulmonary fibrosis.<b>Methods</b> Firstly, the construction of bleomycin-induced pulmonary fibrosis mouse models was evaluated through using measurements such as body mass, lung coefficient, lung wet-to-dry mass ratio, H&E staining and Masson staining. Subsequently, AMs from both the saline controls and the pulmonary fibrosis models (2.5×10<sup>5</sup> cells per sample) were collected using FACS sorting, and protein expression profiles of these cells were obtained through label-free proteomics approach<bold>.</bold> The quality of the proteomic data was assessed by comparing our saline control proteomic data with public proteomic data of physiological AMs. Thirdly, DEPs analysis between the saline controls and the bleomycin groups was carried out using R package Prostar. Functional enrichment analyses of significantly upregulated DEPs were performed using R package Clusterprofiler for GO and KEGG pathways. Finally, the STRING database was used to explore the protein-protein interaction networks related to phagocytosis regulation, inflammatory response regulation, and I-κB/NF-κB signaling pathway. The expression levels of Tlr2 and Pycard were detected respectively by FACS and western blotting.<b>Results</b> Compared to the saline controls, mice in the bleomycin groups exhibited a lower average body mass, extensive infiltration of inflammatory cells, and deposition of collagen in the lungs. This indicates that bleomycin successfully induced pulmonary fibrosis in mouse models. The proteomic data of AMs obtained from these models was of high quality and fulfilled the research requirements. A comprehensive analysis showed that 778 proteins were upregulated in pulmonary fibrosis groups compared with control groups. Moreover, the signal pathways enriched in up-regulated DEPs were related to the I-κB/NF-κB pathway, inflammatory response regulation, phagocytosis regulation, TGF-β signaling, and HIF-1 pathway, indicating that AMs in pulmonary fibrosis microenvironment exerted pro-inflammatory and pro-fibrotic functions. Protein-protein interaction network analysis of the DEPs suggested that the interactions between Tlr2 and Pycard were control nodes for the pro-inflammatory phenotype of AMs, thereby contributing to pulmonary fibrosis progression. Further validation by FACS and Western blotting respectively confirmed that the expression levels of Tlr2 and Pycard in AMs were significantly increased after pulmonary fibrosis.<b>Conclusion</b> This study investigates the changes in the protein expression profile of AMs in the pulmonary fibrosis microenvironment. The results show that AMs notably enhanced the activity of various pathways associated with inflammation and fibrosis, suggesting that the interaction between Tlr2 and Pycard serves as a key control node for the highly pro-inflammatory behavior of AMs.]]></description>
<pubDate>2024/7/24 14:52:00</pubDate>
<category><![CDATA[创刊50周年专刊]]></category>
<author><![CDATA[FU Bin,JI Shu-Hui,LIU Ying,LIU Yu-Chen,LIU Di,TANG Li,WU Xia-Yan]]></author>
</item>
<item>
<title><![CDATA[Research on The Role of Dopamine in Regulating Sleep and Wakefulness Through Exercise]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202404160000002]]></link>
<description><![CDATA[Sleep is an instinctive behavior alternating awakening state, sleep entails many active processes occurring at the cellular, circuit and organismal levels. The function of sleep is to restore cellular energy, enhance immunity, promote growth and development, consolidate learning and memory to ensure normal life activities. However, with the increasing of social pressure involved in work and life, the incidence of sleep disorders (SD) is increasing year by year. In the short term, sleep disorders lead to impaired memory and attention; in the longer term, it produces neurological dysfunction or even death. There are many ways to directly or indirectly contribute to sleep disorder and keep the hormones, including pharmacological alternative treatments, light therapy and stimulus control therapy. Exercise is also an effective and healthy therapeutic strategy for improving sleep. The intensities, time periods, and different types of exercise have different health benefits for sleep, which can be found through indicators such as sleep quality, sleep efficiency and total sleep time. So it is more and more important to analyze the mechanism and find effective regulation targets during sleep disorder through exercise. Dopamine (DA) is an important neurotransmitter in the nervous system, which not only participates in action initiation, movement regulation and emotion regulation, but also plays a key role in the steady-state remodeling of sleep-awakening state transition. Appreciable evidence shows that sleep disorder on humans and rodents evokes anomalies in the dopaminergic signaling, which are also implicated in the development of psychiatric illnesses such as schizophrenia or substance abuse. Experiments have shown that DA in different neural pathways plays different regulatory roles in sleep behavior, we found that increasing evidence from rodent studies revealed a role for ventral tegmental area DA neurons in regulating sleep-wake patterns. DA signal transduction and neurotransmitter release patterns have complex interactions with behavioral regulation. In addition, experiments have shown that exercise causes changes in DA homeostasis in the brain, which may regulate sleep through different mechanisms, including cAMP response element binding protein signal transduction, changes in the circadian rhythm of biological clock genes, and interactions with endogenous substances such as adenosine, which affect neuronal structure and play a neuroprotective role. This review aims to introduce the regulatory effects of exercise on sleep disorder, especially the regulatory mechanism of DA in this process. The analysis of intracerebral DA signals also requires support from neurophysiological and chemical techniques. Our laboratory has established and developed an <i>in vivo</i> brain neurochemical analysis platform, which provides support for future research on the regulation of sleep-wake cycles by movement. We hope it can provide theoretical reference for the formulation of exercise prescription for clinical sleep disorder and give some advice to the combined intervention of drugs and exercise.]]></description>
<pubDate>2024/7/19 15:44:42</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[GENG Ya-Xuan,HOU Li-Juan,HUANG Zhao-Yang,LI Ke,MAO Lan-Qun]]></author>
</item>
<item>
<title><![CDATA[Effects of Sleep Deprivation on Memory Function and Synaptic Plasticity]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202401100000002]]></link>
<description><![CDATA[Sleep deprivation (SD) not only directly affects an individual’s work efficiency but also negatively impacts various cognitive functions such as memory, attention, and learning as fatigue increases. Over the past few decades, numerous researchers have conducted lots of studies on the effects of SD on cognition, particularly memory. In this paper, we first review the effects of SD on memory function based on behavioral studies. Then, we further elaborate on recent advances in the physiological mechanisms of SD, including synaptic plasticity in structure and function, levels of excitatory and inhibitory neurotransmitters, and the expression of related synaptic protein signals. It has been observed that SD modulates the expression of synaptic protein signals and downstream signaling pathways by influencing changes in synaptic activities (such as dendritic spine density, synaptic connectivity strength, and the balance of excitatory and inhibitory synapses), ultimately affecting behavior. This review aims to provide insights into the research progress on the effects of SD on memory and its underlying mechanisms, providing a reference for future studies on sleep function and related mechanisms, as well as the development of strategies to mitigate memory deficits caused by SD.]]></description>
<pubDate>2024/7/10 15:38:53</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[ALan,LI Shuang-Yan,WANG Long-Long,XU Gui-Zhi,ZHENG Wei-Ran]]></author>
</item>
<item>
<title><![CDATA[Neuroinflammation and Its <i>In vitro</i> Models]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202404020000005]]></link>
<description><![CDATA[Neuroinflammation is a complex process triggered by various factors such as injury, infection, oxidative stress, and other activators. In central immune system, microglia and astrocytes release a wide range of inflammatory mediators like cytokines and chemokines in response. Initially, acute neuroinflammation can have protective effects by promoting neuronal repair and maintaining homeostasis. However, chronic activation of neuroinflammation leads to excessive production of inflammatory mediators, resulting in neuronal dysfunction and degeneration. This can contribute to various neurological disorders, including Alzheimer’s disease (AD), Parkinson’s disease (PD), multiple sclerosis (MS), and Huntington’s disease (HD).<i>In vitro</i> cellular models are crucial for elucidating the underlying mechanisms of neuroinflammation. Investigating neuroinflammatory signaling pathways is essential for understanding the intricate network of molecules and cells involved. Key signaling pathways such as NF-κB, MAPK, PI3K/AKT, Nrf2/HO-1, and NLRP3 play critical roles in regulating neuroinflammation. During inflammation, activation of glial cells involves multiple signaling pathways simultaneously, primarily orchestrated by two key factors: MAPK and NF-κB. These pathways guide the inflammatory cascade, leading to the release of numerous inflammatory factors and reactive oxygen species (ROS). These inflammatory factors and ROS have dual effects. Firstly, they can directly harm neighboring neurons, promoting the accumulation of abnormal proteins and triggering neuronal apoptosis. Secondly, inflammatory factor receptors on cell membranes can initiate positive feedback loops that exacerbate the inflammatory response. Neuroinflammation encompasses various cell types within the central nervous system, forming a complex and interconnected malignant cycle. This ultimately culminates in irreversible brain damage. Moreover, innovative therapeutic approaches targeting specific signaling pathways and molecular targets show promise in treating diseases related to neuroinflammation.Various cellular models are commonly employed to investigate neuroinflammation, each focusing on different aspects: pathogen-related models involve substances like lipopolysaccharide(LPS), amyloid β-protein(Aβ), CpG-DNA, and viruses; cytokine models utilize interferon-γ(IFN-γ); metabolic stress models include oxygen-glucose deprivation(OGD), 1-methyl-4-phenylpyridinium (MPP<sup>+</sup>), rotenone, and oxyhemoglobin; environmental toxin models encompass substances such as bisphenol A (BPA), particulate matter (PM2.5), various metals, and nanoparticles; additive substance models involve alcohol, morphine, and methamphetamine (METH). Each model offers distinct advantages and drawbacks for studying neuroinflammation. In conclusion, research on these cellular models and their associated signaling pathways provides crucial insights into the mechanisms underlying neuroinflammation-related diseases. These insights are essential for developing effective therapeutic strategies and advancing clinical practice to address the complexities of neuroinflammatory diseases.]]></description>
<pubDate>2024/7/3 14:27:06</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DING Ye,LI Wei-Ling,SUN Bin-Lian]]></author>
</item>
<item>
<title><![CDATA[Proteomics Data Reveals Alternative Splicing Proteoforms]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202403180000001]]></link>
<description><![CDATA[Alternative splicing is an important regulatory mechanism in organisms, influencing the expression of genes involved in processes such as drug metabolism, pathway activation, and apoptosis. It refers to the process of removing introns from precursor mRNA and joining the remaining exons to produce mature mRNA. During this process, different combinations of exons can result in multiple mature mRNAs. This process is known as alternative splicing. Alternative splicing allows the same gene to produce different transcript variants and protein isoforms, increasing protein diversity and functional complexity. Transcriptomics and proteomics are two main approaches for identifying alternative splicing events. Transcriptomics identifies alternative splicing by analyzing differences between RNA sequencing data and reference sequences in databases. This method relies on the development of modern sequencing technologies. It also depends on increasingly improved splicing identification algorithms. Examples of these algorithms include alignment mapping and sequencing data quality control. The other approach is proteomic data analysis, which identifies corresponding protein products. We consider alternative splicing events more meaningful when they can be detected at the protein level. Alternative splicing proteoforms can be identified using bottom-up proteomics based on mass spectrometry. Due to the high sequence similarity between these alternative splicing proteoforms, general proteomic data analysis pipelines do not achieve good discrimination between them. To improve the identification of proteoforms and obtain differentiation information for different isoforms in proteomic data, two strategies have been developed for improving data processing: the construction of special databases and targeted identification algorithms. We believe that this potential protein isoform information may play a crucial role in life science research. In terms of databases, it is not enough to only use ordinary public databases for searching. To ensure the discovery of as many isoforms as possible, the method of constructing sample-specific databases assisted by RNA sequencing data has been widely used, which can increase the probability of detecting proteoforms. Another key strategy is the improvement of protein identification algorithms. Traditional identification algorithms often struggle to distinguish between highly similar or mutually inclusive proteoforms. To address the complex identification of alternative splicing proteoforms, several inference algorithms have been developed, which are combined with existing search engines to better characterize and detect alternative splicing proteoforms. These include peptide grouping (PeptideClassifier, SEPepQuant, GpGrouper), peptide quantitative correlation (PQPQ, PeCorA, COPF, SpliceVista), machine learning (IsoSVM, Re-Fraction, LibSVM), and major splice isoform theory (ASV-ID). Such methods have shown promising results in focusing on alternative splicing proteoforms. When using these algorithms, we should try different ones based on actual situations. Additionally, the performance of these algorithms is limited by the quality of input data. To ensure reliable identification, it is also essential to perform proper peptide identification and quality control at the front end. In general, the detection and differentiation of spliced protein isoforms are still inadequate, requiring continued attention. This article reviews recent research progress on alternative splicing and its biological functions, as well as the detection of alternative splicing at different levels, and introduces the main methods for identifying alternative splicing proteoforms using bottom-up proteomic data. Identifying different alternative splicing proteoforms helps us understand the comprehensive functions of proteins and is of great significance for discovering related biomarkers and key drug targets.]]></description>
<pubDate>2024/7/3 14:21:29</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[KONG De-Zhi,WU Yi-Ying,ZHANG Wei]]></author>
</item>
<item>
<title><![CDATA[Research on Hyperspectral Image Detection and Recognition of Pepper Early Blight Incubation Period Based on Spectral and Texture Features]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202404030000001]]></link>
<description><![CDATA[<b>Objective</b> Early blight is a common destructive disease in the growth process of <i>Solanaceae</i> crops, which can lead to crop failure and serious losses. Traditional crop disease detection methods are difficult to detect disease characteristics in a timely manner during the incubation period of disease, and thus take scientific and effective prevention and control measures. This study obtained hyperspectral images of early blight of peppers at different infection stages through continuous monitoring with a hyperspectral imager. The earliest identifiable time during the incubation period of early blight in peppers (the earliest identifiable time during the incubation period in this experiment was 24 h after inoculation) was determined using the spectral angle cosine-correlation coefficient and Chebyshev distance.<b>Methods</b> Taking the symptoms of the latent period of early blight in peppers as the research object, 13 characteristic wavelengths were selected using a genetic algorithm. An identification model of crop disease latent period symptoms based on spectral features was established through optimized combinations of characteristic wavelengths combined with a logistic regression model. Simultaneously, a recognition model of the latent period of early blight in peppers based on image texture features was established using local binary patterns.<b>Results</b> The experiment was tested with 120 samples. The accuracy of the identification model of crop disease latent period symptoms based on spectral features reached over 93% in both the training set and the test set. The accuracy of the identification model of crop disease latent period symptoms based on texture features reached 98.96% and 100% in the training set and test set, respectively.<b>Conclusion</b> Both spectral features and texture features can be used to detect and identify crop disease latent period symptoms. Texture features more significantly revealed the characteristics of the latent period of the disease compared to spectral features, effectively improving the detection performance of the model. The research results in this article can provide theoretical references for monitoring and identifying other crop disease latent period symptoms.]]></description>
<pubDate>2024/7/3 14:18:31</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[BAO Hao,SHEN Meng-Jiao,ZHANG Yan]]></author>
</item>
<item>
<title><![CDATA[The Role of α7nAChR in Alzheimer’s Disease]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202403190000001]]></link>
<description><![CDATA[As the global population continues to age, the incidence of Alzheimer’s disease (AD), one of the most common neurodegenerative diseases, continues to rise significantly. As the disease progresses, the patient’s daily living abilities gradually decline, potentially leading to a complete loss of self-care abilities. According to estimates by the Alzheimer’s Association and the World Health Organization, AD accounts for 60%-70% of all other dementia cases, affecting over 55 million people worldwide. The case number is estimated to double by 2050. Despite extensive research, the precise etiology and pathogenesis of AD remain elusive. Researchers have a profound understanding of the disease’s pathological hallmarks, which include amyloid plaques and neurofibrillary tangles resulting from the abnormal phosphorylation of Tau protein. However, the exact causes and mechanisms of the disease are still not fully understood, leaving a vital gap in our knowledge and understanding of this debilitating disease. A crucial player that has recently emerged in the field of AD research is the α7 nicotinic acetylcholine receptor (α7nAChR). α7nAChR is composed of five identical α7 subunits that form a homopentamer. This receptor is a significant subtype of acetylcholine receptor in the central nervous system and is widely distributed in various regions of the brain. It is particularly prevalent in the hippocampus and cortical areas, which are regions associated with learning and memory. α7nAChR plays a pivotal role in several neurological processes, including neurotransmitter release, neuronal plasticity, cell signal transduction, and inflammatory response, suggesting its potential involvement in numerous neurodegenerative diseases, including AD. In recent years, the role of α7nAChR in AD has been the focus of extensive research. Emerging evidence suggests that α7nAChR is involved in several critical steps in the disease progression of AD. These include involvement in the metabolism of amyloid β-protein (Aβ), the phosphorylation of Tau protein, neuroinflammatory response, and oxidative stress. Each of these processes contributes to the development and progression of AD, and the involvement of α7nAChR in these processes suggests that it may play a crucial role in the disease’s pathogenesis. The potential significance of α7nAChR in AD is further reinforced by the observation that alterations in its function or expression can have significant effects on cognitive abilities. These findings suggest that α7nAChR could be a promising target for therapeutic intervention in AD. At present, the results of drug clinical studies targeting α7nAChR show that these compounds have improvement and therapeutic effects in AD patients, but they have not reached the degree of being widely used in clinical practice, and their drug development still faces many challenges. Therefore, more research is needed to fully understand its role and to develop effective treatments based on this understanding. This review aims to summarize the current understanding of the association between α7nAChR and AD pathogenesis. We provide an overview of the latest research developments and insights, and highlight potential avenues for future research. As we deepen our understanding of the role of α7nAChR in AD, it is hoped that this will pave the way for the development of novel therapeutic strategies for this devastating disease. By targeting α7nAChR, we may be able to develop more effective treatments for AD, ultimately improving the quality of life for patients and their families.]]></description>
<pubDate>2024/6/27 18:56:23</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Huan,DING Dao-Bo,HOU Hong-Wei,HU Qing-Yuan,LI Xin,MU Wen-Jun]]></author>
</item>
<item>
<title><![CDATA[Pathologic Function of Cyclin-dependent Kinase 5 and Its Relationship With Exercise]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202404090000001]]></link>
<description><![CDATA[Cyclin-dependent kinases (CDKs) are proline-induced serine/threonine kinases that are primarily involved in the regulation of cell cycle, gene transcription, and cell differentiation. In general, CDKs are activated by binding to specific regulatory subunits of cell cycle proteins and are regulated by phosphorylation of specific T-loops by CDK activated kinases. In the CDKs family, cyclin-dependent kinase 5 (CDK5) is a specialized member whose activity is triggered only by interaction with p35 and p39, which do not have the same sequence as the cell cycle proteins, and this may be one reason why CDK5 is distinguished from other CDK members by its structural and functional differences. In addition, unlike most CDK members that require phosphorylation at specific sites to function, CDK5 does not require such phosphorylation, and it can be activated simply by binding to p35 and p39. More notably, inhibitors that are commonly used to inhibit the activity of other CDK members have almost zero effect on CDK5. In contrast, CDK5, as a unique CDK family member, plays an important role in the development of numerous diseases. In metabolic diseases, elevated CDK5 expression leads to decreased insulin secretion, increased foam cell formation and triggers decreased bone mass in the body, thus accelerating metabolic diseases, and the role of CDK5 in bone biology is gradually gaining attention, and the role of CDK5 in bone metabolic diseases may become a hotspot for research in the future; in neurodegenerative diseases, hyperphosphorylation of Tau protein is an important hallmark of Alzheimer’s disease development, and changes in CDK5 expression are associated with Tau protein phosphorylation and nerve death, indicating that CDK5 is highly related to the development of the nervous system; in tumor diseases, the role of CDK5 in the proliferation, differentiation and migration and invasion of tumor cells marks the development of tumorigenesis, but different researchers hold different views, and further studies are needed in the follow-up. Therefore, the study of its mechanism of action in diseases can help to reveal the pathogenesis and pathological process of diseases. Appropriate exercise not only helps in the prevention of diseases, but also plays a positive role in the treatment of diseases. Exercise-induced mechanical stress can improve bone microstructure and increase bone mass in osteoporosis patients. In addition, exercise can effectively inhibit neuronal apoptosis and improve mitochondrial dysfunction, more importantly, appropriate exercise can inhibit the proliferation of cancer cells to a certain extent. It can be seen that exercise occupies a pivotal position in the prevention and treatment of pathologic diseases. It has been shown that exercise can reduce the expression of CDK5 and affect the pathological process of neurological diseases. Currently, there is a dearth of research on the specific mechanisms of CDK5’s role in improving disease outcomes through exercise. In order to understand its effects more comprehensively, subsequent studies need to employ diverse exercise modalities, targeting patients with various types of diseases or corresponding animal models for in-depth exploration. This article focuses on the pathological functions of CDK5 and its relationship with exercise, with a view to providing new insights into the prevention and treatment of disease by CDK5.]]></description>
<pubDate>2024/6/27 18:53:57</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[GAO Hai-Ning,HUANG Rui-Qi,JIN Dan,YAO Ting-Ting,YI Xue-Jie]]></author>
</item>
<item>
<title><![CDATA[Nanozyme-based Spinal Cord Injury Treatment]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202402230000001]]></link>
<description><![CDATA[Traumatic spinal cord injury (SCI) refers to damage to the structure and function of spinal cord caused by external trauma. This damage results in the loss of sensation, movement, or autonomous functions, which can lead to partial or complete paralysis and impact the patients’ independence and quality of life. Studying drugs related to spinal cord injuries and their mechanisms of action will help enhance patients’ quality of life and alleviate social and economic burdens. Traumatic spinal cord injury can be categorized into primary and secondary injuries. It leads to ongoing neurodegeneration, inflammation, and scarring, necessitating continuous intervention to reduce the cascading effects of secondary injuries. Regenerative repair of SCI has been one of the most challenging problems in medicine. It is characterized by the involvement of microglia, phagocytes (including neutrophils and monocytes), and antigen-presenting cells of the central nervous system, such as dendritic cells. These inflammatory mediators contribute to axonal demyelination and degeneration, leading to severe nerve damage. Currently, there has been little progress in the clinical treatment of SCI. Current clinical modalities, such as surgical interventions and hormone shock therapies, have not yielded specific pharmacotherapeutic options, hindering significant functional recovery. The current treatment methods are ineffective in alleviating oxidative stress and neuroinflammatory responses caused by spinal cord injury. They also do not offer neural protection, resulting in ongoing neurofunctional degradation. Intravenous injection of methylprednisolone through the arm has been used as a treatment option for spinal cord injury. Recent studies have shown that the potential side effects of the drug, such as blood clots and pneumonia, outweigh its benefits. Methylprednisolone is no longer recommended for the routine treatment of spinal cord injury. In recent years, significant progress has been made in spinal cord injury intervention through the use of nanotechnology and biomaterials. Nanozymes can enhance the therapeutic efficacy of spinal cord injury by catalyzing the clearance of free radicals similar to enzymes and suppressing inflammatory responses. Nanozymes can reduce the degree of fibrosis, promote neuron survival and angiogenesis, and provide favorable conditions for tissue regeneration. Through <i>in vitro</i> and <i>in vivo</i> toxicology experiments, it was found that the nanozyme demonstrates good biocompatibility and safety. It did not cause any significant changes in body weight, hematological indicators, or histopathology. These findings indicate the potential for its clinical applications. Based on current research results and discoveries, nanozymes have broad application prospects in the biomedical field. There are numerous potential research directions and application areas that are worthy of further exploration and development. Although there have been preliminary studies on the catalytic performance of nanozymes, further research is needed to thoroughly investigate their catalytic mechanisms. Further exploration of the interaction between nanozymes and substrates, reaction kinetics, and factors affecting catalytic activity will help to better understand their mechanism of action in the field of biocatalysis.]]></description>
<pubDate>2024/6/27 18:50:08</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Shi-Qun,CHEN Zuo-Hong,WANG Hao,WANG Yi-Li,ZHANG Xiao-Dong]]></author>
</item>
<item>
<title><![CDATA[Improvement of Core Behavior in Autism Spectrum Disorder Mice by 8-Week Aerobic Exercise]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202404020000006]]></link>
<description><![CDATA[<b>Objective</b> To investigate the effect of 8-week aerobic exercise on the improvement of core behaviors of male and female autistic mice induced by valproic acid (VPA).<b>Methods</b> Experimental mice were randomly divided into the control group (CTL), VPA-induced autism group (VPA) and VPA+aerobic exercise group (VEX), with 10 mice in each group. The pregnant mice were injected with VPA intraperitoneally at E12.5, and their offspring were used as autistic mice. Pups were weaned 28 d after birth and began an 8-week aerobic exercise intervention. The day after exercise, mice were tested in behavioral experiments to detect exploratory behavior, social skills, repetitive stereotypic behavior, cognitive ability and mood. The mice were tested for social skills, repetitive stereotyped behaviors, cognitive and learning memory abilities, exploratory behaviors, and emotions by behavioral assays on the following day after the exercise.<b>Results</b> Both male and female mice in the CTL group showed a significant decrease in the total distance and percentage of time spent in the interaction zone in the 4th socialization compared to the 1st socialization (<i>P</i><0.01); the total distance and percentage of time spent in the interaction zone in the 5th socialization was significantly increased compared to the 4th socialization (<i>P</i><0.01); in VPA group, both male and female mice showed no significant change in the total distance and percentage of time spent in the interaction zone in the 4th and 5th socialization; in the VEX group, the total distance and percentage of time spent in the interaction zone by male mice in the 4th socialization was significantly decreased compared to the 1st socialization (<i>P</i><0.01, <i>P</i><0.05); and in the VEX group the total distance and percentage of time spent in the social interaction zone by both male and female mice in the 5th socialization was significantly increased compared to the 4th socialization (<i>P</i><0.01, <i>P</i><0.05). The results of the first phase of three-box socialization experiment showed that male and female mice in the CTL group spent more time socializing with their social partners than in contact with the empty cages (<i>P</i><0.01); there was no difference in the time spent by male and female mice in the VPA group in socializing with their social partners and the empty cages; and male and female mice in the VEX group spent a longer time socializing with their social partners (<i>P</i><0.01). The results of the second phase of three-box test showed that male and female mice in the CTL group showed a significant tendency to socialize with new social partners (<i>P</i><0.01), whereas no significant changes were observed in the mice of VPA group; aerobic exercise significantly ameliorated this deficit in male and female mice with autism. Compared with the CTL group, VPA-induced significant decreases were observed in the total distance freely moved in the central area of the open field, the time and percentage of time spent in the open arm of cross maze, and the distance and time spent in the white box in both male and female autistic mice (<i>P</i><0.01); a significant increase in the number of bead burials and time spent in self-grooming (<i>P</i><0.01); a significant decrease in the cognitive index (<i>P</i><0.01); a significantly longer latency to find the platform, and significantly decreased the percentage of time spent in the target quadrant and the number of times they traversed the platform (<i>P</i><0.01). Compared with the VPA group, after 8 weeks of aerobic intervention, male and female mice in the VEX group showed a significant increase in total distance, open-arm dwell time, and percentage of free movement in the central area of the empty field (<i>P</i><0. 05), and a trend toward a decrease in the dwell time of females in the white box was not significant, the number of beads burying and the time of self-combing were significantly lower (<i>P</i><0.01, <i>P</i><0.05); and a significant increase in cognitive index (<i>P</i><0.05), a significantly shorter time to find the platform, and significantly increased percentage of time spent in the target quadrant and the number of times they traversed the platform (<i>P</i><0.01), showing excellent learning memory.<b>Conclusion</b> Autistic mice severely suffer from social and cognitive impairments, repetitive stereotyped behaviors, decreased activity level, and the exhibition of anxiety. 8 weeks of aerobic exercise can improve the social and cognitive abilities, alleviate the stereotyped repetitive behaviors, increase the activity level, and positively regulate the anxiety in autistic mice. It is hypothesized that aerobic exercise has an important role in motor rehabilitation of autism, in order to provide a theoretical basis for clinical research.]]></description>
<pubDate>2024/6/27 18:45:12</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[LIU Niu,WANG Shi-Jiao,XUE Ya-Qi,ZHEN Zhi-Ping]]></author>
</item>
<item>
<title><![CDATA[The Impairment Attention Capture by Topological Change in Children With Autism Spectrum Disorder]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202404180000001]]></link>
<description><![CDATA[<b>Objective</b> Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by difficulties with communication and social interaction, restricted and repetitive behaviors. Previous studies have indicated that individuals with ASD exhibit early and lifelong attention deficits, which are closely related to the core symptoms of ASD. Basic visual attention processes may provide a critical foundation for their social communication and interaction abilities. Therefore, this study explores the behavior of children with ASD in capturing attention to changes in topological properties.<b>Methods</b> Our study recruited twenty-seven ASD children diagnosed by professional clinicians according to DSM-5 and twenty-eight typically developing (TD) age-matched controls. In an attention capture task, we recorded the saccadic behaviors of children with ASD and TD in response to topological change (TC) and non-topological change (nTC) stimuli. Saccadic reaction time (SRT), visual search time (VS), and first fixation dwell time (FFDT) were used as indicators of attentional bias. Pearson correlation tests between the clinical assessment scales and attentional bias were conducted.<b>Results</b> This study found that TD children had significantly faster SRT (<i>P</i>0.05) and VS (<i>P</i>0.05) for the TC stimuli compared to the nTC stimuli, while the children with ASD did not exhibit significant differences in either measure (<i>P</i>0.05). Additionally, ASD children demonstrated significantly less attention towards the TC targets (measured by FFDT), in comparison to TD children (<i>P</i>0.05). Furthermore, ASD children exhibited a significant negative linear correlation between their attentional bias (measured by VS) and their scores on the compulsive subscale (<i>P</i>0.05).<b>Conclusion</b> The results suggest that children with ASD have difficulty shifting their attention to objects with topological changes during change detection. This atypical attention may affect the child’s cognitive and behavioral development, thereby impacting their social communication and interaction. In sum, our findings indicate that difficulties in attentional capture by TC may be a key feature of ASD.]]></description>
<pubDate>2024/6/27 11:29:54</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[DUAN Tao,LI Dan-Dan,LI Jing,WANG Kai,XI Huan-Jun,XU Hui-Lin,ZHU Chun-Yan]]></author>
</item>
<item>
<title><![CDATA[Terahertz Electric Field Induced Double Strand Breakage and Vibrations of dsDNA in a Gold Nanoslit]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202402220000002]]></link>
<description><![CDATA[<b>Objective</b> This work examines the impact of external electric fields at terahertz (THz) frequencies on double-stranded deoxyribonucleic acid (dsDNA) systems adsorbed on Au(111) surfaces in aqueous environments.<b>Methods</b> The investigation utilizes a molecular dynamics (MD) approach at the atomic level and vibrational dynamics calculations using the GolDNA-Amber force field.<b>Results</b> The results reveal that the sugar-phosphate backbone of the DNA exhibits reduced adherence to the gold surface, while the side chains display a stronger affinity. When subjecting the hydrated DNA strands to an electric field with frequencies up to 10 THz, peak intensities of vibrational dynamic density (VDoS) are observed at five different frequencies. Moreover, the strong electric field causes hydrogen bonds in the DNA within the slit to break. The sensitivity to the electric field is particularly pronounced at 8.8 THz and 9.6 THz, with different vibrational modes observed at varying electric field strengths.<b>Conclusion</b> These findings contribute to an enhanced understanding of the molecular organization of gold-plated charged biological interfaces.]]></description>
<pubDate>2024/6/26 14:09:49</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[JIANG Duan-Jie,WANG Yan-Hong,WU Jing-Zhi,ZHANG Rui]]></author>
</item>
<item>
<title><![CDATA[Research Progress and Biomedical Applications of Magneto-controlled Nanobiocatalysis]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202404170000001]]></link>
<description><![CDATA[Enzyme therapy, known for its high efficiency and high selectivity, is an emerging treatment method that utilizes the catalytic activity of exogenous enzyme molecules to initiate specific chemical reactions in the diseased area for disease treatment. With the development of nanoscience and nanotechnology, nanomaterials have brought a new revolution in enzyme therapy. Firstly, nanomaterials with enzyme-like activity (known as nanozymes) have the ability to replace enzymes for catalytic therapy due to their advantages such as tunable nanostructures, high stability, and low cost. Secondly, the construction of nanohybrid enzymes using enzyme engineering techniques can improve the poor stability and limited application performance of enzymes. Finally, many nanomaterials exhibit unique responsiveness to external stimuli such as light, electricity, magnetism, and sound, allowing the catalytic activity of nanozymes and nanohybrid enzymes to be precisely controlled by remote physical fields. Compared to other stimuli, magnetic fields have advantages such as deep tissue penetration, no radiation hazard, remote manipulability, and high spatiotemporal resolution. Under the action of different magnetic fields, magnetic nanomaterials can produce magnetothermal,magnetomechanical,and magnetoelectric effects, respectively. In recent years, significant research progress has been made in utilizing these effects to regulate the catalytic behaviors of nanobiocatalysts. The magnetothermal effect is the process in which magnetic nanomaterials convert electromagnetic energy into heat energy when subjected to a high frequency alternating magnetic field. This effect has been harnessed to remotely regulate the nanobiocatalysts by inducing changes in the surrounding temperature. The magnetomechanical effect refers to the magnetic force generated by the interaction between the magnetic field and magnetic particle when exposed to a low frequency static magnetic field, rotating magnetic field, or gradient magnetic field. This effect regulates enzyme catalytic reactions by altering enzyme conformation or the interaction between an enzyme and its substrate. The magnetoelectric effect involves the charge polarization of a material under the influence of an external alternating magnetic field. This effect enables the energy conversion between magnetic and electric fields. The electrons generated in this process can trigger the redox reaction of nanozymes. These three effects are shown to control the catalytic activity of nanozymes or nanohybrid enzymes under different settings, leading to improved performance of nanobiocatalysts in various biomedical applications. Currently, the concept of magneto-controlled nanobiocatalysis has been applied in the treatment of cancer, bacterial infection and Alzheimer’s disease, demonstrating tremendous potential in precision catalytic therapy. In this paper, the magnetothermal, magnetomechanical, and magnetoelectric effects mediated by magnetic materials were first introduced. Then, current research status on the regulation of nanobiocatalysts under control of magnetic field was comprehensively discussed. Finally, future research suggestions in the field of magneto-controlled nanobiocatalysis was proposed.]]></description>
<pubDate>2024/6/26 13:33:56</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[FAN Hai-Ming,HE Yuan,LI Ga-Long,LI Jia-Qi,SHI Rui-Xing,WANG Ni-Ni,XU Jia-Yao,ZHENG Lu]]></author>
</item>
<item>
<title><![CDATA[Application and Mechanism of Drugs Targeting Short Peptide in The Treatment Pancreatic Cancer]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202312280000002]]></link>
<description><![CDATA[Pancreatic cancer (PC) is a highly fatal disease which originated from pancreatic epithelial and acinar cells, and the survival rate of pancreatic cancer patients is only about 12%. Approximately 95% of pancreatic cancer presents as ductal adenocarcinoma (PDAC). Pancreatic cancer is characterized by high aggressiveness, rapid progression and progression, and high resistance to treatment. Common somatic mutated genes in the early stage of pancreatic cancer include <i>KRAS</i>, <i>CDKN2A</i>, <i>TP53</i>, and <i>SMAD4</i>. Most pancreatic cancer patients are affected by environmental risk factors such as age, sex and diet. Malignant pancreatic cancer is associated with non-invasive, preneoplastic lesions that are thoughted to be precursors, such as pancreatic intraepithelial neoplasia (PanIN), intraductal papillary mucinous neoplasm (IPMN) and mucinous cystadenoma (MCN). In recent years, people have gradually improved the therapy and diagnosis of pancreatic cancer, and the contribution of imaging technology, which enhancing the usage of minimally invasive pancreatectomy that typically includes pancreaticoduodenectomy and distal pancreatectomy. However, combined administration of the chemotherapeutic gemcitabine and erlotinib is still considered a potential first-line treatment for advanced pancreatic cancer, but the development of chemoresistance often leads to poor therapeutic outcomes. Based on the current research progress for pancreatic cancer, its treatment currently remains one of the most important challenges in the medical field. Although some new treatment options have been provided, there were minor clinical success achieved and therefore new safe and effective therapies of pancreatic cancer are still an urgent need for patients. Among these new therapies for pancreatic cancer, short peptide-based treatment protocols have attracted great attention. Peptide is a compound formed by linking α-amino acids together in peptide chains. It is also an intermediate product of proteolysis. The short peptide-based therapy has many advantages such as precise targeting, easy preparation and low toxicity. Short peptides usually act as tumor suppressors by targeting and recognizing tumor-specific expressed proteins. Currently, there is an increased interest in peptides in pharmaceutical and development research, and approximate 140 peptide therapeutics are currently being evaluated in clinical trials. These peptides provide excellent prospects for targeted drug delivery because of their high selectivity, specificity and simplicity of modification. Peptides have high bioactivity and excellent biodegradability. Clinically, short peptides are increasingly used as combination drugs with chemotherapy for tumor treatment. Peptides can induce cancer cell death by numerous mechanisms and peptides have emerged as a promising drug for the treatment of pancreatic cancer. Here we mainly review the roles of peptides on Wnt/β-catenin, NF-κB, autophagy, and the use of peptides as tracer in pancreatic cancer. We also analyzed the benefits and disadvantages existing in the development process of short peptides, which provide the feasibility of targeted short peptides to become new therapeutic approaches for cancer therapy.]]></description>
<pubDate>2024/6/26 13:27:37</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DONG Xue-Ying,LIU Yuan,TANG Jing-Feng,ZHOU Ce-Fan]]></author>
</item>
<item>
<title><![CDATA[Functions of Dynamin and Its Family Proteins]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202402170000001]]></link>
<description><![CDATA[The dynamin superfamily protein (DSP) encompasses a group of large GTPases that are involved in various membrane remodeling processes within the cell. These proteins are characterized by their ability to hydrolyze GTP, which provides the energy necessary for their function in membrane fission, fusion, and tubulation activities. Dynamin superfamily proteins play critical roles in cellular processes such as endocytosis, organelle division, and vesicle trafficking. It is typically classified into classical dynamins and dynamin-related proteins (Drp), which have distinct roles and structural features. Understanding these proteins is crucial for comprehending their functions in cellular processes, particularly in membrane dynamics and organelle maintenance. Classical dynamins are primarily involved in clathrin-mediated endocytosis (CME), a process crucial for the internalization of receptors and other membrane components from the cell surface into the cell. These proteins are best known for their role in pinching off vesicles from the plasma membrane. Structually, classical dynamins are composed of a GTPase domain, a middle domain, a pleckstrin homology (PH) domain that binds phosphoinositides, a GTPase effector domain (GED), and a proline-rich domain (PRD) that interacts with SH3 domain-containing proteins. Functionally, the classical dynamins wrap around the neck of budding vesicles, using GTP hydrolysis to constrict and eventually acting as a “membrane scissor” to cut the vesicle from the membrane. In mammals, there are three major isoforms: dynamin 1 (predominantly expressed in neurons), dynamin 2 (ubiquitously expressed), and dynamin 3 (expressed in testes, lungs, and neurons). Recent studies have also revealed some non-classical functions of classical dynamins, such as regulating the initiation and stabilization of clathrin-coated pits (CCPs) at the early stages of CME, influencing the formation of the actin cytoskeleton and cell division. Drps share structural similarities with classical dynamins but are involved in a variety of different cellular processes, primarily related to the maintenance and remodeling of organelles, and can be mainly categorized into “mediating membrane fission”, “mediating membrane fusion” and “non-membrane-dependent functions”. Proteins like Drp1 are crucial for mitochondrial division, while others like Fis1, Mfn1, and Mfn2 are involved in mitochondrial and peroxisomal fission and fusion processes, which are essential for the maintenance of mitochondrial and peroxisomal integrity and affect energy production and apoptosis. Proteins like the Mx protein family exhibit antiviral properties by interfering with viral replication or assembly, which is critical for the innate immune response to viral infections. Some other proteins are involved in the formation of tubular structures from membranes, which is crucial for the maintenance of organelle morphology, particularly in the endoplasmic reticulum and Golgi apparatus. Studies on dynamin superfamily proteins have been extensive and have significantly advanced our understanding of cellular biology, disease mechanisms, and therapeutic potential. These studies encompass a broad range of disciplines, including molecular biology, biochemistry, cell biology, genetics, and pharmacology. By comprehensively summarizing and organizing the structural features and functions of various members of the dynamin superfamily protein, this review not only deepens the understanding of its molecular mechanisms, but also provides valuable insights for clinical drug research related to human diseases, potentially driving further advancements in the field.]]></description>
<pubDate>2024/6/26 13:18:57</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Zhi-Ming,JIANG Zhao-Hong,YANG Zi-Yan,ZHOU Qian-Yi]]></author>
</item>
<item>
<title><![CDATA[Mechanism of Malignant Transformation in Bronchial Epithelial Cells Induced by The Environmental Carcinogen B[α]PDE]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202403060000002]]></link>
<description><![CDATA[Benzo[a]pyrene (B[α]P) is a common environmental carcinogen, mainly from the smoke generated by the incomplete combustion of coal, oil and natural gas in the industrial production and living process, which undergoes a series of metabolic reactions <i>in vivo</i>, and ultimately generates the active metabolite, benzopyrene dihydroxy epoxide (B[α]PDE) to exert a strong carcinogenic effect. In this paper, we provide an overview of the mechanisms involved in the malignant transformation of bronchial epithelial cells induced by B[α]PDE in terms of DNA base mutations, DNA repair function, related signaling pathways and epigenetic variations. B[α]PDE covalently binds to DNA bases to form B[α]PDE-DNA adducts, which cause DNA base mutations, inducing malignant transformation of bronchial epithelial cells and ultimate tumor formation. Interestingly, it was found that B[α]PDE-DNA adducts showed a high GC-dependent distribution and the single-nucleotide resolution profile of DNA damage profile was highly similar to that of mutations previously identified in the lung cancer genomes of smokers. B[α]PDE can also regulate the expression or silencing of proto-oncogenes and oncogenes by activating the classical AhR signaling pathway, as well as the PI3K/AKT/mTOR and NF-κB signaling pathways, inducing epithelial-mesenchymal transition (EMT) in bronchial epithelial cells, and interfering with cellular metabolism and the cell cycle, thereby inducing the development of lung cancer. The genes mutated in B[α]PDE-induced malignant transformation of bronchial epithelial cells include the proto-oncogenes <i>RAS</i>, <i>KIF11</i>, and <i>PPP1R13L</i> as well as the oncogenes <i>PHLPP2</i> and <i>p53</i>. B[α]PDE exposure leads to single nucleotide polymorphisms in the 3"-UTR of DNA repair enzyme gene, which inhibits the transcription of genes encoding proteins related to DNA damage repair, and subsequently affects the cell cycle, proliferation, and apoptosis of tumor cells. B[α]PDE exposure can induce lung carcinogenesis and progression by inducing hypomethylation of specific gene promoter regions to activate proto-oncogenes and hypermethylation to silence oncogenes. The aberrantly expressed miRNAs or lncRNAs may regulate the expression and signaling of lung cancer-related genes, thereby affecting lung cancer-related biological functions, including cell proliferation, apoptosis, migration and invasion. Poly(ADP-ribose) glycohydrolase (PARG) regulates DNA damage repair and maintains genomic stability, whereas silencing PARG inhibits B[α]PDE-induced deterioration of bronchial epithelial cells. B[α]PDE exposure induces metabolic reprogramming in cancer cells, which provides energy to cancer cells rapidly proliferation by increasing glucose uptake and glycolysis, and also regulates cancer cell growth and survival by affecting lipid and nucleic acid metabolism. In conclusion, in B[α]PDE-induced lung cancer, epigenetic changes such as DNA methylation, miRNAs, lncRNAs, metabolic reprogramming, and PARG work together to form a complex regulatory network that affects gene expression, cellular metabolism, and genomic stability. An in-depth study of the mechanism of B[α]PDE-induced malignant transformation of bronchial epithelial cells can provide a theoretical basis for the study of potential targets for the development of anti-tumor drugs, which will help to guide the prevention and treatment of lung cancer in polluted environments and exposure to smoky environments, and also provide theoretical support for the Healthy China measures of tobacco control and smoking ban.]]></description>
<pubDate>2024/6/25 17:03:46</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LI Cong-Ya,YIN Zhang-Ya,ZHU Jun-Lan]]></author>
</item>
<item>
<title><![CDATA[Effect of SUMOylation on Maintaining Mitochondrial Dynamics Balance by DRP1]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202401230000002]]></link>
<description><![CDATA[Mitochondria, as the center of energy metabolism within the cell, play a crucial role in maintaining cell homeostasis. The regulation of its morphology and function is essential for the normal functioning of cells. In this complex regulatory network, the small ubiquitin-like modifier (SUMO) and dynamin-related protein 1 (DRP1) have become the focus of research, especially their close association with mitochondrial dynamics. SUMOylation is an important form of protein modification that regulates the function of target proteins by binding them to SUMO. This modification also plays a significant role in mitochondrial dynamics. The complex network of interactions between SUMOylation and DRP1 plays a key role in mitochondrial division, fusion and autophagy. DRP1, as a mitochondrial fission protein, regulates the morphology and function of mitochondria with the participation of the endoplasmic reticulum (ER). Recent studies have revealed the complex relationship between DRP1 and SUMOylation. DRP1 completes SUMOylation under the action of mitochondrial-anchored protein ligase (MAPL). SUMOylation mainly occurs in the variable domain of DRP1, and eight lysine residues have been identified as its targets. DRP1 serves as the target protein of SUMO1 and SUMO2/3, which play different regulatory roles in mitochondrial fission. SUMO1 modification can enrich DRP1 into mitochondria, thus promoting mitochondrial fission. However, SUMO2/3 modification can transfer DRP1 to cytoplasm and reduce mitochondrial fission. This dynamic regulatory mechanism allows the cell to flexibly adjust the state of the mitochondria according to energy requirements. Correspondingly, there is also deSUMOylation. SUMO-specific proteases (SENPs) is responsible for the deSUMOylation of proteins, with seven subtypes identified so far. Among them, SENP3/5 is a SUMO2/3 specific deSUMOylation protease. In actual cellular processes, the SUMO1 and SUMO2/3 modifications of DRP1 occur simultaneously, which can be regarded as a competitive relationship between the them. So, the SUMOylation of DRP1 in cells is often determined by SENPs. By increasing the level of SENP3/5, the SUMO2/3 modification level of DRP1 can be reduced, and the SUMO1 modification level can be indirectly increased, thus promoting the division of mitochondria. This dual regulatory mechanism enables cells to more finely control the state of mitochondria and adapt to different cellular environments and physiological needs. In addition, as an important energy supply organelle in the cell, the abnormal dynamic level of mitochondria often leads to the occurrence of a variety of diseases. In some diseases, the increase of the SUMO1 modification level of DRP1 leads to the increase of DRP1 activity, which leads to the increase of mitochondrial fission and mitophagy. For example, it can cause myocardial ischemia-reperfusion injury, ischemic stroke and retinopathy.According to current research progress, the interaction between SUMOylation and DRP1 plays a key role in the regulation of mitochondrial dynamics. The in-depth study of this regulatory mechanism not only helps to reveal the basic principle of cell regulation, but also provides an important reference for the treatment strategy of related diseases. In addition, it also could help identify new therapeutic targets and provide additional tools for disease prevention and treatment. In this review, we review the advances in the study of the interaction between SUMOylation and DRP1 on the regulation of mitochondrial dynamics, and further explore the potential of inhibiting DRP1-SUMOylation as a target for the treatment of related diseases in the future.]]></description>
<pubDate>2024/6/21 15:50:31</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LIU Sen,ZHANG Shuai]]></author>
</item>
<item>
<title><![CDATA[The Uptake Mechanisms of Extracellular Vesicles by Target Cells and Their Applications in Disease Diagnosis and Treatment]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202404160000001]]></link>
<description><![CDATA[Extracellular vesicles (EVs) are nanoscale vesicles secreted by cells and play a pivotal role in intercellular communication. As crucial mediators in cell-to-cell signaling, EVs are instrumental in physiological and pathological processes. They serve not only as significant biomarkers in disease diagnosis but also hold promise as new drug and drug delivery system candidates due to their unique biological properties. The process begins with the cell membrane invagination to form a cup-like structure, selectively encapsulating surface proteins and soluble proteins to create early endosomes. Under the influence of the endosomal sorting complex required for transport (ESCRT), Rab-GTPase, and tetraspanins, these early endosomes evolve into late sorting endosomes, which form multivesicular bodies. Upon fusion with the plasma membrane, these bodies release EVs into the extracellular space. EVs are internalized by target cells through ligand-receptor interactions, endocytosis, and membrane fusion, thereby executing biological functions. Endocytosis is a common uptake mechanism for EVs, with various pathways including clathrin-dependent pathways, caveolae-mediated uptake, macropinocytosis, phagocytosis, and lipid raft-mediated internalization. Once inside the recipient cell, EVs interact with the endosomal system, fuse, and release their contents into the cytoplasm. The absorption and distribution of EVs in the body are influenced by factors such as their origin, targeting, administration method, size, and surface characteristics. Through engineering, EVs can be loaded with specific proteins or RNA to achieve targeted drug delivery to specific organs or cells. In terms of disease diagnosis, the components of EVs can serve as biomarkers, offering new avenues for early detection, progression monitoring, and therapeutic efficacy assessment. They carry RNA and protein molecules that can reveal pathological changes in their originating cells. In terms of disease treatment, EVs have the potential for targeted delivery, serving as platforms for vaccine development and as drug delivery systems to transport drugs directly to specific cells or tissues. Moreover, EVs themselves can be used as therapeutic agents for autoimmune diseases and cancer. In the realm of EV separation and purification technology, common methods include ultracentrifugation, immunoaffinity chromatography, polymer co-precipitation, ultrafiltration, size exclusion chromatography, and microfluidics. However, due to the limitations of a single separation technique in meeting the demand for high-quality and high-purity EVs, multiple methods are often combined to separate and purify EVs effectively. This article concludes by summarizing the broad application prospects of EVs in the prevention and treatment of human diseases and highlights several key scientific questions that require further in-depth research. The potential of EVs in diagnostics and therapeutics, as well as the challenges in their isolation and characterization, underscores the need for continued exploration and innovation in this field.]]></description>
<pubDate>2024/6/21 12:24:30</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HUANG Ning-Ning,QI Li-Li,WANG Jin-Bo,WANG Meng-Ting,WU Yu-Qin]]></author>
</item>
<item>
<title><![CDATA[CDK8 Promotes Cell Proliferation, Migration and Invasion in Esophageal Squamous Cell Carcinoma Through JAK/ STAT3/EMT Pathway]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202403050000001]]></link>
<description><![CDATA[<b>Objective</b> To investigate the expression of cyclin-dependent kinase 8 (CDK8) in esophageal squamous cell carcinoma (ESCC) and its effect on ESCC cells, and to explore its potential molecular mechanism.<b>Methods</b> The expression level of CDK8 mRNA was analyzed using UALCAN database, and then the expression level of CDK8 protein in tumor tissues of ESCC patients was detected by immunohistochemistry (IHC). Esophageal cancer cell lines Kyse-30 and Kyse-150 were stably transfected with lentivirus to achieve knockdown and overexpression of CDK8. EdU proliferation assay, cell colony formation assay, cell cycle assay, cell scratch assay and invasion assay were used to explore the effect of CDK8 protein expression level on the phenotype of ESCC cells. Subsequently, the effect of CDK8 on the growth of esophageal cancer xenografts <i>in vitro</i> was observed by subcutaneous tumor formation assay in mice. Finally, the expression of proliferation and metastasis related proteins was detected by Western blot.<b>Results</b> CDK8 showed high transcription and protein expression levels in ESCC tissues compared with normal esophageal tissues. Knockdown of CDK8 expression significantly inhibited the proliferation, migration and invasion of ESCC cells. In addition, inhibition of CDK8 expression significantly affected the JAK2/STAT3 pathway and the expression of E-cadherin/N-cadherin, while overexpression of CDK8 reversed these effects. Inhibition of STAT3 pathway reversed the promoting effect of CDK8 overexpression on ESCC cell phenotype.<b>Conclusion</b> CDK8 is a cancer-promoting factor of ESCC, which mediates the phosphorylation of JAK2/ STAT3 and epithelial-mesenchymal transition (EMT).]]></description>
<pubDate>2024/6/19 14:40:02</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[BAO Jia-Qian,PAN Yi-Xiao,QU Hang-Shuai,TIAN Xiong,YE Lu-Xia,ZHENG Jing-Min]]></author>
</item>
<item>
<title><![CDATA[Controllability Analysis of Structural Brain Networks in Young Smokers]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202404020000002]]></link>
<description><![CDATA[<b>Objective</b> The controllability changes of structural brain network were explored based on the control and brain network theory in young smokers, this may reveal that the controllability indicators can serve as a powerful factor to predict the sleep status in young smokers.<b>Methods</b> Fifty young smokers and 51 healthy controls from Inner Mongolia University of Science and Technology were enrolled. Diffusion tensor imaging (DTI) was used to construct structural brain network based on fractional anisotropy (FA) weight matrix. According to the control and brain network theory, the average controllability and the modal controllability were calculated. Two-sample <i>t</i>-test was used to compare the differences between the groups and Pearson correlation analysis to examine the correlation between significant average controllability and modal controllability with Fagerstr?m Test of Nicotine Dependence (FTND) in young smokers. The nodes with the controllability score in the top 10% were selected as the super-controllers. Finally, we used BP neural network to predict the Pittsburgh Sleep Quality Index (PSQI) in young smokers.<b>Results</b> The average controllability of dorsolateral superior frontal gyrus, supplementary motor area, lenticular nucleus putamen, and lenticular nucleus pallidum, and the modal controllability of orbital inferior frontal gyrus in the young smokers’ group, supplementary motor area, gyrus rectus, and posterior cingulate gyrus, were all significantly different from those of the healthy controls group (<i>P</i><0.05). The average controllability of the right supplementary motor area (SMA.R) in the young smokers group was positively correlated with FTND (<i>r</i>=0.393 0, <i>P</i>=0.004 8), while modal controllability was negatively correlated with FTND (<i>r</i>=-0.330 1, <i>P</i>=0.019 2).<b>Conclusion</b> The controllability of structural brain network in young smokers is abnormal. which may serve as an indicator to predict sleep condition. It may provide the imaging evidence for evaluating the cognitive function impairment in young smokers.]]></description>
<pubDate>2024/6/18 15:40:20</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[CHENG Yong-Xin,DING Jing-Jing,DONG Fang,MA Yu-Xin,WANG Hong-De,WANG Juan,XUE Ting,YU Da-Hua,YUAN Kai]]></author>
</item>
<item>
<title><![CDATA[Optimization of Dust Collection and DNA Extraction Methods on Object Surfaces]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202311050000003]]></link>
<description><![CDATA[<b>Objective</b> Dust has steadily emerged as a frontier research in the field of forensic science because it is a material evidence with significant features and application potential that carries rich environmental DNA information. However, as a crucial foundational step in forensic applications, the collection and DNA extraction research of dust on object surfaces from the perspective of practical applications in forensic science are still in urgent need of development.<b>Methods</b> Dust was collected from object surfaces using a Copan Liquid Amies Elution Swab. DNA was extracted separately from the swab head, sediment, and supernatant within the sample collection tube to evaluate DNA content, thereby determining which components within the tube should be processed and lysed. Dust samples were collected according to five different sampling areas (25-400 cm2) and the DNA concentration was measured to determine the optimal sampling area. The extraction efficiency of three commercial DNA extraction kits for dust samples was compared. The size of the DNA fragments extracted from the dust was analyzed, as well as the presence of human DNA. Additionally, 16S rDNA amplicon sequencing was used to analyze the bacterial information in dust DNA from object surfaces. This process aimed to establish a quality control method for dust DNA extraction. Regarding the critical step of cell lysis in DNA extraction, the quantity of DNA extracted was compared and evaluated under different cell lysis methods and varying vortexing times. This was done to establish an appropriate cell lysis method for dust DNA extraction.<b>Results</b> The sediment and swab head in the dust sampling tube are the primary sources of DNA, and both should be included in subsequent extraction processes. The sampling area of dust is positively correlated with dust DNA concentration, and it is recommended that the sampling area be larger than 5×5 cm2. Using the DNeasy PowerSoil Pro kit can yield a higher amount of DNA. Additionally, there were no significant differences in the sizes of DNA fragments extracted by the three different DNA extraction kits. No human DNA was detected in the DNA extracted from the dust samples, while bacterial DNA was present in the dust from object surfaces. Furthermore, there were differences in microbial species composition between different sampling points. Additionally, using a biological sample homogenizer to grind and lyse for 4 min (2 min× 2 times) resulted in the highest concentration of dust DNA.<b>Conclusion</b> The extraction of dust DNA is influenced by the sampling area, extraction kits, and lysis methods. It is crucial to establish a comprehensive and suitable dust DNA extraction scheme. This not only lays the foundation for researching and extracting environmental DNA data from dust, but also provides a methodological reference for forensic case work involving environmental samples.]]></description>
<pubDate>2024/6/12 15:00:40</pubDate>
<category><![CDATA[技术与方法]]></category>
<author><![CDATA[GE Wen-Dong,JI An-Quan,KANG Ke-Lai,LU Qi,MEI Hong-Cheng,PENG Jia-Jin,WANG Le,YANG Qi,YE Jian,ZHANG Tao]]></author>
</item>
<item>
<title><![CDATA[Exercise-induced Modulation of Ferroptosis: Potential Mechanisms for Improvement in Parkinson<bold>’</bold>s Disease]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202403300000001]]></link>
<description><![CDATA[Parkinson’s disease (PD) is a neurodegenerative disorder characterized by muscle rigidity, resting tremor, and postural instability, which severely impair the quality of life in middle-aged and elderly individuals. PD’s pathogenesis is complex, involving oxidative stress, immune inflammation, and genetic factors. Despite extensive research, precise therapeutic targets for PD remain elusive, necessitating further investigation into its underlying mechanisms. Recent studies highlight the pivotal role of regional brain iron overload, oxidative stress, and lipid peroxidation in PD’s pathogenesis. Ferroptosis, a form of regulated cell death driven by iron dependency and lipid peroxidation, has emerged as a critical factor in PD pathology. This review examines the relationship between ferroptosis and PD and explores the potential of exercise as a therapeutic intervention to modulate ferroptosis and alleviate PD symptoms. Ferroptosis, distinct from other forms of cell death such as necrosis, autophagy, pyroptosis, and apoptosis, is characterized by mitochondrial shrinkage, reduced cristae, and membrane collapse, without nuclear fragmentation, DNA cleavage, or caspase activation. It is induced by the accumulation of intracellular Fe<sup>2+</sup>, which enhances lipid peroxidation and reactive oxygen species (ROS) generation, ultimately leading to cell death. Studies show disrupted iron metabolism in PD patients, with elevated iron levels in dopaminergic neurons of the substantia nigra correlating with disease severity. Iron chelation therapy has shown promise in alleviating PD symptoms by reducing brain iron levels, highlighting the significance of iron metabolism in PD pathogenesis. Lipid peroxidation, a hallmark of ferroptosis, involves the oxidation of polyunsaturated fatty acids (PUFAs) in cell membranes, compromising membrane integrity and increasing permeability. Elevated lipid peroxidation in the substantia nigra contributes to neuronal damage in PD. Enzymes such as ACSL4 and LPCAT3, crucial in PUFA metabolism, play significant roles in ferroptosis. Exercise has been shown to modulate these enzymes, potentially reducing lipid peroxidation and preventing ferroptosis in PD. Glutathione (GSH) metabolism is another crucial factor in ferroptosis regulation. GSH depletion impairs ROS detoxification, exacerbating oxidative stress and lipid peroxidation. PD patients exhibit reduced GSH levels in the substantia nigra, making dopaminergic neurons more vulnerable to oxidative damage. Exercise enhances GSH synthesis and activity, mitigating oxidative stress and ferroptosis in PD. α-Synuclein aggregation, a hallmark of PD, is closely linked to iron metabolism and oxidative stress. Excessive α-synuclein binds to iron, promoting its aggregation and inducing ferroptosis. Exercise has been found to reduce α-synuclein accumulation and its pathological phosphorylation, potentially through the upregulation of neuroprotective proteins like DJ-1 and Irisin. These proteins enhance antioxidant defenses and facilitate α-synuclein degradation, providing a protective effect against PD progression. Additionally, glutamate excitotoxicity, driven by dysregulated glutamate metabolism and receptor activity, contributes to ferroptosis in PD. Exercise modulates glutamate levels and receptor expression, reducing excitotoxicity and iron-induced neuronal damage. In conclusion, emerging research suggests that exercise may inhibit ferroptosis through multiple mechanisms, including regulation of iron metabolism, enhancement of antioxidant defenses, reduction of α-synuclein aggregation, and modulation of glutamate metabolism. These findings highlight the potential of exercise as a non-pharmacological intervention in the prevention and treatment of PD. Further research is needed to elucidate precise mechanisms and optimize exercise protocols for maximum therapeutic benefit.]]></description>
<pubDate>2024/6/7 22:53:34</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LU Dong-Lei,TAN Si-Jie,YANG Feng-Ying,ZHANG Wen-Yu]]></author>
</item>
<item>
<title><![CDATA[Hippocampal HMGB1/TLR4 Pathway Mediates Cognitive Dysfunction in Chronic Stress Mice]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202405060000003]]></link>
<description><![CDATA[<b>Objective</b> Chronic stress can induce cognitive dysfunction, but the underlying mechanisms remain unknown. Studies have confirmed that the high mobility group box 1/Toll-like receptor 4 (HMGB1/TLR4) pathway is closely associated with cognitive impairment. Therefore, this research aimed to explore whether the HMGB1/TLR4 pathway involves in chronic stress-induced cognitive dysfunction.<b>Methods</b> The chronic unpredictable mild stress (CUMS) mouse model was established by randomly giving different types of stress every day for four consecutive weeks. Cognitive function was detected by novel object recognition test, Y-maze test, and Morris water maze test. The protein expressions of HMGB1, TLR4, B-cell lymphoma 2 (BCL2), and BCL2 associated X (BAX) were determined by Western blot. The damage of neurons in the hippocampal CA1 region was observed by hematoxylin-eosin (HE) staining.<b>Results</b> The protein expressions of HMGB1 and TLR4 were significantly increased in the hippocampus of chronic stress mice. Furthermore, inhibition of the HMGB1/TLR4 pathway induced by ethyl pyruvate (EP, a specific inhibitor of HMGB1) and TAK242 (a selective inhibitor of TLR4) treatment attenuated cognitive impairment in chronic stress mice, according to the novel object recognition test, Y-maze test, and Morris water maze test. In addition, administration of EP and TAK242 also mitigated the increase of apoptosis in the hippocampus of chronic stress mice.<b>Conclusion</b> These results indicate that the hippocampal HMGB1/TLR4 pathway contributes to chronic stress-induced apoptosis and cognitive dysfunction.]]></description>
<pubDate>2024/6/7 19:25:59</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[FENG Xin-Xiang,HU Wen,JIANG Jia-Mei,JIN Xin,KUANG Xin,ZHONG Wen-Long,ZOU Wei]]></author>
</item>
<item>
<title><![CDATA[The Role and Mechanism of eIF2α Kinase-mediated Integrated Stress Response in The Treatment of Cardiovascular Diseases]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202403280000001]]></link>
<description><![CDATA[Integrated stress response (ISR) is an evolutionarily conserved intracellular signaling network. When the body encounters adverse stimuli, ISR is activated to assist cells, tissues, and the body in adapting to the changing environment and maintaining health by reprogramming genes. ISR is implicated in the onset and progression of various diseases, including cardiovascular disease, diabetes, obesity, cancer, and neurological disorders. A key factor in ISR is the eukaryotic initiation factor 2α (eIF2α) kinase. Four eIF2α kinases have been identified, namely general control non-derepressible-2 (GCN2), protein kinase double-stranded RNA-dependent (PKR), PKR-like ER kinase (PERK), and heme-regulated inhibitor (HRI). GCN2, PKR, PERK, and HRI kinases share a common kinase catalytic domain but have distinct regulatory domains that are activated by endoplasmic reticulum stress (ERS), viral infection, heme deficiency, and amino acid deficiency, respectively. Various stress conditions promote the phosphorylation of eIF2α at serine 51 by its 4 kinases. This inhibits the eIF2B-mediated GTP acquisition of eIF2α and reduces the translation rate. At the same time, ISR upregulates ATF4 expression. ATF4 and CCAAT-enhancer binding protein (CHOP) can promote downstream growth arrest and DNA damage-inducible protein 34 (GADD34) to mediate eIF2α dephosphorylation. At the same time, it can promote the downstream expression of Sestrin 2 (SESN2) protein, increase autophagy induced by mTORC1 and AMPK, and thereby reduce the risk of cardiovascular disease. Numerous animal and cellular studies have demonstrated that exercise, drugs, and molecular compounds can prevent and improve pathological myocardial hypertrophy, diabetic cardiomyopathy, ischemic cardiomyopathy, cardiotoxicity, and atherosclerosis by modulating ISR. The relevant mechanism involves gene knockout or inhibitors that directly inhibit the expression of eIF2α kinase. Aerobic exercise, editing of specific molecules, or drugs can indirectly inhibit the expression of eIF2α kinase, ultimately leading to the inhibition of the downstream expression of eIF2α/ATF4. In light of the significant pathological role of ISR in cardiovascular disease, current research on ISR primarily aims to develop medications that can regulate the upstream and downstream signaling activities of ISR. This involves targeting ISR to regulate intracellular protein homeostasis, ultimately aiming to delay or reverse the progression of cardiovascular disease. At present, drugs targeting ISR in cardiovascular disease research mainly include ISRIB, 4-PBA, and Salubrinal. ISRIB reverses eIF2α phosphorylation by suppressing the inhibitory effect of eIF2α on protein synthesis and blocking eIF2α/ATF4 signaling. 4-PBA can inhibit endoplasmic reticulum stress. Salubrinal inhibits eIF2α dephosphorylation by inhibiting the binding of GADD34-PP1 and CReP-PP1 complexes to eIF2α. In conclusion, the integrated stress response mediated by the four eIF2α kinases is essential for the body to adapt to various stress stimuli affecting the heart and blood vessels under normal or pathological conditions. Integrated stress response inhibitors should be promptly administered to clinical cardiovascular patients to assess their effectiveness in the onset and development of various cardiovascular diseases, as well as to evaluate potential side effects. Future studies are needed to explore the role and mechanism of eIF2α kinase-mediated integrative stress response in various diseases. It is also essential to investigate whether the integrative stress response yields different effects in various organs and can potentially exert cross-organ efficacy through inter-organ interaction.]]></description>
<pubDate>2024/6/7 18:54:02</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[CHEN Ming-Hua,FENG Li-Xu,LI Ting-Ting,SUN Zhong-Guang,ZHANG Hui,ZHANG Ming-Chen]]></author>
</item>
<item>
<title><![CDATA[Research on The Intercontinental Population Biogeographic Ancestral Inference Model Based on PCA-XGBoost Method]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202311160000002]]></link>
<description><![CDATA[<b>Objective</b> The inference of biogeographical ancestry (BGA) using DNA is a significant focus within anthropology and forensic science. Current methods often utilize dozens of ancestry-informative SNPs, employing principal component analysis (PCA) and likelihood ratios (LR) to ascertain individual ancestries. Nonetheless, the selection of these SNPs tends to be population-specific and shows limitations in population differentiation. With the development of high-throughput sequencing technologies, acquiring high-density SNP datasets has become easier, challenging traditional statistical models which are often reliant on prior assumptions and struggle with high-density genetic data. The integration of machine learning, which prioritizes data learning and algorithmic iteration over prior knowledge, has propelled forward new developments in BGA research. This study aims to construct a BGA inference model suitable for high-density SNP data, characterized by broad population applicability, higher accuracy, and strong generalization capabilities.<b>Methods</b> Initially, intersection sites of autosomes from the phase III data of the 1000 Genomes Project and commonly used commercial chips were selected to build a reference dataset after thorough site quality control and filtering. This dataset was analyzed using PCA and ADMIXTURE to study population clustering, ancestral component mixing, and genetic substructures. Utilizing spaces of different principal component (PC), combinations, this study visually assessed the PCs’ capabilities to differentiate between continental and intercontinental populations. Following this, the study employed the supervised learning classification model XGBoost, establishing a multidimensional PC-based PCA-XGBoost model with hyperparameters set through ten-fold cross-validation and a greedy strategy. Subsequently, the model was optimized and evaluated based on the LR, considering accuracy and runtime to determine the optimal number of PCs and training rounds, culminating in the study’s optimal BGA inference model. Finally, the performance of the model was subsequently validated at national and regional levels using test sets from other public data to assess its post-optimization generalization capabilities.<b>Results</b> The reference dataset created contains 307 866 SNP sites. Top PCs reflect varying levels of population differentiation capabilities, with some PCs showing population specificity. Under smaller <i>K</i> values in ADMIXTURE results, genetic ancestral components between continents are elucidated, while larger <i>K</i> values reveal some specific ancestral components of certain populations within continents. The number of PCs and training rounds significantly affect the classification accuracy and efficiency of the XGBoost supervised model. With LR-based evaluation methods, the optimized PCA-XGBoost model achieved a continental prediction accuracy of over 98% in the reference set. For subcontinental population levels within the continents, the model achieved an accuracy of over 95% in the reference set and over 90% in the test set.<b>Conclusion</b> The reference dataset effectively represents the genetic substructures of populations at selected sites. Information derived from PC dimensions significantly aids in population differentiation and inference issues, and incorporating more PC dimensions as features in supervised learning models can increase the accuracy of BGA inference. The model of this study is suitable for high-density SNP data and is not confined to specific regional populations, offering enhanced population-wide applicability. Compared to previous ancestry inference models, the optimized PCA-XGBoost model demonstrates high intercontinental population predictive accuracy. LR-based evaluation methods further enhance the reliability of predictions. Additionally, the model’s strong generalization capabilities suggest that updating the reference population data could enable more detailed population analysis and inference.]]></description>
<pubDate>2024/6/6 15:01:36</pubDate>
<category><![CDATA[研究报告]]></category>
<author><![CDATA[FAN Hong,JIANG Li,LI Cai-Xia,WANG Chun-Nian,YAO Hao-Tian]]></author>
</item>
<item>
<title><![CDATA[Application of Nanotechnology in CAR-T-based Cancer Therapy]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202405150000002]]></link>
<description><![CDATA[Chimeric antigen receptor T (CAR-T) cell therapy is an innovative and cutting-edge treatment in the field of adoptive cell therapy. It represents an important milestone in personalized and precision medicine. T cell immunotherapy has gone through more than 30 years of development, making CAR-T cell therapy increasingly mature. Currently, CAR-T cell therapy has achieved significant success in the treatment of hematological system tumors, and the FDA has approved 6 CAR-T cell therapies for the treatment of hematopoietic cancers. However, on one hand, the preparation of CAR-T cells is a highly technical process involving multiple steps, each requiring precise operation and strict condition control to ensure the quality and activity of the cells. The high-quality materials, specialized equipment, and highly specialized personnel required in the production process have led to very high preparation costs for CAR-T cell therapy. The high cost has led to increased treatment fees, which may limit the popularization and accessibility of CAR-T therapy. On the other hand, CAR-T cell therapy faces a series of difficulties and challenges in the treatment of solid tumors. The first is the insufficient targeting and infiltration ability of CAR-T cells to tumors. The tumor microenvironment (TME) of solid tumors is usually composed of dense extracellular matrix, forming a physical barrier that severely limits the targeting and penetration ability of CAR-T cells to tumors. The second is the immunosuppressive factors in the TME. In the TME, there are a large number of immunosuppressive factors, such as interleukin-10, transforming growth factor-β, and suppressive cells including regulatory T cells, tumor-associated macrophages, and myeloid-derived suppressor cells. These factors not only weaken the persistence of CAR-T cells but also severely hinder their effective anti-tumor effect. Finally, CAR-T cell therapy can cause serious cytotoxicity. The activation of CAR-T cells may cause cytokine release syndrome and attack normal cells expressing the CAR-T target antigen, causing “off-target” toxicity, and thus causing systemic inflammatory reactions and potential serious side effects. These factors lead to unsatisfactory therapeutic effects of CAR-T cell therapy. Fortunately, the advancement of nanotechnology has brought new hope to this field. In particular, nano drug delivery systems have become an extremely active research direction in the development of anti-tumor drugs. Nanoparticle delivery systems can address the challenges encountered by CAR-T cell therapy in treating solid tumors through various mechanisms. These mechanisms include enhancing tumor targeting and CAR-T cell penetration ability, regulating the tumor’s suppressive microenvironment, and overcoming the side effects of CAR-T cell therapy. The implementation of these strategies is expected to significantly improve the efficacy of CAR-T cell therapy in the treatment of solid tumors, thereby bringing more significant therapeutic effects to patients. This article focuses on the background of CAR-T therapy and solid tumor treatment, systematically reviews the application of nanotechnology in CAR-T cell preparation and solid tumor treatment <i>in vitro</i> and <i>in vivo</i> in recent years, and provides a forward-looking perspective on future development directions.]]></description>
<pubDate>2024/6/4 15:08:53</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[HU Bo,HUANG Yuan-Yu,JIANG Shao-Ping,RUAN Shao-Bo,XU Lin,ZHENG Lu-Lu]]></author>
</item>
<item>
<title><![CDATA[Methods for Inducing Homologous Protein Dimerization]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202403150000003]]></link>
<description><![CDATA[Proteins in biological systems rarely act alone, but instead bind with other biomolecules to trigger specific cellular reactions. These biomolecules are usually astonishing number of proteins self-assemble to form dimers, which are both in a relatively isolated state and in a protein interaction network and cascade. Dimerization can endow proteins with various structural and functional advantages, including improving stability, controlling the accessibility and specificity of active sites, and increasing complexity. The self-association of proteins to form dimers is a very common phenomenon, and the functional importance of homologous protein dimerization cannot be overestimated. It provides diversity and specificity in many pathways, and most cellular events, such as signal transduction, transcription cofactor recruitment, enzyme activation, and even pathogenic pathways, are significantly regulated through homologous protein-protein interactions. The regulation of protein dimerization is an important process for the growth and development of organisms under internal or external stimuli in the natural environment. Therefore, regulating the dimerization process of homologous proteins and understanding their molecular mechanisms are crucial for biomedical applications and analyzing complex biological regulatory networks. Proximity effects or physical proximity effects of molecules are essential regulatory factors in biological processes, which can be controlled through induced dimerization methods. The application range of induced proximity ranges from manipulating protein folding, activation, localization, and degradation to controlling gene transcription or cell therapy. The chemical induced dimerization (CID) system and light induced dimerization (LID) system based on proximity induction provide powerful tools for regulating the function of dimerized proteins, and have been gradually developed. The concept of CID was proposed as early as 1993. The basic principle of CID is that a small molecule controls the dimerization of a pair of proteins or domains, while binding two proteins and bringing them closer together. Small molecules in the CID system form ternary complexes with target proteins, which can bind to various sites, including “hotspot” and “allosteric sites”. Small molecules play a role by regulating protein proximity. The light induced dimerization system uses photosensitive proteins to undergo conformational changes under light, thereby inducing protein interactions. Multiple photosensitive proteins derived from plants and microorganisms can undergo photo induced homologous interactions, and relying on LID systems, they can be used to study various biological processes, including cell signal transduction, microbial synthesis, and biomedical applications. In recent years, metal ions, nucleic acids, and molecular host guest systems have been proposed as new methods for orthogonal control of homologous protein dimerization, expanding the development and application of dimerization systems. In addition, the chemo-optogenetic approach combines the advantages of CID and LID systems and has also been applied in inducing protein dimerization. This review elaborates on the methods and applications of inducing homodimerization of proteins through CID system, LID system, and supramolecular chemistry, while discussing the advantages and disadvantages of dimerization systems. The development direction of dimerization systems is also discussed, in order to provide some reference and ideas for the future application and development of homologous protein dimerization.]]></description>
<pubDate>2024/5/31 15:14:22</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[GUO Jun-Xia,LIU Sen]]></author>
</item>
<item>
<title><![CDATA[IDH1<sup>R132H</sup> Mutant Glioma and Its Compensatory Mechanisms for Maintaining Telomeres]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202402020000001]]></link>
<description><![CDATA[Isocitrate dehydrogenase 1 (IDH1) R132H is the most common mutated gene in grade II-III gliomas and oligodendrogliomas. Instead of activating telomerase (a reverse transcriptase which using RNA as a template to extend telomere length), the majority of IDH1<sup>R132H</sup> mutant glioma maintain telomere length through an alternative mechanism that relies on homologous recombination (HR), which is known as alterative lengthening of telomere (ALT).The phenotype of ALT mechanism include: ALT associated promyelocytic leukemia protein (PML) bodies (APBs); extrachromosomal telomeric DNA repeats such as C- and T-loops; telomeric sister chromatid exchange (T-SCE),<i> etc.</i> The mechanism of ALT activation is not fully understood. Recent studies have shown that mutation IDH1 contributes to ALT phenotype in glioma cells in at least three key ways. Firstly, the IDH1<sup>R132H</sup> mutation mediates RAP1 down-regulation leading to telomere dysfunction, thus ensuring persistent endogenous telomeric DNA damage, which is important for ALT activation. Spontaneous DNA damage at telomeres may provide a substrate for mutation break-induced replication (BIR)-mediated ALT telomere lengthening, and it has been demonstrated that RAP1 inhibits telomeric repeat-containing RNA, transcribed from telomeric DNA repeat sequences (TERRA) transcription to down-regulate ALT telomere DNA replication stress and telomeric DNA damage, thereby inhibiting ALT telomere synthesis. Similarly, in ALT cells, knockdown of telomere-specific RNaseH1 nuclease triggers TERRA accumulation, which leads to increased replication pressure. Overexpression of RNaseH1, on the other hand, attenuates the recombination capacity of ALT telomeres, leading to telomere depletion, suggesting that RAP1 can regulate the level of replication pressure and thus ALT activity by controlling TERRA expression. Secondly, the IDH1<sup>R132H</sup> also alters the preference of the telomere damage repair pathway by down-regulating XRCC1, which inhibits the alternative non-homologous end joining (A-NHEJ) pathway at telomeres and alters cellular preference for the HR pathway to promote ALT. Finally, the IDH1<sup>R132H</sup> has a decreased affinity for isocitric acid and NADP+ and an increased affinity for α ketoglutarate (α-KG) and NADPH, so that the mutant IDH1<sup>R132H</sup> catalyzes the hydrogenation of α-KG to produce 2-hydroxyglutarate (2-HG)in a NADPH-dependent manner. Because 2-HG is structurally similar to α-KG, which maintains the trimethylation level of H3k9me3 by competitively inhibiting the activity of the α-KG-dependent histone demethylase KDM4B, and recruits heterochromatin protein HP1α to heterochromatinize telomeres, and promote ALT phenotypes in cooperation with the inactivating of ATRX. In addition, it has been shown that APBs contain telomeric chromatin, which is essentially heterochromatin, and HP1α is directly involved in the formation of APBs. Based on these studies, this article reviews the mechanism of IDH1<sup>R132H</sup> mediated telomere dysfunction and the preference of DNA repair pathway at telomeres in cooperate with ATRX loss to promote ALT, which may provide references for clinical targeted therapy of IDH1<sup>R132H</sup> mutant glioma.]]></description>
<pubDate>2024/5/31 13:51:41</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[DAN Ju-Hua,JIA Shu-Ting,LI Xiang-Xiu,LI Yao,LI Yi-Xuan,LI Yi-Fan,TONG Jin-Kai,YAN Si-Xiang]]></author>
</item>
<item>
<title><![CDATA[Structure and Function of GPCR Dimer]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202401290000001]]></link>
<description><![CDATA[G-protein coupled receptors (GPCRs) are an essential family of proteins on the cell membrane, widely distributed in various types of tissues and cells. Typical GPCRs are composed of characteristic 7 transmembrane α-helix domains, extracellular domain and intracellular domain. They play a key role in transmitting information inside and outside cells. These receptors can sense and respond to a variety of external signals, including odor molecules, hormones, neurotransmitters, chemokines, and so on, thereby regulating the physiological functions and metabolic activities of cells. When external signal molecules bind, these receptors undergo conformational changes, thereby activating signal transduction pathways inside cells. The most common downstream signal pathway is the activation of G proteins, but it may also activate the β-arrestin signaling pathway. This series of signal transduction processes ultimately regulates physiological processes such as cell metabolism, proliferation, and differentiation, and also plays an important role in the occurrence and development of diseases. Due to its importance in regulating cell functions and participating in the development of diseases, GPCRs have become important targets in the field of drug research and development. The mechanism of action of many drugs is achieved by intervening in the GPCR signaling pathway. As important form of function regulating, dimerization has attracted widespread attention in the research of GPCR field. In the early days, the formation of GPCR dimerization and its effect on receptor function were mainly studied by immunoprecipitation, immunofluorescence and radioligand binding experiments in overexpression systems. Nowadays, with the continuous development of biochemical and biophysical methods, more and more GPCR dimers have been identified. GPCR dimer refers to the process in which two GPCR subunits bind to each other to form a complex. The same GPCR subunits form homodimers, and different GPCR subunits form heterodimers through direct interaction. Dimerization changes the activity, affinity, internalization, localization and transport, and signal transduction characteristics of GPCR, thereby producing more complex and delicate regulation of cellular physiological processes. In recent years, the research on GPCR dimers has been continuously deepened, revealing its important role in a variety of physiological and pathological processes. In general, the structure of GPCR dimers is complex and diverse, and its formation and stability are affected by many factors, including the specificity of receptor interaction interface, the conformational changes of receptor, and the regulation of intracellular and extracellular environment. By understanding the mechanism of GPCR dimerization, we can better understand the behavior of these receptors in signal transduction and provide new ideas and opportunities for the development of novel drug targets. More and more studies have reported the dimerization of GPCR and its structure and function regulation mechanism. This article reviews the research progress on the structure and function of GPCR dimers, and summarizes some research methods and technologies, which provide a basis for understanding the discovery of GPCR dimers, dimerization methods, structure and function regulation mechanisms, and further targeting GPCR dimers. It provides a research basis for the development of polymer drugs.]]></description>
<pubDate>2024/5/30 15:08:02</pubDate>
<category><![CDATA[综述与专论]]></category>
<author><![CDATA[LI Chen-Hui,LI Chuan-Bao,XUE Li]]></author>
</item>
<item>
<title><![CDATA[Regulation of Mesenchymal Stem Cell FateCommitment]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202405060000001]]></link>
<description><![CDATA[Regulation of Mesenchymal Stem Cell FateCommitment]]></description>
<pubDate>2024/5/28 15:48:25</pubDate>
<category><![CDATA[Highlights]]></category>
<author><![CDATA[FAN Zhi-Peng]]></author>
</item>
<item>
<title><![CDATA[“我们要为国家争气”——怀念贝时璋先生]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/202204020000007]]></link>
<description><![CDATA[贝时璋是著名实验生物学家，细胞生物学家，教育家， 我国细胞学、胚胎学创始人之一， 我国生物物理学奠基人，中国科学院生物物理研究所和中国科学技术大学生物物理系的创始人。 他是1948年第一届中央研究院院士、1955 年首批中国科学院学部委员（1993 年改称中国科学院院士），自1928年获得德国图宾根大学博士学位证书后，相继于1978 年（毕业50 周年）、 1988 年（毕业60 周年）、2003 年（毕业75 周年）和2008 年（毕业80 周年）被德国图宾根大学授予“金博士”、“钻石博士” 等博士学位荣誉证书，被德国政府授予“惟一学术公民” 称号。 为了纪念他对生命科学和航天事业的卓越贡献，太空中有一颗以他名字命名的小行星(36015 号)。<br>
贝时璋出生于1903 年10 月10 日，他的一生与中国科学紧密联结在一起，见证并参与了新中国科学事业的发展与繁荣，为国家培养了一代代科技人才。 进入百岁高龄之后，他仍坚持工作，也依然时刻牵挂着国家的昌盛和科学的发展，是永不退休的科学家。 2003 年9 月，贝时璋用两年半时间主编完成的《细胞重建》论文集第二集正式出版，给了自己一份最好的百岁生日礼物。<br>
2009 年诺贝尔奖公布以后，贝时璋心情很不平静，对我国科学创新问题陷入了深刻的思考之中。他想起，北京大学教授林克椿1981 年在美国斯坦福大学做访问学者时，发现了螺旋状脂质体，1982 年《自然》（Nature）杂志以封面文章的形式发表了这一成果。 他认为这是一项很有意义的创新课题，应该继续研究下去，因此特别邀请林克椿和一些研究人员10 月28 日上午来家里进行讨论。 当天，贝时璋问了林克椿很多关于实验情况的问题，问得很仔细。从贝时璋的询问中，可以感受到他心中对一项有意义工作被中断的那份惋惜。 林克椿虽然已退休，但贝时璋还是鼓励他要把这项研究进一步做下去，争取取得更大的成果，并语重心长地鼓励大家“我们要为国家争气”， 这句话，他说了好几遍，声音很大、很激动， 使当时在场的研究人员们深受感动和鼓舞。<br>
那天，贝时璋精神特别好，特别高兴，和大家讨论了近一个小时。 然而，就在第二天，10 月29日上午9 点30 分，贝时璋在睡眠中安详辞世，永
远地离开了他所热爱的科学、他所热爱的国家和人民。 “我们要为国家争气” ， 成为了贝时璋留给科学界的最后嘱托和遗言，这也应当成为当今每一位科研工作者追求和践行的科学家精神。]]></description>
<pubDate>2022/4/14 16:27:41</pubDate>
<category><![CDATA[学者与科研]]></category>
<author><![CDATA[中国科学院生物物理研究所]]></author>
</item>
</channel>
</rss>